Citrus Sinensis ID: 017131

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370------
Protein Sequence
MMKTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Secondary Structure (PSIPRED)
ccccccccccccccccccEEEEEEEcccccccccEEEEEEEEEEcccccEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEEcEEEEcccccccEEEEEEEEcccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEcccccHHHHHcccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccHHHHHHccHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccEEEEEEEccccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHcHHHHHHHcccccccc
Coil and Loop (DISEMBL)
mmktdepdiidgvgaeTGHVIRttiggrngnskqKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLdhpnivalkhcffsttDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCigichrdikpqnllvnphthqlklcdfgsakvlvkgepnvsyicsryyrapelifgateyttaIDIWSTGCVMAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikphpwhkvfqkrlppeaVDLVCRffqyspnlrctaleacvhpffdelrdpntrlpngrplpplfnfkppelsgippetinrlipEHARKQNLFMALHS
Flexible Loop (DISEMBL)
mmktdepdiidgvgaetghvirttiggrngnskQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVaikkvlqdkrYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNysrihqrmpLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Low Complexity Region (SEG)
MMKTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKeelylnlvleyvpeTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered region (IsUnstruct)
*********IDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR**************************************************
Disordered Region (DISOPRED)
*******************VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF*****
Disordered Region (DISEMBL)
MMKTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered Region (DISPRO)
***************ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MMKTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	376	2.2.26 [Sep-21-2011]
Q39019	421	Shaggy-related protein ki	yes	no	0.994	0.888	0.903	0.0
Q9FVS6	420	Shaggy-related protein ki	no	no	0.994	0.890	0.890	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.989	0.907	0.811	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.986	0.902	0.803	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.957	0.875	0.825	0.0
P43288	405	Shaggy-related protein ki	no	no	0.989	0.918	0.803	0.0
P43289	409	Shaggy-related protein ki	no	no	0.989	0.909	0.798	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.981	0.897	0.807	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	0.973	0.894	0.808	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.968	0.771	0.766	1e-174

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  723 bits (1867), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/374 (90%), Positives = 356/374 (95%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDG GAE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE
Sbjct: 48  RDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGE 107

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           +VAIKKVLQDKRYKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR
Sbjct: 108 VVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNR 167

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           +AR+YSR +Q MPLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CD
Sbjct: 168 VARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICD 227

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPNVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct: 228 FGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGE 287

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRF
Sbjct: 288 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRF 347

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTALEAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+P
Sbjct: 348 FQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVP 407

Query: 363 EHARKQNLFMALHS 376
           EHARKQNLFMALHS
Sbjct: 408 EHARKQNLFMALHS 421

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  714 bits (1844), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/374 (89%), Positives = 356/374 (95%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDGVGAE GHVI TT+ GRNG S+Q VSYIAEHVVGTGSFG+VFQAKCRETGE
Sbjct: 47  RDSEPDIIDGVGAEPGHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGE 106

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           +VAIKKVLQDKRYKNRELQIMQMLDHPN+V LKH F+S T+ EE+YLNLVLE+VPETVNR
Sbjct: 107 VVAIKKVLQDKRYKNRELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNR 166

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
            AR+YSR++Q MPLIYVKLYTYQICR LAY+HNC G+CHRDIKPQNLLVNPHTHQLK+CD
Sbjct: 167 TARSYSRMNQLMPLIYVKLYTYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICD 226

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct: 227 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 286

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRF
Sbjct: 287 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRF 346

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTA+EAC+HPFFDELRDPN RLPNGRPLPPLFNFKP ELSGIPPET++RL+P
Sbjct: 347 FQYSPNLRCTAVEACIHPFFDELRDPNARLPNGRPLPPLFNFKPQELSGIPPETVDRLVP 406

Query: 363 EHARKQNLFMALHS 376
           EHARKQN FMALHS
Sbjct: 407 EHARKQNHFMALHS 420

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  652 bits (1681), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 302/372 (81%), Positives = 334/372 (89%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           K  E  ++DG G ETGH+I TTIGG+NG  KQ +SY+AE +VG GSFG+VFQAKC ETGE
Sbjct: 39  KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGE 98

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
            VAIKKVLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV R
Sbjct: 99  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYR 158

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           ++++YSR +QRMP+IYVKLYTYQICRALAYIH  +G+CHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 159 VSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCD 218

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGE
Sbjct: 219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGE 278

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R 
Sbjct: 279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRL 338

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
            QYSPNLR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP EL G   E +++LIP
Sbjct: 339 LQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIP 398

Query: 363 EHARKQNLFMAL 374
           +HARKQ  F+AL
Sbjct: 399 DHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  643 bits (1658), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 299/372 (80%), Positives = 332/372 (89%), Gaps = 1/372 (0%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           K  E  ++DG   E GHVI TTIGG+NG  KQ +SY+AE  VG GSFGVVFQAKC ETGE
Sbjct: 39  KEMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGE 98

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
            VAIKKVLQDKRYKNRELQ M++LDHPN+V LKHCFFSTT+K+ELYLNLVLE+VPETV+R
Sbjct: 99  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHR 158

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           + R+YS+++QRMPLIYVKLY+YQICR+LAYIHNC+G+ HRDIKPQNLLVNPHTHQLKLCD
Sbjct: 159 VIRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCD 218

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYT+AIDIWS GCV+ ELLLGQPLFPG 
Sbjct: 219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGA 278

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F+KR+PPEAVDLV R 
Sbjct: 279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRL 338

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
            QYSPNLR TALEA VHPFFDELRDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P
Sbjct: 339 LQYSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVP 398

Query: 363 EHARKQ-NLFMA 373
            HARKQ +LF +
Sbjct: 399 SHARKQCSLFAS 410

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  643 bits (1658), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/360 (82%), Positives = 330/360 (91%)

Query: 9   IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 68
           I+DG G ETGH+I TTIGG+NG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKK
Sbjct: 45  IVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKK 104

Query: 69  VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 128
           VLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ R+Y+
Sbjct: 105 VLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYN 164

Query: 129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
           +++QRMP+IYVKLY+YQICRALAYIHN IG+CHRDIKPQNLLVNPHTHQLK+CDFGSAKV
Sbjct: 165 KMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKV 224

Query: 189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
           LVKGEPN+SYICSRYYRAPELIFGATEYTTAIDIWS GCV+ ELLLGQPLFPGESGVDQL
Sbjct: 225 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQL 284

Query: 249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
           VEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPN
Sbjct: 285 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 344

Query: 309 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 368
           LR TALEA VHPF+D++RDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P HARKQ
Sbjct: 345 LRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQ 404

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 299/372 (80%), Positives = 334/372 (89%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           K  E  ++DG G ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE
Sbjct: 34  KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 93

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
            VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R
Sbjct: 94  TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 153

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           + ++Y++++QRMPLIYVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 154 VIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 213

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE
Sbjct: 214 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 273

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R 
Sbjct: 274 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 333

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
            QYSPNLR  AL+  VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+P
Sbjct: 334 LQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVP 393

Query: 363 EHARKQNLFMAL 374
           EHARKQ  ++ L
Sbjct: 394 EHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  641 bits (1654), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 297/372 (79%), Positives = 336/372 (90%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           K  E  I++G   ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE
Sbjct: 38  KEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
            VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R
Sbjct: 98  TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 157

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           + ++Y++++QRMPL+YVKLYTYQI R+L+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 158 VIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 277

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R 
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
            QYSPNLRC AL++ VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+P
Sbjct: 338 LQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVP 397

Query: 363 EHARKQNLFMAL 374
           EHARKQ  +++L
Sbjct: 398 EHARKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 298/369 (80%), Positives = 331/369 (89%)

Query: 6   EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVA 65
           E  ++DG G ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VA
Sbjct: 43  EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 102

Query: 66  IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR 125
           IKKVLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ +
Sbjct: 103 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK 162

Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           +YS+++QRMP+IYVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCDFGS
Sbjct: 163 HYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 222

Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
           AKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE GV
Sbjct: 223 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGV 282

Query: 246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 305
           DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+P EAVDLV R  QY
Sbjct: 283 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQY 342

Query: 306 SPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA 365
           SPNLRC AL+   HPFFDELRDPN RLP GR LPPLFNFKP EL G+P ET+ +L+PEHA
Sbjct: 343 SPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHA 402

Query: 366 RKQNLFMAL 374
           RKQ  F+ L
Sbjct: 403 RKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  633 bits (1633), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 296/366 (80%), Positives = 328/366 (89%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           K  E  I+DG G ETGH+I TTIGGR+G  KQ +SY+AE +VG GSFGVVFQAKC ETGE
Sbjct: 38  KEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGE 97

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
            VAIKKVLQDKRYKNRELQ M++LDHPN+V LKHCFFSTT+K+E+YLNLVLEYVPETV+R
Sbjct: 98  TVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHR 157

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           + ++Y++++QRMPLI VKLYTYQI RAL+YIH+ IG+CHRDIKPQNLLVNPHTHQ+KLCD
Sbjct: 158 VIKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAIDIWS GCV+AELLLGQPLFPGE
Sbjct: 218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGE 277

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNY EFKFPQIK HPWHK+F KR+PPEAVDLV R 
Sbjct: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
            QYSPNLRCTALEA  H FFDELRDPNTRLPNGR LPPLFNFK  EL G+  E + +L+P
Sbjct: 338 LQYSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVP 397

Query: 363 EHARKQ 368
           EHARKQ
Sbjct: 398 EHARKQ 403

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  611 bits (1576), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 279/364 (76%), Positives = 317/364 (87%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           K  E  +++G G ETG VI TT+GGR+G  KQ +SY+A+ VVGTGSFGVVFQAKC ETGE
Sbjct: 103 KDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGE 162

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
            VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFSTTDK+ELYLNLVLEYVPETV R
Sbjct: 163 QVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYR 222

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
            +++Y++++Q MP+I+V+LYTYQICRAL Y+H  +G+CHRDIKPQNLLVNP THQLK+CD
Sbjct: 223 ASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICD 282

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AID+WS GCVMAELLLGQPLFPGE
Sbjct: 283 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGE 342

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R 
Sbjct: 343 SGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 402

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
            QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPPLFNF   EL+G   E   RLIP
Sbjct: 403 LQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIP 462

Query: 363 EHAR 366
            H +
Sbjct: 463 AHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
449460309	428	PREDICTED: shaggy-related protein kinase	0.994	0.873	0.954	0.0
359806970	420	uncharacterized protein LOC100799387 [Gl	0.994	0.890	0.954	0.0
24637171	432	GSK-3-like protein MsK4 [Medicago sativa	0.994	0.865	0.957	0.0
357445263	428	Glycogen synthase kinase-3-like protein	0.994	0.873	0.957	0.0
359806021	420	uncharacterized protein LOC100820098 [Gl	0.997	0.892	0.944	0.0
225465185	422	PREDICTED: shaggy-related protein kinase	0.989	0.881	0.956	0.0
224119932	422	predicted protein [Populus trichocarpa]	0.994	0.886	0.941	0.0
224129720	422	predicted protein [Populus trichocarpa]	0.994	0.886	0.938	0.0
116787454	424	unknown [Picea sitchensis]	0.994	0.882	0.911	0.0
2160191	447	Identical to A. thaliana AtK-1 (gb|X7927	0.997	0.838	0.901	0.0

>gi|449460309|ref|XP_004147888.1| PREDICTED: shaggy-related protein kinase kappa-like [Cucumis sativus]

 Score =  756 bits (1952), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/374 (95%), Positives = 367/374 (98%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDGVGAE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGE
Sbjct: 55  RDSEPDIIDGVGAEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGE 114

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           IVAIKKVLQDKRYKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNR
Sbjct: 115 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNR 174

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           IARNYSRI QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 175 IARNYSRISQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 234

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG+PLFPGE
Sbjct: 235 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGKPLFPGE 294

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF
Sbjct: 295 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 354

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+NRLIP
Sbjct: 355 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTVNRLIP 414

Query: 363 EHARKQNLFMALHS 376
           EHARKQNLFMALH+
Sbjct: 415 EHARKQNLFMALHT 428

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806970|ref|NP_001241073.1| uncharacterized protein LOC100799387 [Glycine max] gi|255641011|gb|ACU20785.1| unknown [Glycine max]

 Score =  753 bits (1945), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/374 (95%), Positives = 367/374 (98%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDGVGAETGHVIRT+IGGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGE
Sbjct: 47  RDSEPDIIDGVGAETGHVIRTSIGGRNGQSKQNVSYIAEHVVGTGSFGVVFQAKCRETGE 106

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           IVAIKKVLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEE+YLNLVLEYVPETVNR
Sbjct: 107 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEEVYLNLVLEYVPETVNR 166

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           IAR+YSRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 167 IARSYSRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 226

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct: 227 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 286

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF
Sbjct: 287 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 346

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTALEAC+HPFFDELRDPNTRLPN RPLPPLFNFKP ELSG+PP+ INRLIP
Sbjct: 347 FQYSPNLRCTALEACIHPFFDELRDPNTRLPNARPLPPLFNFKPQELSGVPPDVINRLIP 406

Query: 363 EHARKQNLFMALHS 376
           EHARKQNLFMALH+
Sbjct: 407 EHARKQNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|24637171|gb|AAN63591.1|AF432225_1 GSK-3-like protein MsK4 [Medicago sativa]

 Score =  753 bits (1943), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/374 (95%), Positives = 365/374 (97%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDGVGAETGHVIRT+I  RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGE
Sbjct: 59  RESEPDIIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGE 118

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           IVAIKKVLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNR
Sbjct: 119 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNR 178

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           IARNYSRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 179 IARNYSRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 238

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct: 239 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 298

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF
Sbjct: 299 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 358

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSGIPP+ INRLIP
Sbjct: 359 FQYSPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPDVINRLIP 418

Query: 363 EHARKQNLFMALHS 376
           EHARKQNLFMALH+
Sbjct: 419 EHARKQNLFMALHT 432

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357445263|ref|XP_003592909.1| Glycogen synthase kinase-3-like protein [Medicago truncatula] gi|92893880|gb|ABE91930.1| Protein kinase [Medicago truncatula] gi|355481957|gb|AES63160.1| Glycogen synthase kinase-3-like protein [Medicago truncatula]

 Score =  753 bits (1943), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/374 (95%), Positives = 365/374 (97%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDGVGAETGHVIRT+I  RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGE
Sbjct: 55  RESEPDIIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGE 114

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           IVAIKKVLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNR
Sbjct: 115 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNR 174

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           IARNYSRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 175 IARNYSRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 234

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct: 235 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 294

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF
Sbjct: 295 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 354

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSGIPP+ INRLIP
Sbjct: 355 FQYSPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPDVINRLIP 414

Query: 363 EHARKQNLFMALHS 376
           EHARKQNLFMALH+
Sbjct: 415 EHARKQNLFMALHT 428

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806021|ref|NP_001240918.1| uncharacterized protein LOC100820098 [Glycine max] gi|255639602|gb|ACU20095.1| unknown [Glycine max]

 Score =  751 bits (1940), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/375 (94%), Positives = 369/375 (98%)

Query: 2   MKTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG 61
           ++  EPDIIDG+GAETGHVIRT++GGRNG SKQ VSYI+EHVVGTGSFGVVFQAKCRETG
Sbjct: 46  VRDSEPDIIDGLGAETGHVIRTSVGGRNGQSKQNVSYISEHVVGTGSFGVVFQAKCRETG 105

Query: 62  EIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVN 121
           EIVAIKKVLQDKRYKNRELQIMQMLDHPNIVAL+HCF+STTDKEE+YLNLVLEYVPETVN
Sbjct: 106 EIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALRHCFYSTTDKEEVYLNLVLEYVPETVN 165

Query: 122 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 181
           RIAR+YSRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC
Sbjct: 166 RIARSYSRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 225

Query: 182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 241
           DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG
Sbjct: 226 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 285

Query: 242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 301
           ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR
Sbjct: 286 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 345

Query: 302 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI 361
           FFQYSPNLRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSG+PP+ INRLI
Sbjct: 346 FFQYSPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGVPPDVINRLI 405

Query: 362 PEHARKQNLFMALHS 376
           PEHARKQNLFMALH+
Sbjct: 406 PEHARKQNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465185|ref|XP_002263398.1| PREDICTED: shaggy-related protein kinase kappa [Vitis vinifera] gi|297739515|emb|CBI29697.3| unnamed protein product [Vitis vinifera]

 Score =  748 bits (1931), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/372 (95%), Positives = 362/372 (97%)

Query: 5   DEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIV 64
            EPDIIDGVGAE GHVIRTT GGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIV
Sbjct: 51  SEPDIIDGVGAEAGHVIRTTFGGRNGQSKQTVSYIAEHVVGTGSFGVVFQAKCRETGEIV 110

Query: 65  AIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIA 124
           AIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE+VPETVNRIA
Sbjct: 111 AIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEFVPETVNRIA 170

Query: 125 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 184
           RNYSRI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG
Sbjct: 171 RNYSRINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 230

Query: 185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 244
           SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG
Sbjct: 231 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 290

Query: 245 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 304
           VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ
Sbjct: 291 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 350

Query: 305 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 364
           YSPNLRCTALEAC+HPFFDELRDP+TRLPNGRPLPPLFNFKP ELSGIP +   RLIPEH
Sbjct: 351 YSPNLRCTALEACIHPFFDELRDPSTRLPNGRPLPPLFNFKPQELSGIPSDIRTRLIPEH 410

Query: 365 ARKQNLFMALHS 376
           ARKQNLFMALH+
Sbjct: 411 ARKQNLFMALHT 422

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119932|ref|XP_002331098.1| predicted protein [Populus trichocarpa] gi|222872826|gb|EEF09957.1| predicted protein [Populus trichocarpa]

 Score =  739 bits (1909), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 352/374 (94%), Positives = 361/374 (96%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDGVGAE GHVIRTTIGGRNG S+Q VSYIAEHVVGTGSFGVV QAKCRETGE
Sbjct: 49  RDSEPDIIDGVGAEAGHVIRTTIGGRNGQSRQTVSYIAEHVVGTGSFGVVVQAKCRETGE 108

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR
Sbjct: 109 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 168

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           IARNYSR + RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCD
Sbjct: 169 IARNYSRNNPRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCD 228

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct: 229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF
Sbjct: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTALEAC+HPFFDELRDP TRLPNGRPLPPLFNFKP ELSGIP + +NRLIP
Sbjct: 349 FQYSPNLRCTALEACIHPFFDELRDPATRLPNGRPLPPLFNFKPQELSGIPTDIVNRLIP 408

Query: 363 EHARKQNLFMALHS 376
           ++ARKQNLFMALH+
Sbjct: 409 DYARKQNLFMALHT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224129720|ref|XP_002328786.1| predicted protein [Populus trichocarpa] gi|222839084|gb|EEE77435.1| predicted protein [Populus trichocarpa]

 Score =  738 bits (1906), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/374 (93%), Positives = 359/374 (95%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           +  EPDIIDGVGAE GHVIRTTIGGRNG S+Q +SYIAEHVVGTGSFGVV QAKCRETGE
Sbjct: 49  RDSEPDIIDGVGAEAGHVIRTTIGGRNGQSRQTISYIAEHVVGTGSFGVVVQAKCRETGE 108

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH FFSTTDKEELYLNLVLEYVP+TVNR
Sbjct: 109 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHSFFSTTDKEELYLNLVLEYVPDTVNR 168

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           IARNYSR  QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP THQLKLCD
Sbjct: 169 IARNYSRNSQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCD 228

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct: 229 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 288

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF
Sbjct: 289 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 348

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
           FQYSPNLRCTALEACVHPFFDELRDP TRLPNGRPLPPLFNFK  ELSGIP + +NRLIP
Sbjct: 349 FQYSPNLRCTALEACVHPFFDELRDPTTRLPNGRPLPPLFNFKSQELSGIPTDIVNRLIP 408

Query: 363 EHARKQNLFMALHS 376
           E+ARKQNLFMALH+
Sbjct: 409 EYARKQNLFMALHT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116787454|gb|ABK24513.1| unknown [Picea sitchensis]

 Score =  726 bits (1875), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/374 (91%), Positives = 360/374 (96%)

Query: 3   KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
           K  EP I+DG+GAE+GH+I TTIGGRNG  KQ +SYIAEHVVGTGSFGVVFQAKCRETGE
Sbjct: 51  KDIEPAIVDGMGAESGHIIATTIGGRNGQPKQTISYIAEHVVGTGSFGVVFQAKCRETGE 110

Query: 63  IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 122
           IVAIKKVLQDKRYKNRELQIM MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR
Sbjct: 111 IVAIKKVLQDKRYKNRELQIMHMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNR 170

Query: 123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
           IAR+Y+R++QRMPLIYVKLY+YQICR+LAYIHNC+GICHRDIKPQNLLVNPHTHQLKLCD
Sbjct: 171 IARHYNRMNQRMPLIYVKLYSYQICRSLAYIHNCVGICHRDIKPQNLLVNPHTHQLKLCD 230

Query: 183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WSTGCVMAELLLGQPLFPGE
Sbjct: 231 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDMWSTGCVMAELLLGQPLFPGE 290

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHKVFQKRLPPEAVDLV R 
Sbjct: 291 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFQKRLPPEAVDLVSRL 350

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
            QYSPNLRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+ RLIP
Sbjct: 351 LQYSPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTLERLIP 410

Query: 363 EHARKQNLFMALHS 376
           EHARKQNLFMALH+
Sbjct: 411 EHARKQNLFMALHT 424

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|2160191|gb|AAB60754.1| Identical to A. thaliana AtK-1 (gb|X79279) [Arabidopsis thaliana]

 Score =  726 bits (1873), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/375 (90%), Positives = 357/375 (95%)

Query: 2   MKTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG 61
           ++  EPDIIDG GAE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETG
Sbjct: 73  LQDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETG 132

Query: 62  EIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVN 121
           E+VAIKKVLQDKRYKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVN
Sbjct: 133 EVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVN 192

Query: 122 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 181
           R+AR+YSR +Q MPLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+C
Sbjct: 193 RVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKIC 252

Query: 182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 241
           DFGSAKVLVKGEPNVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPG
Sbjct: 253 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPG 312

Query: 242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 301
           ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CR
Sbjct: 313 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCR 372

Query: 302 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI 361
           FFQYSPNLRCTALEAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+
Sbjct: 373 FFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLV 432

Query: 362 PEHARKQNLFMALHS 376
           PEHARKQNLFMALHS
Sbjct: 433 PEHARKQNLFMALHS 447

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	376
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.994	0.888	0.871	3.3e-182
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.989	0.907	0.776	1.2e-161
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.989	0.918	0.768	1.4e-160
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.989	0.909	0.763	3.6e-160
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.954	0.871	0.741	7.6e-151
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.954	0.882	0.738	3.3e-150
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.968	0.771	0.730	5.4e-150
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.954	0.944	0.713	5.5e-148
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.954	0.819	0.685	2.8e-137
UNIPROTKB|E2R4Y4	420	GSK3B "Uncharacterized protein	0.938	0.840	0.65	2.5e-120

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1768 (627.4 bits), Expect = 3.3e-182, P = 3.3e-182
 Identities = 326/374 (87%), Positives = 342/374 (91%)

Query:     3 KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
             +  EPDIIDG GAE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE
Sbjct:    48 RDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGE 107

Query:    63 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNR 122
             +VAIKKVLQDKRYKNRELQIMQMLDHPN VALKH FFS TD               TVNR
Sbjct:   108 VVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNR 167

Query:   123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
             +AR+YSR +Q MPLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLVNPHTHQLK+CD
Sbjct:   168 VARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICD 227

Query:   183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
             FGSAKVLVKGEPNVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGE
Sbjct:   228 FGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGE 287

Query:   243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRF
Sbjct:   288 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRF 347

Query:   303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
             FQYSPNLRCTALEAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+P
Sbjct:   348 FQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVP 407

Query:   363 EHARKQNLFMALHS 376
             EHARKQNLFMALHS
Sbjct:   408 EHARKQNLFMALHS 421

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1574 (559.1 bits), Expect = 1.2e-161, P = 1.2e-161
 Identities = 289/372 (77%), Positives = 320/372 (86%)

Query:     3 KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
             K  E  ++DG G ETGH+I TTIGG+NG  KQ +SY+AE +VG GSFG+VFQAKC ETGE
Sbjct:    39 KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGE 98

Query:    63 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNR 122
              VAIKKVLQDKRYKNRELQ M++LDHPN+V+LKHCFFSTT+K              TV R
Sbjct:    99 TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYR 158

Query:   123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
             ++++YSR +QRMP+IYVKLYTYQICRALAYIH  +G+CHRDIKPQNLLVNPHTHQ+KLCD
Sbjct:   159 VSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCD 218

Query:   183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
             FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGE
Sbjct:   219 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGE 278

Query:   243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R 
Sbjct:   279 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRL 338

Query:   303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
              QYSPNLR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP EL G   E +++LIP
Sbjct:   339 LQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIP 398

Query:   363 EHARKQNLFMAL 374
             +HARKQ  F+AL
Sbjct:   399 DHARKQCSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1564 (555.6 bits), Expect = 1.4e-160, P = 1.4e-160
 Identities = 286/372 (76%), Positives = 320/372 (86%)

Query:     3 KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
             K  E  ++DG G ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE
Sbjct:    34 KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 93

Query:    63 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNR 122
              VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K              TV+R
Sbjct:    94 TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 153

Query:   123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
             + ++Y++++QRMPLIYVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCD
Sbjct:   154 VIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 213

Query:   183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
             FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE
Sbjct:   214 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 273

Query:   243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R 
Sbjct:   274 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 333

Query:   303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
              QYSPNLR  AL+  VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+P
Sbjct:   334 LQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVP 393

Query:   363 EHARKQNLFMAL 374
             EHARKQ  ++ L
Sbjct:   394 EHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1560 (554.2 bits), Expect = 3.6e-160, P = 3.6e-160
 Identities = 284/372 (76%), Positives = 322/372 (86%)

Query:     3 KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
             K  E  I++G   ETGH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE
Sbjct:    38 KEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE 97

Query:    63 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNR 122
              VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKHCFFSTT+K              TV+R
Sbjct:    98 TVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR 157

Query:   123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
             + ++Y++++QRMPL+YVKLYTYQI R+L+YIH CIG+CHRDIKPQNLLVNPHTHQ+KLCD
Sbjct:   158 VIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCD 217

Query:   183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
             FGSAKVLVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE
Sbjct:   218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGE 277

Query:   243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
             SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R 
Sbjct:   278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 337

Query:   303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
              QYSPNLRC AL++ VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+P
Sbjct:   338 LQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVP 397

Query:   363 EHARKQNLFMAL 374
             EHARKQ  +++L
Sbjct:   398 EHARKQCPWLSL 409

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1472 (523.2 bits), Expect = 7.6e-151, P = 7.6e-151
 Identities = 267/360 (74%), Positives = 306/360 (85%)

Query:     9 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 68
             +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct:    43 VIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKK 102

Query:    69 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 128
             VLQD+RYKNRELQ+M+++DHPN+V+LKHCFFSTT +              T+ R+ ++Y+
Sbjct:   103 VLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYT 162

Query:   129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
               +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+P THQ KLCDFGSAKV
Sbjct:   163 SSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKV 222

Query:   189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
             LVKGE N+SYICSRYYRAPELIFGATEYT++IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct:   223 LVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQL 282

Query:   249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
             VEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL  R  QYSP+
Sbjct:   283 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 342

Query:   309 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 368
             LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK  ELSG  PE INRLIPEH R+Q
Sbjct:   343 LRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELSGASPELINRLIPEHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1466 (521.1 bits), Expect = 3.3e-150, P = 3.3e-150
 Identities = 266/360 (73%), Positives = 304/360 (84%)

Query:     9 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 68
             +I+G  A TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct:    41 VIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKK 100

Query:    69 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 128
             VLQD+RYKNRELQ+M+ +DHPN+++LKHCFFSTT +              T+ R+ R+Y+
Sbjct:   101 VLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYT 160

Query:   129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
               +QRMP+ YVKLYTYQI R LAYIH   G+CHRD+KPQNLLV+P THQ+KLCDFGSAKV
Sbjct:   161 SSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 220

Query:   189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
             LVKGEPN+SYICSRYYRAPELIFGATEYT +IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct:   221 LVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQL 280

Query:   249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
             VEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL  R  QYSP+
Sbjct:   281 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 340

Query:   309 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 368
             LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK  EL G   E INRLIPEH R+Q
Sbjct:   341 LRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELGGASMELINRLIPEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1464 (520.4 bits), Expect = 5.4e-150, P = 5.4e-150
 Identities = 266/364 (73%), Positives = 303/364 (83%)

Query:     3 KTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGE 62
             K  E  +++G G ETG VI TT+GGR+G  KQ +SY+A+ VVGTGSFGVVFQAKC ETGE
Sbjct:   103 KDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGE 162

Query:    63 IVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNR 122
              VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFSTTDK              TV R
Sbjct:   163 QVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYR 222

Query:   123 IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
              +++Y++++Q MP+I+V+LYTYQICRAL Y+H  +G+CHRDIKPQNLLVNP THQLK+CD
Sbjct:   223 ASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICD 282

Query:   183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
             FGSAK+LV GEPN+SYICSRYYRAPELIFGATEYT AID+WS GCVMAELLLGQPLFPGE
Sbjct:   283 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGE 342

Query:   243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
             SG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R 
Sbjct:   343 SGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 402

Query:   303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIP 362
              QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPPLFNF   EL+G   E   RLIP
Sbjct:   403 LQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIP 462

Query:   363 EHAR 366
              H +
Sbjct:   463 AHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1445 (513.7 bits), Expect = 5.5e-148, P = 5.5e-148
 Identities = 257/360 (71%), Positives = 303/360 (84%)

Query:     9 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 68
             ++DG    TGH+I TTIGG+NG  KQ +SY+AE VVGTGSFG+VFQAKC ETGE VAIKK
Sbjct:    11 VVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKK 70

Query:    69 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 128
             VLQD+RYKNRELQ+M+++DHPN+V LKHCFFSTT K              ++ R+ ++YS
Sbjct:    71 VLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYS 130

Query:   129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
               +QRMPL+YVKLY YQI R LAYIHN  G+CHRD+KPQNLLV+P THQ+K+CDFGSAK 
Sbjct:   131 SANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190

Query:   189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
             LVKGE N+SYICSR+YRAPELIFGATEYTT+IDIWS GCV+AELLLGQPLFPGE+ VDQL
Sbjct:   191 LVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250

Query:   249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
             VEIIKVLGTPTREEI+CMNP+YT+F+FPQIK HPWHK+F KR+PPEA+D   R  QYSP+
Sbjct:   251 VEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPS 310

Query:   309 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 368
             LRCTALEAC HPFFDELR+PN RLPNGRP PPLFNFK  E++G  PE +N+LIP+H ++Q
Sbjct:   311 LRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQ-EVAGSSPELVNKLIPDHIKRQ 369

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
 Identities = 246/359 (68%), Positives = 288/359 (80%)

Query:     9 IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 68
             II G G E+G +I T   G N    + +SY AEHV+GTGSFGVVFQAKC ET E VAIKK
Sbjct:    80 IIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKK 139

Query:    69 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS 128
             VLQDKRYKNRELQIM+MLDHPN+V LKH FFSTT+K              T+ R +R+Y+
Sbjct:   140 VLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYT 199

Query:   129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
             +++Q MPLIY++LYTYQICRA+ Y+H  +G+CHRDIKPQNLLVN  TH++K+CDFGSAK+
Sbjct:   200 KMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKM 259

Query:   189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
             L+ GEPN+SYICSRYYRAPELIFGATEYT+AID+WS GCVMAEL LG PLFPGE+ VDQL
Sbjct:   260 LIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQL 319

Query:   249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
             VEIIK+LGTP REEIK MNP Y +FKFPQIK  PWHK+F++++ PEA+DL  R  QYSPN
Sbjct:   320 VEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPN 379

Query:   309 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 367
             LRCTALEAC HPFFD+LRDP   LPNGR LPPLF+F   EL+G   E  +RLIPEHARK
Sbjct:   380 LRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|E2R4Y4 GSK3B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
 Identities = 234/360 (65%), Positives = 276/360 (76%)

Query:    11 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
             D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct:    31 DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query:    71 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
             QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct:    89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query:   130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
               Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query:   190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
             V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct:   208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query:   250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct:   268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query:   310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
             R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct:   328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7983	0.9893	0.9095	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8037	0.9893	0.9185	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6306	0.9069	0.8811	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7694	0.9547	0.8820	no	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6576	0.8803	0.9220	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7722	0.9547	0.8713	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7444	0.9547	0.9447	no	no
Q388M1	GSK3B_TRYB2	2, ., 7, ., 1, 1, ., 2, 6	0.5147	0.8803	0.9403	N/A	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.9037	0.9946	0.8883	yes	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5872	0.7792	0.7918	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6687	0.8537	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.8903	0.9946	0.8904	no	no
O23145	KSG2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7214	0.9547	0.8329	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8087	0.9734	0.8948	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6805	0.9388	0.8404	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6556	0.8803	0.7087	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8075	0.9813	0.8978	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8037	0.9867	0.9026	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.825	0.9574	0.8759	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7664	0.9680	0.7777	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6805	0.9388	0.8404	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8118	0.9893	0.9073	no	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6713	0.9414	0.8428	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6777	0.9388	0.8404	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6805	0.9388	0.8404	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	376
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-136
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-90
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-86
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-85
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-84
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-81
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-81
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-78
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-78
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-76
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-73
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-72
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-65
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-65
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-64
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-63
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-63
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-63
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-62
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-61
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-60
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-59
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-58
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-58
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-58
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-57
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-57
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-57
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-57
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-54
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-54
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-54
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-53
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-52
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-51
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-51
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-50
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-50
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-50
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-49
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-49
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-49
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-49
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-49
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-48
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-48
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-47
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-47
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-45
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-43
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-39
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-39
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-39
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-38
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-37
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-36
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-35
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-35
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-35
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-34
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-34
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-33
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-28
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-27
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-27
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-24
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-24
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-23
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-21
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-19
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-19
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-18
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-17
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-17
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-16
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.001
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.002
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  394 bits (1014), Expect = e-136
 Identities = 176/337 (52%), Positives = 245/337 (72%), Gaps = 5/337 (1%)

Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 90
           N     SY   +++G GSFGVV++A C +T E VAIKKVLQD +YKNREL IM+ L+H N
Sbjct: 61  NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHIN 120

Query: 91  IVALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           I+ LK  +++     +++ ++LN+V+E++P+TV++  ++Y+R +  +PL  VKLY+YQ+C
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
           RALAYIH+   ICHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ +VSYICSR+YRAP
Sbjct: 181 RALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           EL+ GAT YTT ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MN
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
           PNY + KFP +KP    KVF K  P +A++ + +F +Y P  R   +EA   PFFD+LRD
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Query: 328 PNTRLPNG-RPLPPLFNFKPPELSGIPPETINRLIPE 363
           P  +LP     LP LFNF   E+  +      ++IP+
Sbjct: 360 PCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  275 bits (705), Expect = 1e-90
 Identities = 118/330 (35%), Positives = 178/330 (53%), Gaps = 29/330 (8%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y     +G+G++GVV  A  + TG  VAIKK+      L D +   RE+++++ L H NI
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 92  VALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQIC 147
           + L       S  D  ++Y+  V E +   ++++      I    PL   +++ + YQI 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV------IKSPQPLTDDHIQYFLYQIL 113

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRY 203
           R L Y+H+   + HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+
Sbjct: 114 RGLKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           YRAPEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 264 KCM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
           K + +     +    P+    P  K+F     PEA+DL+ +   + P  R TA EA  HP
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHP 290

Query: 321 FFDELRDPNTRLPNGRPLPPLFNFKPPELS 350
           +  +L DP    P  +P      F   EL+
Sbjct: 291 YLAQLHDPE-DEPVAKPPFDFDFFDDDELT 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  262 bits (672), Expect = 3e-86
 Identities = 117/302 (38%), Positives = 171/302 (56%), Gaps = 37/302 (12%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 89
           Y     +G G++GVV++A+ ++TGEIVA+KK+  D   +         RE+ +++ L HP
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICR 148
           NIV L     +   + +LYL  V EY    +    + Y  +    +    +K   YQ+ R
Sbjct: 59  NIVKLLDVIHT---ERKLYL--VFEYCDMDL----KKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYR 205
            LAY H    I HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YR
Sbjct: 110 GLAYCH-SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYR 165

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE++ G+  Y+TA+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E    
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW-- 223

Query: 266 MNPNYTEFK-----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
             P  T+       FP+  P    KV   RL PE +DL+ +  QY+P  R +A EA  HP
Sbjct: 224 --PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280

Query: 321 FF 322
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  260 bits (667), Expect = 2e-85
 Identities = 116/298 (38%), Positives = 171/298 (57%), Gaps = 25/298 (8%)

Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKN---RELQIMQMLD 87
           QK+  I     G G++GVV++A+ + TGEIVAIKK+              RE+++++ L+
Sbjct: 2   QKLGKI-----GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           HPNI+ L   F     K +LYL  V E++   + ++ ++  R    +P   +K Y YQ+ 
Sbjct: 57  HPNIIKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRA 206
           + LA+ H+  GI HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRA
Sbjct: 109 QGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PEL+ G   Y+T +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E     
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226

Query: 267 NPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                  +F FP+    P  K+F     P+A+DL+ +   Y P+ R TA +A  HP+F
Sbjct: 227 TSLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  257 bits (659), Expect = 3e-84
 Identities = 111/290 (38%), Positives = 168/290 (57%), Gaps = 23/290 (7%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G+ G+VF+AK RETGE VA+KKV   +          RE++ +Q   HP +V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F   +        LV+EY+P  ++ + R+  R    +P   VK Y   + + +AY+H   
Sbjct: 68  FPHGSG-----FVLVMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA-N 118

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELIFGATE 215
           GI HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA +
Sbjct: 119 GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 272
           Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNK 236

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
             FP+ KP P  ++F     PEA+DL+     Y P+ R +A EA  HP+F
Sbjct: 237 ITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  248 bits (636), Expect = 2e-81
 Identities = 105/292 (35%), Positives = 155/292 (53%), Gaps = 45/292 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 92
           Y     +G GSFG V+ A+ ++TG++VAIK +      +D+    RE++I++ L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            L   F    D+++LYL  V+EY    +  + + +       R+     + Y  QI  AL
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            Y+H+  GI HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++
Sbjct: 111 EYLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
            G   Y  A+DIWS G ++ ELL G+P FPG+   DQL+E+ K +G P            
Sbjct: 169 LG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK----------- 213

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                P   P  W       + PEA DL+ +     P  R TA EA  HPFF
Sbjct: 214 -----PPFPPPEW------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  249 bits (638), Expect = 5e-81
 Identities = 112/299 (37%), Positives = 162/299 (54%), Gaps = 29/299 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 88
           Y     +G G++ VV++A+ +ETG IVAIKK+   +R +          RE++++Q L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 89  PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           PNI+ L   F          +NLV E++   + ++ ++ S +        +K Y     R
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIKDKSIVLT---PADIKSYMLMTLR 113

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC---SRYYR 205
            L Y+H+   I HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 266 MN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           +   P+Y EFK     P P  ++F      +A+DL+ R    +PN R TA +A  HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  242 bits (620), Expect = 2e-78
 Identities = 115/292 (39%), Positives = 164/292 (56%), Gaps = 21/292 (7%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALK 95
            VVG G++GVV + + + TGEIVAIKK  +   D+  K    RE+++++ L H NIV LK
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F     K  LYL  V EYV  T+  +          +P   V+ Y +Q+ +A+AY H+
Sbjct: 67  EAFRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS 118

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNVSYICSRYYRAPELIFGA 213
              I HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G 
Sbjct: 119 -HNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 271
           T Y   +D+W+ GC+MAELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP + 
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236

Query: 272 EFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              FP+   P    + +  ++   A+D +    +  P  R T  E   HP+F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  241 bits (616), Expect = 3e-78
 Identities = 98/292 (33%), Positives = 147/292 (50%), Gaps = 39/292 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y     +G+GSFG V++AK + TG+IVA+K + +            RE++I++ L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L   F    DK+ LYL  V+EY          +Y      +     K    QI R L 
Sbjct: 61  VRLIDAF---EDKDHLYL--VMEYCEGGDLF---DYLSRGGPLSEDEAKKIALQILRGLE 112

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELI 210
           Y+H+  GI HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++
Sbjct: 113 YLHSN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL 170

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
            G   Y   +D+WS G ++ ELL G+P F GE+ +DQL  I ++LG P            
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL----------- 219

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              +F + K              EA DL+ +     P+ R TA E   HP+F
Sbjct: 220 ---EFDEPKWSS--------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  235 bits (603), Expect = 6e-76
 Identities = 109/291 (37%), Positives = 172/291 (59%), Gaps = 26/291 (8%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQ-IMQMLDHPNIVALK 95
           +G G+FG V+ A+ +ETGE+VAIKK+ +  ++ +       RE++ + ++ +HPNIV LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F    + +ELY   V EY+   + ++ +   R  +      ++   YQI + LA+IH 
Sbjct: 65  EVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +T 
Sbjct: 118 H-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYT 271
           Y++ +DIW+ GC+MAEL   +PLFPG S +DQL +I  VLGTPT+++     K  +    
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            F+FPQ  P   H++      PEA+DL+    ++ P  R TA +A  HP+F
Sbjct: 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  229 bits (587), Expect = 2e-73
 Identities = 97/292 (33%), Positives = 158/292 (54%), Gaps = 24/292 (8%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G G++G V++A+ ++TGE+VA+KK+  +   K        RE++++Q L HPNIV LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              S   K  +Y+  V EY+   +  +  +      +     +K Y  Q+   L Y+H+ 
Sbjct: 66  IVTSK-GKGSIYM--VFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
            GI HRDIK  N+L+N     LKL DFG A+   K   +  Y   + + +YR PEL+ GA
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLGA 176

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 270
           T Y   +D+WS GC++AEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              K  +       + F+  + P A+DL+ +     P  R +A +A  H +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  228 bits (584), Expect = 2e-72
 Identities = 109/305 (35%), Positives = 176/305 (57%), Gaps = 35/305 (11%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM---QMLDHPNIVAL 94
           +G G++G+V++A  R T E+VA+KK+        D +   RE  IM   ++ DHPNIV L
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDHPNIVKL 72

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQICRALAY 152
            +   +  DK+ +YL  V EY+   ++ + R      +H+R    Y+    YQ+ +AL Y
Sbjct: 73  LNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHKR----YI---MYQLLKALKY 122

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS------YICSRYYRA 206
           IH+   + HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R+YRA
Sbjct: 123 IHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++ G+T YT  +D+WS GC++ E+LLG+PLFPG S ++QL +II+V+G P+ E+I+ +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 267 NPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
              +        P     P  ++   +   +A+DL+ +   ++PN R TA EA  HP+  
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Query: 324 ELRDP 328
           +  +P
Sbjct: 300 QFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  216 bits (553), Expect = 9e-68
 Identities = 109/309 (35%), Positives = 166/309 (53%), Gaps = 28/309 (9%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPN 90
            Y     +G+G++GVV  A    +G+ VAIKK      V    +   REL+I++   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI--YVKLYTYQICR 148
           I+A++         +   + +V++ +   ++ I      IH   PL   +++ + YQ+ R
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHI------IHSDQPLTEEHIRYFLYQLLR 118

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRY 203
            L YIH+   + HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           YRAPEL+    EYTTAID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 264 KCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
             +       Y +   P+ +P PW K+F K   PEA+DL+ +  Q+ P  R T  +A  H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 320 PFFDELRDP 328
           PF  +  DP
Sbjct: 295 PFLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  210 bits (537), Expect = 5e-66
 Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 30/293 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGEIVA+KK+  +   +       RE+ +++ L+HPNIV L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIHN 155
             S     +LYL  V E++    +   + Y  S     +    +K Y YQ+ + +AY H+
Sbjct: 67  VHSEN---KLYL--VFEFL----DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 212
              + HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 118 H-RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 173

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 269
           + +Y+T +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PD 232

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           Y    FP+       KV    L  + +DL+ +   Y P  R +A  A  HP+F
Sbjct: 233 YKP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  209 bits (533), Expect = 3e-65
 Identities = 115/306 (37%), Positives = 170/306 (55%), Gaps = 37/306 (12%)

Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 87
           +K++ I E     G++GVV++A+ ++TGEIVA+KK+  +K  +       RE+ I+  L 
Sbjct: 8   EKLNRIEE-----GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62

Query: 88  HPNIVALKHCFF-STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 146
           HPNIV +K     S  DK  +Y+  V+EYV   +  +      + Q      VK    Q+
Sbjct: 63  HPNIVTVKEVVVGSNLDK--IYM--VMEYVEHDLKSL---METMKQPFLQSEVKCLMLQL 115

Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 203
              +A++H+   I HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +
Sbjct: 116 LSGVAHLHD-NWILHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLW 171

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           YRAPEL+ GA EY+TAID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +  
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 264 KCMNPNYTEFKFPQIKPHPWHKVFQ--KRLPP-----EAVDLVCRFFQYSPNLRCTALEA 316
               P ++E    + K    +   Q  K+ P         DL+ R   Y P  R +A +A
Sbjct: 232 ----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287

Query: 317 CVHPFF 322
             HP+F
Sbjct: 288 LKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  210 bits (537), Expect = 3e-65
 Identities = 108/305 (35%), Positives = 164/305 (53%), Gaps = 26/305 (8%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 89
           Y     VG+G++G V  A   +TG  VAIKK+ +        KR Y  REL++++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 90  NIVALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           N++ L   F   +  E+   + LV   +   +N I +      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            L YIH+  GI HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 269 ----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
               NY +   PQ+    + +VF     P A+DL+ +     P+ R TA EA  HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 325 LRDPN 329
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  208 bits (531), Expect = 1e-64
 Identities = 106/325 (32%), Positives = 175/325 (53%), Gaps = 28/325 (8%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y     +G G++G+V  A  + TG  VAIKK+         +R   RE++I++   H NI
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65

Query: 92  VALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           + +       + +   ++Y+  V E +   + ++ +      Q +   +++ + YQI R 
Sbjct: 66  IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYYR 205
           L YIH+   + HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE++  +  YT AIDIWS GC++AE+L  +PLFPG+  + QL  I+ VLGTP++E++ C
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236

Query: 266 M-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
           + +    NY +   P     PW+K+F     P+A+DL+ +   ++P+ R T  EA  HP+
Sbjct: 237 IISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Query: 322 FDELRDPNTRLPNGRPLPPLFNFKP 346
            ++  DP+       P P  F    
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFD 319

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  202 bits (517), Expect = 4e-63
 Identities = 109/292 (37%), Positives = 164/292 (56%), Gaps = 27/292 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 97
           +G GS+GVVF+ + RETG+IVAIKK ++       K+   RE+++++ L HPN+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 98  FFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 154
           F     + +  L+LV EY   TV N + +N     + +P   +K   +Q  +A+ + H  
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 213
           NCI   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G 
Sbjct: 120 NCI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYT 271
           T+Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  + 
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 272 EFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
               P+ +   P    F   +   A+  +    Q  P  R +  E   HP+F
Sbjct: 236 GLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  204 bits (521), Expect = 6e-63
 Identities = 115/330 (34%), Positives = 181/330 (54%), Gaps = 26/330 (7%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G++G+V  AK  ET E VAIKK+        D +   RE+++++ LDH N++A+K  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 98  FFSTTDK--EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 +   ++Y+  V E +   +++I R+     Q +   + + + YQ+ R L YIH+
Sbjct: 73  MPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGAT 214
              + HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPEL+   +
Sbjct: 127 A-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF 273
           EYTTAID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N     +
Sbjct: 185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244

Query: 274 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 331
               P      + ++F     P A+DL+ +   + P+ R T  EA  HP+   L DP+  
Sbjct: 245 IRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303

Query: 332 LPNGRPLPPLFNFKPPELSGIPPETINRLI 361
                P    F+F+   L+    E I  LI
Sbjct: 304 PVCQTPFS--FDFEEDALT---EEDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  202 bits (516), Expect = 6e-63
 Identities = 116/291 (39%), Positives = 173/291 (59%), Gaps = 23/291 (7%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALKH 96
           +VG GS+G+V + K +ETG+IVAIKK L+   DK  K    RE+++++ L H N+V L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 97  CFFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F     K+ LYL  V E+V  TV + + +  + + +      V+ Y +QI R + + H+
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGAT 214
              I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T
Sbjct: 119 H-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 272
           +Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP +  
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236

Query: 273 FKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            + P++K   P  K F K L    +DL  +  +  P+ R ++ +   H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  201 bits (512), Expect = 3e-62
 Identities = 103/295 (34%), Positives = 160/295 (54%), Gaps = 23/295 (7%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNIVALKH 96
           +G G++G V++A+ + TG++VA+KK   +   +       RE+ ++QML     IV L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                    +  L LV EY+   + + +  N     + +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 212
             G+ HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
           +T Y+T +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 273 FK----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
            +    FPQ KP    +     L PE +DL+ +  +Y P  R +A  A  HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  198 bits (506), Expect = 2e-61
 Identities = 102/287 (35%), Positives = 152/287 (52%), Gaps = 21/287 (7%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQML-DHPNIVALKH 96
           G G+F  V +A+ R+TG+  AIK +   K +K+       RE+Q ++ L  HPNI+ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
             F   D++   L LV E +   +  + +      + +P   VK Y YQ+ ++L ++H  
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +     Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKF 275
              +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  + F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           P  K     K+       E +DL+ +   Y P+ R TA +A  HP+F
Sbjct: 237 PSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  194 bits (495), Expect = 7e-60
 Identities = 107/292 (36%), Positives = 168/292 (57%), Gaps = 28/292 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 98
           +G G++  V++ + R TGEIVA+K++  D          RE+ +M+ L H NIV L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHN 155
             T +K    L LV EY+ + + +    Y   H     +    VK +TYQ+ + +A+ H 
Sbjct: 67  IHTENK----LMLVFEYMDKDLKK----YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 212
              + HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 270
           +  Y+T+IDIWS GC+MAE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            +  FP+  P    ++F     P  +DL+ R  Q +P LR +A +A  HP+F
Sbjct: 235 -KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 3e-59
 Identities = 103/298 (34%), Positives = 162/298 (54%), Gaps = 24/298 (8%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 91
           +Y     +G GS+  V++ + + TG++VA+K++ L+ +        RE  +++ L H NI
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L H    T       L LV EY+   + +   +       + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 208
           Y H    + HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQ-RRVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 265
           ++ G+TEY+T++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            NP +  + FP   P P      +    P   +L  +F QY P  R +A EA  HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  191 bits (488), Expect = 3e-58
 Identities = 104/295 (35%), Positives = 171/295 (57%), Gaps = 25/295 (8%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 97
           VG G+FG+V  A+ + TG+ VAIKK+++        +   REL++++ L H NI++L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F S    E++Y   V E +   ++R+  +     + +   +++ + YQI R L Y+H+  
Sbjct: 78  FISP--LEDIYF--VTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA- 127

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEY 216
           G+ HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAPE++    +Y
Sbjct: 128 GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 273
              +DIWS GC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + + N   F  
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243

Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
             P+ +P P+ + F+    P A+DL+ +   + P  R +A EA  HP+     DP
Sbjct: 244 SLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  191 bits (486), Expect = 4e-58
 Identities = 105/301 (34%), Positives = 150/301 (49%), Gaps = 36/301 (11%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 95
           + +G G++G+V++A+   +GEIVA+KKV  D           RE+ ++  L HPNIV LK
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 154
                   K    + LV+EY  + +  +  N            VK    Q+ R L Y+H 
Sbjct: 73  EV---VVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 211
           N I   HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ 
Sbjct: 127 NFI--IHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLL 181

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 269
           G T YTTAID+W+ GC++AELL  +PL PG+S ++QL  II++LGTP        +  P 
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 270 YTEFKFPQ-----IKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
             +F  P+     +K   PW       L    + L+     Y P  R TA EA    +F 
Sbjct: 242 VGKFTLPKQPYNNLKHKFPW-------LSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Query: 324 E 324
           E
Sbjct: 295 E 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  189 bits (482), Expect = 7e-58
 Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 41/306 (13%)

Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 87
           QKV  I E     G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+
Sbjct: 3   QKVEKIGE-----GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           HPNIV L     +   + +LYL  V E++ + + +           +PLI  K Y +Q+ 
Sbjct: 58  HPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMDASPLSGIPLPLI--KSYLFQLL 110

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 204
           + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +Y
Sbjct: 111 QGLAFCHSH-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWY 166

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
           RAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP      
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV--- 223

Query: 265 CMNPNYTEFK-----FPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEA 316
            + P  T        FP+         F K +PP   +  DL+ +   Y PN R +A  A
Sbjct: 224 -VWPGVTSLPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278

Query: 317 CVHPFF 322
             HPFF
Sbjct: 279 LAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  187 bits (478), Expect = 2e-57
 Identities = 97/291 (33%), Positives = 142/291 (48%), Gaps = 46/291 (15%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 95
            ++G GSFG V+ A  ++TGE++A+K V L     +      RE++I+  L HPNIV   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 96  HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             + S  D+E+  LN+ LEYV   +++ + + + ++ + +    ++ YT QI   LAY+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 211
           +  GI HRDIK  N+LV+     +KL DFG AK L     GE   S   + Y+ APE+I 
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
           G  EY  A DIWS GC + E+  G+P +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
               P+I  H         L  EA D + +  +  P  R TA E   HPF 
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  188 bits (480), Expect = 6e-57
 Identities = 119/333 (35%), Positives = 180/333 (54%), Gaps = 33/333 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++++++L HP+I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR---NYSRIHQRMPLIYVKLYTYQICR 148
           V +KH     + +E   + +V E +   ++++ +   + +  H        + + YQ+ R
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-------QFFLYQLLR 114

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----VSYICSRYY 204
           AL YIH    + HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+Y
Sbjct: 115 ALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 205 RAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           RAPEL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E 
Sbjct: 173 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231

Query: 263 I-KCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACV 318
           I +  N     +     K  P    F ++ P   P A+ L+ R   + P  R TA EA  
Sbjct: 232 ISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289

Query: 319 HPFFDELRDPNTRLPNGRPLPPL-FNFKPPELS 350
            P+F  L     R P+ +P+  L F F+   L+
Sbjct: 290 DPYFKGLAKVE-REPSAQPITKLEFEFERRRLT 321

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  186 bits (475), Expect = 7e-57
 Identities = 110/296 (37%), Positives = 160/296 (54%), Gaps = 36/296 (12%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             S  DK+   L LV EY  + + +    +   +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHS--DKK---LTLVFEYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 215 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E      P  +  
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW----PGVS-- 229

Query: 274 KFPQIKPHP-------WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           K P  KP+P          V   +L     DL+      +P  R +A EA  HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  186 bits (475), Expect = 9e-57
 Identities = 105/298 (35%), Positives = 171/298 (57%), Gaps = 29/298 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ R T E +A+KK+  ++  +       RE+ +++ + H NIV L+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 98  FFSTTDKEELYLNLVLEYVPETVNR---IARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             S     E  L LV EY+   + +    + ++++ + R+    +K Y YQI R +AY H
Sbjct: 70  VHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIAYCH 119

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 211
           +   + HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE++ 
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILL 176

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PN 269
           G+  Y+T +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +   P+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
           Y    FP+  P     V    L P  VDL+ +  +  P+ R TA  A  H +F +L D
Sbjct: 237 YKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  180 bits (460), Expect = 2e-54
 Identities = 99/304 (32%), Positives = 146/304 (48%), Gaps = 35/304 (11%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 97
           G G+FG V++A+  +TG +VA+KK+L     K+       RE++I++ L HPN+V L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 98  FFSTTDKE-----ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
                DK       +Y+  V  Y+   ++ +  N   +      I  K Y  Q+   + Y
Sbjct: 76  AVERPDKSKRKRGSVYM--VTPYMDHDLSGLLEN-PSVKLTESQI--KCYMLQLLEGINY 130

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------------IC 200
           +H    I HRDIK  N+L++ +   LK+ DFG A+      PN               + 
Sbjct: 131 LH-ENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188

Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           +R+YR PEL+ G   YTTA+DIW  GCV AE+   +P+  G+S +DQL  I K+ GTPT 
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248

Query: 261 EEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 318
           E        P           P    + F K   PE +DL+ +     P  R TA +A  
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG-PEGLDLLSKLLSLDPYKRLTASDALE 307

Query: 319 HPFF 322
           HP+F
Sbjct: 308 HPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  181 bits (462), Expect = 2e-54
 Identities = 107/313 (34%), Positives = 159/313 (50%), Gaps = 45/313 (14%)

Query: 44  VGTGSFGVVFQAKCRET--GEIVAIKKV-------LQDKRYKNRELQIMQML-DHPNIVA 93
           +G G++G+V  A+  ET   E VAIKK+       +  KR   REL++++    H NI  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66

Query: 94  LKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           L            ELYL    E +   +++I R+     Q +   + + + YQI   L Y
Sbjct: 67  LYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKY 120

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVS-YICSRYYRAP 207
           IH+   + HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAP
Sbjct: 121 IHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------ 261
           E++     YT AID+WS GC++AELL  +P+F G+  VDQL +I++VLGTP  E      
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238

Query: 262 EIKCMN-----PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
             K  N     PN  +  F  I P+           P A+DL+ +   + P  R +  EA
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNA---------NPLALDLLEKLLAFDPTKRISVEEA 289

Query: 317 CVHPFFDELRDPN 329
             HP+     DP+
Sbjct: 290 LEHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  180 bits (459), Expect = 8e-54
 Identities = 108/301 (35%), Positives = 165/301 (54%), Gaps = 30/301 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A  R TG  VAIKK+       L  KR   REL++++ + H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81

Query: 97  CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F      +  +   LV+ ++   + ++ +     H+++    ++   YQ+ + L YIH 
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     
Sbjct: 137 A-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           YT  +DIWS GC+MAE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY 
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252

Query: 272 EFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           + K P+ +     K F+  LP   P AV+++ +        R TA EA  HP+F+E  DP
Sbjct: 253 K-KLPRFR----KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 329 N 329
            
Sbjct: 308 E 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  178 bits (454), Expect = 1e-53
 Identities = 99/294 (33%), Positives = 162/294 (55%), Gaps = 31/294 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLDHPNIVA 93
           +G G++GVV++ + ++TG+IVA+KK+    R ++          RE+ +++ L HPNIV 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L+         +E  L L+ E++   + +   +     Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 210
           H+   + HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HS-RRVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 268
            G+  Y+T +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           +Y    FP+ K     +   K L  + +DL+ +   Y P  R +A +A  HP+F
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (445), Expect = 4e-53
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 98
           +G G FG V+ A+ ++TG+ VAIK + ++          RE++I++ L+HPNIV L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 99  FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                ++E +L LV+EY    ++  + +       ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN- 111

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 216
           GI HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 275
           +   DIWS G ++ EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 276 PQIKPHP 282
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 2e-52
 Identities = 97/295 (32%), Positives = 150/295 (50%), Gaps = 30/295 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD---HPN 90
           +G G++G V++A+   TG  VA+KKV    R             RE+ +++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV L           EL L LV E+V + +        +    +P   +K    Q+ R +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGV 120

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            ++H    I HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE++
Sbjct: 121 DFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
             ++ Y T +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE    N + 
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVSL 236

Query: 271 TEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
               FP   P      F+  +P    E +DL+ +   ++P+ R +A EA  HP+F
Sbjct: 237 PRSSFPSYTPRS----FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  175 bits (444), Expect = 1e-51
 Identities = 105/302 (34%), Positives = 158/302 (52%), Gaps = 21/302 (6%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNI 91
           Y +   VG+G++G V  A  + TGE VAIKK+    Q + +  R   EL +++ + H N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 92  VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           + L   F S    +E     LV+ Y+   + +I      +   +    V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            YIH+  GI HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ +    
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246

Query: 271 TEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            +  + +  P    K F    P   P+AVDL+ +  +   + R TA EA  HP+FD  RD
Sbjct: 247 AK-SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305

Query: 328 PN 329
            +
Sbjct: 306 AD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  174 bits (441), Expect = 7e-51
 Identities = 90/334 (26%), Positives = 136/334 (40%), Gaps = 48/334 (14%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHP 89
           SY     +G GSFG V+ A+ R+   +VA+K + +    K+       RE+QI+  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 90  -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
            NIV L   F     ++E  L LV+EYV                 +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-------SYICS 201
           AL Y+H+  GI HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 202 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG 256
             Y APE++ G +    +++ DIWS G  + ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
           TP                       P      + +   A DL+ +     P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 317 CVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 350
             H     L+   + L +          +     
Sbjct: 273 LSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPP 306

Length = 384

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  171 bits (435), Expect = 1e-50
 Identities = 106/299 (35%), Positives = 164/299 (54%), Gaps = 23/299 (7%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
           +YI    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L       TDK    L LV EY+ + + +   +   I   M +  VK++ YQI R LA
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 208
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++ G++EY+T ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 269 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           N  +  + FP+ KP P       RL  E ++L+ +F QY    R +A EA  H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  170 bits (432), Expect = 2e-50
 Identities = 114/295 (38%), Positives = 160/295 (54%), Gaps = 30/295 (10%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 96
           VVG G++GVV + + +ET EIVAIKK          K    REL++++ L   NIV LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL----IYVKLYTYQICRALAY 152
            F     + +LYL  V EYV        +N   + + MP       V+ Y YQ+ +A+ +
Sbjct: 68  AF---RRRGKLYL--VFEYV-------EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYICSRYYRAPELI 210
            H    I HRDIKP+NLL++ H   LKLCDFG A+ L +G       Y+ +R+YR+PEL+
Sbjct: 116 CHKN-DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NP 268
            GA  Y  A+D+WS GC++ EL  GQPLFPGES +DQL  I KVLG    E++K    NP
Sbjct: 174 LGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232

Query: 269 NYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            +   +FP +  P    + +   L    +DL+    + +P  R    +   HP F
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  171 bits (435), Expect = 6e-50
 Identities = 109/307 (35%), Positives = 158/307 (51%), Gaps = 43/307 (14%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK---VLQD----KRYKNRELQIMQMLDHPNIV---- 92
           +G G+FGVV+       G+ VA+KK   V Q+    KR   REL+++    H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66

Query: 93  ----ALKHCFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQIC 147
                    F      EE+Y+  V E +   +++ I        Q +   +VK++ YQI 
Sbjct: 67  ILQPPHIDPF------EEIYV--VTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQIL 113

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-----ICSR 202
           R L Y+H+  GI HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + ++
Sbjct: 114 RGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVVTQ 168

Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ E 
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Query: 263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 319
           ++                 P   V          EAV L+CR   + P+ R +A +A  H
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Query: 320 PFFDELR 326
           P+ DE R
Sbjct: 289 PYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  169 bits (429), Expect = 2e-49
 Identities = 102/329 (31%), Positives = 154/329 (46%), Gaps = 54/329 (16%)

Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------- 77
           +  ++      H+ G G++G V +A    TG+IVAIKKV +     N             
Sbjct: 5   SISERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCG 62

Query: 78  ------RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 131
                 REL+IM  + H NI+ L   +      E  ++NLV++ +   + ++     +I 
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYV-----EGDFINLVMDIMASDLKKVVD--RKI- 114

Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---- 187
            R+    VK    QI   L  +H      HRD+ P N+ +N      K+ DFG A+    
Sbjct: 115 -RLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKG-ICKIADFGLARRYGY 171

Query: 188 -VLVKGEPNVSYICSR----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
                       +  R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Query: 237 PLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 293
           PLFPGE+ +DQL  I ++LGTP  +   + K + P YTEF     KP     +F      
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTP--RKPKDLKTIFPNA-SD 287

Query: 294 EAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           +A+DL+    + +P  R +A EA  H +F
Sbjct: 288 DAIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  168 bits (427), Expect = 4e-49
 Identities = 101/304 (33%), Positives = 158/304 (51%), Gaps = 21/304 (6%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           VG+G++G V  A      + VA+KK+      L   R   REL++++ + H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 98  FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F   T  E    + LV   +   +N I +      Q++   +V+   YQ+ R L YIH+ 
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE++     Y
Sbjct: 138 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPEIMLNWMHY 193

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +K ++  +      
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253

Query: 277 QIKPHPWH---KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
            +   P     K+F +   P A+DL+ +      + R +A EA  HP+F +  DP    P
Sbjct: 254 SLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE-P 311

Query: 334 NGRP 337
              P
Sbjct: 312 EAEP 315

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  168 bits (427), Expect = 5e-49
 Identities = 92/307 (29%), Positives = 158/307 (51%), Gaps = 44/307 (14%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-VLQDKR---YKNRELQIMQMLDHPNIVALKHCFF 99
           +G GS G+VF A   +  + VA+KK VL D +   +  RE++I++ LDH NIV +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 100 S-----TTDKEELY----LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
                 T D   L     + +V EY+   +  +          +   + +L+ YQ+ R L
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGL 127

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRY 203
            YIH+   + HRD+KP N+ +N     LK+ DFG A+++   +P+ S+       + +++
Sbjct: 128 KYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKW 183

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTR 260
           YR+P L+     YT AID+W+ GC+ AE+L G+PLF G   ++Q+   +E + V+    R
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 261 EEIKCMNPNYTEFKFPQIKPHPW--HKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALE 315
            E+  + P++       ++       +  +  LP   PEA+D + +   ++P  R TA E
Sbjct: 244 NELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 316 ACVHPFF 322
           A +HP+ 
Sbjct: 297 ALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  167 bits (425), Expect = 5e-49
 Identities = 106/322 (32%), Positives = 151/322 (46%), Gaps = 56/322 (17%)

Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 94
           +G G++G V++AK +    G+  AIKK   DK           RE+ +++ L H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRA 149
              F    DK    + L+ +Y    + +I + + +     I   M    VK   +QI   
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNG 120

Query: 150 LAYIH-NCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNVSY 198
           + Y+H N +   HRD+KP N+LV    P    +K+ D G A       K L   +P V  
Sbjct: 121 VHYLHSNWV--LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV 249
           I   +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL 
Sbjct: 179 I---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 250 EIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----HKVFQKRLP--PEAVDLVC 300
            I +VLGTPT ++   IK M P Y                  K  +K      +  DL+ 
Sbjct: 236 RIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 301 RFFQYSPNLRCTALEACVHPFF 322
           +  +Y P  R TA EA  HP+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  166 bits (422), Expect = 8e-49
 Identities = 98/308 (31%), Positives = 164/308 (53%), Gaps = 23/308 (7%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
           +YI    +G G++  V++ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L H    T    E  L LV EY+ + + +   +       + +  VKL+ +Q+ R L 
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 208
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 266
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
           N  +  + +P+ +    H     RL  +  +L+ +  Q+    R +A EA  HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 327 DPNTRLPN 334
           +   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  165 bits (420), Expect = 1e-48
 Identities = 108/300 (36%), Positives = 163/300 (54%), Gaps = 28/300 (9%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNI 91
           SY+    +G GS+  V++   R  G++VA+K +             RE  +++ L H NI
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 92  VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           V L H    T +     L  V EY+  +    + ++   +H       V+L+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRGL 116

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 207
           AYIH    I HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 AYIHG-QHILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPP 172

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 266
           +++ GAT+Y++A+DIW  GC+  E+L GQP FPG S V +QL +I  VLG PT +    +
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232

Query: 267 N--PNYTEFKFPQIKPHPWHKVFQKRL--PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           +  PNY    F   KP     V+ KRL  PP+A DL  +     P  R +A +A +HP+F
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  166 bits (421), Expect = 3e-48
 Identities = 104/298 (34%), Positives = 158/298 (53%), Gaps = 24/298 (8%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 97  CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F      EE   + LV   +   +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 138

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  162 bits (412), Expect = 9e-48
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 42/285 (14%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHC 97
             +G G FG V++A+ + TG+ VAIK + L+ K  K     E+QI++   HPNIV     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 98  FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           +     K+EL+  +V+E+    ++  + ++    +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
               DIWS G    EL  G+P +  E    + +  I   G P                  
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPP---------------GLR 218

Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
              P  W          E  D + +  Q +P  R TA +   HPF
Sbjct: 219 --NPEKW--------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  161 bits (411), Expect = 1e-47
 Identities = 91/292 (31%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALKH 96
           +G GSFG V   + ++TG++ A+K     K+++ K   +   E  I+  ++HP IV L H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 97  CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             F T +K    L LVLEY P  E  + +++       R      + Y  +I  AL Y+H
Sbjct: 60  YAFQTEEK----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLH 110

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 213
           +  GI +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y  A+D WS G ++ E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CV--HPFF 322
           +FP            + L PEA DL+    Q  P  R  +  A  +  HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  162 bits (412), Expect = 2e-47
 Identities = 97/296 (32%), Positives = 156/296 (52%), Gaps = 23/296 (7%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
           +Y+    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L H    T    E  L LV EY+   + +   N   +   M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 208
           Y H    I HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 266
           ++ G+TEY+T ID+W  GC++ E+  G+P+FPG +  ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           N  +  + FPQ +  P       RL  + +DL+     Y    R +A  A  H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  157 bits (398), Expect = 2e-45
 Identities = 97/310 (31%), Positives = 150/310 (48%), Gaps = 53/310 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 96
            +G G++G V++A+ ++TGE+VA+KKV  D   +       RE++I++ L+H NIV LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 97  CFFSTTD-----KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY------- 144
                 D     K++    LV EY+              H  M L+   L  +       
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMD-------------HDLMGLLESGLVHFSEDHIKS 120

Query: 145 ---QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYI 199
              Q+   L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + +
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
            + +YR PEL+ G   Y  AID+WS GC++ EL   +P+F     + QL  I ++ G+P 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 260 REEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRL-------PPEAVDLVCRFFQYSPNLRC 311
                 + P+  +   F  +KP    K +++RL       P  A+DL+       P+ RC
Sbjct: 239 ----PAVWPDVIKLPYFNTMKP---KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291

Query: 312 TALEACVHPF 321
           TA EA   P+
Sbjct: 292 TAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  152 bits (387), Expect = 4e-43
 Identities = 103/319 (32%), Positives = 161/319 (50%), Gaps = 44/319 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKR-YKNRELQIMQMLDHP 89
           Y     +G+G+ G+V  A    TG+ VAIKK       V   KR Y  REL +M++++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 90  NIVALKHCFFSTTDK-----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 144
           NI+ L + F  T  K     +++YL  V+E +   + ++       H+RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
           Q+   + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
           RAPE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  +II+ LGTP+ E + 
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 265 CMNP---NYTEFKFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNL 309
            + P   NY E + P+   + + ++F             K    +A DL+ +     P  
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 310 RCTALEACVHPFFDELRDP 328
           R +  +A  HP+ +   DP
Sbjct: 302 RISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  145 bits (369), Expect = 6e-41
 Identities = 93/302 (30%), Positives = 141/302 (46%), Gaps = 34/302 (11%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH- 96
           +G G+FG VF+A+ ++T +IVA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 97  CFFSTT----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           C    T     K   YL  V E+     + +A   S  + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAP 207
           IH    I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 266
           EL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 267 N-PNYTEFKFPQ-----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
               + + + PQ     +K      V      P A+DL+ +     P  R  A  A  H 
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKD----PHALDLIDKLLVLDPAKRIDADTALNHD 308

Query: 321 FF 322
           FF
Sbjct: 309 FF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  140 bits (355), Expect = 2e-39
 Identities = 90/287 (31%), Positives = 134/287 (46%), Gaps = 46/287 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL---QDKRYK------NRELQIMQMLDHPNIVAL 94
           +G+GSFG V++    + G+  A+K+V      +  +       +E+ ++  L HPNIV  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
               +  T++EE  L + LE VP     +A+   + +   P   ++LYT QI   L Y+H
Sbjct: 67  ----YLGTEREEDNLYIFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH 119

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
           +     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I    
Sbjct: 120 D-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y  A DIWS GC + E+  G+P +    GV  + +I +    P                
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---------------- 221

Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                P P H      L  EA D + +  Q  P+LR TA E   HPF
Sbjct: 222 -----PIPDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  141 bits (356), Expect = 2e-39
 Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 32/296 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 90
           +G G++G V++A+   +G  VA+K V    R +  E             L+ ++  DHPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 91  IVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQR-MPLIYVKLYTYQIC 147
           IV L   C  S TD+E   + LV E+V + +    R Y  ++    +P   +K    Q  
Sbjct: 64  IVRLMDVCATSRTDRE-TKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 148 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
           R L ++H NCI   HRD+KP+N+LV     Q+KL DFG A++          + + +YRA
Sbjct: 119 RGLDFLHANCI--VHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 233

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           +       F    P P   V  + +      L+     ++P+ R +A  A  HPFF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  139 bits (354), Expect = 3e-39
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y     +G GSFG V+  + +  G++  +K++       +++     E++I++ L+HPNI
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +     F     +E+  L +V+EY     +++  +   +  +  P   +  +  Q+C AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRA 206
            Y+H+   I HRDIKPQN+ +      +KL DFG +KVL      V    +     YY +
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLS 171

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           PEL      Y    DIWS GCV+ EL   +  F GE+
Sbjct: 172 PELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  139 bits (352), Expect = 1e-38
 Identities = 101/302 (33%), Positives = 158/302 (52%), Gaps = 26/302 (8%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 91
           SY     +G GS+  V++ K +  G++VA+K + LQ++        RE  +++ L H NI
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 92  VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           V L H    T +     L LV EYV  +    + ++   +H       VKL+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 207
           +YIH    I HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPP 172

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM 266
           +++ G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232

Query: 267 N--PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
           +  P++   +F    P    + + K      A DL  +  Q  P  R +A  A  H +F 
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292

Query: 324 EL 325
           +L
Sbjct: 293 DL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  135 bits (341), Expect = 3e-37
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 50/294 (17%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 95
           + +G G+FG V+ A   +TGE++A+K++ +QD   K       E++++++L HPN+V   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 96  HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             +     +E++Y+   +EY    T+  +   + RI   +    +++YT Q+   LAY+H
Sbjct: 64  -YYGVEVHREKVYI--FMEYCSGGTLEELLE-HGRI---LDEHVIRVYTLQLLEGLAYLH 116

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRAPEL 209
           +  GI HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+
Sbjct: 117 SH-GIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 210 IFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           I G     +  A DIWS GCV+ E+  G+  +       Q++  +     P         
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-------- 226

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                   P             +L PE  D + R  +  P  R TA E   HPF
Sbjct: 227 -------IPDS----------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  133 bits (338), Expect = 1e-36
 Identities = 88/320 (27%), Positives = 138/320 (43%), Gaps = 77/320 (24%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLD-HP 89
           +    ++G GSF  V  AK +ET +  AIK     +++++K+  Y   E +++  L+ HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            I+ L + F    D+E LY   VLEY P   N     Y R +  +     + Y  +I  A
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAP---NGELLQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRY-- 203
           L Y+H+  GI HRD+KP+N+L++   H +K+ DFG+AKVL                    
Sbjct: 115 LEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 204 ---------------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
                          Y +PEL+        + D+W+ GC++ ++L G+P F G +  + L
Sbjct: 173 EKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYL 229

Query: 249 V--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
              +I+K                  E+ FP               PP+A DL+ +     
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260

Query: 307 PNLRCTALEACV----HPFF 322
           P  R    E       HPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 2e-36
 Identities = 87/288 (30%), Positives = 139/288 (48%), Gaps = 48/288 (16%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALKH 96
           ++G G+FGVV++    ETG+ VAIK++ L+  + +      +E+ +++ L HPNIV    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                  +    L ++LEY    ++ +I + +    + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELIFGAT 214
             G+ HRDIK  N+L       +KL DFG A K+    + + S + + Y+ APE+I   +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
             +TA DIWS GC + ELL G P +                          +NP    F+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNPMAALFR 210

Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
             Q   HP      + + PE  D + + FQ  PNLR TA +   HP+ 
Sbjct: 211 IVQ-DDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  130 bits (328), Expect = 2e-35
 Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 45/271 (16%)

Query: 47  GSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALKHCFF 99
           G++G VF AK + TG+I AIK +   D   KN+      E  I+     P +V L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 100 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           S   K+ LYL  V+EY+P   +  +  N   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNVSYICSRYYRAPEL 209
           I HRD+KP N+L++ + H LKL DFG +KV +             +   + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII--KVLGTPTREEI---- 263
           I G   ++  +D WS GC++ E L+G P F GE+  +++ + I    +  P   E+    
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEA 230

Query: 264 -----KCMNPNYTE---FK-FPQIKPHPWHK 285
                K + P+  +    K   +IK HP+ K
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  132 bits (332), Expect = 4e-35
 Identities = 95/305 (31%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 98  FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F      EE   + LV+E +   + ++  +    H+RM  +      YQ+   + ++H+ 
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGIKHLHSA 142

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 143 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGY 199

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 273
              +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E 
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259

Query: 274 K-------FPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
           +       F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+  
Sbjct: 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319

Query: 324 ELRDP 328
              DP
Sbjct: 320 VWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  131 bits (331), Expect = 5e-35
 Identities = 98/305 (32%), Positives = 154/305 (50%), Gaps = 29/305 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 98  FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F      EE   + LV+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 138

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 139 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 272
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255

Query: 273 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
                   FP++ P    P      K    +A DL+ +     P  R +  EA  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315

Query: 324 ELRDP 328
              DP
Sbjct: 316 VWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  128 bits (324), Expect = 7e-35
 Identities = 74/241 (30%), Positives = 127/241 (52%), Gaps = 21/241 (8%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYK-NRELQIMQMLDHPNIVALKH 96
            V+G GS GVV++ + + TG+I A+KK+     ++ R +  REL+ ++  + P +V    
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F+      E  +++VLEY+   ++  + +       ++P   +     QI + L Y+H 
Sbjct: 67  AFYK-----EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGAT 214
              I HRDIKP NLL+N    ++K+ DFG +KVL    +   +++ +  Y +PE I G +
Sbjct: 118 KRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 215 EYTTAIDIWSTGCVMAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
            Y+ A DIWS G  + E  LG+ P L PG+    +L++ I   G P     +  +P + +
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRD 234

Query: 273 F 273
           F
Sbjct: 235 F 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  127 bits (320), Expect = 3e-34
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 47/290 (16%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKN---RELQIMQMLDHPNIVALKHC 97
            +G G+ GVV +   R TG+I+A+K +    ++  +    REL I+   + P IV     
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F++  D     +++ +EY+      + +    +  R+P   +      + + L Y+H   
Sbjct: 68  FYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 217
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y+
Sbjct: 121 KIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYS 177

Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYTE 272
              DIWS G  + EL  G+  +P E+       + L  I+               P    
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP---- 221

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              P++    +         P+  D V       P  R +  E   HPF 
Sbjct: 222 ---PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  129 bits (324), Expect = 4e-34
 Identities = 96/306 (31%), Positives = 155/306 (50%), Gaps = 31/306 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 98  FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F      EE   + +V+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 145

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   Y
Sbjct: 146 -GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 273
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262

Query: 274 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

Query: 323 DELRDP 328
           +   DP
Sbjct: 322 NVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  125 bits (316), Expect = 2e-33
 Identities = 93/304 (30%), Positives = 154/304 (50%), Gaps = 29/304 (9%)

Query: 34  QKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQML 86
           Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L
Sbjct: 1   QQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 87  D---HPNIVAL-KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 142
           +   HPN+V L   C  S TD+E   L LV E+V + +             +P   +K  
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 115

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
            +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + 
Sbjct: 116 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTL 173

Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+
Sbjct: 174 WYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232

Query: 263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE----AVDLVCRFFQYSPNLRCTALEACV 318
                P                 +  ++   +      DL+ +   ++P  R +A  A  
Sbjct: 233 W----PRDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286

Query: 319 HPFF 322
           HP+F
Sbjct: 287 HPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  124 bits (315), Expect = 3e-33
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 26/207 (12%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 95
            +GTGSFG V   + + +G+  A+K     K+++ K+ +    E +I+Q + HP +V L 
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
             F     +++  L LV+EYVP  E  + + ++      R P    + Y  Q+  AL Y+
Sbjct: 68  GSF-----QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYL 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H+   I +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I  
Sbjct: 118 HSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIILS 172

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLF 239
              Y  A+D W+ G ++ E+L G P F
Sbjct: 173 -KGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  121 bits (305), Expect = 4e-32
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 48/238 (20%)

Query: 41  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
              +G G+FG V++   +         VA+K + +D   +      RE +IM+ LDHPNI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 149
           V L       T++E L   +V+EY+P        +Y R ++   L    L  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 150 LAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 205
           + Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YY+  
Sbjct: 116 MEYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVK 162

Query: 206 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
                    APE +    ++T+  D+WS G ++ E+  LG+  +PG S   +++E +K
Sbjct: 163 GGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  120 bits (303), Expect = 8e-32
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 47/237 (19%)

Query: 41  EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
              +G G+FG V++ K +         VA+K + +D   +      RE +IM+ LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 150
           V L       T++E LY  +V+EY+         +Y R ++ ++ L  +  +  QI R +
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 151 AYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+   N I   HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 116 EYLESKNFI---HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 206 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
                   APE +    ++T+  D+WS G ++ E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 1e-31
 Identities = 98/349 (28%), Positives = 146/349 (41%), Gaps = 87/349 (24%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
           V+G G+FG V+  + ++TG++ A+K + +    K  ++        I+   D P IV L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
             ++S  D+E LY  LV+EY+P  + +N + R         P    + Y  ++  AL  +
Sbjct: 67  --YYSFQDEEHLY--LVMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSV 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 190
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 191 KGEPNVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           +   +               Y APE++ G T Y    D WS G ++ E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 244 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
               L E        T  +I     N+ E  +FP   P          + PEA+DL+CR 
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPPDPP----------VSPEAIDLICRL 268

Query: 303 FQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG 351
                +   +  E   HPFF           N R   P F    PELS 
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF-----KGIDWENLRETKPPF---VPELSS 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  117 bits (294), Expect = 1e-30
 Identities = 93/308 (30%), Positives = 141/308 (45%), Gaps = 67/308 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKN------RELQIMQ 84
           +I   ++G+GSFG V+      +GE++A+K+V           R ++      RE+ +++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 85  MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT 143
            L H NIV               +LN+ LEYVP  +V  +  NY    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGSSLDAD-----HLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV------- 196
            QI + L Y+HN  GI HRDIK  N+LV+ +   +K+ DFG +K   K E N        
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 197 ---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
              S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223

Query: 254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 313
           +                 E   P+I  +         +  EA+D + + F+   N R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258

Query: 314 LEACVHPF 321
            E   HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  117 bits (294), Expect = 2e-30
 Identities = 91/305 (29%), Positives = 142/305 (46%), Gaps = 53/305 (17%)

Query: 36  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYK------NRELQ 81
             ++   ++G G++G V+ A    TGE++A+K+V          D R K        E++
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 82  IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVK 140
            ++ LDH NIV          +  E YL++ LEYVP  ++    R Y R  +++    V+
Sbjct: 61  TLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VR 111

Query: 141 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNVS 197
            +T Q+   LAY+H+  GI HRD+K  NLLV+      K+ DFG +K    +   + N+S
Sbjct: 112 FFTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 198 YICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
              S ++ APE+I   ++ Y+  +DIWS GCV+ E+  G+  +  E              
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------------- 215

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
               E I  M     +   P I P          L P A+D +   F  +P+ R TA E 
Sbjct: 216 ----EAIAAMFKLGNKRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTAREL 266

Query: 317 CVHPF 321
             HPF
Sbjct: 267 LQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  116 bits (292), Expect = 2e-30
 Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 47/287 (16%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFS 100
            +G GS+G V++A  +ETG++VAIK V  ++  +   +E+ I++  D P IV     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 101 TTDKEELYLNLVLEY-VPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
            TD     L +V+EY    +V+ I    N +   + +  I      YQ  + L Y+H+  
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-----LYQTLKGLEYLHS-N 118

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIFGATE 215
              HRDIK  N+L+N    Q KL DFG +  L     + N + I + ++ APE+I     
Sbjct: 119 KKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRN-TVIGTPFWMAPEVIQE-IG 175

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y    DIWS G    E+  G+P                    P  +    ++P    F  
Sbjct: 176 YNNKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMI 211

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           P  KP P      ++  PE  D V +     P  R +A++   HPF 
Sbjct: 212 PN-KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  116 bits (293), Expect = 2e-30
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 22/225 (9%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 96
            +G GSFG V + + +  G+I+  K++       ++K+    E+ I++ L HPNIV    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 D+    L +V+EY     + ++ +   +  + +   ++     Q+  AL   HN
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 156 CIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 208
                  + HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (288), Expect = 2e-29
 Identities = 85/294 (28%), Positives = 129/294 (43%), Gaps = 58/294 (19%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
             +G G+ G V++A  R TG+ VAIKK+ L+ +  +    E+ IM+   HPNIV     +
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 99  FSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
                 +EL++  V+EY+         T N +  N  +I       YV     ++ + L 
Sbjct: 85  L---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQI------AYVCR---EVLQGLE 130

Query: 152 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPE 208
           Y+H  N I   HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           +I    +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K    
Sbjct: 187 VIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK---- 237

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                      P  W   F+        D + +     P  R +A E   HPF 
Sbjct: 238 ----------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 5e-29
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 56/290 (19%)

Query: 47  GSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQ---IMQMLDHPNIVALKHCF 98
           G+FG V+ AK R TG+  AIK      ++   +  N + +   +M   + P +  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYIHN 155
           +S   K+  YL LV+EY+         + + + + +   P  + K Y  ++   +  +H 
Sbjct: 64  YSFQSKD--YLYLVMEYLN------GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  +
Sbjct: 116 -RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
                D WS GCV+ E L G P F  E+  D + + I          I            
Sbjct: 171 -DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRIN----------- 211

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF 322
                  W +  ++   PEAVDL+ R     P  R  A    E   HPFF
Sbjct: 212 -------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  112 bits (283), Expect = 6e-29
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 93
            +G G+FG V++   +  GE     VA+K + +    +       E  IM+ L HPNIV 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
           L       T  E LY  +V EY+P        ++ R H +++ L  +     QI + + Y
Sbjct: 66  LLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 153 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 205
           +   N +   HRD+  +N LV      +K+ DFG ++ + + +         YYR     
Sbjct: 118 LESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGG 164

Query: 206 -------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                  APE +    ++T+  D+WS G ++ E+  LG+  +PG S  +
Sbjct: 165 KLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  111 bits (279), Expect = 2e-28
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 20/214 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPN 90
           +    V+G G+FG V   + R+T ++ A+K     K ++    +N   E +I+Q L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 149
           +V L   ++S  D+E +YL  V++ +     R    Y    + +     VK +  +I  A
Sbjct: 62  LVNL---WYSFQDEENMYL--VVDLLLGGDLR----YHLSQKVKFSEEQVKFWICEIVLA 112

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           L Y+H+  GI HRDIKP N+L++   H + + DF  A  +       S   +  Y APE+
Sbjct: 113 LEYLHS-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEV 170

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           +     Y+ A+D WS G    E L G+  + G S
Sbjct: 171 LCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS 203

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  110 bits (276), Expect = 5e-28
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 56/296 (18%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G G FG V   K +      A+K V          + +   E +I++  +HP IV L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 97  CFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             F    K++ Y+ +++EY       T+ R    +     R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +HN  GI +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I  
Sbjct: 109 LHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
              Y  ++D WS G ++ ELL G+P F GE   D +             +I   N     
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL-- 213

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFD 323
            +FP              +   A DL+ +  + +P  R   L+  +     H +F+
Sbjct: 214 -EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (276), Expect = 6e-28
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 48/228 (21%)

Query: 43  VVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 94
            +G G+FG V++ K +        VA+K + +D   + R     E ++M+ L HPN+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKL--YTYQICR 148
                  T++E LY  LVLEY+         R +R      ++  L    L  +  QI +
Sbjct: 62  LGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 149 ALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 205
            + Y+     +   HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 117 GMEYLASKKFV---HRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 206 -----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
                      APE +     +T+  D+WS G ++ E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  109 bits (273), Expect = 2e-27
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNR---ELQIMQMLDHPN 90
           +  E  +G G F VV++A C   G +VA+KKV    + D + +     E+ +++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           ++     F      E   LN+VLE      ++R+ +++ +  + +P   +  Y  Q+C A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 208
           L ++H+   I HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
            I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  108 bits (272), Expect = 2e-27
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 51/296 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYKN--RELQIMQMLDHPNIV 92
            +GTG+F   +QA+  +TG ++A+K+V         Q++  +   +E+++M  L+HP+I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
                  +T   E+ + NL +E++   +V+ +   Y    +    + +  YT Q+ R L+
Sbjct: 67  ---RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGLS 117

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNVSYICSRYYRA 206
           Y+H    I HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K         I   
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    P I  H         L P   D+  R  +  P  R  + E   HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  109 bits (273), Expect = 4e-27
 Identities = 97/320 (30%), Positives = 153/320 (47%), Gaps = 52/320 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 98
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN+++L+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 99  FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
            S  D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+
Sbjct: 68  LSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 154 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 203
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 254
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240

Query: 255 LGTPTR---EEIKCMNPNYTEFK---------FPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           +G P     E+IK M  + T  K            IK    HKV   +   +A  L+ + 
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKL 297

Query: 303 FQYSPNLRCTALEACVHPFF 322
               P  R T+ +A   P+F
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  109 bits (272), Expect = 4e-27
 Identities = 95/318 (29%), Positives = 156/318 (49%), Gaps = 48/318 (15%)

Query: 44  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 98
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN++AL+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 99  FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
            S +D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+
Sbjct: 68  LSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 154 HNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNVSYICSRY 203
           H    + HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKV 254
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240

Query: 255 LGTPTR---EEIKCMNPNY----TEFKFPQIKPHPWHKVFQK-RLPPEA--VDLVCRFFQ 304
           +G P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +   
Sbjct: 241 MGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299

Query: 305 YSPNLRCTALEACVHPFF 322
             P  R T+ +A   P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 5e-27
 Identities = 86/298 (28%), Positives = 126/298 (42%), Gaps = 59/298 (19%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYKNRELQ---IMQMLDHPNIVALKH 96
           VG G +G VF AK ++TGEIVA+    K +L         L    I+       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHN 155
            F    D E LY  L +EYVP    R   N   +  +     + + Y  ++  A+  +H 
Sbjct: 69  AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
            +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y   +D WS GC++ E L G P F G                          PN T   +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGS------------------------TPNET---W 207

Query: 276 PQIKPHPWHKVFQK--------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
             +K   W +  Q+         L  EA DL+ +          +  +   HPFF E+
Sbjct: 208 ENLK--YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 7e-26
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDH---PNIVAL 94
           ++G G++G V++ K   TG +VA+K +  D    +     RE+ ++  L     PNI   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              +          L +++EY      R       I ++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGA 213
             +G+ HRDIK  N+LV  +T  +KLCDFG A +L +     S ++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
             Y T  DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  101 bits (254), Expect = 2e-24
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 27/210 (12%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 94
             +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 152
           K C+       E    LV+EY   +    A +   +H++ PL  V++    +   + LAY
Sbjct: 81  KGCYL-----REHTAWLVMEYCLGS----ASDILEVHKK-PLQEVEIAAICHGALQGLAY 130

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +H+   I HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I  
Sbjct: 131 LHSHERI-HRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILA 185

Query: 213 ATE--YTTAIDIWSTGCVMAELLLGQ-PLF 239
             E  Y   +D+WS G    EL   + PLF
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  100 bits (250), Expect = 8e-24
 Identities = 102/346 (29%), Positives = 153/346 (44%), Gaps = 63/346 (18%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKH 96
           +GTGSFG V  AK + TGE  AIK     ++L+ K+ +   +E  I+  L HP IV +  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F    D+  +Y   +LE+V   V      + R   R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVY--FLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRAPELIFGAT 214
             I +RD+KP+NLL++   H +K+ DFG AK +    P+ ++ +C +  Y APE+I  + 
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            +  A+D W+ G ++ E + G P F  +              TP R   K +       K
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLK 233

Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPN 329
           FP      W   F  R    A DLV    Q     R   L+  V     HP+F    + +
Sbjct: 234 FPN-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA-NWD 280

Query: 330 TRLPNGRPLP-PLFNFKPPELSGI---PPETINRLIPEHARKQNLF 371
                  P P P+    P + S     P   ++RL P  A +Q  F
Sbjct: 281 KLYARYYPAPIPVRVKSPGDTSNFEKYPDSPVDRLPPLTAAQQAEF 326

Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 99.9 bits (249), Expect = 1e-23
 Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIM-------QMLDHPNIVA 93
           V+G GSFG V  AK +  G+  A+ KVLQ K    K  +  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           L H  F T DK    L  VL+YV   E    + R      +  P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTADK----LYFVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALG 110

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLF 239
                Y   +D W  G V+ E+L G P F
Sbjct: 169 R-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 42/287 (14%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK---NRELQIMQMLDHPNIVALKHCF 98
           V+G G++G+V+ A+   T   +AIK++  +D RY    + E+ +   L H NIV      
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----- 69

Query: 99  FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           +  +D E  +  + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYLHD- 126

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELI-FGAT 214
             I HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  G  
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y    DIWS GC + E+  G+P F                       I+   P    FK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAAMFK 223

Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
               K HP      + L  EA + + R F+  P+ R +A +    PF
Sbjct: 224 VGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 37/285 (12%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 90
           ++  H +G GSFG V+ A    T E+VA+KK+    +  N       +E++ +Q L HPN
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICR 148
            +  K C+      +E    LV+EY   +    A +   +H++ PL  V++   T+   +
Sbjct: 83  TIEYKGCYL-----KEHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQ 132

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            LAY+H+   I HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE
Sbjct: 133 GLAYLHSHNMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPE 187

Query: 209 LIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           +I    E  Y   +D+WS G    EL   +P     + +  L  I +   +PT +  +  
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWT 246

Query: 267 NP-----NYTEFKFPQIKPHPW----HKVFQKRLPPEA-VDLVCR 301
           +      +Y   K PQ +P       H   ++  P    +DL+ R
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 3e-23
 Identities = 67/215 (31%), Positives = 112/215 (52%), Gaps = 36/215 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           VGTG+FG V   + R +    A+K +       L+ +++ + E ++++ + HP I+ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 97  CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            F++  D+  LY+  ++EYVP  E  + + RN  R      L     Y  +I  AL Y+H
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELFSYL-RNSGRFSNSTGL----FYASEIVCALEYLH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAPE 208
           +   I +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE
Sbjct: 119 S-KEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPE 168

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           +I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 169 VI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 81/292 (27%), Positives = 124/292 (42%), Gaps = 50/292 (17%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK---RYKNRELQIMQMLDHPNIVALKHC 97
             +G+G++G V++A+   TGE+VAIK + L+         +E+ +++   HPNIVA    
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAYIHNC 156
           +          L +V+EY      +     +R       I YV   T +    LAY+H  
Sbjct: 69  YLRRD-----KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLHE- 119

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
            G  HRDIK  N+L+      +KL DFG SA++        S+I + Y+ APE+   A E
Sbjct: 120 TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA--AVE 176

Query: 216 ----YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
               Y    DIW+ G    EL   Q P+F         +  ++ L   ++          
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS--------- 219

Query: 271 TEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
             F  P++K    W  VF         D + +     P  R TA +   HPF
Sbjct: 220 -NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 51/292 (17%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR------ELQIMQMLDHPNIVAL 94
           +G G+FG V+     +TG  +A+K+V         K        E+Q+++ L H  IV  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             C     D E L +   +EY+P       ++  + +  +     + YT QI   + Y+H
Sbjct: 70  YGCL---RDDETLSI--FMEYMP---GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPELI 210
           + + I HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +PE+I
Sbjct: 122 SNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
            G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT           
Sbjct: 180 SGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN---------- 225

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                PQ+  H         + P+A + + R F  +   R +A E   H F 
Sbjct: 226 -----PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 71/213 (33%), Positives = 100/213 (46%), Gaps = 36/213 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNI 91
           YI   V+G G+FG     +  E   +V  K+V L     K R     E+ I+ +L HPNI
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           +A  + F      ++  L + +EY       ++I R   +  Q      V  Y +QI  A
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSA 113

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNVSYIC 200
           ++YIH   GI HRDIK  N+ +      +KL DFG +K+L         V G P      
Sbjct: 114 VSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------ 165

Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
             YY +PEL  G  +Y    DIW+ GCV+ ELL
Sbjct: 166 --YYMSPELCQGV-KYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.5 bits (235), Expect = 3e-22
 Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 16/208 (7%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKH 96
           VVG G+FG+V   + +   ++V IK++  ++  K+       E Q++++L HPNI+    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F      E+  L +V+EY P  T+    +   R +  +    +  +  QI  AL ++H 
Sbjct: 67  NFL-----EDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
            + I HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL  G   
Sbjct: 120 KL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KP 177

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
           Y    DIW+ GCV+ EL   +  F   +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 94.4 bits (235), Expect = 4e-22
 Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 49/298 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 97
           +G GS G+V  A  + TG  VA+KK+  D R + R      E+ IM+   HPNIV +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 98  FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           + S    +EL++  V+E++    +  I       H RM    +      + +AL+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA- 133

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATE 215
            G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     
Sbjct: 134 QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y T +DIWS G ++ E++ G+P +  E  +  +            + I+   P       
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP------- 232

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
           P++K    HKV      P     + R     P  R TA E   HPF  +   P++ +P
Sbjct: 233 PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 6e-22
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 29/214 (13%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQML-DHPNIVALKH 96
           V+G G++G V++A+ ++TG++VAIK  + D           E  I++   +HPNI     
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 97  CFF---STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            F       + ++L+  LV+E     +V  + +   +  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 153 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPEL 209
           +H    I   HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+
Sbjct: 129 LHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 210 IFGATE------YTTAIDIWSTGCVMAELLLGQP 237
           I  A +      Y    D+WS G    EL  G+P
Sbjct: 185 I--ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (233), Expect = 1e-21
 Identities = 92/320 (28%), Positives = 139/320 (43%), Gaps = 56/320 (17%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 96
           +G GSFG V Q + R+T  I A+K + +       E+        ++  ++ P IV LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
             FS    E+LYL L      E  + + R       R  L   + YT ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHK- 111

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATE 215
             + +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           YT A+D W+ G ++ E+L G P F  E+ V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--------------- 211

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDPNTRL 332
                      F      +A DL+       P  R     A E   HPFF +L     +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258

Query: 333 PNGRPLPPLFNFKPPELSGI 352
                 PP   FKP   S I
Sbjct: 259 LMKGIQPP---FKPAVSSAI 275

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 57/296 (19%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 92
           +     +G GSFG V++A  + T ++VAIK +       +     +E+Q +     P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
                F   +      L +++EY          +  +   ++   Y+     ++   L Y
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCG---GGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 205
           +H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++ 
Sbjct: 114 LHE-EGKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL        K 
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPKN 213

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            NP       P ++ + + K F+        D V       P  R +A E   H F
Sbjct: 214 -NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 86/321 (26%), Positives = 134/321 (41%), Gaps = 61/321 (19%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 95
           +G G FG V   + + TG++ A KK L  KR K R        E +I++ +    IV+L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 96  HCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + F  T D   L + L+    L+Y    V       +R            Y  QI   L 
Sbjct: 60  YAF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR---------AIFYAAQIICGLE 109

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           ++H    I +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ 
Sbjct: 110 HLHQ-RRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
           G   Y  ++D ++ GC + E++ G+  F       Q  E ++      +EE+K       
Sbjct: 168 GE-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-M 213

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR 326
             ++P             +  PEA DL     Q  P  R      +A E   HP F +L 
Sbjct: 214 AVEYPD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Query: 327 DPNTRLPNGRPLPPLFNFKPP 347
               RL  G   PP   F P 
Sbjct: 262 WR--RLEAGMLEPP---FIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           C+       E    LV+EY   + + +   + +  Q + +  V   T+   + LAY+H+ 
Sbjct: 83  CYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHSH 134

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 215
             + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    E 
Sbjct: 135 -NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEG 189

Query: 216 -YTTAIDIWSTGCVMAELLLGQP 237
            Y   +D+WS G    EL   +P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 79/303 (26%), Positives = 127/303 (41%), Gaps = 51/303 (16%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKHCF 98
           G G++GVV + +   TG I+A+K++   +  +  K    +L I M+ +D P  V      
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           F   D     + + +E +  ++++  +        +P   +      I +AL Y+H+ + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 215
           + HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y    D+WS G  M EL  G+  FP +S             TP                F
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTP----------------F 214

Query: 276 PQIK-----PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
            Q+K     P P  ++  ++  PE  D V +  + +   R    E   HPFF+     NT
Sbjct: 215 QQLKQVVEEPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272

Query: 331 RLP 333
            + 
Sbjct: 273 DVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.5 bits (229), Expect = 4e-21
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 26/205 (12%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q + HPN +  K 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 154
           C+       E    LV+EY   +    A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 93  CYL-----REHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
           +   I HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SHNMI-HRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 215 E--YTTAIDIWSTGCVMAELLLGQP 237
           E  Y   +D+WS G    EL   +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 58/299 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 94
           V+G GSFG V  A+ + T E+ A+K      +LQD   +    E +++ +   HP +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAY 152
            H  F T D+    L  V+EYV    N     +  I +  R      + Y  +I   L +
Sbjct: 62  -HSCFQTKDR----LFFVMEYV----NGGDLMF-HIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 211
           +H   GI +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               Y  A+D W+ G ++ E+L GQ  F G+   D+L + I             +     
Sbjct: 170 Y-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSI-------------LEDEV- 213

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDEL 325
                          + + L  EA  ++  F   +P  R   L         HPFF E+
Sbjct: 214 --------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 98
           G GS+G V++ K     +  A+K+V L     K R     E++I+  ++HPNI++ K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 99  FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIH 154
               D  +L +  V+EY P  +    I++   R  +R  +   +++    Q+ R L  +H
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 155 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 213
               I HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++  
Sbjct: 121 E-QKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKG 175

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
             Y+   DIWS GC++ E+    P F   S  D   ++ +
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 90.7 bits (225), Expect = 7e-21
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYK--NRELQIMQMLDHPNIV 92
           V+G G++G V+       G+++A+K+V  D        K Y+    E+ +++ L H NIV
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
                 +  T  ++  +++ +E+VP     I+   +R       ++ K YT QI   +AY
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPG--GSISSILNRFGPLPEPVFCK-YTKQILDGVAY 117

Query: 153 IH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI-------CSRYY 204
           +H NC+   HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 118 LHNNCV--VHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 237
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.0 bits (226), Expect = 7e-21
 Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 36/286 (12%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 98
           +G G+ G V + K   TG ++A K V    +        RELQIM     P IV+    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 99  FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
            +  +     + + +E++   +++RI +    I    P+  +      +   L Y++N  
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 217
            I HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 218 TAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              D+WS G  + EL LG+ P        D   + + +L                     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223

Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           QI   P  ++     P +  D V       P  R T  + C  P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 92.5 bits (230), Expect = 7e-21
 Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 67/311 (21%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 95
           V+G G+FG V   + + + ++ A+K + + +  K         E  IM   +   IV L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           H  F    +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 109 HYAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----IPEKWARFYTAEVVLALDAI 158

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPE 208
           H+ +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213

Query: 209 LIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           ++    G   Y    D WS G  + E+L+G   F  +S V          GT +    K 
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------GTYS----KI 259

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF- 322
           M+ +     FP              +  +A DL+C F         R    E   HPFF 
Sbjct: 260 MD-HKNSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308

Query: 323 ------DELRD 327
                 D +R+
Sbjct: 309 NDQWTFDNIRE 319

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 39/301 (12%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK-RYKN---RELQIMQMLDHPNIVALKHC 97
            +G G+ GVV +   R +G I+A K + L+ K   +N   REL+++   + P IV     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 98  FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F+S  D E   +++ +E++   +++++ +   RI    P   +   +  + R L Y+   
Sbjct: 68  FYS--DGE---ISICMEHMDGGSLDQVLKKAGRI----PENILGKISIAVLRGLTYLREK 118

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
           T   DIWS G  + E+ +G+   P         E+  + G P   E +    +      P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPV-SEGEAKESHRPVSGHP 230

Query: 277 QIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPF 321
              P P   +F+           +LP      E  D V +  + +P  R    E   HPF
Sbjct: 231 PDSPRPM-AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289

Query: 322 F 322
            
Sbjct: 290 I 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 82/310 (26%), Positives = 139/310 (44%), Gaps = 65/310 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALK 95
           ++  G++G V+  + +ET +  A+KK+  Q+   +N+      E  I+   ++P +V++ 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM- 66

Query: 96  HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            C F T    + +L +V+EYV       + +N       +P+   ++Y  +   AL Y+H
Sbjct: 67  FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNV--------------SYI 199
           N  GI HRD+KP NLL+    H +KL DFG +K+ L+    N+                +
Sbjct: 119 N-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 200 C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 258
           C +  Y APE+I     Y   +D W+ G ++ E L+G   F G++  +   ++I      
Sbjct: 177 CGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----- 230

Query: 259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALE 315
             ++I    P   E                  LP +A DL+ R  + +P  R     A E
Sbjct: 231 --DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAFE 269

Query: 316 ACVHPFFDEL 325
              H FF  L
Sbjct: 270 VKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 52/296 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHC 97
           V+G G+  VV+ A C    E VAIK++  +K   +     +E+Q M   +HPN+V   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 98  FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F     +EL+  LV+ Y+     ++ +  +Y R      +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICSRYYRAPELI 210
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 266
                Y    DIWS G    EL  G        P +     L+  ++             
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQ------------- 221

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           N        P ++    +K + K        ++    Q  P+ R TA E   H FF
Sbjct: 222 ND------PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALA 151
            K   +S   +    L LV+EY+P    R  + ++  R+  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 152 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSR 202
           Y+     +   HRD+  +N+LV      +K+ DFG  KVL          EP  S I   
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175

Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAEL 232
           ++ APE +   ++++ A D+WS G V+ EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 33/209 (15%)

Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 92
           +G G FG V    CR       TGE VA+K        Q +    RE++I++ LDH NIV
Sbjct: 12  LGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 151
             K             L L++EY+P    R    Y + H+ ++ L  + L++ QIC+ + 
Sbjct: 70  KYKGV---CEKPGGRSLRLIMEYLPSGSLRD---YLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYY 204
           Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        EP  S I   +Y
Sbjct: 124 YLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELL 233
            APE +  +  +++A D+WS G  + EL 
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 93
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
               F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C AL +
Sbjct: 67  YYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIF 211
           +H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I 
Sbjct: 122 MHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
               Y    DIWS GC++ E+   Q  F G+
Sbjct: 180 -ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 89.5 bits (222), Expect = 5e-20
 Identities = 85/310 (27%), Positives = 137/310 (44%), Gaps = 47/310 (15%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF---- 98
           V+G GSFG V  A+ + T E  AIK + +D   ++ +++   +      +A +H F    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           F T   +E +L  V+EY+      +  +      R      + Y  +I   L ++H   G
Sbjct: 62  FCTFQTKE-HLFFVMEYL--NGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK-G 116

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYT 217
           I +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G  +Y 
Sbjct: 117 IIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYN 174

Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 277
            ++D WS G ++ E+L+GQ  F GE   D+L + I         +               
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR-------------- 212

Query: 278 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFDELRDPNTRLPNGR 336
               P    F + +  EA D + + F+  P  R     +   HPFF   R  +      R
Sbjct: 213 ----PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWERLEKR 262

Query: 337 PLPPLFNFKP 346
            +PP   FKP
Sbjct: 263 EIPP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 49/285 (17%)

Query: 43  VVGTGSFGVVF---QAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPNIV 92
           V+G GSFG VF   +    + G++ A+K       KV    R K  E  I+  ++HP IV
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICRAL 150
            L H  F T  K    L L+L+++     R    ++R+ + +      VK Y  ++  AL
Sbjct: 62  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPEL 209
            ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 112 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPT--------- 259
           +     +T + D WS G +M E+L G   F G+   + +  I+K  LG P          
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228

Query: 260 -REEIKCMNPNYTEFKFPQ----IKPHP------WHKVFQKRLPP 293
            R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 229 LRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.6 bits (220), Expect = 6e-20
 Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 50/281 (17%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFF 99
           G G+ G V + + + TG I A+K +  D     ++   REL+I +    P IV     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 100 STTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              D+    + + +EY     +     ++ +   RI ++  L  +      + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRAPELI 210
           +   I HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 259
            G   Y+   D+WS G  + E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 260 ----REEIK-----CMNPNYTEFKFP-QIKPHPWHKVFQKR 290
                EE K     C+  + T    P  +  HPW K   K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 87.3 bits (216), Expect = 9e-20
 Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 22/217 (10%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 96
            +G GSFG ++ AK +   E   IK++      +++K    +E+ ++  + HPNIV    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT--- 63

Query: 97  CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            FF++  +E   L +V+EY    + + RI R    +     ++    +  QI   L +IH
Sbjct: 64  -FFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHIH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 212
           +   I HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I  
Sbjct: 119 D-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-ICQ 175

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
              Y    DIWS GCV+ EL   +  F G + + QLV
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 68/304 (22%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           G G+FG V++A+ +ETG   A K +       L+D      E+ I+    HPNIV L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 98  FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 154
           +F         L +++E+     ++ I     R      L    ++    Q+  AL ++H
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI--- 210
           +   + HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++   
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 211 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
            F    Y    DIWS G  + EL   +P                    P  E    +NP 
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPM 214

Query: 270 YTEFKFPQ------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
               K  +       +P  W   F         D +       P+ R TA E   HPF  
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Query: 324 ELRD 327
           +  D
Sbjct: 267 DQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 50/300 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
           +G G++G V++   R TG  +A+K++   L + ++     EL I+     P IV     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 99  FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F      E  + + +EY+   +++++        + +P   ++  TY + + L ++    
Sbjct: 69  F-----IEGAVYMCMEYMDAGSLDKLYAGGVAT-EGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-----FG 212
            I HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I       
Sbjct: 123 NIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQ 180

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPN 269
              YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSG 233

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           Y+                      +A D V +     PN R T  +   HP+  + ++ +
Sbjct: 234 YS---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 57/295 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG+  A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F  T D     L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALGYL 111

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H+C  + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 213

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                         F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 87/282 (30%), Positives = 128/282 (45%), Gaps = 45/282 (15%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 93
           V+G GSFG V  AK +  G+  A+ KVLQ K   NR+ Q         +++ + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           L H  F TT+K    L  VL++V   E    + R  S      P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALG 110

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
           Y+H+ I I +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I
Sbjct: 111 YLHS-INIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------ 259
                Y   +D W  G V+ E+L G P F      +    I+ K L    G         
Sbjct: 169 -RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSIL 227

Query: 260 REEIKCMNPNYTEFK--FPQIKPHP------WHKVFQKRLPP 293
            E ++         K  F +I+ HP      W  + QK++PP
Sbjct: 228 EELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 86.0 bits (213), Expect = 4e-19
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 57/303 (18%)

Query: 43  VVGTGSFGVVFQAKCR---ETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 90
           V+GTG++G VF  +     + G++ A+K      ++Q  +         Q+L+     P 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           +V L H  F T  K    L+L+L+YV   E    +   Y R  +      V++Y  +I  
Sbjct: 67  LVTL-HYAFQTDTK----LHLILDYVNGGELFTHL---YQR--EHFTESEVRVYIAEIVL 116

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 206
           AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y A
Sbjct: 117 ALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 207 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           PE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILKS 227

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 322
             P                  F K +  EA D + +  +  P  R     A E   HPFF
Sbjct: 228 KPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Query: 323 DEL 325
             +
Sbjct: 270 QGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 24/227 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ--DKRYKN---RELQIMQMLDHPNI 91
           +   + +G GSFGVVF+   +    + A+K++ L   ++R +     E +++  LD   I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +     F      ++  LN+V+EY     ++++ +      + +P   V  +  QI   L
Sbjct: 62  IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGL 114

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 206
           A++H+   I HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +
Sbjct: 115 AHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLS 169

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
           PEL      Y    D+W+ G V+ E   G+  F   +    +++II+
Sbjct: 170 PELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 88/300 (29%), Positives = 129/300 (43%), Gaps = 63/300 (21%)

Query: 43  VVGTGSFGVVFQAK---CRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPN 90
           V+G G +G VFQ +     +TG+I A+K VL+         D  +   E  I++ + HP 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           IV L    F T  K    L L+LEY+   E    + R    +           Y  +I  
Sbjct: 62  IVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEISL 111

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAP 207
           AL ++H   GI +RD+KP+N+L++   H +KL DFG  K  +         C    Y AP
Sbjct: 112 ALEHLHQ-QGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E I   + +  A+D WS G +M ++L G P F  E+    + +I+K          K   
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
           P Y                    L PEA DL+ +  + +P+ R       A E   HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 55/314 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 94
           ++G GSFG VF A+ + T +  AIK + +D    + +++   +         +HP +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            +C F T  KE L+   V+EY+      +  +    H +  L     Y  +I   L ++H
Sbjct: 62  -YCTFQT--KENLFF--VMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH 113

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 213
           +  GI +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G 
Sbjct: 114 S-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG- 170

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
            +Y T++D WS G ++ E+L+GQ  F G    +              + I+  NP Y  +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPRW 218

Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNTRL 332
                            L  EA D++ + F   P  R     +   HPFF E+    + L
Sbjct: 219 -----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID--WSAL 259

Query: 333 PNGRPLPPLFNFKP 346
                 PP   FKP
Sbjct: 260 EEREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 30/233 (12%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQ----IMQMLDHPNIVALKHC 97
           +G G+FG V +   + +G I+A+K++    D++ + R L     +M+  D P IV     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK---- 67

Query: 98  FFSTTDKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           F+    +E       EL +++ L+   + V      Y  +   +P   +        +AL
Sbjct: 68  FYGALFREGDCWICMEL-MDISLDKFYKYV------YEVLKSVIPEEILGKIAVATVKAL 120

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            Y+   + I HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179

Query: 211 --FGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 260
                  Y    D+WS G  + E+  G+  +P   S  DQL +++K  G P  
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 86/308 (27%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALK 95
           V+G G+FG V   + ++TG I A+KK+ + +   K +      E  I+   D+P +V L 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F     ++E YL L++EY+P  + +  + +      +     Y+     +   A+  I
Sbjct: 68  YSF-----QDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIA----ETILAIDSI 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPN--VSYI 199
           H  +G  HRDIKP NLL++   H +KL DFG              ++L    P+  + +I
Sbjct: 118 HK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 200 CSRY-------------------------YRAPELIFGATEYTTAIDIWSTGCVMAELLL 234
                                        Y APE +F  T Y    D WS G +M E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 235 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE 294
           G P F  +               P     K +N   T  +FP           +  L PE
Sbjct: 235 GYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSPE 269

Query: 295 AVDLVCRF 302
           A DL+ R 
Sbjct: 270 AKDLIKRL 277

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 92/305 (30%), Positives = 140/305 (45%), Gaps = 60/305 (19%)

Query: 43  VVGTGSFGVVF---QAKCRETGEIVAIKKVLQD----KRYKNRELQIM--QMLDH----P 89
           V+GTG++G VF   +    +TG++ A+K VLQ     ++ K  E       +L+H    P
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLIYVKLYTYQIC 147
            +V L H  F T  K    L+L+L+YV          ++ ++QR       V+ Y+ +I 
Sbjct: 66  FLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YR 205
            AL ++H  +GI +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    Y 
Sbjct: 116 LALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +KC
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILKC 226

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 320
             P                  F   + PEA DL+ +  +  P  R       A E   HP
Sbjct: 227 DPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268

Query: 321 FFDEL 325
           FF  L
Sbjct: 269 FFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 90/301 (29%), Positives = 137/301 (45%), Gaps = 60/301 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQM-LDHPNIVAL 94
           V+G GSFG V  A+ + T E+ AIK      +LQD        E +I+ +   HP + AL
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            HC F T D+    L  V+EYV   + + +I R+      R      + Y  ++  AL +
Sbjct: 62  -HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMF 111

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 211
           +H   G+ +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I 
Sbjct: 112 LHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-IL 168

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
              EY  ++D W+ G +M E++ GQP F  ++  D L E I                 + 
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL----------------HD 211

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC-----VHPFFDE 324
           +  +P      W       L  EAV ++  F   +PN R  C A +        HPFF E
Sbjct: 212 DVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Query: 325 L 325
           +
Sbjct: 260 I 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 84/316 (26%), Positives = 142/316 (44%), Gaps = 59/316 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 94
           V+G GSFG V  A+ +  GE  A+K + +D    + +++   +         ++P +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            +C F T +    +L  V+E++   + +  I         R  L     Y  +I   L +
Sbjct: 62  -YCTFQTKE----HLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQF 111

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 211
           +H+  GI +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ 
Sbjct: 112 LHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
           G  +YT ++D WS G ++ E+L+GQ  F G+   D+L E I+V                 
Sbjct: 170 G-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV----------------- 210

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNT 330
                   PH     + + +  E+ D++ + F+  P  R   +     HPFF  +   N 
Sbjct: 211 ------DTPH-----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NW 256

Query: 331 RLPNGRPLPPLFNFKP 346
                R L P   FKP
Sbjct: 257 TALEKRELDP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.2 bits (205), Expect = 7e-18
 Identities = 67/224 (29%), Positives = 120/224 (53%), Gaps = 28/224 (12%)

Query: 44  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G G+ GVV + + + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F+S  D E   +++ +E++   +++++ +   RI + +    +   +  + R LAY+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 216 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 258
           Y+   DIWS G  + EL +G+ P+ P ++      E+  + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 67/229 (29%), Positives = 122/229 (53%), Gaps = 23/229 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G G+ GVVF+   + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F+S  D E   +++ +E++   +++++ +   RI +++    +   +  + + L Y+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 216 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 263
           Y+   DIWS G  + E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 90/339 (26%), Positives = 142/339 (41%), Gaps = 81/339 (23%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKK----VLQDKR---YKNRELQIMQMLDHPNIVALK 95
           +VG G FG V   + + TG+I A+K     VL  +    +   E  I+ + + P I  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F    DK+ LYL  V+EY P  + ++ + R   +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSRYYRAPELI- 210
           H  +G  HRDIKP+N+L++   H +KL DFGSA  L   +   S   + +  Y APE++ 
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 211 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
                G   Y    D WS G +  E++ G+  F   +       I+              
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222

Query: 267 NPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------CVH 319
             N+  F KFP+            ++  + +DL+        +L C   E       C H
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLI-------QSLLCGQKERLGYEGLCCH 263

Query: 320 PFFDELRDPNTRLPNGRPLPPLF----------NFKPPE 348
           PFF ++   N R      LPP            NF  PE
Sbjct: 264 PFFSKIDWNNIR----NSLPPFVPTLKSDDDTSNFDEPE 298

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 81.8 bits (202), Expect = 8e-18
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNI 91
           Y+    +G GSFG     K +E G+   IK++    +  K  +   +E+ ++  + HPNI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQIC 147
           V  +  F     +E   L +V++Y           Y +I+ +  +++    +  +  QIC
Sbjct: 62  VQYQESF-----EENGNLYIVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 206
            AL ++H+   I HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELL 233
           PE I     Y    DIW+ GCV+ E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 61/297 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 93
           ++G G+FG V+     +TG  +A+K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
              C     D  E  L++ +E++P  ++    ++Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSY 121

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 208
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           +I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT-------NP 228

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
                                 LPP   D  CR F     L+   +EA + P  DEL
Sbjct: 229 ---------------------VLPPHVSDH-CRDF-----LKRIFVEAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHP 89
           ++  E  +G G F  V++A C    + VA+KKV    + D + +    +E+ +++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           N++     F    +     LN+VLE      ++++ + + +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAP 207
           A+ ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
           E I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE----------LQIMQMLDHPNIVA 93
           +G G+FG V+Q + ++T  I A+K + + +    +E          L    + + P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           LK  F + +D     L LV +Y+   E    + +       R      K Y  ++  AL 
Sbjct: 61  LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALE 110

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELI 210
           ++H    I +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++
Sbjct: 111 HLHK-YDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII---------KVLGTPTRE 261
                YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQ 227

Query: 262 EIKCM---NPNY---TEFKFPQIKPHP------WHKVFQKRLPP 293
            +K +   NP +         ++K HP      W  + +K++ P
Sbjct: 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP 271

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 43/237 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 90
           Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           +V L  C F    +++ YL +V+EY+P  + VN ++ NY      +P  + K YT ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVL 153

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSY 198
           AL  IH+ +G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+   
Sbjct: 154 ALDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--- 208

Query: 199 ICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
                Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 65/235 (27%), Positives = 117/235 (49%), Gaps = 27/235 (11%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 93
           ++G G+FG V+     +TG  +A+K+V  D   +           E+Q+++ L H  IV 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
              C     D EE  L++ +EY+P  ++    + Y  + + +     + YT QI + ++Y
Sbjct: 69  YYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNVSYICSRYYRAPE 208
           +H+ + I HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           +I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 180 VISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 93
           V+G GSFG V  AK +  G   A+ KVLQ K    ++ Q         +++ L HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAV-KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           L + F +    E+LY   VL+YV   E    + R    +  R      + Y  ++  A+ 
Sbjct: 61  LHYSFQTA---EKLY--FVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAIG 110

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE +
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-V 167

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLF 239
                Y   +D W  G V+ E+L G P F
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 93
           V+G GSFG V  A+ +   +  A+K VLQ K    K  E  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           L H  F T DK    L  VL+Y+   E    + R    +  R      + Y  +I  AL 
Sbjct: 61  L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
           Y+H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++
Sbjct: 111 YLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLF 239
                Y   +D W  G V+ E+L G P F
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKN----RELQIMQM-LDHPNIVALKHC 97
           +G+G+ G V++ + ++TG ++A+K++ +   + +N     +L ++    D P IV     
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F + +D     + + +E +   ++++ +   RI   +P   +   T  I +AL Y+    
Sbjct: 83  FITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEKH 134

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGAT-- 214
           G+ HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I      
Sbjct: 135 GVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDPN 192

Query: 215 -EYTTAIDIWSTGCVMAELLLGQPLFPG 241
            +Y    D+WS G  + EL  GQ  +  
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 52/293 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 93
           ++G G+FG V+     +TG  +A K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
              C     D+ E  L + +EY+P  +V    + Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNVSYICSRYYRAPE 208
           +H+ + I HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +PE
Sbjct: 122 LHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           +I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT       NP
Sbjct: 180 VISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-------NP 228

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                        P H     R      D +   F  + + R +A E   HPF
Sbjct: 229 -----------QLPSHISEHAR------DFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 79.2 bits (195), Expect = 6e-17
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           Y    VVG GSFG     +   + +  A+K++   K         +E  ++  + HPNIV
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           A K  F     + + +L +V+EY    + + +I     ++    P   +  +  Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPEL 209
            +IH    + HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHE-KRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 210 IFGATEYTTAIDIWSTGCVMAEL 232
           I+    Y    DIWS GC++ EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 66/242 (27%), Positives = 102/242 (42%), Gaps = 47/242 (19%)

Query: 44  VGTGSFGVVFQAKCRETG--EI-VAIK-----KVLQDKRYKNRELQIMQMLDHPNIVALK 95
           +G G+FG V +         E+ VA+K      +   K+   RE  +M  LDHP IV L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 96  HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
                    E L   LV+E  P   + +    Y +  + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 155 NCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 205
           +     HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 206 ----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 258
               APE I     +++  D+WS G  + E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 259 TR 260
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 75/293 (25%), Positives = 137/293 (46%), Gaps = 55/293 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 94
           V+G GS+  V   + ++T  I A+K + ++    + ++  +Q          +HP +V L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             CF     + E  L  V+E+V   + +  + R      +++P  + + Y+ +I  AL +
Sbjct: 62  HSCF-----QTESRLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNF 111

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 211
           +H   GI +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 261
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 262 EIKC-------MNPNYTE-------FKFPQIKPHP------WHKVFQKR-LPP 293
            +K        +N +  E         F  IK HP      W  + QK+ LPP
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 79.7 bits (196), Expect = 9e-17
 Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 57/302 (18%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 97
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 98  FFSTTDKEELYLNLVLEYV-----PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           + S    EEL++  ++E++      + V++   N  +I               + +AL Y
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQI---------ATVCESVLQALCY 132

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 211
           +H+  G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I 
Sbjct: 133 LHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI- 189

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
             T Y T +DIWS G ++ E++ G+P +  +S V  +  +        R+          
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS--------- 232

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 331
                   P P  K   K + P   D + R     P  R TA E   HPF  +   P   
Sbjct: 233 --------PPPKLKNAHK-ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECL 283

Query: 332 LP 333
           +P
Sbjct: 284 VP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 48/239 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR----ELQIMQMLDHPNIVALK 95
           ++G G  G VF  + + TG++ A+K   K    KR K +    E +I+  LDHP +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 96  HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             F + T     YL LV++Y P   + R+ +   +  + +     + Y  ++  AL Y+H
Sbjct: 68  ASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEPN 195
             +GI +RD+KP+N+L++   H + L DF                   GS +  V   P+
Sbjct: 121 -LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 196 VSYICS-----------RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
            ++                Y APE+I G   + +A+D W+ G ++ E+L G   F G +
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 81/305 (26%), Positives = 138/305 (45%), Gaps = 59/305 (19%)

Query: 43  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 90
           V+GTG++G VF   +    ++G++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICR 148
           +V L + F + T      L+L+L+Y+          ++ + QR       V++Y+ +I  
Sbjct: 67  LVTLHYAFQTDTK-----LHLILDYING-----GELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 206
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y A
Sbjct: 117 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 207 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 227

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHP 320
             P      +PQ             +   A D++ R     P  R       A E   HP
Sbjct: 228 EPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269

Query: 321 FFDEL 325
           FF ++
Sbjct: 270 FFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 43/232 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALK 95
           V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F     +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 110 YAF-----QDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLALDAI 158

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNVSYICSRY 203
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K          G P+        
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-------- 208

Query: 204 YRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
           Y +PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 97
           +G GS G+V  A  + +G++VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           +      +EL+  +V+E++       A      H RM    +      + +AL+ +H   
Sbjct: 86  YLV---GDELW--VVMEFLEGG----ALTDIVTHTRMNEEQIAAVCLAVLKALSVLH-AQ 135

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEY 216
           G+ HRDIK  ++L+  H  ++KL DFG    + K  P   S + + Y+ APELI     Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 234

Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
           ++K    HKV      P     + R     P  R TA E   HPF  +   P+  +P
Sbjct: 235 KLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 98
           +G G+FG V++AK +ETG  +A  KV++ K  +       E++I+   +HP IV L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 99  FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           +      +  L +++E+ P   V+ I     R     P I  ++   Q+  AL Y+H+ +
Sbjct: 79  Y-----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QVICRQMLEALQYLHS-M 129

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT-- 214
            I HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   T  
Sbjct: 130 KIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 215 --EYTTAIDIWSTGCVMAELLLGQP 237
              Y    DIWS G  + E+   +P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 62/296 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKNRELQIM-QMLDHPNIVAL 94
           V+G GS+  V   + ++T  I A+K V        +D  +   E  +  Q  +HP +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             CF     + E  L  V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 62  HSCF-----QTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 111

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 211
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII----------- 252
           G  +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I           
Sbjct: 170 GE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 253 ---------KVLGTPTREEIKCMNPNYTEFKFPQIKPHP------WHKVFQKRLPP 293
                      L    +E + C      +  F  I+ HP      W  + QK++ P
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 21/219 (9%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 95
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ + D P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 154
           H  F T D+    L  V+EYV      +  +  ++ + + P      Y  +I   L ++H
Sbjct: 67  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEP--QAVFYAAEISVGLFFLH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 213
              GI +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I   
Sbjct: 119 R-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AY 175

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 67/235 (28%), Positives = 119/235 (50%), Gaps = 32/235 (13%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--------PNIVAL 94
           V+G GS+  V   + ++  +I A+K V ++  + + ++  +Q   H        P +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             CF +T+      L LV+EYV   + +  + R      +++P  + + Y  +IC AL +
Sbjct: 62  HSCFQTTSR-----LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNF 111

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIF 211
           +H   GI +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ 
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 260
           G  EY  ++D W+ G +M E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 170 GE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 66/245 (26%), Positives = 112/245 (45%), Gaps = 37/245 (15%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 95
           +G G FG V   + + TG++ A KK L  KR K +        E +I++ ++ P IV L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 96  HCFFSTTDKEELYLNLV--------LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + F S T     +L LV        L+Y    V        R+      I+   Y+ QI 
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMERV------IH---YSAQIT 105

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
             + ++H+ + I +RD+KP+N+L++      +L D G A  L  G+       +  Y AP
Sbjct: 106 CGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E I     Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  +
Sbjct: 164 E-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEH 219

Query: 268 PNYTE 272
            N+TE
Sbjct: 220 QNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 37/211 (17%)

Query: 43  VVGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 93
           V+G G FG V    +      TGE+VA+K + ++   +N      E+ I++ L H NIV 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
            K C    +++    L L++EYVP       R+Y   H ++ L  + L+  QIC  +AY+
Sbjct: 71  YKGC---CSEQGGKGLQLIMEYVPLGS---LRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE----- 208
           H+   I HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E     
Sbjct: 124 HSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGDSP 173

Query: 209 LIFGATE------YTTAIDIWSTGCVMAELL 233
           + + A E      ++ A D+WS G  + ELL
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 91/315 (28%), Positives = 138/315 (43%), Gaps = 58/315 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 94
           V+G GSFG V  A+ +E+G + A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            +C F T D+    L  V+E+V           SR   R      + Y  +I  AL ++H
Sbjct: 62  -YCCFQTPDR----LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH 113

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGA 213
           +  GI +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I   
Sbjct: 114 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQE 170

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y  ++D W+ G ++ E+L G   F  E+  D L E I        +E+          
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV---------- 213

Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTAL--EACV--HPFFDELRD 327
                       V+   L  +AVD++  F   +P +R     L  E  +  HPFF EL  
Sbjct: 214 ------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL-- 259

Query: 328 PNTRLPNGRPLPPLF 342
            +    N R + P F
Sbjct: 260 -DWEKLNRRQIEPPF 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 41/293 (13%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHC 97
           ++G G+ G V++A    T  I+A+K +  D     ++    EL+I+   D P I+     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           FF      E  +++  E++             +++++P   +      + + L Y+ + +
Sbjct: 68  FFV-----ENRISICTEFMDG-------GSLDVYRKIPEHVLGRIAVAVVKGLTYLWS-L 114

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 217
            I HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  +Y 
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 277
              D+WS G    EL LG+  +P        +  +++L     E+             P 
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219

Query: 278 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
           +    + + F        V  + +  +  P  R        HPF  +  D N 
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
           V+G GSFG V  A+ + T E+ AIK + +D   ++ +++       ++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 153
           H  F T D+        L +V E VN     Y  I Q  +    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-HIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H+  GI +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
              Y  ++D W+ G ++ E+L GQP F GE
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 94/335 (28%), Positives = 142/335 (42%), Gaps = 65/335 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKN----RELQIMQMLDHPNIVALK 95
           V+G G+FG V   K + TG++ A+K   K    KR +      E  ++   D   I  L 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F     ++E  L LV++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKG--EPNVS-----YICSRYYRAP 207
            +G  HRDIKP N+L++ + H ++L DFGS  ++L  G  + NV+     YI     +A 
Sbjct: 121 -LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM 178

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E   G   Y    D WS G  M E+L G+  F  ES V+   +I+               
Sbjct: 179 E--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--------------- 221

Query: 268 PNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFD 323
            N+ E F+FP              +  EA DL+ R    SP  R       +   HPFF+
Sbjct: 222 -NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFFE 270

Query: 324 ELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETIN 358
            +   N R        P      PE+S  P +T N
Sbjct: 271 GIDWDNIRNST----APYV----PEVSS-PTDTSN 296

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 84/326 (25%), Positives = 134/326 (41%), Gaps = 71/326 (21%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 94
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 95  KHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQI 146
            + +  T D   L L L+    L++              I+      +       Y  +I
Sbjct: 66  AYAY-ETKDALCLVLTLMNGGDLKF-------------HIYNMGNPGFDEERAVFYAAEI 111

Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
              L  +H    I +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y A
Sbjct: 112 TCGLEDLHR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMA 169

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++     YT + D W  GC++ E++ G+  F          E +K      REE++  
Sbjct: 170 PEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERR 216

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--C---TALEACVHPF 321
                E              + ++    A  +  +     P  R  C    A E   HPF
Sbjct: 217 VKEDQE-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Query: 322 FDELRDPN-TRLPNGRPLPPLFNFKP 346
           F   R  N  RL  G   PP   F P
Sbjct: 264 F---RTANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 54/289 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 91
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 92  VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           V + + F  T DK    L+L+    L Y       ++++       M     + Y  +I 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQ----------------------PLFPGESGV 245
           E++     Y ++ D +S GC++ +LL G                          P     
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224

Query: 246 DQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 293
           +    +  +L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 97
           +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           +      +EL++  V+E++       A      H RM    +      + RAL+Y+HN  
Sbjct: 88  YLV---GDELWV--VMEFLEGG----ALTDIVTHTRMNEEQIATVCLSVLRALSYLHN-Q 137

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIFGATEY 216
           G+ HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 138 GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPY 195

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGE 242
            T +DIWS G ++ E++ G+P +  E
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 91/348 (26%), Positives = 145/348 (41%), Gaps = 99/348 (28%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHP 89
           ++    +G G+FG V  A   +T  + A+K  L+ K   NR        E  I+   D+ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
            +V L   ++S  DK+ LY   V++Y+P  + ++ + R      +  P +  + Y  ++ 
Sbjct: 62  WVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELT 111

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG------ 192
            A+  +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG      
Sbjct: 112 LAIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 193 --EPN-------------------------------VSYICSRYYRAPELIFGATEYTTA 219
             EP+                                S + +  Y APE++     YT  
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQL 228

Query: 220 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 279
            D WS G ++ E+L+GQP F              +  TPT  ++K +N   T    PQ+K
Sbjct: 229 CDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK 274

Query: 280 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDEL 325
                      L PEAVDL+ +    +     R  A +   HPFF E+
Sbjct: 275 -----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 90
           +Y    VVG GS+G V   + R  G+   IKK+       ++++   +E Q++  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IVA +  +    + E+  L +V+ +  E  +   +   +  + +P   V  +  QI  AL
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPEL 209
            Y+H    I HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHE-KHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 210 IFGATEYTTAIDIWSTGCVMAEL 232
            F    Y    D+W+ GC + E+
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 49/285 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNI 91
           V+G G FG V  A+ ++TGE+ AIK  L+               + R  +      HP +
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           V L  CF     + E ++  V+EY    + +  I  +               Y   +   
Sbjct: 65  VNLFACF-----QTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLG 113

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 208
           L Y+H    I +RD+K  NLL++     +K+ DFG  K  +      S  C +  + APE
Sbjct: 114 LQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG---ESGVDQLV-EIIKVLGTPTREEIK 264
           ++   T YT A+D W  G ++ E+L+G+  FPG   E   D +V + ++     +RE I 
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS 230

Query: 265 CM------NPN----YTEFKFPQIKPHP------WHKVFQKRLPP 293
            M      NP       E     +K  P      W  +  +++ P
Sbjct: 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKP 275

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 56/295 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F  T D+    L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALDYL 111

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H+   + +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +  
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLE 169

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-------- 214

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                         F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 215 --------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 140
             HPNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 141 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 195
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 256 GTPTREEIKCMNPNYTEF 273
           GTP  +  + ++  + +F
Sbjct: 231 GTPELQNPEKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 86/339 (25%), Positives = 136/339 (40%), Gaps = 97/339 (28%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           V+G G+FG V   + ++TG+I A+K +L+ + +K  +L        ++   D P +V+L 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67

Query: 96  HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           + F     ++  YL L++E++P   +  +   Y    + +     + Y  +   A+  +H
Sbjct: 68  YSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNVSYICSR 202
             +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I +R
Sbjct: 119 K-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 203 Y------------------------------------YRAPELIFGATEYTTAIDIWSTG 226
                                                Y APE IF    Y    D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLG 235

Query: 227 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHK 285
            +M E L+G P F  E+  +   +II                N+ E   FP         
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-------- 271

Query: 286 VFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF 322
                L  EA DL+ R    + N   R  A E   HPFF
Sbjct: 272 --DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 31/245 (12%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGE-IVAIKKVL-------QDKRYKNRELQ--------I 82
           + EH+ G+G+FG V++ + +  G+ ++A+K++        +DKR +++ +         I
Sbjct: 4   VLEHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 83  MQMLDHPNIVALKHCFFSTTDKEELYLNLVL-EYVP--ETVNRIARNYSRI-HQRMPLIY 138
            + L HPNIV     F    + + LY+ + L E  P  E  N +     R   +R+  I+
Sbjct: 63  KEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           V     Q+  AL Y+H    I HRD+ P N+++     ++ + DFG AK         S 
Sbjct: 120 V-----QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSV 173

Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 258
           + +  Y  PE++     Y    D+W+ GC++ ++   QP F   + +    +I++ +  P
Sbjct: 174 VGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232

Query: 259 TREEI 263
             E +
Sbjct: 233 LPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 23/205 (11%)

Query: 44  VGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALK 95
           +GTGSFG V  A  + E    VAIK+  + K  K +       E +I+  ++HP  V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F     K+E YL LVLE+V   +      + R ++R P      Y  QI     Y+ +
Sbjct: 98  GSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGAT 214
            + I +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++    
Sbjct: 150 -LNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG 204

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            +  A D W+ G  + E+L+G P F
Sbjct: 205 -HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 28/208 (13%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCF 98
           +G+G+ G V++   R TG + A+K +  +     +R   RE++I++ ++HPN+V   H  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC-HDM 140

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           F    +    + ++LE++    +  +   + I     L  V     QI   +AY+H    
Sbjct: 141 FDHNGE----IQVLLEFM----DGGSLEGTHIADEQFLADV---ARQILSGIAYLHR-RH 188

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI-----FG 212
           I HRDIKP NLL+N     +K+ DFG +++L +  +P  S + +  Y +PE I      G
Sbjct: 189 IVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFP 240
           A +   A DIWS G  + E  LG+  FP
Sbjct: 248 AYD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 86/317 (27%), Positives = 136/317 (42%), Gaps = 53/317 (16%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 94
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            + + +   K+ L L L L    +    I   Y              Y  +IC  L  +H
Sbjct: 66  AYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
               I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++    
Sbjct: 120 Q-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNE 176

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ +     E  
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE-- 222

Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN 329
                       + ++  P+A  L        P  R       A E   HP F ++    
Sbjct: 223 -----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN--F 269

Query: 330 TRLPNGRPLPPLFNFKP 346
            RL  G   PP   FKP
Sbjct: 270 KRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 99
           +G+G++G V++A+   TGE+ AIK +     +D     +E+ +M+   H NIVA    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
           S   +++L++   +E+      +   + +       + YV   T Q    L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 215
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 216 -YTTAIDIWSTGCVMAELLLGQP 237
            Y    DIW+ G    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 62/319 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F  T D+    L  V+EY    E    ++R      +R      + Y  +I  AL Y+
Sbjct: 62  YAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYL 111

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLE 168

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+        
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR-------- 213

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 327
                         F + L PEA  L+    +  P  R       A E   H FF  +  
Sbjct: 214 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259

Query: 328 PNTRLPNGRPLPPLFNFKP 346
            +  +   + LPP   FKP
Sbjct: 260 QD--VVQKKLLPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 31/212 (14%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 91
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 92  VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           V + + F  T DK    L+L+    L Y           +   H       ++ Y  +I 
Sbjct: 60  VCMTYAF-HTPDKLCFILDLMNGGDLHY-----------HLSQHGVFSEKEMRFYATEII 107

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
           E++   T Y ++ D +S GC++ +LL G   F
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.9 bits (173), Expect = 7e-14
 Identities = 72/258 (27%), Positives = 124/258 (48%), Gaps = 38/258 (14%)

Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQM 85
           G+ K+K  Y     +G G+ G VF A    TG+ VAIK++   K+ K      E+ +M+ 
Sbjct: 15  GDPKKK--YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 140
           L +PNIV     F      +EL++  V+EY+      + V     + ++I          
Sbjct: 73  LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAA-------- 119

Query: 141 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 195
                +CR    AL ++H    + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR 172

Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 256 GTPTREEIKCMNPNYTEF 273
           GTP  +  + ++P + +F
Sbjct: 231 GTPELQNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 27/243 (11%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 98
           +G G+FG V++A+ +ETG ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 99  FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 155
           +   +     L +++E+     V+ +     R     PL    +++   Q   AL Y+H 
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHE 121

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
              I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T
Sbjct: 122 N-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 215 E----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                Y    D+WS G  + E+   +P     + +  L++I K    PT  +    +  +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEF 238

Query: 271 TEF 273
            +F
Sbjct: 239 KDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.8 bits (178), Expect = 8e-14
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 41/244 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G G FG VF  K + T E    K +      +R K++   E+ +M+ L H NIV     
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI---YVKLYTYQICRALAYIH 154
           F +  +++   L +++E+       ++RN  + ++    I    +   T Q+  ALAY H
Sbjct: 81  FLNKANQK---LYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135

Query: 155 NCIG------ICHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKVLVKG 192
           N         + HRD+KPQN+ ++     +                K+ DFG +K +  G
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI--G 193

Query: 193 EPNVSYIC--SRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
             ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +   QL+
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253

Query: 250 EIIK 253
             +K
Sbjct: 254 SELK 257

Length = 1021

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 35/208 (16%)

Query: 43  VVGTGSFGVVFQA--KCRETGEI-VAIKKVLQDKRYKNREL-----QIMQMLDHPNIVAL 94
            +G G FG V+Q      E  +I VA+K          RE       IM+  DHP+IV L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYI 153
                      E  + +V+E  P       R+Y ++++  + L  + LY+YQ+  ALAY+
Sbjct: 73  IGVI------TENPVWIVMELAPLGE---LRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 154 H--NCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 205
                +   HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + 
Sbjct: 124 ESKRFV---HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWM 175

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE I     +T+A D+W  G  M E+L
Sbjct: 176 APESI-NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 94
           V+G G FG V   + R TG++ A K+ L+ KR K R        E QI++ ++   +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            + + +   K+ L L L +    +    I   Y+  +          Y  +I   L  +H
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
                 +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++    
Sbjct: 120 R-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQ 176

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPG 241
            YT + D W  GC++ E++ GQ  F G
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 30/295 (10%)

Query: 47  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 106
           GS G VF A  +       + K+ Q K     E  ++Q ++HP+++ +K    S      
Sbjct: 77  GSEGRVFVAT-KPGQPDPVVLKIGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVS----GA 130

Query: 107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 166
           +   ++  Y  +    + +    +     LI  K    QI   L Y+H    I HRD+K 
Sbjct: 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK----QILEGLRYLHA-QRIIHRDVKT 185

Query: 167 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG 226
           +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +  DIWS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 227 CVMAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPNYT 271
            V+ E+L             P    +S    L++II  L       P     + +   + 
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302

Query: 272 EFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           E+   + +P+  +  FQ+  LP +   LV +   +   +R +A E   +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 65/206 (31%), Positives = 90/206 (43%), Gaps = 34/206 (16%)

Query: 59  ETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 110
            TG  VAIK +  D         R++ RE  +   L HPNIVAL      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 170
            V EYVP    R  R        +P         Q+  ALA  HN  GI HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 171 VN-----PHTHQLKLCDFGSAKVLVK-GEPNVS-------YICSRYYRAPELIFGATEYT 217
           V+     PH    K+ DFG   +L    + +V+        + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 218 TAIDIWSTGCVMAELLLGQPLFPGES 243
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 99
           VG+G++G V++A+   TGE+ A+K +      D     +E+ +++   H NIVA    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
           S   +E+L+  + +EY      +   + +     + + YV   T Q    LAY+H+  G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE--- 215
            HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 216 -YTTAIDIWSTGCVMAELLLGQP 237
            Y    DIW+ G    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 81/344 (23%), Positives = 122/344 (35%), Gaps = 113/344 (32%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 95
           +G G+FG V   +  +T  + A+K  L+      R        E  I+   D+  +V L 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVKL- 66

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAY 152
             ++S  DK+ LY   V++Y+P        +   +  R+        + Y  ++  A+  
Sbjct: 67  --YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 153 IHNCIGICHRDIKPQNLLVNPH----------------THQLKL---------------- 180
           +H  +G  HRDIKP N+L++                  TH  K                 
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 181 -------CDFGSAKVLVK------------GEPNVSYICSRYYRAPELIFGATEYTTAID 221
                  C     +   K            G PN        Y APE++   T YT   D
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLCD 226

Query: 222 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 281
            WS G ++ E+L+GQP F  +              TP   ++K +N   T    P     
Sbjct: 227 WWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP----- 266

Query: 282 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 322
                 Q +L  EA DL+ R        R     A E   HPFF
Sbjct: 267 -----SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 54/264 (20%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +G G+FG V++   +   E VA+K          KR   +E +I++  DHPNIV L    
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---I 58

Query: 99  FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 154
                K+ +Y  +V+E VP    +  + +  +    R+ +  +   +      + Y+   
Sbjct: 59  GVCVQKQPIY--IVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK 112

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------AP 207
           NCI   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 208 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           E L +G   YT+  D+WS G ++ E   LG   +PG S               TRE I+ 
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------------TRERIE- 209

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQK 289
               Y     PQ+ P   +++  +
Sbjct: 210 --SGY-RMPAPQLCPEEIYRLMLQ 230

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 16/220 (7%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 102
           V+G G+FG V   K + T  I A+K + + +  K  E    +  +  N++    C + TT
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWITT 65

Query: 103 ----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
                ++E YL LV++Y       +    S+   R+P    + Y  ++  A+  IH  + 
Sbjct: 66  LHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LH 122

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF----G 212
             HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     G
Sbjct: 123 YVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 86/327 (26%), Positives = 131/327 (40%), Gaps = 83/327 (25%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA------LKH 96
           V+G G+FG V   + ++TG I A+K +L+      +E Q+  +    +I+       +  
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKE-QVAHIRAERDILVEADGAWVVK 65

Query: 97  CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  IH
Sbjct: 66  MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIH 118

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFG------------------------------ 184
             +G  HRDIKP NLL++   H +KL DFG                              
Sbjct: 119 Q-LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 185 ----SAKVLVKGEPNVSY--ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 238
                A+   K    ++Y  + +  Y APE +F  T Y    D WS G +M E+L+G P 
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 239 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 298
           F  E              TP     K MN   T   FP   P          +  +A DL
Sbjct: 236 FCSE--------------TPQETYRKVMNWKET-LVFPPEVP----------ISEKAKDL 270

Query: 299 VCRFFQYSPNL--RCTALEACVHPFFD 323
           + RF   S N        E   HPFF+
Sbjct: 271 ILRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 95
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 153
           H  F T D+        L +V E VN     Y +I Q  R    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-QIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 212
           H+  GI +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 51/283 (18%)

Query: 47  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKE 105
           G FG V   K + T + + ++K+++ K +   E  + Q M D+PN + L +    TT K 
Sbjct: 27  GKFGKVSVLKHKPTQK-LFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSV--TTLKG 83

Query: 106 ELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            +   L+++Y+      + +        +   ++    VK    Q+  AL  +H    I 
Sbjct: 84  HV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNII 131

Query: 161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI 220
           H DIK +N+L +    ++ LCD+G  K  + G P+  Y  +  Y +PE I G   Y  + 
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSC-YDGTLDYFSPEKIKGHN-YDVSF 187

Query: 221 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 280
           D W+ G +  ELL G+   P +   D   E +         +++ +              
Sbjct: 188 DWWAVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQQ--------- 224

Query: 281 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFF 322
                 F K +   A D V    +Y+ N R T     + HPF 
Sbjct: 225 --KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 48/234 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 93
           V+G+G+FG V++      GE     VAIK + ++   K       E  +M  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 94  L-------KHCFFSTTDKEELYLNLVLEYVPETVNRIAR----NYSRIHQRMPLIYVKLY 142
           L       +    +    + + L  +L+YV    + I      N+               
Sbjct: 74  LLGICLSSQVQLIT----QLMPLGCLLDYVRNHKDNIGSQYLLNWCV------------- 116

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
             QI + ++Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +
Sbjct: 117 --QIAKGMSYLEE-KRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 203 Y---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
               + A E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 173 VPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + +G+  A+K + ++      E+       ++++   HP + +LK
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F  T D+    L  V+EYV   E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDYL 111

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H+   I +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +  
Sbjct: 112 HSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLE 168

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 39/229 (17%)

Query: 44  VGTGSFGVVFQAKCRE-TGEI--VAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALK 95
           +G GSFGVV + +     G++  VA+K +  DK         +E  IM  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR----MPLIYVKLYTYQICRALA 151
               +        L +V E  P     +     R+ +       +  +  Y  QI   + 
Sbjct: 63  GVVLTHP------LMMVTELAP-----LGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 152 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 205
           Y+     I   HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +    
Sbjct: 112 YLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFA 165

Query: 206 --APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 251
             APE +   T ++ A D+W  G  + E+   G+  + G SG   L +I
Sbjct: 166 WCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 84/353 (23%), Positives = 134/353 (37%), Gaps = 52/353 (14%)

Query: 2   MKTDEPDIIDGVG-AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRET 60
           M  D  DI      ++    +      R G   +K  +        G+ G  F     +T
Sbjct: 59  MDIDIFDIFADEDESDADASLALCAEARAG--IEKAGFSILETFTPGAEGFAFACIDNKT 116

Query: 61  GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETV 120
            E V IK     +     E  I++ ++HP+I+ LK  F         Y       +P   
Sbjct: 117 CEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--------TYNKFTCLILPRYK 166

Query: 121 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 180
             +   Y    + + +  +      + RA+ Y+H    I HRDIK +N+ +N H   + L
Sbjct: 167 TDL-YCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFIN-HPGDVCL 223

Query: 181 CDFGSAKVLVKGEPNVSYICSRYY--------RAPELIFGATEYTTAIDIWSTGCVMAEL 232
            DFG+A   V    N      +YY         APEL+     Y  A+DIWS G V+ E+
Sbjct: 224 GDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEM 276

Query: 233 LLGQPLFPGESGVD-------QLVEIIKVLGTPTRE----------EIKCMNPNYTEFKF 275
                    + G+D       Q+  II+  GT   E          EI       +  K 
Sbjct: 277 ATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRK- 335

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           P  +P  W  +++  LP +   L+C+   +  + R +A        F ++ DP
Sbjct: 336 PGSRP-LWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385

Length = 391

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.5 bits (157), Expect = 7e-12
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 30/221 (13%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G+G FGVV   K R   + VAIK + +    +     E ++M  L HP +V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQL---YGV 67

Query: 101 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            T ++ LY+  V E++     +N + +   ++ + M L   +     +C  + Y+     
Sbjct: 68  CTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLERN-S 120

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELIFG 212
             HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +  PE +F 
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWSPPE-VFN 174

Query: 213 ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII 252
            ++Y++  D+WS G +M E+   G+  F  +S   ++VE+I
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 59/251 (23%)

Query: 42  HVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 90
             +G G+FG V +A+            VA+K +  D   K+      E+++M+M+  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNR-IARNYSRIHQRMPLIYVKLY 142
           I+ L       T +  LY  +V+EY             R      S    R P   +   
Sbjct: 78  IINLLGV---CTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 143 -----TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
                 YQ+ R + ++    CI   HRD+  +N+LV    H +K+ DFG A+       +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVT-EDHVMKIADFGLAR-------D 181

Query: 196 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 242
           + +I   YYR            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 182 IHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI 238

Query: 243 SGVDQLVEIIK 253
             V++L +++K
Sbjct: 239 P-VEELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)

Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 94
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           K      T+     + L++E++P    +  + RN ++I+ +  L     Y  QIC+ + Y
Sbjct: 72  KGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL----KYAVQICKGMDY 124

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYR 205
           + +   + HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +       ++ 
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +  +  Y  A D+WS G  + ELL
Sbjct: 180 APECLIQSKFYI-ASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 23/225 (10%)

Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEIVAIKKV-LQDKR---YKNRELQIMQM 85
           N+ ++  Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +  
Sbjct: 62  NNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA 121

Query: 86  LDHPNIVALKHCF-FSTTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPL--IYVKL 141
            DH  IV  KH   F + DK    L L++EY     +N+  +   R+ + +P     V L
Sbjct: 122 CDHFGIV--KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGL 173

Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSY 198
             YQI  AL  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+
Sbjct: 174 LFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
             + YY APEL +    Y+   D+WS G ++ ELL     F G S
Sbjct: 232 CGTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 85/343 (24%), Positives = 152/343 (44%), Gaps = 60/343 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQML------DHPNIVA 93
           ++G G+FG V +A  R+  E  A+K V    +Y      E+Q M+ +      D   ++ 
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 94  LKHCFFSTTDKEELYLNLVL-EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           ++  F      E  ++ +V+ +Y P  ++ I ++    H+ +  I      +Q   AL Y
Sbjct: 196 IQRYF----QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDY 246

Query: 153 IHNCIGICHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEPNVS 197
            H  + + H D+KP+N+L       V+P T++        +++CD G      +     +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304

Query: 198 YICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
            + +R+YR+PE++ G    Y+T  D+WS GC++ EL  G+ L+     ++ L  + K LG
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362

Query: 257 T-PTREEIKCMNPNYTEF--KFPQIKP--HPWH--KVFQKRLPPEAV------DLVCRFF 303
             P+    +C             Q++P   P H  ++ + R   E +      DL+    
Sbjct: 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422

Query: 304 QYSPNLRCTALEACVHP----FFDELRD-PNTRLPNGRP-LPP 340
            Y    R  A +   HP    ++ E R  PN   P+ R  L P
Sbjct: 423 HYDRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463

Length = 467

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 94
           V+G G FG V   + R TG++ A KK L+ KR K R        E +I++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAY 152
            + + +   K+ L L L +    +    I    N     QR        Y  ++C  L  
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR-----AIFYAAELCCGLED 117

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +     I +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I  
Sbjct: 118 LQR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-N 174

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLF 239
             +YT + D W  GC++ E++ GQ  F
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 22/223 (9%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 95
           V+G G+FG V   K +   ++ A+K + + +  K         E  ++   D+  I  L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F    D+  LYL  V++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELIF-- 211
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 121 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 212 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 22/202 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 98
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 156
              T      L +++EY+         +   + +  PL   ++ T   +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATE 215
             I HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 216 YTTAIDIWSTGCVMAELLLGQP 237
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 43  VVGTGSFGVVFQAKC----RETGEI-VAIKKVLQDKRYKNR-----ELQIMQML-DHPNI 91
            +G G+FG V +A      +    + VA+K +        R     EL+IM  L +H NI
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 92  VALKHCFFSTTDKEELYLNLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           V L     + T    + +  + EY    + +N + R          L+    ++YQ+ + 
Sbjct: 102 VNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS---FSYQVAKG 153

Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 204
           +A++   NCI   HRD+  +N+L+  H   +K+CDFG A+ ++     V    +R    +
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 26/207 (12%)

Query: 41  EHVVGTGSFGVVFQAKCRETG--EI-VAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 92
           E V+G G FG V   + +  G  EI VAIK +     +K+ ++   E  IM   DHPNI+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 151
            L+     T  K  +   +V EY+    N     + R H  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYME---NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 206
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELL 233
           PE I    ++T+A D+WS G VM E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 98
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 156
              T      L +++EY+         +   + +  P    ++ T   +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 215
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 216 YTTAIDIWSTGCVMAELLLGQP 237
           Y +  DIWS G    EL  G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 58/242 (23%)

Query: 44  VGTGSFGVVFQAKCRE-----TGEI-VAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 92
           +G+G+FG V++    +     +G I VA+K        Q+K+   +E  +M   +HPNIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 93  A-LKHCFFSTTDKEELYLNL-------VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 144
             L  C       E  Y+ +       +L Y+ +   R+ R    +     L+ + L   
Sbjct: 63  KLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVA 116

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYIC 200
           + C  L  +H      HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 117 KGCVYLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 201 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
           S YYR            APE L+ G   +TT  D+WS G +M E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 247 QL 248
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.2 bits (153), Expect = 3e-11
 Identities = 80/307 (26%), Positives = 134/307 (43%), Gaps = 63/307 (20%)

Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 140
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 141 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 195
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 120 -----VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 172

Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230

Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 315
           GTP     +  NP                    +RL     D + R  +   + R +A E
Sbjct: 231 GTP-----ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKE 265

Query: 316 ACVHPFF 322
              HPF 
Sbjct: 266 LLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 140
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 74  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 120

Query: 141 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPN 195
                +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +    
Sbjct: 121 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR 173

Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
            + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   
Sbjct: 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATN 231

Query: 256 GTPTREEIKCMNPNYTEF 273
           GTP  +  + ++  + +F
Sbjct: 232 GTPELQNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 79/305 (25%), Positives = 121/305 (39%), Gaps = 83/305 (27%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           V+G G+FG V   + ++TG + A+K      +L+ ++  +   E  I+   D   +V + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM- 66

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
             F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  I
Sbjct: 67  --FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSI 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--------------- 198
           H  +G  HRDIKP NLL++   H +KL DFG    L K      Y               
Sbjct: 118 HQ-LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 199 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 237
                                + +  Y APE +F  T Y    D WS G +M E+L+G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 238 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 297
            F  E              TP     K MN   T   FP   P          +  +A D
Sbjct: 235 PFCSE--------------TPQETYKKVMNWKET-LIFPPEVP----------ISEKAKD 269

Query: 298 LVCRF 302
           L+ RF
Sbjct: 270 LILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 62/322 (19%)

Query: 50  GVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHCFFSTTD 103
            +V  AK + T  +VA+KK+  D   K        E+   + L HPNI+     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 104 KEELYL-----------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             ELY+           +L+  + PE               +P + +      +  AL Y
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNVSYICSRYY 204
           IH+  G  HR +K  ++L++     + L     +  ++K         +   S + +  +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 205 RAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--- 260
            +PE++    + Y    DI+S G    EL  G   F        L+E  KV GT      
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232

Query: 261 -----EEIKCMNPNYTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 312
                     M+ + +  + P  +    HP+ + F           V    Q  P  R +
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFS----EHFHQFVELCLQRDPESRPS 288

Query: 313 ALEACVHPFFDELRDPNTRLPN 334
           A +   H FF + +  NT L +
Sbjct: 289 ASQLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 26/199 (13%)

Query: 44  VGTGSFGVVFQAKCRETGEI-VAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 99
           +G+G FGVV   K R  G+I VAIK + +    ++    E ++M  L HPN+V L   + 
Sbjct: 12  LGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YG 66

Query: 100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIG 158
             T +  +++  V EY+    N    NY R  +        L     +C A+ Y+ +  G
Sbjct: 67  VCTKQRPIFI--VTEYM---ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-G 120

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-----APELIFGA 213
             HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F  
Sbjct: 121 FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDY 175

Query: 214 TEYTTAIDIWSTGCVMAEL 232
           + +++  D+WS G +M E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 98
           +G G++G V++   ++ G + A+ K+L      + E++    I+Q L +HPN+V     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAV-KILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 99  FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           +         L LVLE     +V  + +      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 217 TTA----IDIWSTGCVMAELLLGQP 237
             +     D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 38  YIAEHVVGTGSFGVVF---QAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDH 88
           YI +  +G GSFG V+     K      +  +K++        +    N+E Q++  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 89  PNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           P IV     F      E     ++ EY     ++          + +    V  +  Q+ 
Sbjct: 62  PAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRA 206
             + Y+H    I HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQ-RRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
           PE +     Y +  DIWS GC++ E+      F G++ +  ++ I++
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 31/209 (14%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 92
           E V+G G FG V + + +  G+    VAIK +     DK+  +   E  IM   DHPNI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 150
            L+     +       + ++ EY+    N     + R +  +      V +    I   +
Sbjct: 69  RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYY 204
            Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+ 
Sbjct: 120 KYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELL 233
            APE I    ++T+A D+WS G VM E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 99
           VVG G++G V++ +  +TG++ AIK   V +D+  +   E+ +++   H   +A  +  F
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 100 --STTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              +    +  L LV+E+    +V  + +N       +   ++     +I R LA++H  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH-A 139

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 211
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 140 HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197

Query: 212 -GATEYTTAIDIWSTGCVMAELLLGQP 237
                Y    DIWS G    E+  G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 101 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIGI 159
            T +  +Y  +V EY+    N    NY R H +       L     +C  +AY+ +   I
Sbjct: 68  CTKQRPIY--IVTEYMS---NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEY 216
            HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   +++
Sbjct: 123 -HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKF 178

Query: 217 TTAIDIWSTGCVMAEL 232
           ++  D+W+ G +M E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 98
           +G G++G VF+   ++ G   A+K +L      + E++    I++ L DHPN+V     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 99  FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           +    K    L LVLE     +V  + + + +  +RM    +    ++    L ++H   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGA--- 213
            I HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I      
Sbjct: 145 TI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 214 -TEYTTAIDIWSTGCVMAELLLGQP 237
            + Y    D+WS G    EL  G P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 98
           +G GSFG V++     T E+VAIK + L++   +     +E+ ++   D P I      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 156
              T      L +++EY+         +   + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 215
             I HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 216 YTTAIDIWSTGCVMAELLLGQP 237
           Y    DIWS G    EL  G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 17/160 (10%)

Query: 47  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK------HCFFS 100
           G+FG V+  + +   ++ A+K V++     N+ + + Q+    + +AL       H ++S
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNM-VHQVQAERDALALSKSPFIVHLYYS 72

Query: 101 TTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
                 +YL  V+EY +   V  +   Y    + M + Y+     ++  AL Y+H   GI
Sbjct: 73  LQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-GI 125

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
            HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 126 IHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 26/228 (11%)

Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLD 87
           Q   Y    V+G+G+ G V  AK    GE  A+K V        DK     E+  +   D
Sbjct: 30  QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 88  HPNIVALKHCFFSTTDKEE---LYLNLVLEYV------PETVNRIARNYSRIHQRMPLIY 138
             +IV     F     +     L + LVL+Y        E  +R   N +       L++
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPN 195
           +     Q+  A+ ++H+   I HRDIK  N+L+  +   +KL DFG +K+    V  +  
Sbjct: 150 I-----QVLLAVHHVHSKHMI-HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVG 202

Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
            ++  + YY APE I+    Y+   D++S G ++ ELL  +  F GE+
Sbjct: 203 RTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFST 101
           G G FG V+      T + VA+K +           +E QIM+ L H  +V L   +   
Sbjct: 15  GAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70

Query: 102 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIH--NCI 157
           +++E +Y  +V EY+ + ++    ++      R+P L+ +     QI   +AY+   N I
Sbjct: 71  SEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQIAEGMAYLESRNYI 125

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI-FGA 213
              HRD+  +N+LV  +    K+ DFG A+++   E   +   +++   + APE   +G 
Sbjct: 126 ---HRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYG- 179

Query: 214 TEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
             +T   D+WS G ++ E++  G+  +PG
Sbjct: 180 -RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 95
           +G G FG V   + R TG++ A KK L  KR K R        E +I+  +    IV+L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           + F + TD     L LV+  +     R    N    +   P      YT QI   L ++H
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGA 213
               I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ G 
Sbjct: 115 Q-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 214 TEYTTAIDIWSTGCVMAELL 233
            EY  ++D ++ G  + E++
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 36  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 86
           VS +  E V+G G FG V + + +  G+    VAIK +      K R     E  IM   
Sbjct: 3   VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 87  DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQ 145
           DHPNI+ L+     T  +  + +   +E      N    ++ R +  +  +I +      
Sbjct: 63  DHPNIIHLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 202
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S    
Sbjct: 115 IAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 203 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
               + APE I    ++T+A D+WS G VM E++
Sbjct: 173 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 99
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 100 STTDKEEL--YLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              +   +   L LV+E+    +V  + +N       +   ++     +I R L+++H  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 130

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 211
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 131 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 187

Query: 212 -GATEYTTAIDIWSTGCVMAELLLGQP 237
                Y    D+WS G    E+  G P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + V+G G FG VF+   +  G     VAIK +      K R     E  IM    H NI+
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 150
            L+               ++ EY+    N     Y R H  +      V +    I   +
Sbjct: 70  RLEGVVTKFKP-----AMIITEYME---NGALDKYLRDHDGEFSSYQLVGMLR-GIAAGM 120

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYR 205
            Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 121 KYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE I    ++T+A D+WS G VM E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 184 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 239

Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 255
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +  
Sbjct: 240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 291

Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
               +E  +   P+YT  +  Q     WH
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 60/236 (25%)

Query: 43  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNI 91
            +G G+FG VF  +C         E+VA+ K L++      ++   RE +++    H NI
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRM--------PLIYVKLY 142
           V         T+ +     +V EY+    +N+  R++      +         L   +L 
Sbjct: 71  VKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 143 --TYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
               QI   + Y+   H      HRD+  +N LV  +   +K+ DFG ++ +        
Sbjct: 126 QIAVQIASGMVYLASQH----FVHRDLATRNCLVG-YDLVVKIGDFGMSRDV-------- 172

Query: 198 YICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 239
           Y    YYR             PE I     +TT  D+WS G V+ E+     QP +
Sbjct: 173 YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL- 94
             +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L 
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 95  -----KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
                +  F+  T+    Y NL L+Y+ E  NR         Q +  + +     QI  A
Sbjct: 69  GVCTREPPFYIITEFMT-YGNL-LDYLREC-NR---------QEVNAVVLLYMATQISSA 116

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRA 206
           + Y+     I HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + A
Sbjct: 117 MEYLEKKNFI-HRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTA 173

Query: 207 PELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 241
           PE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 174 PESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 43  VVGTGSFGVVFQAK----CRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIV 92
            +G G FG VF AK      E GE + + K LQ  + +N      REL + + L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYT--YQI 146
            L        + E  Y+  +LEY      +   R  ++     +  PL   +      QI
Sbjct: 72  RL---LGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 205
              + ++ N     HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSN-ARFVHRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 206 ----------APELIFGATEYTTAIDIWSTGCVMAEL 232
                     APE +    +++T  D+WS G +M E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 26/197 (13%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHCFFS 100
           +G G FG V     R  G+ VA+K +  D         E  +M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 101 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
                 LY  +V EY+    + +    SR    + L     +   +C  + Y+       
Sbjct: 71  --QGNPLY--IVTEYM-AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFV 124

Query: 161 HRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATE 215
           HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +    +
Sbjct: 125 HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175

Query: 216 YTTAIDIWSTGCVMAEL 232
           ++T  D+WS G ++ E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)

Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-- 197
           +TYQ+ R + ++   NC+   HRD+  +N+L+      +K+CDFG A+ ++     VS  
Sbjct: 242 FTYQVARGMEFLASKNCV---HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 198 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
                  + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 54/237 (22%), Positives = 104/237 (43%), Gaps = 49/237 (20%)

Query: 43  VVGTGSFGVV-----FQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 92
            +G G FG V     F+ K R     VA+K + ++      R    E  +++ ++HP+++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL----------- 141
            L   + + +    L L  ++EY         R++ R  +++   Y+             
Sbjct: 67  KL---YGACSQDGPLLL--IVEYAKYGS---LRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 142 -------------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
                        + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++ 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLV-AEGRKMKISDFGLSRD 176

Query: 189 LVKGEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
           + + +  V     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)

Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 179 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 234

Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 235 SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 16/95 (16%)

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
           Q+  A+ YIH   GI HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIH-GEGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 205 --------RAPELIFGATEYTTAIDIWSTGCVMAE 231
                    APE++ G   YT ++DIWS G V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 38/225 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G G FG V++     T   VA+K +            E QIM+ L HP ++ L   +  
Sbjct: 14  LGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAV 69

Query: 101 TTDKEELYL-------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
            T +E +Y+         +LEY    +   A    ++ Q + +        Q+   +AY+
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEY----LQGGAGRALKLPQLIDM------AAQVASGMAYL 119

Query: 154 --HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 208
              N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + APE
Sbjct: 120 EAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPE 174

Query: 209 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 250
                  ++   D+WS G ++ E++  G+  +PG +   V Q V+
Sbjct: 175 AAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 19/110 (17%)

Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 192
           ++ Q+ + + ++   NCI   HRD+  +N+L+       K+CDFG A+        +VKG
Sbjct: 217 FSSQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
              +       + APE IF    YT   D+WS G ++ E+  LG+  +PG
Sbjct: 273 NARLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 70/320 (21%), Positives = 124/320 (38%), Gaps = 95/320 (29%)

Query: 35  KVSYIAEHVVGTGSFGVVFQ--AKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQ 84
           K++ I E  +G GSFG+V++  AK    GE    VAIK V ++   + R     E  +M+
Sbjct: 7   KITLIRE--LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64

Query: 85  MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETV--NRIA----RNYSRIHQ------ 132
             +  ++V L              L +V    P  V    +A    ++Y R  +      
Sbjct: 65  EFNCHHVVRL--------------LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENN 110

Query: 133 --RMPLIYVKLYTY--QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
               P    K      +I   +AY+       HRD+  +N +V      +K+ DFG  + 
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTRD 168

Query: 189 LVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG 235
           + + +         YYR            APE +     +TT  D+WS G V+ E+  L 
Sbjct: 169 IYETD---------YYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLA 218

Query: 236 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 295
           +  + G S  +++++ +         +   ++        P+  P    ++ +       
Sbjct: 219 EQPYQGLSN-EEVLKFVI--------DGGHLDL-------PENCPDKLLELMR------- 255

Query: 296 VDLVCRFFQYSPNLRCTALE 315
                  +QY+P +R T LE
Sbjct: 256 -----MCWQYNPKMRPTFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 58/283 (20%)

Query: 44  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 90
           +G G FG V  A+         +    VA+K +  D   K+      E+++M+M+  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNR--------IARNYSRIHQRMP---LIYV 139
           I+ L     + T    LY+  ++EY  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 140 KLY--TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
            L   TYQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVT-ENNVMKIADFG----LARDVNN 189

Query: 196 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
           + Y            + APE +F    YT   D+WS G +M E+  LG   +PG   V++
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEE 247

Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 290
           L +++K  G    +   C N  Y   +        WH +   R
Sbjct: 248 LFKLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 24/198 (12%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCFF 99
           +G+G FG+V+     E  + VAIK +    + ++ +   E Q+M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIHNCI 157
             +      + LV E++    +    +Y R  QR       L      +C  +AY+ +  
Sbjct: 70  ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGAT 214
            I HRD+  +N LV      +K+ DFG  + ++  +   S   +++   + +PE +F  +
Sbjct: 121 VI-HRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFS 176

Query: 215 EYTTAIDIWSTGCVMAEL 232
           +Y++  D+WS G +M E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 8e-08
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 19/110 (17%)

Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKG 192
           ++YQ+ + ++++   NCI   HRD+  +N+L+  H    K+CDFG A+        +VKG
Sbjct: 219 FSYQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKG 274

Query: 193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
              +       + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 68/243 (27%)

Query: 32  SKQKVSYIAEHVVGTGSFGVV-----FQAKCRETGEIVAIK--------KVLQDKRYKNR 78
               V ++ E  +G G+FG V          R +   VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 79  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIA 124
           E ++M  L HPNIV    C      KE+    L  EY+                 V   +
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 125 RNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCD 182
            + +         ++ +   QI   + Y+  H+     HRD+  +N LV      +K+ D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISD 167

Query: 183 FGSAKVLVKGEPNVSYICSRYYR------------APELI-FGATEYTTAIDIWSTGCVM 229
           FG ++ +   +         YYR             PE I +G  ++TT  DIWS G V+
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216

Query: 230 AEL 232
            E+
Sbjct: 217 WEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)

Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           Y++Q+ R + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 178 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 233

Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            +R    + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 234 DARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 27/270 (10%)

Query: 66  IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR 125
           I K +   +   RE+ I++ + H  I+ L H +         + + V   +P+    +  
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLF- 173

Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
            Y      +PL        ++  ALAY+H   GI HRD+K +N+ ++   + + L DFG+
Sbjct: 174 TYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAV-LGDFGA 231

Query: 186 AKVLVKGEPNVSYICSRY-----YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF 239
           A  L       +  C  +       +PEL+     Y    DIWS G V+ E+ +    LF
Sbjct: 232 ACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 240 PGE--SGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPP 293
             +  S   QL  II+ +     E  +  + N    + ++      P+    V +K    
Sbjct: 289 GKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMH 348

Query: 294 EAVD-LVCRFFQYSPNLRCTALEACVHPFF 322
             V+ L+ +   +    R +A +    P F
Sbjct: 349 MDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)

Query: 43  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYK-NREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE     VAIK++ +    K N+E+     +M  +D+P++  
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 94  LKH-CFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           L   C  ST     + +    +L+YV E  + I              Y+  +  QI + +
Sbjct: 74  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQIAKGM 122

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I     YT   D+WS G  + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 41/218 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNR---ELQIMQMLDHPNIVALKHC 97
           ++G G+FG VF+   ++    VA+K   +D  +  K +   E +I++  DHPNIV L   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 98  FFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
               T ++ +Y  +V+E VP     +  R  ++  +  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 154 H--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 205
              NCI   HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + 
Sbjct: 110 ESKNCI---HRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWT 161

Query: 206 APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
           APE L +G   Y++  D+WS G ++ E   LG   +PG
Sbjct: 162 APEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 44  VGTGSFGVVFQA--KCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 95
           +G+G+FG V +   K R+    VAIK VL+++  K+      RE +IM  LD+P IV + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                  + E L   LV+E        + +  S     + +  V    +Q+   + Y+  
Sbjct: 61  ---IGVCEAEALM--LVMEMASG--GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 156 CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-------YRAP 207
                HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + AP
Sbjct: 114 -KNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++++  D+WS G  M E  
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 23/151 (15%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALKH 96
           +G G+FG V  A+  +T  + A+K + + D   +N+      E  I+   D+  +V L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-- 66

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYI 153
            ++S  DK+ LY   V++Y+P        +   +  RM   P    + Y  ++  A+  +
Sbjct: 67  -YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 184
           H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 118 HK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 33/212 (15%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G G FG V+        + VAIK + Q          E  +M+ L HP +V L    ++
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL----YA 68

Query: 101 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIH--NC 156
              +E +Y+  + EY+    N    ++ +  + + L   KL     QI   +A+I   N 
Sbjct: 69  VVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPELI 210
           I   HRD++  N+LV+  T   K+ DFG A+++   E    Y           + APE I
Sbjct: 124 I---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPEAI 175

Query: 211 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
              T +T   D+WS G ++ E++  G+  +PG
Sbjct: 176 NYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 50/236 (21%)

Query: 33  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKV-----LQDKRYKNRELQI 82
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K +        +    RE  +
Sbjct: 4   RNNIEYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 83  MQMLDHPNIVAL--------KHC----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRI 130
           M   DHPNIV L          C    + +  D  E   +          +  +      
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 131 HQRMPLIYVKLY--TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
              +PL   +      Q+   +AY+     + HRD+  +N LV  +   +K+ DFG ++ 
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSRN 179

Query: 189 LVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAEL 232
           +   +         YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 180 IYSAD---------YYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 44/191 (23%)

Query: 65  AIKKVLQDKRYKNRELQIMQMLDHPNIVAL-------KHCFFSTTDKEELYLNLVL-EYV 116
           A     +D     +E++I+  L  PNI  L                 E   LN  L ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 117 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPH 174
            ET        S+      L+Y+     QI   + Y+   N +   HRD+  +N LV   
Sbjct: 115 AETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK- 165

Query: 175 THQLKLCDFGSAKVLVKGEPNVSYICSRYY----RAP--------ELIFGATEYTTAIDI 222
            + +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+
Sbjct: 166 NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDV 215

Query: 223 WSTGCVMAELL 233
           W+ G  + E+L
Sbjct: 216 WAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 43  VVGTGSFGVVFQAKCR-ETGEI--VAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 93
           ++G G FG V + +   + G    VA+K +  D    +       E   M+  DHPN++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 94  LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRA 149
           L    F  +  +++   +V L ++          YSR+    +++PL  +  +   I   
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAP 207
           + Y+ N   I HRD+  +N ++      + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSNRNFI-HRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 208 ELI-----FGATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 241
            +      + A E      YT+  D+W+ G  M E+   GQ  +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 49/243 (20%)

Query: 44  VGTGSFGVVFQA--KCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALK 95
           +G+G+FG V +   K +++ + VA+K +  D      K    RE  +MQ LD+P IV + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYI- 153
                  + E   L + L  +      + +N +        L+      +Q+   + Y+ 
Sbjct: 62  ---IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV------HQVSMGMKYLE 112

Query: 154 -HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------- 205
             N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+       
Sbjct: 113 ETNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKW 160

Query: 206 -----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVEIIKVLGT 257
                APE +    ++++  D+WS G +M E    GQ  + G  G  V Q++E  + +  
Sbjct: 161 PVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219

Query: 258 PTR 260
           P R
Sbjct: 220 PQR 222

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 79/317 (24%), Positives = 124/317 (39%), Gaps = 81/317 (25%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 94  LKHCFFSTTDKEELYL---NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           L     S T +    L     +L+YV E  + I               +  +  QI + +
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQ-----------LLLNWCVQIAKGM 122

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A 
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           E I    ++T   D+WS G  + EL+   G+P                  G PTRE    
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTREI--- 220

Query: 266 MNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
             P+  E   + PQ              PP     +C    Y   ++C  ++A   P F 
Sbjct: 221 --PDLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFK 259

Query: 324 EL--------RDPNTRL 332
           EL        RDP   L
Sbjct: 260 ELAAEFSRMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 26/69 (37%), Positives = 38/69 (55%), Gaps = 9/69 (13%)

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY- 203
           QI  AL  +H+  GI HRD+KPQN++ +  +   K+ D G+A  L  G   ++YI   + 
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 204 ----YRAPE 208
               Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 21/187 (11%)

Query: 114 EYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNL 169
           +Y+P    R  R+ + I++   L Y+ L  ++YQ+   + ++   NC+   HRD+  +N+
Sbjct: 215 QYLPSAPERTRRD-TLINESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNV 270

Query: 170 LVNPHTHQLKLCDFGSAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTG 226
           L+      +K+CDFG A+ +++    +S         + APE IF    YTT  D+WS G
Sbjct: 271 LIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFG 328

Query: 227 CVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK 285
            ++ E+  LG   +P     +Q    IK          +   P +   +  +I    W +
Sbjct: 329 ILLWEIFTLGGTPYPELPMNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEE 381

Query: 286 VFQKRLP 292
            F+ R  
Sbjct: 382 KFEIRPD 388

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 44/218 (20%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVALKHCFF 99
           +G+G FG V++   +     VAIK +  D   K +    E+Q ++ L H ++++L   F 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL---FA 69

Query: 100 STTDKEELYL--------NLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
             +  E +Y+        +L L ++  PE          ++     LI +     Q+   
Sbjct: 70  VCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQVAEG 116

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----Y 204
           +AY+       HRD+  +N+LV       K+ DFG A+++   E    Y+ S       +
Sbjct: 117 MAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI--KED--VYLSSDKKIPYKW 170

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG 241
            APE       ++T  D+WS G ++ E+   GQ  +PG
Sbjct: 171 TAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 59/243 (24%)

Query: 89  PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQI 146
           PN+V L     S     E  + LVL++         + +S I +   +P   VK +  ++
Sbjct: 45  PNMVCLHKYIVS-----EDSVFLVLQHAEG-----GKLWSHISKFLNIPEECVKRWAAEM 94

Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 205
             AL  +H   GI  RD+ P N+L++   H ++L  F       + E +         Y 
Sbjct: 95  VVALDALHR-EGIVCRDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYC 149

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK 264
           APE + G +E T A D WS G ++ ELL G+ L     SG++                  
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------------- 191

Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----H 319
                +T    P+             +  EA  L+ +  Q++P  R  A  A V     H
Sbjct: 192 -----HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234

Query: 320 PFF 322
           PFF
Sbjct: 235 PFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 44  VGTGSFGVVFQAKC--------RETGEIVAIKKVLQDKRYK-NRELQIMQMLDHPNIVAL 94
           +G G+FG VF A+C        +    + A+K+  +  R    RE +++ +L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 95  KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY---------SRIHQRMPLIYVKLY-- 142
              F+    +    L +V EY+    +NR  R++                 L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
             QI   + Y+ + +   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 203 YYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 233
           YYR             PE I    ++TT  DIWS G V+ E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 44  VGTGSFGVVFQAKCRETGEI--VAIK--KVLQDKRYKN----RELQIMQMLDHPNIVALK 95
           +G G FG V + +  +   I  VA+K  K+    R +      E   M+  DHPN++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 96  HCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALA 151
                T + E     +V L ++          YSR+    Q +P   +  +   I   + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           Y+ +   I HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + P + +
Sbjct: 127 YLSSKSFI-HRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP-VKW 180

Query: 212 GATE------YTTAIDIWSTGCVMAELLL-GQPLFPG 241
            A E      YTT  D+WS G  M E+   GQ  +PG
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 93
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 94  -LKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            L  C  ST     + +    +L+YV E  +RI               +  +  QI + +
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQ-----------DLLNWCVQIAKGM 122

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
           +Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A 
Sbjct: 123 SYLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I     +T   D+WS G  + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 83/317 (26%), Positives = 131/317 (41%), Gaps = 75/317 (23%)

Query: 44  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 90
           +G G FG V  A+              VA+K +  D   K+      E+++M+M+  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNR---IAR-----NYSRIHQRMP---LIYV 139
           I+ L     + T    LY+  ++EY  +   R    AR     +YS    ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 140 KLYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
            L +  YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG    L +   N
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVT-EDNVMKIADFG----LARDVHN 186

Query: 196 VSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
           + Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEE 244

Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR----------------- 290
           L +++K       E  +   P     +   I    WH V  +R                 
Sbjct: 245 LFKLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297

Query: 291 LPPEAVDLVCRFFQYSP 307
              E +DL   F QYSP
Sbjct: 298 STDEYLDLSVPFEQYSP 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 56/231 (24%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNR---ELQIMQMLDHPNIVALKH 96
           +G G  G V+ A        VA+KK+ +D       K R   E +I   L HP IV +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67

Query: 97  CFFSTTDKEELYLNLVLEYVP-ETVNRIARNY-------SRIHQRMPL-----IYVKLYT 143
            +   +D + +Y  +   Y+   T+  + ++          + ++  +     I+ K   
Sbjct: 68  -YSICSDGDPVYYTM--PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV 196
             IC  + Y+H+  G+ HRD+KP N+L+      + L D+G+A         L+  + + 
Sbjct: 122 --ICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDE 177

Query: 197 SYICSRY------------YRAPELIFG--ATEYTTAIDIWSTGCVMAELL 233
             IC               Y APE + G  A+E T   DI++ G ++ ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 77/318 (24%), Positives = 134/318 (42%), Gaps = 76/318 (23%)

Query: 44  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQMLD-HPN 90
           +G G FG V +A+         +    VA+K +  +   K+      E+++M+++  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNR------------IARNYSRIHQRMPLIY 138
           I+ L       T +  LY+  ++EY  +   R               + +++ +   L +
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133

Query: 139 VKLYT--YQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 194
             L +  YQ+ R + Y+ +  CI   HRD+  +N+LV    + +K+ DFG    L +G  
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVT-EDNVMKIADFG----LARGVH 185

Query: 195 NVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
           ++ Y            + APE +F    YT   D+WS G +M E+  LG   +PG     
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241

Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---------------- 290
            + E+ K+L    RE  +   P+    +   +    WH V  +R                
Sbjct: 242 -VEELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296

Query: 291 LPPEAVDLVCRFFQYSPN 308
           +  E +DL   F QYSP+
Sbjct: 297 VSEEYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 53/226 (23%)

Query: 43  VVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKRYKNRELQIMQML---------DHP 89
           ++  G+FG +F     +      E V +K V         E+Q+  +L          H 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68

Query: 90  NIVALKH-CFFSTTDKEELY-------LNLVLE---YVPETVNRIARNYSRIHQRMPLIY 138
           NI+ + H C         LY       L L L+          +       +H  M +  
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH--MAI-- 124

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
                 QI   ++Y+H   G+ H+DI  +N +++    Q+K+ D   ++ L   +    Y
Sbjct: 125 ------QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----Y 172

Query: 199 IC-----SRYYR--APELIFGATEYTTAIDIWSTGCVMAELL-LGQ 236
            C     +R  +  A E +    EY++A D+WS G ++ EL+ LGQ
Sbjct: 173 HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 37/218 (16%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIV 92
           + V+G G+FG V +A+ ++ G  +  AIK++ +     D R    EL+++  L  HPNI+
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 93  -ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK----------- 140
             L  C      +   YL L +EY P          SR+ +  P   +            
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 141 --LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPN 195
              +   + R + Y+     I HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 181

Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 40/226 (17%)

Query: 43  VVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 93
           ++G G FG V +A+ +    + + VA+K +  D    +      RE   M+  DHPN++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 94  LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRA 149
           L      +  K  L + +V L ++           SRI +    +PL  +  +   I   
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYR-- 205
           + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YYR  
Sbjct: 126 MEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 206 -APELIFG--ATE------YTTAIDIWSTGCVMAELL-LGQPLFPG 241
            A +L     A E      YTT  D+W+ G  M E++  GQ  + G
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G G+FG VF  + R     VA+K         L+ K  +  E +I++   HPNIV L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA---YI 153
                T K+ +Y  +V+E V     +     + +    P + VK     +  A A   Y+
Sbjct: 59  -IGVCTQKQPIY--IVMELV-----QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 154 HN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE 208
            +  CI   HRD+  +N LV    + LK+ DFG ++    G    +    +    + APE
Sbjct: 111 ESKHCI---HRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166

Query: 209 -LIFGATEYTTAIDIWSTGCVMAE 231
            L +G   Y++  D+WS G ++ E
Sbjct: 167 ALNYG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 37/219 (16%)

Query: 43  VVGTGSFGVVFQAKCRETGEI---VAIKKV-----LQDKRYKNRELQIMQMLDHPNIVAL 94
           V+G G FG V+     ++       A+K +     L++     +E  IM+   HPN+++L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICRAL 150
                     E   L +VL Y+    +   RN+ R     P    LI   L   Q+ + +
Sbjct: 62  LGICL---PSEGSPL-VVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGL---QVAKGM 111

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL- 209
            Y+ +     HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L 
Sbjct: 112 EYLAS-KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLP 165

Query: 210 -IFGATE------YTTAIDIWSTGCVMAELLL-GQPLFP 240
             + A E      +TT  D+WS G ++ EL+  G P +P
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 68/288 (23%)

Query: 44  VGTGSFGVVFQAKC-----RETGEI--VAIKKVLQDKRYKN-----RELQIMQML-DHPN 90
           +G G FG V  A+       +   +  VA+K +  D   K+      E+++M+M+  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNR----------IARNYSRIHQRMPLIYVK 140
           I+ L     + T    LY+  ++EY  +   R          +   Y+        +  K
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 141 LY---TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
                 YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+       +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVT-EDNVMKIADFGLAR-------D 189

Query: 196 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 242
           + +I   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 190 IHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 290
             V++L +++K  G    +   C N  Y   +        WH V  +R
Sbjct: 247 P-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G G FG V+      T + VAIK +           +E QIM+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 101 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
              +E +Y+  V E++ + ++    +     + ++P + V +   QI   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIER-MNY 123

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 215
            HRD++  N+LV  +    K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 216 YTTAIDIWSTGCVMAELLL-GQPLFPG 241
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 27/189 (14%)

Query: 63  IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP 117
           +VA+K +  D  K  +N   +E++IM  L +PNI+ L      + D     L ++ EY+ 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL-GVCVSDDP----LCMITEYME 100

Query: 118 E------TVNRIARNYSRIHQRMPLIYVKLYTY---QICRALAYIHNCIGICHRDIKPQN 168
                     R   +       +P + +    Y   QI   + Y+ + +   HRD+  +N
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRN 159

Query: 169 LLVNPHTHQLKLCDFGSAKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWS 224
            LV  H + +K+ DFG ++ L  G+       + +  R+     ++ G  ++TTA D+W+
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWA 216

Query: 225 TGCVMAELL 233
            G  + E+ 
Sbjct: 217 FGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 76/346 (21%), Positives = 126/346 (36%), Gaps = 83/346 (23%)

Query: 43  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 94
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           +  F    D E   +   + Y     + I  ++      + + Y+      + +AL YIH
Sbjct: 65  RATFI--ADNELWVVTSFMAY-GSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIH 118

Query: 155 NCIGICHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGEP 194
           + +G  HR +K  ++L++                  H  +L++  DF   S KVL    P
Sbjct: 119 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177

Query: 195 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
            V            L      Y    DI+S G    EL  G   F        L+E  K+
Sbjct: 178 EV------------LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KL 223

Query: 255 LGT------------------PTR--------EEIKCMNPNYTEFKFPQIKPHPWHKVFQ 288
            GT                  P+R        E      P  +     +   HP+++ F 
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRTFS 280

Query: 289 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL-RDPNTRLP 333
               P     V +  Q +P+ R +A     H FF ++ R  +  LP
Sbjct: 281 ----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 129 RIHQRMP-----LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF 183
           +I   MP     +  +K    Q+   L  +H  IGI HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 184 GSAKVLVKG---EPNVSYICSRYYRAPELI 210
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 51/225 (22%)

Query: 41  EHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIMQML-DHPNIV 92
           E V+G G+FG V +A  ++ G ++ A  K+L++   +N       EL+++  L  HPNI+
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 93  AL-KHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRM 134
            L   C      +   YL + +EY P              ET    A+ +   S +  + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 135 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 194
            L     +   +   + Y+     I HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LL----QFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 195 NVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 233
              Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G G FG V+        + VA+K +            E QIM+ L H  +V L    ++
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL----YA 68

Query: 101 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
              +E +Y+  V EY+ + ++    ++      ++P + V +   Q+   +AYI   +  
Sbjct: 69  VVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAYIER-MNY 123

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL-IFGATE 215
            HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE  ++G   
Sbjct: 124 IHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG--R 179

Query: 216 YTTAIDIWSTGCVMAELLL-GQPLFPG 241
           +T   D+WS G ++ EL+  G+  +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 24/102 (23%)

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
           QI   + Y+ + +   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYLSS-LNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 205 R------------APELIFGATEYTTAIDIWSTGCVMAELLL 234
           R            A E I    ++TTA D+W+ G  + E+L+
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 8/116 (6%)

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY--ICSR 202
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVL 255
              +PE++ G   Y    DIWS G ++ ++L       G+ G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 48/218 (22%), Positives = 82/218 (37%), Gaps = 48/218 (22%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRE----TGEIVA----------------------IKKVLQ 71
           +  + ++G G FG V++ +C        + VA                      I K+  
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 72  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 131
            K   N        +DH  I     C      +   Y  ++LE + E    I   + RI 
Sbjct: 74  WKNIHN--------IDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEI---FKRIK 121

Query: 132 QR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 190
            +   LI  K     +   L YIH   GI H DIKP+N++V+ + ++  + D+G A   +
Sbjct: 122 CKNKKLI--KNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGN-NRGYIIDYGIASHFI 177

Query: 191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCV 228
               ++      Y +  + +   T Y   +D  +  CV
Sbjct: 178 IHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 40.1 bits (93), Expect = 0.001
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 51/223 (22%)

Query: 43  VVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKNR------ELQIM-QMLDHPNIV-A 93
           V+G G+FG V +A+ ++ G  + A  K +++   K+       EL+++ ++  HPNI+  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIARNY---SRIHQRMPL 136
           L  C      +   YL L +EY P              ET    A      S +  +  L
Sbjct: 62  LGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
            +       + R + Y+     I HRD+  +N+LV  +    K+ DFG    L +G+   
Sbjct: 116 HFAA----DVARGMDYLSQKQFI-HRDLAARNILVGENYVA-KIADFG----LSRGQE-- 163

Query: 197 SYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL 233
            Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 164 VYVKKTMGRLP-VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 49/232 (21%)

Query: 43  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
            +G G+FG V++   R          VA+K + +    ++      E  IM   +H NIV
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 93  ALKHCFFSTTDKEELYLNLVL-------EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 145
                   + ++   ++ L L        ++ E   R  R  S   +   L++      +
Sbjct: 73  ---RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--LLFCARDVAK 127

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRY 203
            C+ L   H      HRDI  +N L+         K+ DFG A+ + +         + Y
Sbjct: 128 GCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASY 174

Query: 204 YR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 243
           YR            P   F    +T+  D+WS G ++ E+  LG   +PG +
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 52/201 (25%)

Query: 63  IVAIKKVLQD--KRYKN---RELQIMQMLDHPNIVAL--------KHC----FFSTTDKE 105
           +VA+K + +D  K  +N   +E++IM  L  PNI+ L          C    +    D  
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK 165
           +       +   E  + +  +YS       LI++     QI   + Y+ + +   HRD+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYST------LIFMAT---QIASGMKYLSS-LNFVHRDLA 157

Query: 166 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA-------------PELIFG 212
            +N LV    + +K+ DFG ++ L  G+         YYR                ++ G
Sbjct: 158 TRNCLVG-KNYTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMSWESILLG 207

Query: 213 ATEYTTAIDIWSTGCVMAELL 233
             ++TTA D+W+ G  + E+L
Sbjct: 208 --KFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 78/331 (23%), Positives = 138/331 (41%), Gaps = 85/331 (25%)

Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 81
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 82  IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLI 137
           +M+     ++V L         K +  L +V+E +     ++  R  R  +  +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 138 YVK---LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 194
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 195 NVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFP 240
                   YYR            APE +     +TT+ D+WS G V+ E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 241 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 300
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 301 RFFQYSPNLRCTALEAC------VHPFFDEL 325
             +Q++P +R T LE        +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 46/207 (22%), Positives = 90/207 (43%), Gaps = 31/207 (14%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQI------MQMLDHPNIVA 93
           ++G+G FG V +      G+ + I    K +QD+  +    +I      M  LDH  IV 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 94  LKH-CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           L   C  ++       L LV +  P    ++ + ++   +  +  L +      QI + +
Sbjct: 74  LLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKGM 122

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRA 206
            Y+     + HR++  +N+L+   +  +++ DFG A +L   +    Y       ++   
Sbjct: 123 YYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELL 233
             ++FG   YT   D+WS G  + E++
Sbjct: 181 ESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	376
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
smart00090	237	RIO RIO-like kinase.	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG1243	690	consensus Protein kinase [General function predict	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
PRK09902	216	hypothetical protein; Provisional	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.78
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.61
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.58
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.54
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.28
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.2
PLN02876	822	acyl-CoA dehydrogenase	98.08
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.06
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.95
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.9
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
KOG2270	520	consensus Serine/threonine protein kinase involved	97.75
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.74
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.68
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.66
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.63
PRK05231	319	homoserine kinase; Provisional	97.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.53
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.48
PRK10593	297	hypothetical protein; Provisional	97.47
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.23
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.18
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.15
PLN02236	344	choline kinase	97.09
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.08
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.97
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.85
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.85
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.75
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.73
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.56
PRK12396	409	5-methylribose kinase; Reviewed	96.48
PLN02756	418	S-methyl-5-thioribose kinase	96.3
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	96.07
PTZ00384	383	choline kinase; Provisional	96.04
PRK11768	325	serine/threonine protein kinase; Provisional	95.5
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.45
KOG2269	531	consensus Serine/threonine protein kinase [Signal	94.5
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.35
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.18
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.14
PRK10271	188	thiK thiamine kinase; Provisional	93.96

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-74  Score=499.79  Aligned_cols=354  Identities=74%  Similarity=1.202  Sum_probs=334.7

Q ss_pred             CCCceEEecccCCCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeecc
Q 017131           16 ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK   95 (376)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~   95 (376)
                      ..+.+..++..+......+...|.-.+.+|+|+||.||.|....+++.||||++..+.+...+|+.+|+.++|||||++.
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~   83 (364)
T KOG0658|consen    4 ESGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLL   83 (364)
T ss_pred             cceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEE
Confidence            45667778888888888888999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC
Q 017131           96 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                      .+|+...+.+..|+.+||||++.+|.+.++.+...+++++...++-+.+||++||+|||+ .||+||||||+|+|+|.+.
T Consensus        84 ~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~t  162 (364)
T KOG0658|consen   84 YFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDT  162 (364)
T ss_pred             EEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCC
Confidence            999877766567889999999999999999888888899999999999999999999998 9999999999999999997


Q ss_pred             CCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017131          176 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  255 (376)
Q Consensus       176 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  255 (376)
                      +.+||||||.|+....+++..++.+|+.|+|||++.+...|+.+.||||.||++.||+-|++.|+|.+..+++..|++.+
T Consensus       163 g~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l  242 (364)
T KOG0658|consen  163 GVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL  242 (364)
T ss_pred             CeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence            79999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCC
Q 017131          256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  335 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~  335 (376)
                      |.|+.+++.+|++++.+..+|++...+|...+....++++.+|+.++|+++|.+|.++.+++.||||+.+++++.+++++
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g  322 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNG  322 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCC
Confidence            99999999999999999999999999999988899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHhhhchHHHhhhhhh
Q 017131          336 RPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF  371 (376)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (376)
                      ..+|++++|+.. .....++..+.+++++.+.++-.
T Consensus       323 ~~lp~lf~f~~~-e~~~~~~~~~~l~p~~~~~~~~~  357 (364)
T KOG0658|consen  323 RPLPPLFNFKRA-ELGISPELVNVLIPEHLREQEKD  357 (364)
T ss_pred             CcCCCccCchHH-HhccchHHHHhhccHhhhhhccc
Confidence            999999999976 55678899999999998876543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-62  Score=425.19  Aligned_cols=318  Identities=37%  Similarity=0.656  Sum_probs=271.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+|...+.||.|+||.|+.|.++.||+.||||++...      .+...||+++|+.++|+||+.+.+++.....+...-+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4677789999999999999999999999999998632      2344589999999999999999999876444455558


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |+|+|+|+.+|.++++.    ++.+++..++.+++|+++||+|+|+ .+++||||||.|++++.+- .+||||||+|+..
T Consensus       102 YiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  102 YLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYL  175 (359)
T ss_pred             EEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeec
Confidence            99999999999888875    3459999999999999999999998 9999999999999999987 7999999999987


Q ss_pred             cC---CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ..   ....+.++.|.||+|||++.+...|+.+.||||+|||+.||++|++.|+|.+..+++..|...+|.|+.+.+..+
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            54   344577889999999999998889999999999999999999999999999999999999999999999988776


Q ss_pred             CcC---cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCC
Q 017131          267 NPN---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  343 (376)
Q Consensus       267 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~  343 (376)
                      ...   -.-.++|..++.+|...|+ ++++.+.||+.+||.+||.+|+|++|+|.|||+..+.++....    ..++.+.
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP----~~~~~~~  330 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP----VCQPIFD  330 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC----CCCCCCc
Confidence            522   1224788899999999995 8999999999999999999999999999999999999887542    1122111


Q ss_pred             CCCCCCCCCCHHHHhhhchHHHhh
Q 017131          344 FKPPELSGIPPETINRLIPEHARK  367 (376)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~  367 (376)
                      .  .+.. .+.+.++.++++++..
T Consensus       331 ~--~~~~-~~~~~~r~~i~~e~~~  351 (359)
T KOG0660|consen  331 S--FEHE-LTEEELRELIYKEILD  351 (359)
T ss_pred             c--cccc-ccHHHHHHHHHHHHHh
Confidence            1  1222 6678888888877543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-63  Score=444.96  Aligned_cols=282  Identities=36%  Similarity=0.655  Sum_probs=255.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|.++++||.|.||.||+|+.+.+|+.||||++++.-     ....||+..|++++ ||||+++.+++.+..    ..
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence            358999999999999999999999999999999886543     22348999999999 999999999985432    26


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +|+|||||+.+|+++++.+   ++.|++..++.|++||+.||+|+|. +|+.|||+||+|||+..+. .|||+|||+||.
T Consensus        85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEecccccccc
Confidence            9999999999999999874   5789999999999999999999998 9999999999999999766 799999999999


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc--
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  266 (376)
                      ..+..+.+.++.|+||+|||+++....|+.+.|+|++|||++|+.+-++.|+|.++.+++.+|+..+|.|..+.|...  
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            998899999999999999999999999999999999999999999999999999999999999999999998776542  


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      -.+...+.+|+....++..+++. +++++.+||.+||.|||.+||||.++|+||||+...
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            23345688999999999999965 999999999999999999999999999999998643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.3e-62  Score=415.27  Aligned_cols=280  Identities=36%  Similarity=0.677  Sum_probs=245.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+|+.+.++|+|+||.||+|+++.||+.||||++....      +...||+++|++++|+|+|.++++|     .....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            46999999999999999999999999999999996432      2345899999999999999999999     556669


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||+|||+.++...+..   ...+++...++.+++|++.|+.|+|+ ++++||||||+|||++.+| .+||||||+|+..
T Consensus        77 hLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhh
Confidence            99999999877555554   45679999999999999999999998 9999999999999999999 8999999999987


Q ss_pred             c-CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh--hc
Q 017131          190 V-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM  266 (376)
Q Consensus       190 ~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~  266 (376)
                      . .++..+.++.|+||+|||++.+..+|+..+||||+||++.||++|.+.|+|.++.+++..|.+.+|...+....  ..
T Consensus       152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            6 66777889999999999999998899999999999999999999999999999999999999999988776554  34


Q ss_pred             CcCcccccCCCcccc-ccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ++-+...++|..... ++...+ ++++..+.||+++||..||.+|++.+++|.||||+++.
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            566666777766443 333334 56888999999999999999999999999999997653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.6e-61  Score=398.62  Aligned_cols=278  Identities=38%  Similarity=0.714  Sum_probs=244.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+|...+.||+|.||.||+|++..||+.||||++....      ....||++.|+.++|+||+.++++|.....     +
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~-----l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN-----L   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc-----e
Confidence            47999999999999999999999999999999996432      234589999999999999999999954333     8


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      .+|+||++.+|+..++..   ...++...++.|+.+++.||+|||+ +.|.||||||.|+|++++| .+||+|||+|+..
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            899999999998888763   4569999999999999999999998 9999999999999999999 8999999999987


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      ..... ....+.|+||+|||++.+...|+..+||||.|||+.||+.|.+.|+|.++.+|+..|+..+|+|..+.|..+. 
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            65433 3334789999999999999999999999999999999999999999999999999999999999999998774 


Q ss_pred             -cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                       ++|..+.  ..+..+....| +..+.++.||+.+||.+||.+|+|+.|+|+||||+...
T Consensus       232 lpdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  232 LPDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence             5665554  33333444455 56889999999999999999999999999999999753

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-59  Score=402.68  Aligned_cols=290  Identities=34%  Similarity=0.565  Sum_probs=252.0

Q ss_pred             CCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           29 NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        29 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      .++++-...|+.+..|++|+||.||+|+|+.|++.||+|+++.+..      ...|||.+|.+++|||||.+..+.....
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            4566777899999999999999999999999999999999975432      2248999999999999999998875433


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          103 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                      -   ..+|+|||||+.+|.+++....   ++|...+++.++.|++.|++|||. +.|+||||||+|+|++..| .+||+|
T Consensus       149 ~---d~iy~VMe~~EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaD  220 (419)
T KOG0663|consen  149 M---DKIYIVMEYVEHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIAD  220 (419)
T ss_pred             c---ceeeeeHHHHHhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecc
Confidence            2   2288999999999988888743   789999999999999999999998 9999999999999999998 799999


Q ss_pred             cCCcccccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          183 FGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       183 fg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ||+|+.+.+.. +.+..+.|.||+|||++++...|++++|+||+|||+.||+++++.|+|....+++.+|++.+|.|+..
T Consensus       221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            99999875542 34566789999999999999999999999999999999999999999999999999999999999998


Q ss_pred             HHhhcC--cCcccccCCCccccccccccccC-CChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          262 EIKCMN--PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       262 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .|....  +....+.++..+...+...|... ++....+|++.+|.+||.+|+||.+.|+|.||.+..
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            776542  22234566666666666666554 679999999999999999999999999999999843

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-60  Score=416.27  Aligned_cols=258  Identities=35%  Similarity=0.519  Sum_probs=212.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----------ccHHHHHHHHHhCCCCCeeeccceeeec
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFST  101 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (376)
                      .-++.|.+.+.||+|+||.|.+|..+.||+.||||++.+..           ...++|+++|+.++|||||+++++|.. 
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-  247 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-  247 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-
Confidence            35678999999999999999999999999999999996532           223589999999999999999999943 


Q ss_pred             CCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC--CCCe
Q 017131          102 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQL  178 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~v  178 (376)
                          .-+.|+||||++| .|.+.+-.    ++.+.+..-+.+++|++.|+.|||+ +||+||||||+|||+..+  ...+
T Consensus       248 ----~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  248 ----PDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             ----CCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEE
Confidence                3337899999986 55444332    4678888889999999999999998 999999999999999765  2269


Q ss_pred             EEEecCCcccccCCCCCceeeeeccccchhhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHh
Q 017131          179 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKVL  255 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~  255 (376)
                      ||+|||+|+.........+.||||.|.|||++.+..  .+..++|+||+||+||-+++|.+||.+..... ...+|.+. 
T Consensus       319 KItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-  397 (475)
T KOG0615|consen  319 KITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-  397 (475)
T ss_pred             EecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-
Confidence            999999999988788888999999999999996432  34568999999999999999999999876555 34444431 


Q ss_pred             CCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                      .+.+.   +..|     ..++.++++||++||..||++|||++++|+||||+..
T Consensus       398 ----------------~y~f~---p~~w-----~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  398 ----------------RYAFG---PLQW-----DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ----------------ccccc---Chhh-----hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                            11110   0111     4689999999999999999999999999999999864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.1e-58  Score=435.99  Aligned_cols=329  Identities=53%  Similarity=0.994  Sum_probs=281.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecC---CCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~l  111 (376)
                      ..+|++++.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||++++++++...   .....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            35799999999999999999999999999999999877777778999999999999999998875532   233456889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      ||||+++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            99999999888887766666789999999999999999999998 99999999999999997765799999999987665


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........+|+.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++.+.++.|..+.+..+++.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55556678899999999987766799999999999999999999999999999999999999999999999998888888


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCC-CCCCCCCCCCCCCCCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN-GRPLPPLFNFKPPELS  350 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  350 (376)
                      ...++......+...++...++++++||++||++||.+|+|+.++|+||||+.++++...++. ....|+++++...+..
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK  383 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence            888888887788888888899999999999999999999999999999999998876655443 2345566666655554


Q ss_pred             CCCHHHHhhhchHH
Q 017131          351 GIPPETINRLIPEH  364 (376)
Q Consensus       351 ~~~~~~~~~~~~~~  364 (376)
                      ...++..+.+.+..
T Consensus       384 ~~~~~~~~~~~~~~  397 (440)
T PTZ00036        384 EMSDACRRKIIPKC  397 (440)
T ss_pred             hCCHHHHHHHhhHH
Confidence            55555555555443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-58  Score=416.14  Aligned_cols=285  Identities=35%  Similarity=0.602  Sum_probs=242.2

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           31 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .....+.|+.+++||+|.||.||+|++..||+.||+|++..+.      ....|||.+|++|+||||+++.++..+.   
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---  188 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---  188 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---
Confidence            3455678999999999999999999999999999999986543      2345999999999999999999988654   


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ....+|||+|||+.+|.-++..   ..-.|++.+++.++.||+.||.|||+ +||.|||||.+|||||.+| .+||+|||
T Consensus       189 ~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADFG  263 (560)
T ss_pred             CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEecccc
Confidence            2345899999999988776654   34479999999999999999999998 9999999999999999998 89999999


Q ss_pred             CcccccCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          185 SAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       185 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      +|+.+....  ..+..+.|.||+|||++++...|+.++|+||+||||.||++|++.|+|.++.+|+.+|++..|.|....
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            999664433  457778899999999999999999999999999999999999999999999999999999999999988


Q ss_pred             HhhcC-cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          263 IKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       263 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      |.... +.+..+.-...-...+.+.+ ..+++.+.+|+..||..||.+|.||.++|+|+||..
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            87322 11122222121123333443 578999999999999999999999999999999953

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-58  Score=422.94  Aligned_cols=258  Identities=30%  Similarity=0.495  Sum_probs=224.5

Q ss_pred             cCCCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeecccee
Q 017131           26 GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCF   98 (376)
Q Consensus        26 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (376)
                      +..+.+.++ .+|...++||+|+|++||.+++..+|+.||+|++.+.       .....+|+++.+.|+|||||+++++|
T Consensus         9 p~~i~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen    9 PEVIEDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             CCeeecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            333344444 7899999999999999999999999999999998652       23455799999999999999999999


Q ss_pred             eecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131           99 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                      .     +..++|+|+|+|.. +|..+++    ..+.++|.+++++++||+.||.|||+ ++|+|||||..|++++++. +
T Consensus        88 E-----Ds~nVYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~  156 (592)
T KOG0575|consen   88 E-----DSNNVYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-N  156 (592)
T ss_pred             e-----cCCceEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-c
Confidence            4     44459999999984 6655554    35789999999999999999999998 9999999999999999998 7


Q ss_pred             eEEEecCCcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 017131          178 LKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  256 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  256 (376)
                      |||+|||+|...... +...+.||||.|.|||++.. ...+..+||||+||+||.|++|+|||...+-.+.+.+|...  
T Consensus       157 VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--  233 (592)
T KOG0575|consen  157 VKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--  233 (592)
T ss_pred             EEecccceeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--
Confidence            999999999887644 67788899999999999965 45899999999999999999999999998888888888762  


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                     ++.+|            ..+|.++++||.+||..||.+|||++++|.|+||+.-
T Consensus       234 ---------------~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  234 ---------------EYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ---------------Ccccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence                           45554            4689999999999999999999999999999999553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-58  Score=401.72  Aligned_cols=257  Identities=33%  Similarity=0.509  Sum_probs=220.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .....|++++.||+|+||+||+++.+.|++.||+|++++..       .....|..+|..++||+||.++..|.+     
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-----   96 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-----   96 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-----
Confidence            44568999999999999999999999999999999886532       334579999999999999999988843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+|+|+||+.| .|...+.    ..+.|++..+++|+.+|+.||.|||+ +|||||||||+|||+|.+|| ++|+|||
T Consensus        97 ~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GH-i~LtDFg  170 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGH-IKLTDFG  170 (357)
T ss_pred             CCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCc-EEEeccc
Confidence            3348999999987 6654444    35789999999999999999999998 99999999999999999995 9999999


Q ss_pred             CcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +++..... ....+.+||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+......+|.+.-        
T Consensus       171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------  241 (357)
T KOG0598|consen  171 LCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------  241 (357)
T ss_pred             cchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------
Confidence            99865444 445567999999999999876 59999999999999999999999999999888888887631        


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC----CHHHHhcCCcccccCCCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELRDPN  329 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----s~~~ll~hp~f~~~~~~~  329 (376)
                               ..           ..+..++.++++||+++|+.||++|.    ++.++.+||||.+++|..
T Consensus       242 ---------~~-----------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  242 ---------LP-----------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             ---------CC-----------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence                     00           11134899999999999999999996    588999999999998643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-57  Score=410.67  Aligned_cols=257  Identities=31%  Similarity=0.570  Sum_probs=225.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhC-CCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (376)
                      +...+|..++.||+|+|++|++|+++.+++.||||++.+.       ..+..+|..+|.+| .||.|++++..|.+.   
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~---  146 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE---  146 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc---
Confidence            4456899999999999999999999999999999987542       35667899999999 899999998888433   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                        ..+|+|+||++ |+|.+++..+    +.|++..+++++.||+.||+|||+ +|||||||||+|||+|.|+ .+||+||
T Consensus       147 --~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF  218 (604)
T KOG0592|consen  147 --ESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF  218 (604)
T ss_pred             --cceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence              33889999998 5887877764    679999999999999999999998 9999999999999999999 6999999


Q ss_pred             CCcccccCCCC--------------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 017131          184 GSAKVLVKGEP--------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  249 (376)
Q Consensus       184 g~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  249 (376)
                      |.|+.+.....              ..+.+||..|.+||++. ....++.+|+|+||||+|+|+.|.+||.+.++...++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            99987643211              14589999999999995 4568999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       250 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      +|++.                 .+.+|            +++++.++|||+++|..||++|+|+.+|.+||||.++.|.+
T Consensus       298 kI~~l-----------------~y~fp------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  298 KIQAL-----------------DYEFP------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHh-----------------cccCC------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            99884                 34444            57899999999999999999999999999999999998866


Q ss_pred             C
Q 017131          330 T  330 (376)
Q Consensus       330 ~  330 (376)
                      .
T Consensus       349 l  349 (604)
T KOG0592|consen  349 L  349 (604)
T ss_pred             h
Confidence            3

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-57  Score=393.50  Aligned_cols=257  Identities=30%  Similarity=0.554  Sum_probs=216.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+.++.||+|..|+||+|+|+.|++.+|+|++...     .+.+.+|+++++..+|||||++|++|+....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3688899999999999999999999999999999432     2345689999999999999999999976542    388


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||++ +|..++..    .++++|..+..++.++++||.|||..++||||||||+|||+++.| .|||||||.++..
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHh
Confidence            99999995 77766664    377999999999999999999999448999999999999999999 8999999999877


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CchHHHHHHHHHhCCCCHHHHh
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-----SGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      .+. ...+++||..|||||.+.+. .|+.++||||||++++|+++|+.||...     +..+.+..|+.   .|+.    
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP----  300 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP----  300 (364)
T ss_pred             hhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC----
Confidence            655 66788999999999999765 5999999999999999999999999874     22333333332   1211    


Q ss_pred             hcCcCcccccCCCcccccccccccc-CCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  331 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~  331 (376)
                               .            ++. .+|+++++||..||++||.+|+|+.|+++|||+++...++..
T Consensus       301 ---------~------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  301 ---------R------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             ---------C------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence                     1            112 389999999999999999999999999999999987765543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-56  Score=377.66  Aligned_cols=250  Identities=29%  Similarity=0.496  Sum_probs=219.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .+|++++.||.|+||.|.+++++.+|..||+|++.+..       .....|.++|+.+.||+++++++.+     .+..+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence            57999999999999999999999999999999987643       2334699999999999999998887     34445


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+||||++| .+.++++    ..++|++..+++++.||+.||+|||+ ++|++|||||+|||+|.+| .+||+|||+|+
T Consensus       119 lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G-~iKitDFGFAK  192 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNG-HIKITDFGFAK  192 (355)
T ss_pred             EEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCC-cEEEEeccceE
Confidence            9999999986 5544444    46789999999999999999999998 9999999999999999999 59999999999


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  ...+.||||.|+|||++.. ..|+.++|+||||+++|||+.|.+||...+....+.+|+..             
T Consensus       193 ~v~~--rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-------------  256 (355)
T KOG0616|consen  193 RVSG--RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-------------  256 (355)
T ss_pred             EecC--cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------
Confidence            8743  3678899999999999965 55999999999999999999999999999999999999873             


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCCC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  328 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~~  328 (376)
                          .+.+|            +.+++++++||+++|+.|-.+|.     ...++.+||||+++.|.
T Consensus       257 ----~v~fP------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  257 ----KVKFP------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             ----cccCC------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence                34444            56899999999999999999994     46899999999998764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.2e-56  Score=385.31  Aligned_cols=290  Identities=35%  Similarity=0.695  Sum_probs=246.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHHHHHHHHHhCCCCC-eeeccceeeecCC-CCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPN-IVALKHCFFSTTD-KEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~-~~~  106 (376)
                      ...|..+++||+|+||+||+|+++.+|+.||+|++.-+..      ...||+.+|+.++|+| |+.+++++.+... ...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3468889999999999999999999999999999864432      2358999999999999 9999999866442 234


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+++|+||++.+|..++.......+.++...++.+++||+.||+|||+ ++|+||||||+|||++++| .+||+|||+|
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchH
Confidence            4688999999999988888755443578889999999999999999998 9999999999999999988 8999999999


Q ss_pred             cccc-CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +... .....+..++|.+|+|||++.+...|++.+||||+|||++||+++++.|+|..+.+++..|+..+|.|..+.|+.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            8665 334456678899999999999998899999999999999999999999999999999999999999999988875


Q ss_pred             cC--cCcccccCCCcc-ccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          266 MN--PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       266 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ..  ++|.. .++... ...+.... +..+++..+++.+||+.+|.+|.|+..+|.||||+.+...
T Consensus       248 v~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  248 VSSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             ccccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            42  33332 344433 34444444 3556799999999999999999999999999999987544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-55  Score=397.92  Aligned_cols=266  Identities=32%  Similarity=0.513  Sum_probs=221.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+.|.+++.||+|+||.||+|+-+.||+.||+|++++..       .....|..+|...++|+||+++..|     ++.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            4468999999999999999999999999999999997643       2334689999999999999999888     445


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .++||||||++| ++-.++..    .+.|++.++++|+.+++.|+..||+ .|+|||||||+|+|||..|| +||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GH-iKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGH-IKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCC-Eeeccccc
Confidence            569999999986 55555543    5789999999999999999999998 99999999999999999995 99999999


Q ss_pred             cccccC------------------------CCC------------------------CceeeeeccccchhhhcCCCCCC
Q 017131          186 AKVLVK------------------------GEP------------------------NVSYICSRYYRAPELIFGATEYT  217 (376)
Q Consensus       186 a~~~~~------------------------~~~------------------------~~~~~~t~~y~aPE~~~~~~~~~  217 (376)
                      +.....                        ...                        ..+.+|||.|+|||++.+.+ |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            843211                        000                        01468999999999998765 99


Q ss_pred             CchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHH
Q 017131          218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD  297 (376)
Q Consensus       218 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (376)
                      ..+|+||||||+||||.|.+||.+.++.+...+|...-.               .+.+|..          ..++++++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~~----------~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPEE----------VDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCCc----------CcccHHHHH
Confidence            999999999999999999999999999999999887310               1222221          357899999


Q ss_pred             HHHHhhccCCCCCCC---HHHHhcCCcccccCCCCCCCCCCCC
Q 017131          298 LVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLPNGRP  337 (376)
Q Consensus       298 li~~~L~~dp~~R~s---~~~ll~hp~f~~~~~~~~~~~~~~~  337 (376)
                      ||.+||+ ||.+|+.   ++||.+||||++++|....-..+..
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apf  463 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPF  463 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCC
Confidence            9999999 9999986   8899999999999987765433333

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-55  Score=404.56  Aligned_cols=285  Identities=30%  Similarity=0.476  Sum_probs=240.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+-|++++.||.|+.|.|-+|++..||+.+|||++.+.       ...+++|+-+|+.+.|||++.+++++     .+..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence            35699999999999999999999999999999999765       45678999999999999999999998     4445


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ++|+|.||++| .|.+++..    .+++++.+++.++.||+.|+.|||. .+|+||||||+|+|+|..+ ++||+|||+|
T Consensus        86 ~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~-nIKIADFGMA  159 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKN-NIKIADFGMA  159 (786)
T ss_pred             eEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhccc-CEeeecccee
Confidence            59999999985 55554443    5789999999999999999999998 9999999999999999998 6999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....+.-..+.||+|+|.|||++.+.++.+.++||||+|||||.|+||+.||.+.+-...+.++.+             
T Consensus       160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-------------  226 (786)
T KOG0588|consen  160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-------------  226 (786)
T ss_pred             ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------
Confidence            9888888888999999999999999988889999999999999999999999997776666666655             


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKP  346 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~  346 (376)
                          ..|.+|            ..+|+++++||++||..||.+|+|.+||++|||+.+..........+.+. .......
T Consensus       227 ----G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~-~~~i~s~  289 (786)
T KOG0588|consen  227 ----GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPV-SVPILSI  289 (786)
T ss_pred             ----CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCc-ccceeec
Confidence                245555            46999999999999999999999999999999999876544321111110 0112234


Q ss_pred             CCCCCCCHHHHhhh
Q 017131          347 PELSGIPPETINRL  360 (376)
Q Consensus       347 ~~~~~~~~~~~~~~  360 (376)
                      |..+.+|+..++.+
T Consensus       290 ps~~~IDp~Il~~l  303 (786)
T KOG0588|consen  290 PSIQEIDPLILQHL  303 (786)
T ss_pred             CCcccCCHHHHhhh
Confidence            56778899888876

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.9e-54  Score=396.93  Aligned_cols=279  Identities=36%  Similarity=0.626  Sum_probs=230.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHH---HHHHHHHhCC-C-----CCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-H-----PNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|.+++.||+|+||+|.+|.+..|++.||||+++.......   .|+.+|..++ |     -|+|+++++|.....    
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H----  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH----  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc----
Confidence            79999999999999999999999999999999987766554   4899999986 3     489999999966554    


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC-CCCeEEEecCCc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~-~~~vkl~Dfg~a  186 (376)
                       +|||+|.++.+|+++++....  .+++...++.++.||+.||.+||+ .||||+||||+||||..- ...|||+|||+|
T Consensus       263 -lciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  263 -LCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             -eeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence             999999999999999987443  469999999999999999999998 999999999999999543 337999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...  +....+++.++.|+|||++++.+ |+.+.||||||||++||++|.+.|+|.+..+++..|+..+|.|+...+...
T Consensus       339 c~~--~q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFE--SQRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             ccc--CCcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            765  44455889999999999999865 999999999999999999999999999999999999999999998877644


Q ss_pred             CcCcccccC----CC--------------------------c----cccccccccccCCChhHHHHHHHhhccCCCCCCC
Q 017131          267 NPNYTEFKF----PQ--------------------------I----KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  312 (376)
Q Consensus       267 ~~~~~~~~~----~~--------------------------~----~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s  312 (376)
                      ......+..    +.                          .    ....+.......-...+.|||.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            322111111    00                          0    0011111111122346899999999999999999


Q ss_pred             HHHHhcCCcccccC
Q 017131          313 ALEACVHPFFDELR  326 (376)
Q Consensus       313 ~~~ll~hp~f~~~~  326 (376)
                      +.++|+||||....
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999999654

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-54  Score=400.70  Aligned_cols=264  Identities=29%  Similarity=0.496  Sum_probs=224.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCC-CCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++++.||+|+||+|++|..+.+++.||||.++++.       .....|.+++...+ ||.++.++.+|     +.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence            3468999999999999999999999999999999987754       23346888887775 99999999999     44


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..++|+||||+.|+.  +.  +....+.|++..+++|+..++.||+|||+ +||||||||.+|||+|.+| -+||+|||+
T Consensus       441 ~~~l~fvmey~~Ggd--m~--~~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eG-h~kiADFGl  514 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGD--LM--HHIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEG-HVKIADFGL  514 (694)
T ss_pred             CCeEEEEEEecCCCc--EE--EEEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccC-cEEeccccc
Confidence            445999999999854  11  12234689999999999999999999998 9999999999999999999 599999999


Q ss_pred             ccccc-CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          186 AKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       186 a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ++... .+....+.+|||.|+|||++.+. .|+.++|+|||||+||||+.|..||+|.+..+....|+..          
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------  583 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------  583 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence            98765 55667788999999999999765 4999999999999999999999999999999999888762          


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCcccccCCCCCCCCCCCCCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPNTRLPNGRPLP  339 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~~ll~hp~f~~~~~~~~~~~~~~~~~  339 (376)
                             +..+|            ..+|.++.++++++|.+||++|+.+     ++|..||||+.++|  ..+.+.+..|
T Consensus       584 -------~~~yP------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w--~~L~~r~i~P  642 (694)
T KOG0694|consen  584 -------EVRYP------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW--DDLLNRRIKP  642 (694)
T ss_pred             -------CCCCC------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH--HHHhhccCCC
Confidence                   23333            4689999999999999999999964     79999999999984  4455555555


Q ss_pred             C
Q 017131          340 P  340 (376)
Q Consensus       340 ~  340 (376)
                      |
T Consensus       643 P  643 (694)
T KOG0694|consen  643 P  643 (694)
T ss_pred             C
Confidence            4

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-54  Score=375.95  Aligned_cols=255  Identities=31%  Similarity=0.523  Sum_probs=218.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...+.|.+.+.||+|+||+||+|+++.++..||||.+.+..      .....|+.+|+.++|||||.++++..+.     
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----   81 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----   81 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----
Confidence            44567999999999999999999999999999999986552      2345799999999999999999998443     


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC-C----CCeEE
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-T----HQLKL  180 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~-~----~~vkl  180 (376)
                      .++|||||||+ |+|..+++.    .+.+++..++.++.||+.||++||+ ++||||||||+|||++.. +    ..+||
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEe
Confidence            35999999999 588877775    4589999999999999999999998 999999999999999865 2    25999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +|||+|+....+....+.+|+|.|||||++. ...|+.++|+||+|+|+|+|++|++||...+..+.+..+.+.-..   
T Consensus       157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~---  232 (429)
T KOG0595|consen  157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI---  232 (429)
T ss_pred             cccchhhhCCchhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc---
Confidence            9999999998888888999999999999995 456999999999999999999999999998888877755442110   


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                             ...++..++....+|+...|+.+|..|.+..+-+.|++...
T Consensus       233 -----------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  233 -----------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             -----------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                                   01122346778889999999999999999999999999865

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-53  Score=389.49  Aligned_cols=252  Identities=35%  Similarity=0.511  Sum_probs=218.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc---------cccHHHHHHHHHhCC-CCCeeeccceeeecC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD-HPNIVALKHCFFSTT  102 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  102 (376)
                      ...++|.+++.||+|+||+|++|.+..+++.||+|++.+.         .....+|+.+++.++ ||||+++++++.+..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3446799999999999999999999999999999977553         123448999999999 999999999995544


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC-CCCeEE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKL  180 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~-~~~vkl  180 (376)
                      .     +|+|||||.| .|.+.+..    .+++.+.+++.++.|++.|++|||+ +||+||||||+|||++.+ + ++||
T Consensus        94 ~-----~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl  162 (370)
T KOG0583|consen   94 K-----IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKL  162 (370)
T ss_pred             e-----EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEE
Confidence            3     8899999986 77666654    5789999999999999999999998 999999999999999999 6 8999


Q ss_pred             EecCCcccc-cCCCCCceeeeeccccchhhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          181 CDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       181 ~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      +|||++... .......+.+||+.|+|||++.+.. +-+.++|+||+|++||.|++|+.||...+....+.+|.+.    
T Consensus       163 ~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~----  238 (370)
T KOG0583|consen  163 SDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG----  238 (370)
T ss_pred             eccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC----
Confidence            999999877 4566778889999999999998766 4578999999999999999999999997777777775542    


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCC-ChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                   .+.+|            ..+ |+++++||++||..||.+|+|+.+++.||||+.
T Consensus       239 -------------~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 -------------EFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -------------CccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                         23333            346 999999999999999999999999999999996

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-53  Score=370.44  Aligned_cols=274  Identities=27%  Similarity=0.467  Sum_probs=229.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      -..|++++.||.|.-|+||+|+...++..+|+|++.+..       ...+.|.+||..++||.++++|..|     +.+.
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence            357999999999999999999999999999999996542       2234599999999999999999999     5666


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      +.|++||||+| +|..+.+  .+.++.|++..+++|+.+++.||+|||. .|||+|||||+||||.++|| |.|+||.++
T Consensus       151 ~~cl~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGH-IMLsDFDLS  226 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGH-IMLSDFDLS  226 (459)
T ss_pred             eeEEEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCc-EEeeecccc
Confidence            79999999986 6655544  3456789999999999999999999998 99999999999999999995 999999986


Q ss_pred             ccccC---------------------------------C-C-----------------------CCceeeeeccccchhh
Q 017131          187 KVLVK---------------------------------G-E-----------------------PNVSYICSRYYRAPEL  209 (376)
Q Consensus       187 ~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aPE~  209 (376)
                      .....                                 . .                       ...+.+||-.|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            43310                                 0 0                       0123567889999999


Q ss_pred             hcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcccccccccccc
Q 017131          210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK  289 (376)
Q Consensus       210 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (376)
                      +.+.+ .+.++|+|+||+++|||+.|..||.|.+..+.+.+|+..                 ...+|..          +
T Consensus       307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------~  358 (459)
T KOG0610|consen  307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------P  358 (459)
T ss_pred             eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------C
Confidence            97755 899999999999999999999999999999999988762                 3344432          2


Q ss_pred             CCChhHHHHHHHhhccCCCCCCC----HHHHhcCCcccccCCCCCCCCCCCCCCCCCCCC
Q 017131          290 RLPPEAVDLVCRFFQYSPNLRCT----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFK  345 (376)
Q Consensus       290 ~~~~~~~~li~~~L~~dp~~R~s----~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~  345 (376)
                      .++..++|||+++|.+||++|+.    |.||.+||||++++|+-.+...++.+|...+..
T Consensus       359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~  418 (459)
T KOG0610|consen  359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG  418 (459)
T ss_pred             cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence            57899999999999999999998    999999999999999866655555566555444

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-54  Score=355.60  Aligned_cols=254  Identities=32%  Similarity=0.478  Sum_probs=216.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec------ccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|.+.+.||+|.|+.|++|.+..||+.+|+|++..      +.+.+++|+++.+.++||||+++.+.+     .+..+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence            3579999999999999999999999999999998732      345567999999999999999998877     56677


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC--CCCeEEEecCC
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGS  185 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~vkl~Dfg~  185 (376)
                      .|+|+|++.| .+..-+-.    +.-+++..+..++.||+.||.|+|. +||||||+||+|+++-+.  +.-|||+|||+
T Consensus        85 ~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             eEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccce
Confidence            8999999987 44332322    1458999999999999999999998 999999999999999543  33699999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      |.....+.......|||.|||||++.. .+|+..+|||+.|+|||-|+.|.+||.+.+....+.+|.+.           
T Consensus       160 Ai~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-----------  227 (355)
T KOG0033|consen  160 AIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-----------  227 (355)
T ss_pred             EEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------
Confidence            998887777778899999999999965 45999999999999999999999999999888888888763           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                            .+.++.   ..|     +++++++++|+++||..||.+|+|+.|+|+|||+.+
T Consensus       228 ------~yd~~~---~~w-----~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  228 ------AYDYPS---PEW-----DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ------ccCCCC---ccc-----CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                  222221   112     468999999999999999999999999999999975

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-51  Score=370.71  Aligned_cols=277  Identities=33%  Similarity=0.633  Sum_probs=229.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+|++.+.||.|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++.+     ..+.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeE
Confidence            357999999999999999999999999999999885322     234579999999999999999998743     3358


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus        79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~  153 (288)
T cd07871          79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAK  153 (288)
T ss_pred             EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeec
Confidence            89999999988766653   23457899999999999999999998 9999999999999999988 7999999998754


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      .... ......+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+.+..+.+..+.++.+.+.... 
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            3222 22345678999999998766668999999999999999999999999999899999999999999888776543 


Q ss_pred             -cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          268 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                       ..+..+.++.....++.... ..+++++++||++||++||.+|+|++|+++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHA-PRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHHhC-CCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             22333334444333433322 4688999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-52  Score=330.04  Aligned_cols=277  Identities=35%  Similarity=0.639  Sum_probs=236.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|.-.++||+|.||+||+|+...|++.||+|.+.-+.      ....||+-+|+.++|.|||+++++..+.     ..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeE
Confidence            4777889999999999999999999999999986432      3456999999999999999999988433     3388


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|+|||...|..+..   ..++.+..+.++.++.|+++||.++|+ +++.||||||+|+||+.+| .+|++|||+++...
T Consensus        78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            999999987755554   456789999999999999999999998 9999999999999999999 89999999998763


Q ss_pred             CCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          191 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       191 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      -.-. ....+.|.+|++|.++.+..-|++..|+||.|||+.|+.. |++.|+|.+..+++.+|+..+|.|..+.|..+. 
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            2221 1234569999999999999999999999999999999987 999999999999999999999999999998774 


Q ss_pred             -cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          268 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                       ++|.  .+|.++....+..+-++++...+||++++|..+|.+|++++++++||||.+.
T Consensus       233 lpdyk--~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  233 LPDYK--PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCCCc--ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence             3333  3344444443344446889999999999999999999999999999999874

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-53  Score=384.81  Aligned_cols=249  Identities=33%  Similarity=0.522  Sum_probs=215.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+|.+.+.||+|+||.||+|+.+.|.+.||||.+.+..+      ...+|+++++.++||||+.+++.|.+.     ..+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-----~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-----AHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-----ceE
Confidence            469999999999999999999999999999999865432      356899999999999999999999444     449


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|+|||.|+|..++..    .+.++|+.++.+++|++.||.|||+ .+|.|||+||.|||++..+ .+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence            99999999988877765    5789999999999999999999998 9999999999999999988 7999999999988


Q ss_pred             cCCCCC-ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..+... ++..|||.|||||++.+ ..|+..+|+||||||+|||++|++||....-......|.+.   |.         
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v---------  217 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV---------  217 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC---------
Confidence            765443 45578999999999975 55999999999999999999999999876655555555441   11         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                           .            .+..++..++.||..+|.+||.+|+|..+++.|||.++-
T Consensus       218 -----~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 -----K------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -----C------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                 1            113689999999999999999999999999999999863

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-54  Score=360.68  Aligned_cols=255  Identities=28%  Similarity=0.500  Sum_probs=211.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec------ccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ...|+++++||+|+||+||++.+..+|+.+|.|.+.-      .....-.|+.+|++|+|||||++++.-+.   +++..
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev   94 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV   94 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence            3479999999999999999999999999999998842      12333479999999999999999884322   33334


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh--c-CCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          109 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C-IGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~-~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      +++|||||+ |+|.++++.+...++.+++..+|.++.|+|.||.++|+  . .-|.||||||.||+++.+| .|||+|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccch
Confidence            789999998 69999999999888999999999999999999999996  1 1389999999999999998 89999999


Q ss_pred             CcccccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +++...+... ..+++|||+||+||++.+. .|+.++||||+||++|||+.-.+||.|.+-.+.-.+|.++ ..|+    
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~----  247 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPP----  247 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCC----
Confidence            9997754432 4578999999999999765 4999999999999999999999999998666655666553 1111    


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                 .|           ....|.++..||..|+..||..||+.     +|+++++.
T Consensus       248 -----------~p-----------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  248 -----------LP-----------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             -----------Cc-----------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence                       11           03578999999999999999999986     56665543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-52  Score=370.97  Aligned_cols=262  Identities=29%  Similarity=0.460  Sum_probs=218.1

Q ss_pred             CCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------------ccHHHHHHHHHhCCCC
Q 017131           28 RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDHP   89 (376)
Q Consensus        28 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h~   89 (376)
                      ......+.++|++.+.||+|.||.|.+|++..+++.||||++.+..                  ....+|+.+|+++.||
T Consensus        89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            3334567789999999999999999999999999999999985431                  2345799999999999


Q ss_pred             CeeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCC-CcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 017131           90 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  168 (376)
Q Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~N  168 (376)
                      |||+++++.   ++.....+|||+|||..+-   +. .....+. +++.+++.|+.+++.||+|||. +|||||||||+|
T Consensus       169 nVV~LiEvL---DDP~s~~~YlVley~s~G~---v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsN  240 (576)
T KOG0585|consen  169 NVVKLIEVL---DDPESDKLYLVLEYCSKGE---VK-WCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSN  240 (576)
T ss_pred             CeeEEEEee---cCcccCceEEEEEeccCCc---cc-cCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhh
Confidence            999999987   4455566999999998532   11 1122334 8999999999999999999998 999999999999


Q ss_pred             EEEcCCCCCeEEEecCCcccccCCC------CCceeeeeccccchhhhcC---CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 017131          169 LLVNPHTHQLKLCDFGSAKVLVKGE------PNVSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLF  239 (376)
Q Consensus       169 ill~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf  239 (376)
                      +|++++| .|||+|||.+.....+.      ......|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||
T Consensus       241 LLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  241 LLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             eEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            9999998 89999999987553221      1234789999999999976   233578999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          240 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      -+....+.+.+|++.                 .+.+|..          +.+..+++|||.+||++||.+|++..++..|
T Consensus       320 ~~~~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  320 FDDFELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ccchHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            999999999998873                 3444443          2468999999999999999999999999999


Q ss_pred             Cccccc
Q 017131          320 PFFDEL  325 (376)
Q Consensus       320 p~f~~~  325 (376)
                      ||...-
T Consensus       373 pwvt~~  378 (576)
T KOG0585|consen  373 PWVTRD  378 (576)
T ss_pred             ceeccC
Confidence            999764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.9e-50  Score=370.17  Aligned_cols=285  Identities=38%  Similarity=0.675  Sum_probs=227.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            599999999999999999999999999999988532      12345799999999999999999988655444445688


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+++++.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999888776653    3569999999999999999999998 9999999999999999988 89999999987543


Q ss_pred             CCCC----CceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KGEP----NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....    .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.++...+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221    1245689999999998542 4589999999999999999999999999888888888888888887765543


Q ss_pred             cCcCccc-c--cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          266 MNPNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       266 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ....... +  .+......++...+ +.+++++.++|.+||+.||++|||+.++++||||+++...
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence            3211000 0  01111111222222 3578899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.4e-50  Score=364.79  Aligned_cols=282  Identities=32%  Similarity=0.555  Sum_probs=218.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++||||+++++++.+     ....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence            457999999999999999999999999999999885432     234579999999999999999998843     2348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+.+++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++..
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            89999999988766653   23568999999999999999999998 9999999999999999888 7999999998654


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCHHHHhhcC
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ... .......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+... .+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            222 2223456789999999987666689999999999999999999999987644 35566666666766655443221


Q ss_pred             c--CcccccCCCccccccccccc-cCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 P--NYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .  .+....+.......+...+. ...++++++||++||+.||++|||+.++++||||+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            1  11100111111111111111 13568899999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-51  Score=360.89  Aligned_cols=257  Identities=34%  Similarity=0.568  Sum_probs=209.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ..+|...+.||+|+||+||++.+..+|+.+|||.+...    ...+.+|+.+|..++|||||++++......+   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            45799999999999999999999999999999988765    3446899999999999999999886432221   4578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC-CCCCeEEEecCCccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  188 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~-~~~~vkl~Dfg~a~~  188 (376)
                      ++|||+.+ ++.+++..+.   +.+++..++.+..|++.||+|||+ +||+||||||+|||++. ++ .+||+|||+++.
T Consensus        93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCccccc
Confidence            99999985 7777776532   269999999999999999999998 99999999999999999 56 799999999886


Q ss_pred             ccC----CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCCHHHH
Q 017131          189 LVK----GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       189 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ...    ........||+.|||||++........++|||||||++.||+||++||... ...+.+..+...   .     
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~-----  239 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D-----  239 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C-----
Confidence            653    122346789999999999975322345999999999999999999999873 333333333221   0     


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                ..|         .++..+|+++++||.+||.+||++||||+++|+|||.+.-.
T Consensus       240 ----------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  240 ----------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ----------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                      111         23457899999999999999999999999999999998743

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-51  Score=372.21  Aligned_cols=253  Identities=29%  Similarity=0.476  Sum_probs=219.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .-...|...++||+|+.|.||.|+...+++.||||.+....    ..+..|+.+|+..+|+|||.+++.|....+     
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----  344 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----  344 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----
Confidence            34468999999999999999999999999999999986433    345589999999999999999998866543     


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +++||||++| +|.+++..     ..++|.+++.++++++.||+|||. +||+|||||.+|||++.+| .+||+|||++.
T Consensus       345 LWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFca  417 (550)
T KOG0578|consen  345 LWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCA  417 (550)
T ss_pred             eEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeee
Confidence            8899999986 66666654     459999999999999999999998 9999999999999999999 79999999998


Q ss_pred             cccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...... ...+.+|||+|||||++.. ..|++++||||||+++.||+-|.+||-..++...++.|... |.|...     
T Consensus       418 qi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk-----  490 (550)
T KOG0578|consen  418 QISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK-----  490 (550)
T ss_pred             ccccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC-----
Confidence            776554 5567789999999999954 56999999999999999999999999998888888887653 333211     


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                          .+..+|+.++|||.+||+.|+.+|++|.+||.||||+.
T Consensus       491 --------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  491 --------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             --------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                                12468999999999999999999999999999999954

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.4e-49  Score=367.93  Aligned_cols=286  Identities=31%  Similarity=0.544  Sum_probs=224.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCC-CCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++..... ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            346899999999999999999999999999999998543      1234479999999999999999998754332 122


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+|+||||+++++.+.+.      ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus        99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCc
Confidence            3478999999988766553      358889999999999999999998 9999999999999999988 8999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +............+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.+.++.+..+.+...
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            765444444556789999999999654 5899999999999999999999999999888888888888888876543322


Q ss_pred             C----------cCcccccCCCccc---cccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          267 N----------PNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       267 ~----------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      .          +.+....+.....   .+.........++++++||.+||+.||++|||+.|+|+||||+.+.++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence            1          1111111100000   000001112357889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-51  Score=343.59  Aligned_cols=254  Identities=28%  Similarity=0.487  Sum_probs=217.6

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------c------ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------K------RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .|.-.+.||.|..++|-+|.++.||..+|+|++...      .      ....+|+.+|+++ .||+|+++.+.|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            588888999999999999999999999999988421      1      1123699999998 799999999998     


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                      +.+.++++|+|.|. |.|.+++..    .-.+++...+.++.|++.|+.|||. ++|+||||||+|||++++. ++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEec
Confidence            55666889999998 577777664    3569999999999999999999998 9999999999999999988 899999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      ||+|+....++.....||||.|+|||.+.     +.+.|+..+|+|++|+|+|.|+.|.+||......-.+..|...   
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG---  243 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG---  243 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc---
Confidence            99999999999999999999999999984     4566899999999999999999999999987777777766653   


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                    .+++.   ...|     .++|.+.+|||++||+.||.+|+|++|+|.||||..+-
T Consensus       244 --------------kyqF~---speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  244 --------------KYQFR---SPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             --------------ccccC---Ccch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence                          12111   1112     46899999999999999999999999999999997653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=352.73  Aligned_cols=272  Identities=25%  Similarity=0.434  Sum_probs=223.2

Q ss_pred             CCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           28 RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        28 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      ....+...+.|++...||.|..++||+|+...+++.||||++.-++     ..+.+|+..|+.++||||++++..|....
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            3345556678999999999999999999999999999999996443     45668999999999999999999996655


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          103 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                      .     +++||+||. |++.+++.....  .+++|..++.++++++.||.|||+ +|.||||||+.||||+.+| .|||+
T Consensus        98 ~-----LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLa  168 (516)
T KOG0582|consen   98 E-----LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLA  168 (516)
T ss_pred             e-----eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEc
Confidence            4     999999998 588888887654  459999999999999999999998 9999999999999999999 89999


Q ss_pred             ecCCcccccCCCCC-----ceeeeeccccchhhh-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017131          182 DFGSAKVLVKGEPN-----VSYICSRYYRAPELI-FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  255 (376)
Q Consensus       182 Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  255 (376)
                      |||.+.........     ....||++|||||++ .+...|+.++||||||++..||.+|..||....+...+-.-++  
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--  246 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--  246 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence            99987655443321     344789999999994 4555699999999999999999999999998887776654433  


Q ss_pred             CCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      +.|+.......  ++.               -...++..++.+|..||++||++||||+++|+|+||+..+.
T Consensus       247 n~pp~~~t~~~--~~d---------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  247 NDPPTLLTSGL--DKD---------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             CCCCCcccccC--ChH---------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            33332111000  000               01356789999999999999999999999999999998654

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.4e-49  Score=359.21  Aligned_cols=281  Identities=35%  Similarity=0.660  Sum_probs=230.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+|++.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++...     ...
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   79 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSL   79 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeE
Confidence            457999999999999999999999999999999886332     2345799999999999999999988432     348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++..
T Consensus        80 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  154 (309)
T cd07872          80 TLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (309)
T ss_pred             EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceec
Confidence            89999999888666543   23458899999999999999999998 9999999999999999988 7999999998754


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+....+.+.++.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            3222 223346788999999987666689999999999999999999999999998888999999999888877655432


Q ss_pred             C--cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .  +..+.++.....++.... ..+++++++||.+||+.||.+|+|+.++++||||+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            1  222333333333333322 46899999999999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.4e-49  Score=357.29  Aligned_cols=279  Identities=32%  Similarity=0.559  Sum_probs=221.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECC-CCcEEEEEEeeccc------ccHHHHHHHHHhC---CCCCeeeccceeeecCCCCc
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~  106 (376)
                      +|++.+.||+|+||.||+|++.. +++.||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999864 46889999885422      1234677777765   69999999998754433444


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+++||||+++++.+.+...  ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            558899999999887777542  23458999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +............+|+.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+.++....+.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            76654444455678999999999965 45899999999999999999999999999999999999988887766554321


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      .. .....+......+.... .+.+++.+++||.+||+.||++|||+.++|+||||
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VA-LPRQAFHSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hc-ccchhccCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            10 11111111122222222 24688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-48  Score=364.95  Aligned_cols=288  Identities=31%  Similarity=0.529  Sum_probs=228.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3468999999999999999999999999999999986431      234479999999999999999988754322 223


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+|+||||+++++...+.      ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus       102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCc
Confidence            4578999999998866553      348889999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +............+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+...+++..++.|..+.+..+
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            866444444456789999999999654 5899999999999999999999999999999999999998888877655443


Q ss_pred             CcC----------cccccCCCcc---ccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCC
Q 017131          267 NPN----------YTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       267 ~~~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~  330 (376)
                      .+.          +..+.+....   ..++........+.++++||.+||+.||.+|||+.++|+||||..+.++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  329 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  329 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence            221          1111110000   001111111234678999999999999999999999999999987665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.7e-49  Score=354.10  Aligned_cols=275  Identities=39%  Similarity=0.702  Sum_probs=219.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|+||+||+|+++.+++.||+|++....      ....+|+.+++.++||||+++++++..     +..++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEEE
Confidence            6999999999999999999999999999999886432      234579999999999999999998833     33588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+++++...+..   ....+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            9999999876554432   24569999999999999999999998 9999999999999999888 89999999997654


Q ss_pred             CCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          191 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       191 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      ...  ......+|+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+..+....+....+..+.+.+.... 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  22345689999999999654 48999999999999999999999999988888888887777776665544321 


Q ss_pred             -cCcccccCCCcc-ccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          268 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       268 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                       +.+.....+... ...+.......+|.++++||++||++||++|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             111111111110 1111122223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-50  Score=330.58  Aligned_cols=251  Identities=30%  Similarity=0.470  Sum_probs=218.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|.+++.||+|.||.||+|+.+.++..||+|++.+..       ....||+++-..|+||||+++|++|.+...    
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r----   96 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR----   96 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce----
Confidence            356999999999999999999999999999999986542       345589999999999999999999965443    


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                       +||++||.. |++...+...  ...++++...+.++.|++.||.|+|. ++++||||||+|+|++.++ .+||+|||.+
T Consensus        97 -iyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdfGws  171 (281)
T KOG0580|consen   97 -IYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADFGWS  171 (281)
T ss_pred             -eEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCCCce
Confidence             899999997 5776666532  34679999999999999999999998 9999999999999999998 8999999998


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .... .....+.|||..|.+||...+. .++..+|+|++|++.||++.|.+||...+..+.+.+|.+.            
T Consensus       172 V~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------------  237 (281)
T KOG0580|consen  172 VHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------------  237 (281)
T ss_pred             eecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc------------
Confidence            6544 5556778999999999999654 4899999999999999999999999999988888888773            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                           ++.+|            ..++.++.|||.+||.++|.+|++..|++.|||+.+.
T Consensus       238 -----~~~~p------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 -----DLKFP------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -----cccCC------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                 23333            5689999999999999999999999999999999764

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-49  Score=362.90  Aligned_cols=257  Identities=32%  Similarity=0.553  Sum_probs=218.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCC-CCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  104 (376)
                      .-...|++.+.||.|.||.||+|+++.||+.+|+|.+.+..       ....+|+.+|+++. ||||+.+++.|.+..  
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--  109 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--  109 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--
Confidence            34457999999999999999999999999999999996543       25678999999998 999999999995544  


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC---CCeEE
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKL  180 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~---~~vkl  180 (376)
                         ++++|||+|.| .|.+.+...     .+++..+..++.|++.|++|||+ .||+||||||+|+|+....   ..+|+
T Consensus       110 ---~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  110 ---SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             ---eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEE
Confidence               48999999985 665555543     39999999999999999999998 9999999999999996542   27999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +|||+|.....+......+||+.|+|||++.. ..|+..+|+||+|+++|.|++|.+||.+.+.......+...      
T Consensus       181 ~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~------  253 (382)
T KOG0032|consen  181 IDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG------  253 (382)
T ss_pred             eeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC------
Confidence            99999998877666778899999999999954 56999999999999999999999999999988777766652      


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                 .+.   +...+|     ..++..+++||++||..||.+|+|+.++|+|||++...
T Consensus       254 -----------~~~---f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  254 -----------DFD---FTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             -----------CCC---CCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence                       111   111222     45799999999999999999999999999999998753

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.8e-50  Score=341.65  Aligned_cols=285  Identities=33%  Similarity=0.584  Sum_probs=230.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCc----EEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ....|++.+.||+|.||.||+|..+.++.    .||||+++.++      ...-||+.+++.++|||++.+..+|...  
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc--
Confidence            34579999999999999999997655533    68999986542      2345899999999999999999998643  


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhc-CCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC----CCCe
Q 017131          104 KEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQL  178 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~----~~~v  178 (376)
                        +..+++++||.+.+|+.+++.++... +.++...++++++||+.|+.|||+ +-|+||||||.|||+..+    | +|
T Consensus       100 --d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~V  175 (438)
T KOG0666|consen  100 --DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RV  175 (438)
T ss_pred             --CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-ee
Confidence              45699999999999999998876543 468999999999999999999998 899999999999999888    6 89


Q ss_pred             EEEecCCcccccCCC----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------Cch
Q 017131          179 KLCDFGSAKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE---------SGV  245 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---------~~~  245 (376)
                      ||+|+|+++.+.+.-    .....+.|.||+|||++++...|+.+.|+|++|||+.||++-.+.|.+.         -..
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            999999999774432    1234677999999999999999999999999999999999999999763         246


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcC--cCcccccCCCcccccccc-----ccc--cCCChhHHHHHHHhhccCCCCCCCHHHH
Q 017131          246 DQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHK-----VFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEA  316 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~li~~~L~~dp~~R~s~~~l  316 (376)
                      +++.+|++.+|.|+...|..+.  +++.. .+...+.+.+.+     .+.  ..-++...+|+.+||++||.+|+|++++
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~-~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQT-LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHH-HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            8899999999999998887653  33211 111111111111     111  1235669999999999999999999999


Q ss_pred             hcCCccccc
Q 017131          317 CVHPFFDEL  325 (376)
Q Consensus       317 l~hp~f~~~  325 (376)
                      |+|+||..-
T Consensus       335 leh~yF~~d  343 (438)
T KOG0666|consen  335 LEHPYFTED  343 (438)
T ss_pred             hcccccccC
Confidence            999999863

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-48  Score=352.92  Aligned_cols=279  Identities=31%  Similarity=0.550  Sum_probs=222.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhC---CCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5999999999999999999999999999999885421      1234677777665   799999999988655444556


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++++|||+.+++...+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            68899999998887766542  22458999999999999999999998 9999999999999999888 79999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ............+|..|+|||++.+. .++.++|+||+||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            66444444456778999999999654 48999999999999999999999999988888888888887777655443210


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                       ......+......++.... +.++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 -TLPRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             -cccccccCCCCCCchHHhC-cCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence             0001111111222222222 4578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=358.26  Aligned_cols=261  Identities=28%  Similarity=0.413  Sum_probs=230.9

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           31 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ..+..+-|.+.+.||+|.|+.|.+|++..||+.||||++.+.+      ..+.+|++.|+.++|||||++|++.     +
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----D   87 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----D   87 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----c
Confidence            3344556999999999999999999999999999999996543      3456899999999999999999987     3


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      ....+|||+|+-++ +|.+++-.+   ..++++..++.|++||+.|+.|+|+ ..+|||||||+|+.+-+.-+-|||+||
T Consensus        88 TQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   88 TQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             ccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeec
Confidence            33348999999885 887777653   5689999999999999999999998 999999999999987665558999999


Q ss_pred             CCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          184 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       184 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      |++..+..+....+.||+..|-|||++++..+..+++||||||||||.|+||++||...++.+.+..|..+         
T Consensus       164 GFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC---------  234 (864)
T KOG4717|consen  164 GFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC---------  234 (864)
T ss_pred             cccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc---------
Confidence            99998888888999999999999999999988889999999999999999999999999999999888774         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                              .|..|            ..++.++++||.+||..||.+|.+.++|..|+|++....+.
T Consensus       235 --------KYtvP------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  235 --------KYTVP------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             --------cccCc------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence                    34433            57899999999999999999999999999999999986544

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.2e-48  Score=360.91  Aligned_cols=286  Identities=32%  Similarity=0.549  Sum_probs=227.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3458999999999999999999999999999999886432      233479999999999999999998754332 223


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ...|+||||+++++...+.      ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCccc
Confidence            3478999999988766553      358889999999999999999998 9999999999999999988 8999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +............+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+...++.+..+.+..+
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            866444444556789999999999654 5899999999999999999999999999888888888888888877655443


Q ss_pred             CcC----------cccccCCCccc---cccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          267 NPN----------YTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       267 ~~~----------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      .+.          +....++....   .+.........+.++++||.+||+.||++|||+.++|+||||....++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            321          11111111100   011111223356789999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.3e-48  Score=362.92  Aligned_cols=284  Identities=35%  Similarity=0.585  Sum_probs=225.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++|+||+++++++..........+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3788999999999999999999999999999885421      2345799999999999999999988654422333588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+.+++...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999887665543    4579999999999999999999998 9999999999999999988 89999999997543


Q ss_pred             CCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          191 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       191 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...  ......+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+++..+...++.++.+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            222  123345788999999997766689999999999999999999999999999999999999999888766543211


Q ss_pred             Ccccc--cCCCccc-cccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEF--KFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .....  ..+..+. ......+....++++.+||.+||+.||.+|||+.++++||||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            11000  0000000 0000112245688999999999999999999999999999998853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-48  Score=351.83  Aligned_cols=285  Identities=32%  Similarity=0.614  Sum_probs=229.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      +..+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ..+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~   78 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKS   78 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCe
Confidence            3457999999999999999999999999999999885322     234579999999999999999998843     334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++||||+++++.+.+..   ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++..
T Consensus        79 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~  153 (301)
T cd07873          79 LTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARA  153 (301)
T ss_pred             EEEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhc
Confidence            889999999888766653   23568999999999999999999998 9999999999999999988 799999999875


Q ss_pred             ccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ..... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+...++.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            43222 22334568899999998766668899999999999999999999999998888888888888888776655432


Q ss_pred             c--CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          268 P--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       268 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .  .+....++........ .....+++++++||.+||+.||.+|||+.++++||||+.+...-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             ccccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence            1  1222233322221111 12246789999999999999999999999999999999876433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-48  Score=360.88  Aligned_cols=285  Identities=34%  Similarity=0.616  Sum_probs=229.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      .++|++.+.||.|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            357999999999999999999999999999999886432      223479999999999999999998753321 2223


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..|++++++++++..++.     ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus        94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~  166 (343)
T cd07878          94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLAR  166 (343)
T ss_pred             cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCccce
Confidence            478999999888876654     3569999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  ......+|+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+.+..+....+.+..+.+....
T Consensus       167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            6533  23456789999999999765668999999999999999999999999988888888888888887766554332


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .....   ..++..+...+...+ ...++.+.+||.+||..||.+|||+.++++||||....++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            21110   011222222222222 35678899999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-48  Score=350.79  Aligned_cols=256  Identities=23%  Similarity=0.376  Sum_probs=206.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.+..       ....+|+.+++.++|+||+++++++..     ..++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence            4889999999999999999999999999999885432       123479999999999999999888733     2348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+.+ +|...+...  ....+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEE
Confidence            899999985 665444321  23468999999999999999999998 9999999999999999888 799999999986


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+........         
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ---------  221 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc---------
Confidence            544444445678999999999965 4589999999999999999999999987665433333322211100         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                                      ..++..+++++.+||++||+.||.+|++     ++++++||||+++.+
T Consensus       222 ----------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         222 ----------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             ----------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                            0122457899999999999999999997     899999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-48  Score=365.21  Aligned_cols=278  Identities=24%  Similarity=0.336  Sum_probs=212.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||....  ....+|+.+++.++||||++++++|..     ....++++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~  162 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLIL  162 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEE
Confidence            34579999999999999999999999999999997543  345689999999999999999998843     23478999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC-
Q 017131          114 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  192 (376)
Q Consensus       114 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  192 (376)
                      |++.+++...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..... 
T Consensus       163 e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        163 PRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDIN  236 (391)
T ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCccccccccc
Confidence            9999887666543    3568999999999999999999998 9999999999999999888 7999999998653221 


Q ss_pred             -CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHHHHHhCCCCHHHHh
Q 017131          193 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       193 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~  264 (376)
                       .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+       ...++..++...+.++.+...
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             ccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence             22334578999999999965 458999999999999999999998775432       345566677766655432110


Q ss_pred             hcCcC----c----ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          265 CMNPN----Y----TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       265 ~~~~~----~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      .....    +    ............|...  ..++.++.+||.+||++||.+|||+.++|+||||+.+..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence            00000    0    0000000001111111  136789999999999999999999999999999988643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-48  Score=352.08  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=207.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCeE
Confidence            6999999999999999999999999999999985421       23457999999999999999988773     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+.+ +|.+++..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            899999975 67666643    4578999999999999999999998 9999999999999999888 799999999876


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...              
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--------------  213 (291)
T cd05612         151 LRD--RTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--------------  213 (291)
T ss_pred             ccC--CcccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence            533  2334568999999999865 44899999999999999999999999887766555554431              


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                         ...            ++..+++.+++||++||+.||.+|++     +.++++||||+.+.+
T Consensus       214 ---~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         214 ---KLE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             ---CcC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence               111            12356889999999999999999995     999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-48  Score=356.16  Aligned_cols=251  Identities=29%  Similarity=0.426  Sum_probs=208.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ....|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++..     .
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~   90 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----E   90 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----C
Confidence            3467999999999999999999999999999999986432       234579999999999999999998843     2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+|+||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~  164 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGF  164 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccC
Confidence            348899999975 66555543    4578999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ++....  ......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...           
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-----------  230 (329)
T PTZ00263        165 AKKVPD--RTFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-----------  230 (329)
T ss_pred             ceEcCC--CcceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence            976533  23356789999999999654 4799999999999999999999999887765555444321           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                            ...            ++..++..+++||++||+.||.+|++     ++++++||||++..+
T Consensus       231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence                  111            11347889999999999999999997     799999999987544

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=340.15  Aligned_cols=254  Identities=28%  Similarity=0.437  Sum_probs=215.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccH-------HHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+.|..++.||+|.||+|-+|+.+.+|+.||||+++++....       ..|-++|+..+||.+..+...|.+     .-
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-----~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-----QD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-----Cc
Confidence            357999999999999999999999999999999887654222       347899999999999988877733     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||..| .|...+.    ..+.|++...+++..+|+.||.|||+ ++||+||||.+|+|+|.+| .+||+|||++
T Consensus       242 rlCFVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDG-HIKitDFGLC  315 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDG-HIKITDFGLC  315 (516)
T ss_pred             eEEEEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCC-ceEeeecccc
Confidence            38999999986 4433332    24679999999999999999999998 9999999999999999999 5999999999


Q ss_pred             cccc-CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +.-. .+....+.||||.|+|||++. ...|+.++|+|.+||++|||+||+.||...+....+..|...           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            8543 345566789999999999995 456999999999999999999999999998877776666542           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCCCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPN  329 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~~~  329 (376)
                            ++.+|            ..++++++.|+..+|.+||.+|+.     +.++++|+||.+++|..
T Consensus       384 ------d~kFP------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ------DLKFP------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ------hccCC------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                  33333            579999999999999999999985     78999999999998754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-49  Score=345.94  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=222.2

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           31 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ..+.+-+|++.+.||+|.||+|-+|++...|+.||||.|.++.       ..+.||+++|..|+||||+.+|++|.    
T Consensus        48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE----  123 (668)
T KOG0611|consen   48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE----  123 (668)
T ss_pred             ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc----
Confidence            3345568999999999999999999999999999999987653       23468999999999999999999993    


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                       +.-.+.+||||.. |.|++++..    .+.+++.+++.+++||..|+.|||. ++++|||||.+|||+|.++ ++||+|
T Consensus       124 -NkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIAD  196 (668)
T KOG0611|consen  124 -NKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIAD  196 (668)
T ss_pred             -CCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeec
Confidence             3333889999998 588888875    4679999999999999999999998 9999999999999999998 899999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ||++..+.......++||+|.|.+||++.+.++-++.+|.||||++||.|+.|..||.|.+......+|...        
T Consensus       197 FGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G--------  268 (668)
T KOG0611|consen  197 FGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG--------  268 (668)
T ss_pred             cchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--------
Confidence            999988888888889999999999999988777799999999999999999999999999988777777652        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                               .|.-             +.-+.++.-||+.||..||.+|.|+.++..|=|+.
T Consensus       269 ---------aYrE-------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  269 ---------AYRE-------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ---------cccC-------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                     1111             34578999999999999999999999999998874

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-47  Score=350.80  Aligned_cols=277  Identities=29%  Similarity=0.511  Sum_probs=210.5

Q ss_pred             eeeeeecCceEEEEEEEC--CCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           41 EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      .++||+|+||+||+|+++  .+++.||+|.+....  ....+|+.+++.++||||+++++++...   ....++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            468999999999999965  467899999886532  3356899999999999999999987543   234588999999


Q ss_pred             cccHHHHHHHhhh-----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc----CCCCCeEEEecCCcc
Q 017131          117 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAK  187 (376)
Q Consensus       117 ~~~l~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~----~~~~~vkl~Dfg~a~  187 (376)
                      ++++..++.....     ....+++..++.++.||+.||+|||+ +||+||||||+|||++    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence            9988877764321     12358999999999999999999998 9999999999999994    344 79999999997


Q ss_pred             cccCCC----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHHHH
Q 017131          188 VLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKV  254 (376)
Q Consensus       188 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~  254 (376)
                      ......    ......+|+.|+|||++.+...++.++|+||+||++|+|++|++||.+...         ..++..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            654322    123456799999999997766789999999999999999999999975432         3567778888


Q ss_pred             hCCCCHHHHhhcCcCcc------cc---cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          255 LGTPTREEIKCMNPNYT------EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ++.|....+.....-..      .+   .........+........+.++.+||++||++||.+|+|++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            88887766554321000      00   0000000000011112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.8e-48  Score=354.97  Aligned_cols=245  Identities=27%  Similarity=0.442  Sum_probs=200.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++..     ..++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence            46999999999999999999999999986432       223469999999999999999888743     335889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-C
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  192 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~  192 (376)
                      |+.+ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9986 5544443    24678999999999999999999998 9999999999999999988 799999999875322 2


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            23345678999999999965 45899999999999999999999999877654444433221                 1


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                      ..            ++..+++++.+||++||+.||++||     ++.++++||||+++.+
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            11            1245799999999999999999999     8999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=347.13  Aligned_cols=286  Identities=35%  Similarity=0.657  Sum_probs=227.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+.+++.++|+||+++++++..........+
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            357999999999999999999999999999999885321     223469999999999999999988755443444568


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++++||+++++.+.+..     +.+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeec
Confidence            89999999887665542     569999999999999999999998 9999999999999999988 7999999998765


Q ss_pred             cCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          190 VKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       190 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .....    .....+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+.......+...++.+..+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            33221    12346788999999886655689999999999999999999999999888888888888888877766543


Q ss_pred             cCcCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          266 MNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       266 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      +......   ...+.....++.... +..++++.+||.+||+.||.+|||+.++++||||+.+.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHh-cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            3211100   011111122222222 3568899999999999999999999999999999988765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-47  Score=353.72  Aligned_cols=251  Identities=29%  Similarity=0.416  Sum_probs=207.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCC-cEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++.+.||+|+||.||+|.+..++ ..||+|.+.+..       ....+|+.+++.++||||+++++++..     
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----
Confidence            4457999999999999999999976655 689999885432       233479999999999999999998843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ..++|+||||+.+ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCC
Confidence            2348899999975 66666543    4579999999999999999999998 9999999999999999888 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +++....  ......||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+.......+...          
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~----------  243 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG----------  243 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC----------
Confidence            9976532  2345678999999999965 44899999999999999999999999987765555554431          


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                             ...            ++..+++.+.++|++||+.||.+|+     ++.++++||||+++.+
T Consensus       244 -------~~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        244 -------IIY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             -------CCC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                   011            1245789999999999999999996     8999999999998754

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.1e-47  Score=364.20  Aligned_cols=282  Identities=22%  Similarity=0.371  Sum_probs=213.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCC------CeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.+.|.      +++.++++|..    .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            367999999999999999999999999999999986432   2334688888777554      57777777642    2


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC---------
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---------  176 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---------  176 (376)
                      ..++++||+++++++.+.+..    .+.+++..++.++.||+.||+|||+..||+||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            235789999998888776653    3579999999999999999999996249999999999999987652         


Q ss_pred             ------CeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 017131          177 ------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  250 (376)
Q Consensus       177 ------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  250 (376)
                            .+||+|||.+...  .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  3999999987543  2233456789999999999764 589999999999999999999999999998888888


Q ss_pred             HHHHhCCCCHHHHhhcCcC-cccc------cCCCcccccccccc------ccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          251 IIKVLGTPTREEIKCMNPN-YTEF------KFPQIKPHPWHKVF------QKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       251 i~~~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                      +.+.++.++.......... ...+      ..+......+....      ....++.+.|||++||++||.+|||++|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            8888887765543211100 0000      00000000000000      001246788999999999999999999999


Q ss_pred             cCCcccccCC
Q 017131          318 VHPFFDELRD  327 (376)
Q Consensus       318 ~hp~f~~~~~  327 (376)
                      +||||++...
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999988543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.4e-47  Score=355.85  Aligned_cols=253  Identities=27%  Similarity=0.431  Sum_probs=204.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||+||+|.+..+++.||||++.+..       ....+|+.+++.++|+||+++++.+.+     ...+
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCeE
Confidence            6999999999999999999999999999999986432       234569999999999999999988843     3348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            899999975 66665543    4679999999999999999999998 9999999999999999988 799999999875


Q ss_pred             ccCCC------------------------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHH
Q 017131          189 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  232 (376)
Q Consensus       189 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  232 (376)
                      .....                                    .....+||+.|+|||++.+. .++.++|+|||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence            42210                                    01235789999999999654 589999999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC---
Q 017131          233 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL---  309 (376)
Q Consensus       233 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~---  309 (376)
                      ++|+.||.+.+..+...++.....               ...+|..          ..+++++++||.+|+. +|.+   
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~----------~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKE---------------TLIFPPE----------VPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcC---------------cccCCCc----------CCCCHHHHHHHHHHcC-ChhhcCC
Confidence            999999998877666665553110               0111110          2368999999999875 5554   


Q ss_pred             CCCHHHHhcCCcccccCC
Q 017131          310 RCTALEACVHPFFDELRD  327 (376)
Q Consensus       310 R~s~~~ll~hp~f~~~~~  327 (376)
                      ||+++++++||||++..+
T Consensus       284 r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         284 APGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCHHHHhCCCCCCCCCH
Confidence            579999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.3e-47  Score=340.29  Aligned_cols=276  Identities=35%  Similarity=0.560  Sum_probs=217.6

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|++|.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++.+     ...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence            5999999999999999999999999999999885421      234579999999999999999998843     23488


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +++||+++++.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .++|+|||+++...
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            9999999887666543   23568999999999999999999998 9999999999999999888 79999999987543


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..| |.+.+..+.+..+.+.++.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            221 122345688899999987766689999999999999999998876 566666677777877777776665543321


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ......++............+.+++++.+||.+||+.||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111111122211111122224688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-47  Score=357.04  Aligned_cols=253  Identities=32%  Similarity=0.508  Sum_probs=205.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||+||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++.+     ..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCeE
Confidence            6999999999999999999999999999999986431       224579999999999999999998843     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+.+ +|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            899999975 66555543    4569999999999999999999998 9999999999999999998 799999999865


Q ss_pred             ccCCC---------------------------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHH
Q 017131          189 LVKGE---------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVM  229 (376)
Q Consensus       189 ~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  229 (376)
                      .....                                       .....+||+.|+|||++.+ ..++.++|+|||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHH
Confidence            42211                                       0112468999999999865 4589999999999999


Q ss_pred             HHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC
Q 017131          230 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL  309 (376)
Q Consensus       230 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  309 (376)
                      |+|++|.+||.+.+..+....+.....               ...++.          ...+++++++||.+||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            999999999998876665555443100               011111          02478999999999996 9999


Q ss_pred             CCC---HHHHhcCCcccccCC
Q 017131          310 RCT---ALEACVHPFFDELRD  327 (376)
Q Consensus       310 R~s---~~~ll~hp~f~~~~~  327 (376)
                      |++   +.++++||||++..+
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCH
Confidence            998   999999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=328.61  Aligned_cols=260  Identities=30%  Similarity=0.473  Sum_probs=208.8

Q ss_pred             cceEEe-eeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           36 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        36 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ..|.+. ++||-|-.|.|..|.++.||+.+|+|++. +.....+|++.--.. .|||||.++++|.... .+..++.+||
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVm  138 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVM  138 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeee
Confidence            356654 57999999999999999999999999765 445566899886655 6999999999985544 3466788999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecCCccccc
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLV  190 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg~a~~~~  190 (376)
                      |.++| .|.+-+..  +..+.|+|.++..|+.||+.|+.|||+ .+|.||||||+|+|....+.  .+||+|||+|+...
T Consensus       139 E~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  139 ECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             ecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            99986 55444433  234569999999999999999999998 99999999999999965432  69999999999876


Q ss_pred             CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHHHHHhCCCCHHHHhhc
Q 017131          191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ----LVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  266 (376)
                      ......+.+.||+|.|||++ +...|+..+|+||+||++|-|++|.+||........    ..+|...            
T Consensus       216 ~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g------------  282 (400)
T KOG0604|consen  216 EPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG------------  282 (400)
T ss_pred             CCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc------------
Confidence            66667778889999999999 556699999999999999999999999987654222    2222221            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                           .|.||.   ..|     ..+|++++|+|+++|..+|++|+|+.++++|||+.+..
T Consensus       283 -----qy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  283 -----QYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             -----CccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence                 122221   112     34799999999999999999999999999999998743

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-47  Score=349.56  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=209.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++||||+++++++..     ..++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCEE
Confidence            6999999999999999999999999999999986432       223469999999999999999988743     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            899999975 77666643    4568999999999999999999998 9999999999999999988 799999999975


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...  ......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+......           
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  216 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-----------  216 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence            533  33456789999999999665 5899999999999999999999999987766655554432100           


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                          ...+...      .....+++++.+||.+||..+|.+|+++.++++||||.+..+
T Consensus       217 ----~~~~~~~------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         217 ----LQRPVYD------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ----ccCCCCC------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                0000000      000247899999999999999999999999999999998654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=378.20  Aligned_cols=270  Identities=29%  Similarity=0.471  Sum_probs=226.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ....|.+++.||+|+||.|.+++++.|++.||+|++.+.       ...+..|..+|..-+.+-|+.++..|     .++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            346899999999999999999999999999999998663       34566789999999999999999988     556


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .|+|+||||+.| +|..++..+    .++++.++++|+..|+.||.-||+ .|+|||||||+|||+|..|| +||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GH-ikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGH-IKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCc-Eeeccchh
Confidence            679999999985 776666653    379999999999999999999998 99999999999999999995 99999999


Q ss_pred             cccccCCCC--CceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          186 AKVLVKGEP--NVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       186 a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      +-.+..++.  ....+|||.|.+||++..    ...|+..+|+||+||++|||+.|..||...+-.+++.+|...-    
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk----  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK----  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence            877754433  235689999999999942    2468999999999999999999999999999999999988741    


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC---HHHHhcCCcccccCCCCCCCCCCC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTRLPNGR  336 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~ll~hp~f~~~~~~~~~~~~~~  336 (376)
                                 ..+.||+.          ..+|+++++||++++ .+|..|++   ++++.+||||.++.|...+-..++
T Consensus       298 -----------~~l~FP~~----------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP  355 (1317)
T KOG0612|consen  298 -----------ESLSFPDE----------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP  355 (1317)
T ss_pred             -----------hhcCCCcc----------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence                       12344421          358999999999998 57899998   999999999999988665544444


Q ss_pred             CCCC
Q 017131          337 PLPP  340 (376)
Q Consensus       337 ~~~~  340 (376)
                      .+|.
T Consensus       356 ~vPe  359 (1317)
T KOG0612|consen  356 VVPE  359 (1317)
T ss_pred             CCCc
Confidence            4444

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-47  Score=356.73  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=203.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|.+++.||+|+||+||+|.+..+++.||||++.+..       ....+|+.+++.++||||+++++++.+     ..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCee
Confidence            6999999999999999999999999999999886432       234569999999999999999998843     3458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            999999974 77666543    3578999999999999999999998 9999999999999999888 799999999863


Q ss_pred             ccCCC------------------------------------------------CCceeeeeccccchhhhcCCCCCCCch
Q 017131          189 LVKGE------------------------------------------------PNVSYICSRYYRAPELIFGATEYTTAI  220 (376)
Q Consensus       189 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  220 (376)
                      .....                                                .....+||+.|+|||++.+ ..++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCce
Confidence            21100                                                0012468999999999965 4589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHH
Q 017131          221 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  300 (376)
Q Consensus       221 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  300 (376)
                      |+|||||++|+|++|.+||.+.+..+.+..+.....               ...++.          ...++.++++||+
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHH
Confidence            999999999999999999988776666555543100               011111          0247899999999


Q ss_pred             HhhccCCCCC---CCHHHHhcCCcccccCC
Q 017131          301 RFFQYSPNLR---CTALEACVHPFFDELRD  327 (376)
Q Consensus       301 ~~L~~dp~~R---~s~~~ll~hp~f~~~~~  327 (376)
                      +||. +|.+|   +++.+++.||||++..+
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9998 77775   59999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8e-47  Score=354.49  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=202.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .|++++.||+|+||+||+|++..+++.||||++.+..       ....+|+.+++.++||||+++++++.+     ..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence            5999999999999999999999999999999986432       224579999999999999999998843     3348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            899999975 66666543    3568999999999999999999998 9999999999999999988 799999998753


Q ss_pred             ccCCC------------------------------------------------CCceeeeeccccchhhhcCCCCCCCch
Q 017131          189 LVKGE------------------------------------------------PNVSYICSRYYRAPELIFGATEYTTAI  220 (376)
Q Consensus       189 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  220 (376)
                      .....                                                .....+||+.|+|||++.+ ..++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCcc
Confidence            21000                                                0123468999999999965 4489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHH
Q 017131          221 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  300 (376)
Q Consensus       221 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  300 (376)
                      |||||||++|+|++|..||...+..+....+.....               ...++.          ...+++++++||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPP----------QVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCC----------CCCCCHHHHHHHH
Confidence            999999999999999999988776555544432100               011111          0247899999999


Q ss_pred             Hhhcc--CCCCCCCHHHHhcCCcccccCC
Q 017131          301 RFFQY--SPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       301 ~~L~~--dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      +|+..  +|..|+++.++++||||+++.+
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            97654  4445999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-47  Score=356.83  Aligned_cols=253  Identities=28%  Similarity=0.476  Sum_probs=204.0

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++++.||+|+||+||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++.+.+     ...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence            5999999999999999999999999999999986432       234579999999999999999998843     2348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            899999975 66665543    3568999999999999999999998 9999999999999999988 799999999753


Q ss_pred             ccCC------------------------------------------------CCCceeeeeccccchhhhcCCCCCCCch
Q 017131          189 LVKG------------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAI  220 (376)
Q Consensus       189 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  220 (376)
                      ....                                                ......+||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001234689999999999654 589999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHH
Q 017131          221 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC  300 (376)
Q Consensus       221 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  300 (376)
                      |||||||++|+|++|++||.+.+..+....+.....               ....+.          ...+++++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIPP----------QAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCCC----------cccCCHHHHHHHH
Confidence            999999999999999999998876665555543110               011110          1357899999999


Q ss_pred             HhhccCCCCCCC---HHHHhcCCcccccCC
Q 017131          301 RFFQYSPNLRCT---ALEACVHPFFDELRD  327 (376)
Q Consensus       301 ~~L~~dp~~R~s---~~~ll~hp~f~~~~~  327 (376)
                      +|+ .||.+|++   +.++++||||+.+.+
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            976 59999997   999999999988654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-46  Score=337.68  Aligned_cols=276  Identities=34%  Similarity=0.630  Sum_probs=217.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|++.+.||+|++|.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEE
Confidence            4899999999999999999999999999999885321      2345799999999999999999988542     3488


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+.+++.+.+.... ....+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988876665422 23568999999999999999999998 9999999999999999988 89999999987543


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc-
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  268 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  268 (376)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+....+.+....+..... 
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 122335678899999987666688999999999999999999999999888888888877777666554432110 


Q ss_pred             -CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                       ++. ...+......... ....+++++.+||++||+.||.+|||+.++++||||
T Consensus       233 ~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         233 PDYK-NTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHH-hhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             000 0111111111111 123579999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.8e-47  Score=352.44  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=209.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++.+     .
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-----~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-----D  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence            3468999999999999999999999999999999986421       224579999999999999999988743     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .++++||||+++ +|..++..     ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~  188 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence            458899999975 67666543     468999999999999999999998 9999999999999999988 899999999


Q ss_pred             cccccCCC--CCceeeeeccccchhhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          186 AKVLVKGE--PNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +.......  ......||+.|+|||++.+.   ..++.++|+|||||++|+|++|++||.+.+....+.++.....    
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----  264 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN----  264 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC----
Confidence            87653322  12345689999999998643   2478999999999999999999999998876666555543110    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~  327 (376)
                                 ...++.          ...+|.++++||++||+.+|.+  |+|++++++||||++..+
T Consensus       265 -----------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         265 -----------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             -----------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                       011111          0247899999999999999998  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-47  Score=352.47  Aligned_cols=254  Identities=31%  Similarity=0.532  Sum_probs=208.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|.+.+.||+|+||+||+|++..+|+.||||++.+..       ....+|+.++..++||||+++++++.+     ..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCeE
Confidence            6999999999999999999999999999999986432       234579999999999999999988743     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            899999975 77666654    3679999999999999999999998 9999999999999999998 799999999876


Q ss_pred             ccCCC------------------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 017131          189 LVKGE------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  238 (376)
Q Consensus       189 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  238 (376)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54332                              12345689999999999654 589999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-HHHHh
Q 017131          239 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEAC  317 (376)
Q Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~~ll  317 (376)
                      |.+.+......++.....               ...++..          ..+++++.+||.+||. ||.+|++ +.+++
T Consensus       230 f~~~~~~~~~~~i~~~~~---------------~~~~p~~----------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKE---------------SLRFPPD----------PPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCC---------------cccCCCC----------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            998876655555443110               0111110          2368999999999997 9999999 99999


Q ss_pred             cCCcccccCCC
Q 017131          318 VHPFFDELRDP  328 (376)
Q Consensus       318 ~hp~f~~~~~~  328 (376)
                      +||||++..+.
T Consensus       284 ~hp~~~~~~~~  294 (350)
T cd05573         284 SHPFFKGIDWE  294 (350)
T ss_pred             cCCCcCCCCHH
Confidence            99999987653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.2e-46  Score=339.05  Aligned_cols=285  Identities=35%  Similarity=0.562  Sum_probs=225.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++|+||+++++++...   ..
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HL   80 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CC
Confidence            34567999999999999999999999999999999885322      1234799999999999999999987532   22


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+++||||+++++.+++...   ...+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||.+
T Consensus        81 ~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~  155 (309)
T cd07845          81 DSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLA  155 (309)
T ss_pred             CeEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcccee
Confidence            347899999998887776542   3568999999999999999999998 9999999999999999888 7999999998


Q ss_pred             ccccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             eecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            7654332 222334578899999987666689999999999999999999999999999899999988888776655433


Q ss_pred             cCc--CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          266 MNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       266 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ...  ....+..+......+...+ ...++++.+||++||++||++|||+.+++.||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hhcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            211  1111222221111111111 23689999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-46  Score=344.22  Aligned_cols=288  Identities=35%  Similarity=0.658  Sum_probs=228.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+|.+.+.||.|+||+||+|++..+++.||||.+...      .....+|+.+++.++|+||+++++++..........+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4699999999999999999999999999999987542      1233469999999999999999998765443334458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |+++||+++++.+.+..    ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++...
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence            89999999887666643    3569999999999999999999998 9999999999999999988 7999999998765


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ... .......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+....+.+..+.+.....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            433 2223456788999999986555589999999999999999999999999888788888888888777665532211


Q ss_pred             C-cccc--cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCC
Q 017131          269 N-YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       269 ~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~  330 (376)
                      . ...+  ..+......+... .+.+++++.+||++||+.||++|||+.++++||||..++++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence            1 0000  0111111111111 2468999999999999999999999999999999999877653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-46  Score=351.29  Aligned_cols=258  Identities=28%  Similarity=0.482  Sum_probs=207.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++.+     .
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----D  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence            346899999999999999999999999999999998642       2234579999999999999999998843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .++|+||||+++ +|.+++..     ..+++.+++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEeccc
Confidence            458899999975 77666643     458999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccCCCC--CceeeeeccccchhhhcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          186 AKVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |........  .....||+.|+|||++.+..   .++.++|+||+||++|+|++|.+||.+.+......++.....    
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~----  264 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN----  264 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----
Confidence            976533221  23456899999999996432   378899999999999999999999998876666655544211    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDP  328 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~~  328 (376)
                                 ...++.          ...++..++++|.+||..++.+  |+|+.++++||||+...+.
T Consensus       265 -----------~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~  313 (370)
T cd05621         265 -----------SLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN  313 (370)
T ss_pred             -----------ccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence                       011111          0246899999999999866544  8899999999999875443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-46  Score=345.15  Aligned_cols=245  Identities=30%  Similarity=0.506  Sum_probs=199.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ +||||+++++++..     ...+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence            47999999999999999999999999986432       1233577788766 79999999998843     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+++ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99986 5544443    34579999999999999999999998 9999999999999999988 799999999875322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------  211 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------  211 (320)
T ss_pred             CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            223344568999999999965 45899999999999999999999999987766655554331                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH------HHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~~ll~hp~f~~~~~  327 (376)
                      ...            ++..++.++.+||++||+.||.+|+++      +++++||||+.+.+
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         212 EVV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            011            123578999999999999999999998      89999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-46  Score=346.45  Aligned_cols=245  Identities=26%  Similarity=0.414  Sum_probs=199.0

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++..     ...+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence            46999999999999999999999999986532       223468999999999999999888743     334889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC-
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  192 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  192 (376)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9986 5544443    24579999999999999999999998 9999999999999999988 7999999998753222 


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            22234568999999999965 45899999999999999999999999877654444333210                 1


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                      ..            ++..+++++.+||++||+.||.+|+     ++.++++||||.+..+
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         212 IK------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             cc------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            11            2245789999999999999999997     8999999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.7e-46  Score=340.01  Aligned_cols=277  Identities=29%  Similarity=0.519  Sum_probs=207.9

Q ss_pred             eeeeeecCceEEEEEEECC--CCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           41 EHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ...||+|+||+||+|++..  ++..||+|.+....  ....+|+.+++.++||||+++++++...   ....++++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            4689999999999999654  56889999886543  2456899999999999999999988543   234578999999


Q ss_pred             cccHHHHHHHhhh-----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE----cCCCCCeEEEecCCcc
Q 017131          117 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK  187 (376)
Q Consensus       117 ~~~l~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill----~~~~~~vkl~Dfg~a~  187 (376)
                      ++++.+.+.....     ....+++..++.++.||+.||+|||+ +||+||||||+||++    +.++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9988777754321     12358899999999999999999998 999999999999999    3445 79999999997


Q ss_pred             cccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHHHH
Q 017131          188 VLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKV  254 (376)
Q Consensus       188 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~  254 (376)
                      .......    .....+|+.|+|||.+.+...++.++||||+||++|+|+||.+||.....         ..++..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543221    23456789999999997666689999999999999999999999975432         3456677777


Q ss_pred             hCCCCHHHHhhcCcC--cccc-------cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          255 LGTPTREEIKCMNPN--YTEF-------KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ++.+....+......  +...       ..................+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            777766655433211  1000       0000000000011112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.3e-47  Score=348.32  Aligned_cols=256  Identities=27%  Similarity=0.466  Sum_probs=208.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|.+.+.||+|+||+||+|++..+|+.||+|++.+..       ....+|+.+++.++|+||+++++++..     ...+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeE
Confidence            6999999999999999999999999999999986532       234578999999999999999888743     3348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            899999964 776666542   3579999999999999999999998 9999999999999999988 799999999976


Q ss_pred             ccCCCCC--ceeeeeccccchhhhcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          189 LVKGEPN--VSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       189 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      .......  ....+|+.|+|||++..     ...++.++|||||||++|+|++|..||.+.+....+.++.....     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-----  226 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-----  226 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            5433322  23467899999999853     34578899999999999999999999988776666555543200     


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                                ...++.          ...+++++.+||.+||. ||.+|+|+.++++||||+.+.+.
T Consensus       227 ----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         227 ----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             ----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                      011111          12578999999999998 99999999999999999987543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-46  Score=343.65  Aligned_cols=242  Identities=31%  Similarity=0.538  Sum_probs=198.3

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++..     ...+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence            699999999999999999999999986421       223469999999999999999888743     33488999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC-CC
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  194 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~  194 (376)
                      .+ +|.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 66555543    4579999999999999999999998 9999999999999999988 7999999998754322 22


Q ss_pred             CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017131          195 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  274 (376)
Q Consensus       195 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .....||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+..+....+...                 ...
T Consensus       150 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~~  211 (312)
T cd05585         150 TNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PLR  211 (312)
T ss_pred             cccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CCC
Confidence            334578999999999965 45899999999999999999999999887655544443321                 111


Q ss_pred             CCCccccccccccccCCChhHHHHHHHhhccCCCCCC---CHHHHhcCCcccccC
Q 017131          275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELR  326 (376)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~~ll~hp~f~~~~  326 (376)
                                  ++..+++++++||.+||..||.+|+   ++.++++||||.+..
T Consensus       212 ------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         212 ------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                        2245789999999999999999997   579999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3e-46  Score=343.25  Aligned_cols=250  Identities=27%  Similarity=0.446  Sum_probs=202.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCC-CeeeccceeeecCCCCceE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~  108 (376)
                      .|++.+.||+|+||.||+|++..+++.||||++.+..       .....|+.++..++|+ +|+.+++++...     ..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence            4899999999999999999999999999999986432       2234688889989775 577787777332     34


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8899999975 66555543    4568999999999999999999998 9999999999999999988 79999999986


Q ss_pred             cccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .... ........||+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+..+....+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------  216 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------  216 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence            4322 2233445689999999999654 4899999999999999999999999887766655554431            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~~ll~hp~f~~~~~  327 (376)
                           ...            ++..+++++.++|++||..||.+|++.     .++++||||+..++
T Consensus       217 -----~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         217 -----NVS------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 011            123578999999999999999999986     89999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-46  Score=343.98  Aligned_cols=248  Identities=28%  Similarity=0.482  Sum_probs=201.2

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHH---HhCCCCCeeeccceeeecCCCCce
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM---QMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      |++.+.||+|+||.||+|.+..+++.||||++.+..       ....+|++++   +.++||||+++++++..     ..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence            789999999999999999999999999999986432       1233455554   45689999999998843     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||+++ +|...+.     ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            48899999986 5443332     3579999999999999999999998 9999999999999999998 8999999998


Q ss_pred             ccccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +.... ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...           
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------  216 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-----------  216 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            75322 222344678999999999965 45899999999999999999999999987766655554431           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                            ...            ++..+++++.+||++||+.||.+||     ++.++++||||+++.+
T Consensus       217 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         217 ------EVR------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                  011            1235789999999999999999999     6899999999988654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.3e-46  Score=344.34  Aligned_cols=285  Identities=32%  Similarity=0.565  Sum_probs=224.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+.+..      ....+|+.+++.++|+||+++++++..... .+..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            457999999999999999999999999999999885421      223469999999999999999998754322 2233


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..|+||||+.+++.+.+..      .+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus        95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCccce
Confidence            4789999999988766542      38899999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ............+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+......++...++.|+.+......
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            6644433344567889999999965 458999999999999999999999999998888888888888888776544332


Q ss_pred             cCcccc--cCCCcccccccccc------------ccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          268 PNYTEF--KFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       268 ~~~~~~--~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      .....+  ..+.....++...+            ....++.+++||.+||+.||++|||+.++|.||||+.+.++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence            111110  00001111111111            12346779999999999999999999999999999976554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-46  Score=345.10  Aligned_cols=245  Identities=27%  Similarity=0.429  Sum_probs=200.2

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++..     ...+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence            47999999999999999999999999986432       123469999999999999999988843     234889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC-
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  192 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  192 (376)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9986 5544443    24578999999999999999999998 9999999999999999988 7999999998753222 


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            22234568999999999865 45899999999999999999999999877665554444321                 1


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                      ..            ++..+++++.+||.+||+.||.+|+     ++.++++||||.+..+
T Consensus       212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            11            1245799999999999999999998     8999999999988653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8e-47  Score=354.14  Aligned_cols=253  Identities=27%  Similarity=0.447  Sum_probs=203.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .|++++.||+|+||.||+|++..+++.||||++.+.       .....+|+.+++.++|+||+++++.+..     ...+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCEE
Confidence            599999999999999999999999999999988542       1234579999999999999999988843     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            899999975 77666653    3568999999999999999999998 9999999999999999988 799999999742


Q ss_pred             ccCC--------------------------------------------CCCceeeeeccccchhhhcCCCCCCCchhHHH
Q 017131          189 LVKG--------------------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWS  224 (376)
Q Consensus       189 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  224 (376)
                      ....                                            ......+||+.|+|||++.+ ..++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeee
Confidence            2100                                            00113468999999999965 45899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhc
Q 017131          225 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  304 (376)
Q Consensus       225 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  304 (376)
                      |||++|+|++|+.||.+.+..+....+.....               ....+.          ...+++++.+||.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIPS----------QAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCCC----------CCCCCHHHHHHHHHHh-
Confidence            99999999999999998876655544432100               001110          1357899999999976 


Q ss_pred             cCCCCCC---CHHHHhcCCcccccCC
Q 017131          305 YSPNLRC---TALEACVHPFFDELRD  327 (376)
Q Consensus       305 ~dp~~R~---s~~~ll~hp~f~~~~~  327 (376)
                      .+|.+|+   ++.++++||||+.+..
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            5999999   9999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.9e-46  Score=335.55  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=199.8

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ||+|+||+||+|.+..+++.||+|.+.+..       .....|+.+++.++|+||+++.+++..     ...+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence            699999999999999999999999986432       123469999999999999999888733     33488999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC-
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  194 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-  194 (376)
                      ++ +|...+.........+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            75 6665554433344679999999999999999999998 9999999999999999888 799999999876543322 


Q ss_pred             CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017131          195 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  274 (376)
Q Consensus       195 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .....+|+.|+|||.+.+. .++.++|+||+||++|+|++|+.||...+.......+.......             .  
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~--  217 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------S--  217 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-------------C--
Confidence            2345678999999999654 58999999999999999999999998755432222222211000             0  


Q ss_pred             CCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCCC
Q 017131          275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  328 (376)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~~  328 (376)
                                ..++..+++++.+++.+||+.||.+|+     +++++++||||++..+.
T Consensus       218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         218 ----------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             ----------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                      012245789999999999999999999     88999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-45  Score=334.80  Aligned_cols=284  Identities=35%  Similarity=0.622  Sum_probs=222.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+. |+||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6999999999999999999999999999999875432      23457999999995 6999999998865554445567


Q ss_pred             EEEEecccccHHHHHHHhhhh-cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC-CCCCeEEEecCCcc
Q 017131          110 NLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAK  187 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~-~~~~vkl~Dfg~a~  187 (376)
                      |++|||+++++.+.+...... ...+++..++.++.||+.||+|||+ +||+||||+|+||+++. ++ .+||+|||+++
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~-~~kl~dfg~~~  159 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKG-LLKIADLGLGR  159 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCC-eEEEeecccce
Confidence            899999999887777654332 3568999999999999999999998 99999999999999998 55 89999999987


Q ss_pred             cccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ..... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+......++...++.+....+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            54322 12223356788999999866566899999999999999999999999998888888888887777765544322


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                      ........++.......... .+.++.++.+||.+||..||.+||++.+++.||||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRA-VPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhccchhhcCcccchhHHHh-ccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            11111111121111111111 135789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-46  Score=335.43  Aligned_cols=257  Identities=24%  Similarity=0.368  Sum_probs=206.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||+||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++...     ..+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeE
Confidence            4899999999999999999999999999999886432       2234699999999999999998887332     348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+.+ +|...+..  .....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            899999975 66555432  123468999999999999999999998 9999999999999999888 799999999986


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+...+....         
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------  221 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence            544444344578899999999965 4589999999999999999999999987665444333332211000         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  328 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~~  328 (376)
                                      ..++..++..+.+||.+||..||.+||     +++++++||||....+.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                            011235789999999999999999999     89999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=338.62  Aligned_cols=261  Identities=26%  Similarity=0.390  Sum_probs=215.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+.|+.-+.||+|+||.||-|+-+.||+.||+|++.+..       .....|..+|..++.+.||.+-..|.+.+.   
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~---  259 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA---  259 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc---
Confidence            3467999999999999999999999999999999874322       223469999999999999999888855444   


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                        +|+|+..|+| +|...+.+.  -+..|++..+++|+.+|+.||++||+ .+||+|||||+|||+|+.| .|+|+|+|+
T Consensus       260 --LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~G-hvRISDLGL  333 (591)
T KOG0986|consen  260 --LCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHG-HVRISDLGL  333 (591)
T ss_pred             --eEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCC-CeEeeccce
Confidence              8999999986 554434332  23579999999999999999999998 9999999999999999999 599999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      |..+..+.+....+||..|||||++.+.. |+...|+|||||++|+|+.|+.||...........+-+.....+      
T Consensus       334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~------  406 (591)
T KOG0986|consen  334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP------  406 (591)
T ss_pred             EEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch------
Confidence            99999888888889999999999996655 99999999999999999999999976544333322222111111      


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCCCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDPN  329 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~~~  329 (376)
                                         ..++.++|++++++++.+|++||.+|+.     +.++.+||||+++++..
T Consensus       407 -------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  407 -------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             -------------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence                               1123578999999999999999999985     67999999999988643

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-46  Score=345.95  Aligned_cols=277  Identities=23%  Similarity=0.347  Sum_probs=206.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEec
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      .+|++.+.||+|+||.||+|.+..+++.||+|+....  ....|+.+++.++||||+++++++...     ...++|||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeC-----CeeEEEEEc
Confidence            4699999999999999999999999999999975432  335799999999999999999988543     347899999


Q ss_pred             ccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC
Q 017131          116 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  195 (376)
Q Consensus       116 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  195 (376)
                      +.+++.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++........
T Consensus       139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            99988776654   34578999999999999999999998 9999999999999999988 7999999999754444444


Q ss_pred             ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCc---------hHHHHHHHHHhCCCCHHHHhh
Q 017131          196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       196 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....||+.|+|||++.+. .++.++|+|||||++|+|+++. ++|.....         ...+..+...++..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            456789999999999654 5899999999999999999854 44443221         123344444444332211100


Q ss_pred             cCcCcc--cccCCCcccccc---ccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYT--EFKFPQIKPHPW---HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ......  ..........++   ...-...++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            000000  000000000010   011112578899999999999999999999999999999863

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-45  Score=332.80  Aligned_cols=276  Identities=40%  Similarity=0.756  Sum_probs=227.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     ..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence            5999999999999999999999999999999886432      234579999999999999999998844     33488


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|+||++++|.+.+...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            99999977887776542   2569999999999999999999998 9999999999999999988 79999999987654


Q ss_pred             CCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          191 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       191 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      ....  .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..+...++.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            3321  2344678899999998766667999999999999999999999999988888888888888888776654432 


Q ss_pred             -cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          268 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                       ..+....++.....++...+ ...+.++.+||.+||..||.+|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             12233334443333443333 45789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-46  Score=344.86  Aligned_cols=246  Identities=28%  Similarity=0.432  Sum_probs=198.8

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.||+|+||.||+|.+..+|+.||+|++.+..       ....+|+++++.++||||+++++++..     ...+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence            46999999999999999999999999986532       223468899999999999999888733     334889999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-C
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  192 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~  192 (376)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+.+||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence            9986 5544333    2457999999999999999999999526999999999999999988 799999999875332 2


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  212 (325)
T ss_pred             cccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            22334568999999999965 45899999999999999999999999877654444433221                 1


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                      ..            ++..+++++.+||++||+.||.+|+     ++.++++||||.+..+
T Consensus       213 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         213 IR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             CC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            11            1245789999999999999999997     8999999999997653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-46  Score=341.62  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=205.0

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||+||+|++..+++.||+|++.+..       ....+|+.+++.++|+||+++++++..     ..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCeE
Confidence            6999999999999999999999999999999986421       224578999999999999999998843     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+.+ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            899999964 77666643   24579999999999999999999998 9999999999999999888 799999999876


Q ss_pred             ccCCCCC--ceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          189 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       189 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .......  ....||+.|+|||++..    ...++.++|+||+||++|+|++|+.||.+.+..+....+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------  225 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence            5433222  23468999999999853    24478899999999999999999999988776665555443110      


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~  327 (376)
                               .+.++.         ....+++++++||++||..++.+  |+++.++++||||.++++
T Consensus       226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence                     011111         01247899999999999765544  789999999999988654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.3e-46  Score=342.88  Aligned_cols=255  Identities=30%  Similarity=0.455  Sum_probs=201.0

Q ss_pred             ceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc--------ccHHHHHHHHHhC-CCCCeeeccceeeecCCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (376)
                      .|++.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.+ .|+||+++++++.     
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ-----   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence            4899999999999999999874   578999999986421        1234689999999 5999999988873     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      ....+++||||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeC
Confidence            33448899999985 66555543    4569999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          184 GSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       184 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      |+++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+......    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            9987643322  2234568999999999976556889999999999999999999999754332222222111000    


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                                           ....++..+++.+.+||.+||+.||++|+     ++.++++||||++..+
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                 00012245789999999999999999999     7889999999997643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.6e-46  Score=346.97  Aligned_cols=257  Identities=28%  Similarity=0.472  Sum_probs=206.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++..     .
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~  115 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D  115 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----C
Confidence            3468999999999999999999999999999999985421       234578999999999999999988843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .++++||||+++ +|.+++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEeCCc
Confidence            458899999975 67666643     458999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccCCCC--CceeeeeccccchhhhcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          186 AKVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      ++.......  .....||+.|+|||++.+..   .++.++|+|||||++|+|++|..||.+.+......++.....    
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----  264 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----  264 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----
Confidence            976543221  23457899999999986432   378999999999999999999999998776665555543210    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~  327 (376)
                                 ...++.          ...++..+++||.+||..++.+  |+++.++++||||++..+
T Consensus       265 -----------~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         265 -----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             -----------cccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                       011111          1357999999999999844433  789999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.7e-45  Score=332.15  Aligned_cols=281  Identities=37%  Similarity=0.661  Sum_probs=222.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---------cHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|.+.+.||+|++|.||+|.+..+|+.||||.+.....         ....|+.+++.++|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            48999999999999999999999999999999865422         23469999999999999999998844     34


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ++++||||+.++|.+++...   ...+++..++.++.||+.||+|||+ +||+|+||+|+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            58899999987887777542   1369999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.++|.+.+..+.+.++...++.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            654332 2223345778999999866566899999999999999999999999998888888888887777766555332


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ...............+....+ ...+.++.+||.+||.+||++|||+.+++.||||++...+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ccccccccccccCCcchhhhc-ccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence            111011111111111122222 4568899999999999999999999999999999985443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=339.48  Aligned_cols=251  Identities=27%  Similarity=0.445  Sum_probs=210.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ...|+..+.||+|+||.||+|.+..|++.||||++.-+.     ..+++|+.+|.+++++||.++|+.|+....     +
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----L   86 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----L   86 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----H
Confidence            346999999999999999999999999999999986443     345689999999999999999999976555     8


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++||||.| ++.++++.    +..+.+..+..++++++.||.|||. ++.+|||||+.|||+..+| .|||+|||.+..
T Consensus        87 wiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~q  160 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceeee
Confidence            899999986 55555543    4445888999999999999999998 9999999999999999997 899999999876


Q ss_pred             ccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...... ..+.+|||.|||||++. ...|+.++||||||++.+||++|.+|+....+...+..|                
T Consensus       161 l~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------  223 (467)
T KOG0201|consen  161 LTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------  223 (467)
T ss_pred             eechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------
Confidence            644333 36789999999999997 455999999999999999999999999887764433332                


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                              |...+..+.    ..+++.+++|+..||++||+.||+|.++|+|+|++..
T Consensus       224 --------pk~~PP~L~----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  224 --------PKSAPPRLD----GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             --------cCCCCCccc----cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                    222222222    3579999999999999999999999999999999863

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.2e-46  Score=340.74  Aligned_cols=245  Identities=30%  Similarity=0.493  Sum_probs=200.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|++..+++.||||++.+..       .....|.+++..+ +||||+++++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence            46999999999999999999999999986532       1233578888765 899999999988432     3488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99986 6554443    24578999999999999999999998 9999999999999999988 799999999875432 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----------------  211 (321)
T ss_pred             CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            222344568999999999865 45899999999999999999999999988766666555431                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-------CHHHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-------TALEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-------s~~~ll~hp~f~~~~~  327 (376)
                      ...            ++..+++++.+||.+||+.||.+|+       ++.++++||||..+.+
T Consensus       212 ~~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         212 DVL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            111            1134789999999999999999999       8999999999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.9e-46  Score=338.67  Aligned_cols=245  Identities=28%  Similarity=0.494  Sum_probs=197.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHh-CCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|++..+++.||||++....       .....|..+++. ++||||+++++++.+.     ..+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence            47999999999999999999999999986532       123357777775 4999999999888432     3488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+++ +|...+..    ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99975 66555543    3568999999999999999999998 9999999999999999988 799999999875322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-----------------  211 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence            2233455689999999999654 5899999999999999999999999887755544443221                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH-HHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~-~ll~hp~f~~~~~  327 (376)
                      ...            ++..++.++++||.+||+.||.+|+++. ++++||||+.+.+
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         212 NPC------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             CCC------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence            000            1134788999999999999999999996 8999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.9e-46  Score=347.37  Aligned_cols=254  Identities=28%  Similarity=0.442  Sum_probs=204.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .|++.+.||+|+||+||+|.+..+++.||||++....       ....+|+.++..++||||+++++.+.+     ..++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-----~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-----KRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCEE
Confidence            5999999999999999999999999999999986421       234469999999999999999988743     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .++|+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            899999985 66665543    4579999999999999999999998 9999999999999999988 799999999864


Q ss_pred             ccCCC------------------------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHH
Q 017131          189 LVKGE------------------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  232 (376)
Q Consensus       189 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  232 (376)
                      .....                                    .....+||+.|+|||++.+. .++.++|+|||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence            32110                                    01234689999999999654 589999999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC
Q 017131          233 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  312 (376)
Q Consensus       233 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s  312 (376)
                      ++|++||.+.+.......+.....               ...++..          ..+++++++||.+|+ .||.+|++
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~----------~~~s~~~~~li~~l~-~~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKE---------------TLVFPPE----------VPISEKAKDLILRFC-TDSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCCC----------CCCCHHHHHHHHHhc-cChhhcCC
Confidence            999999998877666555543100               0111110          136899999999987 59999984


Q ss_pred             ---HHHHhcCCcccccCCC
Q 017131          313 ---ALEACVHPFFDELRDP  328 (376)
Q Consensus       313 ---~~~ll~hp~f~~~~~~  328 (376)
                         +.++++||||+++.+.
T Consensus       284 ~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCHHHHhcCCCCCCCCHH
Confidence               7999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.1e-45  Score=354.06  Aligned_cols=264  Identities=23%  Similarity=0.336  Sum_probs=214.4

Q ss_pred             CccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC--
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD--  103 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--  103 (376)
                      .....+|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+.++..++|+||++++..+.....  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344568999999999999999999999999999999985432      234578999999999999998877643322  


Q ss_pred             -CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          104 -KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       104 -~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                       .....+++||||+. |+|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~  185 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLG  185 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEE
Confidence             12234789999998 48888777655555679999999999999999999998 9999999999999999988 79999


Q ss_pred             ecCCcccccCC---CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          182 DFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       182 Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      |||+++.....   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....   
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~---  261 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR---  261 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---
Confidence            99998765322   22234578999999999965 458999999999999999999999998876555544443210   


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                      .         ..++..+++++.+|+.+||+.||.+||++.++++|||++.+.
T Consensus       262 ----------------~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        262 ----------------Y---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             ----------------C---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                            0         012246789999999999999999999999999999998653

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.7e-46  Score=340.05  Aligned_cols=245  Identities=27%  Similarity=0.464  Sum_probs=196.8

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHh-CCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|++..+|+.||+|.+.+..       .....|..++.. ++||||+++++++..     ..++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence            47999999999999999999999999986532       223457777765 489999999988843     33588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+.+ +|...+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||+++.... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 66555432    4578999999999999999999998 9999999999999999988 799999999864322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~--------------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T--------------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence            2223455689999999999654 5899999999999999999999999877655444333221  0              


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-HHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-~~ll~hp~f~~~~~  327 (376)
                       .            .++..++.++++||++||+.||.+|+++ +++++||||+...+
T Consensus       213 -~------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         213 -P------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             -C------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence             0            0123478999999999999999999997 58899999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3e-45  Score=338.14  Aligned_cols=287  Identities=36%  Similarity=0.673  Sum_probs=229.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+|++.+.||.|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            57999999999999999999999999999999886432      22346999999999999999998875433 334568


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+.+++.+.+..    ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999999877665542    4569999999999999999999998 9999999999999999988 7999999998755


Q ss_pred             cCCCC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          190 VKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      .....     .....++..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+...++..+....+.|+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     1234678899999998665568999999999999999999999999998888888888888888876654


Q ss_pred             hcCcCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCC
Q 017131          265 CMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       265 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~  330 (376)
                      ....+...   ..++.....++.... +..++++.++|++||+.||.+|||+.+++.||||.+...+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIF-PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHc-ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence            33221110   012222222333222 457899999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.2e-46  Score=342.13  Aligned_cols=245  Identities=27%  Similarity=0.455  Sum_probs=196.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHH-HHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||+||+|++..+|+.||||++.+...       ...+|.. +++.++||||+++++.+..     ...+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence            479999999999999999999999999864321       1123333 5678999999999988743     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+.+ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99986 5655443    24578999999999999999999998 9999999999999999988 7999999998754222


Q ss_pred             -CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                       .......||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------  211 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-----------------  211 (323)
T ss_pred             CCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22334568999999999865 45899999999999999999999999887765555444331                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH----HHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~~ll~hp~f~~~~~  327 (376)
                      ...            +...+++++.++|++||+.||.+|+++    .++++||||....+
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         212 PLR------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            000            113578999999999999999999997    69999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=341.37  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=221.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +.|..++++|.|+||.+++++++..++.|++|.+.-.      ......|+.+++++.|||||.+++.|+    .++.++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            5799999999999999999999999999999998533      234457999999999999999999884    334458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++|+||+| ++.+.+....  +..|+++.+..|+.|++.|++|||+ ++|+|||||+.||+++.++ .|||+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999986 7777776644  4679999999999999999999998 9999999999999999998 689999999998


Q ss_pred             ccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ..+.. ...++.|||.|++||++.+ .+|+.++|||||||++|||++-+++|.+.+-.....+|......|.        
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl--------  226 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL--------  226 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC--------
Confidence            87665 6678899999999999965 5599999999999999999999999999998888888887543222        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                          +...+.+++.+|+.||..+|..||++.++|.+|....
T Consensus       227 --------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  227 --------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             --------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                                2467899999999999999999999999999999874

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-45  Score=338.95  Aligned_cols=250  Identities=27%  Similarity=0.419  Sum_probs=203.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHHHHHhC-CCCCeeeccceeeecCCCCceE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .|.+.+.||+|+||.||+|++..+++.||||++.+...       ....|..++..+ .|++|+.+++++..     ...
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence            48999999999999999999999999999999865321       223577777776 57888889888743     234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8899999975 66554432    3568999999999999999999998 9999999999999999998 79999999987


Q ss_pred             cccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------  216 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------  216 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            5432 223334568999999999965 45899999999999999999999999988766665555431            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                           ...            ++..++.++.+|+.+||+.||.+|++     ..++++||||+.+.+
T Consensus       217 -----~~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         217 -----NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             -----CCC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 111            12357899999999999999999998     489999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-45  Score=337.11  Aligned_cols=288  Identities=37%  Similarity=0.672  Sum_probs=232.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||.|++|.||+|++..+++.||||.+....      ....+|+.+++.++|+||+++++++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5999999999999999999999999999999885432      3455799999999999999999988655433334588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ++|||+++++.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||.+....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999877666543    3479999999999999999999998 9999999999999999998 89999999997664


Q ss_pred             CCC----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          191 KGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       191 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...    ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.+..+.+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            432    2334567889999999976646899999999999999999999999999988888899888888877655422


Q ss_pred             CcC-cccc--cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCC
Q 017131          267 NPN-YTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  331 (376)
Q Consensus       267 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~  331 (376)
                      ... ...+  ..+.....++.... +.++.++.+||.+||++||.+|||+.+++.||||+++..+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence            111 0000  11222222333332 4578999999999999999999999999999999998776543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-45  Score=338.05  Aligned_cols=245  Identities=29%  Similarity=0.496  Sum_probs=199.2

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||+||+|.+..+++.||||++.+..       ....+|..+++.+ +||||+++++++..     ...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence            47999999999999999999999999987532       2234688888877 79999999998843     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+.+ +|...+..    ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99975 55444432    4579999999999999999999998 9999999999999999988 799999999865322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .......++|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            222334568999999999965 45899999999999999999999999877655544443321                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~~ll~hp~f~~~~~  327 (376)
                      ...            ++..++.++.+||++||..||.+|||+     .++++||||+...+
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         212 EVR------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CCC------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            011            123578999999999999999999999     99999999988654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-45  Score=337.99  Aligned_cols=245  Identities=29%  Similarity=0.485  Sum_probs=196.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHh-CCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|++..+++.||||++..+.       .....|..++.. .+||||+++++++..     ..++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence            46999999999999999999999999986532       122346666654 489999999988733     33588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+++ +|...+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++.....
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99975 66555443    4579999999999999999999998 9999999999999999988 7999999999754332


Q ss_pred             -CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                       ......+||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------  211 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             223345789999999999654 4899999999999999999999999987765555444321                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-HHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-~~ll~hp~f~~~~~  327 (376)
                      ..            .++..++.++.+||.+||..||.+|+++ .++++||||..+.+
T Consensus       212 ~~------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         212 RP------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence            00            1123578999999999999999999986 58889999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=328.21  Aligned_cols=276  Identities=35%  Similarity=0.667  Sum_probs=216.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ++|++.+.||+|++|.||+|.+..+++.||||.+....     ....+|+.+++.++|+||+++++++..     ..+.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeEE
Confidence            57999999999999999999999999999999885432     233579999999999999999998743     33588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+.++|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence            9999999888776653   23468999999999999999999998 9999999999999999988 79999999986542


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.. ..+....+.+.++.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            211 11223457889999998765668999999999999999999999998766 5566677777777776665543321


Q ss_pred             --CcccccCCCccccccccccccCCC--hhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 --NYTEFKFPQIKPHPWHKVFQKRLP--PEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 --~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                        .+.....+.....+....+ ..++  .++.++|.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence              1112222222222221211 1344  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-45  Score=339.23  Aligned_cols=246  Identities=26%  Similarity=0.494  Sum_probs=195.5

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|..+++.+ +||||+++++++..     ...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence            46999999999999999999999999986532       2244788898888 79999999998843     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc-C
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~-~  191 (376)
                      ||+++ +|...+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++... .
T Consensus        76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99986 6644443    24679999999999999999999998 9999999999999999988 79999999987532 2


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch--------HHHHHHHHHhCCCCHHHH
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--------DQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~  263 (376)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||......        +...+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            333345678999999999965 45899999999999999999999999632211        111111110         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC------HHHHhcCCcccccCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  327 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~~ll~hp~f~~~~~  327 (376)
                             ....            ++..++.++.++|++||+.||.+|+|      +.++++||||..+.+
T Consensus       220 -------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         220 -------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             -------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   0011            22457899999999999999999997      789999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-44  Score=326.50  Aligned_cols=276  Identities=37%  Similarity=0.661  Sum_probs=213.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++|+|++++++++..     ....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence            36999999999999999999999999999999875432      224579999999999999999998843     3348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++...+.   .....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceec
Confidence            8999999986543332   234568999999999999999999998 9999999999999999988 7999999999766


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+.+..+............
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            4433 223345678899999987656688999999999999999999999998887777777766655443321111100


Q ss_pred             --CcccccCCCccc-cccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 --NYTEFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                        -+.....+.... .+....+ ..++..+.+||.+||+.||.+||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKF-PNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHHHh-ccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              001111111111 1111111 3578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.8e-45  Score=330.64  Aligned_cols=279  Identities=38%  Similarity=0.625  Sum_probs=224.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +.|++.+.||+|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++....   ..+.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            57999999999999999999999999999999886432      12347999999999999999999875432   2458


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |+||||+++++.+++...   ...+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            899999998887766542   2368999999999999999999998 9999999999999999988 7999999998766


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+...++....+.+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            443 2223445688899999987666678999999999999999999999999988888888888888877766543211


Q ss_pred             --CcccccCCCccccccccccccC-CChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 --NYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                        ..............+...++.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              0111111122222233334333 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-45  Score=337.06  Aligned_cols=276  Identities=25%  Similarity=0.428  Sum_probs=205.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++.+.||+|+||.||+|++..+|..+|+|.+....     ....+|+++++.++||||+++++++...     ..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence            357999999999999999999999999999999886432     2355799999999999999999988543     248


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+||+++.++ .+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccc
Confidence            899999986 77666643    356899999999999999999999723699999999999999988 799999999875


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh----
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK----  264 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----  264 (376)
                      ... .......+|+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.. .+   ++.+......    
T Consensus       154 ~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~---~~~~~~~~~~~~~~  227 (331)
T cd06649         154 LID-SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AI---FGRPVVDGEEGEPH  227 (331)
T ss_pred             ccc-cccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH---hcccccccccCCcc
Confidence            533 223345689999999999654 5899999999999999999999999876643322 22   2211100000    


Q ss_pred             hcCcCc----cc---ccCCCcc------------ccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          265 CMNPNY----TE---FKFPQIK------------PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       265 ~~~~~~----~~---~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ...+..    ..   .......            ...........+++++++||.+||++||++|||+.++++||||+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence            000000    00   0000000            0000000012468899999999999999999999999999999875


Q ss_pred             C
Q 017131          326 R  326 (376)
Q Consensus       326 ~  326 (376)
                      .
T Consensus       308 ~  308 (331)
T cd06649         308 E  308 (331)
T ss_pred             c
Confidence            4

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=335.96  Aligned_cols=247  Identities=31%  Similarity=0.461  Sum_probs=202.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcE-EEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEI-VAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ....+.+.||+|+||+||++...  |.. ||||++....      ..+.+|+.+|.+++|||||++++++.....    .
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~  114 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----S  114 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----c
Confidence            35666777999999999999987  555 9999986532      356789999999999999999998844331    3


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-ccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      +++||||+++ +|..++...  ....++...+..++.||+.||.|||+ ++ ||||||||+|||++.++..+||+|||++
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            7899999985 777777653  35679999999999999999999998 89 9999999999999988536999999999


Q ss_pred             ccccCC-CCCceeeeeccccchhhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          187 KVLVKG-EPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       187 ~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +..... ...+...||+.|||||++.+ ...|+.++||||+|+++|||+||..||.+.........+......|+     
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-----  266 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-----  266 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----
Confidence            876543 33444788999999999974 35699999999999999999999999999887555555544322222     


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                            ++..+++.+..|+.+||..||.+||+..+++.
T Consensus       267 ----------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 ----------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ----------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                  22348899999999999999999999987763

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-48  Score=318.36  Aligned_cols=286  Identities=30%  Similarity=0.506  Sum_probs=231.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC---C
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---K  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~  104 (376)
                      ....|.-..+||+|.||.||+|+.+.+|+.||+|++.-+.      ....+|+.+|..++|+|++.+++++-+...   .
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3456889999999999999999999999999998764321      123489999999999999999887754333   3


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ....+|+||.+|+.+|..++.+   ...+++..+++.++.+++.||.|+|+ ..|+|||+|+.|+||+.+| .+||+|||
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFG  169 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFG  169 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeeccc
Confidence            3456899999999988777765   34679999999999999999999998 8999999999999999999 89999999


Q ss_pred             CcccccCCCC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      +++..+....     .+..+.|.+|++||.+.+...|++..|+|+.|||+.||+||.+.|.+.+...++..|...+|..+
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            9976644322     24456799999999999999999999999999999999999999999999999999999999988


Q ss_pred             HHHHhhcCc--CcccccCCCccccccc---ccccc-CCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          260 REEIKCMNP--NYTEFKFPQIKPHPWH---KVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       260 ~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      .+.|..+..  =|.....+..+....+   +...+ .-.+++.||+.+||..||.+|++++++++|-||..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            887765531  1222222222111111   11100 12468999999999999999999999999999975

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.2e-45  Score=337.53  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||.||++++..+++.||+|++.+..       ....+|+.++..++|+||+++++++.+     ...+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCEE
Confidence            6999999999999999999999999999999985421       224568889999999999999988843     2348


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+. ++|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            89999997 477666653   23568999999999999999999998 9999999999999999888 799999999875


Q ss_pred             ccCCCCC--ceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          189 LVKGEPN--VSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       189 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .......  ....||+.|+|||++.+    ...++.++|+|||||++|+|++|+.||.+.+..+....+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------  225 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence            4332221  23468999999999852    34578999999999999999999999998876666655543100      


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~  327 (376)
                               ...++.         ....+++++++||++||..++.+  |+++.++++||||+++.+
T Consensus       226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                     011111         01357999999999999765555  689999999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.2e-45  Score=342.71  Aligned_cols=278  Identities=22%  Similarity=0.324  Sum_probs=211.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC--CCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ..+|.+++.||.|+||.||+|...  .+++.||+|.+... ....+|+.+++.++||||+++++++..     ...+|++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRW-----KSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEee-----CCEEEEE
Confidence            357999999999999999999864  45678999987654 345689999999999999999988743     2348899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          113 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       113 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||++.+++...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||+++.....
T Consensus       165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            9999988876663    24679999999999999999999998 9999999999999999988 7999999998765433


Q ss_pred             CC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHHHhCCCCHHHHhhc
Q 017131          193 EP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       193 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ..   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..   ....+..+.+.++..+.+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   234568999999999965 458999999999999999999999997754   34556666666654432211000


Q ss_pred             C----cCcccccCCCcccccccccc-ccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 N----PNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 ~----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      .    ..+..+.............+ ...++.++++||++||..||.+|||+.++|+||||++.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            0    00000110000000000111 12467889999999999999999999999999999863

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-45  Score=337.54  Aligned_cols=245  Identities=31%  Similarity=0.485  Sum_probs=198.9

Q ss_pred             eeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc--------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           41 EHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.++||||+++++++..     +..+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence            368999999999999873   578899999986421        123469999999999999999988843     2348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+.+ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        76 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  149 (323)
T cd05584          76 YLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKE  149 (323)
T ss_pred             EEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCee
Confidence            899999986 5555443    24568899999999999999999998 9999999999999999988 899999999875


Q ss_pred             ccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .... .......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+...             
T Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------  215 (323)
T cd05584         150 SIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------  215 (323)
T ss_pred             cccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence            4322 223345689999999999654 4789999999999999999999999887766555544331             


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~  326 (376)
                          ...            ++..+++++.+||++||+.||.+|+     ++.++++||||+...
T Consensus       216 ----~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         216 ----KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             ----CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence                111            1245789999999999999999999     899999999998754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-44  Score=326.15  Aligned_cols=275  Identities=36%  Similarity=0.630  Sum_probs=218.1

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.....     ...+|+.++..+. |+|++++++++.+.   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            7889999999999999999999999999998864321     1236888888885 99999999988543   1234789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      ||||+++++.+.+..   ....+++..++.++.|++.||+|||+ .|++||||+|+||+++. + .+||+|||+++....
T Consensus        78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            999999887766653   23468999999999999999999998 99999999999999998 6 899999999986654


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC-c
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  270 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  270 (376)
                      ........++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444445567889999998765556789999999999999999999999999888888888887777766543222111 1


Q ss_pred             ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ..+.++.......... ...++.++.+||.+||..||.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKL-LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHH-cccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1122222222222111 23578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.8e-45  Score=328.57  Aligned_cols=275  Identities=37%  Similarity=0.679  Sum_probs=217.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|++.+.||.|++|.||+|++..+|+.||||.+..+.      ....+|+++++.++||||+++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence            4899999999999999999999999999999885432      234579999999999999999998743     23478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+.+++...+...  ....+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            99999988776666432  23568999999999999999999998 9999999999999999988 79999999987543


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC--
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  267 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  267 (376)
                      ... ......++..|+|||.+.+...++.++|+|||||++|+|+||+.||.+.+..+...++.+..+.+....+....  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            322 12233457889999988766667899999999999999999999999988888888888888777654432211  


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      +.+. ..++.......... ...++++++++|.+||+.||.+|||+.++++||||
T Consensus       232 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYK-PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHH-hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0000 11222222222222 23578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-45  Score=345.10  Aligned_cols=276  Identities=25%  Similarity=0.326  Sum_probs=206.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ....|.+.+.||+|+||.||+|.+..+++.||||...  .....+|+++|+.++|+||+++++++...     ...++||
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~  239 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVL  239 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEE
Confidence            3457999999999999999999999999999999643  23356899999999999999999987432     3478999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC
Q 017131          114 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  193 (376)
Q Consensus       114 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  193 (376)
                      +++.+++...+..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++......
T Consensus       240 e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        240 PKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSW  314 (461)
T ss_pred             EccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceeccccc
Confidence            9999888766653   22469999999999999999999998 9999999999999999888 79999999997653321


Q ss_pred             C---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHHHHHhCCCCHHH-
Q 017131          194 P---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREE-  262 (376)
Q Consensus       194 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~-  262 (376)
                      .   .....||+.|+|||++.+. .++.++|||||||++|||++|..++....       ...++.++++..+....+. 
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            1   1234689999999999654 48999999999999999999875543221       1234555555433221110 


Q ss_pred             -------HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          263 -------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       263 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                             .............+......|...  ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                   000000000001111112222222  146789999999999999999999999999999974

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-45  Score=338.36  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=205.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.+.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..++|+||+++++++..     ..+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence            36999999999999999999999999999999886421       224468899999999999999988843     345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .|+||||+.+ +|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~  150 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCL  150 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEecccee
Confidence            8899999975 77666653   23578999999999999999999998 9999999999999999888 79999999987


Q ss_pred             cccCCCCC--ceeeeeccccchhhhcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          188 VLVKGEPN--VSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       188 ~~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ........  ....||+.|+|||++.+.    ..++.++|+||+||++|+|++|+.||.+.+..+....+.....     
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----  225 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-----  225 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-----
Confidence            65433221  234689999999998542    3478899999999999999999999988776655555443110     


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCCC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDP  328 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~~  328 (376)
                                ...++.        .+ ..++.++++||.+||..++++  |++++++++||||+...+.
T Consensus       226 ----------~~~~p~--------~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         226 ----------RFQFPS--------HI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             ----------cccCCC--------cc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence                      011111        01 247899999999999876655  5689999999999987543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=332.01  Aligned_cols=281  Identities=35%  Similarity=0.604  Sum_probs=216.0

Q ss_pred             ceEEeeeeeecCceEEEEEEECC--CCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|.+.+.||+|++|.||+|.+..  +++.||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            48999999999999999999988  89999999987632       2345799999999999999999988543   224


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcC-CCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC----CCCCeEEEe
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----HTHQLKLCD  182 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~-~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~----~~~~vkl~D  182 (376)
                      .+++||||+++++.+.+........ .+++..++.++.|++.||+|||+ +||+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            5889999999888777765444333 78999999999999999999998 99999999999999998    77 799999


Q ss_pred             cCCcccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---------HHHH
Q 017131          183 FGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------DQLV  249 (376)
Q Consensus       183 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~  249 (376)
                      ||++........    .....++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533221    223456888999999876666899999999999999999999999876543         3456


Q ss_pred             HHHHHhCCCCHHHHhhcC--cCccc----ccCCCcccccccccccc--CCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          250 EIIKVLGTPTREEIKCMN--PNYTE----FKFPQIKPHPWHKVFQK--RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       250 ~i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                      .++..++.+....+....  +++..    ..............+..  ..+.++.++|.+||..||++|||+.+++.|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            666666666654443211  11111    00000000011111111  56789999999999999999999999999999


Q ss_pred             c
Q 017131          322 F  322 (376)
Q Consensus       322 f  322 (376)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-45  Score=325.52  Aligned_cols=252  Identities=35%  Similarity=0.564  Sum_probs=204.6

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc------HHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |++++.||+|+||+||+|.+..+++.||+|++......      ..+|+.+++.++||||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            89999999999999999999999999999999764322      1248999999999999999998855     334789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc-
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  189 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~-  189 (376)
                      +||++.+ +|.+++.    ....+++..+..++.|++.||++||+ +||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence            9999998 8877776    34679999999999999999999998 9999999999999999888 8999999998753 


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ..........++..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            223333455678999999998635568999999999999999999999998874444444443332111111000     


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                       .....+..+.++|.+||+.||++|||+.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             001124799999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-44  Score=327.53  Aligned_cols=282  Identities=36%  Similarity=0.650  Sum_probs=220.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++..     ..+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence            46999999999999999999999999999999885421      234579999999999999999998843     2348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++.+.+...  ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            899999998876665432  12346888899999999999999998 999999999999999865547999999998754


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      .... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+...++....+.+....+.... 
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            3221 12334568899999998765668999999999999999999999999988888888888887777665543211 


Q ss_pred             -cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          268 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                       +++ ....+....... ....+.+++++.+++.+||+.||++||++.+++.||||.++..
T Consensus       234 ~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        234 LPDY-KSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             chhh-hhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence             011 001111111111 1122457899999999999999999999999999999998653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=317.12  Aligned_cols=282  Identities=32%  Similarity=0.545  Sum_probs=231.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCC-C
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-E  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~  105 (376)
                      ....+|.-++.+|.|+. .|..|.|.-+++.||+|+....      .+...+|..++..++|+||++++.+|...... +
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34458999999999999 8999999999999999987543      23445899999999999999999988543321 2


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..-+|+|||+++.++...+..      .+....++++++|++.|++|||+ .||+||||||+||++..+. .+||+|||+
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~  164 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVILM------ELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGL  164 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchh
Confidence            333789999999999887763      47778899999999999999998 9999999999999999988 899999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      |+.....-..+.++.|+.|+|||++.+.. |...+||||+||++.||++|+..|+|.+..++..++...+|.|++.....
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             hcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            98765554567788999999999998876 99999999999999999999999999999999999999999999988776


Q ss_pred             cCcCcccc--cCCCcccccccccccc-----------CCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          266 MNPNYTEF--KFPQIKPHPWHKVFQK-----------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       266 ~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      +.+....+  ..|+.....+...++.           .-+..+++++.+||..||++|.|++++|+||||+-
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v  315 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV  315 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence            64332111  1122211222222211           12356899999999999999999999999999993

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-45  Score=335.69  Aligned_cols=246  Identities=27%  Similarity=0.497  Sum_probs=193.8

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++...     ..+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence            47999999999999999999999999986532       2234688888766 899999999988443     3488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+++ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99985 5544443    34679999999999999999999998 9999999999999999998 799999999875322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHHHHHHhCCCCHHHH
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  263 (376)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....        .....+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            223345678999999999965 4589999999999999999999999953211        1111111110         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC------HHHHhcCCcccccCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  327 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~~ll~hp~f~~~~~  327 (376)
                             ...            .++..++..+.+||++||+.||.+|++      +.++++||||+...+
T Consensus       220 -------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         220 -------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             -------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   001            122457899999999999999999998      579999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-44  Score=333.12  Aligned_cols=285  Identities=29%  Similarity=0.515  Sum_probs=215.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCC-------
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-------  104 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-------  104 (376)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|.+....    ....+|+.+++.++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57999999999999999999999999999999885432    2345799999999999999999876443211       


Q ss_pred             --CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          105 --EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       105 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                        .....+++|||+++++.+.+.     ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++..++|+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence              123578999999987765553     2468999999999999999999998 99999999999999986654799999


Q ss_pred             cCCcccccCCC----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          183 FGSAKVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       183 fg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      ||.++......    ......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+......+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987542211    11223567889999988665568899999999999999999999999888777777766655444


Q ss_pred             CHHHHhhcCcCcccc-c-CCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          259 TREEIKCMNPNYTEF-K-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      ............... . .......+.... ...++.++++||.+||+.||.+|||+.+++.||||+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDL-LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHH-ccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            332221110000000 0 000111111111 2357899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.7e-45  Score=332.93  Aligned_cols=250  Identities=27%  Similarity=0.439  Sum_probs=201.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCC-CCeeeccceeeecCCCCceE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~  108 (376)
                      +|+..+.||+|+||+||+|++..+|+.||+|++.++.       .....|..+++.+.| ++|+++++++..     ...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence            3788999999999999999999999999999986532       123458888888865 667778877733     234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+||||+++ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8899999975 6655543    24579999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...... ......||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+.......+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------  216 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------  216 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            543222 2334568999999999965 45899999999999999999999999887766555555431            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                           ...            ++..++.++.+++.+||+.||.+|++     ..++++||||+.+.+
T Consensus       217 -----~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         217 -----NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             -----CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                 111            12357899999999999999999997     478999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-44  Score=360.65  Aligned_cols=263  Identities=27%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ...+|++++.||.|+||+||+|.+..++..||+|.+...      ...+.+|+.+++.++||||++++++|...   ...
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---ANQ   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CCC
Confidence            345799999999999999999999999999999988532      12345799999999999999999988643   233


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-------ccccCCCCCcEEEcCCC----
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-------ICHRDIKPQNLLVNPHT----  175 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-------iiH~Dlkp~Nill~~~~----  175 (376)
                      .+|+||||+++ +|..++.........+++..++.|+.||+.||.|||+ .+       |+||||||+|||++.+.    
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCccccc
Confidence            58899999984 8888887655555679999999999999999999997 54       99999999999996421    


Q ss_pred             ------------CCeEEEecCCcccccCCCCCceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 017131          176 ------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGE  242 (376)
Q Consensus       176 ------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~  242 (376)
                                  ..+||+|||++.............+|+.|+|||++.+. ..++.++|||||||++|+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                        14899999999766444444456789999999998543 34789999999999999999999999877


Q ss_pred             CchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       243 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      +....+...+...  +.               ++           ....+.++.+||.+||..+|.+||++.++|.|||+
T Consensus       247 ~~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        247 NNFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CcHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            6655544433311  00               00           02468899999999999999999999999999999


Q ss_pred             cccCCC
Q 017131          323 DELRDP  328 (376)
Q Consensus       323 ~~~~~~  328 (376)
                      +.+..+
T Consensus       299 k~i~~p  304 (1021)
T PTZ00266        299 KNVGPP  304 (1021)
T ss_pred             hhcCCC
Confidence            876543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.2e-46  Score=304.36  Aligned_cols=283  Identities=31%  Similarity=0.576  Sum_probs=232.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec-ccccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .+.|++.+++|+|.|+.||.|....+++.++||+++. ..+.+.||+.+|+.+. ||||++++++..++.   .....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCchhH
Confidence            4579999999999999999999999999999998864 3455679999999996 999999999885543   3446799


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          113 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       113 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      +||++..-.      ...-+.++...++.++.|++.||.|||+ +||.|||+||.|++||.....++|+|||+|.....+
T Consensus       114 FE~v~n~Df------k~ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDF------KQLYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccH------HHHhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999986321      1223568888999999999999999998 999999999999999987778999999999988877


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCHHHHh-----hc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CM  266 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~  266 (376)
                      ......+.+++|-.||++.....|+.+-|+|||||++..|++.+.| |.|.+..+++.+|.+.+|+......-     .+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            7777788899999999998888899999999999999999997655 57889999999999999876543211     12


Q ss_pred             CcCcccccCCCcccccccccccc----CCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ++.+..+ +....+.+|...+++    -+++++.|||.++|.+|-.+|+||.|++.||||..+...
T Consensus       267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            3333321 223344555555443    257999999999999999999999999999999876543

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7e-45  Score=326.90  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=196.5

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ||+|+||.||++.++.+|+.||+|.+....       .....|+++++.++||||+++++++..     ..++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence            699999999999999999999999885321       123459999999999999999888733     34588999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  195 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  195 (376)
                      .+ +|...+...  ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            75 665555332  23458889999999999999999998 9999999999999999888 7999999998766544433


Q ss_pred             ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 017131          196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  275 (376)
Q Consensus       196 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ....+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+.........+......          .   ....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~---~~~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE----------D---EVKF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc----------c---cccc
Confidence            4456788999999996554 899999999999999999999999765432222222111000          0   0000


Q ss_pred             CCccccccccccccCCChhHHHHHHHhhccCCCCCCCH----HHHhcCCcccccCCC
Q 017131          276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRDP  328 (376)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~~ll~hp~f~~~~~~  328 (376)
                                 ....+++++++||++||+.||.+||++    .+++.||||+.+.++
T Consensus       218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence                       013578999999999999999999999    678899999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-44  Score=326.84  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=203.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+....       ....+|+.+++.++|++|+.+++.+.+     ...+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence            4888999999999999999999999999999885431       123469999999999999999888743     2348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceee
Confidence            899999975 676665432  23468999999999999999999998 9999999999999999988 799999999876


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.................          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------  220 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----------
Confidence            544443344578899999999965 458999999999999999999999998754322111111110000          


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                                     ...+...+++++.+||++||+.||.+|+|     +.++++||||+.+.+
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         221 ---------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             ---------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence                           00112457899999999999999999999     999999999988654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-46  Score=324.01  Aligned_cols=281  Identities=28%  Similarity=0.493  Sum_probs=216.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHhCCC--C----CeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLDH--P----NIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h--~----~iv~~~~~~~~~~~~~  105 (376)
                      ..+|.+++.+|+|.||.|..|.|..++..||||+++.-.++   ..-|+++|+++++  |    -++++.++|     +-
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            35799999999999999999999999999999988643332   3359999999942  1    366777777     45


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC-----------
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-----------  174 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~-----------  174 (376)
                      .+.+|+|+|.++-++.+.+...  ...+++...++.+++|++.++++||+ .+++|-||||+|||+-+.           
T Consensus       163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence            5568999999988887777652  23469999999999999999999998 999999999999998321           


Q ss_pred             --------CCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH
Q 017131          175 --------THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  246 (376)
Q Consensus       175 --------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  246 (376)
                              ...|+|+|||.|+..  .+.....+.|..|+|||++++.+ ++..+|+||+||||+|+.+|...|++.++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    115999999999764  34456778899999999998865 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcC---------cCcccccCCC------ccccccccccc--cCCChhHHHHHHHhhccCCCC
Q 017131          247 QLVEIIKVLGTPTREEIKCMN---------PNYTEFKFPQ------IKPHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNL  309 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~  309 (376)
                      .+.-+...+|..+.--+....         -++.+.....      ....++.....  .....++.|||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            998888888866654443320         1111111100      00111111110  112246899999999999999


Q ss_pred             CCCHHHHhcCCcccccC
Q 017131          310 RCTALEACVHPFFDELR  326 (376)
Q Consensus       310 R~s~~~ll~hp~f~~~~  326 (376)
                      |+|+.|+|.||||+.+.
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998753

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=339.81  Aligned_cols=244  Identities=28%  Similarity=0.473  Sum_probs=195.1

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHHHHHhC---CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ||+|+||+||+|++..+++.||||++.+...       ...+|..++...   +||||+++++++...     ..+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence            6999999999999999999999999864321       112456666555   799999999888433     3488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+.+ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||+++.....
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99975 5554443    34679999999999999999999998 9999999999999999988 7999999998754322


Q ss_pred             -CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 -EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                       ......+||+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             23345678999999999976666899999999999999999999999887655544443321                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC----CHHHHhcCCcccccC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELR  326 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----s~~~ll~hp~f~~~~  326 (376)
                      ...++.           ..+++++.+||++||+.||.+|+    ++.++++||||....
T Consensus       213 ~~~~~~-----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         213 KVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCCC-----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            111111           24689999999999999999998    689999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-45  Score=338.02  Aligned_cols=245  Identities=28%  Similarity=0.461  Sum_probs=195.8

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHH-HHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||+||+|++..+|+.||+|++.+..       ....+|.. +++.++||||+++++.+..     ...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence            46999999999999999999999999986431       11223443 4677899999999888743     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+.+ ++...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99986 5544443    34679999999999999999999998 9999999999999999988 799999999875322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------  211 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------  211 (325)
T ss_pred             CCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            223345578999999999965 45899999999999999999999999887765555444331                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH----HHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~~ll~hp~f~~~~~  327 (376)
                      ..            .+.+..+..+.++|++||+.||.+||++    .++++||||....+
T Consensus       212 ~~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         212 PL------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             Cc------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            00            0113578899999999999999999986    59999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.8e-44  Score=323.22  Aligned_cols=276  Identities=36%  Similarity=0.664  Sum_probs=221.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +|++.+.||.|++|.||+|.+..+|+.||||.+....     ....+|+.+++.++|+||+++++++....     ..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence            4899999999999999999999999999999886432     23457999999999999999999885432     3789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      ||||+++++.+.+..... ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||+++....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999988776654321 3468999999999999999999998 9999999999999999888 799999999875432


Q ss_pred             CC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017131          192 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  270 (376)
Q Consensus       192 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  270 (376)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+...++......|....+..+. ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            21 12234568889999998665667899999999999999999999999998888888888888888776654332 11


Q ss_pred             cc--ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          271 TE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       271 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ..  ..++......... +.+.++.+++++|.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11  1122221122211 223568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-44  Score=348.54  Aligned_cols=254  Identities=27%  Similarity=0.353  Sum_probs=209.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCC-CcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ..|.+.+.||+|++|.||+|.+..+ ++.||+|.+....    ....+|+.+++.++||||+++++++...     ..+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEE
Confidence            4599999999999999999998877 7889999764332    2345799999999999999999988443     3488


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||++ ++|.+.+.........+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceec
Confidence            9999997 58877776555455679999999999999999999998 9999999999999999988 7999999999865


Q ss_pred             cCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            43221   234568999999999865 45899999999999999999999999887765555554431000         


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                         .++..+++++++||.+||..||.+||++.+++.|||++.+
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                               0113578999999999999999999999999999999653

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-45  Score=337.09  Aligned_cols=246  Identities=30%  Similarity=0.471  Sum_probs=200.3

Q ss_pred             eeeeeecCceEEEEEEE---CCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           41 EHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++.||+|+||.||++++   ..+|+.||+|++.+..      ....+|+++++.++||||+++++++..     ...+|+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEE
Confidence            36799999999999986   4678999999986432      223469999999999999999988843     334889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++...
T Consensus        76 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~  149 (318)
T cd05582          76 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESI  149 (318)
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccC
Confidence            9999974 66555532    4568999999999999999999998 9999999999999999988 79999999987654


Q ss_pred             CC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .. .......||+.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+...               
T Consensus       150 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~---------------  213 (318)
T cd05582         150 DHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA---------------  213 (318)
T ss_pred             CCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC---------------
Confidence            33 22334568999999999965 45789999999999999999999999887766555544331               


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                        ...            ++..+++++.+||++||+.||.+||+     +.++++||||+.+.+
T Consensus       214 --~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         214 --KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             --CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence              111            12357899999999999999999999     678999999987643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=314.78  Aligned_cols=268  Identities=25%  Similarity=0.410  Sum_probs=202.4

Q ss_pred             ceEE-eeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      -|++ .+.||+|+|+.|--|....||..||||++.+..    ....||++++.+. .|+||++++++|.+     +..+|
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-----d~~FY  152 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-----DTRFY  152 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-----cceEE
Confidence            4544 457999999999999999999999999997643    3455899999998 59999999999943     33489


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecCCcc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK  187 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg~a~  187 (376)
                      ||||-+.| .+.+.+.    .+..|++.++..++.+|+.||.+||. +||.||||||+|||.....+  -||||||.++.
T Consensus       153 LVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             EEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence            99999986 5544444    35679999999999999999999998 99999999999999965432  59999999875


Q ss_pred             cccCC--------CCCceeeeeccccchhhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017131          188 VLVKG--------EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  255 (376)
Q Consensus       188 ~~~~~--------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  255 (376)
                      .+..+        ....+.+|+..|||||+..    ....|+.++|.||||+|+|-|++|.+||.|.-..+--+.    -
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd----r  303 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD----R  303 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc----C
Confidence            44222        1234567788899999872    334689999999999999999999999986432110000    0


Q ss_pred             CCCCH----HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          256 GTPTR----EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       256 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      |.+.+    ..+..+..  ..|.+|+   ..|     ..+|.+++|||+.+|..|+..|.++.++++|||++.....
T Consensus       304 Ge~Cr~CQ~~LFesIQE--GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQE--GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             CCccHHHHHHHHHHHhc--cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            00000    00111111  1233332   223     4689999999999999999999999999999999987543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.5e-45  Score=338.26  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=197.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ...|++++.||+|+||.||+|.+..+++.||||++....     ....+|+++++.++|+||+++++++..     ...+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeE
Confidence            357999999999999999999999999999999985432     234579999999999999999998733     3348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+.+...   ..    ....++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       148 ~lv~e~~~~~~L---~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~  218 (353)
T PLN00034        148 QVLLEFMDGGSL---EG----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSRIL  218 (353)
T ss_pred             EEEEecCCCCcc---cc----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEcccccceec
Confidence            899999986431   11    1345677888999999999999998 9999999999999999988 7999999998765


Q ss_pred             cCCC-CCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      .... ......||..|+|||.+..    ....+.++|||||||++|+|++|+.||......+....+.......      
T Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------  292 (353)
T PLN00034        219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------  292 (353)
T ss_pred             ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------
Confidence            3322 2234578999999998742    1234568999999999999999999997433222211111110000      


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                         .......++.++++||.+||..||.+|||+.++++||||.+-.
T Consensus       293 -------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        293 -------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             -------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence                               0001135789999999999999999999999999999998743

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=7.2e-44  Score=325.54  Aligned_cols=282  Identities=34%  Similarity=0.613  Sum_probs=220.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC---C
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---K  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~  104 (376)
                      ..++|++.+.||.|+||.||+|.+..+++.+|||.+....      ....+|+++++.++||||+++++++.....   .
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            3578999999999999999999999999999999885321      234579999999999999999988755432   2


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ....+++++||+.+++...+..   ....+++..++.++.|++.||+|||+ +||+|+||||+||+++.++ .++|+|||
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg  160 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFG  160 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCc
Confidence            3446789999999877655543   23579999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccCCCC------------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017131          185 SAKVLVKGEP------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  252 (376)
Q Consensus       185 ~a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  252 (376)
                      +++.......            .....+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9875432211            1233567889999998665568999999999999999999999999998888888888


Q ss_pred             HHhCCCCHHHHhhcC--cCccc-ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          253 KVLGTPTREEIKCMN--PNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ...+.+....+....  +.... ...... .......+ ..+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCC-CccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            877776665443221  11000 011111 11111111 2456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-44  Score=330.94  Aligned_cols=285  Identities=36%  Similarity=0.636  Sum_probs=226.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      .++|++.+.||+|++|.||+|++..+++.||||++....      ....+|+.+++.++|+|++++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            457999999999999999999999999999999875421      223469999999999999999887754332 2334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..++|+||++++|.+++..     ..+++..++.++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEccccccc
Confidence            5789999999888777653     569999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .....  .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+....+.++...+....
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65332  3345678889999998665568899999999999999999999999988888888888877777765544332


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .....   ...+......+...+ ..+++++.+||.+||+.||.+|||+.++++||||++...+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence            11100   011111111222222 34689999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.5e-45  Score=334.52  Aligned_cols=245  Identities=25%  Similarity=0.431  Sum_probs=196.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHH-HHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRE-LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||+||+|++..+++.||+|++.+...       ...+| ..+++.++||||+++++++..     ...+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence            479999999999999999999999999864321       11223 335677899999999988743     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+.+ ++...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99986 56555543    4568899999999999999999998 9999999999999999988 799999999875432 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------  211 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------  211 (325)
T ss_pred             CCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence            223345578999999999965 45899999999999999999999999987766655554331                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH----HHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL----EACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~----~ll~hp~f~~~~~  327 (376)
                      ...            +...+++.+.++|.+||+.||.+|+++.    ++++|+||....+
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         212 PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             CcC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            000            1145789999999999999999999875    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-43  Score=320.65  Aligned_cols=277  Identities=36%  Similarity=0.624  Sum_probs=211.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ..|++.+.||+|+||.||+|.+..+|+.||+|.+....     ....+|+.+++.++|+||+++++++..     ..+.+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCeEE
Confidence            57999999999999999999999999999999885432     134579999999999999999998743     23478


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+.+++.+.+..   ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            9999999887655532   23457888899999999999999998 9999999999999999888 89999999987543


Q ss_pred             CC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          191 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      .. .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+. .+.+.++....+.|....+.... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            22 1223345688899999986655678899999999999999999999976543 45566666667766655433221 


Q ss_pred             -cCcccccCCCccccccccccc-cCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          268 -PNYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       268 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                       +++.....+............ -..++++.+++.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             111111111111111111110 0236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.2e-44  Score=325.41  Aligned_cols=284  Identities=30%  Similarity=0.501  Sum_probs=216.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC---C
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---K  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~  104 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.++||||+++++++.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            4457999999999999999999999999999999885432      123469999999999999999998755432   1


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      .....++||||+.+++.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCC
Confidence            2345789999999888766643   23468999999999999999999998 9999999999999999888 89999999


Q ss_pred             CcccccCCCC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      ++........     .....++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+.......+....+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9875533221     12335678899999986655578999999999999999999999998887777777777666555


Q ss_pred             HHHHhhcC--cCcccccCCCcccccccccc-ccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          260 REEIKCMN--PNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       260 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      .+.+....  ..+....++..........+ ....+..+.+||.+||..||.+|||++++++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            44332211  00111122221111111111 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-44  Score=329.35  Aligned_cols=282  Identities=36%  Similarity=0.618  Sum_probs=223.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  108 (376)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++.+..      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            47999999999999999999999999999999885421      224579999999999999999998754322 12234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++|+||+..++....      ...+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||+++.
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6899999987654432      2468999999999999999999998 9999999999999999988 899999999875


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...  ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..+.......
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            422  233456788999999986655689999999999999999999999999888888888888777776665443321


Q ss_pred             Ccc---cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          269 NYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       269 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ...   ....+......+...+ +..++++.+||.+||+.||.+||++.+++.||||..+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            100   0112222222222222 3578899999999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-44  Score=331.77  Aligned_cols=246  Identities=27%  Similarity=0.493  Sum_probs=195.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..+ .||||+.+++++...     ..+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence            47999999999999999999999999987532       2234688888887 699999999988432     3488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+++ +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99975 66544432    4579999999999999999999998 9999999999999999988 799999999875322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHHHHhCCCCHHHHhh
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....      .+...+....  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            233345678999999999965 4589999999999999999999999964321      1122222110  0        


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC------HHHHhcCCcccccCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~~ll~hp~f~~~~~  327 (376)
                            ...            ++..++..+.++|++||+.||.+|++      ..++++||||+.+.+
T Consensus       219 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         219 ------PIR------------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence                  011            22457899999999999999999998      579999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-44  Score=329.55  Aligned_cols=285  Identities=35%  Similarity=0.589  Sum_probs=224.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.+..      ....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            357999999999999999999999999999999886432      234469999999999999999988754322 1223


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..|++++++++++.+++..     ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus        96 ~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~  168 (345)
T cd07877          96 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLAR  168 (345)
T ss_pred             cEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEecccccc
Confidence            4778999998888666542     468999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...  .......++..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+....+..+....+.+.........
T Consensus       169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            543  223345678899999998665568899999999999999999999999888878888888877777666554332


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .....   ...+..+...+.... ...++++++||.+||+.||.+|+++.+++.||||++...+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            21100   011111111111111 24688999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-44  Score=321.19  Aligned_cols=274  Identities=36%  Similarity=0.657  Sum_probs=217.1

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |++.+.||.|++|.||+|.+..+|+.||+|++..+.      ....+|+.+++.++|||++++++++..     ..+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence            678899999999999999999999999999886432      234579999999999999999998843     245889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      +|||+++++.+.+....  ...+++..+..++.|++.||+|||+ ++++||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999888877665422  1368999999999999999999998 9999999999999999987 899999999875432


Q ss_pred             CC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc--
Q 017131          192 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  268 (376)
Q Consensus       192 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  268 (376)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+......++.+..+.+....+.....  
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            21 122335578899999886655678999999999999999999999999888888888888877777665432211  


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ++. ..++......... ....++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       232 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYK-PTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhh-hhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            100 0111111111111 124678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.6e-44  Score=321.23  Aligned_cols=276  Identities=37%  Similarity=0.647  Sum_probs=212.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++.     .....+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeEE
Confidence            6999999999999999999999999999999875422      22457999999999999999999883     334588


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|+||+++++...+   ......+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            99999997553322   2233468999999999999999999998 9999999999999999988 79999999987653


Q ss_pred             CCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .... .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.............
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 234557888999999876566788999999999999999999999988877777777766554432211111100


Q ss_pred             --cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          270 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       270 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                        ......+............+.++..+.+|+.+||..||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence              00111111111111111124678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.9e-44  Score=328.85  Aligned_cols=277  Identities=36%  Similarity=0.581  Sum_probs=218.8

Q ss_pred             ccceE-EeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------------------cHHHHHHHHHhCCCCCeeecc
Q 017131           35 KVSYI-AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALK   95 (376)
Q Consensus        35 ~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~~~   95 (376)
                      .++|. +.+.||.|+||+||+|.+..+++.||||++.....                  ...+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34676 45779999999999999999999999998854321                  245799999999999999999


Q ss_pred             ceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC
Q 017131           96 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                      +++...     .+.+++|||+++++.+.+..    ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++
T Consensus        87 ~~~~~~-----~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         87 DVYVEG-----DFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG  156 (335)
T ss_pred             EEEecC-----CcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC
Confidence            988432     34889999999988776653    3568999999999999999999998 9999999999999999988


Q ss_pred             CCeEEEecCCcccccCC---------------CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 017131          176 HQLKLCDFGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP  240 (376)
Q Consensus       176 ~~vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~  240 (376)
                       .++|+|||.++.....               .......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        157 -ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             -CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence             7999999998755311               111223457789999998766667999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHhCCCCHHHHhhcC--cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          241 GESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +.+..+.+..+...++.+....+....  +.+..+  ........... ....+.++.++|.+||+.||.+|||+++++.
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            999888888888888877765443221  111110  00111111111 1356889999999999999999999999999


Q ss_pred             CCccccc
Q 017131          319 HPFFDEL  325 (376)
Q Consensus       319 hp~f~~~  325 (376)
                      ||||+..
T Consensus       313 ~~~~~~~  319 (335)
T PTZ00024        313 HEYFKSD  319 (335)
T ss_pred             CcccCCC
Confidence            9999864

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-44  Score=332.35  Aligned_cols=245  Identities=27%  Similarity=0.430  Sum_probs=194.7

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHH-HHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|++..+++.||+|++.+...       ...+|. .+++.++||||+++++.+..     ....|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence            479999999999999999999999999864321       122343 46788999999999988743     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC-
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  191 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  191 (376)
                      ||+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99986 5544443    24578999999999999999999998 9999999999999999988 799999999875322 


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........+|+.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+.......+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-----------------  211 (321)
T ss_pred             CCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            222334568999999999865 45899999999999999999999999887655444443321                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH----HHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~~ll~hp~f~~~~~  327 (376)
                      ...            ++...+.++.++|.+||+.||.+|+++    .++++||||..+.+
T Consensus       212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         212 PLQ------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            001            123568899999999999999999975    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.1e-44  Score=330.88  Aligned_cols=278  Identities=25%  Similarity=0.412  Sum_probs=203.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+....     ....+|+++++.++||||+++++++...     ..+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence            357999999999999999999999999999999876432     2345899999999999999999988543     348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+.+ +|.+++..    .+.+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~  153 (333)
T cd06650          79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (333)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchh
Confidence            899999975 77766653    356899999999999999999999624799999999999999888 799999999875


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH--hCCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--LGTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~  266 (376)
                      ... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......+.. .+...  .+.+........
T Consensus       154 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         154 LID-SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhh-hccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcc
Confidence            432 22234567889999999965 45899999999999999999999999865543222 11110  000000000000


Q ss_pred             -C------cCcccccCCC--------cccccccccc-ccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 -N------PNYTEFKFPQ--------IKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 -~------~~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                       .      ..+.....+.        .........+ ...++.++++||.+||++||++|||+.+++.||||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence             0      0000000000        0000000000 11357889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-43  Score=326.54  Aligned_cols=285  Identities=35%  Similarity=0.598  Sum_probs=224.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCC--CcEEEEEEeeccc------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRET--GEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+....      ....+|+.+++.+ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            489999999999999999999888  8999999875421      2335799999999 5999999988654322 2233


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++++++++++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||+++
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4779999999887766643    4578999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccCCCC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          188 VLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       188 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .......     .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..+...++.++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            5533211     22346788999999886655689999999999999999999999999988889999999999887765


Q ss_pred             HhhcCcCcc-c--ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          263 IKCMNPNYT-E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       263 ~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      +..+..... .  ..........+... ....+..+.+|+.+||+.||.+|||+.+++.||||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~  302 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPD  302 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcc
Confidence            543321100 0  01111111112111 234688999999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-43  Score=327.52  Aligned_cols=284  Identities=35%  Similarity=0.635  Sum_probs=222.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCC-Cce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  107 (376)
                      .++|++.+.||+|+||.||+|.+..++..||||.+....      ....+|+.+++.++||||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            457999999999999999999999999999999885421      2244799999999999999999988543221 123


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++||||+++++..++..     ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            4689999998887666542     568999999999999999999998 9999999999999999888 79999999987


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+......++.+..+.+..+....+.
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            5532  22344668899999998664558899999999999999999999999888777777777766665554433222


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      .....   ...+......+.. +...+++++.++|.+||+.||.+|||+.+++.||||+..+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             chhHHHHHHhccccCcchHHH-hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            11000   0111111111111 224678899999999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.5e-44  Score=330.14  Aligned_cols=285  Identities=36%  Similarity=0.696  Sum_probs=226.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.+|+|++.+.      .....+|+.+++.+ +||||+++++++..   ....
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence            45799999999999999999999999999999987432      12344799999999 99999999988743   2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..++||||+.++|...+..     ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++.
T Consensus        83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~~  155 (337)
T cd07852          83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLAR  155 (337)
T ss_pred             eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccchh
Confidence            4789999999887666543     367888999999999999999998 9999999999999999998 79999999987


Q ss_pred             cccCCC------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          188 VLVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       188 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ......      ......++..|+|||.+.+...++.++|+||+||++|+|++|++||.+....+...++....+.+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            553322      22335678899999988666668899999999999999999999999988888888888888877766


Q ss_pred             HHhhcCcCcccc---cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCC
Q 017131          262 EIKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       262 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~  330 (376)
                      .+..+.......   ........+..... +.++.++.+||.+||+.||.+|||+.++++||||+.+..+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~  306 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD  306 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence            554432211111   11111111222222 347899999999999999999999999999999999865543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=321.82  Aligned_cols=254  Identities=28%  Similarity=0.452  Sum_probs=214.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-------HHHHHHHHHhC-CCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQML-DHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...|..+..||+|+||.|.+|..+.|.+.||||+++++...       ...|.++|... +-|.+++++.+|.+.+.   
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR---  424 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR---  424 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh---
Confidence            34789999999999999999999999999999998765422       22477777766 56788899999855444   


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                        +|+||||+.| +|-..++    .-++|-+..+.+++.+|+.||=+||+ +||++||||.+||++|.+| .+||+|||+
T Consensus       425 --LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eG-HiKi~DFGm  496 (683)
T KOG0696|consen  425 --LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM  496 (683)
T ss_pred             --eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCC-ceEeeeccc
Confidence              8899999986 4433333    24679999999999999999999998 9999999999999999999 599999999


Q ss_pred             cccccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          186 AKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       186 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ++.... +....+.+|||.|+|||++. ..+|+.++|+||+||+||||+.|++||.|.+..+.++.|...          
T Consensus       497 cKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----------  565 (683)
T KOG0696|consen  497 CKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----------  565 (683)
T ss_pred             ccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------
Confidence            976443 44556789999999999995 456999999999999999999999999999999999888763          


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCcccccCCCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDPN  329 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~~ll~hp~f~~~~~~~  329 (376)
                             ..++            +..+|.++.++++.+|.+.|.+|+..     .++-.||||+.+.|..
T Consensus       566 -------nvsy------------PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  566 -------NVSY------------PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             -------cCcC------------cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence                   2233            35789999999999999999999874     5889999999988644

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.7e-44  Score=320.81  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=206.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+.+.+.+..     ...+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEE
Confidence            4888999999999999999999999999999885431       224579999999999999999888743     2348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++|||+.+ ++...+...  ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCccee
Confidence            899999986 555444321  23469999999999999999999998 9999999999999999888 799999999876


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........++..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.........+........         
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------  221 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence            5444333455789999999999654 589999999999999999999999987665444444333211100         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                                      ..+...++.++.+|+.+||+.||.+||+     +.+++.||||+....
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence                            0112457889999999999999999999     889999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.8e-44  Score=321.40  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=203.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHH-HHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|+||.||+|.+..+|+.||||.+.....     ....|+.. ++.++||||+++++++....     .+|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cEE
Confidence            69999999999999999999999999999998864321     22235554 66679999999999885432     388


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+++++.+++.........+++..++.++.|++.||+|||+ + +++||||||+||+++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~  154 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL  154 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence            999999999888887655455679999999999999999999998 7 999999999999999988 8999999998765


Q ss_pred             cCCCCCceeeeeccccchhhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCCHHHHhh
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ..........++..|+|||.+.+.   ..++.++|+||+||++|+|++|..||.... ..+.+..+....  .       
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------  225 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S-------  225 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C-------
Confidence            433333334678889999988542   346889999999999999999999996532 223333322210  0       


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                             ..++           ...+|.++.++|.+||..||.+||++.++++||||....
T Consensus       226 -------~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 -------PQLP-----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -------CCCC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                   0000           124689999999999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.2e-43  Score=322.72  Aligned_cols=283  Identities=36%  Similarity=0.717  Sum_probs=224.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||.|+||.||+|.+..+++.||+|++.+.      .....+|+.+++.++||||+++++++....    .
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~   83 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----E   83 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----C
Confidence            345799999999999999999999999999999987532      123457999999999999999999874322    2


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..++++||+++++..++.     ...+++..+..++.|++.||+|||+ +||+||||+|+||+++.++ .++|+|||.+.
T Consensus        84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCcccccc
Confidence            377999999888766654     2468889999999999999999998 9999999999999999888 79999999987


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  ......++..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+.......+.+.++.++.+.+....
T Consensus       157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            5422  22345668889999988665568999999999999999999999999988877777788888887766554321


Q ss_pred             cCc-ccc--cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCC
Q 017131          268 PNY-TEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       268 ~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~  330 (376)
                      ..- ..+  ..+.....+....+ ..++..+.++|++||+.||++|||+.+++.||||...+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~  299 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD  299 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence            110 000  11111111222222 357899999999999999999999999999999998876643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=324.89  Aligned_cols=259  Identities=29%  Similarity=0.505  Sum_probs=209.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|++|+||+|.+..+++.||+|.+....       ....+|+++++.++|+||+++++.+..     ..+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCEE
Confidence            6999999999999999999999999999999886532       224569999999999999999988733     3458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++|||+.+ +|.+++..  .....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999975 77666543  123578999999999999999999998 9999999999999999988 799999999865


Q ss_pred             ccCCCC------------------------------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 017131          189 LVKGEP------------------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  238 (376)
Q Consensus       189 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  238 (376)
                      ......                              .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            422211                              1123567889999999654 479999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC----HH
Q 017131          239 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT----AL  314 (376)
Q Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~~  314 (376)
                      |.+.+....+..+...                 ...++.          ...++.+++++|.+||+.||.+|||    ++
T Consensus       232 f~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            9887766655544321                 011110          0126899999999999999999999    99


Q ss_pred             HHhcCCcccccCCCCCCC
Q 017131          315 EACVHPFFDELRDPNTRL  332 (376)
Q Consensus       315 ~ll~hp~f~~~~~~~~~~  332 (376)
                      ++++||||++.+++...+
T Consensus       285 ~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         285 EIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHHcCchhhcCChhhccc
Confidence            999999999987665443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-45  Score=334.70  Aligned_cols=259  Identities=28%  Similarity=0.422  Sum_probs=220.1

Q ss_pred             CCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           30 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ...+..+.|.+.+.||+|.|+.|.+|++..||..||||.+.+..      ....+|+++|+.++|||||+++.+..+...
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            34455668999999999999999999999999999999986542      224589999999999999999999865554


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                           +|+||||+.+ .+.+++..    +++..+..++.++.|++.|++|||+ ++|+|||||.+|||++.+. ++||+|
T Consensus       130 -----lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaD  198 (596)
T KOG0586|consen  130 -----LYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIAD  198 (596)
T ss_pred             -----eEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeec
Confidence                 9999999985 55555554    5677889999999999999999998 9999999999999999998 799999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ||++.....+....+.+|++.|.|||++.+..+.++++|+||+|+++|.|++|..||.|.+-.+.-...+.         
T Consensus       199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------  269 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------  269 (596)
T ss_pred             cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee---------
Confidence            99999888888888999999999999998888789999999999999999999999998763322222111         


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                              ..+.+|            --++.++.++|+++|..+|.+|++.++++.|.|.......
T Consensus       270 --------gk~rIp------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 --------GKYRIP------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             --------eeeccc------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                    112222            2478999999999999999999999999999999876544

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=318.66  Aligned_cols=276  Identities=40%  Similarity=0.700  Sum_probs=218.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||+++++++...     ...+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEEE
Confidence            699999999999999999999999999999987532      12345799999999999999999998542     3488


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ++|||+++++...+.   .....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++....
T Consensus        77 iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            999999987654433   234568999999999999999999998 9999999999999999988 79999999987654


Q ss_pred             CCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC-
Q 017131          191 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  267 (376)
Q Consensus       191 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  267 (376)
                      ...  ......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+.+..+....+........... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            433  23345678889999999766468999999999999999999999999888877777777776665554332221 


Q ss_pred             -cCcccccCCCcc-ccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          268 -PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       268 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                       ..+....++... ...+...++..++.++++||++||..||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             111111111111 1112222334468999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=339.39  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=214.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-cccH---HHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYK---NRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~---~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+-|.|+..||.|+||.||+|..+.++-..|.|+|.-. ...+   .-|+++|..++||+||++++.|+..+.     +
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----L  104 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----L  104 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----e
Confidence            345789999999999999999999999988999988432 2222   249999999999999999999876554     8


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++.|||+|+.-+.+-.  ..+..+++.++..+++|+|.||.|||+ ++|||||||..|||++-+| .|+|+|||.+...
T Consensus       105 wiliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn  180 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKN  180 (1187)
T ss_pred             EEEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccc
Confidence            89999999865544432  346789999999999999999999998 9999999999999999999 7999999986433


Q ss_pred             -cCCCCCceeeeeccccchhhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          190 -VKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 -~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                       .......+++|||+|||||+..    ...+|++++||||||++|.||..+.+|....++...+.+|.+.  .|+.    
T Consensus       181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPT----  254 (1187)
T KOG0579|consen  181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT----  254 (1187)
T ss_pred             hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCc----
Confidence             2233456789999999999973    3456999999999999999999999999999888888777662  1110    


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                          -.-+.+.+..+.|||++||.+||..||++.++|+||||++.
T Consensus       255 --------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  255 --------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             --------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                                01124678899999999999999999999999999999865

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=300.62  Aligned_cols=258  Identities=25%  Similarity=0.338  Sum_probs=205.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .++|++.+.||+|+|+.||+++...++..||+|++.-..    ....+|++..++++|||+++++++......+.....|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            358999999999999999999999999999999986433    4456899999999999999999988766666677789


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ++++|.. |++.+.+......+..+++.++..|+.++++||++||+ ..  ++||||||.|||+.+.+ .++|.|||.++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCcc
Confidence            9999987 67999999888877789999999999999999999998 88  99999999999999877 89999999986


Q ss_pred             cccCCCC----------CceeeeeccccchhhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017131          188 VLVKGEP----------NVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  255 (376)
Q Consensus       188 ~~~~~~~----------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  255 (376)
                      ...-.-.          ...-.+|..|+|||++.-.  ...+.++|||||||++|+|+.|..||...-         ...
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~G  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQG  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcC
Confidence            5421110          1233568889999998422  236889999999999999999999995311         100


Q ss_pred             CCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      +....   ...+   ..+++|..          ..+|..+.+||+.||+.||.+||++.+++.+
T Consensus       249 gSlaL---Av~n---~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GSLAL---AVQN---AQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CeEEE---eeec---cccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            00000   0000   11233322          3479999999999999999999999999853

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=319.46  Aligned_cols=274  Identities=40%  Similarity=0.731  Sum_probs=221.3

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|+||+++++++...     ...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence            678899999999999999999999999999885432      2345799999999999999999987543     34889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      ++||+++++.+.+...   ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999998887666542   3578999999999999999999998 9999999999999999888 799999999876544


Q ss_pred             CC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc--
Q 017131          192 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  268 (376)
Q Consensus       192 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  268 (376)
                      .. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+..+....+...++.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 223345678899999997654689999999999999999999999999998888888888888777665544322  


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ......++.......... .+.++.++.+||.+||..||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKL-FPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHHHh-hhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            111222332222222221 24578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=315.90  Aligned_cols=248  Identities=28%  Similarity=0.449  Sum_probs=201.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|.+.+.||+|++|.||.|.+..+++.||+|.+....         ....+|+.+++.++||||+++++++...     
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence            36999999999999999999999999999999875321         2345799999999999999999988432     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+++++||+++ ++.+.+..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~  150 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGA  150 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccc
Confidence            358899999975 66555543    3568999999999999999999998 9999999999999999888 799999999


Q ss_pred             cccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          186 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       186 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ++........    ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......++.....     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----  224 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-----  224 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC-----
Confidence            8754322111    234567889999999664 489999999999999999999999987655544433322100     


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                            ...++..++.++.++|++||..||.+|||+.++++||||
T Consensus       225 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ----------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ----------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                  011224578999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=334.72  Aligned_cols=251  Identities=28%  Similarity=0.446  Sum_probs=217.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..|.-++.||+|+||.||.|++..|.+.||||++.-..       ..+.+|++.|++++|||++.+.+||....+     
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----
Confidence            46888999999999999999999999999999985322       123479999999999999999999965444     


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .+||||||-|+..+++.-+.   +++.+.++..|..+.+.||+|||+ .+.||||||..|||++..| .|||+|||.|..
T Consensus       101 aWLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi  175 (948)
T KOG0577|consen  101 AWLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASI  175 (948)
T ss_pred             HHHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhh
Confidence            78999999999988888753   679999999999999999999998 9999999999999999998 899999999976


Q ss_pred             ccCCCCCceeeeeccccchhhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .   .+..+++|||+|||||+++  ..+.|+-++||||||++..||.-.+||+...+....++-|.+. ..|+       
T Consensus       176 ~---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPt-------  244 (948)
T KOG0577|consen  176 M---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT-------  244 (948)
T ss_pred             c---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCC-------
Confidence            5   4566889999999999995  3457999999999999999999999999999999888888762 1111       


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                 ..        ....|..++.|+..||++-|.+|||++++|.|+|+..-+
T Consensus       245 -----------Lq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  245 -----------LQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             -----------CC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                       11        134688999999999999999999999999999997543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.6e-43  Score=318.09  Aligned_cols=261  Identities=24%  Similarity=0.368  Sum_probs=208.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|.+....   ....+|+.+++.+ +|||++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            467999999999999999999999999999999885432   3345789999988 899999999988654433344578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ +|.+++.........+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999975 7777776544445679999999999999999999998 9999999999999999888 7999999998765


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      .... ......++..|+|||.+....    .++.++|+||+||++|+|++|++||...+....+..+.+.  .+.     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~-----  251 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--PPP-----  251 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--CCC-----
Confidence            3322 122345688899999985432    2688999999999999999999999876654444433221  000     


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                             ..            ..+...+..+.+||.+||+.||.+||++.++++||||+
T Consensus       252 -------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 -------TL------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -------CC------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                   00            01124677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=332.09  Aligned_cols=249  Identities=31%  Similarity=0.531  Sum_probs=210.2

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      .+.||+|.||+||-|++++||+.||||+|.+-      ......|+.+|+.+.||.||.+...|.+.+.     +++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er-----vFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER-----VFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-----EEEEeh
Confidence            46899999999999999999999999998542      3455679999999999999999777744333     889999


Q ss_pred             cccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCeEEEecCCcccccCC
Q 017131          115 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       115 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg~a~~~~~~  192 (376)
                      -+.|++...+...  ..+++++...++++.||+.||+|||. ++|+|+||||+|||+.+..  .++||||||+|+++...
T Consensus       644 Kl~GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KLHGDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhcchHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            9999887776543  35789999999999999999999998 9999999999999997653  27999999999999888


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ....+.+|||.|+|||++.+. .|...-|+||+|+|+|--+.|..||....+.  -.+|.+.                 .
T Consensus       721 sFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNA-----------------a  780 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNA-----------------A  780 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccch--hHHhhcc-----------------c
Confidence            888899999999999999764 5999999999999999999999999654332  2222221                 2


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      +.+   +..+|     ..++++++|||..+|+..-++|.|.+..|.|||+++.
T Consensus       781 FMy---Pp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  781 FMY---PPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ccc---CCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            222   33455     3479999999999999999999999999999999875

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-43  Score=316.85  Aligned_cols=275  Identities=39%  Similarity=0.692  Sum_probs=221.2

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |.+.+.||+|++|+||+|.+..+++.||||.+.....     ...+|+..++.++ |+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            7889999999999999999999999999998754322     2346899999998 9999999998854     234789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      ||||+++++.+.+....  ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888877665422  2468999999999999999999998 9999999999999999988 799999999976654


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC--
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--  269 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--  269 (376)
                      ........++..|+|||.+.+...++.++|+||||+++++|++|++||.+.+..+...++...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            444445567889999998866666899999999999999999999999999988999999888888776544322110  


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      .....++..........+ ...+.++.+||++||+.||.+|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            111122222222222222 2347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=342.00  Aligned_cols=248  Identities=25%  Similarity=0.446  Sum_probs=200.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCC-CCCeeeccc-eeeecCCCC-ceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKH-CFFSTTDKE-ELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~-~~~~~~~~~-~~~  108 (376)
                      -+++|.+.|.+|||+.||+|++...|..||+|++....    ....+|+.+|+.|+ |+|||.+++ ......... ..-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            47999999999999999999999988999999875432    23458999999996 999999999 433333333 345


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          109 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      +.|+||||. |+|.+++..+..  .+|++.++..|++|+|+|+.+||. ..  |||||||-|||||..++ ..||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence            778999999 699888887554  459999999999999999999997 77  99999999999999998 799999999


Q ss_pred             cccccCCCCC----------ceeeeeccccchhhh--cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017131          186 AKVLVKGEPN----------VSYICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       186 a~~~~~~~~~----------~~~~~t~~y~aPE~~--~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  253 (376)
                      |.........          .....|+.|+|||++  .+....++++|||+|||+||-|+....||.+.....    |++
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Iln  268 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----ILN  268 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EEe
Confidence            8654333211          123568999999998  234458999999999999999999999997653221    111


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                       ..|.+|..          ++++..+++||+.||+.||.+||++.+++.
T Consensus       269 -----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  269 -----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             -----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                             13445542          468999999999999999999999988875

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.9e-43  Score=316.95  Aligned_cols=261  Identities=24%  Similarity=0.351  Sum_probs=207.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ...+|++.+.||+|+||.||+|.+..+++.+|+|++....   ....+|+.+++.+ +||||+++++++.........++
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            3457999999999999999999999999999999875422   3345799999998 79999999998765444445568


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++ +|.+++.........+++..++.++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||+++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCceee
Confidence            899999975 7777776554445678999999999999999999998 9999999999999999988 799999999876


Q ss_pred             ccCCC-CCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          189 LVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       189 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ..... ......+++.|+|||.+..    ...++.++|+||+||++|+|++|..||...+....+.++...  .+     
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~-----  246 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP-----  246 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC-----
Confidence            53322 2234467889999998842    234788999999999999999999999876543333222110  00     


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                  +       ....+..++.++.+||.+||+.||.+|||+.++++||||
T Consensus       247 ------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 ------------P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ------------C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                        0       000112357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=316.37  Aligned_cols=256  Identities=29%  Similarity=0.461  Sum_probs=214.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ....-|.++++||+|+||.||+|.++.+|..+|||.+..+.  +.+-+|+.+|++++.|++|++|+.|+...+     ++
T Consensus        30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LW  104 (502)
T KOG0574|consen   30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LW  104 (502)
T ss_pred             ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eE
Confidence            33457999999999999999999999999999999986544  455689999999999999999999977666     89


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|||||+ |+..++++..   ++.+++.++..++..-+.||+|||. ..-+|||||..|||++.+| ..||+|||.|...
T Consensus       105 IVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQL  179 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQL  179 (502)
T ss_pred             eehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchh
Confidence            9999998 6888887763   4689999999999999999999998 8999999999999999999 6999999998655


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ... ....+.+|||.|||||++..- .|+..+||||||++..||..|++||.+-.+...+                    
T Consensus       180 TDTMAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------------  238 (502)
T KOG0574|consen  180 TDTMAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------------  238 (502)
T ss_pred             hhhHHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCccccccccee--------------------
Confidence            332 234577899999999999654 4999999999999999999999999876543322                    


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                          +.+|..++..+..  +...|.++.||+++||.++|++|-|+.++++|||+++.
T Consensus       239 ----FMIPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  239 ----FMIPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ----EeccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence                2233333322222  12468899999999999999999999999999999864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4e-43  Score=317.63  Aligned_cols=248  Identities=30%  Similarity=0.500  Sum_probs=206.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+....       ....+|+++++.++||||+++++++..     ....
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCeE
Confidence            6999999999999999999999999999999886422       234579999999999999999998843     2348


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||++ ++|.+.+..    ...+++..+..++.|++.||+|||+ +|++|+||+|.||+++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 577666654    3679999999999999999999998 9999999999999999988 799999999876


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ....  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+...              
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------  213 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--------------  213 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence            5433  3344678899999998654 5789999999999999999999999877644444443321              


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                         ...            ++..++..++++|.+||..||.+|+     +++++++||||+.+.+
T Consensus       214 ---~~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         214 ---KVR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             ---Ccc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence               001            1235689999999999999999999     8999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-43  Score=315.81  Aligned_cols=256  Identities=24%  Similarity=0.384  Sum_probs=202.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhC-CCCCeeeccceeeecCCCC-ceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE-ELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~-~~~~~  110 (376)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+|+.+++.+ +|+||+++++++......+ ...++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            46999999999999999999999999999999986432   3345799999988 7999999999886543321 34578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+.+ ++.+++...  ....+++..++.++.|++.||+|||+ ++|+|+||||+||+++.++ .++|+|||++...
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~  161 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceec
Confidence            99999985 776666542  23468999999999999999999998 9999999999999999988 7999999998754


Q ss_pred             cCC-CCCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ... .......++..|+|||++.+    ...++.++|+||+||++|+|++|..||...........+...   +      
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~------  232 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------  232 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C------
Confidence            322 22234567889999999853    234788999999999999999999999765543333222110   0      


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                        ........++.++.+||.+||..||.+|||+.+++.||||
T Consensus       233 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 ------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                              0001113468899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=301.75  Aligned_cols=259  Identities=25%  Similarity=0.425  Sum_probs=211.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----HHHHHHHHHh-CCCCCeeeccceeeecCCCCc
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----KNRELQIMQM-LDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      -..+..+.+..||+|+.|+|++++.+.+|..+|||.+.+....     +...+.++.. ..+|+||+.+++|....+   
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d---  165 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD---  165 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch---
Confidence            3445677888999999999999999999999999998654321     1223333332 358999999999987665   


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                        +.+.||.|..-++.++..   ..++++|..+-.+...++.||.||...+||+|||+||+|||+|..| ++||||||.+
T Consensus       166 --V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIs  239 (391)
T KOG0983|consen  166 --VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGIS  239 (391)
T ss_pred             --HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccccc
Confidence              778899987655555543   4567999999999999999999999878999999999999999998 8999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCCHHHH
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ....++...+...|.+.|||||.+..  ...|+..+||||||+.++||+||..||.+.+ +.+.+.++.+.  .|+.   
T Consensus       240 GrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~---  314 (391)
T KOG0983|consen  240 GRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL---  314 (391)
T ss_pred             ceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC---
Confidence            98888888888889999999999942  3458999999999999999999999999854 45666666652  2211   


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                 ++.          ...+|+++++|+..||.+|+.+||...++|+|||+...+
T Consensus       315 -----------L~~----------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  315 -----------LPG----------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             -----------CCc----------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                       110          134899999999999999999999999999999998764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-43  Score=317.40  Aligned_cols=277  Identities=34%  Similarity=0.610  Sum_probs=217.5

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |.+.+.||+|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|+|++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            788999999999999999999999999999987542      22457999999999999999999874431   245889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |+||+++++..++...   ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998876666432   2478999999999999999999998 9999999999999999988 899999999876544


Q ss_pred             CC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          192 GE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       192 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ..  ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+....+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            32  1233455788999998866556899999999999999999999999998888888888887777765544322110


Q ss_pred             --cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          270 --YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       270 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                        .................+...+++.+.++|++||..||.+||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00011111111111122222248999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.1e-43  Score=317.40  Aligned_cols=282  Identities=31%  Similarity=0.520  Sum_probs=219.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-----
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-----  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----  103 (376)
                      ..+|++.+.||.|++|.||+|.++.+|+.||+|.+....      ....+|+.+++.++||||+++++++.+..+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            457999999999999999999999999999999885432      223479999999999999999988755431     


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          104 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      ....++++++||+++++...+..   ....+++..++.++.|++.||+|||+ .||+|+||||+||+++.++ .+||+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCcc
Confidence            12236889999999877665543   23468999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          184 GSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       184 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      |++........  .....++..|+|||.+.+...++.++|+||+||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99876543321  1223457789999988665567899999999999999999999999888888888888877777655


Q ss_pred             HHhhcCc--CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          262 EIKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       262 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      .+.....  .+............+...+ ..++..+.++|.+||..||.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            4432211  0000000000001111111 3478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-43  Score=313.97  Aligned_cols=274  Identities=40%  Similarity=0.707  Sum_probs=224.4

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |++.+.||+|++|.||+|.+..+++.||+|.+....      ....+|+.+++.++|+|++++++++...     .+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            678899999999999999999999999999886532      2334699999999999999999988443     34889


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |+||+++++.+.+....   ..+++..++.++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||.++....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999998877776522   469999999999999999999998 9999999999999999988 799999999876533


Q ss_pred             CC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC-
Q 017131          192 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  269 (376)
Q Consensus       192 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  269 (376)
                      .. .......+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+..+... 
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            22 2223345778999999876656899999999999999999999999999988888899988888888766544222 


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      +....++..........+ +.++..+.++|++||..||++||++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            122333444333333333 3458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-43  Score=316.77  Aligned_cols=257  Identities=28%  Similarity=0.430  Sum_probs=203.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +.|++++.||.|+||.||+|++..+++.+|+|.+....    ....+|+.+++.++|+||+++++.+...     ..+++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEE
Confidence            57999999999999999999999999999999986443    2234699999999999999999988543     34889


Q ss_pred             EEeccccc-HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||++++ +..++..   ....+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            99999874 4333322   23568999999999999999999998 9999999999999999887 79999999986543


Q ss_pred             CC-CCCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .. .......+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||...+......++...  .++      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~------  233 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP------  233 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc------
Confidence            22 12234567889999998842    334688999999999999999999999876654433333211  000      


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                            .            ...+..++.++.++|.+||..||++||++.++++||||..+...
T Consensus       234 ------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 ------T------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ------c------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                  0            00113568899999999999999999999999999999887643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-43  Score=326.41  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=192.5

Q ss_pred             cceEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (376)
                      ++|++.+.||+|+||.||+|.+     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---   83 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP---   83 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC---
Confidence            5799999999999999999985     2445789999886432     2345799999999 899999999877432   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  129 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  129 (376)
                       ...++++|||+++ +|.+++.....                                                      
T Consensus        84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence             2237899999984 77777754211                                                      


Q ss_pred             ----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC---Cceeeeec
Q 017131          130 ----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSR  202 (376)
Q Consensus       130 ----~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~  202 (376)
                          ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.......   .....+++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCc
Confidence                02347888899999999999999998 9999999999999999888 799999999976532221   11223467


Q ss_pred             cccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcccc
Q 017131          203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH  281 (376)
Q Consensus       203 ~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      .|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+........               ..        
T Consensus       241 ~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---------------~~--------  296 (338)
T cd05102         241 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT---------------RM--------  296 (338)
T ss_pred             cccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC---------------CC--------
Confidence            8999999865 458999999999999999997 9999988654443333322100               00        


Q ss_pred             ccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          282 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       282 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                          ..+..+++++.+|+.+||..||.+|||+.++++
T Consensus       297 ----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         297 ----RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                011357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=313.60  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=208.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhC-CCCCeeeccceeeecCC-CCceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~  108 (376)
                      ..++|++.+.||.|++|.||+|.+..+++.+++|++....   ....+|+.+++.+ +|+||+++++++..... ....+
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4568999999999999999999999999999999886543   3456799999998 79999999999866543 33556


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +++||||+++ ++.+++.........+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~  161 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVSA  161 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCccce
Confidence            8899999986 7766666544345679999999999999999999998 9999999999999999888 79999999987


Q ss_pred             cccCCC-CCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          188 VLVKGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       188 ~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ...... ......++..|+|||.+..    ...++.++|+|||||++|+|++|.+||...+......++....   .   
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~---  235 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---P---  235 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---C---
Confidence            543322 2234567889999998843    2346789999999999999999999998765554444433210   0   


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                   +..       .....++.++++||.+||..||++|||+.++++|||+
T Consensus       236 -------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 -------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                         000       0012367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=329.47  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=223.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ...+++..||-|+||.|=++........+|+|++++.+       .....|.++|.....|.||++|..|     .++.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            46788889999999999999987665568999876532       2234699999999999999999988     66777


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|++||-|- |.++.+++.    .+.|.+...++++..++.|++|||+ +|||+|||||+|++++.+| .+||.|||+|+
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAK  568 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAK  568 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHH
Confidence            999999886 577777764    5789999999999999999999998 9999999999999999999 79999999999


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....+....+.+|||.|.|||++++.+ .+.++|.||||+++|||++|.+||.+.++...+..|++.+.           
T Consensus       569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----------  636 (732)
T KOG0614|consen  569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----------  636 (732)
T ss_pred             HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----------
Confidence            999999999999999999999998755 89999999999999999999999999999999999988542           


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCCC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  328 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~~  328 (376)
                          .+.            ++..++..+.+||+++...+|.+|+.     +.++.+|.||.+++|.
T Consensus       637 ----~i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  637 ----KIE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             ----hhh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence                122            23578999999999999999999997     7899999999998754

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.4e-43  Score=322.69  Aligned_cols=276  Identities=21%  Similarity=0.353  Sum_probs=198.5

Q ss_pred             Eeeeeeec--CceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           40 AEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        40 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++++||+|  +|++||++.++.+|+.||+|++....      ....+|+.+++.++||||+++++++...     ...++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            56789999  67899999999999999999986432      2455799999999999999999988543     24789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ ++.+++....  ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999985 6766665422  2458999999999999999999998 9999999999999999888 79999998654322


Q ss_pred             CCCC--------CceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC---
Q 017131          191 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP---  258 (376)
Q Consensus       191 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---  258 (376)
                      ....        .....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||............... ..+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~  231 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLL  231 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccc
Confidence            1111        1122456779999998653 35899999999999999999999999875544333322211 000   


Q ss_pred             -----CHHHHhhcC------cCcccc-c----CCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          259 -----TREEIKCMN------PNYTEF-K----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       259 -----~~~~~~~~~------~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                           +.+.+....      ...... .    .+.... .........+++++.+||++||+.||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGE-SSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccC-CcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                 001000000      000000 0    000000 00011223467899999999999999999999999999999


Q ss_pred             cccC
Q 017131          323 DELR  326 (376)
Q Consensus       323 ~~~~  326 (376)
                      +.+.
T Consensus       311 ~~~~  314 (327)
T cd08227         311 KQIK  314 (327)
T ss_pred             hhcc
Confidence            8764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-43  Score=316.56  Aligned_cols=251  Identities=26%  Similarity=0.444  Sum_probs=197.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..+.     ....+|+.++++++||||+++++.+....     ..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEEE
Confidence            5889999999999999999999999999999886432     23447999999999999999999885432     3779


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      ||||+++......       ..+++..+..++.|++.||+|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997443221       357888999999999999999998 9999999999999999998 799999999875533


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~  268 (376)
                      . ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.........   ...........         
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  216 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------  216 (279)
T ss_pred             c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence            2 23345778899999998654 4899999999999999999999999653321110   11111100000         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            .+        .......++++.+||.+||+.||.+||++.++++||||+...
T Consensus       217 ------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         217 ------PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             ------CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence                  00        000124688999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-44  Score=322.59  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=197.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (376)
                      -.+..|+++++||+||.+.||++..... ..||+|++....      .....|+..|.+| .|.+|++++++-.     .
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~  431 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----T  431 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----c
Confidence            3456899999999999999999997544 557777664221      2344799999999 5899999998763     3


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      +.++|+||||-+.+|..++....   ...+.-++++|..||+.|+.++|+ .||||.||||.|+|+-. | .+||+|||.
T Consensus       432 d~~lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlVk-G-~LKLIDFGI  505 (677)
T KOG0596|consen  432 DGYLYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLVK-G-RLKLIDFGI  505 (677)
T ss_pred             CceEEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEEe-e-eEEeeeech
Confidence            66799999999999988887643   234445899999999999999998 99999999999999984 5 799999999


Q ss_pred             cccccCCCC---CceeeeeccccchhhhcCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017131          186 AKVLVKGEP---NVSYICSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  252 (376)
Q Consensus       186 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  252 (376)
                      |..+.....   ..+.+||+.||+||.+....          ..++++||||||||||+|+.|++||..-.  ....++ 
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl-  582 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKL-  582 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHH-
Confidence            987755443   24678999999999984211          15789999999999999999999996422  122222 


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ..+..|.           .++.+|+..           -..+++++++.||.+||.+|||..++|+|||++-..
T Consensus       583 ~aI~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  583 HAITDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             HhhcCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            2222221           122333321           123499999999999999999999999999998643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=324.93  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=202.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc---cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ....+++++.||+|.||.||.|....+ ..||+|.++..   .....+|+.+|+.|+|+|||++++++....     -+|
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piy  277 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIY  277 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceE
Confidence            334677889999999999999998743 46999988653   244558999999999999999999984433     388


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |||||+. |+|.++++.  ..+..+.......++.|||.|++||.+ +++|||||...|||++.+. .+||+|||+|+..
T Consensus       278 IVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLI  353 (468)
T ss_pred             EEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEccccccccc
Confidence            9999998 688888876  345679999999999999999999998 9999999999999999988 8999999999954


Q ss_pred             cCCCCCceeee---eccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          190 VKGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       190 ~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .++. .....+   ...|.|||.+. ...++.+|||||||++||||+| |+.||.+.+..+.+..+.+..          
T Consensus       354 ~d~~-Y~~~~~~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy----------  421 (468)
T KOG0197|consen  354 GDDE-YTASEGGKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY----------  421 (468)
T ss_pred             CCCc-eeecCCCCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC----------
Confidence            3322 222222   45599999995 4559999999999999999999 999999999888888877643          


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                              ++|.          +..+|+++.+++..||..+|++|||.+.+.
T Consensus       422 --------Rlp~----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  422 --------RLPR----------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             --------cCCC----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                    3332          257999999999999999999999998664

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=312.12  Aligned_cols=278  Identities=34%  Similarity=0.598  Sum_probs=216.8

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhC---CCCCeeeccceeeecCCCCceE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      |++.+.||+|++|.||+|.+..+++.||+|.+....      ....+|+.+++.+   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            788999999999999999999899999999886321      1233577777666   6999999999987655445556


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++++|||+.+++.+.+....  ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999988776665421  2358999999999999999999998 9999999999999999997 899999999877


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........++..|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+..+.+.++....+.+....+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence            6544444445578889999999654 48899999999999999999999999988888888887766655443322110 


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      ......++........... +.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFV-PEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhh-hhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            0000111111222222211 3567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.7e-42  Score=306.47  Aligned_cols=249  Identities=28%  Similarity=0.437  Sum_probs=201.0

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|++.+.||.|++|.||++.+..+++.||+|.+..+.      ....+|+.+++.++|+|++++++.+.    ..+..++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4999999999999999999999999999999985432      23456999999999999999987662    2234578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+++ ++.+.+...  ....+++.+++.++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999975 676666532  23468999999999999999999998 9999999999999999888 7999999998765


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+.......+....             
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-------------  218 (257)
T ss_pred             cccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            3322 2233457888999999865 458899999999999999999999998766544443333210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                            .+         ..+..+++++.+|+.+||+.||.+|||+.++++||||
T Consensus       219 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 ------LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00         0113578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-43  Score=313.59  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=204.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++++...     .+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence            36999999999999999999999999999999886432     2345799999999999999999987433     4588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|+||+.+ ++.+.+..     ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++ .++|+|||+++..
T Consensus        76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~  148 (274)
T cd06609          76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQL  148 (274)
T ss_pred             EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceee
Confidence            99999986 66655543     378999999999999999999998 9999999999999999988 8999999999766


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ... .......+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||...+.......+....             
T Consensus       149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------  214 (274)
T cd06609         149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------  214 (274)
T ss_pred             cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------
Confidence            443 2233456788899999996544 8999999999999999999999998766444333322210             


Q ss_pred             CcccccCCCccccccccccccC-CChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            .+         .+... ++.++.+++.+||..||.+|||+.++++||||++..
T Consensus       215 ------~~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         215 ------PP---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             ------CC---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                  00         01112 688999999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-43  Score=314.97  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=203.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++.+..     ..++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence            6899999999999999999999999999999886431     234479999999999999999998743     345889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ ++..++... .....+++..+..++.|++.||.|||+..||+|+||||+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999986 665555431 11347899999999999999999999625999999999999999987 79999999987543


Q ss_pred             CCCCCceeeeeccccchhhhcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KGEPNVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .. ......+++.|+|||.+.+..     .++.++|+||+||++|+|++|+.||...........+......+.      
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  227 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------  227 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------
Confidence            22 223345678899999985432     358899999999999999999999976554333332222111000      


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                                         ..++..++.++.+||.+||..||.+||++.++++||||......
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 -------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             -------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                               01123578999999999999999999999999999999876533

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.3e-42  Score=313.55  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=203.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ...+|++.+.||.|++|.||+|.+..+++.||+|.+....    ....+|+.+++.++|+|++++++.+...     ...
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~   92 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DEL   92 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEE
Confidence            3458999999999999999999999999999999886432    2345799999999999999999988542     248


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+.+ +|.+++..     ..+++.++..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~  165 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  165 (296)
T ss_pred             EEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchh
Confidence            899999975 67665542     458899999999999999999998 9999999999999999888 899999999875


Q ss_pred             ccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+... +.+.        
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--------  235 (296)
T cd06654         166 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE--------  235 (296)
T ss_pred             ccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC--------
Confidence            432221 223467889999999865 44789999999999999999999999877654433322210 0000        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                       ...+..++..+.++|.+||..||.+|||+.++++||||...
T Consensus       236 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         236 -----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             -----------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                             00113578899999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.6e-43  Score=316.15  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ....+|++.+.||.|++|.||+|.+..+++.||+|.+....    ....+|+.+++.++|+||+++++++..     ..+
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   90 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE   90 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCE
Confidence            34468999999999999999999999999999999886432    234578999999999999999998843     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||||+++ ++.+++..     ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++.
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~  163 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCA  163 (297)
T ss_pred             EEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccce
Confidence            8899999975 66655532     468899999999999999999998 9999999999999999888 89999999987


Q ss_pred             cccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+.. .+.+.       
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~-------  234 (297)
T cd06656         164 QITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE-------  234 (297)
T ss_pred             EccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC-------
Confidence            5433221 223467888999999865 4588999999999999999999999987654333222111 00000       


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                        ...+..++..+.+|+.+||..||.+||++.++++||||+..+
T Consensus       235 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         235 ------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                              001135788999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=313.19  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=204.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+....    ....+|+.+++.++||||+++++.+..     ....++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEEE
Confidence            46999999999999999999999899999999886432    234479999999999999999998843     234889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ ++.+++..   ....+++..++.++.|++.||.|||+ +||+|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence            9999986 66555543   23569999999999999999999998 9999999999999999988 89999999886543


Q ss_pred             CCC-CCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KGE-PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ... ......+++.|+|||.+..    ...++.++|+||+||++|+|++|++||.+.+......++...  .+       
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------  225 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP-------  225 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC-------
Confidence            222 2234567889999999842    234678999999999999999999999877654444333221  00       


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                +..       ..+..++.++.++|.+||+.||.+||++.++++||||.+..
T Consensus       226 ----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 ----------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             ----------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                      000       01135788999999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.1e-42  Score=312.62  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=205.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ...+|++.+.||.|++|.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+...     ..+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~   91 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DEL   91 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceE
Confidence            3457999999999999999999999999999999885432    2345799999999999999999988432     348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++|+||+.+ +|...+.     ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~  164 (296)
T cd06655          92 FVVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQ  164 (296)
T ss_pred             EEEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchh
Confidence            899999986 5555443     2468999999999999999999998 9999999999999999888 799999999875


Q ss_pred             ccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+... ..+.        
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------  234 (296)
T cd06655         165 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------  234 (296)
T ss_pred             cccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc--------
Confidence            433322 223457888999999855 44889999999999999999999999887765544433221 0000        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                           ..            .+..+++.+.+||.+||..||.+||++.+++.||||+...
T Consensus       235 -----~~------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 -----LQ------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             -----cC------------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                 00            1135788999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-42  Score=312.36  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=202.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhC-CCCCeeeccceeeecCC-CCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~~  110 (376)
                      +.|++.+.||.|+||.||+|.+..+++.+|+|++....   .....|+.+++.+ +|+||+++++++..... ....+++
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            57999999999999999999999999999999885432   2345688888888 79999999998864322 2345688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+++ ++.+++....  ...+++..++.++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||++...
T Consensus        96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~  171 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhh
Confidence            99999986 7777665422  3458889999999999999999998 9999999999999999988 7999999998754


Q ss_pred             cCC-CCCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ... .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+...   ..     
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~-----  243 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP-----  243 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC-----
Confidence            321 22234567889999999853    234788999999999999999999999765543333222110   00     


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                 +        ......++.++.+||++||..||.+|||+.++++||||
T Consensus       244 -----------~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -----------P--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -----------C--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                       0        00113578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.5e-43  Score=315.14  Aligned_cols=261  Identities=22%  Similarity=0.370  Sum_probs=202.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|...+.||+|+||.||++.+..+++.+|+|.+....     ....+|+.++.++. |+||+++++++....     ..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cEE
Confidence            5777889999999999999999999999999886432     23456888998885 999999999875432     267


Q ss_pred             EEEecccccHHHHHHHhh-hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+..++.++..... .....+++..+..++.|++.||+|||+..|++||||||+||+++.++ .++|+|||+++..
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            999999887665544322 22467999999999999999999999624999999999999999888 7999999998765


Q ss_pred             cCCCCCceeeeeccccchhhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ..........++..|+|||.+.+.  ..++.++|+||+||++|+|++|+.||.....  ....+.+......        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~--------  228 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP--------  228 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC--------
Confidence            444333445678889999999655  3689999999999999999999999976541  2222222111000        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                              +...     ......++.++.+||++||+.||.+|||++++++||||+...
T Consensus       229 --------~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         229 --------PILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             --------CcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                    0000     001134789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.7e-42  Score=314.81  Aligned_cols=273  Identities=26%  Similarity=0.430  Sum_probs=202.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|+++++.++||||+++++++...     .++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEEE
Confidence            5999999999999999999999999999999875432     2245799999999999999999988543     34889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+++|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 77666653    356899999999999999999999624899999999999999888 79999999987543


Q ss_pred             CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC-CCHHHH-hhcCc
Q 017131          191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT-PTREEI-KCMNP  268 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~-~~~~~  268 (376)
                      .. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+... ...+...... ...... .....
T Consensus       152 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DS-MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             cc-ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            32 2234567889999999865 448899999999999999999999997665322 2222211000 000000 00000


Q ss_pred             Cc------------ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NY------------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ..            .........  +  ..-...++.++.+|+.+||..||++|||+.++++||||.+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPP--P--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCC--c--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            00            000000000  0  000013678899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-42  Score=308.26  Aligned_cols=246  Identities=34%  Similarity=0.551  Sum_probs=198.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+....             ....+|+.+++.++||||+++++++...  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence            4889999999999999999999999999999885421             1244799999999999999999987432  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                         .+.+++|||+++ +|.+++..    ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++ .++|+|
T Consensus        79 ---~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          79 ---DHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             ---CccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEecc
Confidence               347899999976 66666643    3568999999999999999999998 9999999999999999888 799999


Q ss_pred             cCCcccccCCCC-------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017131          183 FGSAKVLVKGEP-------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  255 (376)
Q Consensus       183 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  255 (376)
                      ||.++.......       .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+... 
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  227 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-  227 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-
Confidence            999876542111       112346788999999865 44789999999999999999999999876554433332220 


Q ss_pred             CCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                        ..+         .++..++..+.++|++||+.||.+||++.++++||||
T Consensus       228 ------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ------------------ASP---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------------CCC---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                              000         1123578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=328.99  Aligned_cols=248  Identities=32%  Similarity=0.508  Sum_probs=203.3

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeec----ccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecccc
Q 017131           43 VVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE  118 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~  118 (376)
                      .||+|.||+||.|+|..|...+|||-+..    ..+....|+.+-++++|.|||++.+++     .+++++-+.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            69999999999999999999999998843    234456899999999999999999987     556678899999985


Q ss_pred             -cHHHHHHHhhhhcCCC--cHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC-
Q 017131          119 -TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  194 (376)
Q Consensus       119 -~l~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-  194 (376)
                       +|.++++...   +++  ++..+.++..||+.||+|||+ ..|||||||-+|+|++.-.+.+||+|||.+++...-.+ 
T Consensus       657 GSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             8888887633   455  888999999999999999999 99999999999999987766899999999987654433 


Q ss_pred             Cceeeeeccccchhhhc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 017131          195 NVSYICSRYYRAPELIF-GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  273 (376)
Q Consensus       195 ~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..+..||..|||||++. +...|+.++|||||||++.||.||++||.........  +++. |.              .-
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-Gm--------------yK  795 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-GM--------------YK  795 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-cc--------------ee
Confidence            44677899999999994 4456999999999999999999999999765432221  1111 00              00


Q ss_pred             cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ..|         .++..++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus       796 vHP---------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  796 VHP---------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             cCC---------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            111         1335678999999999999999999999999999999864

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-42  Score=308.59  Aligned_cols=252  Identities=27%  Similarity=0.496  Sum_probs=200.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      +|+..+.||+|++|.||+|.+..+++.||+|.+....          ....+|+.+++.++|+||+++++++...     
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----
Confidence            4888999999999999999999999999999886422          2345799999999999999999988432     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ...++|+||+.+ +|.+++..    ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            347899999986 66666543    3568999999999999999999998 99999999999999988775699999999


Q ss_pred             cccccCCCC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          186 AKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +........     .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+......   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876543211     122356788999999865 45889999999999999999999999765543333322221000   


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                                  ..         ...++..+++++.+++.+||..||.+||++.++++||||+
T Consensus       227 ------------~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ------------TT---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ------------CC---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                        00         0012235789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.4e-42  Score=304.90  Aligned_cols=249  Identities=27%  Similarity=0.443  Sum_probs=204.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|||++++++.+..     ....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence            5999999999999999999999999999999885432      234579999999999999999987732     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ +|.+++....  ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999975 7777765422  3458999999999999999999998 999999999999999876656899999999876


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ..........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            55444445567889999999865 4478999999999999999999999987765544444332100             


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                     ..++..++.++.+++.+||..||.+|||+.++++||||
T Consensus       219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                           00113578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-42  Score=308.97  Aligned_cols=250  Identities=28%  Similarity=0.457  Sum_probs=198.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+....         ....+|+.+++.++||||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            36999999999999999999999999999999875321         2345799999999999999999877432   23


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+++++||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~  152 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGA  152 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCC
Confidence            457899999975 67666643    3468999999999999999999998 9999999999999999888 799999999


Q ss_pred             cccccCC----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          186 AKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       186 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ++.....    .......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+...   +.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~--  226 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT--  226 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC--
Confidence            8754321    11123456788999999865 45899999999999999999999999876544433322211   00  


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                                            ...++..+++.++++| +||..||.+||+++++++||||+
T Consensus       227 ----------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ----------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ----------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                  0011234688899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.6e-42  Score=308.20  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=204.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ++|++.+.||.|++|+||+|....++..+|+|++....     ....+|+.+++.++|+||+++++.+..     ....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence            36999999999999999999999899999999885432     334579999999999999999887743     23478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||++.+ ++.+.+..... ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHh
Confidence            99999975 66666654221 2468999999999999999999998 9999999999999999987 7999999998765


Q ss_pred             cCCCCC-----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          190 VKGEPN-----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       190 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ......     ....++..|+|||.+.....++.++|+|||||++|+|++|+.||...+......++...  .+.     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-----  225 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP-----  225 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC-----
Confidence            433221     23457888999999866546899999999999999999999999876655444443331  000     


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                             .  ++..       .....+++.+.+++.+||..||.+||++.++++||||
T Consensus       226 -------~--~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 -------S--LETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -------C--cCCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                   0  0000       0013578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-42  Score=310.79  Aligned_cols=251  Identities=27%  Similarity=0.377  Sum_probs=198.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++.+...     ...++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEEE
Confidence            47999999999999999999999999999999886432    2345799999999999999999888433     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++ .++|+|||+++...
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999985 66655542    3568999999999999999999998 9999999999999999888 79999999987653


Q ss_pred             CCC-CCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGE-PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ... ......+++.|+|||.+..  ...++.++|+||+||++|+|++|..||...+.......+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 2234567889999998742  334788999999999999999999999655433222211110             


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                          .+..+.     +.  ....++..+.+||++||..||++|||++++++|+|
T Consensus       225 ----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 ----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                000000     00  01246889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.1e-42  Score=305.75  Aligned_cols=252  Identities=26%  Similarity=0.434  Sum_probs=205.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++|+||+++++.+...   .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            4899999999999999999999999999999875322      2234689999999999999998877532   234578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH-----hcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-----NCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ++|||+++ +|.+.+.........+++..++.++.||+.||.|||     + .+++|+||+|+||+++.++ .+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999975 788888765555677999999999999999999999     8 8999999999999999888 89999999


Q ss_pred             CcccccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ++........ .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------  225 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---------  225 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence            9886644332 334567889999999865 44889999999999999999999999877643333222210         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                ..+         .++..++.++.+++.+||..+|.+||++.++++|||+
T Consensus       226 ----------~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ----------KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ----------CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                      000         1224578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-43  Score=337.68  Aligned_cols=278  Identities=21%  Similarity=0.308  Sum_probs=196.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc-EEEEE------------------Eeecc---cccHHHHHHHHHhCCCCCeee
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE-IVAIK------------------KVLQD---KRYKNRELQIMQMLDHPNIVA   93 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK------------------~~~~~---~~~~~~E~~~l~~l~h~~iv~   93 (376)
                      .+|++++.||+|+||+||+|..+.... ..++|                  .+...   .....+|+.+|+.++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            579999999999999999998654322 12222                  11111   123457999999999999999


Q ss_pred             ccceeeecCCCCceEEEEEEecccccHHHHHHHhh-hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131           94 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                      +++++....     ..|++++++.+++...+.... ..........++.++.||+.||+|||+ +||+||||||+|||++
T Consensus       228 l~~~~~~~~-----~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~  301 (501)
T PHA03210        228 IEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLN  301 (501)
T ss_pred             EeEEEEECC-----eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC
Confidence            999885433     378999999887766654321 112334566788899999999999998 9999999999999999


Q ss_pred             CCCCCeEEEecCCcccccCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCC--CchHH
Q 017131          173 PHTHQLKLCDFGSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGE--SGVDQ  247 (376)
Q Consensus       173 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~--~~~~~  247 (376)
                      .++ .+||+|||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|..+ |.+.  +...+
T Consensus       302 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        302 CDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            988 799999999976543322  2345789999999999654 589999999999999999998754 4322  33455


Q ss_pred             HHHHHHHhCCCCHHH-------HhhcCcCcccccCCCcccccccccc-ccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          248 LVEIIKVLGTPTREE-------IKCMNPNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       248 ~~~i~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      +.+++..++....+.       +..+.    ...+.... ......+ ...++.++.++|.+||++||.+|||+.|+|.|
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~----~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYID----SAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhh----hhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            555555544332211       00000    00000000 0000111 12467889999999999999999999999999


Q ss_pred             CcccccC
Q 017131          320 PFFDELR  326 (376)
Q Consensus       320 p~f~~~~  326 (376)
                      |||....
T Consensus       455 p~f~~~~  461 (501)
T PHA03210        455 PLFSAEE  461 (501)
T ss_pred             hhhhcCC
Confidence            9998753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=302.44  Aligned_cols=264  Identities=27%  Similarity=0.477  Sum_probs=211.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhC-CCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (376)
                      -..|.+++.||+|+|++|.+++++.|.+.||+|+++++       ....+.|..+..+- +||.+|.++.+|.+     .
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-----e  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-----E  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-----c
Confidence            35899999999999999999999999999999988653       34556788888766 79999999999943     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+++|.||++| +|-    .+.+....++++.++++..+|+.||.|||+ +||++||||.+|+|+|..| .+||+|+|.
T Consensus       324 srlffvieyv~ggdlm----fhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeg-hikltdygm  397 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLM----FHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGM  397 (593)
T ss_pred             ceEEEEEEEecCccee----eehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCC-ceeecccch
Confidence            348899999987 332    222334679999999999999999999998 9999999999999999999 599999999


Q ss_pred             cccc-cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CCchHHHHHHHHHhCC
Q 017131          186 AKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-------ESGVDQLVEIIKVLGT  257 (376)
Q Consensus       186 a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-------~~~~~~~~~i~~~~~~  257 (376)
                      ++.- ..+....+.+|||.|.|||++.+. .|+..+|+|+||++++||+.|+.||.-       .+..+.+.+++-.   
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---  473 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---  473 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh---
Confidence            8754 345566778999999999999764 599999999999999999999999952       2223333333221   


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC------HHHHhcCCcccccCCCCCC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRDPNTR  331 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s------~~~ll~hp~f~~~~~~~~~  331 (376)
                                   ..+.            ++..+|-.+..+++..|++||.+|+.      ..++..||||+.+.|.  .
T Consensus       474 -------------kqir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd--~  526 (593)
T KOG0695|consen  474 -------------KQIR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD--L  526 (593)
T ss_pred             -------------hccc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH--H
Confidence                         0111            23467888899999999999999975      6899999999988753  2


Q ss_pred             CCCCCCCCC
Q 017131          332 LPNGRPLPP  340 (376)
Q Consensus       332 ~~~~~~~~~  340 (376)
                      +...+..||
T Consensus       527 leqk~v~pp  535 (593)
T KOG0695|consen  527 LEQKQVLPP  535 (593)
T ss_pred             HhhcccCCC
Confidence            334444444

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.5e-42  Score=310.20  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +-|++.+.||.|+||.||+|.+..++..+|+|.+....    ....+|+.+++.++|||++++++.+...     ...++
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~   79 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI   79 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence            34789999999999999999999999999999885432    2334699999999999999999988442     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |+||+++ ++...+..   ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~  154 (282)
T cd06643          80 LIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  154 (282)
T ss_pred             EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEcccccccccc
Confidence            9999986 44343332   23568999999999999999999998 9999999999999999888 79999999986543


Q ss_pred             CCC-CCceeeeeccccchhhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KGE-PNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ... ......++..|+|||.+.    ....++.++|+||+||++|+|++|.+||...+.......+.....  .      
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~------  226 (282)
T cd06643         155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P------  226 (282)
T ss_pred             ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--C------
Confidence            221 123345788999999984    233477899999999999999999999987765555444433110  0      


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                              .          ...+..++.++.+||.+||..||.+||++.++++||||+..
T Consensus       227 --------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 --------T----------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             --------C----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                    0          00113478899999999999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.8e-42  Score=302.66  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=202.0

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++||||+++++++..     ....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence            388999999999999999999999999999987532      2234468999999999999999988743     23588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+.+ +|.+++...  ....+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||+++..
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            99999974 777766642  23578999999999999999999998 9999999999999999988 7999999998765


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------  217 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            43322 2234578889999998654 48899999999999999999999998777544444333210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                            .+         .++..++.++.++|.+||+.+|++||++.+++.|||+
T Consensus       218 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ------FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  00         0112468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.3e-43  Score=317.70  Aligned_cols=302  Identities=31%  Similarity=0.520  Sum_probs=234.5

Q ss_pred             cccccCCCCCCceEEecccCCCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHH
Q 017131            8 DIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQ   84 (376)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~   84 (376)
                      ..-+.|+..+| |+.+.++..+..     +|.+....|.|-|++|..|.|..-|..||||+|....   ..-.+|+++|+
T Consensus       410 ~L~DNWdDaEG-YYrv~igE~LD~-----RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLk  483 (752)
T KOG0670|consen  410 GLQDNWDDAEG-YYRVRIGELLDS-----RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILK  483 (752)
T ss_pred             ccccCcccccc-eEEEehhhhhcc-----eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHH
Confidence            34455555555 455666655544     8999999999999999999999999999999997654   23357999999


Q ss_pred             hCCC------CCeeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC
Q 017131           85 MLDH------PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG  158 (376)
Q Consensus        85 ~l~h------~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~  158 (376)
                      .|+.      -|.+.++..|..     ..++|||+|-+.-+|..++..+.. .-+|....++.|+.|+..||..|.. .|
T Consensus       484 KL~~AD~Edk~Hclrl~r~F~h-----knHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~  556 (752)
T KOG0670|consen  484 KLNDADPEDKFHCLRLFRHFKH-----KNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CG  556 (752)
T ss_pred             HhhccCchhhhHHHHHHHHhhh-----cceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cC
Confidence            9953      478888888844     444999999999899888887654 4568889999999999999999998 89


Q ss_pred             ccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 017131          159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  238 (376)
Q Consensus       159 iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  238 (376)
                      |+|.||||+|||+++....+||||||.|.....++ .+.|..+..|+|||++++.+ |+...|+||+||+||||.||+..
T Consensus       557 vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIl  634 (752)
T KOG0670|consen  557 VLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKIL  634 (752)
T ss_pred             eeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeecccee
Confidence            99999999999999888789999999997765443 45677788999999999865 99999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHhCCCCHHHHhhcC-------cCcccc--------------cCCCccc-cccccccc--cCCC--
Q 017131          239 FPGESGVDQLVEIIKVLGTPTREEIKCMN-------PNYTEF--------------KFPQIKP-HPWHKVFQ--KRLP--  292 (376)
Q Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~-------~~~~~~--------------~~~~~~~-~~~~~~~~--~~~~--  292 (376)
                      |+|.+..+.+......-|..+.-.+....       .+...+              .+...++ ..+...+-  +.++  
T Consensus       635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de  714 (752)
T KOG0670|consen  635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE  714 (752)
T ss_pred             cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence            99999999888888877776654433210       110000              1111111 11111100  0122  


Q ss_pred             -----hhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          293 -----PEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       293 -----~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                           ..+++||.+||..||++|.|..++|+||||+.
T Consensus       715 q~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  715 QPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             hHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                 35889999999999999999999999999974

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-42  Score=304.97  Aligned_cols=252  Identities=28%  Similarity=0.412  Sum_probs=202.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++|++.+.||.|++|.||+|.+..+++.+|+|.+....    ....+|+.+++.++||||+++++.+...     ..+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEEE
Confidence            57999999999999999999999999999999886432    3456799999999999999999887443     34889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+++ ++..++..   ....+++..++.++.|++.||+|||+ +|++|+||+|+||+++.++ .++|+|||++....
T Consensus        78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999986 66555443   22579999999999999999999998 9999999999999999888 79999999987654


Q ss_pred             CCC-CCceeeeeccccchhhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ... ......++..|+|||.+.+.  ..++.++|+||+||++|+|++|.+||.+.+.......+....-.+.        
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  224 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--------  224 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc--------
Confidence            322 22344678889999998543  2578899999999999999999999988775554443322100000        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                               .       .......+.++.+||++||..||.+|||+.+++.|||
T Consensus       225 ---------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 ---------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                     0       0011246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.2e-42  Score=305.69  Aligned_cols=247  Identities=28%  Similarity=0.479  Sum_probs=197.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      +|++.+.||.|+||.||+|.+ .+++.+|+|.+....          ....+|+.+++.++|+||+++++++..     .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence            488999999999999999987 578899999875321          224579999999999999999998843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .+.++++||+.+ +|.+.+..    ...+++..+..++.|++.||+|||+ .||+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchh
Confidence            458899999976 66666543    3568999999999999999999998 9999999999999999888 899999999


Q ss_pred             cccccCC-------CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          186 AKVLVKG-------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       186 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      +......       .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....+  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--  225 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--  225 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC--
Confidence            8754211       11123456888999999865 4488999999999999999999999987654443333222100  


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                     ..+         .++..++.++.++|++||..||.+||++.++++||||
T Consensus       226 ---------------~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 ---------------LMP---------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------------CCC---------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                           000         1124578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-42  Score=309.85  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+...     ...++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEE
Confidence            57999999999999999999999999999999886432    2345799999999999999999987433     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+++ +|.+++..    .+.+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999985 77665543    4579999999999999999999998 9999999999999999888 79999999986543


Q ss_pred             CCC-CCceeeeeccccchhhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGE-PNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ... ......++..|+|||.+.  ....++.++|+|||||++|+|++|..||................            
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~------------  225 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN------------  225 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC------------
Confidence            221 223456789999999874  23347889999999999999999999997655433332221110            


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                           ...+     .+..  ...++..+.++|.+||+.||++|||+.++++|||
T Consensus       226 -----~~~~-----~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         226 -----FQPP-----KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -----CCCC-----cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                 0000     0000  0246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-41  Score=307.00  Aligned_cols=266  Identities=25%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+++++.++||||+++++++...   ....++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence            36999999999999999999999999999999886432     2345799999999999999999887543   233478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ +|.+++.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~  155 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGEL  155 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeeccccccc
Confidence            99999975 7777766554455678999999999999999999998 9999999999999999888 7999999998654


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... ....+............      
T Consensus       156 ~~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  227 (287)
T cd06621         156 VNSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE------  227 (287)
T ss_pred             cccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh------
Confidence            3222 223456778999999854 45899999999999999999999999865320 00011111111000000      


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            .+...      ......++.+.+||.+||..||.+|||+.|++.||||++..
T Consensus       228 ------~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         228 ------LKDEP------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             ------hccCC------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                  00000      00012467899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=324.50  Aligned_cols=244  Identities=30%  Similarity=0.448  Sum_probs=199.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ...|.+...+|.|+|+.|-.|.+..+++.+++|++.+......+|+.++... +||||+++++.+     ......|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeeee
Confidence            4579999999999999999999999999999999988877777888776555 899999999988     4455589999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE-cCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill-~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      |.+.|...  +.. ......+. .++..|++||+.|+.|||+ +|++||||||+|||+ +..+ .++|+|||.++.....
T Consensus       396 e~l~g~el--l~r-i~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGEL--LRR-IRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHH--HHH-HHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCchh
Confidence            99997431  111 11122333 7788899999999999998 999999999999999 4676 7999999999765333


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                        ..+.+-|..|.|||++. ...|+.++||||||++||+|++|+.||......   ..+...++.+..            
T Consensus       470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~------------  531 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF------------  531 (612)
T ss_pred             --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc------------
Confidence              33445688899999996 456999999999999999999999999876655   233333332221            


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                     ...+|.++++||++||+.||.+|+++.+++.||||
T Consensus       532 ---------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  532 ---------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                           13589999999999999999999999999999999

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.3e-42  Score=303.73  Aligned_cols=248  Identities=33%  Similarity=0.540  Sum_probs=201.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|+..+.||+|++|+||+|.+..+++.||+|.+....         ....+|+.+++.++|+||+++++++...     .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----D   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----C
Confidence            4888999999999999999999899999999875432         2345799999999999999999877332     3


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++++||+++ +|.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            47899999975 67666643    3468999999999999999999998 9999999999999999888 8999999998


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .............++..|+|||.+.....++.++|+||+||++|+|++|..||...........+....           
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----------  218 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-----------  218 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-----------
Confidence            765444333445678889999998554348899999999999999999999997765433333322210           


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                             ..+         .++..+++++.+++++||..||.+||++.+++.|||+
T Consensus       219 -------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 -------ELP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -------cCC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                   000         1224578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.7e-42  Score=305.90  Aligned_cols=248  Identities=28%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+.+..       ....+|++++++++||||+++++++.     +..+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence            4999999999999999999999999999999886432       23457999999999999999998873     33458


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++|+||+.+ +|...+..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            899999976 66555543    2578999999999999999999998 9999999999999999998 799999999876


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.. ....+......           
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET-----------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc-----------
Confidence            6444333445678889999998654 4899999999999999999999999876642 11111111100           


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH--HHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~--~~ll~hp~f  322 (376)
                                    ....++..++.++.++|.+||..||.+|+++  .++++||||
T Consensus       217 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 --------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             --------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                          0011224578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.9e-42  Score=304.58  Aligned_cols=250  Identities=30%  Similarity=0.458  Sum_probs=202.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+....  ....+|+.+++.++|+||+++++++...     .+.|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEE
Confidence            46999999999999999999999889999999986543  3456899999999999999999988543     3488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+++ +|.+++..   ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99986 66666543   23568999999999999999999998 9999999999999999988 7999999998765433


Q ss_pred             C-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 E-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      . ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+.......+...   .             
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-------------  215 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P-------------  215 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C-------------
Confidence            2 22334567889999998654 5899999999999999999999999876543322221110   0             


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                         .+     .  ...+..++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       216 ---~~-----~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 ---PP-----T--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ---CC-----C--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence               00     0  00113467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.8e-42  Score=307.98  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=197.7

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ||+|+||+||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++.+..     ....|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence            689999999999999999999999885421       123469999999999999999888733     23478999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  195 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  195 (376)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 6666554322  2468999999999999999999998 9999999999999999988 7999999998765443333


Q ss_pred             ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 017131          196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  275 (376)
Q Consensus       196 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...........+.....                 . 
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~-  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----------------E-  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----------------c-
Confidence            3445678899999986544 89999999999999999999999977654222222211100                 0 


Q ss_pred             CCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCCC
Q 017131          276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  328 (376)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~~  328 (376)
                             ....++..+++++.++|.+||+.||.+||     ++.++++||||..+++.
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence                   00012235789999999999999999999     88999999999987754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=322.69  Aligned_cols=236  Identities=24%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEeccc-cc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ET  119 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~  119 (376)
                      ++-||+|+.|.||+|+..  ++.||||++.   ...+.+|+-|++|+||||+.+.+++     ...-++|+|||||. |.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~---elkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVR---ELKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHh---hhhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            567999999999999976  7889999874   3445789999999999999999998     44455899999998 67


Q ss_pred             HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceee
Q 017131          120 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI  199 (376)
Q Consensus       120 l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~  199 (376)
                      |+.+++.    ++.++...+..|..+|+.|+.|||. +.|||||||.-||||..+. .|||+|||.++.........++.
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            7777765    5678999999999999999999998 8999999999999999888 89999999999887777778899


Q ss_pred             eeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcc
Q 017131          200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  279 (376)
Q Consensus       200 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (376)
                      ||..|||||++.+ .+.+.++|||||||+||||+||..||.+-+....+.-+    |                       
T Consensus       273 GTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----G-----------------------  324 (904)
T KOG4721|consen  273 GTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----G-----------------------  324 (904)
T ss_pred             hhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEec----c-----------------------
Confidence            9999999999965 55999999999999999999999999876543222111    1                       


Q ss_pred             ccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 017131          280 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  320 (376)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp  320 (376)
                      ...+.-.++..+++.++-||+.||+-.|..||++.++|.|-
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            11112223457899999999999999999999999999883

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=301.72  Aligned_cols=287  Identities=33%  Similarity=0.555  Sum_probs=229.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec------ccccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      +.-+.+-.+.||-|+||.||.+.|..+|+.||+|++..      ..+...+|+++|.-++|.|++...++.....-+-..
T Consensus        51 qq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   51 QQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             ccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            44567778899999999999999999999999998743      234455899999999999999998877433222122


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+|+++|.+..+|..++-.    .+.++...++.+++||++||+|||+ .||.||||||.|+|+++|- .+||||||+|+
T Consensus       131 EiYV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGLAR  204 (449)
T KOG0664|consen  131 ELYVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEeccccccc
Confidence            2678889888887776654    5679999999999999999999998 9999999999999999987 89999999998


Q ss_pred             cccCCCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          188 VLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       188 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ........  +..+.|.+|+|||++.+...|+.++||||+|||+.||+-.+..|...++.+++..|...+|+|..+.+..
T Consensus       205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            76443322  3345688999999999999999999999999999999999999999999999999999999999998865


Q ss_pred             cCcCcccccCCCccccc-cccc--cc--cCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          266 MNPNYTEFKFPQIKPHP-WHKV--FQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~-~~~~--~~--~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ..+....-.+..-...+ +..+  +.  ..-..+..+++.++|.+||.+|.+.++++.|++....+
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            44332221111111111 1111  11  12345788999999999999999999999999998765

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.5e-42  Score=304.28  Aligned_cols=245  Identities=29%  Similarity=0.476  Sum_probs=198.1

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ||.|++|.||+|.+..+++.+|+|++.+..       ....+|+.+++.++||||+++++.+...     ..+++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence            689999999999999999999999986432       2345799999999999999999987433     3388999998


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  195 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  195 (376)
                      ++ +|.+.+..    ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            74 77666653    3458999999999999999999998 9999999999999999988 7999999999876544333


Q ss_pred             ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 017131          196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  273 (376)
Q Consensus       196 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+  ..+....+....               ...
T Consensus       150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~  213 (262)
T cd05572         150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKL  213 (262)
T ss_pred             ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCC
Confidence            44567889999999854 448999999999999999999999998766  322333222100               001


Q ss_pred             cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                      .            ++...++++.++|.+||..||.+|++     +.|+++||||+++.+
T Consensus       214 ~------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         214 E------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             C------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            1            12345889999999999999999999     999999999998653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.7e-42  Score=306.76  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=190.4

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHHHHH---hCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           43 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQ---MLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .||+|+||.||+|.+..+++.+|+|.+.+...       ...+|..+++   ...||||+.+++.+...     ...++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence            48999999999999999999999998854321       1223443333   34799999998887432     237899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+.+ +|...+.    ..+.+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999985 5655443    24569999999999999999999998 9999999999999999888 799999999865433


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      . ......++..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....               
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------  212 (279)
T cd05633         150 K-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------  212 (279)
T ss_pred             c-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence            2 2233467899999999865455899999999999999999999999765432211 1111000               


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  328 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~~  328 (376)
                        .        ....++..+++++.++|++||..||.+|+     |+.++++||||++++..
T Consensus       213 --~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         213 --T--------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             --c--------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence              0        00012245789999999999999999999     69999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-41  Score=300.66  Aligned_cols=248  Identities=32%  Similarity=0.472  Sum_probs=203.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||.|+||.||.+++..+++.+++|.+....      ....+|+.+++.++|+||+++++++...     ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence            5999999999999999999999999999999875322      2345799999999999999999998542     3488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999975 7776665421  3468999999999999999999998 9999999999999999988 7999999998765


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            3332 22345678899999998654 4788999999999999999999999887665555554321  000         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                       .....++.++.++|.+||..||.+||++.++++|||+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                             0013578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-41  Score=303.24  Aligned_cols=250  Identities=29%  Similarity=0.458  Sum_probs=198.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++.+.||+|+||.||.|.+..+++.||||.+..+.         ....+|+.+++.+.||||+++++++.+.   ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence            46999999999999999999999999999999875321         1345699999999999999999877432   23


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..++++|||+++ +|.+.+..    ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~  152 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGA  152 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCcc
Confidence            457899999975 67665543    3458899999999999999999998 9999999999999999888 899999999


Q ss_pred             cccccCC----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          186 AKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       186 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ++.....    .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+......++..   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--  226 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--  226 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC--
Confidence            8754321    11223457888999999865 4489999999999999999999999987654443332221   110  


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                                            ...++..++..+.++|++|+ .+|.+||+++++++|||+.
T Consensus       227 ----------------------~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ----------------------NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ----------------------CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence                                  00112356788999999999 4999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-41  Score=308.11  Aligned_cols=253  Identities=28%  Similarity=0.494  Sum_probs=201.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....       ....+|+.+++.++||||+++++.+..     ..++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCEE
Confidence            5999999999999999999999999999999886432       223478999999999999999988732     3358


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .++|+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            899999986 67666643    3568999999999999999999998 9999999999999999888 899999998863


Q ss_pred             ccCCC----------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017131          189 LVKGE----------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  252 (376)
Q Consensus       189 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  252 (376)
                      .....                ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21100                0012345778999999865 458999999999999999999999998776554444433


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC---HHHHhcCCcccccCC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  327 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~ll~hp~f~~~~~  327 (376)
                      ...                 ...+.         ....++.++.++|++||+.||.+||+   +.++++||||....+
T Consensus       230 ~~~-----------------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         230 SDD-----------------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             hcc-----------------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            310                 00110         00247889999999999999999998   789999999987554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.5e-42  Score=310.37  Aligned_cols=254  Identities=29%  Similarity=0.428  Sum_probs=203.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..|.....||+|+||.||++.+..+++.||||.+....    ....+|+.+++.++|+||+++++.+...     .+.++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEE
Confidence            45777888999999999999999999999999875422    2345799999999999999999987433     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ ++.+++.     .+.+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||++....
T Consensus        97 v~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~  169 (292)
T cd06658          97 VMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVS  169 (292)
T ss_pred             EEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhcc
Confidence            9999986 5544442     2468999999999999999999998 9999999999999999888 79999999986543


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.......           
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  237 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-----------  237 (292)
T ss_pred             cccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------
Confidence            222 2234567889999999854 458999999999999999999999998776655444333211000           


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                           .+          ....++..+.++|.+||..||.+|||+.++++||||.....+
T Consensus       238 -----~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         238 -----VK----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             -----cc----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence                 00          012468899999999999999999999999999999875433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-41  Score=310.01  Aligned_cols=249  Identities=28%  Similarity=0.421  Sum_probs=202.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .+|.+.+.||+|+||+||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++....     .
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence            46999999999999999999999999999999885321       22447999999999999999999885433     3


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++|+||+.+++.+.+..   ..+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCccee
Confidence            789999999988666643   23568999999999999999999998 9999999999999999988 799999999865


Q ss_pred             ccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...   .....+++.|+|||.+.+  ...++.++|+||+|+++|+|++|.+||.+.+.......+...  .+        
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~--------  231 (307)
T cd06607         165 VSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS--------  231 (307)
T ss_pred             cCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--------
Confidence            432   234467788999998742  345788999999999999999999999877654444333210  00        


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                               +..        ....++..+.++|.+||..||.+||++.+++.||||..
T Consensus       232 ---------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         232 ---------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             ---------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                     000        01235788999999999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-41  Score=300.90  Aligned_cols=248  Identities=28%  Similarity=0.440  Sum_probs=201.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++.     ...+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence            5999999999999999999999999999999885321      23457999999999999999999873     334588


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|+||+.+ ++.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999975 776655431  22357899999999999999999998 9999999999999999888 7999999998755


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+....  .          
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------  218 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--Y----------  218 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--C----------
Confidence            33221 1233567889999998654 47889999999999999999999998766555554443210  0          


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                             +         ..+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus       219 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 -------P---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------C---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                   0         0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-41  Score=302.90  Aligned_cols=252  Identities=32%  Similarity=0.527  Sum_probs=198.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--------------ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+....              ....+|+.+++.++|+|++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            5999999999999999999999999999999874311              1234699999999999999999877432 


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                          ...++||||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+ +|++||||+|+||+++.++ .++|+
T Consensus        81 ----~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          81 ----EYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             ----CceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEe
Confidence                347899999975 67666654    2568999999999999999999998 9999999999999999888 89999


Q ss_pred             ecCCcccccCCC---CCceeeeeccccchhhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          182 DFGSAKVLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       182 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |||+++......   ......++..|+|||.+.... .++.++|+||||+++|++++|..||...+......++......
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA  230 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence            999987543221   122345678899999986543 4789999999999999999999999765544333322111000


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                             ..........++.++.++|.+||..||.+|||++++++||||
T Consensus       231 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 -----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                   000011123578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.8e-42  Score=305.34  Aligned_cols=255  Identities=30%  Similarity=0.518  Sum_probs=201.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +|++.+.||+|++|.||+|.++.+++.+|+|.+....     ....+|+++++.++||||+++++.+...     ...++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEE
Confidence            5888999999999999999999999999999886542     2345799999999999999999988443     44889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ++||++ ++|.+++....   ..+++..+..++.|++.||+|||+..|++|+||||+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~  152 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhH
Confidence            999999 57777665422   67899999999999999999999536999999999999999988 79999999986553


Q ss_pred             CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHH-hCCCCHHHHhhcCc
Q 017131          191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKV-LGTPTREEIKCMNP  268 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~  268 (376)
                      .... ....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+. ........+. ...+          
T Consensus       153 ~~~~-~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  220 (265)
T cd06605         153 NSLA-KTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP----------  220 (265)
T ss_pred             HHHh-hcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC----------
Confidence            2222 125678889999998654 589999999999999999999999976521 1111111111 0000          


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            .+..        ....+++++.++|.+||..||.+|||+.+++.||||+...
T Consensus       221 ------~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         221 ------PPRL--------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             ------CCCC--------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                  0000        0012688999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-42  Score=317.92  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=207.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      .+.-|..++.||-|+||.|.+++...|...||+|.+.+..       .....|..||..-+++-||++|..|.+.     
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----  701 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----  701 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----
Confidence            4457999999999999999999999999999999886533       2234699999999999999998887333     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      -.+|+||+|+.| ++-.++-.    -+-|+|..+++|+.++..|+++.|. .|+|||||||+|||||.+| .+||+|||+
T Consensus       702 dnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdG-HIKLTDFGL  775 (1034)
T KOG0608|consen  702 DNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGL  775 (1034)
T ss_pred             CceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCC-ceeeeeccc
Confidence            238899999986 55444433    3679999999999999999999998 9999999999999999999 599999999


Q ss_pred             ccccc---------CCCCC----------------------------------ceeeeeccccchhhhcCCCCCCCchhH
Q 017131          186 AKVLV---------KGEPN----------------------------------VSYICSRYYRAPELIFGATEYTTAIDI  222 (376)
Q Consensus       186 a~~~~---------~~~~~----------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~Di  222 (376)
                      ++.+.         ++...                                  -..+||+.|+|||++... .|+..+|+
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdw  854 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDW  854 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-Cccccchh
Confidence            85431         11000                                  135789999999999754 49999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHh
Q 017131          223 WSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF  302 (376)
Q Consensus       223 wslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  302 (376)
                      ||.|||||||+.|++||...++.+.-.++++...               .+.++          ...++|+++.++|.++
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~---------------~l~~~----------~~~~ls~e~~~li~kL  909 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRN---------------FLHIP----------YQGNLSKEALDLIQKL  909 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh---------------ccccc----------cccccCHHHHHHHHHH
Confidence            9999999999999999998877666555544110               01111          1146899999999986


Q ss_pred             hccCCCCCCC---HHHHhcCCcccccCCCCCC
Q 017131          303 FQYSPNLRCT---ALEACVHPFFDELRDPNTR  331 (376)
Q Consensus       303 L~~dp~~R~s---~~~ll~hp~f~~~~~~~~~  331 (376)
                      . .+++.|+.   ++++..||||+.+++...+
T Consensus       910 c-~sad~RLGkng~d~vKaHpfFkgIDfsslR  940 (1034)
T KOG0608|consen  910 C-CSADSRLGKNGADQVKAHPFFKGIDFSSLR  940 (1034)
T ss_pred             h-cChhhhhcccchhhhhcCccccccchHhhh
Confidence            5 67899986   6789999999998765543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-41  Score=304.10  Aligned_cols=240  Identities=17%  Similarity=0.213  Sum_probs=192.2

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      ..||+|+++.||+|..  +|+.||||.+....       ....+|+.+|++++||||+++++++.+.. ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5799999999999997  58899999986432       22348999999999999999999885522 22345789999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  193 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  193 (376)
                      |+++ +|.+++..    .+.+++.....++.|++.||.|||+..+++||||||+||+++.++ .+||+|||+++....  
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~--  175 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS--  175 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--
Confidence            9996 67666653    456889999999999999999999724899999999999999988 899999999876532  


Q ss_pred             CCceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          194 PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       194 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      ......++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+              
T Consensus       176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  241 (283)
T PHA02988        176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------  241 (283)
T ss_pred             ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence            22345678899999998542 458999999999999999999999998877655555443311100              


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                       .            ++..+++++++|+.+||+.||.+|||+.++++
T Consensus       242 -~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -K------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -C------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             0            11257899999999999999999999999974

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.8e-41  Score=302.76  Aligned_cols=247  Identities=25%  Similarity=0.379  Sum_probs=190.7

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHH---HHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           43 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .||+|+||.||+|.+..+++.||+|.+.+...       ....|.   ..++...||+|+++++++..     ...+++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence            48999999999999999999999998864321       112233   34445689999999888743     2348899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+.+ +|...+.    ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999986 5544443    24579999999999999999999998 9999999999999999988 799999999875433


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      . ......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+...............              .
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------~  214 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------------M  214 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--------------c
Confidence            2 223456789999999996555589999999999999999999999987633221111000000              0


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                      ..            .++..++.++.+++.+||..||.+|+     ++.++++||||+...+
T Consensus       215 ~~------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         215 AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             CC------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence            00            11234689999999999999999999     9999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=300.45  Aligned_cols=246  Identities=33%  Similarity=0.527  Sum_probs=192.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHHH-HHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||.|+||.||+|.+..+|+.||+|.+.+...       ....|..+ ....+|+|++++++++..     ...+|+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence            578999999999999999999999998864321       11234433 345589999999998843     23488999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+++ +|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99975 77666543    3568999999999999999999998 9999999999999999887 799999999875432 


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                        .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+....                 
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  209 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-----------------  209 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-----------------
Confidence              22345678899999986654 8999999999999999999999998776554443332210                 


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC---HHHHhcCCcccccCC
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  327 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~ll~hp~f~~~~~  327 (376)
                      ..        +.......+++++.++|.+||+.||++||+   +.|+++||||+++++
T Consensus       210 ~~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         210 IN--------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             cC--------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            00        001111357899999999999999999995   479999999988764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.2e-41  Score=300.70  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=191.7

Q ss_pred             ceEEeeee--eecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           37 SYIAEHVV--GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        37 ~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      .|.+.+.+  |+|+||.||++.++.+++.+|+|.+..... ...|+.....+ +||||+++++.+...     ...++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTL-----KGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEecC-----CeeEEEE
Confidence            56676666  999999999999999999999998865322 12244433333 799999999988443     2488999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||++ ++|.+++..    ...+++..++.++.|++.||+|||+ .|++||||||+||+++.++..++|+|||++......
T Consensus        89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9997 477766654    3479999999999999999999998 999999999999999988757999999998755322


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                         ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........ ..........              
T Consensus       164 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  225 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--------------  225 (267)
T ss_pred             ---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------
Confidence               23457888999999965 4489999999999999999999999986543321 1111111000              


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-HHHHhcCCcccc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDE  324 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~~ll~hp~f~~  324 (376)
                      ..            ...+.+++.+.+||.+||+.||.+|++ .+++|+||||.+
T Consensus       226 ~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 KL------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             cC------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            00            011357999999999999999999996 599999999963

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.3e-41  Score=304.06  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=200.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .|+..+.||.|+||.||+|.+..+++.||||.+....     ....+|+.+++.++|+||+++++++...     .+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEE
Confidence            5889999999999999999999999999999886432     2345799999999999999999988443     34889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ +|.+.+..     ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999976 66655542     468999999999999999999998 9999999999999999888 79999999987654


Q ss_pred             CCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+.......+...  .            
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------  217 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--N------------  217 (277)
T ss_pred             CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--C------------
Confidence            3322 2233567889999998654 4899999999999999999999999876544333222110  0            


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                           .         ..+...++..+.+++.+||..||.+||++.++++||||...
T Consensus       218 -----~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         218 -----P---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             -----C---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence                 0         01113467899999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.1e-41  Score=305.39  Aligned_cols=254  Identities=20%  Similarity=0.276  Sum_probs=191.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC----------------CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeee
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVA   93 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~   93 (376)
                      ..+|++.+.||+|+||.||+|.+..                ++..||+|.+....     ....+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4579999999999999999998643                34479999886432     23457999999999999999


Q ss_pred             ccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhh---------------cCCCcHHHHHHHHHHHHHHHHHHHhcC
Q 017131           94 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRI---------------HQRMPLIYVKLYTYQICRALAYIHNCI  157 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~---------------~~~l~~~~~~~i~~qi~~al~~LH~~~  157 (376)
                      +++++....     ..+++|||+.+ +|.+++......               ...+++..+..++.||+.||+|||+ .
T Consensus        84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~  157 (304)
T cd05096          84 LLGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L  157 (304)
T ss_pred             EEEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence            999885432     37899999975 777776543211               1246778899999999999999998 9


Q ss_pred             CccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh
Q 017131          158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  234 (376)
Q Consensus       158 ~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt  234 (376)
                      ||+||||||+|||++.++ .+||+|||+++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++
T Consensus       158 ~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         158 NFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             CccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHH
Confidence            999999999999999988 7999999999765332211   12233677999999865 458999999999999999986


Q ss_pred             --CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC
Q 017131          235 --GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  312 (376)
Q Consensus       235 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s  312 (376)
                        +..||.+.+..+....+.........            ..         ....+..++..+.+|+.+||..||.+|||
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGR------------QV---------YLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccc------------cc---------cccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence              56788776655544443322100000            00         00011357889999999999999999999


Q ss_pred             HHHHh
Q 017131          313 ALEAC  317 (376)
Q Consensus       313 ~~~ll  317 (376)
                      +.++.
T Consensus       295 ~~~i~  299 (304)
T cd05096         295 FSDIH  299 (304)
T ss_pred             HHHHH
Confidence            99984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.6e-41  Score=297.99  Aligned_cols=249  Identities=27%  Similarity=0.415  Sum_probs=200.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|.+.+.||+|+||.||+|.+..+|..+|+|.+...      .....+|+.+++.++|+||+++++.+..     ....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence            489999999999999999999999999999988542      2344579999999999999999998733     33488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 776666432  22357899999999999999999998 999999999999999988656799999998765


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            43322 1233578889999988544 48899999999999999999999998766444433322210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                            .         ..+...++.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  0         00113578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-41  Score=307.00  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=202.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .-|.....||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++|||++++++++...     ...++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~i   95 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWV   95 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEE
Confidence            34666778999999999999999999999999885322    2345799999999999999999988443     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ++||+++ ++..++.     ...+++..++.++.|++.||+|||+ +|++||||||+||+++.++ .++|+|||++....
T Consensus        96 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~  168 (297)
T cd06659          96 LMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQIS  168 (297)
T ss_pred             EEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhcc
Confidence            9999986 5555443     2568999999999999999999998 9999999999999999988 79999999986543


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ... ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+..+.+..+...   +..         
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~---------  235 (297)
T cd06659         169 KDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP---------  235 (297)
T ss_pred             cccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC---------
Confidence            322 22345678899999999654 4899999999999999999999999876655544433210   000         


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                                  .+  .....++..+.++|++||+.||.+||++.++++||||.+...+
T Consensus       236 ------------~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         236 ------------KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             ------------Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence                        00  0113578899999999999999999999999999999875543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.8e-41  Score=297.50  Aligned_cols=252  Identities=31%  Similarity=0.511  Sum_probs=204.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .|++.+.||.|++|.||+|.+..+++.||+|++....     ....+|+..+..++|+|++++++++...     ...++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEEE
Confidence            5899999999999999999999999999999886543     3455799999999999999999988433     44889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||++ ++|.+.+..    ...+++..+..++.|++.||+|||+..|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~  151 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLE  151 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecc
Confidence            999999 577666654    267899999999999999999999427999999999999999988 89999999987664


Q ss_pred             CCCCCc-eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.  .....+.+.  ....        
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~~~--------  220 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--DGPP--------  220 (264)
T ss_pred             cCCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--cCCC--------
Confidence            433332 4567888999999855 4589999999999999999999999987652  222111111  0000        


Q ss_pred             cCcccccCCCccccccccccccC-CChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                              +         .++.. ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus       221 --------~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 --------P---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------C---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                    0         01123 788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.4e-41  Score=301.98  Aligned_cols=254  Identities=30%  Similarity=0.467  Sum_probs=203.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..|...+.||+|++|.||++.+..+++.+|+|.+....    ....+|+.+++.++|||++++++++...     .+.++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~   93 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWV   93 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEE
Confidence            46777889999999999999999999999999875322    2345799999999999999999987543     23789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ++||+.+ +|.+.+..     ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++ .++|+|||.+....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~  166 (285)
T cd06648          94 VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVS  166 (285)
T ss_pred             EEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhc
Confidence            9999975 76665543     468999999999999999999998 9999999999999999988 89999999876543


Q ss_pred             CCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+.......+.... .+.          
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~----------  234 (285)
T cd06648         167 KEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK----------  234 (285)
T ss_pred             cCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC----------
Confidence            3221 2234578899999998654 48999999999999999999999998766555544433210 000          


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                           ..          ....++..+.+|+++||..||.+|||+.++++||||++..++
T Consensus       235 -----~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         235 -----LK----------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             -----Cc----------ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                 00          012368899999999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.3e-42  Score=306.95  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=200.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ..|+..+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ....+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceE
Confidence            35888899999999999999999999999999876332     234579999999999999999998843     23478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ ++.+.+.     ...+++..++.++.|++.|+.|||+ +|++|+||+|+||+++.++ .++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~  151 (277)
T cd06642          79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQL  151 (277)
T ss_pred             EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEccccccccc
Confidence            99999986 5555443     2568999999999999999999998 9999999999999999888 7999999998765


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...              
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------  216 (277)
T cd06642         152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------  216 (277)
T ss_pred             cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------
Confidence            43221 1223567889999998654 5889999999999999999999999765543332221110              


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                           .         ...+...++.++.++|.+||..+|.+||++.++++||||....
T Consensus       217 -----~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 -----S---------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             -----C---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                 0         0011234688999999999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=302.93  Aligned_cols=251  Identities=27%  Similarity=0.482  Sum_probs=200.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCC---CCCeeeccceeeecCCCCceE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.+.   |||++++++++..     ...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence            4888999999999999999999999999999875431     23457899999986   9999999998743     234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++|||+.+ +|.+++..     ..+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            7899999976 66555532     368999999999999999999998 9999999999999999987 89999999987


Q ss_pred             cccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....... .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+..             
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------  216 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------  216 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-------------
Confidence            6544322 23346788899999986655678999999999999999999999976553322211100             


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            ...+.        .....++.++.+++.+||..||.+||++.+++.||||++..
T Consensus       217 ------~~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         217 ------SKPPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ------CCCCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                  00000        00013688999999999999999999999999999998743

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-40  Score=304.74  Aligned_cols=250  Identities=28%  Similarity=0.447  Sum_probs=203.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..|...+.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++|||++++++++.+.     ..
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~   95 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HT   95 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CE
Confidence            35888899999999999999999999999999885321       1244799999999999999999988543     34


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .|+||||+.+++...+..   ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||++..
T Consensus        96 ~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCcc
Confidence            789999999887766643   23568999999999999999999998 9999999999999999888 799999999864


Q ss_pred             ccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ..   ......++..|+|||.+..  ...++.++|+|||||++|+|++|.+||...+.......+...  ..        
T Consensus       171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~--------  237 (313)
T cd06633         171 SS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS--------  237 (313)
T ss_pred             cC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CC--------
Confidence            32   2234567888999999842  345788999999999999999999999887665555544321  00        


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                               +.        .....++..+++|+.+||+.+|.+||++.+++.||||+..
T Consensus       238 ---------~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         238 ---------PT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ---------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                     00        0112467789999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-41  Score=315.79  Aligned_cols=249  Identities=23%  Similarity=0.320  Sum_probs=192.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCC-----cEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .++|++.+.||+|+||.||+|.+..+|     ..||+|.+....     ....+|+.+++.+ +|+||+++++++...  
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            457999999999999999999965443     579999986432     2345799999999 899999999987433  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSR-----------------------------------------------------  129 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  129 (376)
                         ..+++||||+.+ +|.+.+.....                                                     
T Consensus       115 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         115 ---GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             ---CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence               337899999984 77776654211                                                     


Q ss_pred             -------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCc
Q 017131          130 -------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV  196 (376)
Q Consensus       130 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~  196 (376)
                                   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         01247888999999999999999998 9999999999999999887 79999999987653332211


Q ss_pred             ---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          197 ---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       197 ---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                         ...++..|+|||++.+ ..++.++|+|||||++|+|++ |+.||..................+              
T Consensus       270 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~--------------  334 (374)
T cd05106         270 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM--------------  334 (374)
T ss_pred             eccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------
Confidence               1123457999999865 458999999999999999997 999998765444443333210000              


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                   ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus       335 -------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 -------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         011246899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.9e-41  Score=296.43  Aligned_cols=250  Identities=30%  Similarity=0.494  Sum_probs=204.6

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|.+.+.||.|++|.||++.+..+++.||+|++....      ....+|+++++.++|+|++++.+.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            4899999999999999999999999999999986432      2345799999999999999999888543     4488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++|++++ +|...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 7877776644334679999999999999999999998 9999999999999999887 7999999998765


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4332 22345678889999988554 48899999999999999999999997766433333322210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                            .+         .++..++.++.+++.+||..||.+|||+.++++||||
T Consensus       220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                  00         0113578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-40  Score=297.04  Aligned_cols=250  Identities=30%  Similarity=0.513  Sum_probs=197.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+.....      ...+|+.+++.++|+||+++++.+..     ....+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence            59999999999999999999999999999999864432      34579999999999999999887633     23478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|+||+.+ +|.+.+..    ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 66665543    3458899999999999999999998 9999999999999999987 7999999998765


Q ss_pred             cCCCCCc-----eeeeeccccchhhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          190 VKGEPNV-----SYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       190 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .......     ...++..|+|||.+.+..  .++.++|+||+|+++|+|++|..||...+........... +.+    
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----  224 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK----  224 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----
Confidence            4332211     235678899999986432  3788999999999999999999999765432222211111 000    


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                ..++.          ...+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus       225 ----------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         225 ----------PPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ----------CCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                      00110          02358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.1e-41  Score=296.78  Aligned_cols=245  Identities=27%  Similarity=0.435  Sum_probs=197.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +|++.+.||.|+||.||++.+..+++.||+|.+....     ....+|+.+++.++|+||+++++.+.+     ..++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence            4899999999999999999999999999999875322     234568999999999999999998843     335889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+++ ++.+.+...  ....+++..++.++.|++.||.|||+ +||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999975 666555431  23468999999999999999999998 9999999999999999888 79999999987653


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ... ......+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...+.......+....              
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  216 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS--------------  216 (255)
T ss_pred             ccccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--------------
Confidence            322 2234567888999999855 448999999999999999999999998766544444332210              


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                           .         ..++..++..+.+||.+||+.||.+|||+.++++-
T Consensus       217 -----~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -----Y---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----C---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 0         00113468899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-41  Score=303.11  Aligned_cols=256  Identities=29%  Similarity=0.445  Sum_probs=199.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+|++.+.||+|+||+||+|.+..+|+.||+|++....     ....+|+++++.++||||+++++.+...     ..+
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence            357999999999999999999999999999999875432     2345799999999999999999988443     348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++ +|...+..    .+.+++..+..++.|++.||.|||+..+++||||+|+||+++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~  153 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGE  153 (284)
T ss_pred             EEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccc
Confidence            899999986 55554433    356899999999999999999999635899999999999999888 899999999865


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-------HHHHHHHhCCCCHH
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-------LVEIIKVLGTPTRE  261 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~~~~~~  261 (376)
                      .... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||........       ........-..   
T Consensus       154 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  228 (284)
T cd06620         154 LINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE---  228 (284)
T ss_pred             hhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---
Confidence            4322 22344678899999998654 588999999999999999999999986543211       11111110000   


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                  ..+..        -...++.++.+|+.+||+.||.+|||+.++++||||..-
T Consensus       229 ------------~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 ------------PPPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             ------------cCCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                        00000        001267899999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=298.59  Aligned_cols=298  Identities=26%  Similarity=0.417  Sum_probs=223.0

Q ss_pred             cccCCCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHhCC--------CCCee
Q 017131           24 TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD--------HPNIV   92 (376)
Q Consensus        24 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~--------h~~iv   92 (376)
                      |..-++|..-...+|.+.++||=|.|++||+|.|..+.+.||+|+.+....+.   ..||++|++++        ..+||
T Consensus        66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             CceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            33334444445579999999999999999999999999999999987765444   36999999983        34799


Q ss_pred             eccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131           93 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                      ++++.|-.. +.+..++|+|+|+++.+|..++....  .++++...++.|++||+.||.|||...||||-||||+|||+.
T Consensus       146 ~LlD~Fkhs-GpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  146 QLLDHFKHS-GPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eeeccceec-CCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            999988543 46677899999999999988887643  478999999999999999999999878999999999999981


Q ss_pred             CC------------------------------------------------------------------------------
Q 017131          173 PH------------------------------------------------------------------------------  174 (376)
Q Consensus       173 ~~------------------------------------------------------------------------------  174 (376)
                      .+                                                                              
T Consensus       223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s  302 (590)
T KOG1290|consen  223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQES  302 (590)
T ss_pred             ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccc
Confidence            10                                                                              


Q ss_pred             --------C-----------------------------------------------------------------------
Q 017131          175 --------T-----------------------------------------------------------------------  175 (376)
Q Consensus       175 --------~-----------------------------------------------------------------------  175 (376)
                              +                                                                       
T Consensus       303 ~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p  382 (590)
T KOG1290|consen  303 YNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNP  382 (590)
T ss_pred             cccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCC
Confidence                    0                                                                       


Q ss_pred             --------CCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC------
Q 017131          176 --------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG------  241 (376)
Q Consensus       176 --------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~------  241 (376)
                              .+|||+|||-|.-.  ....+.-+.|+.|+|||++.+.+ |++.+||||++|+++||+||...|..      
T Consensus       383 ~~~~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y  459 (590)
T KOG1290|consen  383 DIPLPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENY  459 (590)
T ss_pred             CCCCCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence                    01444444444322  12223345578899999999876 99999999999999999999988853      


Q ss_pred             CCchHHHHHHHHHhCCCCHHHHhhcCcCcccc-------cCCCccccccccccc------cCCChhHHHHHHHhhccCCC
Q 017131          242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKVFQ------KRLPPEAVDLVCRFFQYSPN  308 (376)
Q Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dp~  308 (376)
                      ..+.+.+..|+..+|..+.............|       .+..++..++...+-      ..-..++.+||.-||+++|.
T Consensus       460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe  539 (590)
T KOG1290|consen  460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE  539 (590)
T ss_pred             CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence            23567899999999988876543221111111       122222222222211      11235688999999999999


Q ss_pred             CCCCHHHHhcCCcccccCC
Q 017131          309 LRCTALEACVHPFFDELRD  327 (376)
Q Consensus       309 ~R~s~~~ll~hp~f~~~~~  327 (376)
                      +|+||.++|+|||+...-.
T Consensus       540 KR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  540 KRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             ccccHHHHhcCccccCCCC
Confidence            9999999999999987644

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.2e-41  Score=303.75  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=199.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..+.|++.+.||+|++|.||+|.+..+++.||||.+.....     ...+|+.++... .|+||+++++++.+.     .
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----S   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----C
Confidence            34679999999999999999999999999999999864321     223466655555 599999999988443     3


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..|++|||+++.+.++...   ....+++..+..++.|++.||+|||+..||+||||+|+||+++.++ .+||+|||++.
T Consensus        88 ~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          88 DVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             eEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence            4889999998877666544   2347899999999999999999999624999999999999999888 89999999987


Q ss_pred             cccCCCCCceeeeeccccchhhhcCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCHHHH
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  263 (376)
                      ............++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||...... +.+..+...   ..    
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~----  236 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP----  236 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC----
Confidence            65443333344567789999998543   23788999999999999999999999754322 222222210   00    


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                               ...+          ....++.++.+||.+||..||.+||++.+++.||||+...
T Consensus       237 ---------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         237 ---------PSLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ---------CCCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                     0000          0024688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.8e-41  Score=310.67  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=193.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (376)
                      ++|++.+.||+|+||.||+|.+..     +++.||+|++....     ....+|+.+++.+ +|+||+++++++...   
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~---   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP---   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence            479999999999999999997543     45789999885422     2234699999999 899999999877532   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  129 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  129 (376)
                       ...++++|||+.+ +|.+.+.....                                                      
T Consensus        84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             2347899999985 77666643211                                                      


Q ss_pred             ---hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC---Cceeeeecc
Q 017131          130 ---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRY  203 (376)
Q Consensus       130 ---~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~  203 (376)
                         ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||+++.......   .....++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12368899999999999999999998 9999999999999999888 799999999976533221   112234567


Q ss_pred             ccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccc
Q 017131          204 YRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP  282 (376)
Q Consensus       204 y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (376)
                      |+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.+........               ..         
T Consensus       241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------------~~---------  295 (337)
T cd05054         241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT---------------RM---------  295 (337)
T ss_pred             ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC---------------CC---------
Confidence            9999998654 58999999999999999998 9999987554444433322100               00         


Q ss_pred             cccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          283 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       283 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                         ..+...++++.+++.+||+.+|.+||++.++++|
T Consensus       296 ---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         296 ---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               0113468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.6e-41  Score=310.09  Aligned_cols=277  Identities=21%  Similarity=0.316  Sum_probs=195.8

Q ss_pred             eeeeec--CceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ..||.|  +||+||+|.+..+|+.||+|++....      ....+|+.+++.++||||++++++|...     .+.++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence            456666  99999999999999999999886432      2345788999999999999999988432     3478999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+.+ ++.+++....  ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99985 7766665432  2458999999999999999999998 9999999999999999888 7999999864332211


Q ss_pred             CCC--------ceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH--
Q 017131          193 EPN--------VSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  261 (376)
Q Consensus       193 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--  261 (376)
                      ...        ....++..|+|||.+.+. ..++.++|+||+||++|+|++|++||.+.................+..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            111        011235569999998653 347899999999999999999999998876554444333211110000  


Q ss_pred             -------HHhhcCcCcc----cccC-----CCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          262 -------EIKCMNPNYT----EFKF-----PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       262 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                             .+......+.    ....     .......+.......+++.+++||++||+.||.+|||+.++++||||..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                   0000000000    0000     00000011111123467889999999999999999999999999999886


Q ss_pred             CC
Q 017131          326 RD  327 (376)
Q Consensus       326 ~~  327 (376)
                      ..
T Consensus       315 ~~  316 (328)
T cd08226         315 KE  316 (328)
T ss_pred             HH
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.3e-40  Score=296.04  Aligned_cols=247  Identities=29%  Similarity=0.475  Sum_probs=191.7

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ...||+|+||.||+|.+..++..||+|.+....    ....+|+.+++.++|+||+++++++..     ..+.++++||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEecC
Confidence            458999999999999999999999999875432    245589999999999999999988743     23488999999


Q ss_pred             cc-cHHHHHHHhhhhcCCC--cHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC
Q 017131          117 PE-TVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  193 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  193 (376)
                      .+ +|.+.+...   ...+  ++..+..++.|++.||+|||+ +||+||||||+||+++.+...++|+|||.+.......
T Consensus        88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          88 PGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            75 777666542   1234  788899999999999999998 9999999999999998744489999999987553322


Q ss_pred             C-CceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          194 P-NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       194 ~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      . .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||.................               
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  228 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK---------------  228 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc---------------
Confidence            2 2234568889999998543 2478899999999999999999999976432211111000000               


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                 ....++..+++++.+|+++||..+|.+|||+.+++.||||
T Consensus       229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                       0001224578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.3e-41  Score=302.53  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=201.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+....    ....+|+.+++.++|||++++++.+....     ..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEE
Confidence            367999999999999999999999899999999875322    23456899999999999999999885433     378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|+||+++ ++.+++..     ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999975 66655542     458889999999999999999998 9999999999999999887 7999999987654


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..... .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||...+.......+.. .+.+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~---------  234 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------  234 (293)
T ss_pred             cccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence            33222 223457888999999865 4588999999999999999999999987654433222111 00000         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                    +  .....++..++++|++||..||.+||++.+++.||||+..+
T Consensus       235 --------------~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         235 --------------L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             --------------C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                          0  01124678999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-40  Score=297.06  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=196.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .+|++.+.||+|+||.||+|++..+++.||||.+....       ....+|+.+++.++||||+++++++...     ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            46999999999999999999999999999999774311       1235699999999999999999988543     23


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++++||+++ ++.+++.........+++..+..++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999985 7777776554445568999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCHHHHhh
Q 017131          188 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       188 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...... ......+...+.++      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6543221 1234567889999998654 4789999999999999999999999654321 22222222111111      


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                          ......+..+.++|.+||..||++||++.++++
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                001246788999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=295.53  Aligned_cols=249  Identities=28%  Similarity=0.463  Sum_probs=198.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++.+.||+|++|.||+|.+..+++.||+|.+..+.         ....+|+.+++.++|+||+++++++.+.   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            46999999999999999999999999999999874321         2345799999999999999999887432   22


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+++++||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~  152 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGA  152 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcccc
Confidence            347799999975 66655543    3458899999999999999999998 9999999999999999888 799999999


Q ss_pred             cccccCC----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          186 AKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       186 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ++.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++..   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--  226 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--  226 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC--
Confidence            8754321    112234578889999998654 478999999999999999999999987655444333221   111  


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                            ...++..+++.+.++|++||. +|.+||++.+++.|||.
T Consensus       227 ----------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ----------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                  111235688999999999999 57999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-40  Score=297.96  Aligned_cols=245  Identities=21%  Similarity=0.267  Sum_probs=191.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+|++.+.||+|+||.||+|.+.   ..+..||+|.+....     ....+|+.+++.++||||+++++++...     
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-----   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----
Confidence            357999999999999999999865   446689999886532     2345799999999999999999987432     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ...++||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ +|++||||||+||+++.++ .++++|||.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~  153 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRR  153 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCcc
Confidence            237899999986 56555543   23468999999999999999999998 9999999999999999988 799999998


Q ss_pred             cccccCCCCCc--eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          186 AKVLVKGEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       186 a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      +..........  ...++..|+|||.+.+ ..++.++|+||+||++|++++ |..||.+.+..+....+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------  225 (266)
T cd05064         154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-------  225 (266)
T ss_pred             cccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-------
Confidence            75432221111  1223567999999865 458999999999999999875 999998876655444332210       


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                 ..+          .+..++..+.+++.+||+.+|.+||++.++++
T Consensus       226 -----------~~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         226 -----------RLP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -----------CCC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                       000          12457899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-41  Score=313.51  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=192.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      ..+|++.+.||+|+||.||+|.+     ..++..||+|++....     ....+|+.+++.+ +||||+++++++...  
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            34799999999999999999974     3567789999885432     2345799999999 899999999988433  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhh-----------------------------------------------------
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSR-----------------------------------------------------  129 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------------------------------------------  129 (376)
                         ...++||||+++ +|.+.+.....                                                     
T Consensus       112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence               237899999984 77766653210                                                     


Q ss_pred             ------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          130 ------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       130 ------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                                        ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                              01247888899999999999999998 9999999999999999877 799999999876543


Q ss_pred             CCCCc---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          192 GEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       192 ~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .....   ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+........+.+...            
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------  333 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG------------  333 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC------------
Confidence            22111   1223567999999965 458999999999999999998 899998766554444433310            


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           ...          ..+...+.++.+||.+||+.||++|||+.++++
T Consensus       334 -----~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         334 -----YRM----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             -----ccC----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                 000          011235789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.2e-40  Score=293.86  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=203.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+....      ....+|+.+++.++|+||+++++++...     ...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence            4899999999999999999999999999999886422      2234689999999999999999888543     3488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|+||+++ +|.+.+.........+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999975 7777776544445678999999999999999999998 9999999999999999887 7999999998766


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+...               
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------  216 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------  216 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence            444 3334557888999999865 45888999999999999999999999877654333322210               


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                          .++.         ++..++.++++++.+||..+|.+|||+.++++||++
T Consensus       217 ----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 ----KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                0110         113468899999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.6e-41  Score=297.54  Aligned_cols=244  Identities=33%  Similarity=0.566  Sum_probs=196.5

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ||.|+||.||+|.+..+|+.+|+|.+.....       ...+|+.+++.++||||+++++.+.     .....|+++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence            6899999999999999999999998864322       3456899999999999999988773     334488999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC--
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  193 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--  193 (376)
                      .+ +|.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            75 77666654    2468999999999999999999998 9999999999999999988 89999999987543331  


Q ss_pred             -------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          194 -------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       194 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                             ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------  216 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG------------  216 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------
Confidence                   122345678899999986544 889999999999999999999999877655444333220            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH---HHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~---~~ll~hp~f~~~~  326 (376)
                           ....+..          ..++..+.+++.+||+.+|.+|||+   .++++||||+++.
T Consensus       217 -----~~~~~~~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         217 -----KIEWPED----------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             -----CcCCCcc----------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                 0111100          1258999999999999999999999   9999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-40  Score=330.61  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=192.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++..+.       ....+|+++++.++||||+++++++..     ...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence            47999999999999999999999999999999986431       234579999999999999999988743     234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhh-------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                      .+++|||++| +|.+++......       ...++...+..++.||+.||+|||+ +||+||||||+||+++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEE
Confidence            8899999985 777777643211       2345667788999999999999998 9999999999999999988 7999


Q ss_pred             EecCCcccccCCC-------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017131          181 CDFGSAKVLVKGE-------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  241 (376)
Q Consensus       181 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  241 (376)
                      +|||+++......                   ......||+.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997651110                   01124689999999998654 489999999999999999999999987


Q ss_pred             CCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .+.......  .....|.              ..     .+     ...+++.+.+++.+||..||++|++..+.+.
T Consensus       234 ~~~~ki~~~--~~i~~P~--------------~~-----~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        234 KKGRKISYR--DVILSPI--------------EV-----AP-----YREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             cchhhhhhh--hhccChh--------------hc-----cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            543322211  1000000              00     00     0357899999999999999999998765553

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-40  Score=303.03  Aligned_cols=249  Identities=28%  Similarity=0.415  Sum_probs=203.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..|...+.||+|+||.||+|++..++..+|+|.+....       ....+|+.+++.++|||++++++++....     .
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~   99 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----T   99 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----e
Confidence            35999999999999999999999999999999886431       12446999999999999999999885432     3


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++||||+.+++.+.+..   ....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++ .++|+|||++..
T Consensus       100 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~  174 (317)
T cd06635         100 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASI  174 (317)
T ss_pred             EEEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCccc
Confidence            789999999987666543   23568999999999999999999998 9999999999999999888 799999999865


Q ss_pred             ccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...   .....+++.|+|||.+..  ...++.++|+||+||++|+|++|..||...+.......+......+        
T Consensus       175 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  243 (317)
T cd06635         175 ASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------  243 (317)
T ss_pred             cCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------
Confidence            422   234467888999999742  3457889999999999999999999998776555555544321000        


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                         .....+++.+++|+.+||+.+|.+||++.++++|||+..
T Consensus       244 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         244 -------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                               001246788999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-40  Score=298.61  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=199.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      -|++.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.+++.++||||+++++++...     .+.++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence            4888999999999999999999999999999875322     2345799999999999999999988432     34789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ ++...+.     ...+++..+..++.|++.|+.+||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999986 5655553     2468999999999999999999998 9999999999999999888 79999999987553


Q ss_pred             CCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+... .             
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------  217 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N-------------  217 (277)
T ss_pred             cchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C-------------
Confidence            3221 123456788999999854 45788999999999999999999999766543333322110 0             


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                           .         ..+...++.++.+++.+||..||.+||++.++++||||...
T Consensus       218 -----~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         218 -----P---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             -----C---------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                 0         01123578899999999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.5e-40  Score=303.41  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=202.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..|...+.||+|++|.||+|++..+++.+|+|.+....       ....+|+.+++.++|+|++++++++...     ..
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Ce
Confidence            46888999999999999999999999999999875321       1234699999999999999999988543     23


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++||||+.+++.+.+..   ....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~  164 (308)
T cd06634          90 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (308)
T ss_pred             eEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCccccee
Confidence            789999999887666543   23468999999999999999999998 9999999999999999888 799999999875


Q ss_pred             ccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...   .....+++.|+|||.+.+  ...++.++|+|||||++|+|++|..||...+..+....+.... .         
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~---------  231 (308)
T cd06634         165 MAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S---------  231 (308)
T ss_pred             ecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-C---------
Confidence            432   234457888999999842  2447889999999999999999999997765544444333210 0         


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                               +.        .....++..+.+||++||..+|.+||++.++++|||+...
T Consensus       232 ---------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         232 ---------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ---------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                     00        0013468899999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1e-40  Score=300.70  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=196.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCC-----cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ....+|+.++..++||||+++++++...    
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~----   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE----   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC----
Confidence            47999999999999999999986655     679999885432     2345799999999999999999987432    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                       ...+++|||+++ +|.+.+......            ...+++..+..++.|++.||.|||+ +|++|+||||+||+++
T Consensus        81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~  158 (283)
T cd05048          81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG  158 (283)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence             237899999974 777766543211            1458889999999999999999998 9999999999999999


Q ss_pred             CCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q 017131          173 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  248 (376)
Q Consensus       173 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  248 (376)
                      .++ .++|+|||+++.......   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            888 799999999875533221   2233457789999998654 48999999999999999998 99999887765544


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       249 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..+.+..                   .+         ..+..+++++.+|+.+||+.||.+||++.+++++
T Consensus       237 ~~i~~~~-------------------~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQ-------------------LL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCC-------------------cC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            4433210                   00         0124578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=314.09  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=203.4

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEe-----ecc-c--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-K--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-----~~~-~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+....||+|+|-+||+|.|..+|-.||--.+     .+. .  ..+..|+.+|+.|+||||+++|+.+.+..   +.++
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~i  118 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTI  118 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Ccee
Confidence            45677899999999999999999988885322     122 2  34557999999999999999998876543   3568


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--CccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+|.+. |+|..+..    ..++.+...++.|++||+.||.|||+ +  .|||||||.+||+|+.+.+.|||+|+|+|
T Consensus       119 n~iTEL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             eeeeecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHH
Confidence            89999997 56554444    45778999999999999999999997 5  59999999999999988889999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +.... ....+.+|||.|||||++.  ..|+..+||||||+.+.||+|+..||.......++++-+.. |..+...-   
T Consensus       194 tl~r~-s~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~sl~---  266 (632)
T KOG0584|consen  194 TLLRK-SHAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAALS---  266 (632)
T ss_pred             HHhhc-cccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHHhh---
Confidence            86643 3445689999999999995  56999999999999999999999999988777666654432 22222111   


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                            .--.+++++||.+||.. .+.|+|+.|+|+||||+.
T Consensus       267 ----------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  267 ----------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             ----------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                                  11368999999999999 999999999999999986

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-40  Score=298.42  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ..+|++.+.||+|+||.||+|.++.     .+..||+|.+.....     ...+|+.+++.++||||+++++++...   
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG---   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence            3579999999999999999997652     345799998754322     234688999999999999999987432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                        ...++||||+. ++|.+.+......      ...++...+..++.|++.||.|||+ +||+||||||+||+++.++ .
T Consensus        82 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~-~  157 (288)
T cd05061          82 --QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF-T  157 (288)
T ss_pred             --CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-c
Confidence              23789999997 5888777653221      1235667889999999999999998 9999999999999999988 7


Q ss_pred             eEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  253 (376)
                      ++|+|||+++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999998754332211   11233567999999865 458999999999999999998 7899987665443333321


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc------CCcccccC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDELR  326 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~------hp~f~~~~  326 (376)
                      . +.+               .            .+..+++.+.+++.+||+.||++|||+.++++      ||||+++.
T Consensus       237 ~-~~~---------------~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         237 G-GYL---------------D------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             C-CCC---------------C------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            0 000               0            11346789999999999999999999999986      99998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-40  Score=304.66  Aligned_cols=278  Identities=21%  Similarity=0.300  Sum_probs=195.0

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |.+++.+|.|  |.||.+++..+++.||||++....      ....+|+.+++.++|+||+++++++...     ...++
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~   76 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYV   76 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEE
Confidence            3344444444  556666667789999999986541      2455799999999999999999988443     33789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+++ ++.+++....  ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||.+....
T Consensus        77 ~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~  152 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMI  152 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeec
Confidence            9999984 6766665432  3468999999999999999999998 9999999999999999888 79999999886543


Q ss_pred             CCCC--------CceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          191 KGEP--------NVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       191 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ....        .....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||...+..........  +.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~  230 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCL  230 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccc
Confidence            2211        1223456789999998543 3478999999999999999999999987654443322221  111000


Q ss_pred             ----HHhhcCcCccc----ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          262 ----EIKCMNPNYTE----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       262 ----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                          .......+...    ...+ .............++.++.+|+.+||.+||++|||+.++++||||+.++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~  305 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN  305 (314)
T ss_pred             cccCchhhhcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence                00000000000    0000 0001111112224567899999999999999999999999999999876443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-40  Score=295.56  Aligned_cols=245  Identities=21%  Similarity=0.342  Sum_probs=194.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ..|.+.+.||+|++|.||+|.+..+++.||+|.+..+..   ...+|+++++.++|+||+++++++...     ..++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEEE
Confidence            469999999999999999999999999999998865432   345799999999999999999887432     337899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||++ ++|.+.+...  ....+++..++.++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            99997 4776666432  23458999999999999999999998 9999999999999999888 799999999876543


Q ss_pred             CCCCc--eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .....  ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            22111  1223557999998855 458999999999999999998 999998876544433332210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           .          ...+..++.++.++|.+||..||++|||+.++++
T Consensus       223 -----~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 -----R----------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             -----C----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                 0          0112457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-40  Score=300.08  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=195.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ..+|.+.+.||+|+||.||+|.+..     +++.||+|.+....     ....+|+++++.++|+||+++++++...   
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence            4579999999999999999998753     46789999886532     2345799999999999999999988543   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhh----------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYS----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  173 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~  173 (376)
                        ...+++|||+.+ +|.+++....          .....+++..+..++.|++.||+|||+ +|++||||||+||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~  157 (280)
T cd05049          81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY  157 (280)
T ss_pred             --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence              348899999974 7777765432          122457889999999999999999998 99999999999999999


Q ss_pred             CCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017131          174 HTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  249 (376)
Q Consensus       174 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  249 (376)
                      ++ .++|+|||+++.......   .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus       158 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~  235 (280)
T cd05049         158 DL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE  235 (280)
T ss_pred             CC-eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            98 899999999875432221   123344678999999865 458999999999999999998 999998776555444


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       250 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .+...  ..                          ...+..++..+.+++.+||+.||.+||++.++++
T Consensus       236 ~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         236 CITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33321  00                          0011357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=312.73  Aligned_cols=245  Identities=19%  Similarity=0.284  Sum_probs=193.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ....+...||+|.||+||+|++..+   ||||++..+.      +.+..|+.++++-+|.||+-+.+++.     +.. +
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~-~  462 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPP-L  462 (678)
T ss_pred             HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCc-e
Confidence            4567889999999999999998643   9999986542      34567999999999999999999883     223 3


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .+|+.+|+| +|+.+++..   ...|.....+.|+.|+++|+.|||. ++|||||||..||++.+++ .|||+|||++..
T Consensus       463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFGLATV  537 (678)
T ss_pred             eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEecccceee
Confidence            789999998 777777653   2568889999999999999999998 9999999999999999887 899999999853


Q ss_pred             c---cCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          189 L---VKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       189 ~---~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      -   ..........+...|||||++..  ..+|++++||||+|+++|||+||..||........+..+-+....|...  
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s--  615 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS--  615 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch--
Confidence            2   11222233456778999999953  3458999999999999999999999999555444433332222222211  


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                            .+..+++.++++|+..||.+++++||...+||.
T Consensus       616 ----------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  616 ----------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ----------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                  112468889999999999999999999998875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.8e-40  Score=300.32  Aligned_cols=252  Identities=29%  Similarity=0.449  Sum_probs=200.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .|.....||+|+||.||++.+..+++.||||++....    ....+|+.+++.++|+||+++++.+...     .+.+++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv   95 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVV   95 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEE
Confidence            4556678999999999999999999999999874322    2345699999999999999999988543     348899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+++ ++.+++.     ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~  168 (292)
T cd06657          96 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSK  168 (292)
T ss_pred             EecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceeccc
Confidence            999986 5544432     2468999999999999999999998 9999999999999999988 799999998865533


Q ss_pred             CC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017131          192 GE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  270 (376)
Q Consensus       192 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  270 (376)
                      .. ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+....  +.           
T Consensus       169 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~-----------  234 (292)
T cd06657         169 EVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP-----------  234 (292)
T ss_pred             ccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--Cc-----------
Confidence            22 1233457888999998854 447899999999999999999999998766554443332211  00           


Q ss_pred             ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                         .+        .  ....+++.+.+++.+||..||.+||++.+++.||||.....
T Consensus       235 ---~~--------~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         235 ---KL--------K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             ---cc--------C--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence               00        0  01346889999999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.1e-40  Score=296.90  Aligned_cols=245  Identities=33%  Similarity=0.578  Sum_probs=200.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      +|.+.+.||+|++|.||+|.+..+++.||+|++.+.       .....+|+.+++.+. |+||+++++++..     ...
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cce
Confidence            699999999999999999999999999999988542       123457899999998 9999999998733     334


Q ss_pred             EEEEEecc-cccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~-~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++||++ .++|.+.+..    ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            88999999 4677766654    3479999999999999999999998 9999999999999999888 79999999987


Q ss_pred             cccCCCC---------------------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH
Q 017131          188 VLVKGEP---------------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  246 (376)
Q Consensus       188 ~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  246 (376)
                      .......                     .....++..|+|||.+.+ ..++.++|+||||++++++++|..||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            5533221                     112345788999998855 448899999999999999999999998877544


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH----HHHhcCCcc
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFF  322 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~~ll~hp~f  322 (376)
                      .+..+...                 ...            ++..+++.+.+||.+||+.||.+||++    .++++||||
T Consensus       230 ~~~~~~~~-----------------~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKL-----------------EYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhc-----------------CCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44443321                 111            123568999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-39  Score=289.74  Aligned_cols=250  Identities=35%  Similarity=0.536  Sum_probs=201.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+....      ....+|+.+++.++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4889999999999999999999999999999886543      23457999999999999999998875431   24578


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++||++ +++.+++..    ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999995 577666654    2378999999999999999999998 9999999999999999887 8999999998776


Q ss_pred             cCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....   .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+...  ........          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc----------
Confidence            55432   3345678889999998554 48999999999999999999999998766211  11111100          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                    ......++..++..++++|.+||+.||.+||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000011224568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.8e-40  Score=294.16  Aligned_cols=249  Identities=25%  Similarity=0.450  Sum_probs=197.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc---------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|.+.+.||+|+||.||++.+..++..+++|.+...         .....+|+.+++.++||||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-----   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----
Confidence            599999999999999999999888777777765321         112346889999999999999999874332     


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..++++||+.+ ++...+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++. + .++|+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-C-CEeecccCce
Confidence            37899999985 7777776655555679999999999999999999998 99999999999999985 4 6999999998


Q ss_pred             ccccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+...   +       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~-------  221 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---P-------  221 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---C-------
Confidence            76533322 223456788999998854 44788999999999999999999999765544333332210   0       


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                               .+         .++..++.++.++|.+||..||++||++.++++||||
T Consensus       222 ---------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ---------TP---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ---------CC---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                     00         0113578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.9e-40  Score=298.03  Aligned_cols=256  Identities=28%  Similarity=0.462  Sum_probs=200.3

Q ss_pred             ceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc--------ccHHHHHHHHHhC-CCCCeeeccceeeecCCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (376)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|++....        ....+|+.+++.+ +|+||+++++++.     
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-----   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence            3899999999999999999975   478999999886421        2345699999999 5999999988873     


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      .+..+|+||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeC
Confidence            33458899999985 66555543    4568999999999999999999998 9999999999999999988 8999999


Q ss_pred             CCcccccCCC--CCceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          184 GSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       184 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |++.......  ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+.......  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987653322  12234578889999998643 246789999999999999999999997543332222222211000  


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  328 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~~  328 (376)
                                 .            ..++..+++.+.+++.+||..||.+|+     ++.+++.||||+...+.
T Consensus       228 -----------~------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         228 -----------E------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             -----------C------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence                       0            001235788999999999999999997     78999999999988753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.7e-40  Score=296.19  Aligned_cols=249  Identities=21%  Similarity=0.289  Sum_probs=192.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|++....     ....+|+.+++.++||||+++++++..    
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----   80 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   80 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC----
Confidence            4579999999999999999998752     45679999875432     123479999999999999999988732    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                       ....++||||+++ +|.+++......      ...++...+..++.|++.||.|||+ .|++||||||+||+++.++ .
T Consensus        81 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~-~  157 (277)
T cd05062          81 -GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  157 (277)
T ss_pred             -CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-C
Confidence             2347899999984 777777543211      1235778889999999999999998 9999999999999999988 7


Q ss_pred             eEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  253 (376)
                      ++|+|||+++........   ....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998754332211   12234677999999865 458999999999999999999 7899987765444433322


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      . +                  .+         ..+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       237 ~-~------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 G-G------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             C-C------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1 0                  00         0113578899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.2e-40  Score=288.79  Aligned_cols=248  Identities=29%  Similarity=0.484  Sum_probs=201.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .|.+.+.||+|++|.||++.+..+++.+++|++....    ....+|+.+++.++|+|++++++++...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            3889999999999999999999899999999986543    3456799999999999999999988443     337899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      +||++ ++|.+.+...   ...+++..+..++.|++.||++||+ +|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 5776665542   2578999999999999999999998 9999999999999999887 799999999876654


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+........... ..+.            
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------  216 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------  216 (253)
T ss_pred             cccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC------------
Confidence            4323455678889999998654 4889999999999999999999999876544443332220 0000            


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                         .+          ....++..+.++|.+||+.||++|||+.+++.|||
T Consensus       217 ---~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ---LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ---cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence               00          00124889999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.7e-40  Score=302.28  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=191.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcE--EEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..|++.+.||+|+||.||+|.+..++..  +|+|.+....     ....+|+.++.++ +|+||+++++++..     ..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----CC
Confidence            4799999999999999999999877764  5777654321     2345799999999 89999999998733     33


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  174 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~  174 (376)
                      +.++||||++ ++|.+++.....            ....+++..++.++.|++.||+|||+ +|++||||||+|||++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCC
Confidence            4889999997 577777764321            12358899999999999999999998 999999999999999988


Q ss_pred             CCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017131          175 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       175 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  253 (376)
                      + .+||+|||++..............+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             C-cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            8 799999999864322111112223567999998854 458999999999999999998 9999987665443332211


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .                  ....          .+..+++++.+||.+||+.||.+||++.+++.+
T Consensus       239 ~------------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 G------------------YRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             C------------------CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                  0000          112468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=288.91  Aligned_cols=246  Identities=35%  Similarity=0.581  Sum_probs=201.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +|.+.+.||+|++|.||++.+..+++.||+|.+.....      ...+|+++++.++|+|++++++++...     .+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEE
Confidence            48999999999999999999999999999998865432      345799999999999999999887432     3488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+++ +|.+++..    ...+++..++.++.|++.||.+||+ .||+||||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 66665543    3578999999999999999999998 9999999999999999887 8999999998766


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+......+....              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            44332 22345688899999986544 889999999999999999999999876644444333210              


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                           ..         ..++..++..+.+++.+||..+|++|||+.+++.||||
T Consensus       215 -----~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 -----DH---------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             -----CC---------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                 00         01224578999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.9e-40  Score=327.16  Aligned_cols=142  Identities=27%  Similarity=0.428  Sum_probs=123.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||.|+||+||+|.+..+++.||||++....       ....+|+.+++.++||||++++.++..     ..
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----AN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CC
Confidence            357999999999999999999999999999999986532       345679999999999999999887733     23


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ++|+||||+. ++|..++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls  151 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLS  151 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCC
Confidence            4889999996 477666653    3568999999999999999999998 9999999999999999888 7999999987


Q ss_pred             c
Q 017131          187 K  187 (376)
Q Consensus       187 ~  187 (376)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.3e-40  Score=297.51  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=194.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      +..|.+.+.||+|+||+||++.+.     .++..+|+|.+....    ....+|+.+++.++||||+++++++..     
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            457999999999999999999863     345679999886432    234579999999999999999998743     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhh---------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSR---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                      ..+.+++|||+. ++|.+++.....         ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            234789999997 477777654321         12348999999999999999999998 9999999999999999988


Q ss_pred             CCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017131          176 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  251 (376)
Q Consensus       176 ~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  251 (376)
                       .++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+
T Consensus       158 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         158 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             -cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             799999999875533221   112234667999999855 458999999999999999998 99999877655544444


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ....  .                 .         ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus       236 ~~~~--~-----------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         236 TQGR--V-----------------L---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HcCC--c-----------------C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3210  0                 0         011347889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.4e-40  Score=299.49  Aligned_cols=248  Identities=22%  Similarity=0.297  Sum_probs=191.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc--EEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+....     ....+|+.++.++ +||||+++++++..     ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence            469999999999999999999887765  46888775321     2345799999999 79999999998733     23


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  174 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~  174 (376)
                      .+++++||++ ++|.+.+.....            ....+++..++.++.|++.||+|||+ +||+||||||+||+++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCC
Confidence            4789999997 477777754221            11358899999999999999999998 999999999999999988


Q ss_pred             CCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017131          175 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       175 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  253 (376)
                      + .+||+|||++..............+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 799999999864322111111222456999999855 448999999999999999997 9999988776554444322


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ...                  .          ..+..++..+.+||.+||..||.+|||++++++.
T Consensus       234 ~~~------------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYR------------------M----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC------------------C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                  0          0113578999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-40  Score=294.37  Aligned_cols=251  Identities=21%  Similarity=0.296  Sum_probs=193.9

Q ss_pred             eEEeeeeeecCceEEEEEEECC---CCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      |.+.+.||+|+||.||+|.+..   ++..||+|.+..+.      ....+|+..++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999999764   34789999886432      234579999999999999999987754433 2344


Q ss_pred             EEEEEEecccc-cHHHHHHHhhh--hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ..++++||+.+ ++...+.....  ....+++..+..++.|++.||.|||+ +|++||||||+||++++++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence            57899999984 77666654321  12468999999999999999999998 9999999999999999987 79999999


Q ss_pred             CcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          185 SAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       185 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +++........   .....+..|+|||.+.+ ..++.++|+|||||++|||++ |.+||.+.+..+....+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            99765433211   11223567999999854 458999999999999999999 999998766544433332210     


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                 ...            .+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       233 -----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 -----------RLK------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             -----------CCC------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       000            113578999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.9e-40  Score=301.06  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=190.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcE----EEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++.+.||+|+||.||+|.+..+++.    ||+|.+....     ....+|+.+++.++||||+++++++...    
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence            35799999999999999999998766664    8999875332     2344689999999999999999887432    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        ..+++++|+. |++.+.+..   ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        82 --~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG  154 (316)
T cd05108          82 --TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFG  154 (316)
T ss_pred             --CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEcccc
Confidence              1568899887 467666653   23458889999999999999999998 9999999999999999888 79999999


Q ss_pred             CcccccCCCCCce---eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          185 SAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       185 ~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +++..........   ..++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+ +..+....     
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~-----  227 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKG-----  227 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCC-----
Confidence            9986643332211   223567999999865 458999999999999999997 999997765433 23332210     


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                  ...+          .+..++.++.+++.+||..||.+||++.+++.+
T Consensus       228 ------------~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         228 ------------ERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------------CCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        0000          013467899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=339.18  Aligned_cols=256  Identities=28%  Similarity=0.463  Sum_probs=208.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      -..+++-..+||.|.||.||.|.+..||+..|+|-+.-.      .....+|..+|..++|||+|+++++=.+...    
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek---- 1308 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK---- 1308 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH----
Confidence            345788899999999999999999999999999976421      2345589999999999999999988755444    


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                       +++.||||++ +|.+++..    ++..++...+.+..|++.|+.|||+ +|||||||||.||+++.+| .+|++|||.|
T Consensus      1309 -v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1309 -VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSA 1381 (1509)
T ss_pred             -HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeecccce
Confidence             7789999985 66666654    4457777888899999999999998 8999999999999999999 8999999999


Q ss_pred             ccccCCC-----CCceeeeeccccchhhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCC
Q 017131          187 KVLVKGE-----PNVSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTP  258 (376)
Q Consensus       187 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~  258 (376)
                      .....+.     ......||+.|||||++.+..  ....+.|||||||+..||+||+.||...+. +..++.+.. ..  
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh-- 1458 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GH-- 1458 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cC--
Confidence            8775542     224678999999999997643  357799999999999999999999987553 333333322 11  


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                                      .|+         ++.++|++.+|||.+||+.||++|+++.|++.|-|-+.-.+.
T Consensus      1459 ----------------~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1459 ----------------KPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             ----------------CCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                            111         234689999999999999999999999999999998775543

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7e-40  Score=295.80  Aligned_cols=256  Identities=30%  Similarity=0.460  Sum_probs=206.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ....|++.+.||+|++|.||+|.+..++..||+|.+....   ....+|+++++.++|+|++++++++...     ...+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEE
Confidence            4456999999999999999999999899999999986543   2445799999999999999999988554     3488


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++||++ ++|.+++....   ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhh
Confidence            9999999 58877776532   379999999999999999999998 9999999999999999888 7999999987654


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.         
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---------  235 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP---------  235 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence            3221 11233467889999998654 4899999999999999999999999876655444433221 0000         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            .          .....++.++.+||.+||+.+|.+||++.+++.||||++..
T Consensus       236 ------~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         236 ------L----------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             ------C----------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                  0          00123688999999999999999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.2e-40  Score=294.17  Aligned_cols=249  Identities=28%  Similarity=0.448  Sum_probs=195.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .+|++.+.||.|++|.||+|.+..+++.+|||.+....       ....+|+.+++.++|+||+++++++...     ..
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence            36899999999999999999999999999999875321       2334699999999999999999988543     34


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++|||+.+ +|.+++.........+++..++.++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence            7899999985 7877776544445678999999999999999999998 9999999999999999888 79999999987


Q ss_pred             cccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCHHHHhh
Q 017131          188 VLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       188 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.... ....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----------  223 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC----------
Confidence            6543322 223467888999999855 44889999999999999999999999764422 1111111100          


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                              ..+..        ....+++.++++|.+||..||.+|||+.++++
T Consensus       224 --------~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         224 --------DYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             --------CCCCC--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                    00000        01247889999999999999999999997753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.6e-40  Score=293.70  Aligned_cols=251  Identities=20%  Similarity=0.271  Sum_probs=190.8

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCc--EEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCC-CCceE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  108 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  108 (376)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.+...      .....+|+.+++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999887775  6899987542      1234468999999999999999987654322 12234


Q ss_pred             EEEEEeccc-ccHHHHHHHhhh--hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          109 LNLVLEYVP-ETVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .+++|||+. +++.+.+.....  ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 466665533221  22358899999999999999999998 9999999999999999888 799999999


Q ss_pred             cccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          186 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       186 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ++.......   .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+.+. .     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~-----  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-N-----  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-C-----
Confidence            986543321   112234667999999854 458999999999999999999 89999876654433332210 0     


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                  ..          ..+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       232 ------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 ------------RL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ------------CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                        00          0113578899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=293.08  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=194.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCC-----CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++||||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG---   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence            45899999999999999999998654     3789999875432     2345799999999999999999987433   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                        ...++||||++ ++|.+.+......      ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .
T Consensus        82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-C
Confidence              34789999997 5887777653321      2247888999999999999999998 9999999999999999998 8


Q ss_pred             eEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  253 (376)
                      +||+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            99999999875533221   122345678999999854 448999999999999999998 9999987665444333321


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                       ...               ..            ++..++.++.++|.+||+.+|++|||+.++++
T Consensus       237 -~~~---------------~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 -GGH---------------LD------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -CCC---------------CC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             000               00            11346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-39  Score=290.41  Aligned_cols=245  Identities=24%  Similarity=0.328  Sum_probs=193.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.++||+|++|.||+|.+. ++..||+|.+....   ....+|+.+++.++|+||+++++++..     ....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcEE
Confidence            457999999999999999999975 45779999876432   234579999999999999999887733     233789


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+. ++|.+++...  ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 4777766542  23568888999999999999999998 9999999999999999888 79999999997654


Q ss_pred             CCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+.......+....            
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------  221 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY------------  221 (261)
T ss_pred             CCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC------------
Confidence            3221  112234567999999854 458899999999999999998 999998766555444433210            


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                            ..+          ....++.++.+++.+||..||++||+++++.+
T Consensus       222 ------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 ------RMP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ------CCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                  000          01347889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.9e-40  Score=290.05  Aligned_cols=245  Identities=20%  Similarity=0.287  Sum_probs=192.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ...|++.+.||+|+||+||.|.+.. +..+|+|.+....   ....+|+.+++.++||||+++++++...     ..+++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYI   76 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEE
Confidence            3579999999999999999998754 4469999886432   2345799999999999999999987332     23789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+.+ ++.+.+...   ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .+||+|||.++...
T Consensus        77 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~  151 (256)
T cd05113          77 VTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVL  151 (256)
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecC
Confidence            9999975 666665432   2368999999999999999999998 9999999999999999888 89999999987554


Q ss_pred             CCCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .....  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.+....          
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  220 (256)
T cd05113         152 DDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------  220 (256)
T ss_pred             CCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------
Confidence            33211  112335679999999654 48999999999999999998 99999876654444444321100          


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                        ..+...+..+++++.+||..||.+||++.+++.+
T Consensus       221 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 ------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                              0012367899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9e-40  Score=289.54  Aligned_cols=238  Identities=23%  Similarity=0.309  Sum_probs=184.8

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      +.||+|+||.||+|.+..+++.||+|.+....     ....+|+++++.++||||+++++++...     ...++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence            46899999999999999999999999875432     2345799999999999999999987433     3378999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  195 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  195 (376)
                      .+ ++.+.+..   ....+++..++.++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++.........
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            75 66655543   23468999999999999999999998 9999999999999999888 7999999998754322111


Q ss_pred             c---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          196 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       196 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .   ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+.......+....                
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~----------------  213 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----------------  213 (252)
T ss_pred             ccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------
Confidence            0   1112346999999855 448999999999999999998 899997655433322222100                


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..            .++..++..+.+|+.+||+.||++|||+.++++
T Consensus       214 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         214 RL------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CC------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00            011346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-39  Score=306.61  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=192.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCC-----CcEEEEEEeeccc-----ccHHHHHHHHHhCC-CCCeeeccceeeecC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTT  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  102 (376)
                      ...+|++++.||+|+||.||+|.+...     +..||||++....     ....+|+.+++.+. ||||+++++++..  
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            356899999999999999999987533     3479999886432     23457999999996 9999999998843  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhh----------------------------------------------------
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSR----------------------------------------------------  129 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------  129 (376)
                         ...+|+|||||++ +|.+++.....                                                    
T Consensus       113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence               2348899999974 77666654211                                                    


Q ss_pred             ----------------------------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcE
Q 017131          130 ----------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  169 (376)
Q Consensus       130 ----------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Ni  169 (376)
                                                              ....+++..+..++.|++.||+|||+ .||+||||||+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Ni  268 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhE
Confidence                                                    01347888899999999999999998 9999999999999


Q ss_pred             EEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 017131          170 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  245 (376)
Q Consensus       170 ll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  245 (376)
                      +++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......
T Consensus       269 ll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         269 LLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            999887 799999999876533221   122345677999999865 458999999999999999997 99999876544


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..........                 ...+          .+..++.++.+++.+||+.||++|||+.++.+
T Consensus       347 ~~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         347 STFYNKIKSG-----------------YRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHHhcC-----------------CCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            4333332210                 0000          11357899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-39  Score=289.32  Aligned_cols=250  Identities=29%  Similarity=0.491  Sum_probs=196.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+...       .....+|+++++.++|+|++++++.+...     ..
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence            4699999999999999999999999999999987531       22345799999999999999999988542     34


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++|||+++ +|..++.........+++..++.++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 8877776544444568999999999999999999998 9999999999999999988 79999999987


Q ss_pred             cccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||......  .........          
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~----------  221 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE----------  221 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhh----------
Confidence            553322 2234467888999999865 44899999999999999999999999654311  111111100          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           ....+..        ....++..+.++|.+||..+|++|||+.++++
T Consensus       222 -----~~~~~~~--------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         222 -----KCDYPPL--------PADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -----cCCCCCC--------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                 0000000        01246789999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-39  Score=288.93  Aligned_cols=243  Identities=22%  Similarity=0.314  Sum_probs=192.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .+|++.+.||+|+||.||++..+. +..+|+|.+....   ....+|+.+++.++||||+++++++...     ...+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEEE
Confidence            469999999999999999998754 5679999876432   2445799999999999999999887332     337899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||++ ++|.+.+...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            99997 4676655431   2358999999999999999999998 9999999999999999888 799999999875533


Q ss_pred             CCCCc--eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .....  ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ |+.||...+..+....+.....            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------  219 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------------  219 (256)
T ss_pred             CceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            22211  1233557999999854 458999999999999999999 9999988776555555433100            


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                          .            ..+...+.++.+++.+||+.||.+||++.++++
T Consensus       220 ----~------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 ----L------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----C------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                0            011235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=287.01  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=205.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHH-HhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ...+-+..||.|+||+|++..++.+|+..|||.+.....     .+..|.+.. +.-+.||||++|+..+...+     .
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c  138 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C  138 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence            455667789999999999999999999999999965332     223455443 34479999999999876655     7


Q ss_pred             EEEEecccccHHHHHHH-hhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++.||+|+-++..+-.. +.-....++|..+-.+..-.+.||.||.....|||||+||+|||++..| .|||||||.+..
T Consensus       139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHh
Confidence            89999999877654443 2233457999999999889999999999878999999999999999999 799999999977


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh-CCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  266 (376)
                      ..++-..+.-.|...|||||.+..... |+.++|+||||++|||+.||..|+.+.+.  .+.++.... |.|+.-     
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l-----  290 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL-----  290 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee-----
Confidence            666555566677888999999965443 89999999999999999999999987654  333333322 222211     


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                             ..+.       .  .-+.+..+..+|.-||.+|-+.||...+++++||++....
T Consensus       291 -------~~~~-------~--~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  291 -------LFDK-------E--CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             -------cCcc-------c--ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence                   0000       0  0247899999999999999999999999999999987643

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-39  Score=292.82  Aligned_cols=250  Identities=20%  Similarity=0.287  Sum_probs=193.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .++|.+.+.||+|++|.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||+++++++....  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence            3579999999999999999999987     77899999875332     23456999999999999999999874432  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCe
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQL  178 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~v  178 (376)
                         ..+++|||+. ++|.+++......   ...+++..+..++.||+.||+|||+ ++++||||||+||+++.++  ..+
T Consensus        83 ---~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          83 ---PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             ---CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence               3679999996 4787777653211   1258899999999999999999998 9999999999999998654  259


Q ss_pred             EEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017131          179 KLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  254 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~  254 (376)
                      ||+|||+++........   .....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999765322111   111224579999999654 48999999999999999997 99999877655433322210


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                       ..               .            ..+..++..+.+++.+||+.||++|||+.++++|
T Consensus       238 -~~---------------~------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 -GR---------------L------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -Cc---------------C------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             00               0            0123578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.2e-40  Score=296.77  Aligned_cols=247  Identities=20%  Similarity=0.261  Sum_probs=192.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCC-----CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .+|++.+.||.|+||.||+|.+..+     +..||||++....     ....+|+.++..++||||+++++++....   
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~---   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ---   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC---
Confidence            4688999999999999999997543     5789999986433     22457899999999999999999874332   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                        ..++++||+.+ ++.+++....            .....+++..+..++.|++.||+|||+ +||+||||||+||+++
T Consensus        82 --~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~  158 (283)
T cd05091          82 --PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF  158 (283)
T ss_pred             --ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence              37899999974 6666654211            112358888999999999999999998 9999999999999999


Q ss_pred             CCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q 017131          173 PHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  248 (376)
Q Consensus       173 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  248 (376)
                      .++ .+||+|||+++........   ....+++.|+|||.+.+. .++.++|+|||||++|||++ |..||.+....+..
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 7999999998765332211   122346789999998654 48999999999999999998 88999887665544


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       249 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+......                            .++..++.++.+|+.+||+.||.+||++.+++.
T Consensus       237 ~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         237 EMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            444331000                            012457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-39  Score=293.22  Aligned_cols=248  Identities=20%  Similarity=0.313  Sum_probs=192.5

Q ss_pred             cceEEeeeeeecCceEEEEEEEC----CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++.+.||+|+||+||+|...    .++..+|+|.+....     ....+|+.+++.++||||+++++++....    
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ----   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence            46999999999999999999853    456789999886422     23457999999999999999999874332    


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhh-------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSR-------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                       ..|++|||+.+ +|.+++.....             ....+++..+..++.|++.||+|||+ +|++||||||+||+++
T Consensus        81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~  158 (283)
T cd05090          81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG  158 (283)
T ss_pred             -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence             37899999985 77666643211             12347888999999999999999998 9999999999999999


Q ss_pred             CCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q 017131          173 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  248 (376)
Q Consensus       173 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  248 (376)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+..
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 799999999976533221   122334567999999865 448999999999999999998 99999876644333


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       249 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..+... ..                 .          ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       237 ~~~~~~-~~-----------------~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKR-QL-----------------L----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcC-Cc-----------------C----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            333221 00                 0          0113578999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-39  Score=289.09  Aligned_cols=243  Identities=25%  Similarity=0.358  Sum_probs=190.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|++.+.||+|+||.||+|.+..+ ..||+|.+....   ....+|+.+++.++||||+++++.+.    .  ...++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS----E--EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC----C--CCcEEE
Confidence            4799999999999999999998765 459999886533   23457999999999999999987652    1  126799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+.+ ++.+++...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 777666532  23457899999999999999999998 9999999999999999888 799999999976543


Q ss_pred             CCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ....  ....++..|+|||...+ ..++.++|+|||||++|+|++ |..||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  220 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------  220 (262)
T ss_pred             cccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------
Confidence            3221  12234567999998854 448999999999999999999 889998776554444332210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           ..          .....++..+.+++.+||+.||++||++.++++
T Consensus       221 -----~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 -----RM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----CC----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                 00          011357889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=288.74  Aligned_cols=244  Identities=22%  Similarity=0.323  Sum_probs=192.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .+|++.+.||+|++|.||+|.+.. ++.||+|.+....   ....+|+.+++.++||||+++++++...     ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCeeee
Confidence            469999999999999999999754 5779999886532   3355799999999999999999877432     237899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+. ++|.+.+....  ...+++..+..++.|++.||.+||+ +|++||||||+||+++.++ .++|+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99994 67877765422  3468999999999999999999998 9999999999999999988 799999999876542


Q ss_pred             CCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ....  .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+.......+....             
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  221 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-------------  221 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2111  11112346999998855 458999999999999999999 999998776555444432210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           ..+          .+..++..+.+++.+||+.||.+||++.+++.
T Consensus       222 -----~~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         222 -----RMP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----CCC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                 000          11346889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=288.80  Aligned_cols=242  Identities=26%  Similarity=0.387  Sum_probs=195.1

Q ss_pred             eeeeecCceEEEEEEECCC---CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+++++.++|+||+++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999999865   8899999986543     344579999999999999999988844     33488999


Q ss_pred             eccc-ccHHHHHHHhhhh-----cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          114 EYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       114 e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ||+. ++|.+.+......     ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence            9994 6887777653221     3679999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          188 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       188 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ......   ......++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            664432   12334567889999998654 58999999999999999999 699998876554444433210        


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                          ....+..+++++.+++.+||+.||.+|||+.+++++
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                001124578999999999999999999999999865

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=286.40  Aligned_cols=238  Identities=35%  Similarity=0.575  Sum_probs=194.1

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ||.|+||.||+|.+..+++.+|+|.+.+..       ....+|+.+++.++|+||+++++.+.     .....+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence            689999999999999899999999886532       24457999999999999999998873     334588999999


Q ss_pred             -cccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC-CC
Q 017131          117 -PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  194 (376)
Q Consensus       117 -~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-~~  194 (376)
                       +++|.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence             5677666654    3468999999999999999999998 9999999999999999988 7999999998765433 22


Q ss_pred             CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017131          195 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  274 (376)
Q Consensus       195 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .....++..|+|||.+.+. ..+.++|+||||+++|++++|..||...+.......+...                 ...
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~~  211 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----------------PLR  211 (250)
T ss_pred             ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----------------CCC
Confidence            3345568889999998654 4788999999999999999999999776653333333220                 011


Q ss_pred             CCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH---HHHhcCCcc
Q 017131          275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF  322 (376)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~---~~ll~hp~f  322 (376)
                                  ++..++..+.++|++||..||.+||++   +++++||||
T Consensus       212 ------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         212 ------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                        123468999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=289.44  Aligned_cols=244  Identities=22%  Similarity=0.327  Sum_probs=191.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+.+..   ....+|+.+++.++||||+++++++..     ..+.++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCceEEE
Confidence            46999999999999999999986 46689999886432   234579999999999999999887732     2347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+++ +|.+.+...   ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||+++....
T Consensus        78 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceeccc
Confidence            999975 676665432   2368999999999999999999998 9999999999999999988 799999999876533


Q ss_pred             CCCCc--eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPNV--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .....  ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-------------  218 (256)
T ss_pred             ccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            22111  1122346999999865 458999999999999999999 899998766554443332210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                           ..          ..+..++..+.+++.+||..+|++|||+.++++.
T Consensus       219 -----~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 -----RL----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -----cC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                 00          0113478999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.2e-39  Score=291.78  Aligned_cols=254  Identities=20%  Similarity=0.211  Sum_probs=186.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCC---CcEEEEEEeecccccHH---------------HHHHHHHhCCCCCeeeccce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVALKHC   97 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~~iv~~~~~   97 (376)
                      .+|++.+.||+|+||+||+|.+..+   +..+|+|+.........               .+...+..+.|+|++.++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998877   67788886433222211               12234456689999999887


Q ss_pred             eeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131           98 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                      ..... ....+.+++++++..++..++..    ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-c
Confidence            64433 22345678899887776655543    2346788899999999999999998 9999999999999999887 7


Q ss_pred             eEEEecCCcccccCCC--------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 017131          178 LKLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  249 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  249 (376)
                      ++|+|||+|+......        ......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999997653221        1123468999999999865 458999999999999999999999998774333222


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       250 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ...+.      +.+..+...  ...             ...+++.+.++++.|+..+|.+||+..++++
T Consensus       244 ~~~~~------~~~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKC------DFIKRLHEG--KIK-------------IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHH------HHHHHhhhh--hhc-------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            21111      000000000  000             1346889999999999999999999998864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.9e-39  Score=314.17  Aligned_cols=281  Identities=22%  Similarity=0.273  Sum_probs=184.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCC----CcEEEEEEeecccccHHHHHHHHHhC---CCCCeeeccceeeecCC-CC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQDKRYKNRELQIMQML---DHPNIVALKHCFFSTTD-KE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~-~~  105 (376)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|++.....   .|+.+...+   .+.++..+...+..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456899999999999999999999988    89999998754321   233322222   33334433333322111 33


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhh----------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSR----------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  168 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~N  168 (376)
                      ....++|+||+++ +|.+++.....                .........++.++.||+.||+|||+ +||+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence            4447899999985 67666653210                00112234577899999999999998 999999999999


Q ss_pred             EEEcCCCCCeEEEecCCcccccCC--CCCceeeeeccccchhhhcCCC---------------------CCCCchhHHHH
Q 017131          169 LLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRYYRAPELIFGAT---------------------EYTTAIDIWST  225 (376)
Q Consensus       169 ill~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diwsl  225 (376)
                      ||++.+...+||+|||+|+....+  .......+++.|+|||.+....                     .++.++||||+
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            999864337999999999754322  2234567899999999763221                     23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhcc
Q 017131          226 GCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY  305 (376)
Q Consensus       226 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  305 (376)
                      ||++|||+++..+  ..+....+..++...+... ..|.......   ..+..  ......+ ...+..+.+||++||++
T Consensus       366 GviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~~~~--~~~~~~~-d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDL-VAWRKLVEPR---ASPDL--RRGFEVL-DLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcH-HHHHHhhccc---cchhh--hhhhhhc-cccchHHHHHHHHHccC
Confidence            9999999986644  3444445555544433322 2221111000   00000  0000000 12345677999999999


Q ss_pred             CCCCCCCHHHHhcCCcccccCC
Q 017131          306 SPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       306 dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      ||++|||+.++|+||||++...
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999987543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-39  Score=292.68  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=196.9

Q ss_pred             ceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc--------ccHHHHHHHHHhC-CCCCeeeccceeeecCCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (376)
                      .|++.+.||+|++|.||+|.+.   .+++.||||.+.+..        ....+|+.++..+ +||||+++++++..    
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~----   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT----   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence            3899999999999999999864   467889999886421        2234699999999 59999999988732    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       ....++||||+.+ +|...+..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++ .++|+||
T Consensus        77 -~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          77 -DTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             -CCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEEC
Confidence             3347899999985 66554432    3568999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccCCCC--CceeeeeccccchhhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          184 GSAKVLVKGEP--NVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       184 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |+++.......  .....++..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+.......+.+....   
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---  226 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK---  226 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence            99876543322  12345688899999985432 3688999999999999999999999754332222222221000   


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC---HHHHhcCCcccccCCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDP  328 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~ll~hp~f~~~~~~  328 (376)
                                  ..          ...+..++.++.++|.+||+.||++|||   +.++|+||||+.+.++
T Consensus       227 ------------~~----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         227 ------------SK----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             ------------cC----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                        00          0011347889999999999999999998   5678999999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-39  Score=292.17  Aligned_cols=256  Identities=26%  Similarity=0.357  Sum_probs=188.2

Q ss_pred             eEEeeeeeecCceEEEEEE----ECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           38 YIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      |++.+.||+|+||+||++.    ...++..||+|.+....     ....+|+.+++.++||||+++++++...   ....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCce
Confidence            4999999999999998865    34568899999886432     2345799999999999999999876432   2345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ++++|||+.+ ++.+.+..     ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||+++
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeeccccc
Confidence            7899999985 66555542     469999999999999999999998 9999999999999999887 79999999987


Q ss_pred             cccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH-hCCCCHHH
Q 017131          188 VLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREE  262 (376)
Q Consensus       188 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~  262 (376)
                      ........    ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......  +...... .+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~  232 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVR  232 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhh
Confidence            65432221    12234566999999854 45899999999999999999999998654321  1111110 00000000


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +...            .........+..++..+.+++.+||+.||++|||+.+++.
T Consensus       233 ~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         233 LIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000            0000001122457899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-39  Score=292.80  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=194.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|.+.+.||+|+||.||+|.+..     ++..+++|.+....    ....+|+.+++.++|+||+++++++...    
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   79 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----   79 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC----
Confidence            3569999999999999999998643     45669999876433    3456899999999999999999987432    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                       ...++||||++ ++|.+.+.....            ....+++..++.++.||+.||+|||+ +||+||||||+||+++
T Consensus        80 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~  157 (291)
T cd05094          80 -DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVG  157 (291)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc
Confidence             33789999997 577777764321            12358899999999999999999998 9999999999999999


Q ss_pred             CCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q 017131          173 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  248 (376)
Q Consensus       173 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  248 (376)
                      .++ .++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+..
T Consensus       158 ~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         158 ANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             cCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            988 899999999875533221   123345678999999865 458999999999999999999 99999876655443


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       249 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+...                   ..+.         ....++..+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~-------------------~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         236 ECITQG-------------------RVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHhCC-------------------CCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            332210                   0000         11346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=288.13  Aligned_cols=245  Identities=25%  Similarity=0.338  Sum_probs=192.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCC---CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+|++.+.||+|+||+||+|.+..+   ...||||.+....     ....+|+.+++.++||||+++++.+..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----SR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----CC
Confidence            5799999999999999999998654   4579999875432     223469999999999999999998733     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+++|||+.+ +|.+.+...   ...+++..+..++.|++.||+|||+ +||+|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchh
Confidence            37899999975 776666532   2468999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCCCCCc---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          187 KVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       187 ~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      +.........   ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------  225 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------  225 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-------
Confidence            8764221111   1223567999999854 458999999999999999998 999997766544443332210       


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                 ..+          .+..++..+.+|+.+||+.||++||++.+++++
T Consensus       226 -----------~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         226 -----------RLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -----------CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                       000          013468899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-39  Score=294.38  Aligned_cols=249  Identities=22%  Similarity=0.343  Sum_probs=193.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCC-----cEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      ..+|++.+.||+|+||.||++.+...+     ..+|+|.+....     ....+|+.+++.+ +|+||+++++++..   
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   87 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ---   87 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC---
Confidence            457999999999999999999986443     689999886432     2244799999999 89999999988733   


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  170 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nil  170 (376)
                        ...++++|||+.+ +|..++....            .....+++..+..++.|++.||+|||+ .||+||||||+||+
T Consensus        88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil  164 (293)
T cd05053          88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL  164 (293)
T ss_pred             --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence              2337899999874 7777765421            234568999999999999999999998 99999999999999


Q ss_pred             EcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 017131          171 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  246 (376)
Q Consensus       171 l~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  246 (376)
                      ++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+
T Consensus       165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99888 899999999976543221   111223467999998854 458999999999999999997 999998766544


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ....+....                  ..          ..+..++.++.+|+.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~~~~------------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGY------------------RM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCC------------------cC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            443322110                  00          0113468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-39  Score=290.21  Aligned_cols=245  Identities=21%  Similarity=0.321  Sum_probs=196.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...|++.+.||.|+||.||+|.+.. ++.+|+|.+....    ....+|+.+++.++|+||+++++++...     ...+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeE
Confidence            3579999999999999999999987 8899999986543    2345799999999999999998887433     2378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++|||+++ +|.+++...  ....+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++ .+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999985 887777542  23568999999999999999999998 9999999999999999988 7999999998765


Q ss_pred             cCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          190 VKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       190 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+.+..+.....           
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------  222 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-----------  222 (261)
T ss_pred             CCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-----------
Confidence            32211 112234567999999855 458999999999999999998 8999988776555554432110           


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                             .          ..+..+++.+.+++.+||+.||.+|||+.++++
T Consensus       223 -------~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 -------M----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -------C----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                   0          011357899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4e-39  Score=286.08  Aligned_cols=242  Identities=23%  Similarity=0.323  Sum_probs=191.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      .+|++.+.||+|+||.||++...  |..+|+|.+..+..  ...+|+.+++.++|+|++++++++...    ....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            47999999999999999999865  78899998865432  345799999999999999999876432    22378999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+++ +|.+.+...  ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99985 777766542  12348889999999999999999998 9999999999999999888 8999999998754332


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .  ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||...+..+....+.+..                
T Consensus       156 ~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  216 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  216 (256)
T ss_pred             C--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2  22334567999999854 458999999999999999997 999998765444333332210                


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                  .......+++.+.+++.+||..||.+|||+.++++
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        00112457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.1e-39  Score=289.13  Aligned_cols=244  Identities=21%  Similarity=0.316  Sum_probs=189.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCc----EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++.+.||+|+||+||+|.+..+++    .||+|.+....     ....+|+.+++.++||||+.+++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            4579999999999999999999877776    48999875432     2344789999999999999998877421    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        ..+++++|++ |++.+.+..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG  154 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFG  154 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCC
Confidence              1568999997 477665543   23468999999999999999999998 9999999999999999887 79999999


Q ss_pred             CcccccCCCCCc---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          185 SAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       185 ~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +++.........   ...++..|+|||.+.+. .++.++|+|||||++|||++ |..||......... ..+.....++ 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~-  231 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLP-  231 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC-
Confidence            997654322211   12235679999998654 48999999999999999998 99999765543322 2222110000 


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                                .+..++.++.+++.+||..||++||++.+++.
T Consensus       232 --------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 --------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             --------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      01346889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-39  Score=299.38  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=190.7

Q ss_pred             cceEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  104 (376)
                      ++|++.+.||+|+||.||+|.+     ..+++.||||.+....     ....+|+.++..+ +||||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---   83 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   83 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence            5799999999999999999985     3567899999986432     2345799999999 689999999877432   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhh------------------------------------------------------
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSR------------------------------------------------------  129 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  129 (376)
                       ...++++|||+++ +|.+++.....                                                      
T Consensus        84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             2347899999985 77776654210                                                      


Q ss_pred             ---------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC---ce
Q 017131          130 ---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VS  197 (376)
Q Consensus       130 ---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~  197 (376)
                               ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++........   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence                     01347888889999999999999998 9999999999999999888 8999999998764322211   11


Q ss_pred             eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 017131          198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  276 (376)
Q Consensus       198 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+...............               ...  
T Consensus       241 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------~~~--  302 (343)
T cd05103         241 ARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------RMR--  302 (343)
T ss_pred             CCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---------------CCC--
Confidence            233567999999865 458999999999999999997 9999987654333322222100               000  


Q ss_pred             CccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                .+...++++.+++.+||+.||.+|||+.++++|
T Consensus       303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      112357889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.5e-39  Score=286.45  Aligned_cols=242  Identities=24%  Similarity=0.334  Sum_probs=190.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|++.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+.+++.++|+|++++++++.    ..  ..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~~--~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----EE--PIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----CC--CcEEE
Confidence            47999999999999999999875 45679999886432   33558999999999999999988662    11  26799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+.+ +|.+++...  ....+++..++.++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            999975 777666532  23458999999999999999999998 9999999999999999887 799999999976533


Q ss_pred             CCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ....  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+..+....+.....            
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  221 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR------------  221 (260)
T ss_pred             cccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            2211  11233457999998854 458899999999999999999 8999988765555544432100            


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                            .          ..+...+..+.+|+.+||..||.+|||+.++.
T Consensus       222 ------~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         222 ------M----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             ------C----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                  0          01134688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-39  Score=291.79  Aligned_cols=255  Identities=19%  Similarity=0.276  Sum_probs=193.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCC----------------cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeee
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETG----------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVA   93 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~   93 (376)
                      ..+|++++.||+|+||.||+|.+..++                ..||+|.+....     ....+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999886544                568999886542     23457999999999999999


Q ss_pred             ccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhh-------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 017131           94 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK  165 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlk  165 (376)
                      +++++...     ...+++||++.+ +|.+++.....       ....+++..++.++.|++.||+|||+ +|++|||||
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk  157 (296)
T cd05051          84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA  157 (296)
T ss_pred             EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence            99887432     347899999974 77776654321       11258999999999999999999998 999999999


Q ss_pred             CCcEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q 017131          166 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFP  240 (376)
Q Consensus       166 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~  240 (376)
                      |+||+++.++ .++|+|||+++.......   .....+++.|+|||.+.+ ..++.++|+|||||++|+|++  |..||.
T Consensus       158 p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         158 TRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             hhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999987 899999999875433221   122344678999999865 358999999999999999998  778887


Q ss_pred             CCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          241 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+..+.+............           ....          ..+..++.++.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-----------~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDGR-----------QIYL----------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CcChHHHHHHHHhccccccc-----------cccC----------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            76655544443322100000           0000          011346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-39  Score=286.19  Aligned_cols=228  Identities=25%  Similarity=0.324  Sum_probs=181.4

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHH
Q 017131           47 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIAR  125 (376)
Q Consensus        47 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  125 (376)
                      |.+|.||+|++..+++.||+|.+..... ..+|...+....||||+++++++...     ...+++|||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHH
Confidence            8999999999999999999999876443 34566666667899999999988432     348899999985 7766664


Q ss_pred             HhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeecccc
Q 017131          126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR  205 (376)
Q Consensus       126 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~  205 (376)
                      .    ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .++++|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            3    2458999999999999999999998 9999999999999999988 7999999987654322  22334567799


Q ss_pred             chhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcccccccc
Q 017131          206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  285 (376)
Q Consensus       206 aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (376)
                      |||.+.+ ..++.++|+||+||++|+|++|..||......     + .               .....            
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~---------------~~~~~------------  195 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N---------------THTTL------------  195 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c---------------ccccc------------
Confidence            9998854 44789999999999999999999887532110     0 0               00000            


Q ss_pred             ccccCCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCcc
Q 017131          286 VFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFF  322 (376)
Q Consensus       286 ~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~~ll~hp~f  322 (376)
                      .++..+++.++++|.+||+.||.+|+++     +++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1224578999999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.4e-39  Score=287.11  Aligned_cols=244  Identities=27%  Similarity=0.379  Sum_probs=191.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+....     ....+|+.+++.++||||+++++++..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence            479999999999999999999865544   79999875432     234579999999999999999988732     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      +.+++|||+++ +|.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            47899999975 67666643   23468999999999999999999998 9999999999999999888 7999999999


Q ss_pred             ccccCCCCCc----eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ..........    ...++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+..      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------  226 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------  226 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC------
Confidence            7654332211    1112457999999965 458999999999999999886 999998776555444333210      


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                  ..+          .+..+++.+.+++.+||+.+|.+||++.++++
T Consensus       227 ------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         227 ------------RLP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ------------cCC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                        000          01346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-38  Score=284.24  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=191.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|++.+.||+|++|.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc----C--CCcEEE
Confidence            5799999999999999999998665 459999876433   23457999999999999999987762    1  126799


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||+++....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 777777542  23457899999999999999999998 9999999999999999988 799999999976533


Q ss_pred             CCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ....  ....++..|+|||...+ ..++.++|+||||+++|+|++ |..||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  220 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------------  220 (260)
T ss_pred             CcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            2211  12234567999998854 448999999999999999999 999998876555444432210             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           ..          .++...+..+.+++++||..||.+||+++++++
T Consensus       221 -----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 -----RM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----CC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                 00          011357889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.9e-39  Score=293.24  Aligned_cols=247  Identities=22%  Similarity=0.327  Sum_probs=190.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECC-------CCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  102 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  102 (376)
                      ++|.+.+.||+|+||.||+|.+..       ++..+|+|.+..+.     ....+|+.+++.+ +||||+++++++... 
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-   96 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-   96 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence            579999999999999999998743       23469999886532     1234689999999 799999999987432 


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  169 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Ni  169 (376)
                          ...++||||+.+ +|.+++.....            ....+++..+..++.|++.||+|||+ +|++||||||+||
T Consensus        97 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  171 (307)
T cd05098          97 ----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  171 (307)
T ss_pred             ----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHhe
Confidence                347899999974 78777765321            12358889999999999999999998 9999999999999


Q ss_pred             EEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 017131          170 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  245 (376)
Q Consensus       170 ll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  245 (376)
                      +++.++ .++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..
T Consensus       172 ll~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         172 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             EEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            999888 799999999875533211   111223467999999865 448999999999999999998 88999765543


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +... .+....                 .          ...+..++.++.+|+.+||..+|.+|||+.++++
T Consensus       250 ~~~~-~~~~~~-----------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         250 ELFK-LLKEGH-----------------R----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HHHH-HHHcCC-----------------C----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            3222 222100                 0          0011357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.9e-39  Score=291.10  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=193.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeec
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  101 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  101 (376)
                      -..++|.+.+.||+|+||.||+|.+     ..++..+|+|.+....     ....+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            3446899999999999999999986     3345689999886432     2345799999999 799999999987433


Q ss_pred             CCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          102 TDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                           ...+++|||+. ++|.+++....  ...+++..+..++.|++.||+|||+ ++|+|+||||+||+++.++ .++|
T Consensus       112 -----~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l  182 (302)
T cd05055         112 -----GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKI  182 (302)
T ss_pred             -----CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEE
Confidence                 23789999997 57766665311  2338999999999999999999998 9999999999999999887 7999


Q ss_pred             EecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhC
Q 017131          181 CDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  256 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  256 (376)
                      +|||+++........   ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+....+...+..... 
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-  260 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-  260 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-
Confidence            999998755432211   122346779999998654 48999999999999999998 999998776555444433210 


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                      ...          ..+...++++.+|+.+||..+|++|||+.++++
T Consensus       261 ----------------~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 ----------------YRM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ----------------CcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                            000          011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-39  Score=284.43  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=194.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||.||+|.+. .+..+|||.+....   ....+|+.+++.++|+||+++++++..     ....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceEE
Confidence            457999999999999999999976 45779999886532   345579999999999999999988733     233789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999975 776666542  23468999999999999999999998 9999999999999999988 79999999987654


Q ss_pred             CCCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .....  .....+..|+|||.+.+ ..++.++|+||+||++|+|++ |+.||.+.+....+..+......+         
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------  224 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP---------  224 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            32111  11223467999999865 458999999999999999998 999998877655555543311000         


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                         .+...+.++.+++.+||..||.+||+++++..
T Consensus       225 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         225 -------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                               11345889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.2e-39  Score=291.31  Aligned_cols=246  Identities=21%  Similarity=0.370  Sum_probs=188.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....     ....+|+.+++.++||||+++++.+..     .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence            48899999999999999999753     23568899876432     234579999999999999999988733     2


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK  165 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlk  165 (376)
                      ...++++||+. ++|.+++.....                    ....+++..+..++.|++.||+|||+ .|++|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence            23779999998 577776654221                    12357889999999999999999998 999999999


Q ss_pred             CCcEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 017131          166 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG  241 (376)
Q Consensus       166 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  241 (376)
                      |+||+++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999887 899999999875433221   112234567999998855 458999999999999999998 9999987


Q ss_pred             CCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .........+...                  +..          ..+..++.++.+|+.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTG------------------YRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCC------------------CCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            6544332221110                  000          011357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.5e-39  Score=285.95  Aligned_cols=235  Identities=25%  Similarity=0.353  Sum_probs=183.6

Q ss_pred             eeeecCceEEEEEEE--CCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           43 VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.++||||+++++++.     .. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence            589999999999964  5677899999885432      23457899999999999999988752     11 2578999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  193 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  193 (376)
                      |+++ +|.+.+..    ...+++..+..++.|++.||+|||+ +||+||||||.||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9985 56665543    3568999999999999999999998 9999999999999999887 79999999987654332


Q ss_pred             CC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          194 PN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       194 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..    ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+.+.. .           
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~-----------  216 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-R-----------  216 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-C-----------
Confidence            21    11223468999998854 458899999999999999998 999998766554444332210 0           


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                          ..            ++..+++++.+||.+||+.||.+||++.+|..
T Consensus       217 ----~~------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 ----ME------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ----CC------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                00            12357899999999999999999999988853

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=310.01  Aligned_cols=204  Identities=28%  Similarity=0.415  Sum_probs=171.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec-----ccccHHHHHHHHHhCCCCCeeeccceeeecC-CCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  109 (376)
                      ..+...+.||+|+||.||+++++.||+.||||.+.+     .....-+|+++|++++|+|||++.++-.+.. ..-...-
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            358889999999999999999999999999999864     2344458999999999999999977542221 0002224


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC--C-CCeEEEecCC
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--T-HQLKLCDFGS  185 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~--~-~~vkl~Dfg~  185 (376)
                      .++||||.| +|...+..- ....++++.++..++..++.||.|||+ +||+||||||.||++-..  | +.-||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            589999985 776666543 234679999999999999999999998 999999999999998432  2 2579999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  241 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  241 (376)
                      |+...+++...+.+||+.|.+||++..+..|+..+|.||+||++|+++||..||..
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            99999999899999999999999997667799999999999999999999999964

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=282.96  Aligned_cols=241  Identities=25%  Similarity=0.377  Sum_probs=191.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ..|++.+.||.|++|.||+|...  |+.||+|.+.....   ...+|+.+++.++|+||+++++++...     ...++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeEEE
Confidence            47999999999999999999875  78999999876543   345799999999999999999987542     237899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+++ +|.+.+....  ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++ .++|+|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            999984 7777665421  2368999999999999999999998 9999999999999999888 799999999976532


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  270 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  270 (376)
                      ..  .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+...                
T Consensus       155 ~~--~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------  215 (256)
T cd05039         155 GQ--DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------  215 (256)
T ss_pred             cc--ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence            21  22334567999998854 458899999999999999997 99999766543332222110                


Q ss_pred             ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                        +.          ...+..+++.+.++|.+||..+|.+|||+.++++
T Consensus       216 --~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 --YR----------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             --CC----------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence              00          0011357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.9e-39  Score=284.52  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=192.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....   ....+|+.+++.++|+||+++++++..      ...++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEE
Confidence            357999999999999999999864 56789999886543   334579999999999999999876521      12789


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||+. +++.+.+...  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05067          78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecC
Confidence            999997 4776666432  23468999999999999999999998 9999999999999999988 79999999987654


Q ss_pred             CCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  .....++..|+|||.+.. ..++.++|+||||+++|+|++ |++||.+.+..+....+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-----------  221 (260)
T ss_pred             CCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-----------
Confidence            2221  112234567999998854 458899999999999999999 9999987765544443322100           


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                             .+          .+...+.++.+++.+||..||++|||++++++
T Consensus       222 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 -------MP----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -------CC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                   00          11346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.1e-39  Score=288.79  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=192.1

Q ss_pred             cceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      .+|.+.+.||+|+||.||+|...     .++..+|+|.+....    ....+|+++++.++|+||+++++++...     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-----   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence            47999999999999999999753     356789999875432    3355799999999999999998877432     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhh-----------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  174 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~  174 (376)
                      ...+++|||+.+ +|.+++.....           ....+++..+..++.|++.||+|||+ +|++||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCC
Confidence            237899999974 77777654321           01348889999999999999999998 999999999999999988


Q ss_pred             CCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Q 017131          175 THQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  250 (376)
Q Consensus       175 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  250 (376)
                      + .+||+|||+++.......   .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |.+||......+....
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 799999999875432221   1122346779999998654 48999999999999999998 9999977665554444


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       251 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +....  +              .            ..+..+++.+.+||.+||+.||.+||++.+++.
T Consensus       237 ~~~~~--~--------------~------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGR--E--------------L------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCc--c--------------C------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33210  0              0            011357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-39  Score=290.60  Aligned_cols=255  Identities=21%  Similarity=0.285  Sum_probs=191.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCC--------------cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeecc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETG--------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALK   95 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~   95 (376)
                      ..+|++.+.||+|+||.||+|++..++              ..||+|.+....     ....+|+++++.++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            458999999999999999999876432              358999886432     2345799999999999999999


Q ss_pred             ceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhh--------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 017131           96 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRI--------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  166 (376)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp  166 (376)
                      +++...     ...++||||+.+ +|.+++......        ...+++..+..++.|++.||+|||+ +|++||||||
T Consensus        84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp  157 (295)
T cd05097          84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT  157 (295)
T ss_pred             EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence            988433     237899999985 777766432110        1236888899999999999999998 9999999999


Q ss_pred             CcEEEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 017131          167 QNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  241 (376)
Q Consensus       167 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~  241 (376)
                      +||+++.++ .+||+|||++.........   ....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||..
T Consensus       158 ~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         158 RNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             hhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            999999887 7999999998755332211   112335679999998654 48999999999999999998  6688887


Q ss_pred             CCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .+..+....+........            ....         ...+..+++.+.+|+.+||..||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~------------~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         236 LSDEQVIENTGEFFRNQG------------RQIY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             cChHHHHHHHHHhhhhcc------------cccc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            665554444333110000            0000         0011346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-39  Score=286.85  Aligned_cols=242  Identities=26%  Similarity=0.392  Sum_probs=187.1

Q ss_pred             EEeeeeeecCceEEEEEEEC----CCCcEEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           39 IAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        39 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...     .....+|++.++.++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            56889999999999999987    45678999998542     2344579999999999999999999863322     7


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++|+||+. |+|.+++...  ....+++..+..++.|++.||.|||+ ++++|++|+++||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence            79999998 5888888763  23569999999999999999999998 9999999999999999988 899999999876


Q ss_pred             ccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          189 LVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       189 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      .......   ........|+|||.+.+.. ++.++||||||+++|||++ |+.||.+.+..+....+.+..         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------  222 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------  222 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------
Confidence            5222111   2234566799999986544 8999999999999999999 789998876665555553210         


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                               .          ..++..++..+.++|.+||..||.+|||+.++++
T Consensus       223 ---------~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 ---------R----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ---------E----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ---------c----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                     0          0112457899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-38  Score=285.59  Aligned_cols=244  Identities=26%  Similarity=0.397  Sum_probs=191.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..|++.+.||+|+||.||+|.+..+++   .||||.+....     ....+|+.+++.++||||+++++++..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CC
Confidence            469999999999999999999887665   59999886432     234569999999999999999988733     23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..++||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCccc
Confidence            37899999986 66665543   23568999999999999999999998 9999999999999999887 7999999998


Q ss_pred             ccccCCCCCcee---e---eeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          187 KVLVKGEPNVSY---I---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       187 ~~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      ............   .   .+..|+|||.+.+ ..++.++|+||+||++|||++ |..||.+.+..+....+...     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-----  227 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-----  227 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-----
Confidence            755332221111   1   1346999999854 458999999999999999886 99999877655444433221     


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                   ...+          .+..++..+.+++.+||..+|.+||++.+++.
T Consensus       228 -------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         228 -------------YRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -------------CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0010          11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-38  Score=291.01  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=192.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECC-------CCcEEEEEEeecccc-----cHHHHHHHHHhC-CCCCeeeccceeee
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFS  100 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~  100 (376)
                      ...+|.+.+.||+|+||.||+|.+..       ....+|+|.+.....     ...+|+.+++.+ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            34689999999999999999998642       345799998764321     234799999999 69999999998743


Q ss_pred             cCCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131          101 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                           ...++++|||+.+ +|.+++.....            ....+++..+..++.|++.||+|||+ +|++||||||+
T Consensus        90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~  163 (314)
T cd05099          90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR  163 (314)
T ss_pred             -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence                 2347899999974 78777765321            12458889999999999999999998 99999999999


Q ss_pred             cEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017131          168 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  243 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  243 (376)
                      ||+++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+
T Consensus       164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999888 799999999976532211   111223457999999865 458999999999999999999 899998766


Q ss_pred             chHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          244 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       244 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+....+....                ..            ..+..++.++++++.+||..||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         242 VEELFKLLREGH----------------RM------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHHcCC----------------CC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            544443332200                00            011357889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-38  Score=283.97  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=191.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..|+..+.||+|+||.||+|.+..+++   .+|+|.+....     .....|+++++.++|+||+++.+++...     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----K   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----C
Confidence            468999999999999999999876665   79999875432     2345699999999999999999887432     2


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..++||||+++ +|..++..   ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccc
Confidence            37899999986 66555543   23568999999999999999999998 9999999999999999887 7999999998


Q ss_pred             ccccCCCCCce----eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEPNVS----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~~~~----~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ...........    ...+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+.....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-----  228 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-----  228 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-----
Confidence            76543222111    112346999999865 458999999999999999997 9999987766554444432110     


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                   .+          ....++.++.+++.+||+.||.+||++.++++
T Consensus       229 -------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         229 -------------LP----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                         00          01246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-38  Score=287.28  Aligned_cols=249  Identities=18%  Similarity=0.259  Sum_probs=193.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC----CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      +++|++.+.||+|+||.||+|.+..    ++..||+|++....     ....+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            4589999999999999999999876    35789999876432     2245799999999999999999876432    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhc----CCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIH----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                      ....+++++|+. +++.+++.......    ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEE
Confidence            223678999987 57777765532211    468999999999999999999998 9999999999999999888 7999


Q ss_pred             EecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhC
Q 017131          181 CDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  256 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  256 (376)
                      +|||+++........   ....++..|+|||.+.+. .++.++|||||||++|++++ |..||...+..+....+...  
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--  235 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG--  235 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC--
Confidence            999999765332211   112345679999998654 48999999999999999999 99999876654432222110  


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                      +..+          ....+++++.+++.+||..||++|||+.++++
T Consensus       236 ----------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ----------------YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----------------CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            0000          01246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-38  Score=290.55  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=192.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeec
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  101 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  101 (376)
                      ..+|.+.+.||+|+||.||+|++.       ..+..||+|.+....     ....+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            458999999999999999999853       234579999875432     2345799999999 899999999987432


Q ss_pred             CCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 017131          102 TDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  168 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~N  168 (376)
                           ...+++|||+.+ +|.+++.....            ....++...+..++.||+.||+|||+ +|++||||||+|
T Consensus        94 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  167 (304)
T cd05101          94 -----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARN  167 (304)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccce
Confidence                 347899999975 77777765321            12357888899999999999999998 999999999999


Q ss_pred             EEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017131          169 LLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  244 (376)
Q Consensus       169 ill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  244 (376)
                      |+++.++ .+||+|||+++.......   .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+.
T Consensus       168 ili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         168 VLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             EEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999888 799999999976533221   112234567999999865 448999999999999999998 8899987665


Q ss_pred             hHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          245 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       245 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .+....+....                  ..          ..+..++.++++|+.+||..+|.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~------------------~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEGH------------------RM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcCC------------------cC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            44433332110                  00          0113578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-39  Score=286.53  Aligned_cols=241  Identities=24%  Similarity=0.341  Sum_probs=184.4

Q ss_pred             eeeeecCceEEEEEEECCCCc--EEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|.+..++.  .+|+|.+....     ....+|+.+++.+ .||||+++++++..     ..+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence            368999999999999988876  46888775321     2344699999999 89999999998843     23478999


Q ss_pred             eccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          114 EYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       114 e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                      ||+. ++|.+++.....            ....+++..++.++.|++.||+|||+ +|++||||||+||+++.++ .+||
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl  153 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKI  153 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEE
Confidence            9997 578777764321            11347899999999999999999998 9999999999999999988 7999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      +|||++..............+..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+...     
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----  227 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-----  227 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence            99999863322111112223556999999854 458999999999999999997 99999876644433332110     


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                   ...+          .+..++.++.+|+.+||..||.+|||+.++++
T Consensus       228 -------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 -------------YRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------CCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                         0000          11246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-38  Score=294.36  Aligned_cols=248  Identities=22%  Similarity=0.321  Sum_probs=191.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCC-------CcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  102 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  102 (376)
                      .+|++++.||+|+||.||+|++...       +..||+|.+....     ....+|+.+++++ +||||+++++++..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            4799999999999999999986432       2368999876432     2345799999999 89999999998743  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  169 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Ni  169 (376)
                         ...+++++||+++ +|.+++.....            ....++...+..++.|++.||+|||+ +|++||||||+||
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni  165 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV  165 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence               2347899999975 77777764321            12347888899999999999999998 9999999999999


Q ss_pred             EEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 017131          170 LVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  245 (376)
Q Consensus       170 ll~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  245 (376)
                      +++.++ .+||+|||+++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..
T Consensus       166 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         166 LVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999888 7999999998765332211   11223457999999965 458899999999999999998 88999877654


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      +....+....                  ..          ..+..++.++.+|+.+||+.+|.+|||+.+++++
T Consensus       244 ~~~~~~~~~~------------------~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         244 ELFKLLKEGH------------------RM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHcCC------------------CC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            4433332210                  00          0113568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-38  Score=284.39  Aligned_cols=249  Identities=21%  Similarity=0.380  Sum_probs=195.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECC-CCcEEEEEEeeccc--------------ccHHHHHHHHHh-CCCCCeeeccceeee
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK--------------RYKNRELQIMQM-LDHPNIVALKHCFFS  100 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~~-l~h~~iv~~~~~~~~  100 (376)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            38899999999999999999987 68899999874211              112357777754 799999999998743


Q ss_pred             cCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeE
Q 017131          101 TTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  179 (376)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vk  179 (376)
                           +.+.+++|||+++ ++.+++.........+++..++.++.|++.||.|||+..|++|+||+|+||+++.++ .++
T Consensus        81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence                 3358899999975 777777654445567999999999999999999999526899999999999999988 799


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+......+.
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL  233 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence            999999976544433345567888999999965 4489999999999999999999999976654443333322110000


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                                 ....+++++.++|.+||+.||++||++.++..+
T Consensus       234 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 ---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                       012468899999999999999999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-38  Score=285.55  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=188.9

Q ss_pred             cceEEeeeeeecCceEEEEEE----ECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..|++.+.||+|+||.||+|.    +..+++.||+|.+....    ....+|+.+++.++||||+++++++....   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence            479999999999999999998    44678899999986433    23457999999999999999988765432   23


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++||||++ ++|.+++...   ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCccc
Confidence            4789999997 5777766432   2458999999999999999999998 9999999999999999888 7999999999


Q ss_pred             ccccCCCCCc----eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC-CCCHH
Q 017131          187 KVLVKGEPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-TPTRE  261 (376)
Q Consensus       187 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~  261 (376)
                      +.........    ...++..|+|||.+.+ ..++.++|+|||||++|+|++|..++..... .....+..... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  233 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchH
Confidence            8654332211    1122345999999865 4589999999999999999998876643321 11100000000 00000


Q ss_pred             HH-hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          262 EI-KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       262 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .+ ..+...   ...          .....++.++.+|+.+||..+|++|||+.++++
T Consensus       234 ~~~~~~~~~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLKNN---GRL----------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHhcC---CcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            00 000000   000          012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-38  Score=298.45  Aligned_cols=252  Identities=22%  Similarity=0.346  Sum_probs=194.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----ccHHHHHHHHHhCC-CCCeeeccceeeec
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFST  101 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  101 (376)
                      ...++|.+.+.||+|+||.||+|++.     .+++.||+|++....     ....+|+.+|..+. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34467999999999999999999964     355689999986542     13457999999997 99999999987443


Q ss_pred             CCCCceEEEEEEeccc-ccHHHHHHHhhh---------------------------------------------------
Q 017131          102 TDKEELYLNLVLEYVP-ETVNRIARNYSR---------------------------------------------------  129 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------------------------------------------------  129 (376)
                           ..+++||||+. |+|.+++.....                                                   
T Consensus       114 -----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         114 -----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             -----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                 23789999998 477777754211                                                   


Q ss_pred             -------------------------------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 017131          130 -------------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  166 (376)
Q Consensus       130 -------------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp  166 (376)
                                                                 ....+++..+..++.||+.||+|||+ .|++||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp  267 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAA  267 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCc
Confidence                                                       01236777889999999999999998 9999999999


Q ss_pred             CcEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 017131          167 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  242 (376)
Q Consensus       167 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  242 (376)
                      +|||++.++ .+||+|||+++.......   .....++..|+|||.+.+ ..++.++|+||+||++|||++ |..||...
T Consensus       268 ~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         268 RNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             ceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999877 799999999975432221   122345778999999965 448999999999999999998 89999876


Q ss_pred             CchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       243 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ...+.....+...                 ...          ..+..++.++.+|+.+||..||.+||++.++++.
T Consensus       346 ~~~~~~~~~~~~~-----------------~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         346 PMNEQFYNAIKRG-----------------YRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CchHHHHHHHHcC-----------------CCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6555444333210                 000          0123578999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-38  Score=287.50  Aligned_cols=254  Identities=20%  Similarity=0.299  Sum_probs=189.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECC----------------CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeec
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL   94 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~   94 (376)
                      ++|++.+.||+|+||.||+|.+..                ++..+|+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999996532                34579999886432     234579999999999999999


Q ss_pred             cceeeecCCCCceEEEEEEeccc-ccHHHHHHHhhhh-------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 017131           95 KHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  166 (376)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp  166 (376)
                      ++++....     ..+++|||+. ++|.+++......       ...+++..+..++.|++.||+|||+ +|++||||||
T Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            99874432     3789999997 4777777653211       1247788899999999999999998 9999999999


Q ss_pred             CcEEEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 017131          167 QNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPG  241 (376)
Q Consensus       167 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~  241 (376)
                      +||+++.++ .++|+|||+++........   ....++..|+|||...+. .++.++|+|||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999887 7999999998765332211   112335679999987554 58999999999999999998  7788876


Q ss_pred             CCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .+..+..........        .   .......+          .+..+++.+.+|+.+||+.||.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~--------~---~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFR--------D---QGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHh--------h---ccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            655444332221100        0   00000000          11346789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.8e-38  Score=283.64  Aligned_cols=249  Identities=22%  Similarity=0.305  Sum_probs=192.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .+|++.+.||.|+||.||+|+.+.     +.+.+|+|.+.....     ...+|+++++.++|+||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-----   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence            579999999999999999999754     346799998754332     35679999999999999999987732     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhh-----cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeE
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  179 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vk  179 (376)
                      ..+.++||||++ ++|.+++......     ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence            234789999998 5777776643211     1158999999999999999999998 9999999999999999988 799


Q ss_pred             EEecCCcccccCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhC
Q 017131          180 LCDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  256 (376)
Q Consensus       180 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  256 (376)
                      ++|||++.......  ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.........+...  
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--  234 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--  234 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence            99999986442221  12233557779999988654 47899999999999999998 88899765544333332210  


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                     ...+          .....++..+.+++.+||+.||.+|||+.+++++
T Consensus       235 ---------------~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 ---------------KLEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ---------------CcCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                           0000          0113578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=281.70  Aligned_cols=236  Identities=25%  Similarity=0.358  Sum_probs=184.4

Q ss_pred             eeeeecCceEEEEEEECCCC---cEEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|.+..++   ..+|+|.+.....     ...+|+.+++.++|+||+++++++.     .+ ..+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence            47999999999999876554   7899998865432     3457999999999999999988652     11 267999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+.+ +|.+.+..    ...+++..+..++.|++.||+|||. .|++|+||||+||+++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            99874 77666653    3468999999999999999999998 9999999999999999988 7999999998765433


Q ss_pred             CCCc----eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          193 EPNV----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       193 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....    ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+... .           
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~-----------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-E-----------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C-----------
Confidence            3211    1112356999999854 458999999999999999998 99999876654433332211 0           


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                            ..          ..+..++..+.++|.+||..||.+||++.++++
T Consensus       216 ------~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 ------RL----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------cC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  00          011357889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-38  Score=281.13  Aligned_cols=243  Identities=27%  Similarity=0.380  Sum_probs=193.3

Q ss_pred             eEEeeeeeecCceEEEEEEECCCC----cEEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      +++.+.||.|+||.||+|.+..++    ..+|+|.+.....     ...+|+.+++.++|+||+++++++...     ..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence            357889999999999999998766    8999999865432     445799999999999999999988443     34


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++|||+.+ ++.+.+....  ...+++..+..++.|++.||++||+ .|++|+||||+||+++.++ .++|+|||+++
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~  151 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSR  151 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCce
Confidence            8899999975 7766665422  1228999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCCCCce--eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          188 VLVKGEPNVS--YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       188 ~~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ..........  ..+++.|+|||.+. ...++.++|+||+||++|+|++ |.+||...+.......+....         
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------  221 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY---------  221 (258)
T ss_pred             ecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------
Confidence            6644322111  23567899999984 4558999999999999999998 889998766554444433210         


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                .         ...+..++.++.+++.+||..||.+|||+.++++
T Consensus       222 ----------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 ----------R---------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ----------C---------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                      0         0011347899999999999999999999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-38  Score=287.47  Aligned_cols=247  Identities=24%  Similarity=0.317  Sum_probs=192.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++||||+++++++...    
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~----   80 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG----   80 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC----
Confidence            579999999999999999999753     67889999886432     2345799999999999999999877432    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhh------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSR------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  166 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp  166 (376)
                       ...+++|||+.+ +|.+++.....                  ....+++..+..++.|++.||.|||+ +|++||||||
T Consensus        81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p  158 (288)
T cd05050          81 -KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLAT  158 (288)
T ss_pred             -CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccH
Confidence             237899999985 77777764221                  11247888899999999999999998 9999999999


Q ss_pred             CcEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 017131          167 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  242 (376)
Q Consensus       167 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  242 (376)
                      +||+++.++ .++|+|||++........   ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.
T Consensus       159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999988 799999999875432211   112233567999999865 458999999999999999997 88899876


Q ss_pred             CchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       243 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +..+....+...                 .  ..         ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~-----------------~--~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDG-----------------N--VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcC-----------------C--CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            655444333221                 0  00         011356889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-38  Score=281.31  Aligned_cols=236  Identities=24%  Similarity=0.306  Sum_probs=182.7

Q ss_pred             eeeecCceEEEEEEEC--CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEec
Q 017131           43 VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      .||+|+||.||+|.+.  .++..||+|++....     ....+|+.+++.++||||+++++++..      ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999765  445679999886432     224579999999999999999887621      136799999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC
Q 017131          116 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  194 (376)
Q Consensus       116 ~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~  194 (376)
                      +++ +|.+.+..   ....+++..++.++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            975 66665543   23568999999999999999999998 9999999999999999887 799999999875433221


Q ss_pred             C----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          195 N----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       195 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .    ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+.+.. .            
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C------------
Confidence            1    11122467999999854 448999999999999999996 999998776555443332210 0            


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                         .            .++...++++.++|.+||..||++||++.++.+
T Consensus       217 ---~------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---L------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---C------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               0            012357899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-38  Score=281.25  Aligned_cols=239  Identities=25%  Similarity=0.356  Sum_probs=188.5

Q ss_pred             eeeeecCceEEEEEEECC-CCc--EEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|++|.||+|.+.. .++  .||||.+..+..     ...+|+.+++.++||||+++++.+..      ...+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 333  699998875543     34579999999999999999988743      3478999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||++ ++|.+.+.....  ..+++..++.++.|++.||+|||+ +|++|+||||+||+++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9996 577766654321  468999999999999999999998 9999999999999999988 7999999998766432


Q ss_pred             CCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          193 EPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       193 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...    ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+.....           
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-----------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            211    12334667999998854 458999999999999999998 9999987766555544432100           


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                          ...            .+..++..+.+++.+||+.+|++|||+.++++
T Consensus       219 ----~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         219 ----RLE------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ----cCC------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                000            11246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.1e-38  Score=279.55  Aligned_cols=244  Identities=20%  Similarity=0.320  Sum_probs=190.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ..|++.+.||.|+||.||+|.+. ++..+|+|.+....   ....+|+++++.++|||++++++++...     ...+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEEE
Confidence            46999999999999999999885 46789999886432   3456799999999999999998887332     347899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999985 56555543   22458899999999999999999998 9999999999999999887 799999999875533


Q ss_pred             CCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ....  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+....             
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-------------  218 (256)
T ss_pred             CcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-------------
Confidence            2211  12233567999999865 458999999999999999998 999998766544443332110             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                           .          ...+...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus       219 -----~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 -----R----------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -----C----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                 0          00112367899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-39  Score=304.06  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=216.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc---cccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +.|++...||.|.+|.||+++++.+|+..|+|+...+   ...++.|.++|+.. .|||++.++++|.-......-.++|
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            5699999999999999999999999999999987543   34456788999887 6999999999997665555556999


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |||||+| +..++++...  +.++.|+.+..|++.++.||.+||. ..++|||||-.|||++.++ .|||+|||.+....
T Consensus        99 VMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  174 (953)
T ss_pred             EeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeeeeeee
Confidence            9999985 7888888765  7889999999999999999999998 8999999999999999999 79999999987653


Q ss_pred             CC-CCCceeeeeccccchhhhcCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KG-EPNVSYICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .. ....+.+|||+|||||++....    .|+..+|+||||++..||.-|.+|+.+..+...+..|-.   .|++     
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPP-----  246 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP-----  246 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCc-----
Confidence            32 3345678999999999995432    367799999999999999999999988877665544422   2221     


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                      .+..  +.+.+.++.+||..||.+|..+||+..++|.|||++..
T Consensus       247 ----------------kLkr--p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  247 ----------------KLKR--PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ----------------cccc--hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                            1111  13568899999999999999999999999999999854

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-38  Score=283.43  Aligned_cols=244  Identities=25%  Similarity=0.342  Sum_probs=191.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCc----EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++.+.||+|+||.||+|.++.+|+    .+|+|.+....     ....+|+.+++.++||||+++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3579999999999999999999877665    58999876543     234479999999999999999998754     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                       ...+++|||+. +++.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg  154 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFG  154 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCc
Confidence             23779999997 477666543   23458999999999999999999998 9999999999999999888 79999999


Q ss_pred             CcccccCCCCCce---eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          185 SAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       185 ~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      .++..........   ..++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+....+....+.+..     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----  228 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-----  228 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-----
Confidence            9976543322111   112457999998854 458999999999999999998 999998776544333332210     


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                   ..          ..+...+.++.+++.+||..||.+||++.++++
T Consensus       229 -------------~~----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 -------------RL----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             -------------CC----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                         00          011346789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.6e-39  Score=315.84  Aligned_cols=259  Identities=28%  Similarity=0.423  Sum_probs=194.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCC----
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD----  103 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  103 (376)
                      +--..|+.+..||+||||.||+|+.+-+|+.||||+|.-.     ...+.+|+..|.+|+|||||+++..+.....    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3445788999999999999999999999999999998543     2334589999999999999998765411000    


Q ss_pred             --------------------------------------------------------------------------------
Q 017131          104 --------------------------------------------------------------------------------  103 (376)
Q Consensus       104 --------------------------------------------------------------------------------  103 (376)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------CC-------ceEEEEEEecccccHHHHHHHhhhhcCCC-cHHHHHHHHHHHHHHHHH
Q 017131          104 -----------------------KE-------ELYLNLVLEYVPETVNRIARNYSRIHQRM-PLIYVKLYTYQICRALAY  152 (376)
Q Consensus       104 -----------------------~~-------~~~~~lv~e~~~~~l~~~~~~~~~~~~~l-~~~~~~~i~~qi~~al~~  152 (376)
                                             .+       ..++|+-||||+..+.+.+.....   .. ....++.+++||+.||.|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHH
Confidence                                   00       156899999999866554443221   11 367899999999999999


Q ss_pred             HHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc-------------------CCCCCceeeeeccccchhhhcCC
Q 017131          153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNVSYICSRYYRAPELIFGA  213 (376)
Q Consensus       153 LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~  213 (376)
                      +|+ +|||||||||.||++++++ .|||+|||+|+...                   +....+..+||..|+|||++.+.
T Consensus       713 IH~-~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  713 IHD-QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HHh-CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            998 9999999999999999888 79999999997621                   11134567899999999999766


Q ss_pred             C--CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCC
Q 017131          214 T--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL  291 (376)
Q Consensus       214 ~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (376)
                      .  .|+.++||||||+|++||+.   ||..  ..+.. .++..+..+               .+|.    +  ..|...-
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa-~iL~~LR~g---------------~iP~----~--~~f~~~~  843 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERA-SILTNLRKG---------------SIPE----P--ADFFDPE  843 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCc--hHHHH-HHHHhcccC---------------CCCC----C--ccccccc
Confidence            6  69999999999999999985   4643  22322 222322211               1111    0  1111223


Q ss_pred             ChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          292 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       292 ~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                      -+.-..+|++||+.||++||||.|+|++-||-
T Consensus       844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  844 HPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             chHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            45677899999999999999999999999997

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-38  Score=278.18  Aligned_cols=237  Identities=25%  Similarity=0.366  Sum_probs=185.4

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ++||.|++|.||+|.+.. ++.||+|.+....     ....+|+.+++.++|+||+++++++....     ..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcC
Confidence            468999999999999987 9999999876432     23457999999999999999998874432     378999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  195 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  195 (376)
                      .+ ++.+.+..   ....+++..+..++.|++.||+|||+ +|++||||+|+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            75 66655543   23468899999999999999999998 9999999999999999888 7999999998754322111


Q ss_pred             ---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          196 ---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       196 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                         .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+....                
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----------------  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------------  212 (251)
T ss_pred             eccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------------
Confidence               11122456999999855 458999999999999999999 889998766544333322110                


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                        ..          ..+..++.++.+++.+||..+|.+|||+.++++
T Consensus       213 --~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 --RM----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             --CC----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence              00          011356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-38  Score=286.09  Aligned_cols=256  Identities=23%  Similarity=0.366  Sum_probs=188.3

Q ss_pred             cceEEeeeeeecCceEEEEEEE----CCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++++.||+|+||.||+|..    ..++..||+|.+....     ....+|+.+++.++||||+++++++...   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            4589999999999999999984    4578899999885332     2345799999999999999998877432   22


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ...+++|||+++ +|.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~  155 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGL  155 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCcc
Confidence            347899999974 67666543   12358999999999999999999998 9999999999999999888 799999999


Q ss_pred             cccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC--
Q 017131          186 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT--  259 (376)
Q Consensus       186 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--  259 (376)
                      ++........    ....++..|+|||.+.+. .++.++|+|||||++|+|+++..|+....  ....   +..+...  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~--~~~~---~~~~~~~~~  229 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPM--TLFL---KMIGPTHGQ  229 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCcccc--chhh---hhccccccc
Confidence            8765433221    123346679999998654 48899999999999999999876653321  1111   1100000  


Q ss_pred             --H-HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 --R-EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                        . ..+......   ..          ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         230 MTVTRLVRVLEEG---KR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             ccHHHHHHHHHcC---cc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              0 000000000   00          0012357899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-39  Score=284.45  Aligned_cols=236  Identities=19%  Similarity=0.287  Sum_probs=181.2

Q ss_pred             eeeeecCceEEEEEEECCCCcE-------EEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~-------vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +.||+|+||.||+|.+..++..       +|+|.+....    ....+|+.+++.++|||++++++++.....     .+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-----~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-----SI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-----cE
Confidence            4689999999999998665443       8888775432    234568999999999999999998854332     67


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC-------eEEEe
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-------LKLCD  182 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~-------vkl~D  182 (376)
                      +||||+++ +|..++...   ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 666665432   2358999999999999999999998 999999999999999877632       79999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ||++.....   .....++..|+|||.+.+...++.++|+|||||++|+|++| .+||...+...... ....       
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------  220 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------  220 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------
Confidence            999865432   22345678899999997655689999999999999999998 46665544333221 1110       


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                ...            ++...+.++.+||.+||+.||.+|||++++++.
T Consensus       221 ----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------RHQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------ccc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                      001            112356789999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.5e-38  Score=278.98  Aligned_cols=244  Identities=24%  Similarity=0.367  Sum_probs=191.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||.||++.+. .+..+|+|.+....   ....+|+.+++.++|+||+++++.+..      ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            357999999999999999999865 45669999886533   234579999999999999999887743      23679


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|||++ +++.+++...  ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .+||+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence            999997 4777776542  23457888899999999999999998 9999999999999999888 89999999987553


Q ss_pred             CCCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .....  ....++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+.+.......+...             
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------------  219 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------------  219 (260)
T ss_pred             CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-------------
Confidence            32211  12234566999999854 458999999999999999999 99999876654444333221             


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           +..+          .....+.++.+++.+||+.||++||++.++++
T Consensus       220 -----~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         220 -----YRMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -----CCCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                 0000          11357889999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.7e-38  Score=281.29  Aligned_cols=246  Identities=21%  Similarity=0.299  Sum_probs=182.7

Q ss_pred             eeeeecCceEEEEEEECC--CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.||+|+||.||+|....  ....+|+|.+....     ....+|+.+++.++|+||+++++.+...     ...++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence            368999999999997532  34578888765332     2334799999999999999999987432     33789999


Q ss_pred             cccc-cHHHHHHHhhhh-cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          115 YVPE-TVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      |+++ +|.+.+...... ....++..+..++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccc
Confidence            9985 787777653321 2335678889999999999999998 9999999999999999988 8999999998654222


Q ss_pred             CC---CceeeeeccccchhhhcC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          193 EP---NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       193 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ..   .....++..|+|||++..      ...++.++|+|||||++|+|++ |..||......+.+..+......     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI-----  228 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc-----
Confidence            11   112234567999998742      2346889999999999999999 88999877665555544332110     


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                 .++.       ..+...++..+.+++..|+ .||.+|||++++++
T Consensus       229 -----------~~~~-------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 -----------KLPK-------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -----------cCCC-------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                       0000       0122457889999999998 59999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.6e-38  Score=281.50  Aligned_cols=244  Identities=27%  Similarity=0.379  Sum_probs=191.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCC---CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      +.+|.+.+.||.|+||.||+|.+...   ...||||......     ....+|+.+++.++||||+++++++.+    . 
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~-   79 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----N-   79 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC----C-
Confidence            45799999999999999999997544   3468999875432     234579999999999999999987632    1 


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                       ..++||||+.+ +|.+.+...   ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||+
T Consensus        80 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~  153 (270)
T cd05056          80 -PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGL  153 (270)
T ss_pred             -CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCce
Confidence             25699999974 776666432   3358999999999999999999998 9999999999999999888 799999999


Q ss_pred             cccccCCCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          186 AKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       186 a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ++........  ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------  225 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------  225 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------
Confidence            8765433211  11223457999998854 458999999999999999986 999998877655544432210       


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                 ..          ..+..++..+.++|.+||..+|.+|||+.+++.
T Consensus       226 -----------~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         226 -----------RL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             -----------cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       00          012457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.1e-38  Score=282.63  Aligned_cols=243  Identities=21%  Similarity=0.291  Sum_probs=187.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc----EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++.+.||+|+||+||+|.+..+++    .+++|.+....     .....|+..+..++||||+++++++..     .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence            579999999999999999999987776    47777764321     123356778889999999999987621     1


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                       ..++++||+. ++|.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence             2568899987 577766653   23568999999999999999999998 9999999999999999887 899999999


Q ss_pred             cccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          186 AKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       186 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ++.......   .....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+...... .++......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---  230 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERL---  230 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC---
Confidence            976533321   122335667999999865 458999999999999999998 9999987654332 2222210000   


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                  .            .+..++.++.+++.+||..||.+|||+.++++
T Consensus       231 ------------~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         231 ------------A------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ------------C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                        0            01235778999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-38  Score=281.12  Aligned_cols=236  Identities=17%  Similarity=0.197  Sum_probs=177.1

Q ss_pred             eeeeecCceEEEEEEECCC------------CcEEEEEEeecccc----cHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           42 HVVGTGSFGVVFQAKCRET------------GEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      +.||+|+||.||+|.....            ...+|+|.+.....    ...+|+.+++.++||||+++++++....   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~---   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV---   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            4689999999999985322            23588887754322    3346889999999999999999874332   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC------Ce
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QL  178 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~------~v  178 (376)
                        ..+++|||+++ ++..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.      .+
T Consensus        78 --~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          78 --ENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             --CCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCcee
Confidence              26799999986 44443322   23468999999999999999999998 99999999999999986652      28


Q ss_pred             EEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCC
Q 017131          179 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      +++|||++......   ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            99999998654322   23456778999998865566899999999999999998 588888765432221 11110   


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                    ...            .....+.++.+||.+||+.||.+||++.+++.+
T Consensus       225 --------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 --------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                          000            001246789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.3e-38  Score=279.40  Aligned_cols=246  Identities=20%  Similarity=0.248  Sum_probs=181.8

Q ss_pred             eeeeecCceEEEEEEEC--CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.||+|+||.||+|...  .++..+|+|.+....     ....+|+.+++.++||||+++++++...     ...++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence            46899999999999854  456789999875432     2345699999999999999999887432     23789999


Q ss_pred             ccc-ccHHHHHHHhhhh-cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          115 YVP-ETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       115 ~~~-~~l~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      |++ ++|.+.+...... ....++..++.++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 5777777653321 2345677888999999999999998 9999999999999999887 7999999998654322


Q ss_pred             CC---CceeeeeccccchhhhcCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          193 EP---NVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       193 ~~---~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ..   .....++..|+|||++.+.      ..++.++|+||+||++|+|++ |..||...+..+..........      
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------  227 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ------  227 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc------
Confidence            21   1123456779999998532      135789999999999999996 9999987665443332221100      


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                ...+.       ..+....++.+.+++.+|+ .+|.+|||+++++.
T Consensus       228 ----------~~~~~-------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         228 ----------LKLPK-------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ----------CCCCC-------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                      00000       0011246788999999999 68999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.1e-38  Score=279.25  Aligned_cols=240  Identities=23%  Similarity=0.361  Sum_probs=189.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      .+|++.+.||+|+||.||++.  .+++.||+|.+..+.  ....+|+.+++.++|||++++++++..   . .  .+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~-~--~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH---N-G--LYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC---C-C--cEEEE
Confidence            469999999999999999986  468889999886432  334579999999999999999988732   1 1  57999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            99974 887776542  22358899999999999999999998 9999999999999999888 8999999998754322


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                        ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.+.                 
T Consensus       154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-----------------  213 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-----------------  213 (254)
T ss_pred             --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----------------
Confidence              122233567999998854 458999999999999999997 99999877654433322210                 


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                       ...+          ....++..+.+++++||+.+|.+||++.+++.
T Consensus       214 -~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         214 -YRME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -CCCC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             0000          11357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-37  Score=276.01  Aligned_cols=237  Identities=24%  Similarity=0.362  Sum_probs=184.2

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      +.||+|+||.||+|... ++..+|+|.+....     ....+|+.+++.++||||+++++++...     ...++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence            46899999999999864 67889999876432     1345799999999999999999987433     2378999999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCC
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  195 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  195 (376)
                      ++ ++.+.+..   ....+++..+..++.|++.||.|||+ +|++||||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            75 66555532   23458899999999999999999998 9999999999999999888 7999999998654322211


Q ss_pred             c--eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 017131          196 V--SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  272 (376)
Q Consensus       196 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  272 (376)
                      .  ...++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+.........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            1  1123556999999854 458999999999999999998 999998776544433332210                 


Q ss_pred             ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                       .          ..++..++.++.+++.+||..+|++||++.++++
T Consensus       212 -~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -R----------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -C----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence             0          0011357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.3e-39  Score=307.26  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .+.+..+.||+|+||+||+|+-..     ....||||.++...     ..++||++++..++|||||++++++...+   
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~---  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD---  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC---
Confidence            457778899999999999999642     34579999887543     34568999999999999999999984433   


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhh------cCC----CcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRI------HQR----MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  174 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~----l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~  174 (376)
                        -+|+|+|||. |+|.+++......      ++.    ++..+...++.||+.|+.||-+ +.+|||||-..|+||.++
T Consensus       563 --P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 --PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             --eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccc
Confidence              3889999998 7998888875432      223    8889999999999999999998 999999999999999998


Q ss_pred             CCCeEEEecCCcccccCCCCCc---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHH
Q 017131          175 THQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  250 (376)
Q Consensus       175 ~~~vkl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  250 (376)
                      . .|||+|||+++...+.+-..   ...-...|||||.+.- ..|+++|||||+||+|||+++ |..||.+..+.+.+.-
T Consensus       640 l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  640 L-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             e-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            8 89999999998765443221   1223567999999965 459999999999999999998 9999999998888877


Q ss_pred             HHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHH
Q 017131          251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  316 (376)
Q Consensus       251 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~l  316 (376)
                      |.+..                -+.            -+.++|.++.+|+..||+.+|.+||++.||
T Consensus       718 i~~g~----------------lL~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  718 IRAGQ----------------LLS------------CPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHcCC----------------ccc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            76521                011            125799999999999999999999999888

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.8e-38  Score=281.46  Aligned_cols=235  Identities=17%  Similarity=0.240  Sum_probs=177.7

Q ss_pred             eeeecCceEEEEEEECCC------------------------CcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeec
Q 017131           43 VVGTGSFGVVFQAKCRET------------------------GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVAL   94 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~   94 (376)
                      .||+|+||.||+|....+                        ...||+|.+....    ....+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            689999999999985321                        2358888875432    233468889999999999999


Q ss_pred             cceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC
Q 017131           95 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP  173 (376)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~  173 (376)
                      ++++....     ..++||||+++ +|...+..   ....+++.++..++.|++.||+|||+ +||+||||||+||+++.
T Consensus        82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEeCC-----ceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence            99885433     37899999986 45444432   24568999999999999999999998 99999999999999975


Q ss_pred             CCC------CeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCchH
Q 017131          174 HTH------QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD  246 (376)
Q Consensus       174 ~~~------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~  246 (376)
                      .+.      .+|++|||++......   ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||.+....+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            431      3899999987644222   22346778999999866566899999999999999995 6999998765433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ... ....                 ....            +...++++.++|.+||+.+|.+|||+.+++++
T Consensus       230 ~~~-~~~~-----------------~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KER-FYEK-----------------KHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHh-----------------ccCC------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            221 1110                 0001            12245789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6e-38  Score=285.52  Aligned_cols=246  Identities=22%  Similarity=0.339  Sum_probs=190.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCc----EEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      +...|+..+.||+|+||.||+|.+..+|+    .+|+|.+.....     ...+|+.+++.++||||+++++++...   
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence            34579999999999999999999987776    468887754322     345789999999999999999977421   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                         ..+++++|+. |++.+.+..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+||
T Consensus        82 ---~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Df  153 (303)
T cd05110          82 ---TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDF  153 (303)
T ss_pred             ---CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEccc
Confidence               1458899998 467666543   23468899999999999999999998 9999999999999999887 7999999


Q ss_pred             CCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          184 GSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       184 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+ ...+......  
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~--  229 (303)
T cd05110         154 GLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGER--  229 (303)
T ss_pred             cccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCC--
Confidence            999765433221   12234668999999854 458999999999999999997 899997765332 3333221100  


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                     .+          .+...+.++.+++.+||..||++||++.++++.
T Consensus       230 ---------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         230 ---------------LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ---------------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           00          013467899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-37  Score=279.65  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=189.1

Q ss_pred             eEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC-ce
Q 017131           38 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-EL  107 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-~~  107 (376)
                      |.+.+.||+|+||.||+|.+.   .+++.||||.+..+.      ....+|+.+++.++||||+++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   467899999886432      12447999999999999999999875543322 22


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhh--hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ..+++++|+. +++...+.....  ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence            3467889887 466555543211  11247889999999999999999998 9999999999999999887 79999999


Q ss_pred             CcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          185 SAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       185 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +++.......   .....+++.|++||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+... .    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~----  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-N----  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-C----
Confidence            9876533221   112234567999999854 458899999999999999999 89999876654433332221 0    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                 ...            .+...+..+.+++.+||..+|.+|||+.+++.
T Consensus       233 -----------~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         233 -----------RLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             -----------cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       000            01246789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-37  Score=276.89  Aligned_cols=239  Identities=22%  Similarity=0.342  Sum_probs=179.8

Q ss_pred             eeeeecCceEEEEEEECC---CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           42 HVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.||+|+||.||+|.+..   .+..+|||.+....     ....+|+.+++.++||||+++++++...    +...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998653   34579999875321     2334689999999999999998866432    22367999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+.+ ++.+++...   ....++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            99974 776666532   2346777888899999999999998 9999999999999999988 7999999998754322


Q ss_pred             CC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          193 EP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       193 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ..     .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+...  .         
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~---------  219 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--R---------  219 (262)
T ss_pred             cceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--C---------
Confidence            11     112234667999999865 458999999999999999999 56778766544433322210  0         


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                           ...            .+..+++.+.+++.+||..+|++||++.++++
T Consensus       220 -----~~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         220 -----RLL------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             -----CCC------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                 000            11246789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=293.06  Aligned_cols=250  Identities=23%  Similarity=0.378  Sum_probs=197.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc---E-EEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE---I-VAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .+-.+.++||+|+||.||+|..+..+.   . ||+|....+.       ....+|+++|+.++|||||+++++.....- 
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P-  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP-  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence            345566999999999999999865422   3 8999876421       233479999999999999999998754433 


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                          +++|||+|.| +|.++++..   .+.++..+...++.+.+.||+|||+ ++++||||-..|+|++.++ .+||+||
T Consensus       236 ----l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKISDF  306 (474)
T KOG0194|consen  236 ----LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKISDF  306 (474)
T ss_pred             ----cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeCcc
Confidence                8899999986 776666642   2359999999999999999999998 9999999999999999887 6899999


Q ss_pred             CCcccccCCCCCc-eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          184 GSAKVLVKGEPNV-SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       184 g~a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      |+++......... .......|+|||.+.. ..|+.++||||+||++||+++ |..||.+....+...+|...       
T Consensus       307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~-------  378 (474)
T KOG0194|consen  307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN-------  378 (474)
T ss_pred             ccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc-------
Confidence            9987543111111 1123567999999965 479999999999999999998 88999999988888877542       


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                .+..+          .+...+.++..++.+|+..||+.|+|+.++.+  ++..+
T Consensus       379 ----------~~r~~----------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~  420 (474)
T KOG0194|consen  379 ----------GYRMP----------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEAL  420 (474)
T ss_pred             ----------CccCC----------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHH
Confidence                      11111          12357889999999999999999999988864  44443

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-37  Score=279.06  Aligned_cols=242  Identities=22%  Similarity=0.344  Sum_probs=185.6

Q ss_pred             eeeeecCceEEEEEEECCCC------cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           42 HVVGTGSFGVVFQAKCRETG------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +.||+|+||.||+|.+..+.      +.+|||.+....     ....+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence            46899999999999986544      679999875432     23457999999999999999998874322     378


Q ss_pred             EEEeccc-ccHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC----CCeEEEe
Q 017131          111 LVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCD  182 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~----~~vkl~D  182 (376)
                      ++|||++ ++|.+.+......   ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999997 4777777653321   2347889999999999999999998 9999999999999998754    2599999


Q ss_pred             cCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          183 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       183 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      ||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+... .  
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G--  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence            999875533211   112234677999999865 458999999999999999998 99999876654443332210 0  


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                   ..            ..+..++..+.++|.+||..+|.+||++.++++
T Consensus       231 -------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------RL------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------cc------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                         00            011357889999999999999999999998864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.1e-37  Score=275.93  Aligned_cols=246  Identities=19%  Similarity=0.258  Sum_probs=181.7

Q ss_pred             eeeeecCceEEEEEEECCC--CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRET--GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.||+|+||.||+|.....  ...+++|.+....     ....+|+.+++.++||||+++++.+...     ...++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence            3689999999999975433  2356677664322     2345788899999999999999987432     34789999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  193 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  193 (376)
                      |+++ +|.+.+.........+++..++.++.|++.||+|||+ ++++||||||+|||++.++ .++|+|||++.......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKED  153 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcch
Confidence            9984 7777776533333456777889999999999999998 9999999999999999988 79999999986432211


Q ss_pred             ---CCceeeeeccccchhhhcCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          194 ---PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       194 ---~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                         ......++..|+|||++...      ..++.++|+|||||++|+|++ |..||...+..+.+..+.+....      
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------  227 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------  227 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc------
Confidence               12234567889999987421      235789999999999999997 67888776665555554432110      


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                ..       +...+...+++.+.+++..|| .+|.+||++.++++
T Consensus       228 ----------~~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 ----------KL-------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ----------cc-------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                      00       001111346788999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=286.14  Aligned_cols=255  Identities=27%  Similarity=0.430  Sum_probs=202.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      .++|.++++||+|+|+.||+|.|....+.||+|+-...+           +..-||.++-+.|.||.||++|++|.-..+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            468999999999999999999999999999999763221           112379999999999999999999854333


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCcEEEcCC---CCCe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIGICHRDIKPQNLLVNPH---THQL  178 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~iiH~Dlkp~Nill~~~---~~~v  178 (376)
                          .+|-|+|||+| +|..+++.    ++-+++.+++.|+.||+.||.||.. .-.|||=||||.|||+-..   | .+
T Consensus       542 ----sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG-eI  612 (775)
T KOG1151|consen  542 ----SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG-EI  612 (775)
T ss_pred             ----cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc-ee
Confidence                27899999998 56555554    4669999999999999999999997 1369999999999998532   3 69


Q ss_pred             EEEecCCcccccCCCCC--------ceeeeeccccchhhhcC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH
Q 017131          179 KLCDFGSAKVLVKGEPN--------VSYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  247 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  247 (376)
                      ||+|||+++++......        ....||.||++||.+.-   .+..+.++||||+|||+|.++.|+.||........
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd  692 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD  692 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence            99999999988554322        23467999999998842   34478899999999999999999999976432222


Q ss_pred             HH---HHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          248 LV---EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       248 ~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      +.   .|++.                .+..+|.-          +.+++++++||++||++--+.|....++..||+|.-
T Consensus       693 ILqeNTIlkA----------------tEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  693 ILQENTILKA----------------TEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHhhhchhcc----------------eeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            11   12221                23344432          358999999999999999999999999999999964

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=286.78  Aligned_cols=260  Identities=26%  Similarity=0.378  Sum_probs=190.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +.|.-...||+|+||.||+|.... |..||||++....    ..+.+|+.++.+++|||+|++++++.....    ..+|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~L  149 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRLL  149 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEEE
Confidence            467777899999999999999764 4899999886533    347789999999999999999999954332    3779


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--CccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||+. |+|.+.+......  .++|.....|+.+++.||+|||...  .|+||||||+|||+|++. +.||+|||+|+.
T Consensus       150 VYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~  226 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKL  226 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCccc
Confidence            999998 5887777653221  7899999999999999999999733  399999999999999998 899999999976


Q ss_pred             ccC-CCCCcee-eeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHH-HhCCCCHHHH
Q 017131          189 LVK-GEPNVSY-ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEIIK-VLGTPTREEI  263 (376)
Q Consensus       189 ~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~-~~~~~~~~~~  263 (376)
                      ... ....... .||..|+|||.+.. ...+.++||||+|+++.||+||+.+.....  ....+..+.. .+......  
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~--  303 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR--  303 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh--
Confidence            544 3333333 78999999999954 568999999999999999999998886532  1111222221 11111100  


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                      .-+++....        .....   ...-..+..+..+|++.+|.+||+..+++
T Consensus       304 eiiD~~l~~--------~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  304 EIVDPRLKE--------GEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             heeCCCccC--------CCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence            001111100        00000   00112366788899999999999999874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=289.48  Aligned_cols=245  Identities=30%  Similarity=0.470  Sum_probs=195.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCC--Cc--EEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRET--GE--IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~--~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      .++...++.++||.|.||.||.|.....  |+  .||||..+.+     ...+..|..+|+.++||||+++++++.... 
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-
Confidence            3444566778999999999999996432  33  4889988653     234457999999999999999999884321 


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                           .++|||.+. |.|..+++.   ....++...+..+++||+.||.|||+ +.+|||||-..|||+.+.. .|||+|
T Consensus       465 -----~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaD  534 (974)
T KOG4257|consen  465 -----MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLAD  534 (974)
T ss_pred             -----eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecc
Confidence                 789999998 677666654   34579999999999999999999998 9999999999999999988 799999


Q ss_pred             cCCcccccCCCCCceeee--eccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          183 FGSAKVLVKGEPNVSYIC--SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      ||+++............+  ..-|||||.+ +...++.++|+|.|||.+||++. |..||.|-...+.+..+.+.-.   
T Consensus       535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---  610 (974)
T KOG4257|consen  535 FGLSRYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---  610 (974)
T ss_pred             cchhhhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC---
Confidence            999997755443332233  4459999999 56679999999999999999986 9999999776666555443211   


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                                     +|          .++++|+.+..|+++||++||.+||...++.
T Consensus       611 ---------------lP----------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  611 ---------------LP----------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ---------------CC----------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                           11          1367999999999999999999999986654

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.7e-37  Score=273.70  Aligned_cols=234  Identities=20%  Similarity=0.242  Sum_probs=179.4

Q ss_pred             eeeeecCceEEEEEEECCCC----------cEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           42 HVVGTGSFGVVFQAKCRETG----------EIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ....+|+.+++.++||||+++++++.. ..     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~-----   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE-----   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CC-----
Confidence            46899999999999998776          358888765433   345579999999999999999998754 22     


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC------CeEEE
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------QLKLC  181 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~------~vkl~  181 (376)
                      .++||||+.+ +|.+++...   ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++.      .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeC
Confidence            5799999985 665555432   2268999999999999999999998 99999999999999987652      49999


Q ss_pred             ecCCcccccCCCCCceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       182 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |||++.....   .....++..|+|||.+.+. ..++.++|+|||||++|+|++ |..||...+..+.......      
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------  221 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------  221 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc------
Confidence            9999876533   2233456679999998654 358999999999999999999 5788866543222111110      


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                  ....            +......+.++|.+||..||.+|||+.++++
T Consensus       222 ------------~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 ------------QHRL------------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ------------CCCC------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                        0000            0112378999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=305.99  Aligned_cols=248  Identities=20%  Similarity=0.350  Sum_probs=201.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCc-----EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ...-++.+.||+|+||.||.|.......     .||||.+.+..     ..+.+|..+|+.++|||||+++++.++... 
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC-
Confidence            3578899999999999999999754333     49999886542     334579999999999999999999977433 


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                          .++++|||.+ +|..+++.-+..   ...++...+..++.||++|++||++ +++|||||...|+|++... .|||
T Consensus       770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKI  843 (1025)
T KOG1095|consen  770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKI  843 (1025)
T ss_pred             ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEE
Confidence                6799999985 887777764221   3458899999999999999999998 9999999999999999987 8999


Q ss_pred             EecCCcccccCCCCCce---eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhC
Q 017131          181 CDFGSAKVLVKGEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLG  256 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  256 (376)
                      +|||+|+.+...+....   ..-...|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+....... 
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-  921 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-  921 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence            99999995533322111   122456999999965 569999999999999999999 999999998887776555421 


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                       +++          .+..++..+.+++..||+.+|++||+...+++
T Consensus       922 -----------------RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 -----------------RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -----------------ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                             111          12578999999999999999999999998886

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.3e-37  Score=275.97  Aligned_cols=260  Identities=25%  Similarity=0.367  Sum_probs=189.9

Q ss_pred             cceEEeeeeeecCceEEEEEEEC----CCCcEEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++.+.||+|+||.||+|...    .+++.+|+|.+.....     ...+|+.+++.++|+||+++++++...   ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence            46889999999999999999964    3588999999865433     356799999999999999998876432   23


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .+.+++|||+++ ++.+++...   ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++ .++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEccccc
Confidence            447899999974 777666542   2358999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-HhCCCCH
Q 017131          186 AKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-VLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~~~~~  260 (376)
                      +.........    ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.........  +.. ..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~  232 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV  232 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence            9766432211    112334569999988654 5899999999999999999999998654321100  000 0000000


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+......  ....+          .+..++.++.+|+.+||..||.+|||+.++++
T Consensus       233 ~~~~~~~~~--~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKE--GERLP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHc--CCcCC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000  00000          11346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=287.52  Aligned_cols=272  Identities=21%  Similarity=0.293  Sum_probs=182.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC----------------CCCcEEEEEEeecccc------------------cHHHH
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR----------------ETGEIVAIKKVLQDKR------------------YKNRE   79 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~E   79 (376)
                      ..++|.+.++||+|+||+||+|.+.                ..++.||||++..+..                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                3356799999854321                  11236


Q ss_pred             HHHHHhCCCCCe-----eeccceeeecCC---CCceEEEEEEecccc-cHHHHHHHhhh--------------------h
Q 017131           80 LQIMQMLDHPNI-----VALKHCFFSTTD---KEELYLNLVLEYVPE-TVNRIARNYSR--------------------I  130 (376)
Q Consensus        80 ~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------------~  130 (376)
                      +.++..++|.++     +.+++++.....   ......++||||+++ +|.+++.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     455555532211   112347899999985 77776653210                    1


Q ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCce--eeeeccccchh
Q 017131          131 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAPE  208 (376)
Q Consensus       131 ~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~t~~y~aPE  208 (376)
                      ...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++ .+||+|||+++....+.....  ..+|+.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            1234667889999999999999998 9999999999999999988 799999999975543322222  23478999999


Q ss_pred             hhcCCCC-------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          209 LIFGATE-------------------Y--TTAIDIWSTGCVMAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       209 ~~~~~~~-------------------~--~~~~DiwslG~il~elltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .+.....                   |  ....|+||+||++|+|++|.. ||.+.......   .+.. ......|...
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~-~~~~~~~r~~  456 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY-DNDLNRWRMY  456 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc-cchHHHHHhh
Confidence            9853211                   1  224799999999999999874 77543211111   0000 0000111110


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCC---CCCCCHHHHhcCCccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP---NLRCTALEACVHPFFD  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~s~~~ll~hp~f~  323 (376)
                      ...  .+.++          .....++.++||+++||..+|   .+|+|+.|+|+||||.
T Consensus       457 ~~~--~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        457 KGQ--KYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             ccc--CCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            000  01111          124578999999999999876   6899999999999995

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=3.7e-37  Score=272.18  Aligned_cols=281  Identities=30%  Similarity=0.488  Sum_probs=210.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEECC---CCcEEEEEEeec--ccccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQ--DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..+.|.++++||.|+|++||++.+..   .++.||+|.+..  ....+..|+++|..+ .+.||+++.+++     ..+-
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence            44679999999999999999999887   788999998843  345577899999998 588999999988     3333


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ...+|+||++. ...++.       ..++..+++.+++.++.||+++|. .|||||||||.|+|.+.....-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhH
Confidence            47899999986 333333       347889999999999999999998 999999999999999987778899999998


Q ss_pred             cccc-----------------C--CC------------C--------------CceeeeeccccchhhhcCCCCCCCchh
Q 017131          187 KVLV-----------------K--GE------------P--------------NVSYICSRYYRAPELIFGATEYTTAID  221 (376)
Q Consensus       187 ~~~~-----------------~--~~------------~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~D  221 (376)
                      ....                 .  +.            +              .....||++|+|||++...+.-++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            6210                 0  00            0              012457999999999988887899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHHHhCCCCHHHHhhcCcC------------------cccccCCCccc--
Q 017131          222 IWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKP--  280 (376)
Q Consensus       222 iwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~--  280 (376)
                      |||.|+|+..++++..||-. .++.+.+..+...+|...-.........                  |.......+..  
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999988754 5566777777776654332221111100                  11110000100  


Q ss_pred             --cccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          281 --HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       281 --~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                        ..+........+..+.||+.+||..||.+|+|++++|+||||.....
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence              01122222335678999999999999999999999999999997543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-37  Score=245.58  Aligned_cols=214  Identities=24%  Similarity=0.430  Sum_probs=177.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHh-CCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..+....+..||+|+||.|-+.++..+|...|+|.+....     ....+|+.+..+ ..+|++|++++.++...+    
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd----  119 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD----  119 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc----
Confidence            3455667788999999999999999999999999885322     222346655444 379999999998876555    


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                       +++.||.|+.++..+-..-...++.++|..+-.++..++.||.|||+...++|||+||+|||++.+| +||+||||.+.
T Consensus       120 -vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG  197 (282)
T KOG0984|consen  120 -VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISG  197 (282)
T ss_pred             -EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccce
Confidence             8899999999998888888888889999999999999999999999977999999999999999999 89999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHH
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIK  253 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~  253 (376)
                      ...++-..+...|...|||||.+.   +...|+-++|+||||+.+.||.+++.||... ++.+++.+++.
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            766554444456777899999983   3346899999999999999999999999754 55566666654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.2e-35  Score=259.08  Aligned_cols=238  Identities=39%  Similarity=0.653  Sum_probs=191.3

Q ss_pred             CceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecccc-cHH
Q 017131           48 SFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN  121 (376)
Q Consensus        48 ~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  121 (376)
                      +||.||+|.+..+|+.+|+|++....     ....+|+..++.++|+|++++++.+...     ...++++|++++ ++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence            58999999999999999999986432     3456899999999999999999988543     347899999997 777


Q ss_pred             HHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeee
Q 017131          122 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS  201 (376)
Q Consensus       122 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t  201 (376)
                      ..+..    ...++...+..++.+++.++.+||+ .+++|+||+|+||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            66654    2238899999999999999999998 9999999999999999987 7999999999876554344456678


Q ss_pred             ccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcccc
Q 017131          202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH  281 (376)
Q Consensus       202 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (376)
                      ..|+|||.+.+ ..++.++|+||+|+++++|++|..||..........+........                ..     
T Consensus       150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----------------~~-----  207 (244)
T smart00220      150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----------------FP-----  207 (244)
T ss_pred             cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----------------Cc-----
Confidence            88999999864 457889999999999999999999997744444333332210000                00     


Q ss_pred             ccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          282 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       282 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                          .....++.++.+++.+||..||++||++.++++||||
T Consensus       208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                0001178899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=277.27  Aligned_cols=243  Identities=21%  Similarity=0.390  Sum_probs=199.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ....++.++||.|.||.||.|.+++..-.||||.++.+..   .+.+|+.+|+.++|||+|++++++....     -+|+
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFYI  340 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFYI  340 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeEE
Confidence            3467888999999999999999999999999999987653   4457999999999999999999984332     2889


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |+|||. |+|.++++...+  ..++...+.+++.||..|++||.. +++|||||-..|+|+.++. .||++|||+++.+.
T Consensus       341 iTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMT  416 (1157)
T ss_pred             EEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhc
Confidence            999986 788888876433  457788889999999999999998 9999999999999999886 89999999999874


Q ss_pred             CCCCCceeee---eccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          191 KGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       191 ~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .+ ..+...|   ..-|.|||.+. ...++.++|||+|||+|||+.| |-.||+|-+-.+.+..+.+             
T Consensus       417 gD-TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-------------  481 (1157)
T KOG4278|consen  417 GD-TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-------------  481 (1157)
T ss_pred             CC-ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-------------
Confidence            43 2222222   45599999984 4458999999999999999998 9999999875544443333             


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHH
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  316 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~l  316 (376)
                           .|++..          +..+++...+|++.||+|+|..||+..++
T Consensus       482 -----gyRM~~----------PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  482 -----GYRMDG----------PEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             -----cccccC----------CCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                 222222          25799999999999999999999998876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=292.14  Aligned_cols=249  Identities=29%  Similarity=0.448  Sum_probs=189.8

Q ss_pred             eEEeeeeeecCce-EEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           38 YIAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        38 y~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      |.-.+.+|.|+.| .||+|...  |+.||||.+..+.. ..+||+..|+.- +|||||+++..-     .+..+.|+..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence            4555678999988 57999876  78999999876543 678999999988 699999985432     45667899999


Q ss_pred             cccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC---CC-CCeEEEecCCccccc
Q 017131          115 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVLV  190 (376)
Q Consensus       115 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~---~~-~~vkl~Dfg~a~~~~  190 (376)
                      .|..+|.+++...............+.++.|++.||++||+ .+||||||||.||||+.   ++ -+++|+|||+++...
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99999999998741111112224567888999999999998 99999999999999986   33 279999999998876


Q ss_pred             CCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .+..    .....||-.|+|||++.... -+.++|||||||++|..++| ..||...  .+.-..|+..           
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~-----------  728 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTG-----------  728 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcC-----------
Confidence            5543    23456799999999996654 57799999999999999995 8999643  2222333331           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                            .+.+...         .+.-..++.|||.+||..||..||+|.++|.||||=
T Consensus       729 ------~~~L~~L---------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  729 ------NYTLVHL---------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ------ccceeee---------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                  1111110         011122899999999999999999999999999993

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=287.58  Aligned_cols=244  Identities=26%  Similarity=0.389  Sum_probs=206.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ....|.+.||.|.||.|++|+.+..|+   .||||.++..     ...+..|+.||=+++||||+++.++..     ...
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~  703 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSK  703 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCc
Confidence            457899999999999999999987774   5999998643     233446999999999999999999873     233


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      -+.+|+|||+ |+|+.+++..   .+.|+..++..+++.|+.|++||-+ .|+|||||...|||++++- ..|++|||++
T Consensus       704 PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLS  778 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLS  778 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEeccccce
Confidence            3779999998 6888888764   3569999999999999999999998 9999999999999999998 8999999999


Q ss_pred             ccccCCCC-Cceeee---eccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEP-NVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~-~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      +...++.. ..+..|   ...|.|||.+. ...++.++|+||+|++|||.++ |..||.+.++.+.+..|.+..+-|++ 
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-  856 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-  856 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-
Confidence            97655442 222222   46799999994 5569999999999999999886 99999999999999988875544432 


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                                 .++|..+.+|+..||++|-.+||...+|++
T Consensus       857 ---------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 ---------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ---------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                       478999999999999999999999999986

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=278.83  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=201.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCC-C--cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+..+.++||+|+||.|++|.+... |  -.||||.+..+.     ..+.+|+.+|..|+|+|++++|++..+..     
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp-----  184 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP-----  184 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence            4678889999999999999998653 3  369999886554     33568999999999999999999986521     


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                       +-+|||++. |+|.+.++.  .....|....+..|+.||+.|++||.+ +++|||||-..|+|+-... .|||||||+.
T Consensus       185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLm  259 (1039)
T KOG0199|consen  185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLM  259 (1039)
T ss_pred             -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeecccce
Confidence             568999998 577666665  345678889999999999999999998 9999999999999998876 8999999999


Q ss_pred             ccccCCCCCceeee----eccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEPNVSYIC----SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      +....++.......    ...|+|||.+. ...++.++|+|++||++|||++ |..||.|......+.+|-+.-      
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------  332 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------  332 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc------
Confidence            98876655442222    34599999994 5569999999999999999998 899999999877776664311      


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                                  .++.          ++.++.++.+++..||..+|.+|||+.+|...-+..
T Consensus       333 ------------rLpR----------Pk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  333 ------------RLPR----------PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ------------cCCC----------CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence                        1110          146899999999999999999999998886544443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-36  Score=271.85  Aligned_cols=256  Identities=22%  Similarity=0.312  Sum_probs=200.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .....++++||+|.||.|.+|.-.. +.+||+|+++.+.     ..+.+|+++|.+++||||+.+.+++....-     +
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----i  610 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----L  610 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----h
Confidence            3568899999999999999999643 6899999986542     345589999999999999999999865433     7


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++|+||++ |+|.+++..+....  +.......++.||+.|++||.+ .++|||||.+.|+|++.++ ++||+|||.++.
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~  686 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRN  686 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCcccccc
Confidence            89999998 68777776543221  3444566799999999999998 8999999999999999998 799999999987


Q ss_pred             ccCCCCCc---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHH--hCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          189 LVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL--LGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       189 ~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ...++...   ..+-...|||||.+... .+++++|+|++|+++||++  +...||...++.+........+..+.....
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            65554322   22336779999999764 4999999999999999986  478999887776666555544333322111


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                               ..            -++-++..+.+++.+||..|-.+||+.+++  |-+|++
T Consensus       766 ---------l~------------~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  766 ---------LS------------RPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             ---------cc------------CCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence                     11            123578999999999999999999999998  445544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=262.15  Aligned_cols=272  Identities=24%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             cccccCCCCCCceEEecccCCCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec-ccccHHHHHHHHHh-
Q 017131            8 DIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM-   85 (376)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~-   85 (376)
                      ...+|+|...+-.++-++++.         .++.+.||+|.||.||+|+++  |+.||||+|.. ++....||.++.+. 
T Consensus       192 ~~tSGSGSGlplLVQRTiarq---------I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTv  260 (513)
T KOG2052|consen  192 LETSGSGSGLPLLVQRTIARQ---------IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTV  260 (513)
T ss_pred             hccCCCCCCchhHhHHhhhhe---------eEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHH
Confidence            345677777777777777766         899999999999999999987  89999999964 55666677777765 


Q ss_pred             -CCCCCeeeccceeeecCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc-------
Q 017131           86 -LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------  156 (376)
Q Consensus        86 -l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------  156 (376)
                       |+|+||+.++..-.... ..-..++||++|-+ |+|.+++..     ..++...+..++..++.||++||..       
T Consensus       261 mLRHENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgK  334 (513)
T KOG2052|consen  261 MLRHENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGK  334 (513)
T ss_pred             HhccchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCC
Confidence             59999999987653332 23445899999998 799888875     5688999999999999999999951       


Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC-----CCceeeeeccccchhhhcCCCCC-----CCchhHHHHH
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNVSYICSRYYRAPELIFGATEY-----TTAIDIWSTG  226 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG  226 (376)
                      -.|.|||||..|||+.+++ ..-|+|+|+|.......     .....+||..|||||++......     -..+||||||
T Consensus       335 PaIAHRDlKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafg  413 (513)
T KOG2052|consen  335 PAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFG  413 (513)
T ss_pred             chhhccccccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHH
Confidence            2599999999999999999 89999999997654432     23567899999999999543221     1258999999


Q ss_pred             HHHHHHHhC----------CCCCCCCCc----hHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCC
Q 017131          227 CVMAELLLG----------QPLFPGESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP  292 (376)
Q Consensus       227 ~il~elltg----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (376)
                      .++||++..          ++||.+.-+    .+.+.+++.                  ...+....+..|..   ...-
T Consensus       414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVC------------------v~~~RP~ipnrW~s---~~~l  472 (513)
T KOG2052|consen  414 LVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVC------------------VQKLRPNIPNRWKS---DPAL  472 (513)
T ss_pred             HHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhccee------------------ecccCCCCCccccc---CHHH
Confidence            999999853          367755321    122222211                  11111111122211   1122


Q ss_pred             hhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          293 PEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       293 ~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+-.+++.||..||.-|.||-.+.+
T Consensus       473 ~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  473 RVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            35668899999999999999977653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=301.81  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=183.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecc
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      .|...+.||+|+||.||+|.+..++..||+|++........+|++.+++++||||+++++++....     ..++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCC
Confidence            456678899999999999999999999999998765555567899999999999999999985432     278999999


Q ss_pred             c-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH---hcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          117 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH---NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       117 ~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      + ++|.+++.       .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++ ..++. ||.+..... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            8 47766663       3788999999999999999999   5 6999999999999999877 56665 665543221 


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                        .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .....+..........  ..       
T Consensus       835 --~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~-------  902 (968)
T PLN00113        835 --DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH--LD-------  902 (968)
T ss_pred             --CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc--hh-------
Confidence              123367889999999865 4589999999999999999999999954321 1112221111100000  00       


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .+.-+.....   .........++.+++.+||+.||++|||+.++++.
T Consensus       903 ~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        903 MWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             heeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0000000000   00001123467899999999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=264.00  Aligned_cols=196  Identities=29%  Similarity=0.435  Sum_probs=170.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccH------------HHHHHHHHhCC---CCCeeecccee
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK------------NRELQIMQMLD---HPNIVALKHCF   98 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~E~~~l~~l~---h~~iv~~~~~~   98 (376)
                      +...|..++.+|.|+||.|++|.++.+...|+||.|.+++-..            --|+.+|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            4456999999999999999999999999999999987654322            24999999997   99999999999


Q ss_pred             eecCCCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC
Q 017131           99 FSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  176 (376)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~  176 (376)
                           +++.++|++||--+.  +|.+++.    ....++|.+++.++.|++.|+++||+ .||||||||-+|+.++.+| 
T Consensus       639 -----Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g-  707 (772)
T KOG1152|consen  639 -----EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNG-  707 (772)
T ss_pred             -----ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCC-
Confidence                 555568899998765  4444444    45789999999999999999999998 9999999999999999999 


Q ss_pred             CeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017131          177 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  241 (376)
Q Consensus       177 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  241 (376)
                      -+||+|||.|... .+.+.....||..|.|||++.+.++.+...|||+||++||.++....||..
T Consensus       708 ~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  708 FVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            6999999998754 455667889999999999998888779999999999999999999988853

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=253.02  Aligned_cols=264  Identities=25%  Similarity=0.330  Sum_probs=190.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec-ccccHHHHHHHHHh--CCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ...++.+.+|+|.||.||+|...  ++.||||++.. ++.....|.++...  ++|+||++++..-...... ..-+.||
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywLV  286 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWLV  286 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeEE
Confidence            46788999999999999999875  69999999964 44556667666665  5899999987654322222 3346799


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc--------CCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--------IGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      ++|.+ |+|.+++..     ..+++.....++..+++||+|||+.        ..|+|||||..|||+..|+ +..|+||
T Consensus       287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDF  360 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADF  360 (534)
T ss_pred             eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeecc
Confidence            99987 699888876     5689999999999999999999961        3699999999999999999 8999999


Q ss_pred             CCcccccCCCC---CceeeeeccccchhhhcCCCCCC-----CchhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHHH
Q 017131          184 GSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYT-----TAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKV  254 (376)
Q Consensus       184 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~  254 (376)
                      |+|.....+..   ....+||..|||||++.+...+.     .+.||||+|.+||||++....+. +..+.-++.--...
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            99987765433   23468899999999997766555     36899999999999998775553 22222222222223


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH
Q 017131          255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  314 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~  314 (376)
                      ...|+.+.+...--.  +-..|.+ +..|..   ..-...+++.+..||..||+-|+|+.
T Consensus       441 G~hPt~e~mq~~VV~--kK~RP~~-p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVR--KKQRPKI-PDAWRK---HAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             cCCCCHHHHHHHHHh--hccCCCC-hhhhhc---CccHHHHHHHHHHHcCCchhhhhhhH
Confidence            345555555432100  0000100 011111   12346789999999999999999984

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=269.06  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=209.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .-+++|.++..+|+|.||.||+|+++.+++..|+|+++.+    -...+.|+-+++..+||||+.+++.|.....     
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----   86 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----   86 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----
Confidence            4457899999999999999999999999999999998643    3556789999999999999999998865444     


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++.||||+|+..   +......+.+++.++.++.++.+.||+|||+ .|=+|||||-.|||+++.| .||++|||.+..
T Consensus        87 lwicMEycgggsl---Qdiy~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsaq  161 (829)
T KOG0576|consen   87 LWICMEYCGGGSL---QDIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSAQ  161 (829)
T ss_pred             cEEEEEecCCCcc---cceeeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchhh
Confidence            8899999997432   2223356789999999999999999999998 9999999999999999998 799999998754


Q ss_pred             ccC-CCCCceeeeeccccchhhh--cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          189 LVK-GEPNVSYICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       189 ~~~-~~~~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +.. -....+.+||++|||||+-  .....|...+|+|++|+...|+---++|-....+...+....+..-.|       
T Consensus       162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp-------  234 (829)
T KOG0576|consen  162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP-------  234 (829)
T ss_pred             hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC-------
Confidence            422 2334578999999999986  234568999999999999999988887776666655555544422111       


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                |..+..       .+.++.+.+|++.+|.++|++|||++.+|.|||...
T Consensus       235 ----------p~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  235 ----------PTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ----------CcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                      111111       346788999999999999999999999999999964

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-32  Score=264.35  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=190.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECC-------CCcEEEEEEeecc-----cccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      +..+.+.||+|+||+|++|.-..       ....||||..+..     ......|+++|+.+ .|+||+.+.+++..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            34677799999999999998431       1356999987543     23455799999998 59999999998844   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhh---hh-------c--CCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYS---RI-------H--QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  170 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~~-------~--~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nil  170 (376)
                        ...+++|+||+. |+|..+++...   ..       .  ..++...+..+++||+.|++||++ ++++||||-..|||
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL  450 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence              344889999998 68877777654   00       1  138899999999999999999998 99999999999999


Q ss_pred             EcCCCCCeEEEecCCcccccCCCCCcee--e--eeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 017131          171 VNPHTHQLKLCDFGSAKVLVKGEPNVSY--I--CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  245 (376)
Q Consensus       171 l~~~~~~vkl~Dfg~a~~~~~~~~~~~~--~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  245 (376)
                      +..+. .+||+|||+|+...........  .  -...|||||.+.. ..|+.++||||+|++|||+++ |..||++....
T Consensus       451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99887 8999999999865443322211  1  1334999999966 569999999999999999998 89999985533


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+.+.++...                 .+.          -+..+++++.++++.||+.+|.+||+..++..
T Consensus       529 ~~l~~~l~~G~-----------------r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  529 EELLEFLKEGN-----------------RME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHhcCC-----------------CCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            33333333111                 111          12468999999999999999999999988763

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-32  Score=254.39  Aligned_cols=242  Identities=26%  Similarity=0.348  Sum_probs=192.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCc----EEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..+..++||+|+||+||+|.....|+    +||||++...     ...+.+|+-+|..++|||+++++++.....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            35667899999999999999876665    5788877543     234557999999999999999999885432     


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                       +-||++|++ |.|.++++.+   +..+.......|.+||+.|++|||. ++++||||-..|||+.+-. .|||+|||+|
T Consensus       772 -~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgla  845 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGLA  845 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecchh
Confidence             558999998 5787777763   4678889999999999999999998 9999999999999999887 6999999999


Q ss_pred             ccccCCCCCceeee---eccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          187 KVLVKGEPNVSYIC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       187 ~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      +.....+......+   .+-|||=|.+.. ..|+.++||||+||++||++| |..|+.+....+.-..+.+.        
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------  916 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------  916 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc--------
Confidence            87765554443333   455889898854 569999999999999999998 99999887644433222211        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                -++++          ++.++.++..++.+||..|+..||+++++..
T Consensus       917 ----------eRLsq----------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  917 ----------ERLSQ----------PPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ----------ccCCC----------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                      01111          2468899999999999999999999987753

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=229.75  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=186.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .+.|.|.+.||+|.||.+.+|+|+.+...+++|.+.+..   ..+.||...--.| -|.||+.-|++-+...+    +++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eEE
Confidence            357999999999999999999999999999999886543   3344666655555 58999998887655443    466


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE-cCCCCCeEEEecCCccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill-~~~~~~vkl~Dfg~a~~  188 (376)
                      +++||++ |+|.+-+..     .++.|...+.++.|++.|+.|||+ +++||||||.+|||| +.|..+|||||||+.+.
T Consensus        99 F~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccc
Confidence            8999998 566444432     568899999999999999999998 999999999999998 45555899999999875


Q ss_pred             ccCCCCCceeeeeccccchhhhcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCCCHHHH
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEI  263 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  263 (376)
                      ...-  ....--+..|.+||++...    -...+.+|+|.||+++|.++||++||......+ .+.+..+-.+...    
T Consensus       173 ~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~----  246 (378)
T KOG1345|consen  173 VGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN----  246 (378)
T ss_pred             cCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC----
Confidence            4221  1111224559999987432    225778999999999999999999997543222 2223332211110    


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCC---CCHHHHhcCCcccc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDE  324 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~s~~~ll~hp~f~~  324 (376)
                               ...|        ..| ..+++.+..+.++-|..++++|   .++.....--|...
T Consensus       247 ---------~~~P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  247 ---------PALP--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             ---------ccCc--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence                     0111        112 3578999999999999999999   45555555666643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.5e-30  Score=219.04  Aligned_cols=207  Identities=35%  Similarity=0.578  Sum_probs=174.2

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEeccc-
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-  117 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-  117 (376)
                      ||+|++|.||++.+..+++.+++|++....     ....+|+..++.++|++++++++++...     ...++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            689999999999998889999999987654     3467899999999999999999888433     44789999999 


Q ss_pred             ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC-CCCCeEEEecCCcccccCCC-CC
Q 017131          118 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  195 (376)
Q Consensus       118 ~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~-~~~~vkl~Dfg~a~~~~~~~-~~  195 (376)
                      +++.+++....   ..++...++.++.+++.++++||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            67777665421   468999999999999999999998 99999999999999998 66 79999999987653332 12


Q ss_pred             ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 017131          196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  275 (376)
Q Consensus       196 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  275 (376)
                      ....+...|++||.+.....++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3345677899999985543678999999999999999                                           


Q ss_pred             CCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 017131          276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  320 (376)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp  320 (376)
                                       ..+.+++.+|+..||.+||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1467899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.3e-31  Score=271.21  Aligned_cols=206  Identities=16%  Similarity=0.170  Sum_probs=145.6

Q ss_pred             hCCC-CCeeeccceeeecC--CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccc
Q 017131           85 MLDH-PNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  161 (376)
Q Consensus        85 ~l~h-~~iv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH  161 (376)
                      .++| .||+.+++.|-...  ......+++++|+++++|.+.+..   ....+++.+++.++.||+.||+|||+ +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence            3455 57777777652211  112234678899999998887753   23569999999999999999999998 99999


Q ss_pred             cCCCCCcEEEcCCC------------------CCeEEEecCCcccccCCC-----------------CCceeeeeccccc
Q 017131          162 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNVSYICSRYYRA  206 (376)
Q Consensus       162 ~Dlkp~Nill~~~~------------------~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a  206 (376)
                      |||||+|||++..+                  ..+|++|||+++......                 ......+|++|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999995432                  146677777765321100                 0012357889999


Q ss_pred             hhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccc
Q 017131          207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV  286 (376)
Q Consensus       207 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (376)
                      ||++.+. .|+.++|||||||+||||++|.+|+....  .....+.... .++.                          
T Consensus       184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~--------------------------  233 (793)
T PLN00181        184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ--------------------------  233 (793)
T ss_pred             hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence            9998664 48999999999999999999988875322  1111111110 0000                          


Q ss_pred             cccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          287 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       287 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      . ....+...+++.+||+.||.+||++.++++||||...
T Consensus       234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            0 0124566799999999999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.6e-29  Score=218.16  Aligned_cols=197  Identities=36%  Similarity=0.586  Sum_probs=164.8

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+...     .....+|+..++.++|+|++++++.+...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            67889999999999999999988999999998653     23455799999999999999999887433     337899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCC-CcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          113 LEYVPE-TVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +|++++ +|.+.+...    .. +++..+..++.|++.++.+||+ .+++|+||+|.||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999997 777766542    23 8899999999999999999998 8999999999999999887 89999999987765


Q ss_pred             CCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCch
Q 017131          191 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGV  245 (376)
Q Consensus       191 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~  245 (376)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            443  334556778899999884344578899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.2e-28  Score=206.05  Aligned_cols=167  Identities=21%  Similarity=0.157  Sum_probs=125.0

Q ss_pred             ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCce
Q 017131          118 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS  197 (376)
Q Consensus       118 ~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~  197 (376)
                      |+|.+++...   +..+++..++.++.|++.||+|||+ ++      ||+||+++.++ .+|+  ||+++.....    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            4566666542   3569999999999999999999998 77      99999999988 7888  9998765332    2


Q ss_pred             eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 017131          198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFP  276 (376)
Q Consensus       198 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ..+|+.|+|||++.+ ..++.++||||+||++|||++|..||........ +..+.........                
T Consensus        64 ~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------------  126 (176)
T smart00750       64 SRVDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP----------------  126 (176)
T ss_pred             CCCcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----------------
Confidence            267899999999965 4589999999999999999999999976554332 2222221110000                


Q ss_pred             CccccccccccccCCCh--hHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          277 QIKPHPWHKVFQKRLPP--EAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       277 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      ..  .+    ....++.  ++.++|.+||..||.+||++.++++|+|+..
T Consensus       127 ~~--~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      127 RD--RS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cc--cc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            00  00    0012333  6999999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-28  Score=213.15  Aligned_cols=249  Identities=19%  Similarity=0.272  Sum_probs=189.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCC-----cEEEEEEeecccccH-----HHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~-----~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ++.+++....+-+|.||.||.|.+...+     +.|.+|.++.....+     ..|...+..+.|||+..+.++.....+
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            4467899999999999999999665322     345667665544333     257778888899999999887754322


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh----hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCe
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL  178 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~v  178 (376)
                          ..++++++++ |+|...+..-+.    ..+.++..++..++.|++.|++|||+ +|+||.||-..|.+||+.- +|
T Consensus       362 ----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qV  435 (563)
T KOG1024|consen  362 ----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QV  435 (563)
T ss_pred             ----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eE
Confidence                2556778877 566666653221    12346777888999999999999998 9999999999999999887 89


Q ss_pred             EEEecCCcccccCCCCCc---eeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017131          179 KLCDFGSAKVLVKGEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  254 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~  254 (376)
                      ||+|=.+++.....+-..   .-.....||+||.+.+ ..|+.++|+||||+++|||+| |+.|+..-++.+...-+.+.
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            999999998765443321   1112456999999965 569999999999999999998 99999988877766554432


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                                        +++.+          +-++|+++..++.-||..+|++||+.+|+.
T Consensus       515 ------------------yRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  515 ------------------YRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             ------------------ceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence                              22221          137999999999999999999999999886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=9.9e-29  Score=239.93  Aligned_cols=257  Identities=24%  Similarity=0.332  Sum_probs=190.7

Q ss_pred             EEeeeeeecCceEEEEEEECCCCcEEEEEEeec----cccc------HHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           39 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        39 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .....+|.|++|.|+.+......+.++.|.+..    ....      ...|+-+-..+.|+|++.....++....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            567889999999999888877677677765431    1111      2235566667899999887776644332     


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .+-.||||+++|..++..    ...++..++..++.|++.|++|||+ .||.|||+||+|+++..+| .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCccee
Confidence            223499999866665553    2468888999999999999999998 9999999999999999998 899999999865


Q ss_pred             ccCCC-----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH-HHHHHhCCCCHHH
Q 017131          189 LVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREE  262 (376)
Q Consensus       189 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~  262 (376)
                      .....     .....+|+..|+|||++.+........||||.|+++..|++|+.||.-....+... .....        
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~--------  541 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS--------  541 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc--------
Confidence            43322     23456789999999999877766778999999999999999999997655443321 00000        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                              .....    ..... .+...++...+.+|.+||+.||.+|.|+++|++.+||+.+..
T Consensus       542 --------~~~~~----~~~~~-~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  542 --------DQRNI----FEGPN-RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             --------ccccc----ccChH-HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence                    00000    00000 111357889999999999999999999999999999998753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-26  Score=190.82  Aligned_cols=206  Identities=23%  Similarity=0.299  Sum_probs=165.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCC-CCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|+++++||+|+||.+|+|....+|+.||||.-++..  .....|..+.+.+++ ..|+.+..+.     .+..+-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----ccccccee
Confidence            346999999999999999999999999999999876543  345579999999975 4566665544     44455679


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCeEEEecCCcccc
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  189 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg~a~~~  189 (376)
                      ||+.++.+|++++..   ....|+...+..++.|++.-++|+|. ++++||||||+|+|..-+.  +.+.|+|||+|+..
T Consensus        89 VMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   89 VMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhh
Confidence            999999999888765   45789999999999999999999998 9999999999999985443  36999999999876


Q ss_pred             cCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 017131          190 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  250 (376)
Q Consensus       190 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  250 (376)
                      .+...        .....||..|.+=-...+.. -+...|+=|+|.+|..+..|..||.|.......++
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            44322        23557888888766654433 57889999999999999999999998765544443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-25  Score=203.17  Aligned_cols=250  Identities=20%  Similarity=0.207  Sum_probs=188.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCC-cEEEEEEeeccc----ccHHHHHHHHHhCCC----CCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK----RYKNRELQIMQMLDH----PNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~~~  107 (376)
                      +|.+.+.||+|+||.||.|.+..++ +.+|+|......    .....|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999998775 678999775432    146679999998873    57777766552    2445


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC----CCeEEEec
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCDF  183 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~----~~vkl~Df  183 (376)
                      +-++||+.++.+|.++.....  .+.++...+..++.|++.+|++||+ .|++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            578999999999988776543  5789999999999999999999998 9999999999999998653    46999999


Q ss_pred             CCcc--cccCCC--------C-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017131          184 GSAK--VLVKGE--------P-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  252 (376)
Q Consensus       184 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  252 (376)
                      |+|+  ......        . .....||..|.++....+. ..+.+.|+||++.++.+++.|..||.+........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 1234589999999988654 48999999999999999999999997766443333332


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +.....               ....         .....+.++.++...+-..+...+|....+..
T Consensus       251 ~~~~~~---------------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  251 KDPRKL---------------LTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             HHhhhh---------------cccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            211000               0000         11234577888888888889999998776654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.6e-28  Score=223.00  Aligned_cols=236  Identities=30%  Similarity=0.442  Sum_probs=189.9

Q ss_pred             eeecCceEEEEEEE---CCCCcEEEEEEeeccc------ccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEEEE
Q 017131           44 VGTGSFGVVFQAKC---RETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        44 lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +|.|+||.|++++-   ...|..||+|+..+..      .....|..++...+ ||.+++++..|.+..+     .++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-----l~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-----LYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-----hhHhh
Confidence            68999999998874   3457789999775421      12234778888886 9999999988854443     78999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC
Q 017131          114 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  193 (376)
Q Consensus       114 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  193 (376)
                      ++..++.   +-........+.+..++.+...++.|++++|+ .||+|||+|++||+++.+| .+++.|||+++......
T Consensus        77 d~~rgg~---lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   77 DFLRGGD---LFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             hhcccch---hhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccC-ccccCCchhhhHhHhhh
Confidence            9998732   22223345668889999999999999999998 9999999999999999999 59999999998776554


Q ss_pred             CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 017131          194 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  273 (376)
Q Consensus       194 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  273 (376)
                      ..   +||..|||||++.   ....++|+||+|+++++|+||..||.+    +....|.+.                 ..
T Consensus       152 ~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-----------------~~  204 (612)
T KOG0603|consen  152 IA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-----------------EL  204 (612)
T ss_pred             hc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-----------------cc
Confidence            43   8999999999995   368899999999999999999999987    555556552                 11


Q ss_pred             cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCcccccCCC
Q 017131          274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDP  328 (376)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~~ll~hp~f~~~~~~  328 (376)
                      .+            +..++..+++++..++..+|..|...     .++++|+||+.+.+.
T Consensus       205 ~~------------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  205 EM------------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             CC------------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            11            13578899999999999999999864     799999999998764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=1.1e-25  Score=197.19  Aligned_cols=238  Identities=22%  Similarity=0.294  Sum_probs=149.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHH-------HHHHHHHhCC----------CCCeeecccee
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD----------HPNIVALKHCF   98 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~E~~~l~~l~----------h~~iv~~~~~~   98 (376)
                      .++..+..||.|+++.||.+.|..||+.+|+|++........       +|.-....+.          |-.++...+..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            368899999999999999999999999999999854432221       2221222211          11222222222


Q ss_pred             eec---------CCCCce---EEEEEEecccccHHHHHHHhhhhcCC---CcHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 017131           99 FST---------TDKEEL---YLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRD  163 (376)
Q Consensus        99 ~~~---------~~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~iiH~D  163 (376)
                      ...         .+....   ..+++|+-+.++|..++.........   +.......+..|++..+++||+ .|++|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecc
Confidence            111         111111   24688999999998887765443333   2223334555899999999998 9999999


Q ss_pred             CCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCC-------CCCCCchhHHHHHHHHHHHHhCC
Q 017131          164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQ  236 (376)
Q Consensus       164 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~  236 (376)
                      |+|+|++++.+| .+.|+||+........  ......+..|.|||.....       -.++.+.|.|+||+++|.|+||.
T Consensus       171 i~~~nfll~~~G-~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQDG-GVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TTS--EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCCC-CEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            999999999999 7999999887654221  1112345779999987432       23788999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCC
Q 017131          237 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  310 (376)
Q Consensus       237 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  310 (376)
                      .||.........                       ..        .+..+  .++|+.+++||+.+|+.||.+|
T Consensus       248 lPf~~~~~~~~~-----------------------~~--------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADP-----------------------EW--------DFSRC--RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTS-----------------------GG--------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccc-----------------------cc--------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence            999764321100                       00        12222  2689999999999999999988

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=6.8e-26  Score=207.01  Aligned_cols=157  Identities=20%  Similarity=0.285  Sum_probs=118.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-CCcEEEEEEeecc---------cccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ..+|.+.+.||+|+||+||+|++.. +++.+|||++...         .....+|+++|+.++|+|++..+..+   .  
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~--   91 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G--   91 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C--
Confidence            3569999999999999999999876 6788899986422         12356899999999999998532211   1  


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCC-CCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dl-kp~Nill~~~~~~vkl~Df  183 (376)
                         ..|+||||++|.......       ...   ...++.|++.||.|||+ +||+|||| ||+|||++.++ .+||+||
T Consensus        92 ---~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLiDF  156 (365)
T PRK09188         92 ---KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVIDF  156 (365)
T ss_pred             ---CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEEEC
Confidence               167999999874322111       111   14578899999999998 99999999 99999999887 7999999


Q ss_pred             CCcccccCCCC---------Cceeeeeccccchhhhc
Q 017131          184 GSAKVLVKGEP---------NVSYICSRYYRAPELIF  211 (376)
Q Consensus       184 g~a~~~~~~~~---------~~~~~~t~~y~aPE~~~  211 (376)
                      |+|+.......         .....+++.|+|||.+.
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99986543321         12345677799999884

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.9e-25  Score=188.23  Aligned_cols=202  Identities=23%  Similarity=0.302  Sum_probs=167.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec--ccccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+..|+++++||+|+||.++.|...-++++||||.-..  +...+..|.+..+.|. .+.|..+|.+-     .+..+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchh
Confidence            345689999999999999999999999999999996543  3344567999999885 67888775433     555667


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC----CCCeEEEecCC
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGS  185 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~----~~~vkl~Dfg~  185 (376)
                      .||+|+++.+|++++..   ++++|+...+..++.|++.-++|+|+ +.+|+|||||+|+||..-    .+.|.++|||+
T Consensus       100 iLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  100 ILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            79999999999888875   56789999999999999999999998 999999999999999643    33699999999


Q ss_pred             cccccCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 017131          186 AKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG  244 (376)
Q Consensus       186 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  244 (376)
                      |+...+...        ..+..||..||+=-.-++.. -+...|+=|||-+++..+.|..||.|...
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            987654322        24567899999877766654 68899999999999999999999998543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=4.2e-26  Score=222.24  Aligned_cols=229  Identities=28%  Similarity=0.489  Sum_probs=171.7

Q ss_pred             CCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           30 GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ........|..++.|-.|+||.||+++|+.|.+.+|+| +.++.-....   ++....+|.+|                 
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee-----------------
Confidence            34455678999999999999999999999999999995 5444332211   22222223222                 


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                              |+-..+++.    -+.++.        +++.+++|||+ .||+|||+||+|.+|+.-| .+|++|||+++..
T Consensus       136 --------gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 --------GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKG  193 (1205)
T ss_pred             --------chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhh
Confidence                    211111221    233443        33778999998 9999999999999999998 6999999998653


Q ss_pred             cCCCC----------------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017131          190 VKGEP----------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       190 ~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  253 (376)
                      .....                ....+|||.|+|||++...+ |+..+|||++|+|+|+.+.|+.||.+.++.+.+.+.+.
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis  272 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  272 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence            21111                12358899999999997654 99999999999999999999999999999998888776


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC---HHHHhcCCcccccCCC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDP  328 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~ll~hp~f~~~~~~  328 (376)
                      ...                 .+++-         ...++++++++|.++|+.+|..|..   +.++.+|+||+.+.|.
T Consensus       273 d~i-----------------~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  273 DDI-----------------EWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             hhc-----------------ccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            421                 22211         1347899999999999999999974   6788999999998865

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.1e-23  Score=193.08  Aligned_cols=259  Identities=34%  Similarity=0.494  Sum_probs=194.5

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCC-CeeeccceeeecCCCCceEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~  109 (376)
                      |.+.+.||.|+||.||.+.+.   ..+|+|.+....       ....+|+.++..+.|+ +++++.+.+...     ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence            889999999999999999987   778999885432       2345789999999988 799999988322     226


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++++++.+ .+...+...... ..++...+..++.|++.+++|+|+ .+++|||+||+||+++..+..++++|||.++.
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            799999986 443233221100 268999999999999999999998 99999999999999998763599999999875


Q ss_pred             ccCCC-------CCceeeeeccccchhhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhC
Q 017131          189 LVKGE-------PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG  256 (376)
Q Consensus       189 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~  256 (376)
                      .....       ......+|..|+|||.+.+.  ..++...|+||+|++++++++|..||.....   .......+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            43332       23566889999999999763  4689999999999999999999999877664   344444433322


Q ss_pred             CC-CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          257 TP-TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       257 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .+ ..              ....      ..........+.+++.+++..+|..|.+..+...++|.....
T Consensus       232 ~~~~~--------------~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         232 TPSLA--------------SPLS------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             Ccccc--------------cccC------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            21 00              0000      000011236789999999999999999999998887776543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-24  Score=188.49  Aligned_cols=208  Identities=22%  Similarity=0.323  Sum_probs=148.7

Q ss_pred             CCCCeeeccceeeecC----------------------CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHH
Q 017131           87 DHPNIVALKHCFFSTT----------------------DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY  144 (376)
Q Consensus        87 ~h~~iv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~  144 (376)
                      +|||||.+...|.+..                      -.+...+|+||-....+|..++..     +..+....+.++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            6999999988885431                      134566899999998888777764     5577778888999


Q ss_pred             HHHHHHHHHHhcCCccccCCCCCcEEEcCC--CC-CeEEEecCCcccccCC-------CCCceeeeeccccchhhhcCCC
Q 017131          145 QICRALAYIHNCIGICHRDIKPQNLLVNPH--TH-QLKLCDFGSAKVLVKG-------EPNVSYICSRYYRAPELIFGAT  214 (376)
Q Consensus       145 qi~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~-~vkl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~  214 (376)
                      |+++|+.|||+ +||.|||+|.+|||+.-+  +. .+.|+|||.+-.....       +......|.-..||||+....+
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999998 999999999999998433  21 5889999987433221       1122334566789999984322


Q ss_pred             C-----CCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcccccccccccc
Q 017131          215 E-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK  289 (376)
Q Consensus       215 ~-----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (376)
                      .     .-.++|.|+.|.+.||++....||.+......-.                  .+|.+-.+|.         .+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------------r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------------RTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------------hhhhhhhCCC---------Ccc
Confidence            1     1237899999999999999999998733211000                  1122223333         225


Q ss_pred             CCChhHHHHHHHhhccCCCCCCCH---HHHhc------CCcccccCC
Q 017131          290 RLPPEAVDLVCRFFQYSPNLRCTA---LEACV------HPFFDELRD  327 (376)
Q Consensus       290 ~~~~~~~~li~~~L~~dp~~R~s~---~~ll~------hp~f~~~~~  327 (376)
                      .+++.+++|+..+|+.||++|+++   +.+++      |.|++...+
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~  527 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMME  527 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcc
Confidence            689999999999999999999995   34443      556655543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=211.42  Aligned_cols=240  Identities=28%  Similarity=0.430  Sum_probs=174.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHH--HHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKN--RELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~--~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .|...+.||++.|=+|.+|++.+ |. |+||++.+...      ..+  +|++ ....++||.+.+....     ..+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            68889999999999999999853 55 89999865431      111  3444 6667999999886654     23334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .|||-+|...+|++-+..    +.-+.+.+.+.|+.|++.||.-+|. .||+|||||.+||||++=. -+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeec-hhhhhcccccCC
Confidence            678999998888776654    3447888999999999999999998 9999999999999999866 799999986543


Q ss_pred             cc---CCCCCcee-ee----eccccchhhhcCCC----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017131          189 LV---KGEPNVSY-IC----SRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  249 (376)
Q Consensus       189 ~~---~~~~~~~~-~~----t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  249 (376)
                      ..   ++.....+ ..    -.+|.|||.+....          ..+++-||||+||+++||++ |++||.    ..++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHH
Confidence            21   11111122 12    23599999985411          15778999999999999998 899994    22333


Q ss_pred             HHHHHhCCCCHH-HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          250 EIIKVLGTPTRE-EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       250 ~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ...... ....+ .+..                     +   -+..++.+|..|++.||++|.+|++.|+-
T Consensus       246 aYr~~~-~~~~e~~Le~---------------------I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQLLEK---------------------I---EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHHHHh---------------------C---cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            322211 11111 1111                     1   24589999999999999999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=2.8e-23  Score=174.82  Aligned_cols=135  Identities=18%  Similarity=0.217  Sum_probs=103.1

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccc------------------------------cHHHHHHHHHhCCCCC
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN   90 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~~   90 (376)
                      .+.||+|++|.||+|.+. +|+.||||++.....                              ...+|+..+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999986 899999999864311                              1124999999998877


Q ss_pred             eeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHH-HhcCCccccCCCCCcE
Q 017131           91 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGICHRDIKPQNL  169 (376)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~iiH~Dlkp~Ni  169 (376)
                      +.......  ..   .  .++||||++|+......   .....+++..+..++.|++.+|.++ |+ .||+||||||+||
T Consensus        81 v~~p~~~~--~~---~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK---S--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec---C--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            64332221  11   1  26999999974321111   1235789999999999999999999 67 8999999999999


Q ss_pred             EEcCCCCCeEEEecCCcccc
Q 017131          170 LVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       170 ll~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++. + .++|+|||+|...
T Consensus       150 li~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-C-cEEEEEccccccC
Confidence            9984 5 7999999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=6.4e-23  Score=174.61  Aligned_cols=170  Identities=12%  Similarity=0.140  Sum_probs=125.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----ccc---------HHHHHHHHHhCCCCCeeeccceeeec
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRY---------KNRELQIMQMLDHPNIVALKHCFFST  101 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (376)
                      .++|++.+.||.|+||.||++.+  ++..+|||.+...    ...         .++|+..+.++.|++|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            45799999999999999999765  4668999988532    111         46789999999999999998876543


Q ss_pred             CCC---CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131          102 TDK---EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus       102 ~~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                      ...   .....+++|||++| +|.+..        .+++.    ...+++.+|..||+ .|++|||+||.||+++.++  
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~~----~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISED----VKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh--------hccHH----HHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--
Confidence            211   12347799999998 453331        23332    35699999999998 9999999999999999876  


Q ss_pred             eEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  233 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  233 (376)
                      ++|+|||..........            -+.+.-...|..++|+||||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKA------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhh------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            99999998764422111            111212234678999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=6.5e-22  Score=167.12  Aligned_cols=135  Identities=16%  Similarity=0.225  Sum_probs=105.2

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------------------------------cHHHHHHHHHhCCCC
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHP   89 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~   89 (376)
                      +.+.||+|++|+||+|.+. +|+.||||++.....                              ...+|...+..+.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999998864311                              124688999999999


Q ss_pred             CeeeccceeeecCCCCceEEEEEEeccccc-HH-HHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131           90 NIVALKHCFFSTTDKEELYLNLVLEYVPET-VN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      ++.....+...  .     .++||||++|. +. ..+.     ...++...+..++.|++.++.++|+..||+||||||+
T Consensus        80 ~i~~p~~~~~~--~-----~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~  147 (190)
T cd05145          80 GVPVPEPILLK--K-----NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY  147 (190)
T ss_pred             CCCCceEEEec--C-----CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence            87544333211  1     36999999874 21 1121     2467888999999999999999995379999999999


Q ss_pred             cEEEcCCCCCeEEEecCCcccc
Q 017131          168 NLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ||+++ ++ .++|+|||++...
T Consensus       148 NIll~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         148 NILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             hEEEE-CC-CEEEEEcccceec
Confidence            99999 66 7999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=2.1e-21  Score=161.85  Aligned_cols=182  Identities=16%  Similarity=0.123  Sum_probs=132.0

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc--------cHHHHHHHHHhCC-CCCeeeccceeeecCCCCceE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..+...|++|+||+|+.+..  .+.+++.+.+.....        ...+|+++|+++. |+++++++++.    .     
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~-----   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G-----   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-----
Confidence            34678899999999998875  477888776654332        3468999999995 47788886641    1     


Q ss_pred             EEEEEeccccc-HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCC-CCCcEEEcCCCCCeEEEecCCc
Q 017131          109 LNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       109 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dl-kp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++|+|+.|. |....          +.. ...++.|++.+|+++|+ +||+|||| ||+|||++.++ .++|+|||+|
T Consensus        73 ~~lvmeyI~G~~L~~~~----------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A  139 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRP----------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLA  139 (218)
T ss_pred             EEEEEeeecCccHHhhh----------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCc
Confidence            57999999874 32111          111 13467899999999998 99999999 79999999888 7999999999


Q ss_pred             ccccCCCCC----c----------eeeeeccccchhhhcCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 017131          187 KVLVKGEPN----V----------SYICSRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGES  243 (376)
Q Consensus       187 ~~~~~~~~~----~----------~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~  243 (376)
                      .........    .          -...++.|+.|+.-.-....+ ...++++.|+-+|.++|+..++.+.+
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            754433211    0          012366788887653222233 46688899999999999998886654

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.2e-20  Score=157.63  Aligned_cols=134  Identities=21%  Similarity=0.253  Sum_probs=102.1

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhC-----CCCCeeeccceeeecCCCCceE-E
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-----DHPNIVALKHCFFSTTDKEELY-L  109 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~-~  109 (376)
                      -.+.||+|++|.||.  +..++.. +||++...    .....+|+.+++.+     +||||+++++++.+..+  ..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g--~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG--TGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC--CeEEE
Confidence            357899999999995  7777666 69987643    34466899999999     67999999999865432  233 3


Q ss_pred             EEEEeccc---ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHH-HHHHhcCCccccCCCCCcEEEcCCC---CCeEEEe
Q 017131          110 NLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL-AYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCD  182 (376)
Q Consensus       110 ~lv~e~~~---~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~iiH~Dlkp~Nill~~~~---~~vkl~D  182 (376)
                      .+|+||++   ++|.+++..     ..+++.  ..++.|++.++ +|||+ ++|+||||||+|||++.++   ..++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            47899955   588887754     245555  35678888888 99998 9999999999999997432   2699999


Q ss_pred             cCCc
Q 017131          183 FGSA  186 (376)
Q Consensus       183 fg~a  186 (376)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            6544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2.3e-20  Score=185.54  Aligned_cols=189  Identities=26%  Similarity=0.428  Sum_probs=145.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCC---CCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+..|-|.+.||+|+||+||+|.+.. |+.||+|+-+...   .++-  ..++.+|+   -+.|+++..++...+.    
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~--~q~~~RLk~~~~~~~~~~~~a~~~~~~----  768 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC--LQVMERLKPQMLPSIMHISSAHVFQNA----  768 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh--HHHHHhhchhhhcchHHHHHHHccCCc----
Confidence            44689999999999999999999877 9999999764432   2221  23334444   2345555554433332    


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC------CCCCeEE
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP------HTHQLKL  180 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~------~~~~vkl  180 (376)
                       -++|++|.+ |+|.+++.    ..+.+++..+.++..|++..++.||. .+|||+||||+|+||..      +...++|
T Consensus       769 -S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 -SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             -ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEE
Confidence             458999998 68877776    46779999999999999999999998 89999999999999832      2225999


Q ss_pred             EecCCccccc---CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCC
Q 017131          181 CDFGSAKVLV---KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  236 (376)
Q Consensus       181 ~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  236 (376)
                      +|||.+..+.   ++........|-.+-.+|...| ..+++++|.|.|+.+++-|++|+
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence            9999985442   3333445566888999999966 45999999999999999999997

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.7e-21  Score=161.19  Aligned_cols=238  Identities=16%  Similarity=0.205  Sum_probs=176.2

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec------ccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      +..+..+|.+...|..|+|+..  |..++.|++..      -.+.++.|.-.|+.+.||||+.+++.+-++.     .+.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----Cce
Confidence            4566778999999999999987  45667776632      2344567899999999999999999884433     377


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc-CCCCCcEEEcCCCCCeEEE--ecCCc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR-DIKPQNLLVNPHTHQLKLC--DFGSA  186 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~-Dlkp~Nill~~~~~~vkl~--Dfg~a  186 (376)
                      ++..|++ |+|++++....  .--....++..++.++++|++|||+-..++-| -|+...+++|++- +.+|.  |--++
T Consensus       264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence            8999998 68888887532  23356678889999999999999983334444 5888999999876 45543  22221


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEY--TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      -      ......-.|.|++||.+...+..  -.++|+|||++++|||.|...||....+.+---+|.-.          
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----------  404 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----------  404 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----------
Confidence            1      11123347889999999654432  45799999999999999999999988877655554321          


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                                       -+...+++.++..+..|++-|+.-||.+||..+.++
T Consensus       405 -----------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  405 -----------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -----------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                             122345678999999999999999999999887653

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=4.6e-20  Score=160.54  Aligned_cols=138  Identities=16%  Similarity=0.121  Sum_probs=105.0

Q ss_pred             ceEEeeeeeecCceEEEEEE-ECCCCcEEEEEEeeccc----------------------------ccHHHHHHHHHhCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD   87 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~   87 (376)
                      -|.+.+.||+|++|.||+|. +..+|+.||||++....                            ....+|+.+++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58999999999999999999 77889999999886431                            11347999999997


Q ss_pred             CCCeeeccceeeecCCCCceEEEEEEeccccc-HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-ccccCCC
Q 017131           88 HPNIVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIK  165 (376)
Q Consensus        88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-iiH~Dlk  165 (376)
                      +. .+.+...+.. ..     .++||||+++. +....    .....+....+..++.|++.++++||+ .| ++|||||
T Consensus       109 ~~-~i~~p~~~~~-~~-----~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dik  176 (237)
T smart00090      109 EA-GVPVPKPIAW-RR-----NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLS  176 (237)
T ss_pred             hc-CCCCCeeeEe-cC-----ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCC
Confidence            53 3333333311 11     36999999983 32211    112345666778999999999999998 89 9999999


Q ss_pred             CCcEEEcCCCCCeEEEecCCccc
Q 017131          166 PQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       166 p~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 55 799999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=6.5e-20  Score=167.96  Aligned_cols=180  Identities=29%  Similarity=0.449  Sum_probs=131.2

Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ..|+|+.|++|.. +|.+.+.. .......+....+.++.|+..|++|    +|.+|+|+||.||....+. .+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhh
Confidence            3468899999985 55555542 3344557778899999999999999    5899999999999998887 89999999


Q ss_pred             CcccccCCC-------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          185 SAKVLVKGE-------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       185 ~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      +........       ..+...||.+||+||.+.+. .|+.++||||||++|+|++.-   |............+.. |.
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~---f~T~~er~~t~~d~r~-g~  476 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQ---FSTQFERIATLTDIRD-GI  476 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHH---hccHHHHHHhhhhhhc-CC
Confidence            987776555       45667899999999999764 599999999999999999972   2211111111111110 00


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                      .+.+.+                          .--++-.+|+.+||...|.+||++.+.-.|+|.
T Consensus       477 ip~~~~--------------------------~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  477 IPPEFL--------------------------QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CChHHh--------------------------hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            000000                          113456799999999999999988887777775

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.2e-17  Score=143.74  Aligned_cols=129  Identities=19%  Similarity=0.342  Sum_probs=100.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      +.||+|++|.||+|.+  .|..+++|+.....            ....+|+.++..+.|++++....++.....     .
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-----F   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-----C
Confidence            5789999999999987  57789999754321            123468999999999988766555533222     5


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++|||++| ++.+.+...       .. ....++.+++.+|.++|+ .|++|+|++|.||+++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            689999986 666555421       11 678889999999999998 9999999999999999 55 799999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=8.8e-18  Score=143.02  Aligned_cols=131  Identities=18%  Similarity=0.180  Sum_probs=99.9

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--------------------------ccHHHHHHHHHhCCCCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------------RYKNRELQIMQMLDHPN   90 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~~   90 (376)
                      .|.+.+.||+|+||.||+|... +|+.||||++..+.                          ....+|+.++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4889999999999999999874 79999999865321                          01346888888887774


Q ss_pred             e--eeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131           91 I--VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus        91 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      +  +..++    ..     ..+++|||++| ++..+..          ......++.+++.++.++|+ .||+||||||+
T Consensus        95 i~v~~~~~----~~-----~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~  154 (198)
T cd05144          95 FPVPKPID----WN-----RHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEF  154 (198)
T ss_pred             CCCCceee----cC-----CceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcc
Confidence            3  33221    11     14799999987 3322211          13456788899999999998 99999999999


Q ss_pred             cEEEcCCCCCeEEEecCCcccc
Q 017131          168 NLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ||+++.++ .++|+|||.+...
T Consensus       155 Nill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         155 NILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             cEEEcCCC-cEEEEECCccccC
Confidence            99999887 8999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=9.4e-18  Score=156.51  Aligned_cols=203  Identities=28%  Similarity=0.413  Sum_probs=147.4

Q ss_pred             HHhCCCCCeeeccceeeecCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCc-c
Q 017131           83 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI-C  160 (376)
Q Consensus        83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i-i  160 (376)
                      |+.+.|.|+.++++..++...     .+.|.+||+ |+|.+.+..   ....++.-+...++++|+.||+|||. ..| .
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~-----~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~-s~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPE-----MIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHN-SPIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecCCc-----eEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhc-Cccee
Confidence            467899999999999876633     778999998 688887776   34568888899999999999999998 444 9


Q ss_pred             ccCCCCCcEEEcCCCCCeEEEecCCcccccCC---CCCceeeeeccccchhhhcCCCC------CCCchhHHHHHHHHHH
Q 017131          161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATE------YTTAIDIWSTGCVMAE  231 (376)
Q Consensus       161 H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~e  231 (376)
                      |+.++..|.++|..- .+||+|||+.......   .......-...|.|||.+.+...      .+.+.|+||+|++++|
T Consensus        72 hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            999999999999988 8999999998655320   11111112345999999965311      3667999999999999


Q ss_pred             HHhCCCCCCCCCchH----HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCC
Q 017131          232 LLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP  307 (376)
Q Consensus       232 lltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  307 (376)
                      +++...||.......    ....+.+....+....+                     ... ..+++++..++..||.-+|
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i---------------------~~~-~e~~~~l~~l~~~cw~e~P  208 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSI---------------------ELL-NELPPELLLLVARCWEEIP  208 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcch---------------------hhh-hhcchHHHHHHHHhcccCh
Confidence            999999998643222    22222220111111111                     000 1356689999999999999


Q ss_pred             CCCCCHHHHh
Q 017131          308 NLRCTALEAC  317 (376)
Q Consensus       308 ~~R~s~~~ll  317 (376)
                      .+||+++++-
T Consensus       209 ~~rPs~~~i~  218 (484)
T KOG1023|consen  209 EKRPSIEQIR  218 (484)
T ss_pred             hhCccHHHHH
Confidence            9999998774

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3e-19  Score=173.99  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=190.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCC-CcEEEEEEeeccc---cc---HHHHHHHHHhCC-CCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK---RY---KNRELQIMQMLD-HPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~---~~---~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...|.+.+.||+|+|+.|-.+....+ ...+|.|.+....   ..   ...|..+-+.+. |.|++++++..     ...
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence            34699999999999999999987443 3456677654322   12   224777777776 99999998876     333


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcC-CCcHHHHHHHHHHHHHHHHHHH-hcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~-~l~~~~~~~i~~qi~~al~~LH-~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      .+.++++++..| ++...+.   .... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++..+..++++||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             cccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCc
Confidence            447789999765 3222221   1122 5677788899999999999999 8 899999999999999987746999999


Q ss_pred             CCcccccC-CCCC---ceeee-eccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          184 GSAKVLVK-GEPN---VSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       184 g~a~~~~~-~~~~---~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      |+|..... ....   ...+| ++.|.|||...+........|+||+|+++..+++|..|+......+...         
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---------  240 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---------  240 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc---------
Confidence            99987655 3222   34567 8999999999776667889999999999999999999987654333111         


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                    ..+..... .........++....+++.+++..+|..|.+.+++..+||+..
T Consensus       241 --------------~~~~~~~~-~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 --------------SSWKSNKG-RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             --------------eeeccccc-ccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                          01111110 0011111468899999999999999999999999999999988

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=4.1e-17  Score=139.10  Aligned_cols=125  Identities=18%  Similarity=0.327  Sum_probs=93.4

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           43 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .||+|++|.||+|..  +|..+++|......            ....+|+++++.+.|+++....-++.....     .+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-----~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-----KT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-----CE
Confidence            479999999999984  57789999854321            223469999999988875544333322221     56


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++|||++| ++.+.+...    . .      .++.|++.+|.+||+ .|++|+|++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----N-D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhc----H-H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            99999986 554443321    0 0      678899999999998 9999999999999999 55 799999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=1e-16  Score=156.54  Aligned_cols=131  Identities=18%  Similarity=0.291  Sum_probs=98.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------------cccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ..|...+.||+|+||+||++.+..  ..+++|+....            .....+|+++++.++|++++....+......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345778999999999999998754  34444432111            1224579999999999998876554433221


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                           .++||||+++ +|.+.+.            ....++.|++.+|.+||+ .|++||||||+|||++ ++ .++|+|
T Consensus       411 -----~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liD  470 (535)
T PRK09605        411 -----KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLID  470 (535)
T ss_pred             -----CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEe
Confidence                 5699999986 5554443            245678899999999998 9999999999999994 45 799999


Q ss_pred             cCCccc
Q 017131          183 FGSAKV  188 (376)
Q Consensus       183 fg~a~~  188 (376)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2.8e-16  Score=132.57  Aligned_cols=131  Identities=20%  Similarity=0.197  Sum_probs=91.2

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecccccH----------------------------HHHHHHHHhCCCCC--
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK----------------------------NRELQIMQMLDHPN--   90 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~~--   90 (376)
                      .+.||+|+||+||+|.+. +|+.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999986 89999999876432110                            23444555544332  


Q ss_pred             eeeccceeeecCCCCceEEEEEEecccccHH--HHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 017131           91 IVALKHCFFSTTDKEELYLNLVLEYVPETVN--RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  168 (376)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~N  168 (376)
                      +.+.+.+    .     ..+++|||+++...  ..+....     . ...++.++.+++.++.++|...||+|+||||+|
T Consensus        81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            2222221    1     14799999997210  1121110     1 156788899999999999953799999999999


Q ss_pred             EEEcCCCCCeEEEecCCcccc
Q 017131          169 LLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       169 ill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |+++ ++ .++|+|||.+...
T Consensus       146 ili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CC-cEEEEECcccccc
Confidence            9999 66 7999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=1.5e-15  Score=132.57  Aligned_cols=133  Identities=15%  Similarity=0.235  Sum_probs=96.7

Q ss_pred             eeee-ecCceEEEEEEECCCCcEEEEEEeeccc-----------------ccHHHHHHHHHhCCCCCe--eeccceeeec
Q 017131           42 HVVG-TGSFGVVFQAKCRETGEIVAIKKVLQDK-----------------RYKNRELQIMQMLDHPNI--VALKHCFFST  101 (376)
Q Consensus        42 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~~i--v~~~~~~~~~  101 (376)
                      ..|| .|+.|+||.+...  +..++||.+....                 ....+|++++..+.|++|  +..+.+....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7888899988864  7789999774311                 123469999999998885  4454443221


Q ss_pred             CCCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeE
Q 017131          102 TDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  179 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vk  179 (376)
                      . ......++|||+++|  ++.+++..     ..+++..    +.|++.+|.+||+ +||+||||||.|||++.++ .++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence            1 111223599999986  66555532     3455543    5689999999998 9999999999999999887 799


Q ss_pred             EEecCCccc
Q 017131          180 LCDFGSAKV  188 (376)
Q Consensus       180 l~Dfg~a~~  188 (376)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=8.6e-16  Score=143.60  Aligned_cols=254  Identities=25%  Similarity=0.263  Sum_probs=193.1

Q ss_pred             CCccccceEEeeeeee--cCceEEEEEEE--CCCCcEEEEEEee------cccccHHHHHHHHHhC-CCCCeeeccceee
Q 017131           31 NSKQKVSYIAEHVVGT--GSFGVVFQAKC--RETGEIVAIKKVL------QDKRYKNRELQIMQML-DHPNIVALKHCFF   99 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~   99 (376)
                      .+.....+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+      .......+|+...+.+ .|+|.++.+..+ 
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-  187 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-  187 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-
Confidence            4445567899999999  99999999998  8899999999732      1223344677777777 488988866555 


Q ss_pred             ecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHH----HHHHHHhcCCccccCCCCCcEEEcCCC
Q 017131          100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                          .+....++-+|+|+..+..+...   ...-+++..++..+.+...    ||.++|+ .+++|-|+||.||+...+.
T Consensus       188 ----e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  188 ----EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             ----ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheeccccc
Confidence                34444788999999777555543   3345888899999999999    9999998 9999999999999999994


Q ss_pred             CCeEEEecCCcccccCCCCCcee------eeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CchHH
Q 017131          176 HQLKLCDFGSAKVLVKGEPNVSY------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE--SGVDQ  247 (376)
Q Consensus       176 ~~vkl~Dfg~a~~~~~~~~~~~~------~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~  247 (376)
                      ...+++|||+...+..+......      .+..-|++||+..+  -++...|++++|.++.+-.+|..++...  +.+.+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence            48999999998877665432222      34566999999843  4899999999999999999987666544  33333


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       248 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      +..+.     .+                         ..+-...+.++...+..|+..+|..|+++..+++|+++...
T Consensus       338 ~r~~~-----ip-------------------------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  338 LRQGY-----IP-------------------------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ccccc-----Cc-------------------------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            32211     00                         11113456777779999999999999999999999999753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=2.1e-15  Score=122.20  Aligned_cols=130  Identities=20%  Similarity=0.265  Sum_probs=101.0

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHhCCC--CCeeeccceeeecCCCCceEEEEEEec
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      +++.||+|.++.||++....  ..+++|.......  ...+|+..++.+.|  .++++++..+...     ...+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEEEe
Confidence            46789999999999999854  6899998865542  56789999999976  4777776655221     347799999


Q ss_pred             ccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC---CccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          116 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       116 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +.+....          .++......++.+++.+++++|. .   +++|+|++|.||+++..+ .++++|||.+..
T Consensus        75 ~~g~~~~----------~~~~~~~~~~~~~~~~~l~~lh~-~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLD----------EVSEEEKEDIAEQLAELLAKLHQ-LPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecc----------cCCHHHHHHHHHHHHHHHHHHhC-CCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            9873211          11445567778899999999997 4   699999999999999866 799999998853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=8.7e-16  Score=150.92  Aligned_cols=267  Identities=23%  Similarity=0.280  Sum_probs=189.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+.+.+.+-+-+|+++.++.+.-..+|-..++|.....       .....++-.++-...+|.++....-+   .....
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~---~~rsP  878 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF---PCRSP  878 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC---CCCCC
Confidence            345688888999999999999998888866666654322       12222233333333445555432222   11112


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                        .+|+++|.++ ++...+++    ....+++-.+.++..+..++++||. ..+.|+|++|.|+++..++ ..+++|||.
T Consensus       879 --~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t  950 (1205)
T KOG0606|consen  879 --LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGT  950 (1205)
T ss_pred             --cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCcccc
Confidence              6789999975 55444443    3457777788888999999999998 7799999999999999998 599999984


Q ss_pred             cccccCC--------------------------------CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHH
Q 017131          186 AKVLVKG--------------------------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  233 (376)
Q Consensus       186 a~~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  233 (376)
                      .....--                                .......+|+.|.+||.+.+.. ....+|+|+.|+++++.+
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence            3221100                                0011245689999999997755 788899999999999999


Q ss_pred             hCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH
Q 017131          234 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  313 (376)
Q Consensus       234 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~  313 (376)
                      +|.+||........+..|...                 ...++.         .+...+.++++++.++|..+|.+|..+
T Consensus      1030 ~g~pp~na~tpq~~f~ni~~~-----------------~~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNR-----------------DIPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             cCCCCCCCcchhhhhhccccC-----------------CCCCCC---------CccccChhhhhhhhhhhccCchhccCc
Confidence            999999988877666555442                 111111         123578999999999999999999998


Q ss_pred             H---HHhcCCcccccCCCCCCCCCCCCC
Q 017131          314 L---EACVHPFFDELRDPNTRLPNGRPL  338 (376)
Q Consensus       314 ~---~ll~hp~f~~~~~~~~~~~~~~~~  338 (376)
                      .   ++..||||+...+....+..-.++
T Consensus      1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~ 1111 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFV 1111 (1205)
T ss_pred             ccccccccCCccCCCCccccccccCccC
Confidence            7   888999999988766554443333

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.56  E-value=1e-13  Score=131.21  Aligned_cols=180  Identities=22%  Similarity=0.286  Sum_probs=129.3

Q ss_pred             ceEEeeeeeecCceEEE-EEEECCCCcEEEEEEeecccc----cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVF-QAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~-~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      -|.+ ...+-++.+ +| .|..+.++.+|.|...+....    ...+-++.|+.++||||+++++.+.     .+..+|+
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~yl   86 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLYL   86 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceEE
Confidence            3555 333334444 44 466677888888887765433    2456789999999999999999883     3335899


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |+|-+.. |...+..       ++...+..-++||+.||.|||...+++|++|..+.|+++..| ..||++|.++.....
T Consensus        87 vTErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~  157 (690)
T KOG1243|consen   87 VTERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASG  157 (690)
T ss_pred             Eeecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEecccc
Confidence            9999864 3333433       346778888999999999998548999999999999999999 799999998755433


Q ss_pred             CCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC
Q 017131          192 GEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  235 (376)
Q Consensus       192 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg  235 (376)
                      ... ......--.|..|+.+..   -.-..|.|.|||++++++.|
T Consensus       158 ~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  158 FNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence            221 111111223677776522   12467999999999999999

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=2.6e-13  Score=117.81  Aligned_cols=213  Identities=19%  Similarity=0.234  Sum_probs=147.0

Q ss_pred             HHHHHhCCCCCeeeccceeeecCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc-C
Q 017131           80 LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-I  157 (376)
Q Consensus        80 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~  157 (376)
                      +..|.++-|.||++++.++-+....+.....++.||++ |++.+.++........+.....++|+-||+.||.|||++ -
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            34556678999999999886655544555778999998 688888888777788899999999999999999999983 2


Q ss_pred             CccccCCCCCcEEEcCCCCCeEEEecCCcccc--cCC---CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHH
Q 017131          158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--VKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  232 (376)
Q Consensus       158 ~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~--~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  232 (376)
                      -|+|+++..+.|++..+| -+|+.--.-....  ...   .......+-++|.+||.=. ....+.++|||++|....+|
T Consensus       198 piihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             ccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHH
Confidence            599999999999999887 4665422111000  000   0011223456799998653 23467799999999999999


Q ss_pred             HhCCCCCC-CCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC
Q 017131          233 LLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC  311 (376)
Q Consensus       233 ltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  311 (376)
                      ..|..--. +.+....-..+.+..                               + ..-...-++++++||+-.|..||
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i-------------------------------~-~len~lqr~~i~kcl~~eP~~rp  323 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVI-------------------------------I-GLENGLQRGSITKCLEGEPNGRP  323 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhe-------------------------------e-eccCccccCcCcccccCCCCCCc
Confidence            88763221 111111111111100                               0 01123346799999999999999


Q ss_pred             CHHHHhcCCcccccC
Q 017131          312 TALEACVHPFFDELR  326 (376)
Q Consensus       312 s~~~ll~hp~f~~~~  326 (376)
                      ++.+++-||..-++.
T Consensus       324 ~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  324 DARLLLFHPLLFEVH  338 (458)
T ss_pred             chhhhhcCceeeecc
Confidence            999999999987654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=1.4e-12  Score=108.88  Aligned_cols=132  Identities=17%  Similarity=0.208  Sum_probs=93.4

Q ss_pred             eeeeeecCceEEEEEEECC------CCcEEEEEEeec--------------ccc----------------cHHHHHHHHH
Q 017131           41 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQ--------------DKR----------------YKNRELQIMQ   84 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~--------------~~~----------------~~~~E~~~l~   84 (376)
                      ...||.|--+.||.|....      .+..+|||+.+-              +.+                ..++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998653      357899997621              100                0126999999


Q ss_pred             hCCC--CCeeeccceeeecCCCCceEEEEEEeccccc-H-HHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHH-HhcCCc
Q 017131           85 MLDH--PNIVALKHCFFSTTDKEELYLNLVLEYVPET-V-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGI  159 (376)
Q Consensus        85 ~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l-~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~i  159 (376)
                      ++..  -+++..+.+.    .     -++||||++++ + ...+.     ...+++.....+..|++.+|..| |+ .|+
T Consensus        82 rl~~~Gv~vP~pi~~~----~-----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVLK----K-----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNL  146 (197)
T ss_pred             HHHHcCCCCCeEEEec----C-----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            8853  3444544321    1     45899999863 1 11121     12355566777889999999998 87 899


Q ss_pred             cccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       160 iH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|+||++.||+++. + .+.|+|||.+...
T Consensus       147 VHGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            99999999999984 4 6999999988544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=2.3e-12  Score=122.07  Aligned_cols=136  Identities=22%  Similarity=0.273  Sum_probs=88.6

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeeccc-cc-------------------------------------------H
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RY-------------------------------------------K   76 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~-------------------------------------------~   76 (376)
                      .+.||.|++|+||+|+.+ +|+.||||+..... ..                                           .
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            457999999999999974 78999999874321 00                                           1


Q ss_pred             HHHHHHHHhC----CCCCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHH-HH
Q 017131           77 NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR-AL  150 (376)
Q Consensus        77 ~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~-al  150 (376)
                      .+|+..+.++    +|.+-+.+..++....+    ..++||||++| ++.+.....   .....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHH
Confidence            1244444444    23333344343322221    14699999987 444433321   11122   2334555555 46


Q ss_pred             HHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       151 ~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ..+|. .|++|+|++|.||+++.++ .++++|||++...
T Consensus       271 ~ql~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l  307 (437)
T TIGR01982       271 NQVLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRL  307 (437)
T ss_pred             HHHHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeEC
Confidence            78898 8999999999999999888 8999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=2.3e-12  Score=106.78  Aligned_cols=124  Identities=16%  Similarity=0.158  Sum_probs=89.8

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCee-eccceeeecCCCCceEEEEEEecc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ++.|+.|.++.||++...  ++.|++|......   ....+|+.+++.+.+.+++ +++...     ...  -++|||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            467899999999999865  7889999875443   3356899999998765544 333221     111  35899999


Q ss_pred             cccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCc-----cccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          117 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       117 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i-----iH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|....   ..        ......++.+++.+|+.||+ .++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        74 ~G~~l~---~~--------~~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELL---TE--------DFSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccc---cc--------cccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            983211   00        01123456799999999998 775     9999999999999 45 69999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=2e-12  Score=124.04  Aligned_cols=139  Identities=19%  Similarity=0.257  Sum_probs=89.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------------------------------------------
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------------------   74 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------------------   74 (376)
                      .|.. +.||+|++|+||+|+.+.+|+.||||+......                                          
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3565 789999999999999988899999998853310                                          


Q ss_pred             --cHHHHHHHHHhC----CCCCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhc---CCCcHHHHHHHHH
Q 017131           75 --YKNRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIH---QRMPLIYVKLYTY  144 (376)
Q Consensus        75 --~~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~l~~~~~~~i~~  144 (376)
                        ...+|+..+.++    .+.+.+.+..++.+..+    .-++||||+.| .+.++.. ....+   ..+.+..+..++.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~-l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAA-LRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHH-HHhcCCCHHHHHHHHHHHHHH
Confidence              011244333333    24444444444422211    15699999997 4433221 11111   1244455555555


Q ss_pred             HHHHHHHHHHhcCCccccCCCCCcEEEcCCC---CCeEEEecCCcccc
Q 017131          145 QICRALAYIHNCIGICHRDIKPQNLLVNPHT---HQLKLCDFGSAKVL  189 (376)
Q Consensus       145 qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~---~~vkl~Dfg~a~~~  189 (376)
                      |++       . .|++|+|+||.||+++.++   .+++++|||++...
T Consensus       275 Qif-------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        275 QVF-------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHH-------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            554       4 7999999999999998775   26999999998765

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.36  E-value=5.6e-11  Score=109.60  Aligned_cols=214  Identities=17%  Similarity=0.214  Sum_probs=151.4

Q ss_pred             ceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecccc--cHHH
Q 017131           49 FGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNR  122 (376)
Q Consensus        49 ~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~  122 (376)
                      -.+.|+|....+|..|++|++.-++    .....-+++++++.|+|+|++.++|.+. .-++..+++|++|.++  +|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~-tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTY-TFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhh-ccCcceEEEEEecCCCCchHHH
Confidence            4588999999999999999983222    1223568999999999999999998733 3456778999999985  4443


Q ss_pred             HHHHhh-----------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          123 IARNYS-----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       123 ~~~~~~-----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      +--.-.           ..+...++..+|.++.|+..||.++|+ .|+.-+-|.|.+||++.+. +++|+..|.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence            322111           112357889999999999999999998 8999999999999999887 799998887654433


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNY  270 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  270 (376)
                      +.           .  |.+.    -..+-|.=.||.++..|.||..--...+ ..+...+.+                  
T Consensus       446 d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------  490 (655)
T KOG3741|consen  446 DP-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------  490 (655)
T ss_pred             CC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence            32           0  1121    1235689999999999999963211111 111101111                  


Q ss_pred             ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                       ....+.+++++|.-+..-++++ -++.+++.
T Consensus       491 -----------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  491 -----------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             -----------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                             1346788888888888888876 56666664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=4.4e-13  Score=125.59  Aligned_cols=250  Identities=22%  Similarity=0.205  Sum_probs=173.7

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEC-CCCcEEEEEEeecccc------cHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKR------YKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      +....+|..+..||.|.|+.|+.+.-. .++..|++|-..+...      .-..|+-+...+ .|.+++.+...+.... 
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-  339 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-  339 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-
Confidence            344567999999999999999998865 6788999997654322      222466666555 5888888766553222 


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          104 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                          ..|+-.|||.+....+-.   .....+.+...+.+..|++.++.++|+ +.++|+|++|+||++..++...++.||
T Consensus       340 ----~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  340 ----QGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             ----cccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccc
Confidence                255888999764333222   233567888899999999999999998 999999999999999987447899999


Q ss_pred             CCcccccCCCCCceeeeecccc-chhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          184 GSAKVLVKGEPNVSYICSRYYR-APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       184 g~a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      |.+....  -..........+. .+|++.....+..+.|++|||..+.+.++|.+.-.......   .|...        
T Consensus       412 ~~~t~~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~--------  478 (524)
T KOG0601|consen  412 GCWTRLA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSG--------  478 (524)
T ss_pred             ccccccc--eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeecc--------
Confidence            9886421  1111222233344 35666566668999999999999999999874332222111   11100        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                 ..+.          ....+.+++.+.+.++..|+..|+.+.++..|.=|..
T Consensus       479 -----------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  479 -----------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -----------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                       0000          0234478889999999999999999999988876643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=6.5e-13  Score=126.26  Aligned_cols=154  Identities=21%  Similarity=0.332  Sum_probs=112.3

Q ss_pred             HHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC--------Ccee--eeeccccchhhhcCCC
Q 017131          145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------NVSY--ICSRYYRAPELIFGAT  214 (376)
Q Consensus       145 qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~--~~t~~y~aPE~~~~~~  214 (376)
                      ++..|+.|+|.+.++||++|.|++|.++.++ .+||+.|+.+........        ....  .....|.|||.+.. .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3448999999888999999999999999998 799999998754433111        0111  12445999999965 5


Q ss_pred             CCCCchhHHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCCh
Q 017131          215 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP  293 (376)
Q Consensus       215 ~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (376)
                      ..+.++|++|+||++|.+. .|+..+...........-....+.             .            ...+..++++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-------------~------------~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-------------G------------AFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-------------c------------cccccccCcH
Confidence            5789999999999999999 566666554332222211111000             0            0112256899


Q ss_pred             hHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          294 EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       294 ~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ++++=|.++|..|+..||++..++..|||++.
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            99999999999999999999999999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=1.2e-10  Score=93.67  Aligned_cols=139  Identities=19%  Similarity=0.272  Sum_probs=98.2

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEee-cc-----------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+..+-+|+-+.|+++...  |+.+.||.-. +.           .....+|++.|.++.--.|.--.-+|.+...    
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            5778899999999999865  8888888532 21           1223368888888754443322223333222    


Q ss_pred             EEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCe--EEEec
Q 017131          108 YLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDF  183 (376)
Q Consensus       108 ~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~v--kl~Df  183 (376)
                       -.++|||++|  ++.+.+.....  ......-...++.+|-..+.-||. .+|||+||..+||++.+++..+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence             3478999998  66666654332  223333347788899999999998 9999999999999998887655  89999


Q ss_pred             CCccc
Q 017131          184 GSAKV  188 (376)
Q Consensus       184 g~a~~  188 (376)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=3.6e-10  Score=91.44  Aligned_cols=126  Identities=15%  Similarity=0.290  Sum_probs=84.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEee-cc-----------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVL-QD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+++|+-+.++.+...  |..+++|.-. +.           .....+|++++..+.--.|..-.-++++...     .
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G   74 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence            45788999999999664  5567777432 21           1122369999988754433322222222222     3


Q ss_pred             EEEEecccccHHH-HHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~~l~~-~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++|||++|.+.. .+...       .    ..++..+-.-+.-||. .||+|+||.++||++..+  .+.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~~-------~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-------R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-------c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            4899999996532 33321       1    3445677777889998 999999999999999965  499999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=3.2e-09  Score=95.98  Aligned_cols=263  Identities=16%  Similarity=0.189  Sum_probs=156.7

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHhC-CCCCeeeccce---eeecCCCCceEEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQML-DHPNIVALKHC---FFSTTDKEELYLNLV  112 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~l~~l-~h~~iv~~~~~---~~~~~~~~~~~~~lv  112 (376)
                      ....+.||+|+-+.+|-.-..  +. .+.|+.....-. ..+-+..|... .||-+-.-+.+   ..... ++...+.++
T Consensus        13 i~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl   88 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL   88 (637)
T ss_pred             cCCCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence            345678999999999876543  22 345766543322 22333333333 55543320110   01111 233337789


Q ss_pred             Eeccccc--HHHHHHH--hhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          113 LEYVPET--VNRIARN--YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       113 ~e~~~~~--l~~~~~~--~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+.+.|-  ...+..-  ..+......+..+..+++.++.+.+-||. .|.+-+|++++|+|+.+++ .|.|.|=..-..
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQI  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceee
Confidence            9988762  2111111  11122347788899999999999999998 8999999999999999888 799998765444


Q ss_pred             ccCCCCCceeeeeccccchhhhc-C---CCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          189 LVKGEPNVSYICSRYYRAPELIF-G---ATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~-~---~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ..++......+|.+.|.+||... +   .-.-+...|.|.||+++++++.| +.||.|-....      . -+.|-+..+
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~------~-ap~p~E~~I  239 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS------D-APNPLETDI  239 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC------C-CCCcchhhh
Confidence            44444444556788999999763 1   11246688999999999999986 99998732100      0 011111122


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccC--CCCCCCHH
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS--PNLRCTAL  314 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d--p~~R~s~~  314 (376)
                      ....-.|....-+..+..+-.--+ .-++++++.|..+|+...  +.-|||++
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            211111111111111111111111 247899999999999653  56899974

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=7.7e-10  Score=92.17  Aligned_cols=121  Identities=21%  Similarity=0.256  Sum_probs=76.2

Q ss_pred             EEEEEEECCCCcEEEEEEeecc--------------c----------------ccHHHHHHHHHhCCCC--Ceeecccee
Q 017131           51 VVFQAKCRETGEIVAIKKVLQD--------------K----------------RYKNRELQIMQMLDHP--NIVALKHCF   98 (376)
Q Consensus        51 ~V~~~~~~~~~~~vaiK~~~~~--------------~----------------~~~~~E~~~l~~l~h~--~iv~~~~~~   98 (376)
                      .||.|.. ..|+.+|+|+....              .                ....+|.+.|..+...  ++++.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899987 45789999976321              0                1123699999999765  455554332


Q ss_pred             eecCCCCceEEEEEEeccc--ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHH-HHhcCCccccCCCCCcEEEcCCC
Q 017131           99 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY-IHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                           .    -++||||++  |.....+..     ..++......++.+++..+.. +|. .||+|+||.+.||+++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence                 1    248999999  632222222     122234456677788885555 577 999999999999999976 


Q ss_pred             CCeEEEecCCcccc
Q 017131          176 HQLKLCDFGSAKVL  189 (376)
Q Consensus       176 ~~vkl~Dfg~a~~~  189 (376)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             5999999998644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=6.4e-09  Score=91.90  Aligned_cols=109  Identities=13%  Similarity=0.172  Sum_probs=77.9

Q ss_pred             HHHHHHHHHhCCCCCeeec--cceeeecCCCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHH
Q 017131           76 KNRELQIMQMLDHPNIVAL--KHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  151 (376)
Q Consensus        76 ~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~  151 (376)
                      ..+|...+..+...+|...  +.+.....+.....-++|+|++++  ++.+++....  ....+......++.+++..+.
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence            5689999988854444433  333322222212335689999997  5766664322  234566778899999999999


Q ss_pred             HHHhcCCccccCCCCCcEEEcCC------CCCeEEEecCCcc
Q 017131          152 YIHNCIGICHRDIKPQNLLVNPH------THQLKLCDFGSAK  187 (376)
Q Consensus       152 ~LH~~~~iiH~Dlkp~Nill~~~------~~~vkl~Dfg~a~  187 (376)
                      -||. .||+|+|+++.|||++.+      ...+.|+||+.+.
T Consensus       153 ~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        153 DMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9998 999999999999999852      2379999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.03  E-value=2.8e-09  Score=92.13  Aligned_cols=137  Identities=14%  Similarity=0.162  Sum_probs=90.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecc-----cccHHHHHHHHHhCCCCC--eeeccceeeecCCCCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      +.|+.|..+.||++.... |+.+++|.....     .....+|+.+++.+.+.+  +++++.+...  .......++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~--~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCED--PSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCC--CCccCCceEEEE
Confidence            678999999999998743 678999987543     235678999999997643  4555443311  111123569999


Q ss_pred             ccccc-HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 017131          115 YVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--------------------------------------  155 (376)
Q Consensus       115 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--------------------------------------  155 (376)
                      |++|. +.....     ...+++.....++.+++.+|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99873 211110     0234455555555666666666653                                      


Q ss_pred             -----------------cCCccccCCCCCcEEEcC--CCCCeEEEecCCcc
Q 017131          156 -----------------CIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAK  187 (376)
Q Consensus       156 -----------------~~~iiH~Dlkp~Nill~~--~~~~vkl~Dfg~a~  187 (376)
                                       ...++|+|++|.||+++.  ++ .+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~-~~~iID~e~~~  205 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPR-VVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCc-EEEEEeccccc
Confidence                             034799999999999998  44 58999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=1.2e-08  Score=87.60  Aligned_cols=133  Identities=20%  Similarity=0.174  Sum_probs=94.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--------------------------cccHHHHHHHHHhCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------------------------KRYKNRELQIMQMLDHP   89 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~E~~~l~~l~h~   89 (376)
                      .-+.++.+||-|--|.||.|.+. .|.++|||.-.-.                          ....++|.++|+.|...
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             hHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            35778899999999999999985 6899999953110                          01224799999998654


Q ss_pred             --CeeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131           90 --NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus        90 --~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                        .+++.+++-        . -.+|||+++|..   +..     -++.......++..|+.-+.-+-. .||||+|+++-
T Consensus       170 G~~VP~P~~~n--------R-HaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSef  231 (304)
T COG0478         170 GVKVPKPIAWN--------R-HAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEF  231 (304)
T ss_pred             CCCCCCccccc--------c-ceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchh
Confidence              566553321        1 458999999832   111     112344455556666666666666 89999999999


Q ss_pred             cEEEcCCCCCeEEEecCCccc
Q 017131          168 NLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ||+++.|| .+.++||-.+..
T Consensus       232 NIlV~~dg-~~~vIDwPQ~v~  251 (304)
T COG0478         232 NILVTEDG-DIVVIDWPQAVP  251 (304)
T ss_pred             eEEEecCC-CEEEEeCccccc
Confidence            99999998 799999987643

>PRK09902 hypothetical protein; Provisional

Probab=98.80  E-value=2.3e-07  Score=77.89  Aligned_cols=138  Identities=11%  Similarity=0.085  Sum_probs=96.8

Q ss_pred             eecCceEEEEEEECCCCcEEEEEEeec----------ccccHHHHHHHHHhCCCCCe--eeccceeeecCCCCceEEEEE
Q 017131           45 GTGSFGVVFQAKCRETGEIVAIKKVLQ----------DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        45 g~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv  112 (376)
                      |.||-+.|+.....  |+.|-+|.-..          ....+.+|+..++.+..-++  ++.. ++..........-+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            55888889887754  44677886531          22345689999999864443  3333 2222222334446799


Q ss_pred             Eecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC-CeEEEecCCccc
Q 017131          113 LEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  188 (376)
Q Consensus       113 ~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~-~vkl~Dfg~a~~  188 (376)
                      +|-+++  +|.+.+....  ..+.+..+...++.+++.+++-||+ .|+.|+|+.+.||+++.++. .++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998884  7766654321  1245777778999999999999998 99999999999999986661 399999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.78  E-value=2.1e-07  Score=78.44  Aligned_cols=136  Identities=17%  Similarity=0.215  Sum_probs=85.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHH-------------HHHHHHHhCCCCCeeeccc---ee
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLDHPNIVALKH---CF   98 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------~E~~~l~~l~h~~iv~~~~---~~   98 (376)
                      ..+|.+.+.+-......|.+..-.  |+.+++|.........+             +++..+..+....+.....   +.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            356999999999888888777654  78899997754332222             3444444443222222111   11


Q ss_pred             eecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131           99 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                      .-....-....+++|||++| .+.++.        .+++    .+...+..++.-||+ .|+.|+|.+|.|++++.++  
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~--  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG--  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc--
Confidence            11111112235589999998 332221        1222    234567788999998 9999999999999999654  


Q ss_pred             eEEEecCCcc
Q 017131          178 LKLCDFGSAK  187 (376)
Q Consensus       178 vkl~Dfg~a~  187 (376)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=1.4e-07  Score=80.49  Aligned_cols=107  Identities=21%  Similarity=0.313  Sum_probs=77.1

Q ss_pred             HHHHHHHHHhCCCCCee--eccceeeecCCCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHH
Q 017131           76 KNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  151 (376)
Q Consensus        76 ~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~  151 (376)
                      ..+|...+..+..-.|.  ..+.+........ ...++|+|++++  +|.+++....    ..+......++.++...++
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHH
Confidence            45788888887544433  3333333322222 446799999987  5666555422    2566678889999999999


Q ss_pred             HHHhcCCccccCCCCCcEEEcCCC--CCeEEEecCCccc
Q 017131          152 YIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  188 (376)
Q Consensus       152 ~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg~a~~  188 (376)
                      -||. .||+|+|+++.|||++.++  ..+.++||+.++.
T Consensus       133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9998 9999999999999998764  2599999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.69  E-value=2.5e-07  Score=78.82  Aligned_cols=134  Identities=16%  Similarity=0.170  Sum_probs=90.5

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------------------------ccHHHHHHHHHhCCCC--C
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLDHP--N   90 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~h~--~   90 (376)
                      ...|.+|--+.||+|.. ..+..+|+|++....                            ....+|+..|+++...  .
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34777788889999986 568899999874321                            1123588888887433  3


Q ss_pred             eeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 017131           91 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  170 (376)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nil  170 (376)
                      +++-+.+.     .    -.|||||++...   ...-....-++...+...+..+++..+.-|-...|+||+||+.-|||
T Consensus       132 vP~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL  199 (268)
T COG1718         132 VPEPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL  199 (268)
T ss_pred             CCCceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence            34443332     1    348999998531   11100111223444677778888888887774379999999999999


Q ss_pred             EcCCCCCeEEEecCCcccc
Q 017131          171 VNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       171 l~~~~~~vkl~Dfg~a~~~  189 (376)
                      +. ++ .+.|+|||.|...
T Consensus       200 ~~-~~-~p~iID~~QaV~~  216 (268)
T COG1718         200 VH-DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             EE-CC-eEEEEECcccccc
Confidence            99 45 6999999998654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.61  E-value=1.3e-07  Score=90.59  Aligned_cols=137  Identities=22%  Similarity=0.252  Sum_probs=83.6

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecccc--------------------------------------------cHH
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------------------------YKN   77 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------------------~~~   77 (376)
                      +.|+.++-|+||+|+.+ +|+.||||+....-.                                            ...
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57889999999999985 499999998633210                                            001


Q ss_pred             HHHHHHHhC----CCCCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHH
Q 017131           78 RELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY  152 (376)
Q Consensus        78 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  152 (376)
                      +|...+.++    .+..-+.+-.+|.+....    -.|+|||++| .+.+.....   ..+++...+...+.++.  ++.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHH
Confidence            355555554    233333344444222221    4589999998 443332221   13344333322222221  122


Q ss_pred             HHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       153 LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +=. .|+.|.|.+|.||+++.++ .+.+.|||......
T Consensus       281 ~~~-dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~  316 (517)
T COG0661         281 LLR-DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD  316 (517)
T ss_pred             HHh-cCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence            222 6999999999999999998 89999999986553

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.58  E-value=4.8e-07  Score=91.58  Aligned_cols=203  Identities=18%  Similarity=0.279  Sum_probs=133.4

Q ss_pred             HHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh
Q 017131           77 NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  155 (376)
Q Consensus        77 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  155 (376)
                      +-|+..+..+.|+|++.++.+-......+ ..+.+..++|.+ ++...+..    -...+...++.+..+++.||.|+|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            35778888899999999877664433322 122334456664 44333433    3568889999999999999999998


Q ss_pred             cCCccccCCCCC---cEEEcCCCCCeEEE--ecCCcccccCCCCCceeeeeccccchhhhcCCCCC--CCchhHHHHHHH
Q 017131          156 CIGICHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY--TTAIDIWSTGCV  228 (376)
Q Consensus       156 ~~~iiH~Dlkp~---Nill~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwslG~i  228 (376)
                       ....|.-|.-.   +...+.++ .+.++  ||+..+.............+..+.+||.... ..+  ....|+|++|..
T Consensus       305 -~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  305 -LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             -hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHH
Confidence             65555544443   33344444 46666  8887766655444444455666788887743 223  334799999999


Q ss_pred             HHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCC
Q 017131          229 MAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN  308 (376)
Q Consensus       229 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  308 (376)
                      ...+..|..+-...      ......                                .+........+++.+|+.-+++
T Consensus       382 ~~~~~~~~~i~~~~------~~~~~~--------------------------------l~~~~~~~~~d~~~~~~~~~~~  423 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKS------AVPVSL--------------------------------LDVLSTSELLDALPKCLDEDSE  423 (1351)
T ss_pred             HhhhhhcCcccccc------cchhhh--------------------------------hccccchhhhhhhhhhcchhhh
Confidence            99999876332110      000000                                0011222788999999999999


Q ss_pred             CCCCHHHHhcCCccccc
Q 017131          309 LRCTALEACVHPFFDEL  325 (376)
Q Consensus       309 ~R~s~~~ll~hp~f~~~  325 (376)
                      +|+++.+++.|||.+.-
T Consensus       424 ~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  424 ERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hccchhhhhhchhcccc
Confidence            99999999999999753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.54  E-value=9.2e-09  Score=97.51  Aligned_cols=247  Identities=18%  Similarity=0.163  Sum_probs=162.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCC-eeeccceeeecCCCCceEEEEEEe
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN-IVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      .-|...+-+++|+++++++.+...+.... .+.+... ....-++++|.+++||| .+..++     +.+.+-+..+.++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMR  314 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhh
Confidence            45777888999999999999987765555 7766544 33445899999999999 333222     2345556788999


Q ss_pred             cccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC
Q 017131          115 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  194 (376)
Q Consensus       115 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~  194 (376)
                      ++++.-.. ..........+.+-+.....+.-+.+++++|+ .-=+|+|    ||+..+.  .++..||+..........
T Consensus       315 i~s~~rs~-~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  315 ICSTGRSS-ALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             hhcCCccc-cccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCcccc
Confidence            99864100 00000111123334455566677789999997 5568888    8888764  599999998876654445


Q ss_pred             CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 017131          195 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  274 (376)
Q Consensus       195 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  274 (376)
                      .....+++.++|||+.... .+....|.|++|.-..+|.-|-+|-.....  ..    ...|..+              .
T Consensus       387 ~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~p--------------~  445 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNGP--------------N  445 (829)
T ss_pred             cccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCCC--------------C
Confidence            6677889999999988554 488999999999887788878777654110  00    0000000              0


Q ss_pred             CCCccc-cccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          275 FPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       275 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      .+.... ..|...       .-.++...|+..-|..|+....++-|.+|...
T Consensus       446 s~~L~~~~aw~~~-------~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  446 SPMLTDKSAWSPV-------FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             ccccchhhhcCcc-------cccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            000000 111111       11257788999999999999999999998764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=3.2e-06  Score=73.57  Aligned_cols=74  Identities=16%  Similarity=0.201  Sum_probs=50.0

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCC--eeeccceeeecCCCCceEEEEEEecc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  ++.++...  ..+......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            5789999999999999864  48999987554  344567889988885443  34444322  1222333478999999


Q ss_pred             cc
Q 017131          117 PE  118 (376)
Q Consensus       117 ~~  118 (376)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            87

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.28  E-value=9.5e-06  Score=70.24  Aligned_cols=135  Identities=17%  Similarity=0.139  Sum_probs=74.9

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCCe--eeccceeeecCCCCceEEEEEEeccc
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVP  117 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~  117 (376)
                      ..||.|..+.||+..    |..+++|.....  .....+|.++++.+..-.+  ++.+.+.     .......+||++++
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            578999999999842    456788977542  2345789999998864433  3333332     11112567999998


Q ss_pred             cc--HH--------------HHHHH-hhhhcC----CCcHHH-HHHHHHH----------HHH-HHHHHHh---cCCccc
Q 017131          118 ET--VN--------------RIARN-YSRIHQ----RMPLIY-VKLYTYQ----------ICR-ALAYIHN---CIGICH  161 (376)
Q Consensus       118 ~~--l~--------------~~~~~-~~~~~~----~l~~~~-~~~i~~q----------i~~-al~~LH~---~~~iiH  161 (376)
                      |.  +.              ..+.. ....+.    ..+... ...+..+          +.. ..++|..   ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            83  11              11111 011111    111110 0001000          011 1122221   135789


Q ss_pred             cCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          162 RDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       162 ~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+.|.||+++.++  +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC--cEEEechhcC
Confidence            99999999999765  8999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=6.7e-06  Score=78.76  Aligned_cols=135  Identities=20%  Similarity=0.264  Sum_probs=80.6

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-----------------------------------------HHHH
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----------------------------------------KNRE   79 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~E   79 (376)
                      .+.||..+.|+|++|+.+. |+.||||+-...-+.                                         ..+|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            4679999999999999866 999999975322100                                         0124


Q ss_pred             HHHHHh----CCCCC---eeeccceeeecCCCCceEEEEEEecccc----cHHHHHHHhhhhcCCCcHHHHHHHHHHHHH
Q 017131           80 LQIMQM----LDHPN---IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICR  148 (376)
Q Consensus        80 ~~~l~~----l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~----~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~  148 (376)
                      ++...+    +.|-+   -|.+-.++.+...    .-.|+||||+|    ++. .+.     ..+++...+...+.+...
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~-~i~-----~~gi~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLD-AID-----KRGISPHDILNKLVEAYL  314 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHH-HHH-----HcCCCHHHHHHHHHHHHH
Confidence            333322    23444   2223333322111    14599999997    332 222     234555544333333222


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEcC---CCCCeEEEecCCcccc
Q 017131          149 ALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  189 (376)
Q Consensus       149 al~~LH~~~~iiH~Dlkp~Nill~~---~~~~vkl~Dfg~a~~~  189 (376)
                       -.-++  .|++|+|=+|-||++..   .+..+.+.|||+....
T Consensus       315 -~qIf~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  315 -EQIFK--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             -HHHHh--cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence             12222  58999999999999994   2448999999998654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.20  E-value=1.1e-05  Score=65.33  Aligned_cols=127  Identities=19%  Similarity=0.302  Sum_probs=85.3

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEec
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      -+..+.||+|.+|.||+|...  |..+|+|+-..+  ...++.|+++|..++..++-+=+..+ .   .    ..+.|||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~   93 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEY   93 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhh
Confidence            556788999999999999875  668999976544  35567899999999876655322212 1   1    2256999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCC-CCcEEEcCCCCCeEEEecCCcc
Q 017131          116 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK-PQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       116 ~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlk-p~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +.| .|......       .....    +..++.+.--|-. .||-|+.|. |...++-.++ .+.|+||..|+
T Consensus        94 i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At  154 (201)
T COG2112          94 IDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDR-LGIEHGELSRPWKNVLVNDR-DVYIIDFDSAT  154 (201)
T ss_pred             hcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHH-hccchhhhcCCceeEEecCC-cEEEEEccchh
Confidence            998 44322221       11222    2345555444555 899999995 6655555555 69999999986

>PLN02876 acyl-CoA dehydrogenase

Probab=98.08  E-value=4.7e-05  Score=78.60  Aligned_cols=78  Identities=15%  Similarity=0.190  Sum_probs=50.8

Q ss_pred             EeeeeeecCceEEEEEEECCCC--cEEEEEEeecc-----cccHHHHHHHHHhCC-CCCe--eeccceeeecCCCCceEE
Q 017131           40 AEHVVGTGSFGVVFQAKCRETG--EIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYL  109 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~  109 (376)
                      -++.++.|.++.+|+......+  ..+++|+....     .....+|+++|+.+. |.++  ++++.++.+.  ......
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCc
Confidence            3677899999999998765432  46778875321     234678999999995 6664  4444333221  112235


Q ss_pred             EEEEeccccc
Q 017131          110 NLVLEYVPET  119 (376)
Q Consensus       110 ~lv~e~~~~~  119 (376)
                      |+||||++|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            6899999873

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.06  E-value=4.6e-05  Score=63.70  Aligned_cols=126  Identities=27%  Similarity=0.351  Sum_probs=86.7

Q ss_pred             cceEEeeeeeecCc-eEEEEEEECCCCcEEEEEEeecc---------------c----------ccHHHHHHH---HHhC
Q 017131           36 VSYIAEHVVGTGSF-GVVFQAKCRETGEIVAIKKVLQD---------------K----------RYKNRELQI---MQML   86 (376)
Q Consensus        36 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~---------------~----------~~~~~E~~~---l~~l   86 (376)
                      ..++.++.||+|.- |.||+++..  |+.||+|++...               .          ..+..|-+.   |+.+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57999999999999 999999976  789999984210               0          011234444   4445


Q ss_pred             CCCCe--eeccceeeecCC-------------CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHH
Q 017131           87 DHPNI--VALKHCFFSTTD-------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  151 (376)
Q Consensus        87 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~  151 (376)
                      .+.++  +++++++.-..+             .......+|.||+...-            .++...    +.+|++-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            56666  888887744321             11222457888876532            122222    457888899


Q ss_pred             HHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       152 ~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|. .||+-+|+++.|..   +   =+|+|||.+
T Consensus       179 ~~~k-~gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHK-LGIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             HHHH-CCeeeccCcccccc---C---CEEEecccC
Confidence            9998 99999999999985   3   389999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.95  E-value=0.00017  Score=60.70  Aligned_cols=125  Identities=21%  Similarity=0.285  Sum_probs=83.2

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeeccc--------------------ccHHHHHHHHHhCC------CCCeeec
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------RYKNRELQIMQMLD------HPNIVAL   94 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~~   94 (376)
                      ...||+|+.-.||.--+   +....||+.....                    ....+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35789999999997654   3346788876544                    33446777766665      7889999


Q ss_pred             cceeeecCCCCceEEEEEEeccc---c----cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131           95 KHCFFSTTDKEELYLNLVLEYVP---E----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      ++...+..+     ..+|+|.+.   |    +|.+++.     .+.+++ .+..   .+-.-.+||-+ .+|+.+|++|.
T Consensus        83 ~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~---~L~~f~~~l~~-~~Iv~~dl~~~  147 (199)
T PF10707_consen   83 YGFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQ---ALDEFKRYLLD-HHIVIRDLNPH  147 (199)
T ss_pred             eEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHH---HHHHHHHHHHH-cCCeecCCCcc
Confidence            998855444     667777663   3    5555553     245665 3332   33344567777 89999999999


Q ss_pred             cEEEcCCC--C-CeEEEec
Q 017131          168 NLLVNPHT--H-QLKLCDF  183 (376)
Q Consensus       168 Nill~~~~--~-~vkl~Df  183 (376)
                      ||++..+.  . .+.|+|-
T Consensus       148 NIv~~~~~~~~~~lvlIDG  166 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDG  166 (199)
T ss_pred             cEEEEecCCCceEEEEEeC
Confidence            99996443  2 4667764

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.90  E-value=0.00013  Score=64.07  Aligned_cols=68  Identities=15%  Similarity=0.073  Sum_probs=41.9

Q ss_pred             eeecCc-eEEEEEEECCCCcEEEEEEeecc-cccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEEEEecccc
Q 017131           44 VGTGSF-GVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVPE  118 (376)
Q Consensus        44 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~  118 (376)
                      |-.|.+ +.||++...  +..+.+|+.... .....+|+++++.+. +--+++++.+...   .  ...++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~---~--~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD---D--GRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec---C--CccEEEEEeeCC
Confidence            334444 789999753  367888876432 134568999998884 3233444443321   1  225689999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00014  Score=64.46  Aligned_cols=132  Identities=22%  Similarity=0.264  Sum_probs=73.8

Q ss_pred             eeecCceEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHhCCCCCee-eccceeeecCCCCceEEEEEEecccc
Q 017131           44 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYVPE  118 (376)
Q Consensus        44 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~~  118 (376)
                      +..|-.+.+|+..  .+++.+++|.......    ...+|..+++.+....+. +++...     .    -++|+||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567788899887  3466788997643322    246799999998654332 222211     1    1478999886


Q ss_pred             cH------------HHHHHHhhhhcC------CCcH-HHHHHHHHHH---------HHHHHHHHh-------cCCccccC
Q 017131          119 TV------------NRIARNYSRIHQ------RMPL-IYVKLYTYQI---------CRALAYIHN-------CIGICHRD  163 (376)
Q Consensus       119 ~l------------~~~~~~~~~~~~------~l~~-~~~~~i~~qi---------~~al~~LH~-------~~~iiH~D  163 (376)
                      ..            ..+.....+.+.      .++. ..+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            22            112222222211      1111 1122222122         111222221       02589999


Q ss_pred             CCCCcEEEcCCCCCeEEEecCCccc
Q 017131          164 IKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       164 lkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +.|.||+++.++  +.|+||..|..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999999765  78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.0004  Score=60.53  Aligned_cols=69  Identities=19%  Similarity=0.327  Sum_probs=44.3

Q ss_pred             eeeeeecCceEEEEEEECC-CCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCee-eccceeeecCCCCceEEEEEEec
Q 017131           41 EHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      ++.|..|-...+|++.... .++.|++|+.....   ....+|+.+++.+....++ +++..+   .+      .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~---~~------~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF---QN------GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe---CC------cEEEEe
Confidence            4667888899999997543 35678899765332   1234799999988544443 333221   11      269999


Q ss_pred             ccc
Q 017131          116 VPE  118 (376)
Q Consensus       116 ~~~  118 (376)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.75  E-value=0.00021  Score=64.68  Aligned_cols=138  Identities=18%  Similarity=0.208  Sum_probs=95.4

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeec------cc------------------------ccHHHHHHHHHhCC
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DK------------------------RYKNRELQIMQMLD   87 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~------------------------~~~~~E~~~l~~l~   87 (376)
                      -.+..+|..|--+.||.|.. .+|..+|||+++-      +.                        -+.++|++.|++++
T Consensus       146 ~~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             eecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            34566788899999999985 5688899997632      10                        12246899999987


Q ss_pred             CCCeeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131           88 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus        88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      ...|+.---+..- .      -.|||+++++.-+   ..-....-.++...+..+-.|++.-+.-|-+..++||.||.=-
T Consensus       225 ~aGIP~PePIlLk-~------hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf  294 (520)
T KOG2270|consen  225 NAGIPCPEPILLK-N------HVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF  294 (520)
T ss_pred             hcCCCCCCceeee-c------ceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence            7665433222211 1      3589999984221   1111122456767778888888888888776579999999999


Q ss_pred             cEEEcCCCCCeEEEecCCccc
Q 017131          168 NLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+|+.. | .+.|+|.+.+..
T Consensus       295 N~Lyhd-G-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  295 NLLYHD-G-KLYIIDVSQSVE  313 (520)
T ss_pred             hheEEC-C-EEEEEEcccccc
Confidence            999984 4 699999988753

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.74  E-value=0.00027  Score=61.66  Aligned_cols=30  Identities=33%  Similarity=0.407  Sum_probs=24.8

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++|+|+.+.||+++.++ ..-|+||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            4589999999999998654 45699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.68  E-value=7.1e-05  Score=78.40  Aligned_cols=261  Identities=16%  Similarity=0.037  Sum_probs=153.9

Q ss_pred             HHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC
Q 017131           79 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI  157 (376)
Q Consensus        79 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~  157 (376)
                      |..-++...|+++...+.-.....   +...+..++|+. |.+.+.+-........+....+-....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~---s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSE---STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCC---ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            444555668998887655443222   222456788886 4555555544333333444433333333377777777522


Q ss_pred             ----CccccCCCCCcEEEcCCCCCeEEEecCCcccc-cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHH
Q 017131          158 ----GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL  232 (376)
Q Consensus       158 ----~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  232 (376)
                          -.+|++||+-|.+|..+. +||+.++|+.+.. ..........+++.|+.|++.. .-.++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence                268899999999999887 7999999999832 2222233446688899999873 44578789999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC
Q 017131          233 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  312 (376)
Q Consensus       233 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s  312 (376)
                      ..|..+|.     ..++.+.+..           -.+-...+++.            ..|.++-.....+|-+.-..||.
T Consensus      1434 s~~n~~fi-----~flq~~Lkgi-----------idn~tf~sIe~------------l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKGI-----------IDNHTFFSIEK------------LKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             hcccHHHH-----HHHHHHHcCc-----------ccccccccccc------------cCCCcccHHHHHHHHHHhhhcch
Confidence            98887773     2222222211           01111222221            23556666666777777789999


Q ss_pred             HHHHhcCCcccccCCCC---------CCCCCCCCCCC----CCCCCCCCCCCCCHHHHhhhchHHHhhhhhhhhh
Q 017131          313 ALEACVHPFFDELRDPN---------TRLPNGRPLPP----LFNFKPPELSGIPPETINRLIPEHARKQNLFMAL  374 (376)
Q Consensus       313 ~~~ll~hp~f~~~~~~~---------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (376)
                      -...+.-+.|.-...+.         ..+++..+..+    ...|..+.+..-+.+.+.+  -.+..+|.-|+.|
T Consensus      1486 q~isls~d~~a~~~~d~~k~i~~~a~rglpEH~~iad~s~v~s~~~~i~L~S~d~E~ii~--~~~lheKe~fitL 1558 (2724)
T KOG1826|consen 1486 QYISLSRDHFAVGLRDICKMIYLLAYRGLPEHAPIADGSFVFSRFKEIALVSPDSENIIR--EHHLHEKEEFITL 1558 (2724)
T ss_pred             hhhhcccccccccccCcchhHHHHHhhCCCCCCccCCCCcceehcccccccCccHHHHHH--HHHHhhhhHHHHH
Confidence            98888888775432221         11222222211    1224555555544444443  4555566666655

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.66  E-value=0.00029  Score=63.79  Aligned_cols=141  Identities=14%  Similarity=0.125  Sum_probs=77.4

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeec-ccccHHHHHHHHHhCCCCC--eeeccceeeecCC----CCceEEEEEE
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD----KEELYLNLVL  113 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~----~~~~~~~lv~  113 (376)
                      .+.|..|....+|++...  +..+++|+... .......|+.++..+.+..  +++++..   ..+    ......+.++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~---~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIAD---RDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccC---CCCcEeeeeCCceEEEE
Confidence            567778888899998653  34688998763 2334557888888885433  3333221   111    0112356899


Q ss_pred             ecccccH---------HHHHHHhhhhc---CCCc--------HHHHHH------------HHHHHHHHHHHHHh------
Q 017131          114 EYVPETV---------NRIARNYSRIH---QRMP--------LIYVKL------------YTYQICRALAYIHN------  155 (376)
Q Consensus       114 e~~~~~l---------~~~~~~~~~~~---~~l~--------~~~~~~------------i~~qi~~al~~LH~------  155 (376)
                      ++++|..         ..+.+...+.+   ..+.        ......            ....+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9997621         11111111110   0110        010000            11112233344432      


Q ss_pred             cCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       156 ~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..+++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            14799999999999999865 56899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.63  E-value=0.0001  Score=69.29  Aligned_cols=172  Identities=20%  Similarity=0.249  Sum_probs=111.2

Q ss_pred             HHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh
Q 017131           76 KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  155 (376)
Q Consensus        76 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~  155 (376)
                      ..-...+++.+.|+|...++++--.   .... ..+|||+++-++++++....     +-..       +++       .
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~---~~~r-~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~   85 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRG---KHER-VIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A   85 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecC---ccce-EEEEehhhccchHHHHHhcc-----cchh-------hhc-------c
Confidence            3456888999999999988765422   2222 66899999999988876522     1100       111       1


Q ss_pred             cCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC
Q 017131          156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  235 (376)
Q Consensus       156 ~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg  235 (376)
                       +|+.|-     |        .++.+| .++.   .            |  |-      ...+++||||+|.++.++.-|
T Consensus        86 -~~~~~~-----~--------~~~~td-~~~t---~------------~--~~------~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   86 -HGVLHL-----N--------IIYITD-HFLT---K------------Y--PS------PIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             -ccccee-----h--------hhhccc-cccc---c------------C--CC------CCCcchhhhhHHHHHHHHHHh
Confidence             333331     1        344444 1110   0            0  11      122599999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHH
Q 017131          236 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE  315 (376)
Q Consensus       236 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~  315 (376)
                      ...+......+....+.+....+..-..-.+.                 ..+...++....+++.+|+-..|..||...+
T Consensus       128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-----------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  128 ISLEAELTESEYLEILLKYYTDDQELLSTAME-----------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             hHHHHHHHHHHHHHHHHHhccCchhHHHHHHH-----------------HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            98888877777777666654333221111110                 0122346788899999999999999999999


Q ss_pred             HhcCCccccc
Q 017131          316 ACVHPFFDEL  325 (376)
Q Consensus       316 ll~hp~f~~~  325 (376)
                      +++++-|.+.
T Consensus       191 ~~k~~i~~ev  200 (725)
T KOG1093|consen  191 LSKRCSFTEV  200 (725)
T ss_pred             HhcCccHHHH
Confidence            9999999875

>PRK05231 homoserine kinase; Provisional

Probab=97.59  E-value=0.0016  Score=59.60  Aligned_cols=30  Identities=27%  Similarity=0.286  Sum_probs=25.4

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||+|+.|.||+++.+. ..-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            4899999999999998654 45799999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.53  E-value=0.0013  Score=59.90  Aligned_cols=144  Identities=13%  Similarity=0.118  Sum_probs=78.5

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCC--eeeccceeeecCC----CCceEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFSTTD----KEELYL  109 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~----~~~~~~  109 (376)
                      ..-.+.++.|....+|++.. .+| .+++|+....  ......|.+++..|....  +++++.   +..+    ......
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~---t~~g~~~~~~~g~~   98 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVK---SRDGRQLSTLAGKP   98 (307)
T ss_pred             ceeccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCcccc---CCCCCeehhcCCeE
Confidence            33466778888889999874 333 5788976542  234456788887774322  233322   1110    112335


Q ss_pred             EEEEecccccH------------HHHHHHhhhhcCCCc---------HHHH----H----------HHHHHHHHHHHHHH
Q 017131          110 NLVLEYVPETV------------NRIARNYSRIHQRMP---------LIYV----K----------LYTYQICRALAYIH  154 (376)
Q Consensus       110 ~lv~e~~~~~l------------~~~~~~~~~~~~~l~---------~~~~----~----------~i~~qi~~al~~LH  154 (376)
                      +++++|++|..            ...+...-.....++         ..+.    .          .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            78999987611            111111111011110         0000    0          00111233444453


Q ss_pred             h------cCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          155 N------CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       155 ~------~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .      ..+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence            2      26899999999999999876 56899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.48  E-value=0.0022  Score=59.97  Aligned_cols=71  Identities=20%  Similarity=0.279  Sum_probs=46.6

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeec-----------ccccHHHHHHHHHhCC---CCCeeeccceeeecCCCCc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~  106 (376)
                      .+.||.|.+..||++.+...++.++||.-..           .......|.+.|+.+.   ..++++++.+-     .+.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            4678999999999999864445899997431           1122346888888763   23455665432     111


Q ss_pred             eEEEEEEecccc
Q 017131          107 LYLNLVLEYVPE  118 (376)
Q Consensus       107 ~~~~lv~e~~~~  118 (376)
                        .++|||++++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              4589999874

>PRK10593 hypothetical protein; Provisional

Probab=97.47  E-value=0.003  Score=57.19  Aligned_cols=77  Identities=9%  Similarity=0.008  Sum_probs=50.9

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeec--ccccHHHHHHHHHhCCC---CCeeeccceeeecCCCCceEEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      -.-.+.||.|..+.||...+.. + .+.+|..+.  ......+|...|+.+..   -.++++++++....  .....++|
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCC-C-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEE
Confidence            3446789999999999997532 3 467787543  23467799999998854   24556655442221  12225799


Q ss_pred             Eecccc
Q 017131          113 LEYVPE  118 (376)
Q Consensus       113 ~e~~~~  118 (376)
                      ||+++|
T Consensus        92 mE~i~G   97 (297)
T PRK10593         92 LERLRG   97 (297)
T ss_pred             EeccCC
Confidence            999886

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.23  E-value=0.0011  Score=55.57  Aligned_cols=101  Identities=24%  Similarity=0.215  Sum_probs=73.6

Q ss_pred             HHHHHHHHhCCC-CCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH
Q 017131           77 NRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  154 (376)
Q Consensus        77 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH  154 (376)
                      +.|.-+++.+.+ ++++++++.+     .    -.++.||.+. ++...-... ..-...++.....++.+++..+.+|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHh
Confidence            358889999976 5889998877     1    2368899874 332110000 00123688899999999999999999


Q ss_pred             hc--CCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          155 NC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       155 ~~--~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ..  ..+.-.|++|+|+-++.++ ++|++|.+.+..
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~  111 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV  111 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence            51  2367789999999999888 799999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.18  E-value=0.00038  Score=61.97  Aligned_cols=128  Identities=15%  Similarity=0.186  Sum_probs=85.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec----------cc----------------ccHHHHHHHHHhCC-CC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DK----------------RYKNRELQIMQMLD-HP   89 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~----------------~~~~~E~~~l~~l~-h~   89 (376)
                      -|.++.+||-|.-+-||.+-+ ..|++.++|.-..          ..                -...+|+..|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            578899999999999999987 4588899995311          00                11236888888884 33


Q ss_pred             C-eeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131           90 N-IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus        90 ~-iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      . +++.+++        +. -++|||++.| .|.++-       .-...   ..+...+..-+--|.. +|+||+|++-=
T Consensus       172 fpVPkpiD~--------~R-H~Vvmelv~g~Pl~~v~-------~v~d~---~~ly~~lm~~Iv~la~-~GlIHgDFNEF  231 (465)
T KOG2268|consen  172 FPVPKPIDH--------NR-HCVVMELVDGYPLRQVR-------HVEDP---PTLYDDLMGLIVRLAN-HGLIHGDFNEF  231 (465)
T ss_pred             CCCCCcccc--------cc-eeeHHHhhcccceeeee-------ecCCh---HHHHHHHHHHHHHHHH-cCceecccchh
Confidence            3 2233222        12 5689999887 221111       11222   2233445555666776 89999999999


Q ss_pred             cEEEcCCCCCeEEEecCCc
Q 017131          168 NLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a  186 (376)
                      ||+++.++ .++++||-..
T Consensus       232 Nimv~dd~-~i~vIDFPQm  249 (465)
T KOG2268|consen  232 NIMVKDDD-KIVVIDFPQM  249 (465)
T ss_pred             eeEEecCC-CEEEeechHh
Confidence            99999887 7999999754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.15  E-value=0.0086  Score=54.34  Aligned_cols=51  Identities=18%  Similarity=0.218  Sum_probs=34.3

Q ss_pred             eeeeeecCceEEEEEEECC------CCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCe
Q 017131           41 EHVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNI   91 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i   91 (376)
                      ++.|..|-...+|++....      +++.|++|+.....   ....+|.++++.+....+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~   62 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL   62 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC
Confidence            3556677777888887543      35789999875432   234579889988854333

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.09  E-value=0.0067  Score=56.12  Aligned_cols=141  Identities=17%  Similarity=0.259  Sum_probs=76.0

Q ss_pred             eEEeeeeeecCceEEEEEEECC----CCcEEEEEEeecccc---cHHHHHHHHHhCCCCCee-eccceeeecCCCCceEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYL  109 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~  109 (376)
                      ..-+..|-.|-...+|++....    +++.|++|+......   ...+|..+++.+...++. ++++.+     .+    
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~----  108 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PN----  108 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CC----
Confidence            3344456568888999987432    346899998754322   124699999988644443 333333     11    


Q ss_pred             EEEEecccc-cH-----------HHHHHHhhhhcC--------CCcHHHHHHHHHHH-----------------HHHHHH
Q 017131          110 NLVLEYVPE-TV-----------NRIARNYSRIHQ--------RMPLIYVKLYTYQI-----------------CRALAY  152 (376)
Q Consensus       110 ~lv~e~~~~-~l-----------~~~~~~~~~~~~--------~l~~~~~~~i~~qi-----------------~~al~~  152 (376)
                      ..|.+|+++ .+           ..+.....+.+.        ......+..++.++                 ...+..
T Consensus       109 g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~  188 (344)
T PLN02236        109 GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL  188 (344)
T ss_pred             ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence            135666654 11           111111111111        01112233332221                 111111


Q ss_pred             HH---h----cCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          153 IH---N----CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       153 LH---~----~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      |.   .    ...++|+|+++.||+++.+...+.++||..|.
T Consensus       189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            21   1    13689999999999998643379999998874

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.08  E-value=0.0056  Score=56.30  Aligned_cols=29  Identities=28%  Similarity=0.473  Sum_probs=25.0

Q ss_pred             ccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       159 iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ++|+|+.+.|||++.++..++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            79999999999997554379999999874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.97  E-value=0.016  Score=52.76  Aligned_cols=29  Identities=28%  Similarity=0.592  Sum_probs=25.2

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            57999999999999987 4 58999999763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.85  E-value=0.02  Score=52.67  Aligned_cols=69  Identities=20%  Similarity=0.242  Sum_probs=42.3

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeecc-----------cccHHHHHHHHHhCC--CC-CeeeccceeeecCCCCceE
Q 017131           43 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~  108 (376)
                      .||.|....||++.+...++-++||.-...           .....-|.+.|+...  -| .+++++.+  +    ... 
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D----~e~-   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D----TEM-   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c----ccc-
Confidence            579999999999998644467999964211           122235888887763  23 34444332  1    111 


Q ss_pred             EEEEEecccc
Q 017131          109 LNLVLEYVPE  118 (376)
Q Consensus       109 ~~lv~e~~~~  118 (376)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            3479998863

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.85  E-value=0.019  Score=52.29  Aligned_cols=30  Identities=13%  Similarity=0.190  Sum_probs=26.9

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||+|+.+.|+|++.++ .+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            4799999999999999887 69999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.75  E-value=0.012  Score=52.54  Aligned_cols=31  Identities=29%  Similarity=0.528  Sum_probs=25.3

Q ss_pred             CccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       158 ~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++|+|++|.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997552356999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.73  E-value=0.017  Score=52.24  Aligned_cols=30  Identities=27%  Similarity=0.524  Sum_probs=26.9

Q ss_pred             CccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       158 ~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++|+|+.+.|++++.++ -+-+.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            389999999999999888 599999999864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.56  E-value=0.0064  Score=55.22  Aligned_cols=107  Identities=16%  Similarity=0.192  Sum_probs=71.5

Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          104 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      .+..|.|++|++-++.+.. +       .....+++..++.+.+..+.-+...-.+-|||+..+||||+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISI-I-------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            5667889999998776521 1       12345677888888888777777645789999999999999 77 7999999


Q ss_pred             CCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHH
Q 017131          184 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTG  226 (376)
Q Consensus       184 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  226 (376)
                      -+++....+....    ....--|-.+.|.  -+.+.+||-+-
T Consensus       366 klsRl~~~q~~is----y~rldhp~lF~G~--dd~QFeIYrlM  402 (488)
T COG5072         366 KLSRLSYSQGIIS----YNRLDHPDLFNGV--DDYQFEIYRLM  402 (488)
T ss_pred             eeeecccCCceee----ccccCchhhhcCc--cceeeeHHHHH
Confidence            9998543332211    1112233344332  35666776643

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.48  E-value=0.026  Score=52.52  Aligned_cols=71  Identities=15%  Similarity=0.200  Sum_probs=44.7

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeec----------ccccHHHHHHHHHhCC--CC-CeeeccceeeecCCCCce
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DKRYKNRELQIMQMLD--HP-NIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~  107 (376)
                      .+.||.|.-..||++.+...++-++||.-..          +.....-|.+.|+...  .| .+++++.+      +...
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence            6788999999999999843356799996421          1122235888888763  34 34455432      1112


Q ss_pred             EEEEEEecccc
Q 017131          108 YLNLVLEYVPE  118 (376)
Q Consensus       108 ~~~lv~e~~~~  118 (376)
                       ..+|||+++.
T Consensus       108 -~~~vMEdL~~  117 (409)
T PRK12396        108 -NCCVMEDLSD  117 (409)
T ss_pred             -hhHHHHhCcc
Confidence             3478998863

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.30  E-value=0.082  Score=49.60  Aligned_cols=70  Identities=16%  Similarity=0.187  Sum_probs=44.9

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeec-----------ccccHHHHHHHHHhCC---CCCeeeccceeeecCCCC
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+.||.|....||+..+.  +..++||.-..           +......|.+.|+.+.   ..++++++.+.     .+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            4778899999999999873  45688996531           1222235777777664   23566665543     11


Q ss_pred             ceEEEEEEecccc
Q 017131          106 ELYLNLVLEYVPE  118 (376)
Q Consensus       106 ~~~~~lv~e~~~~  118 (376)
                      .  -+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            1  3478999865

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=96.07  E-value=0.016  Score=54.81  Aligned_cols=30  Identities=17%  Similarity=0.313  Sum_probs=24.4

Q ss_pred             ccccCCCCCcEEEcCCCC----CeEEEecCCccc
Q 017131          159 ICHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  188 (376)
Q Consensus       159 iiH~Dlkp~Nill~~~~~----~vkl~Dfg~a~~  188 (376)
                      ++|+||...|||.+.++.    -..|+||-.++.
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            899999999999998653    356889987654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>PTZ00384 choline kinase; Provisional

Probab=96.04  E-value=0.092  Score=49.20  Aligned_cols=29  Identities=28%  Similarity=0.389  Sum_probs=24.5

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..++|.|+-+.||+.+.+  .+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            468999999999998754  49999998774

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.50  E-value=0.3  Score=44.78  Aligned_cols=28  Identities=25%  Similarity=0.367  Sum_probs=23.8

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||+|+.+.|||++ +  .+.|+||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            4799999999999995 3  37899999874

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.45  E-value=0.4  Score=43.04  Aligned_cols=73  Identities=14%  Similarity=0.113  Sum_probs=43.6

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-cccHHHHHHHHHhCC---CCCeeeccceeeecCCCCceEEEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      .+-.+.++.|....+|+..  .+++.+.+|+-... ......|++-|+.|.   --.+++++.+......     -+|||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLll   91 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLL   91 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEE
Confidence            4556778889999999987  56788999977633 345678999999883   2345555555432222     36999


Q ss_pred             eccc
Q 017131          114 EYVP  117 (376)
Q Consensus       114 e~~~  117 (376)
                      ||++
T Consensus        92 e~l~   95 (288)
T PF03881_consen   92 EFLE   95 (288)
T ss_dssp             E---
T ss_pred             Eeec
Confidence            9986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=94.50  E-value=0.035  Score=49.83  Aligned_cols=131  Identities=18%  Similarity=0.227  Sum_probs=86.6

Q ss_pred             EeeeeeecCceEEEEEEE-------CC---CCcEEEEEEeec-------------cc-----------------ccHHHH
Q 017131           40 AEHVVGTGSFGVVFQAKC-------RE---TGEIVAIKKVLQ-------------DK-----------------RYKNRE   79 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~-------~~---~~~~vaiK~~~~-------------~~-----------------~~~~~E   79 (376)
                      |..+|..|.-+.|+.|+-       ..   ....+|||+++.             +.                 ...++|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            455677888888888843       11   234688987621             00                 011245


Q ss_pred             HHHHHhC-----CCCCeeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH
Q 017131           80 LQIMQML-----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  154 (376)
Q Consensus        80 ~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH  154 (376)
                      ...|.++     .+|-+|.+..            -.|||-+++..-   +..-....-.++..+.+..-.|+..++.-|-
T Consensus       336 mhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~~---~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY  400 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQG---LAAPKLKNVELTDDERRNAYDQVQSIMCRLY  400 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCCC---CCCccccccccChHHHHHHHHHHHHHHHHHH
Confidence            5555554     4677776643            338999987421   1111122345888888888889998887765


Q ss_pred             hcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       155 ~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ...-+||-||.--|+|...+  .|.++|...+.
T Consensus       401 ~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQsv  431 (531)
T KOG2269|consen  401 KECLLVHADLSEYNLLWTPG--KVWVIDVSQSV  431 (531)
T ss_pred             HhhheeecchhhhhheecCC--ceEEEechhcc
Confidence            43789999999999999964  69999987764

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.35  E-value=0.065  Score=48.49  Aligned_cols=78  Identities=21%  Similarity=0.340  Sum_probs=44.7

Q ss_pred             EEEecccccHHHHHHHhhhh-cCCCcHHHHHHHHHHHHHHHH---HHHhcCCccccCCCCCcEEEcCCCC----------
Q 017131          111 LVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALA---YIHNCIGICHRDIKPQNLLVNPHTH----------  176 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~---~LH~~~~iiH~Dlkp~Nill~~~~~----------  176 (376)
                      +|++.+-.+...+-...-.. +-.--.+-++.++.||+.-.-   .|-.|.+++|-||||+|||+-+...          
T Consensus       248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~  327 (434)
T PF05445_consen  248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN  327 (434)
T ss_pred             EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence            78887765433322221111 111223457777778765331   1223568999999999999843221          


Q ss_pred             -------CeEEEecCCccc
Q 017131          177 -------QLKLCDFGSAKV  188 (376)
Q Consensus       177 -------~vkl~Dfg~a~~  188 (376)
                             ..+|.||.+++.
T Consensus       328 ~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  328 YVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             EEecccceeeecccCHHHh
Confidence                   356777777754

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.18  E-value=0.14  Score=47.64  Aligned_cols=61  Identities=25%  Similarity=0.236  Sum_probs=38.6

Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                      .++-+|..| ++...+..     ...+++..+.++.-..+|+--+---.+++|.|++|.||++..+.
T Consensus       321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            355566665 44444432     34566666777666666654333226899999999999996544

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.14  E-value=0.043  Score=46.58  Aligned_cols=39  Identities=26%  Similarity=0.307  Sum_probs=32.9

Q ss_pred             HHHHHHHHh-cCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          147 CRALAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       147 ~~al~~LH~-~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      +.+|.-.|+ +.+.+|+|..|+||+.|+.| .+||.|-+.-
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~L  190 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVCL  190 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhhh
Confidence            456778883 46899999999999999999 7999998753

The function of this family is unknown.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.96  E-value=0.049  Score=45.29  Aligned_cols=28  Identities=29%  Similarity=0.387  Sum_probs=24.5

Q ss_pred             CccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       158 ~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      -.+|+|+.|.||+++.++  ++|+||+.|.
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCccc
Confidence            469999999999998665  8999999885

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	376
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-132
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-131
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-131
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-131
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-131
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-131
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-131
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-131
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-130
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-130
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-130
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-130
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-130
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-130
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-130
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-129
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-129
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-129
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-128
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-128
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-127
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-124
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-86
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-79
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-43
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-42
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-42
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-42
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-42
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-42
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-42
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-42
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-42
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-42
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-42
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-42
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-42
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-42
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-42
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-42
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-42
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-42
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-42
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-42
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-42
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-42
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-42
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-42
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-42
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-42
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-42
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-42
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-42
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-42
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-42
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-42
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-42
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-42
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-41
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-41
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-41
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-41
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-41
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-41
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-41
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-41
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-41
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-41
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-41
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-41
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-40
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-40
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-40
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-40
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-40
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-40
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-40
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-40
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-40
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-40
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-40
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-40
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-40
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-40
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-40
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-40
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-40
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-40
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-40
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-40
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-39
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-39
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-39
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-39
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-39
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-39
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-39
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-38
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-38
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-38
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-38
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-37
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-37
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-37
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-37
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-37
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-37
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-37
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-37
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-37
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-37
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-37
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-37
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-37
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-37
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-37
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-37
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-37
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-37
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-37
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-37
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-37
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-37
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-37
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-37
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-37
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-37
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-37
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-37
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-37
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-37
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-37
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-37
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-37
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-37
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-37
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-37
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-37
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-37
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-37
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-37
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-37
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-37
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-37
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-37
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-37
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-37
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-37
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-37
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-37
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-37
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-37
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-37
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-36
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-36
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-36
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-36
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-36
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-36
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-36
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-36
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-35
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-34
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-32
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-32
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-31
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-31
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-31
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-31
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-30
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-30
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-30
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-30
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-30
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-30
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-29
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-29
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-29
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-29
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-29
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-29
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-29
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-29
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-29
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-29
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-29
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-29
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-29
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-29
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-29
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-29
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-29
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-29
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-29
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-29
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-29
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-29
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-29
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-28
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-28
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-28
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-28
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-28
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-28
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-28
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-28
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-28
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-26
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-26
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-26
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-26
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-26
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-26
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-24
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-24
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-24
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-23
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-23
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-22
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-22
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-22
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-21
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-20
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-19
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-19
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-19
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-18
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-17
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-16
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-13
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-13
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-12
3soa_A	444	Full-Length Human Camkii Length = 444		6e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		9e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-05
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-05
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-05
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-04
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  466 bits (1200), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 379

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  466 bits (1199), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  466 bits (1198), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 387

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  466 bits (1198), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 430

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  465 bits (1197), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 389

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  465 bits (1197), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 233/359 (64%), Positives = 275/359 (76%), Gaps = 7/359 (1%)
Query: 14  GAETGHVIRTTIG--GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 71
           GA +   + T +   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 60
Query: 72  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 130
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 131 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 190
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 121 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179
Query: 191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 250
           +GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 180 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239
Query: 251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 240 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299
Query: 311 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 300 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 356

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  465 bits (1196), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/360 (65%), Positives = 276/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 364

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  463 bits (1192), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  462 bits (1189), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  462 bits (1188), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  461 bits (1187), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 370

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  461 bits (1187), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 233/360 (64%), Positives = 275/360 (76%), Gaps = 7/360 (1%)
Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 359

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  461 bits (1186), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/342 (66%), Positives = 268/342 (78%), Gaps = 5/342 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 366
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  459 bits (1182), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 231/357 (64%), Positives = 274/357 (76%), Gaps = 7/357 (1%)
Query: 12  GVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 71
            +G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 2   AMGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 59
Query: 72  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 130
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 131 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 190
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV
Sbjct: 120 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178
Query: 191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 250
           +GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 179 RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 239 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298
Query: 311 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 366
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 299 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 353

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  459 bits (1182), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 229/344 (66%), Positives = 268/344 (77%), Gaps = 5/344 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  458 bits (1178), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 12  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 71
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 132 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 190
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 250
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 251 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 366
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 311 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 350

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  458 bits (1178), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 366
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  458 bits (1178), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 228/342 (66%), Positives = 267/342 (78%), Gaps = 5/342 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 366
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  456 bits (1172), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 227/342 (66%), Positives = 266/342 (77%), Gaps = 5/342 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 366
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  456 bits (1172), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 227/344 (65%), Positives = 266/344 (77%), Gaps = 5/344 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 368
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 225/342 (65%), Positives = 264/342 (77%), Gaps = 5/342 (1%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 366
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  442 bits (1136), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/352 (61%), Positives = 268/352 (76%), Gaps = 4/352 (1%)
Query: 20  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 79
           VI+          +++++Y    V+G GSFGVVFQAK  E+ E VAIKKVLQDKR+KNRE
Sbjct: 24  VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 80  LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIY 138
           LQIM+++ HPN+V LK  F+S  DK               TV R +R+Y+++ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPNVS 
Sbjct: 143 IKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 258
           ICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 318
           +RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +Y+P+ R TA+EA  
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 319 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 370
           HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I+RL+P+HA  + L
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQHAEAELL 372

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  316 bits (810), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 162/369 (43%), Positives = 228/369 (61%), Gaps = 43/369 (11%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHC 97
           Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH NI+ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 98  FFSTTDK---------------------------------XXXXXXXXXXXXXXTVNRIA 124
           F++T D+                                               T++++ 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 125 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 184
           +++ R  + +P+  + +Y YQ+ RA+ +IH  +GICHRDIKPQNLLVN   + LKLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 244
           SAK L+  EP+V+ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 245 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 304
           +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+DL+ +  +
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 305 YSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPPELSGIPPE 355
           Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P ELS IP  
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 356 TINRLIPEH 364
            +NR++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  291 bits (744), Expect = 6e-79,   Method: Compositional matrix adjust.
 Identities = 154/339 (45%), Positives = 207/339 (61%), Gaps = 10/339 (2%)
Query: 33  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ---MLDHP 89
           K+   +  E + G G+FG V   K + TG  VAIKKV+QD R++NRELQIMQ   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 90  NIVALKHCFFS--TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           NIV L+  F++    D+              T++R  RNY R     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 148 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
           R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L   EPNV+YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 267 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
           NP++T+      K  PW  VF     +   EA DL+    QY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 324 ELRDPNTRLPNGRPLP-PLFNFKPPELSGIPPETINRLI 361
           EL DP T+LPN + LP  LF F P E+  +      +L+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/345 (31%), Positives = 179/345 (51%), Gaps = 28/345 (8%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIV 92
           Y     +G G++G+V  A        VAIKK+   + + Y  R   E+QI+    H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            ++    ++T +               + ++ ++     Q++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-----QQLSNDHICYFLYQILRGLKY 159
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPE 208
           IH+   + HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 266
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 267 --NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
               NY +   P      W K+F K    +A+DL+ R   ++PN R T  EA  HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 325 LRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
             DP        P    F F   EL  +P E +  LI  E AR Q
Sbjct: 336 YYDPTDEPVAEEP----FTFA-MELDDLPKERLKELIFQETARFQ 375

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 110/321 (34%), Positives = 166/321 (51%), Gaps = 56/321 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 171
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 317 CVHPFFDELRDPNTRLPNGRP 337
             HPFF ++  P   L   RP
Sbjct: 286 LAHPFFQDVTKPVPHLRLERP 306

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/320 (31%), Positives = 170/320 (53%), Gaps = 29/320 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 97
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 206
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S           Y+ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 265
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 266 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 323 DELRDPNTRLPNGRPLPPLF 342
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 171/320 (53%), Gaps = 29/320 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 97
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------VSYICSRYYRA 206
            + HRD+KP NLL+N +   LK+CDFG A+++ +      EP       V ++ +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 265
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 266 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 323 DELRDPNTRLPNGRPLPPLF 342
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 168
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 174
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 231
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 232 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 288
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 289 LAHPFFQDVTKP 300

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 166
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 171
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 228
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 229 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 286 LAHPFFQDVTKP 297

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 227
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 228 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 285 LAHPFFQDVTKP 296

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/344 (32%), Positives = 172/344 (50%), Gaps = 26/344 (7%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 98  FFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 154
              T                 + +++I      IH   PL   +V+ + YQ+ R L Y+H
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPEL 209
           +   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL
Sbjct: 176 SA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           +    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +   
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293
Query: 270 YTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                    P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  +  
Sbjct: 294 RVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352
Query: 327 DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 370
           DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 353 DPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 396

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 73  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 235
Query: 275 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 275 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + L++ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLSFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 106/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEHVDQDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 275 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 168
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 225
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 226 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 283 LAHPFFQDVTKP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 163/312 (52%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 226
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 227 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 284 LAHPFFQDVTKP 295

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 172/345 (49%), Gaps = 26/345 (7%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 97  CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 153
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----VSYICSRYYRAPE 208
           H+   + HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPE
Sbjct: 176 HSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           L+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +  
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 269 NYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
                     P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  + 
Sbjct: 294 ERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 370
            DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 353 HDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 397

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 72  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 234
Query: 275 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/308 (34%), Positives = 161/308 (52%), Gaps = 56/308 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDE 324
             HPFF +
Sbjct: 282 LAHPFFQD 289

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T   
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS-- 236
Query: 275 FPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
            P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 167
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 224
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 225 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 282 LAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 162/312 (51%), Gaps = 56/312 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 145
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSR 202
           + + LA+ H+   + HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + 
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTL 166
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP    
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD--- 223
Query: 263 IKCMNPNYTEFKFPQIKPH--PWHKV-FQKRLPPEAVD---LVCRFFQYSPNLRCTALEA 316
            + + P  T    P  KP    W +  F K +PP   D   L+ +   Y PN R +A  A
Sbjct: 224 -EVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
Query: 317 CVHPFFDELRDP 328
             HPFF ++  P
Sbjct: 281 LAHPFFQDVTKP 292

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 101/320 (31%), Positives = 169/320 (52%), Gaps = 29/320 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 97
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----------YICSRYYRA 206
            + HRD+KP NLL+N +   LK+CDFG A+++ +   + S            + +R+YRA
Sbjct: 132 NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKC 265
           PE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250
Query: 266 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+ 
Sbjct: 251 IESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309
Query: 323 DELRDPNTRLPNGRPLPPLF 342
               DPN   P G P+PP F
Sbjct: 310 QTYHDPNDE-PEGEPIPPSF 328

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/294 (35%), Positives = 155/294 (52%), Gaps = 31/294 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 94
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              F   ++                +  I ++ S +   +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 211
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPN 269
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 270 YTEFK-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           Y  FK FP I   P H +F      + +DL+   F ++P  R TA +A    +F
Sbjct: 246 YVTFKSFPGI---PLHHIFSAA-GDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 155/308 (50%), Gaps = 29/308 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 98  FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F  +T+ +               +N I ++     Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKS-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 277 QIKPHPWHKVFQKRLP-------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
            + P P     QK L        P A+DL+ R      + R +A EA  H +F +  DP 
Sbjct: 267 SLPPMP-----QKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321
Query: 330 TRLPNGRP 337
              P   P
Sbjct: 322 DE-PEAEP 328

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 90
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 141
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 103 VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGMEFS 142
Query: 142 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 198
Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 312
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 259 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 313 ALEACVHPFFDELRDPNTRLPNGRPL 338
           A +A  HPFF+  RDP       +P 
Sbjct: 318 AAQALTHPFFEPFRDPEEETEAQQPF 343

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 104/326 (31%), Positives = 158/326 (48%), Gaps = 49/326 (15%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 90
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 141
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 85  VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS 124
Query: 142 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
                   YQ+ + L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+        
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEM 180
Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
             Y+ +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV 
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCT 312
           G P  E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R T
Sbjct: 241 GVPGTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 313 ALEACVHPFFDELRDPNTRLPNGRPL 338
           A +A  HPFF+  RDP       +P 
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPF 325

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 339 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 317 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 266 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 324 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 267 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 325 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 361

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 258 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 316 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 352

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 269 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 363

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 339 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/341 (30%), Positives = 173/341 (50%), Gaps = 32/341 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MNP 268
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
                  P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  DP
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321
Query: 329 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           +       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 322 SDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 175/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 317 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 175/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  D
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 106/342 (30%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAI+K+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 154/308 (50%), Gaps = 29/308 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 98  FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 151 -GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 206
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 207 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 266
Query: 277 QIKPHPWHKVFQKRLP-------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
            + P P     QK L        P A+DL+ R      + R +A EA  H +F +  DP 
Sbjct: 267 SLPPMP-----QKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321
Query: 330 TRLPNGRP 337
              P   P
Sbjct: 322 DE-PEAEP 328

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 176/342 (51%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKC-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 272
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 272
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
             F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  161 bits (407), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 107/342 (31%), Positives = 174/342 (50%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 174/339 (51%), Gaps = 28/339 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 214
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 270
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+ 
Sbjct: 268 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 331 RLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
                 P    F F   EL  +P E +  LI  E AR Q
Sbjct: 326 EPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 174/339 (51%), Gaps = 28/339 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY----ICSRYYRAPELIFGAT 214
           + HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNY 270
            YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+ 
Sbjct: 269 L-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 331 RLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
                 P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 EPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 100/333 (30%), Positives = 168/333 (50%), Gaps = 57/333 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLD-HPNIVALKH 96
           +G G++G+V+++  R TGE+VA+KK+        D +   RE+ I+  L  H NIV L +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              +  D+               V R A     +H++    YV    YQ+ + + Y+H+ 
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIR-ANILEPVHKQ----YV---VYQLIKVIKYLHSG 128
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK---------------------GEPN 195
            G+ HRD+KP N+L+N   H +K+ DFG ++  V                       +P 
Sbjct: 129 -GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 196 VS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++QL  II V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 255 LGTPTREEIKCMNPNYTEFKFPQIKPH-------------PWHKVFQKRLP-----PEAV 296
           +  P+ E+++ +   + +     +K                W  +  K  P      EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 297 DLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           DL+ +  Q++PN R +A +A  HPF     +PN
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 153/308 (49%), Gaps = 29/308 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 98  FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
            GI HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++     Y
Sbjct: 143 -GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWMHY 198
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +      
Sbjct: 199 NQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ 258
Query: 277 QIKPHPWHKVFQKRLP-------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
            + P P     QK L        P A+DL+ R      + R +A EA  H +F +  DP 
Sbjct: 259 SLPPMP-----QKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 313
Query: 330 TRLPNGRP 337
              P   P
Sbjct: 314 DE-PEAEP 320

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 146
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 203
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLW 165
Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 261
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 262 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 318 VHPFFDE 324
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 106/342 (30%), Positives = 173/342 (50%), Gaps = 34/342 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRY---KNRELQIMQMLDHPNIVALKHCF 98
           +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------VSYICSRYYRAPELIF 211
           + HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 267
            +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            NY     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 328 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 368
           P+       P    F F   EL  +P E +  LI  E AR Q
Sbjct: 319 PSDEPIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 27/297 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 97
           +G GS+GVVF+ + R+TG+IVAIKK L+       K+   RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--N 155
           F                      + +     R  + +P   VK  T+Q  +A+ + H  N
Sbjct: 71  F--------RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFG 212
           CI   HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G
Sbjct: 123 CI---HRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVG 176
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNY 270
            T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  +
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
           +  K P  +     ++    +   A+ L+       P  R T  +   HP+F+ +R+
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 146
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 203
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 261
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 262 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 318 VHPFFDE 324
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 100/307 (32%), Positives = 155/307 (50%), Gaps = 56/307 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 146
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRY 203
              +AY H+   + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLW 165
Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 261
           YRAP+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +  
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 262 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
               E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A 
Sbjct: 226 PNVTELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 318 VHPFFDE 324
            H +F E
Sbjct: 280 EHAYFKE 286

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 104/318 (32%), Positives = 160/318 (50%), Gaps = 25/318 (7%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  +   ++G  +A+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  +T+ +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 172
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 271
           Y   +DIWS GC+MAELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 331
               PQ+    +  VF     P AVDL+ +      + R TA EA  HP+F +  DP+  
Sbjct: 289 N-SLPQMPKRNFADVFIGA-NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE 346
Query: 332 LPNGRPLPPLFNFKPPEL 349
            P   P    F  +  E+
Sbjct: 347 -PESEPYDQSFESRQLEI 363

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDX-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I ++     Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKS-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 153
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 270 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVNEDX-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 103/320 (32%), Positives = 159/320 (49%), Gaps = 29/320 (9%)
Query: 27  GRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKR 74
            R+G  +Q+V+  A  V         VG+G++G V  A    TG  VAIKK+    Q + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 75  YKNR---ELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 131
           +  R   EL++++ + H N++ L   F  T D+                  + +     H
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVF--TPDETLDDFTDFYLVMPFMGTDLGKLMK--H 122
Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           +++    ++   YQ+ + L YIH   GI HRD+KP NL VN    +LK+ DFG A+    
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--A 178
Query: 192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 251
                  + +R+YRAPE+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI
Sbjct: 179 DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 252 IKVLGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 307
           +KV GTP  E ++ +      NY +   P+++   +  +      P AV+L+ +      
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMK-GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDA 296
Query: 308 NLRCTALEACVHPFFDELRD 327
             R TA EA  HP+F+ L D
Sbjct: 297 EQRVTAGEALAHPYFESLHD 316

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 96/308 (31%), Positives = 155/308 (50%), Gaps = 23/308 (7%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
           +YI    +G G++  V++ K + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L       T+K                     N   +H       VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKSLTLVFEYLDKDLKQYLDDCGNIINMHN------VKLFLFQLLRGLA 114
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 208
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 266
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
           N  +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPFF  L 
Sbjct: 231 NEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 327 DPNTRLPN 334
           +   +LP+
Sbjct: 290 ERIHKLPD 297

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 95/290 (32%), Positives = 154/290 (53%), Gaps = 21/290 (7%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 96
           +VG GS+G+V + + ++TG IVAIKK L+       K+   RE+++++ L H N+V L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
                  K               ++ +    + +  ++    V+ Y +QI   + + H+ 
Sbjct: 90  --LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV----VQKYLFQIINGIGFCHSH 143
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNVSYICSRYYRAPELIFGATE 215
             I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +
Sbjct: 144 -NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 273
           Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 274 KFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + P+IK   P  + + K L    +DL  +     P+ R    E   H FF
Sbjct: 262 RLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 156 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 266 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 141
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 271 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 279 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 153/298 (51%), Gaps = 34/298 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 215 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 274 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F + 
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 167 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 283 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 103/311 (33%), Positives = 158/311 (50%), Gaps = 25/311 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 331
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+  
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 317
Query: 332 LPNGRPLPPLF 342
            P   P    F
Sbjct: 318 -PVADPFDQSF 327

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 151 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 152/298 (51%), Gaps = 34/298 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 215 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
            Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 274 KFPQIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           K P  KP+P +           +L     DL+    + +P  R +A EA  HP+F + 
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 265 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 142
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 258
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 259 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +       ++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----AKLTDDHVQFLIYQILRGLKYIHS 139
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 256 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 164 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 280 Q-SLAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 99/298 (33%), Positives = 154/298 (51%), Gaps = 24/298 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 96
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 97  CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 144 A-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 271
           Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           +    Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 Q-SLTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 95/297 (31%), Positives = 148/297 (49%), Gaps = 26/297 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 98
           +G G++  V++   + TG  VA+K+V  D          RE+ +M+ L H NIV L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
            +                    +R   N  R    + L  VK + +Q+ + LA+ H    
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPR---GLELNLVKYFQWQLLQGLAFCHEN-K 128
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYT 217
           I HRD+KPQNLL+N    QLKL DFG A+   +      S + + +YRAP+++ G+  Y+
Sbjct: 129 ILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYS 187
Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNPNYT 271
           T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP         ++   NPN  
Sbjct: 188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN-- 245
Query: 272 EFKFPQIKPHPWHKVFQ----KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                Q  P    +V Q    + L    +D +    Q +P++R +A +A  HP+F E
Sbjct: 246 ---IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 154/297 (51%), Gaps = 24/297 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 99
           +G G  G+VF A   +  + VAIKK++    Q  ++  RE++I++ LDH NIV +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 100 STTDKXXXXXXXXXXXXXXTVNR--IARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 155
            +  +               + +  +  + + + ++ PL+  + +L+ YQ+ R L YIH+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS 138
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-------ICSRYYRAPE 208
              + HRD+KP NL +N     LK+ DFG A+++   +P+ S+       + +++YR+P 
Sbjct: 139 A-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLSEGLVTKWYRSPR 194
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKC 265
           L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+   +E I V+    R+E+  
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + P Y   +    +PH         +  EAVD + +   +SP  R TA EA  HP+ 
Sbjct: 255 VIPVY--IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 82
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 139
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 260 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 315
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 316 ACVHPFFDELRDP 328
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 32/313 (10%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 82
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 139
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           + + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y+
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYV 194
Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 260 REEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 315
            E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQ 313
Query: 316 ACVHPFFDELRDP 328
           A  HP+F+ L DP
Sbjct: 314 ALRHPYFESLFDP 326

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 151
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 268
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 317
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 318 VHPFFDELRDPN 329
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 151
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 268
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 317
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 318 VHPFFDELRDPN 329
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 154/312 (49%), Gaps = 41/312 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 151
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 268
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 317
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 318 VHPFFDELRDPN 329
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 323 DELRDP 328
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 110/398 (27%), Positives = 166/398 (41%), Gaps = 79/398 (19%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNI 91
           Y   H++GTGS+G V +A  +    +VAIKK+L+      D +   RE+ I+  L+H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V +         +                 ++ R    + +    +++K   Y +   + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVGVK 170
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------------- 197
           Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S              
Sbjct: 171 YVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 198 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL---------- 233
                         ++ +R+YRAPELI     YT AID+WS GC+ AELL          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 234 -LGQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
               PLFPG S                      DQL  I  +LGTP+ E+I+ +     +
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELR--- 326
            ++ +I P        +R P  + D   L+ R   ++PN R T  E   HPFF E+R   
Sbjct: 349 -RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407
Query: 327 -DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 363
            + N       P     N   P+L     + I R  PE
Sbjct: 408 VETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 323 DELRDP 328
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 137
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 323 DELRDP 328
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 323 DELRDP 328
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 151
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 268
           G   Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 317
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 318 VHPFFDELRDPN 329
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 151
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 268
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 317
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 318 VHPFFDELRDPN 329
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 142/291 (48%), Gaps = 23/291 (7%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALKHCFFST 101
           +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L       
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL------- 97
Query: 102 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 161
            D                VN    ++ +++Q +    ++ Y Y+I +AL Y H  +GI H
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNT--DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMH 154
Query: 162 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAID 221
           RD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 222 IWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKF 275
           +WS GC++A ++   +P F G    DQLV I KVLGT    +        ++P + +   
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-L 273
Query: 276 PQIKPHPW----HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            +     W    H   Q  + PEA+D + +  +Y    R TA EA  HP+F
Sbjct: 274 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 96/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 151
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I 
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 268
           G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P   
Sbjct: 199 GMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVR 257
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEAC 317
            Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA 
Sbjct: 258 TYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 318 VHPFFDELRDPN 329
            HP+ +   DP+
Sbjct: 317 QHPYINVWYDPS 328

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 151/305 (49%), Gaps = 21/305 (6%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 84
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 85  MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 140
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 141 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 200
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 321 FFDEL 325
           +F +L
Sbjct: 299 YFQDL 303

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 323 DELRDP 328
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 323 DELRDP 328
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322
Query: 323 DELRDP 328
           +   DP
Sbjct: 323 NVWYDP 328

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 148 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 206
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 207 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 267 ------DGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVR 343

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 323 DELRDP 328
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 323 DELRDP 328
           +   DP
Sbjct: 322 NVWYDP 327

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 143
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 144 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 200
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320
Query: 323 DELRDP 328
           +   DP
Sbjct: 321 NVWYDP 326

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315
Query: 323 DELRDP 328
           +   DP
Sbjct: 316 NVWYDP 321

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 151/306 (49%), Gaps = 21/306 (6%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIM 83
            + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ ++
Sbjct: 8   RADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 84  QMLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYV 139
           + L+   HPN+V L   C  S TD+                  + +        +P   +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETI 122
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           K   +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S +
Sbjct: 123 KDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVV 180
Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
            + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P 
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
            E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  H
Sbjct: 240 EEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 320 PFFDEL 325
           P+F +L
Sbjct: 298 PYFQDL 303

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 137
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 138 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 194
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314
Query: 323 DELRDP 328
           +   DP
Sbjct: 315 NVWYDP 320

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 323 DELRDP 328
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 183 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 239
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
Query: 323 DELRDP 328
           +   DP
Sbjct: 360 NVWYDP 365

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 129 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 187
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 188 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 248 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 301
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 302 RYDHQERLTALEAMTHPYFQQVR 324

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 144/301 (47%), Gaps = 31/301 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ 
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321
Query: 323 D 323
           +
Sbjct: 322 N 322

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G A+    G+     
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 257
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 258 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 303
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 146/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 202 YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                   KF ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 323 DELRDP 328
               DP
Sbjct: 322 TVWYDP 327

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 149/302 (49%), Gaps = 21/302 (6%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 84
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 85  MLD---HPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 140
            L+   HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 141 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 200
              +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
           E+    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 321 FF 322
           +F
Sbjct: 299 YF 300

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 149/308 (48%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 94  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 146
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+        V ++ +RYYRAPE+I G   
Sbjct: 147 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG- 203
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 204 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 263
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 264 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 322
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 323 INVWYDPS 330

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 94/308 (30%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 93  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 145
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 146 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 202
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 203 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 263 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 322 INVWYDPS 329

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 145/306 (47%), Gaps = 31/306 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 98  FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 142
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 143 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG- 199
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 273 -------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+ 
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 323 DELRDP 328
               DP
Sbjct: 320 TVWYDP 325

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/305 (29%), Positives = 149/305 (48%), Gaps = 50/305 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK-- 95
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 96  -------HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
                  H  F   +                     + Y   +  + +  +K + YQ+  
Sbjct: 102 IHHNHRLHLIFEYAENDL------------------KKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 149 ALAYIHN--CIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNVSY---I 199
            + + H+  C+   HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I
Sbjct: 144 GVNFCHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEI 198
Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
            + +YR PE++ G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P 
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258
Query: 260 REEIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                 +   P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A 
Sbjct: 259 DTTWPGVTALPDWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
Query: 318 VHPFF 322
            HP+F
Sbjct: 318 EHPYF 322

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+L++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 102/354 (28%), Positives = 162/354 (45%), Gaps = 75/354 (21%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 90
           +YI +H++G GS+G V+ A  + T + VAIKKV      L D +   RE+ I+  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQI 146
           I+ L                         V  IA +  +   + P+     ++K   Y +
Sbjct: 87  IIRLYDLIIPDD--------LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNV--------- 196
                +IH   GI HRD+KP N L+N     +K+CDFG A+ +  + + N+         
Sbjct: 139 LLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 197 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQ------ 236
                        S++ +R+YRAPELI     YT +IDIWSTGC+ AELL + Q      
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 237 ----PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
               PLFPG                 +S  DQL  I  ++GTPT +++K +N      K+
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV-IKY 315
Query: 276 PQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
            ++ PH      +++ P    + ++L+    +++PN R T  +A  HP+  ++R
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 118 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 295
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 125 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 183
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 184 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 243
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 244 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 302
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ ++ Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N++++    +L+L D+G 
Sbjct: 120 DFKQLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+    G+     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 245 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 295
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 296 VDLVCRFFQYSPNLRCTALEACVHPFF 322
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 93/308 (30%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 97  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 149
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 150 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 206
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 207 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 266
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 267 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 325
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 326 INVWYDPS 333

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 86  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 138
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I G   
Sbjct: 139 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG- 195
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 255
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 256 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 314
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 315 INVWYDPS 322

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 179
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 180 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 239
Query: 245 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 292
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 240 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 295
Query: 293 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 296 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 18/210 (8%)
Query: 126 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS 185
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N++++    +L+L D+G 
Sbjct: 126 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 184
Query: 186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 244
           A+     +     + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 185 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 244
Query: 245 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 292
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 245 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 300
Query: 293 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 301 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP    +K + P   NY E
Sbjct: 202 YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVE 261
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 90
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 91  IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 147
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 148 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRA 179
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 212
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 273 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 212
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 273 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 90
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 91  IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 147
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 148 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRA 179
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 143
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 212
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 144 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 202
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 261
Query: 273 FKFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 262 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 33/308 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 97
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I G   
Sbjct: 145 A-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG- 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE 272
           Y   +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 273 FKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+
Sbjct: 262 NR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 322 FDELRDPN 329
            +   DP+
Sbjct: 321 INVWYDPS 328

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 140/295 (47%), Gaps = 20/295 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--VSYICSRYYRAPELIFG 212
            I HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR PEL+ G
Sbjct: 145 KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLG 203
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  
Sbjct: 204 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYEL 262
Query: 273 FKFPQIKPHPWHKVFQKRL-----PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           ++  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 YEKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 32/296 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 90
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 91  IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 147
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 148 RALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
           R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +YRA
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRA 179
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    
Sbjct: 180 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 237
Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 238 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 105/372 (28%), Positives = 158/372 (42%), Gaps = 80/372 (21%)
Query: 26  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRE 79
           G    N K   +Y  +H++G GS+G V+ A  +   + VAIKKV      L D +   RE
Sbjct: 18  GAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILRE 77
Query: 80  LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-- 137
           + I+  L    I+ L H      D                V  IA +  +   + P+   
Sbjct: 78  ITILNRLKSDYIIRL-HDLIIPED-------LLKFDELYIVLEIADSDLKKLFKTPIFLT 129
Query: 138 --YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
             +VK   Y +     +IH   GI HRD+KP N L+N     +K+CDFG A+  +  + +
Sbjct: 130 EQHVKTILYNLLLGEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKD 186
Query: 196 V---------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCV 228
           +                           S++ +R+YRAPELI     YT +IDIWSTGC+
Sbjct: 187 IHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCI 246
Query: 229 MAELLLGQ-----------PLFPG-----------------ESGVDQLVEIIKVLGTPTR 260
            AELL              PLFPG                 +S  DQL  I  V+GTP  
Sbjct: 247 FAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPE 306
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKR---LPPEAVDLVCRFFQYSPNLRCTALEAC 317
           E++KC+       K+ ++ P        K+   +  E +DL+    +++   R T  +A 
Sbjct: 307 EDLKCITKQEV-IKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKAL 365
Query: 318 VHPFFDELRDPN 329
            HP+  ++R  N
Sbjct: 366 SHPYLKDVRKEN 377

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 140/299 (46%), Gaps = 35/299 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLD--- 87
           +G G++G V++A+   +G  VA+K V    R  N             RE+ +++ L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 88  HPNIVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTY 144
           HPN+V L   C  S TD+               V++  R Y        +P   +K    
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 145 QICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 203
           Q  R L ++H NCI   HRD+KP+N+LV      +KL DFG A++          + + +
Sbjct: 128 QFLRGLDFLHANCI--VHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++ 
Sbjct: 185 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243
Query: 264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 244 P-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 99/351 (28%), Positives = 150/351 (42%), Gaps = 61/351 (17%)
Query: 28  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQ 84
           +NG  K    Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E+++++
Sbjct: 28  KNG-EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 85  MLDHPN------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY 138
           +++  +      IV LK  F                      N   R  S       L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNL 139
Query: 139 VKLYTYQICRALAYIHN-CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
            + +  Q+C AL ++    + I H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWH----KVFQKRLPPEAV---------------- 296
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 257 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 314
Query: 297 -----------------DLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                            DL+ R   Y P  R     A  H FF +  D  T
Sbjct: 315 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 123/242 (50%), Gaps = 22/242 (9%)
Query: 28  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQ 84
           +NG  K    Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E+++++
Sbjct: 47  KNG-EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 85  MLDHPN------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY 138
           +++  +      IV LK  F                      N   R  S       L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNL 158
Query: 139 VKLYTYQICRALAYIHN-CIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
            + +  Q+C AL ++    + I H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 257 TP 258
            P
Sbjct: 276 IP 277

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/242 (32%), Positives = 124/242 (51%), Gaps = 22/242 (9%)
Query: 28  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQ 84
           +NG  K    Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E+++++
Sbjct: 47  KNG-EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 85  MLDHPN------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY 138
           +++  +      IV LK  F                      N   R  S       L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNL 158
Query: 139 VKLYTYQICRALAYIHN-CIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNV 196
            + +  Q+C AL ++    + I H D+KP+N+L+ NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 257 TP 258
            P
Sbjct: 276 IP 277

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 134/282 (47%), Gaps = 38/282 (13%)
Query: 78  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQR---M 134
           RE+ +++ L HPN+++L+  F S  D+               + +  R  S+ +++   +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA-SKANKKPVQL 125
Query: 135 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL-- 189
           P   VK   YQI   + Y+H    + HRD+KP N+LV    P   ++K+ D G A++   
Sbjct: 126 PRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 190 -VKGEPNVS-YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-------- 239
            +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F        
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244
Query: 240 -PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFKFPQ---------IKPHPWHKV 286
                  DQL  I  V+G P     E+IK M  + T  K  +         IK    HKV
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304
Query: 287 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
              +   +A  L+ +     P  R T+ +A   P+F  L DP
Sbjct: 305 ---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/326 (26%), Positives = 144/326 (44%), Gaps = 63/326 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 102
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H              
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH----------LRKQ 153
Query: 103 DKXXXXXXXXXXXXXXTVNRIARNYSRIH------------QRMPLIYVKLYTYQICRAL 150
           DK                N I   +  +             Q   L  V+ + + I + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
             +H    I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+
Sbjct: 214 DALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEV 270
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +
Sbjct: 271 ILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDAS 326
Query: 270 YTEFKFPQIKPHPWH------------------KVFQKRLPPEA---------------V 296
                F   K +P +                  +  + R PPE+               +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 297 DLVCRFFQYSPNLRCTALEACVHPFF 322
           D + +  ++ P +R T  +A  HP+ 
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/326 (26%), Positives = 144/326 (44%), Gaps = 63/326 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 102
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H              
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH----------LRKQ 153
Query: 103 DKXXXXXXXXXXXXXXTVNRIARNYSRIH------------QRMPLIYVKLYTYQICRAL 150
           DK                N I   +  +             Q   L  V+ + + I + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
             +H    I H D+KP+N+L+       +K+ DFGS+    + +   + I SR+YRAPE+
Sbjct: 214 DALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEV 270
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +
Sbjct: 271 ILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDAS 326
Query: 270 YTEFKFPQIKPHPWH------------------KVFQKRLPPEA---------------V 296
                F   K +P +                  +  + R PPE+               +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 297 DLVCRFFQYSPNLRCTALEACVHPFF 322
           D + +  ++ P +R T  +A  HP+ 
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 90
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ L   F    DK                + I    SR  +R   +       Q+   +
Sbjct: 112 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEI---ISR--KRFSEVDAARIIRQVLSGI 163
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 164 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 223 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 266
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 267 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 90
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ L   F    DK                + I    SR  +R   +       Q+   +
Sbjct: 111 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEI---ISR--KRFSEVDAARIIRQVLSGI 162
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 163 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 222 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 265
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 266 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 90
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/326 (26%), Positives = 141/326 (43%), Gaps = 63/326 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 102
           V+G G FG V +A   +  + VA+K V  +KR+  +  + +++L+H              
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH----------LRKQ 153
Query: 103 DKXXXXXXXXXXXXXXTVNRIARNYSRIH------------QRMPLIYVKLYTYQICRAL 150
           DK                N I   +  +             Q   L  V+ + + I + L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
             +H    I H D+KP+N+L+       +K+ DFGS+    + +     I SR+YRAPE+
Sbjct: 214 DALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEV 270
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P +   K ++ +
Sbjct: 271 ILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ---KLLDAS 326
Query: 270 YTEFKFPQIKPHPWH------------------KVFQKRLPPEA---------------V 296
                F   K +P +                  +  + R PPE+               +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 297 DLVCRFFQYSPNLRCTALEACVHPFF 322
           D + +  ++ P +R T  +A  HP+ 
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 90
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 94  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 145
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            Y+H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 146 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 205 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 248
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 249 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 124/293 (42%), Gaps = 45/293 (15%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 90
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I  L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IXKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            Y H    I HRD+KP+NLL+   +    +++ DFG +      +     I + YY APE
Sbjct: 140 TYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            YT F+ PQ     W KV        A DL+ +   Y P+ R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 86
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 87  DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 135
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 190
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 244
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 245 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 291
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 292 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 342
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 98/358 (27%), Positives = 150/358 (41%), Gaps = 51/358 (14%)
Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 86
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 87  DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 135
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 190
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------ 244
             E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 245 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRL 291
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 292 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 342
             E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 52/298 (17%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIV 92
           ++I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQICR 148
            L+  + STT                        + RI +R   +Y +    L   Q+  
Sbjct: 70  TLEDIYESTTHYYLVMQLVSG----------GELFDRILERG--VYTEKDASLVIQQVLS 117
Query: 149 ALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSR-YYR 205
           A+ Y+H   GI HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
               Y EF+ P          F   +   A D +C   +  PN R T  +A  HP+ D
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 137/307 (44%), Gaps = 52/307 (16%)
Query: 30  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIM 83
           G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIYV 139
           + LDHPNI+ L   F   TD                V   R+ R  + +RI +       
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------- 113
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
                 +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   +
Sbjct: 114 -----DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  GT
Sbjct: 168 KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT 223
Query: 258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                          F FP+     W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 224 ---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 318 VHPFFDE 324
            H +F++
Sbjct: 261 EHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 52/308 (16%)
Query: 29  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQI 82
            G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++I
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEI 76
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIY 138
           M+ LDHPNI+ L   F   TD                V   R+ R  + +RI +      
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------ 130
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQN--LLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
                  +  A+AY H  + + HRD+KP+N   L +     LKL DFG A     G+   
Sbjct: 131 ------DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
           + + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  G
Sbjct: 184 TKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--G 239
Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
           T               F FP+     W  V      P+A  L+ R    SP  R T+L+A
Sbjct: 240 T---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 276
Query: 317 CVHPFFDE 324
             H +F++
Sbjct: 277 LEHEWFEK 284

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSASKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 325 LRDPN 329
           +   N
Sbjct: 297 VTWEN 301

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 49/308 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 95
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                ++                 +  I R     H    +I       Q+   + Y+H 
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK------QVFSGITYMHK 139
Query: 156 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 213
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+   ++  ++  P
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 334 NGRPLPPL 341
               LP L
Sbjct: 289 TISDLPSL 296

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 84
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 77  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 202
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 203 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 229
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 230 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 282
Query: 321 FFDE 324
           +  +
Sbjct: 283 WLQD 286

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 84
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 202
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 203 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 321 FFDE 324
           +  +
Sbjct: 277 WLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 84
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 70  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 202
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 203 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 222
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 223 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 275
Query: 321 FFDE 324
           +  +
Sbjct: 276 WLQD 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 84
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 202
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 203 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 321 FFDE 324
           +  +
Sbjct: 277 WLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 136/304 (44%), Gaps = 52/304 (17%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 84
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L+HP I+ +K+ FF   D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKN-FFDAED---YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 202
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 203 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 321 FFDE 324
           +  +
Sbjct: 277 WLQD 280

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 132/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 103
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            CF                      N     Y R          + YT +I  AL Y+H 
Sbjct: 104 FCF--------QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 156 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 214 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 254
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 255 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 301
Query: 325 LRDPN 329
           +   N
Sbjct: 302 VTWEN 306

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 325 LRDPN 329
           +   N
Sbjct: 298 VTWEN 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+  
Sbjct: 148 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 246
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 247 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 293
Query: 325 LRDPN 329
           +   N
Sbjct: 294 VTWEN 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSAXKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL---------------- 249
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 325 LRDPN 329
           +   N
Sbjct: 297 VTWEN 301

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 325 LRDPN 329
           +   N
Sbjct: 295 VTWEN 299

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 95
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 156 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 213
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 46/288 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 95
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 156 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 213
              I HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 84
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 202
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 203 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 355 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 321 FFDE 324
           +  +
Sbjct: 402 WLQD 405

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVV + + R +G I+A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI + +    +   +  + R LAY+     
Sbjct: 84  YSDGE----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREKHQ 135
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE + G T Y+ 
Sbjct: 136 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERLQG-THYSV 192
Query: 219 AIDIWSTGCVMAELLLGQ 236
             DIWS G  + EL +G+
Sbjct: 193 QSDIWSMGLSLVELAVGR 210

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 84
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSR 202
           Q+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 203 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 368
Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 369 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 415
Query: 321 FFDE 324
           +  +
Sbjct: 416 WLQD 419

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 135/307 (43%), Gaps = 64/307 (20%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-- 206
Query: 213 ATEYTT--AIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNP 268
            TE +   + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+              
Sbjct: 207 -TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL-------------- 249
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFF 322
              E+ FP+            +  P+A DLV +      +  L C  +E       HPFF
Sbjct: 250 ---EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294
Query: 323 DELRDPN 329
           + +   N
Sbjct: 295 ESVTWEN 301

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 325 LRDPN 329
           +   N
Sbjct: 297 VTWEN 301

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 152 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 210 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 250
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 251 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 297
Query: 325 LRDPN 329
           +   N
Sbjct: 298 VTWEN 302

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 325 LRDPN 329
           +   N
Sbjct: 297 VTWEN 301

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 151 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 209 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 249
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 250 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296
Query: 325 LRDPN 329
           +   N
Sbjct: 297 VTWEN 301

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 94
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 75  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 126
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 211
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 127 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 269
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 185 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 226
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 323
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 227 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272
Query: 324 ELRDPN 329
            +   N
Sbjct: 273 SVTWEN 278

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 325 LRDPN 329
           +   N
Sbjct: 295 VTWEN 299

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 94
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 73  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 124
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 211
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 125 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 269
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 183 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 224
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 323
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 225 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270
Query: 324 ELRDPN 329
            +   N
Sbjct: 271 SVTWEN 276

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 325 LRDPN 329
           +   N
Sbjct: 295 VTWEN 299

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 79
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 80  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 133 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 191 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 231
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 232 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 278
Query: 325 LRDPN 329
           +   N
Sbjct: 279 VTWEN 283

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 94
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 74  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 211
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 126 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 269
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 184 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 225
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 323
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 226 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
Query: 324 ELRDPN 329
            +   N
Sbjct: 272 SVTWEN 277

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDHPNIVAL 94
           ++G GSF  V  A+   T    AIK +L+ +         Y  RE  +M  LDHP  V L
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              +F+  D                 N     Y R          + YT +I  AL Y+H
Sbjct: 76  ---YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 127
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIF 211
              GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 128 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPN 269
             +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+               
Sbjct: 186 EKSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL--------------- 227
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFD 323
             E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+
Sbjct: 228 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273
Query: 324 ELRDPN 329
            +   N
Sbjct: 274 SVTWEN 279

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 134/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 148 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 206 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 246
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 247 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 293
Query: 325 LRDPN 329
           +   N
Sbjct: 294 VTWEN 298

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 46/323 (14%)
Query: 43  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 101
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 102 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 159
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 160 CHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            H D+KP+N+L                     +NP    +K+ DFGSA      E + + 
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTL 194
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-- 256
           + +R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG  
Sbjct: 195 VSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 257 -------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 303
                  T  R+       ++ E      +     KP     + Q        DL+ +  
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 304 QYSPNLRCTALEACVHPFFDELR 326
           +Y P  R T  EA  HPFFD L+
Sbjct: 314 EYDPAKRITLREALKHPFFDLLK 336

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK---NRELQIMQMLDHPNIVALKHCF 98
           V+G G++G+V+  +       +AIK++  +D RY    + E+ + + L H NIV     +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 84
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             +  +              +++ + R+ +  +      I    YT QI   L Y+H+  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN- 141
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIF-GATE 215
            I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y  A DIWS GC + E+  G+P F                        +   P    FK 
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKV 238
Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 239 GMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 98
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 70
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
             +  +              +++ + R+ +  +      I    YT QI   L Y+H+  
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN- 127
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIF-GATE 215
            I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y  A DIWS GC + E+  G+P F                        +   P    FK 
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKV 224
Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 225 GMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 133/305 (43%), Gaps = 60/305 (19%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF     A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 149 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNY 270
            +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                
Sbjct: 207 KSACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL---------------- 247
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDE 324
            E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ 
Sbjct: 248 -EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
Query: 325 LRDPN 329
           +   N
Sbjct: 295 VTWEN 299

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/322 (24%), Positives = 134/322 (41%), Gaps = 46/322 (14%)
Query: 44  VGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 102
           +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F    
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 103 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGIC 160
                            +     ++ + +  +P  L +++   YQIC+++ ++H+   + 
Sbjct: 82  MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KLT 140
Query: 161 HRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           H D+KP+N+L                     +NP    +K+ DFGSA      E + + +
Sbjct: 141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHHSTLV 195
Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--- 256
             R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG   
Sbjct: 196 XXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP 254
Query: 257 ------TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 304
                 T  R+       ++ E      +     KP     + Q        DL+ +  +
Sbjct: 255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314
Query: 305 YSPNLRCTALEACVHPFFDELR 326
           Y P  R T  EA  HPFFD L+
Sbjct: 315 YDPAKRITLREALKHPFFDLLK 336

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 92
           +I +  +G+G+FG V   + R +G    IK + +D+          E+++++ LDHPNI+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            +   F    D                + RI    +R  + +   YV     Q+  ALAY
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAY 139
Query: 153 IHNCIGICHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
            H+   + H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+
Sbjct: 140 FHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
                + T   DIWS G VM  LL G   F G S    L E+        +++     PN
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPN 243
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           Y      + +P          L P+AVDL+ +     P  R +A +   H +F +
Sbjct: 244 YA----VECRP----------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 133/307 (43%), Gaps = 64/307 (20%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 42  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 100
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 101 --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRAPELIFG 212
             GI HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+  
Sbjct: 154 K-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-- 209
Query: 213 ATEYTT--AIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNP 268
            TE +   + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+              
Sbjct: 210 -TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL-------------- 252
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFF 322
              E+ FP                P+A DLV +      +  L C  +E       HPFF
Sbjct: 253 ---EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 297
Query: 323 DELRDPN 329
           + +   N
Sbjct: 298 ESVTWEN 304

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G G+ GVVF+   + +G ++A       IK  ++++    RELQ++   + P IV    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F+S  +               +++++ +   RI +++    +   +  + + L Y+   
Sbjct: 134 AFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 185
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y
Sbjct: 186 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 242
Query: 217 TTAIDIWSTGCVMAELLLGQ 236
           +   DIWS G  + E+ +G+
Sbjct: 243 SVQSDIWSMGLSLVEMAVGR 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 219 AIDIWSTGCVMAELLLGQ-PLFPGESGVDQ 247
             DIWS G  + E+ +G+ P+ P ++  D 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 101 YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 152
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 153 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 209
Query: 219 AIDIWSTGCVMAELLLGQ 236
             DIWS G  + E+ +G+
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 16/214 (7%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 93  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 144
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 145 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 201
Query: 219 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             DIWS G  + E+ +G+      SG   + E++
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 219 AIDIWSTGCVMAELLLGQ 236
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 219 AIDIWSTGCVMAELLLGQ 236
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 187
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFP 230
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++ + R T  E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 48/284 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 95
            +G GSFG V   +  +T ++ A+K     K ++    +N  +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 151
           + F    D                V+ +     R H +  + +    VKL+  ++  AL 
Sbjct: 82  YSFQDEED------------MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           Y+ N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+  
Sbjct: 130 YLQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 212 G--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TRE 261
                 Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQE 246
Query: 262 EI----KCMNPN----YTEFK----FPQIKPHPWHKVFQKRLPP 293
            +    K + PN    +++      FP +    W  VFQKRL P
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 219 AIDIWSTGCVMAELLLGQ 236
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T Y+ 
Sbjct: 126 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYSV 182
Query: 219 AIDIWSTGCVMAELLLGQ 236
             DIWS G  + E+ +G+
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ + +  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F  +T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDST----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  D    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 98
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 80
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 156
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 157 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 141 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 198
Query: 215 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 274 KFPQIKPHPWH 284
           KF  + P P H
Sbjct: 255 KFSSVLPTPNH 265

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 115/251 (45%), Gaps = 17/251 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 98
           +GTG FG V +   ++TGE VAIK+  Q+   KNRE     +QIM+ L+HPN+V+ +   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 81
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 156
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 157 IGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
             I HRD+KP+N+++ P   +L  K+ D G AK L +GE    ++ +  Y APEL+    
Sbjct: 142 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 199
Query: 215 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 255
Query: 274 KFPQIKPHPWH 284
           KF  + P P H
Sbjct: 256 KFSSVLPTPNH 266

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 43  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 93
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 151
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 210
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 258
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 99
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 100 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 118 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 170
Query: 160 CHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYT 217
            H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    Y 
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 277
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 231 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 276
Query: 278 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 335
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 277 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 323
Query: 336 R-----------------PLPPL 341
           R                 PLPPL
Sbjct: 324 RYTKIRDSIKTKYDAWPEPLPPL 346

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 116/281 (41%), Gaps = 39/281 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFST 101
           +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V     +F  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 102 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 161
           TD                +    RN +     +  I          + L Y+H    I H
Sbjct: 97  TDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATIL-----QSTLKGLEYLHFMRKI-H 148
Query: 162 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEYTTAI 220
           RDIK  N+L+N   H  KL DFG A  L       + +    ++ APE+I     Y    
Sbjct: 149 RDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEIGYNCVA 206
Query: 221 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 280
           DIWS G    E+  G+P +        +  +  +   PT       NP  T F+    KP
Sbjct: 207 DIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT-------NPPPT-FR----KP 248
Query: 281 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
             W   F         D V +    SP  R TA +   HPF
Sbjct: 249 ELWSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 99
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 100 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 224 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 276
Query: 160 CHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA-TEYT 217
            H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    Y 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 277
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 337 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 382
Query: 278 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 335
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 383 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
Query: 336 R-----------------PLPPL 341
           R                 PLPPL
Sbjct: 430 RYTKIRDSIKTKYDAWPEPLPPL 452

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 209
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 43  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 93
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 151
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 210
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 258
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 137/310 (44%), Gaps = 51/310 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G+G++G V   + + T    AIK + +     +       E+ ++++LDHPNI+ L + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL-YD 103
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHN 155
           FF   DK                + I      IH RM    +   +   Q+   + Y+H 
Sbjct: 104 FFE--DKRNYYLVMECYKGGELFDEI------IH-RMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 156 CIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 213
              I HRD+KP+NLL+        +K+ DFG + V    +     + + YY APE++   
Sbjct: 155 H-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--R 211
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
            +Y    D+WS G ++  LL G P F G++  DQ  EI++          K     YT F
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----------KVEKGKYT-F 256
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
             P+     W     K +   A DL+ +  Q+    R +A +A  HP+  E+    ++  
Sbjct: 257 DSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM---CSKKE 303
Query: 334 NGRPLPPLFN 343
           +G  LP L N
Sbjct: 304 SGIELPSLAN 313

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 43  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 93
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 151
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 92  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 210
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 142 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 258
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 200 -NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 120/287 (41%), Gaps = 45/287 (15%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 96
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 72  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 157 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 124 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 180
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K                  +F 
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILK-------------RVEKGKFS 223
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 224 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 93  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 144
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 145 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 200
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 243
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 244 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 121/287 (42%), Gaps = 45/287 (15%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 96
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 89  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 157 IGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
             I HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE++    
Sbjct: 141 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 197
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K +                +F 
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV-------------EKGKFS 240
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 241 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 75  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 126
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 127 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 182
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 225
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 226 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 37  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 89
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 131
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 182
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 208
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 183 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 240
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 241 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 284
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 285 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333
Query: 329 NTRLP 333
            + +P
Sbjct: 334 ASIVP 338

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 131
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 132 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 187
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 230
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 231 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 98
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 77  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 128
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
           I HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T Y+ 
Sbjct: 129 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYSV 185
Query: 219 AIDIWSTGCVMAELLLGQ 236
             DIWS G  + E+ +G+
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM-H 186
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 188
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 37  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 89
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 81
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 132
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 208
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 133 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 190
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 191 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 234
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 235 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 283
Query: 329 NTRLP 333
            + +P
Sbjct: 284 ASIVP 288

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 37  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 89
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 86
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 137
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 208
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 138 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 195
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 196 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 239
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 240 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 288
Query: 329 NTRLP 333
            + +P
Sbjct: 289 ASIVP 293

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 37  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 89
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 77
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 128
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 208
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 129 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 186
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 187 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 230
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 231 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
Query: 329 NTRLP 333
            + +P
Sbjct: 280 ASIVP 284

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 37  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 89
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 88
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 139
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 208
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 140 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 197
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 198 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 241
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 242 NLP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 290
Query: 329 NTRLP 333
            + +P
Sbjct: 291 ASIVP 295

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 128/305 (41%), Gaps = 48/305 (15%)
Query: 37  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 89
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 208
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 259
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPE 208
           L+ +H   G+ HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APE
Sbjct: 260 LSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE 317
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           LI     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  
Sbjct: 318 LI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRD 361
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           N      P++K    HKV      P     + R     P  R TA E   HPF  +   P
Sbjct: 362 NLP----PRLK--NLHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410
Query: 329 NTRLP 333
            + +P
Sbjct: 411 ASIVP 415

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 184
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 154 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 209
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 252
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 253 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 93
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
               F    +                ++R+ +++ +  + +P   V  Y  Q+C AL ++
Sbjct: 97  YYASFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFG 212
           H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE I  
Sbjct: 153 HS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 209
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
              Y    DIWS GC++ E+   Q  F G+
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 130/314 (41%), Gaps = 51/314 (16%)
Query: 24  TIGGRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIK----KVL 70
           ++   NG S       AE +         +GTG+F  V  A+ + TG++ A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 71  QDKRYK-NRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSR 129
           + K      E+ +++ + H NIVAL+  + S                   +  + + +  
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYT 118
Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL--CDFGSAK 187
                 LI       Q+  A+ Y+H  +GI HRD+KP+NLL      + K+   DFG +K
Sbjct: 119 EKDASTLIR------QVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 247
           +  KG+   +   +  Y APE +     Y+ A+D WS G +   LL G P F  E+    
Sbjct: 172 MEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 307
             +I+K                  E++F    P+ W  +        A D +    +  P
Sbjct: 231 FEQILK-----------------AEYEFDS--PY-WDDI-----SDSAKDFIRNLMEKDP 265
Query: 308 NLRCTALEACVHPF 321
           N R T  +A  HP+
Sbjct: 266 NKRYTCEQAARHPW 279

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 128 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM-H 183
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 226
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 227 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 120/291 (41%), Gaps = 42/291 (14%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 92
           Y    V+GTG+F  V  A+ + T ++VAI    KK L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 153 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------------- 232
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            E++F    P+ W  +        A D +    +  P  R T  +A  HP+
Sbjct: 233 AEYEFDS--PY-WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX-H 188
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM-H 184
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 227
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 97
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 214
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 266
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 267 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 185
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 154
           C+                         A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 122 CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 171
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 215 E--YTTAIDIWSTGCVMAELLLGQP 237
           E  Y   +D+WS G    EL   +P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 73  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 124
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 125 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 180
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 223
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 224 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM-H 186
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 137/339 (40%), Gaps = 76/339 (22%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 87
           Y  +  +G GS+GVV  A   +T  I AIK + ++K          R K  E+++M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 88  HPNIVALKHCF--------------------------FSTTDKXXXXXXXXXXXXXXTVN 121
           HPNI  L   +                            +T K                N
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 122 RIARNYSRIHQRMPLIYV---KLYT---YQICRALAYIHNCIGICHRDIKPQNLLVNPH- 174
             A N S    R  L +V   KL +    QI  AL Y+HN  GICHRDIKP+N L + + 
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNK 205
Query: 175 THQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELIFGATE-YTTAIDIWSTGCV 228
           + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D WS G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 229 MAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ 288
           +  LL+G   FPG +  D + +++        +++   NPNY                  
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN----------------- 301
Query: 289 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
             L P A DL+      + + R  A+ A  HP+  +  D
Sbjct: 302 -VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM-H 186
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 62/292 (21%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNVSYICSRYYRAPEL 209
             + HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  PE+
Sbjct: 129 -RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLPPEM 178
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           I G   +   +D+WS G +  E L+G+P F   +  +    I +V               
Sbjct: 179 IEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------- 222
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
             EF FP              +   A DL+ R  +++P+ R    E   HP+
Sbjct: 223 --EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 29  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQ 84
           +G+++  +S  +  E  +G G+  +V++ K + T +  A+K  K   DK+    E+ ++ 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L HPNI+ LK  F + T+                 +RI        +R     VK    
Sbjct: 104 RLSHPNIIKLKEIFETPTE---ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK---- 155
Query: 145 QICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNVSYICSR 202
           QI  A+AY+H   GI HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C  
Sbjct: 156 QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCGT 213
Query: 203 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
             Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          R 
Sbjct: 214 PGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FRR 262
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            + C      E+ F      PW       +   A DLV +     P  R T  +A  HP+
Sbjct: 263 ILNC------EYYFIS----PWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHN 155
           C+                         A +   +H++ +  + +   T+   + LAY+H+
Sbjct: 83  CYLREHTAWLVMEYCLGS---------ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    E
Sbjct: 134 H-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMDE 188
Query: 216 --YTTAIDIWSTGCVMAELLLGQP 237
             Y   +D+WS G    EL   +P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP 212

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALK 95
            +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F    D                 + +     R  QR P    K Y  ++C AL Y+H+
Sbjct: 73  GTF---QDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSR-YYRAPELIFGA 213
              I +RD+KP+N+L++ + H +K+ DFG AK +    P+V+Y +C    Y APE++   
Sbjct: 125 K-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV-ST 177
Query: 214 TEYTTAIDIWSTGCVMAELLLG 235
             Y  +ID WS G ++ E+L G
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAG 199

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 131 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 186
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 229
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G   +
Sbjct: 130 -RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 185
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 228
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 180 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 234
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 151
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 23  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 82
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 83  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 134
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 135 AQIVLTFEYLH-SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 189
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 190 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 112/266 (42%), Gaps = 30/266 (11%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 92
           Y    V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 153 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMN 267
                Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I    
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 268 PNY----------TEFKFPQIKPHPW 283
            ++            F   Q   HPW
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 57  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 116
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 168
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 169 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGATWT--LCGTP 223
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 97
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 214
            + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I       
Sbjct: 130 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+   DIWS G  M EL + +  FP +S            GTP ++             
Sbjct: 189 GYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ------------- 222
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 112/266 (42%), Gaps = 30/266 (11%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 92
           Y    V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 153 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMN 267
                Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I    
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 268 PNY----------TEFKFPQIKPHPW 283
            ++            F   Q   HPW
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 112/266 (42%), Gaps = 30/266 (11%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYK-NRELQIMQMLDHPNIV 92
           Y    V+GTG+F  V  A+ + T ++VAI    K+ L+ K      E+ ++  + HPNIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           AL   + S                   +        R   R+         +Q+  A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKY 131
Query: 153 IHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           +H+ +GI HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMN 267
                Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I    
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 268 PNY----------TEFKFPQIKPHPW 283
            ++            F   Q   HPW
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 43  VVGTGSFGVVFQAKCR---ETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVA 93
           V+G GSFG VF  +     ++G + A+K +      ++D+     E  I+  ++HP +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 151
           L H  F T  K                 R    ++R+ + +      VK Y  ++   L 
Sbjct: 95  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELI 210
           ++H+ +GI +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 145 HLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 258
                ++ + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 203 -NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKG 214
Query: 216 YTTAIDIWSTGCVMAELLLGQPLF 239
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
            + + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKG 214
Query: 216 YTTAIDIWSTGCVMAELLLGQPLF 239
           Y  A+D W+ G ++ E+  G P F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM-H 188
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/335 (23%), Positives = 137/335 (40%), Gaps = 48/335 (14%)
Query: 43  VVGTGSFGVVFQ-AKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHC- 97
            +G G+FG V Q    R  G  VA+K +   ++YK     E+ +++ ++  +      C 
Sbjct: 40  TLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCV 99
Query: 98  -FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
             F   D               T + +  N    +   P+  V+   +Q+C+A+ ++H+ 
Sbjct: 100 QMFDWFDYHGHMCISFELLGLSTFDFLKDNN---YLPYPIHQVRHMAFQLCQAVKFLHDN 156
Query: 157 IGICHRDIKPQNLLVNPHTHQL------------------KLCDFGSAKVLVKGEPNVSY 198
             + H D+KP+N+L     ++L                  ++ DFGSA      E + + 
Sbjct: 157 -KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHEHHSTI 213
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-T 257
           + +R+YRAPE+I     ++   D+WS GC++ E  +G  LF      + L  + ++LG  
Sbjct: 214 VSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 272
Query: 258 PTREEIKCMNPNY--------------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 303
           P+R   K     Y                +     KP   +   +     +  DL+    
Sbjct: 273 PSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESML 332
Query: 304 QYSPNLRCTALEACVHPFFDELRD--PNTRLPNGR 336
           +Y P  R T  EA  HPFF  LR   PN    + R
Sbjct: 333 EYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 27  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 77
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 78  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 137
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE   +
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRT 169
Query: 198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 39/284 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQ----IMQMLDHPNIVALKHC 97
           +G G++G V +   + +G+I+A+K++    D++ + + L     +M+  D P IV     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   D               + ++  +  YS +   +P   +   T    +AL ++   
Sbjct: 90  LFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 215
           + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +   
Sbjct: 145 LKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 216 --YTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTP---TREEIKCMNPN 269
             Y    D+WS G  + EL  G+  +P  + V DQL +++K  G P   +  E +  +P+
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSNSEEREFSPS 261
Query: 270 YTEF-------------KFPQIKPHPWHKVFQKRLPPEAVDLVC 300
           +  F             K+ ++  HP+  ++++R    AV++ C
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYEER----AVEVAC 301

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 144
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 145 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 199
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 48/285 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G   +
Sbjct: 133 -RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM-H 188
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
              +D+WS G +  E L+G+P F   +  +    I +V                 EF FP
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP 231
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                         +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 DF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R ++  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FAEPHAR-------FYA 147
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 27  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 77
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 78  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 137
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
             +    QI  A+ Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE    
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRD 169
Query: 198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
              S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 59/301 (19%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-RYKN------------- 77
           SY     +G+G++G V    C+E        I  IKK   DK RY +             
Sbjct: 37  SYFKVRKLGSGAYGEVLL--CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 78  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 137
            E+ +++ LDHPNI+ L   F    DK                 +I  N  +  +     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF---EDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAAN 150
Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPN 195
            +K    QI   + Y+H    I HRDIKP+N+L+      L  K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 196 VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
              + + YY APE++    +Y    D+WS G +M  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 315
                         Y +F       + W     K +  EA +L+     Y  N RCTA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 316 A 316
           A
Sbjct: 299 A 299

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ ++  G P F
Sbjct: 214 GYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 151
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 152 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 206
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 96
            +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F +                          + +   +  L     Y  +I   L ++H+ 
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATE 215
            GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +
Sbjct: 138 -GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QK 194
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP Y  +  
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFYPRW-- 240
Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDEL 325
                          L  EA DL+ + F   P  R     +   HP F E+
Sbjct: 241 ---------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 57  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 116
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 168
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 169 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 223
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 113/245 (46%), Gaps = 41/245 (16%)
Query: 14  GAETGHVIRTTIGGRNGNSK-QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 72
           G +TG++   TIGG+   ++   +  + E  +G+G+ G V++ + R+TG ++A+K++   
Sbjct: 7   GKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM--- 58
Query: 73  KRYKNRELQ---------IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRI 123
           +R  N+E           +++  D P IV     F + TD                +  +
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD------------VFIAMELM 106
Query: 124 ARNYSRIHQRM----PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 179
                ++ +RM    P   +   T  I +AL Y+    G+ HRD+KP N+L++    Q+K
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIK 165
Query: 180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG 235
           LCDFG +  LV  +          Y APE I        +Y    D+WS G  + EL  G
Sbjct: 166 LCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 236 QPLFP 240
           Q  FP
Sbjct: 226 Q--FP 228

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 38  YIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPN 90
           Y+A  + +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N
Sbjct: 46  YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V +   +    +                V          H RM    +      + RAL
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIATVCLSVLRAL 154
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPEL 209
           +Y+HN  G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+
Sbjct: 155 SYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEV 212
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQP 237
           I     Y T +DIWS G ++ E++ G+P
Sbjct: 213 I-SRLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 147
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 147
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 31  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 90
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 91  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 142
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 143 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 197
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 198 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 40/299 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLDHPNIVALKHCFF 99
           +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF- 117
Query: 100 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
              DK                +RIA    ++ +   + Y++    Q C  L ++H    I
Sbjct: 118 --EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHEH-SI 170
Query: 160 CHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
            H DIKP+N++        +K+ DFG A  L   E       +  + APE++        
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGF 229
Query: 219 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 278
             D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  F  +
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAFSSV 277
Query: 279 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD-ELRDPNTRLPNGR 336
            P             EA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R
Sbjct: 278 SP-------------EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +   H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYA 147
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H+ + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IM 83
           N+ Q   +     +GTGSFG V   K +E+G   A+K + + K  K ++++       I+
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95
Query: 84  QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYT 143
           Q ++ P +V L+  F   ++                + RI R +S  H R        Y 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYA 147
Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR- 202
            QI     Y+H  + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            Y AP +I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 EYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH 88
           +Y  +  +G G+F  V  A+   TG  VA+K +  DK   N        RE++IM++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 89  PNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           PNIV L    F   +                V     +Y   H RM     +    QI  
Sbjct: 74  PNIVKL----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVS 125
Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           A+ Y H    I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APE
Sbjct: 126 AVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           L  G       +D+WS G ++  L+ G   F G++
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 90
           YI    +G GSFG V  A   +T + VA+K + +    K+       RE+  +++L HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ L     + TD                V +         +RM     + +  QI  A+
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---------KRMTEDEGRRFFQQIICAI 121
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            Y H    I HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
            G       +D+WS G V+  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQML-DHPNIVAL 94
           V+G GSFG V  A+ +ETG++ A+K + +D   ++ +++       I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             C F T D+                 + +R +     R        Y  +I  AL ++H
Sbjct: 90  -FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-------FYAAEIISALMFLH 141
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFGA 213
           +  GI +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I   
Sbjct: 142 D-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQE 198
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             Y  A+D W+ G ++ E+L G   F  E+  D L E I
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 176
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 150 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 177 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 209 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 265
Query: 234 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 280
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 266 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 325
Query: 281 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF
Sbjct: 326 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 176
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 177 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 233
Query: 234 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 280
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 281 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 41/289 (14%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHC 97
            ++G G FG V + +   TG  +A K +    ++DK     E+ +M  LDH N++ L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F S  D                 +RI      + +   ++++K    QIC  + ++H   
Sbjct: 155 FESKND---IVLVMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMHQMY 207
Query: 158 GICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI-FGATE 215
            I H D+KP+N+L VN    Q+K+ DFG A+     E       +  + APE++ +    
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           + T  D+WS G +   LL G   F G++  + L  I+        EE             
Sbjct: 267 FPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE------------- 311
Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                      FQ  +  EA + + +      + R +A EA  HP+  +
Sbjct: 312 -----------FQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 89
           YI    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           +I+ L     + +D                + +  R   +  +R+          QI   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQQILSG 128
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           + Y H  + + HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y APE+
Sbjct: 129 VDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNYAAPEV 186
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLG 235
           I G       +DIWS+G ++  LL G
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------NPHTH------ 176
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 177 ---QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E  
Sbjct: 186 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 242
Query: 234 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKP 280
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 243 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 302
Query: 281 HPWHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            P    + Q  L   +  DL+ R  ++ P  R T  EA +HPFF
Sbjct: 303 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 43  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 91
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 147
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRA 206
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 43  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 91
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 147
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRA 206
            AL ++H   GI +RD+KP+N+++N H   +KL DFG  K  +         C    Y A
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMA 189
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
           PE++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 190 PEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C    Y APE+I  + 
Sbjct: 160 SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SK 214
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
            + + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-SK 213
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLF 239
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 97
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           +    +                V+++  N  +I               + +ALAY+H   
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---------ATVCEAVLQALAYLH-AQ 160
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEY 216
           G+ HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
            T +DIWS G ++ E++ G+P +  +S V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
           ++K    HKV      P   D + R     P  R TA E   HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 34/285 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 102
           ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H F +  
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 103 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 162
                                   + +   +  L     Y  +I   L ++H+  GI +R
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVYR 143
Query: 163 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGATEYTTAID 221
           D+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G  +Y  ++D
Sbjct: 144 DLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVD 201
Query: 222 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 281
            WS G ++ E+L+GQ  F G+   +                I+  NP Y  +        
Sbjct: 202 WWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPFYPRW-------- 241
Query: 282 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDEL 325
                    L  EA DL+ + F   P  R     +   HP F E+
Sbjct: 242 ---------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 277

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 96
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 123 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGES 243
              +D+WS G ++  +L  +  F  ES
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 96
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 126
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 127 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGES 243
              +D+WS G ++  +L  +  F  ES
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 96
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 132
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 133 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGES 243
              +D+WS G ++  +L  +  F  ES
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 126/320 (39%), Gaps = 60/320 (18%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 90
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 145
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 204
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE   +   +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKTLCGTPNY 208
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 325 LRDPNTRLPNG-RPLPPLFN 343
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 96
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 131
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             I HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+I G    
Sbjct: 132 -KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGES 243
              +D+WS G ++  +L  +  F  ES
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 112/251 (44%), Gaps = 28/251 (11%)
Query: 19  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 78
             + T   G+  +S     +    V+G GS+  V   + ++T  I A+K V ++    + 
Sbjct: 3   EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE 62
Query: 79  ELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI 130
           ++  +Q          +HP +V L  CF + +                 + R        
Sbjct: 63  DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-------- 114
Query: 131 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 190
            +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K  +
Sbjct: 115 QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGL 172
Query: 191 KGEPNVSYICSR-YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF--------PG 241
           +     S  C    Y APE++ G  +Y  ++D W+ G +M E++ G+  F        P 
Sbjct: 173 RPGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 231
Query: 242 ESGVDQLVEII 252
           ++  D L ++I
Sbjct: 232 QNTEDYLFQVI 242

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 116/254 (45%), Gaps = 28/254 (11%)
Query: 16  ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 75
           E    + T   G+  +S     +    V+G GS+  V   + ++T  I A++ V ++   
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN 91
Query: 76  KNRELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNY 127
            + ++  +Q          +HP +V L  CF + +                 + R     
Sbjct: 92  DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----- 146
Query: 128 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 187
               +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L++   H +KL D+G  K
Sbjct: 147 ---QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCK 201
Query: 188 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF------- 239
             ++ G+   ++  +  Y APE++ G  +Y  ++D W+ G +M E++ G+  F       
Sbjct: 202 EGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
Query: 240 -PGESGVDQLVEII 252
            P ++  D L ++I
Sbjct: 261 NPDQNTEDYLFQVI 274

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 60/320 (18%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 90
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 145
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 204
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 208
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           C+   Y      +IK + +     + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 325 LRDPNTRLPNG-RPLPPLFN 343
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 94
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 127
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 213
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 128 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 252
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 186 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 94
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 123
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGA 213
              GI +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G 
Sbjct: 124 ER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 252
            +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 182 -DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 60/320 (18%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 90
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 145
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 88  VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 204
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 135 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 192
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 193 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 229
Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           C+   Y      +IK + +     + + P A  L+ R     P LR +  E     FF  
Sbjct: 230 CLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282
Query: 325 LRDPNTRLPNG-RPLPPLFN 343
              P  RLP     +PP F+
Sbjct: 283 GYAP-MRLPTSCLTVPPRFS 301

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 125/320 (39%), Gaps = 60/320 (18%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 90
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 145
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYY 204
             + + Y+HN   + HRD+K  NL +N     +K+ DFG A K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKXLCGTPNY 208
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            APE +     ++  +DIWS GC++  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           C+   Y   K  +           + + P A  L+ R     P LR +  E     FF  
Sbjct: 246 CLKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 325 LRDPNTRLPNG-RPLPPLFN 343
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 76
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 77  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 130 K-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 78
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 79  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G     +  S  Y APEL  G   
Sbjct: 132 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKN--RELQIMQMLDHPNIV 92
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           AL+        K               +NR+        +R+P   +  +  QI R + Y
Sbjct: 70  ALRGVCL----KEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNY 120
Query: 153 IHN--CIGICHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 203
           +H+   + I HRD+K  N+L+       +     LK+ DFG A+   +    +S   +  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYA 179
Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
           + APE+I  A+ ++   D+WS G ++ ELL G+  F G  G+
Sbjct: 180 WMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDKRYKNRELQIMQMLDHPN 90
           Y+    +G G FG+V   +C ET        + V +K    D+    +E+ I+ +  H N
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRN 62
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ L   F S  +                  RI  +   +++R  + YV    +Q+C AL
Sbjct: 63  ILHLHESFESMEE---LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 151 AYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
            ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           +      +TA D+WS G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           YT   F +       + F K +  EA+D V R        R TA EA  HP+  +
Sbjct: 220 YT---FDE-------EAF-KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 93
           V+G GSFG V  A+  +  E+    KVLQ K    K  E  IM       + + HP +V 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAY 152
           L H  F T DK               +N     Y    +R  L    + Y  +I  AL Y
Sbjct: 104 L-HFSFQTADKLYFVLDY--------INGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIF 211
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE + 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLF 239
               Y   +D W  G V+ E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSL------RDYLQAHAERIDHIKLLQYTSQICKGMEY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 25  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 136
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 137 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 191
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 192 APESL-TESKFSVASDVWSFGVVLYELF 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 49  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 161 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 215
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 216 APESL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 126/321 (39%), Gaps = 60/321 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 151
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 210
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 331 RLP-NGRPLPPLFNFKPPELS 350
           RLP     +PP F+  P  L 
Sbjct: 279 RLPITCLTIPPXFSIAPSSLD 299

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWY 184
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 22  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 133
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 134 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 188
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 189 APESL-TESKFSVASDVWSFGVVLYELF 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 23  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 134
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 135 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 189
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 190 APESL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 24  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 135
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 136 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 190
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 191 APESL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 80  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G   
Sbjct: 133 K-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
           V+G GSFG V  A  + T E+ AIK + +D   ++ +++       ++ +LD P  +   
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 153
           H  F T D+               VN     Y  I Q  +        Y  +I   L ++
Sbjct: 86  HSCFQTVDRLYFVMEY--------VNGGDLMY-HIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNVSYICSRYYRAPELIFG 212
           H   GI +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I  
Sbjct: 137 HKR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-A 193
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
              Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 16  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 127
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 128 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 182
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 183 APESL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 39  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 93
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 152
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 153 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 200
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 201 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 313
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 314 LEACVHPFF 322
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 17  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 128
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 129 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 183
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 184 APESL-TESKFSVASDVWSFGVVLYELF 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 130 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 184
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 185 APESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 141/309 (45%), Gaps = 56/309 (18%)
Query: 39  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 93
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 152
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 153 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 200
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 201 -----SRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
                +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 313
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 314 LEACVHPFF 322
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 148 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 202
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 203 APESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 126/321 (39%), Gaps = 60/321 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 151
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 210
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 188
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 226
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 227 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 278
Query: 331 RLP-NGRPLPPLFNFKPPELS 350
           RLP     +PP F+  P  L 
Sbjct: 279 RLPITCLTIPPRFSIAPSSLD 299

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 77  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 128
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 129 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 186
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 229
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 230 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 126/321 (39%), Gaps = 60/321 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 151
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 88  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 210
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +
Sbjct: 136 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-V 192
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 193 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 230
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 231 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 282
Query: 331 RLP-NGRPLPPLFNFKPPELS 350
           RLP     +PP F+  P  L 
Sbjct: 283 RLPITCLTIPPRFSIAPSSLD 303

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGS------LREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 133 LGTKRYI-HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWY 187
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 188 APESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 218 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 269
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 270 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 327
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 370
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 371 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 75  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 126
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 127 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 184
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 227
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 228 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 95
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 71
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
              F   +                V     +Y   H  M     +    QI  A+ Y H 
Sbjct: 72  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y APEL  G   
Sbjct: 125 KF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGES 243
               +D+WS G ++  L+ G   F G++
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 76  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 127
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 128 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 228
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 52/293 (17%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 215 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 266
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    
Sbjct: 267 EKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDN 324
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---------- 367
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 368 ------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 16/222 (7%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V  +  F    +                  RI      + Q   ++    +  QIC AL 
Sbjct: 86  VQYRESF---EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLALK 139
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELI 210
           ++H+   I HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE I
Sbjct: 140 HVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPE-I 196
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
                Y    DIW+ GCV+ EL   +  F   S  + +++II
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 40/285 (14%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 100
           +G+G+FGV    + + T E+VA+K + +         RE+   + L HPNIV  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T                 +    R +S    R        +  Q+   ++Y H+ + IC
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGR-FSEDEAR-------FFFQQLLSGVSYCHS-MQIC 138
Query: 161 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 219
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGK 197
Query: 220 I-DIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 277
           I D+WS G  +  +L+G  P    E   D    I ++L                ++  P 
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSIPD 243
Query: 278 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                       R+ PE   L+ R F   P  R +  E   H +F
Sbjct: 244 ----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 97
           +G G++GVV + +   +G+I A+K++      Q+++    +L I  + +D P  V     
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI---FGAT 214
            + HRD+KP N+L+N    Q+K CDFG +  LV           + Y APE I       
Sbjct: 157 SVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQK 215
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y+   DIWS G    EL + +  FP +S            GTP ++             
Sbjct: 216 GYSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ------------- 249
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
             Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 250 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 29/226 (12%)
Query: 43  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 90
           V+GTG++G VF   +    +TG++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICR 148
           +V L + F + T                 +N     ++ + QR       V++Y  +I  
Sbjct: 121 LVTLHYAFQTET---------KLHLILDYING-GELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRA 206
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 207 PELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 251
           P+++ G  + +  A+D WS G +M ELL G   F  +   +   EI
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 125/321 (38%), Gaps = 60/321 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 151
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 108 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 210
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 156 YLHRN-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 212
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 250
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 251 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 302
Query: 331 RLP-NGRPLPPLFNFKPPELS 350
           RLP     +PP F+  P  L 
Sbjct: 303 RLPITCLTIPPRFSIAPSSLD 323

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 125/321 (38%), Gaps = 60/321 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 151
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 106 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 210
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 154 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 210
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 211 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 248
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 249 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 300
Query: 331 RLP-NGRPLPPLFNFKPPELS 350
           RLP     +PP F+  P  L 
Sbjct: 301 RLPITCLTIPPRFSIAPSSLD 321

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 90/346 (26%), Positives = 131/346 (37%), Gaps = 65/346 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 93
           V+G G+F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 208
           H+   I HRD+KP+N+L+    +   +KL DFG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE---- 324
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E    
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKERDRY 296
Query: 325 ------------LRDPNTRLP-NGRPLPPLFNFKPPELSGIPPETI 357
                       LR  N R    G  L  + + K     G PPE +
Sbjct: 297 AYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEEL 342

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 100
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 161 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 219
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 220 IDIWSTGCVMAELLLG 235
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ +++  IVA+K + + +  K        RE++I   L HPNI+ L +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F+   D+                  + ++ +   QR   I  +L       AL Y H  
Sbjct: 91  YFY---DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-----ADALMYCHGK 142
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G   +
Sbjct: 143 -KVIHRDIKPENLLLGLKG-ELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRM-H 198
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-----LGTPTREE---IKCMNP 268
              +D+W  G +  ELL+G P F   S  +    I+KV        PT  +    K +  
Sbjct: 199 NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRH 258
Query: 269 NYTE-FKFPQIKPHPWHKVFQKR-LPPEAVDLVC 300
           N +E     Q+  HPW +   +R LPP A+  V 
Sbjct: 259 NPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 44  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G+F VV +     A      +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 140
Query: 158 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 213
           G+ HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 198
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 241
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+
Sbjct: 242 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 136
Query: 161 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 219
           HRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++         
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 196
Query: 220 IDIWSTGCVMAELLLG 235
            D+WS G  +  +L+G
Sbjct: 197 ADVWSCGVTLYVMLVG 212

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 89
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 130 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 180
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
           L  IH  +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 181 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 237
Query: 207 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 44  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 93
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 19  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 152
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 130
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYR 205
           +     I HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ 
Sbjct: 131 LGTKRYI-HRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWY 185
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL 233
           APE +   ++++ A D+WS G V+ EL 
Sbjct: 186 APESL-TESKFSVASDVWSFGVVLYELF 212

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 23/228 (10%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 89
            Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            +V L   F +  D                VN ++ NY      +P  + K YT ++  A
Sbjct: 136 WVVQL---FCAFQDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVLA 186
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS-AKVLVKGEPNV-SYICSRYYRAP 207
           L  IH+ +G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + +  Y +P
Sbjct: 187 LDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISP 244
Query: 208 ELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
           E++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 89
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 207 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 78  RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 136
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 137 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 193
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 194 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
              S   +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 309 LRCTALEACVHPFFDE 324
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 89
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
           L  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K E  V   + + +  Y +
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 242
Query: 207 PELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
           PE++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLD-HPNIVALKHC 97
           V+  G F  V++A+   +G   A+K++L ++  KNR    E+  M+ L  HPNIV     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL---IYVKLYTYQICRALAYIH 154
                ++                 ++     ++  R PL     +K++ YQ CRA+ ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAVQHMH 153
Query: 155 NCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----------- 202
                I HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R           
Sbjct: 154 RQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEEITRN 211
Query: 203 ---YYRAPELIFGATEYTTA--IDIWSTGCVMAELLLGQPLF 239
               YR PE+I   + +      DIW+ GC++  L   Q  F
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 124/317 (39%), Gaps = 60/317 (18%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 96
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 151
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 82  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSYICSRYYRAPELI 210
           Y+H    + HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +
Sbjct: 130 YLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-V 186
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                ++  +D+WS GC+M  LL+G+P F                      E  C+   Y
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETY 224
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                 +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  
Sbjct: 225 L-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-A 276
Query: 331 RLP-NGRPLPPLFNFKP 346
           RLP     +PP F+  P
Sbjct: 277 RLPITCLTIPPRFSIAP 293

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 95
           ++G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F    +                +NR  +N  +          + + +QI   + Y+H+
Sbjct: 78  NYF----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLHS 130
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGAT 214
             GI HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   +
Sbjct: 131 H-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRS 187
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            +    D+WS GC+   LL+G+P F  ++  + L +++                   +++
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LADYE 230
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 331
            P              L  EA DL+ +  + +P  R +      HPF    R+ +T+
Sbjct: 231 MPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS--RNSSTK 273

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFF-- 99
            ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH NIV    C+   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 100 ----------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
                     S+  K              T+ +      R  +   ++ ++L+  QI + 
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFE-QITKG 134
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE 
Sbjct: 135 VDYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQ 192
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I  + +Y   +D+++ G ++AELL
Sbjct: 193 I-SSQDYGKEVDLYALGLILAELL 215

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 68
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 69  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 219
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 220 KEKKTYLNPWKKI 232

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 140/313 (44%), Gaps = 60/313 (19%)
Query: 39  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 93
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 152
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 153 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 200
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+ +     
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 201 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 310 RCTALEACVHPFF 322
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 14  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 153
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 72  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 154 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 176
Query: 212 GATEYTTAIDIWSTGCVMAELL 233
             + Y+   D++S G ++ E++
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVI 198

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 96
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 157 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
            G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 211 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
                Y    DIWS G ++  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
               KF  +    W+ V +      A DLV +     P+ R TA +   HP+  +
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 153
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 71  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 154 HNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 175
Query: 212 GATEYTTAIDIWSTGCVMAELL 233
             + Y+   D++S G ++ E++
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVI 197

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 29/267 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 83  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 134
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 135 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 190
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPN 269
              +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 250
Query: 270 YTEFKFP--QIKPHPWHKVFQKR-LPP 293
           +   + P   +  HPW K   +R LPP
Sbjct: 251 HPPQRLPLKGVMEHPWVKANSRRVLPP 277

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 130 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 173
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 174 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 233 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 285
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 286 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 330
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 331 IMQSTKVPQTPLHTSRVL 348

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 79  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 122
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 123 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 182 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 234
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 235 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 279
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 280 IMQSTKVPQTPLHTSRVL 297

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 167
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 279
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 280 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 324
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 325 IMQSTKVPQTPLHTSRVL 342

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 98
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 129
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 213
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 214 TEYTTAIDIWSTGCVMAELLLGQP 237
           T Y    DIWS G  + E+   +P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 84  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 127
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 128 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 186
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 187 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 239
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 240 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 284
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 285 IMQSTKVPQTPLHTSRVL 302

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 29/267 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 96
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 82  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 133
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEY 216
             + HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G T +
Sbjct: 134 -KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-H 189
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPN 269
              +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRY 249
Query: 270 YTEFKFP--QIKPHPWHKVFQKR-LPP 293
           +   + P   +  HPW K   +R LPP
Sbjct: 250 HPPQRLPLKGVMEHPWVKANSRRVLPP 276

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF--F 99
            ++G+G FG VF+AK R  G+   I++V  +     RE++ +  LDH NIV    C+  F
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 77
Query: 100 STTDKXXXXXXXXXXXXXXTVNRIARNYSR-----------------IHQRM-----PLI 137
               +                   +R+ ++                 I +R       ++
Sbjct: 78  DYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 137
Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
            ++L+  QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 138 ALELFE-QITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
              +  Y +PE I  + +Y   +D+++ G ++AELL
Sbjct: 195 SKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 96
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 157 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
            G+ HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 211 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
                Y    DIWS G ++  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
               KF  +    W+ V +      A DLV +     P+ R TA +   HP+
Sbjct: 244 ----KFT-LSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 85  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 128
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 129 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 188 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 240
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 241 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 285
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 286 IMQSTKVPQTPLHTSRVL 303

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----LQIMQMLDHPNIVALKHCF 98
           +G G+FG V++AK +ETG + A  KV++ K  +  E     ++I+   DHP IV L   +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 137
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI----FGA 213
           I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 214 TEYTTAIDIWSTGCVMAELLLGQP 237
           T Y    DIWS G  + E+   +P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 94
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++I ++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
               F   +                V     +Y   H R      +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVXEYASGGEV----FDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
               I HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y APEL  G  
Sbjct: 131 QKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGES 243
                +D+WS G ++  L+ G   F G++
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 94  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 137
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 138 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 196
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 197 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 249
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 250 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 294
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 295 IMQSTKVPQTPLHTSRVL 312

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 86  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 129
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 130 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 189 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 241
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 242 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 286
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 287 IMQSTKVPQTPLHTSRVL 304

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 78  RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 136
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 108
Query: 137 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 193
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 109 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 165
Query: 194 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225
Query: 249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 226 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 260
Query: 309 LRCTALEACVHPFFDE 324
            R TA EA  HPFF +
Sbjct: 261 KRYTAEEALAHPFFQQ 276

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 98
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 215
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 216 --YTTAIDIWSTGCVMAELLLGQP 237
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 47/256 (18%)
Query: 78  RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 136
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 137 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 193
              +  T +I RAL  +    + + I HRD+KP+N+L++   + +KL DFG +  L  GE
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGE 178
Query: 194 PNVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
                  +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
             I              M+ NY +F  P+   +               DLV RF    P 
Sbjct: 239 RMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQ 273
Query: 309 LRCTALEACVHPFFDE 324
            R TA EA  HPFF +
Sbjct: 274 KRYTAEEALAHPFFQQ 289

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 101/243 (41%), Gaps = 58/243 (23%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK----------V 188
           V+ Y   + +AL  IH   GI HRD+KP N L N    +  L DFG A+           
Sbjct: 119 VREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 189 LVKGEP-------NVSYIC-SRY-----------YRAPELIFGATEYTTAIDIWSTGCVM 229
            V+ E        N   IC SR            +RAPE++      TTAID+WS G + 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 230 AELLLGQ-PLFPGESGVDQLVEIIKVLGT--------------------PTR------EE 262
             LL G+ P +     +  L +I+ + G+                    P +      E 
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER 297
Query: 263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           ++ M+ +  +     I+ H  +      +P EA DL+ +    +P  R TA EA +HPFF
Sbjct: 298 LRGMDSSTPKLT-SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356
Query: 323 DEL 325
            ++
Sbjct: 357 KDM 359

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 139/313 (44%), Gaps = 60/313 (19%)
Query: 39  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 93
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 152
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 153 IHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNVSYIC 200
           +H+ + I HRD+KPQN+LV+  +             ++ + DFG  K L  G+       
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 201 -----SRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
                +  +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 310 RCTALEACVHPFF 322
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 98
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 215
           I HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 216 --YTTAIDIWSTGCVMAELLLGQP 237
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I  ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 221
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 222 KEKKTYLNPWKKI 234

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 70
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 211
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 124 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 180
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 272 EFKFPQIKPHPWHKV 286
           ++K  +   +PW K+
Sbjct: 220 DWKEKKTYLNPWKKI 234

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 211
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 272 EFKFPQIKPHPWHKV 286
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 91
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 150
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 254
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 255 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 293
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK             +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVAL 94
           I   V+G G FG   +   RETGE++ +K+++    + +R   +E+++M+ L+HPN++  
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK- 71
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
              F     K              T+  I ++   +  + P      +   I   +AY+H
Sbjct: 72  ---FIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPN-------------VSYI 199
           + + I HRD+   N LV  + + + + DFG A+++V  K +P               + +
Sbjct: 126 S-MNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
            + Y+ APE+I G + Y   +D++S G V+ E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 91
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 150
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 254 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 305 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 361
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 254
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 421
Query: 255 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 293
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 422 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 77  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 128
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 129 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 185
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 228
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 91
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 150
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 254
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 255 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 293
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 91
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 150
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVL 362
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV----------- 254
                Y ++ D +S GC++ +LL G   F       +  +D++   + V           
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422
Query: 255 ------LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 293
                 L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 161 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 219
           HRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 220 IDIWSTGCVMAELLLG 235
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDN 180
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 44  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 158 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 213
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 74
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 75  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 126
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 127 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 183
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 226
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 227 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G+ G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNVSYICSRY-YRAPELIFGA 213
           IGI HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+   
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             +   +D+WS G V+  +L G+   P +   D   E                   Y+++
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDW 220
Query: 274 KFPQIKPHPWHKV 286
           K  +   +PW K+
Sbjct: 221 KEKKTYLNPWKKI 233

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 53/293 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F  T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YAF-QTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFGAT 214
              + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE +    
Sbjct: 124 R-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDN 180
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---------- 223
Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 322
                       F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 211
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE-------------------YS 218
Query: 272 EFKFPQIKPHPWHKV 286
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 44  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 158 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 213
           GI HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 223
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 224 DFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 120/288 (41%), Gaps = 46/288 (15%)
Query: 44  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G+F VV +     A       I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 129
Query: 158 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 213
           G+ HR++KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLRK 187
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y   +D+W+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAY 230
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+
Sbjct: 231 DFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 94
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 152
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 208
            H   GI HRD+KP N+L++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
              G +      D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 211
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 272 EFKFPQIKPHPWHKV 286
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 57/306 (18%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYKNRELQIM-Q 84
           Y  + V+G G   VV +   R TG   A+K            ++ + +    RE  I+ Q
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLY 142
           +  HP+I+ L   + S++                 + R    +  + +++ L     +  
Sbjct: 156 VAGHPHIITLIDSYESSS----------FMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
              +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE       + 
Sbjct: 206 MRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTP 263
Query: 203 YYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
            Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I      
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI------ 317
Query: 258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                   M   Y +F  P+     W             DL+ R  Q  P  R TA +A 
Sbjct: 318 --------MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQAL 358
Query: 318 VHPFFD 323
            HPFF+
Sbjct: 359 QHPFFE 364

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 43/255 (16%)
Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 96
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAPELIF 211
           IGI HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL+ 
Sbjct: 123 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPELLK 179
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               +   +D+WS G V+  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 272 EFKFPQIKPHPWHKV 286
           ++K  +   +PW K+
Sbjct: 219 DWKEKKTYLNPWKKI 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 98
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATE-- 215
           I HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 216 --YTTAIDIWSTGCVMAELLLGQP 237
             Y    D+WS G  + E+   +P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALK 95
            Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +    D                +++I R      +    +      + I + + Y+H 
Sbjct: 83  DVY---DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH- 133
Query: 156 CIGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPEL 209
             G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFVAPE- 190
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMNP 268
           +     Y  A DIWS G ++  +L G    P  +G D    EI+  +G+           
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYT--PFANGPDDTPEEILARIGSG---------- 238
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF---FDEL 325
                KF  +    W+ V        A DLV +     P+ R TA     HP+   +D+L
Sbjct: 239 -----KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 29  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQI 82
           N ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 142
            + L HPNIV L       +                 +  +AR +         I     
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI----- 134
Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYIC 200
             QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 135 -QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           +  Y +PE +     Y+  +DIW+ G ++  LL+G P F  E   DQ             
Sbjct: 193 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQ---------HRLY 239
Query: 261 EEIKCMNPNYTEFKFPQIKPHP-WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
            +IK    +Y         P P W  V      PEA  L+      +P  R TA +A   
Sbjct: 240 AQIKAGAYDY---------PSPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 320 PFF 322
           P+ 
Sbjct: 286 PWI 288

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 161 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 219
           HRD+K +N L++     +LK+C FG +K  V        + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKV 197
Query: 220 IDIWSTGCVMAELLLG 235
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 94
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 152
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 208
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 94
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 152
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 208
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
              G +      D++S GCV+ E+L G+P F G+S
Sbjct: 190 QARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 94
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAY 152
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 208
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 93
           Y+    +G G F  V   +    G   A+K++L    QD+    RE  + ++ +HPNI+ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 94  L-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIAR-----NYSRIHQRMPLIYVKLYTYQIC 147
           L  +C      K                N I R     N+    Q + L+        IC
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL------GIC 144
Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKGEPNVSYI----- 199
           R L  IH   G  HRD+KP N+L+     Q  L D GS   A + V+G      +     
Sbjct: 145 RGLEAIH-AKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 200 --CSRYYRAPELIFGATEYTTA---IDIWSTGCVMAELLLGQ 236
             C+  YRAPEL F    +       D+WS GCV+  ++ G+
Sbjct: 203 QRCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 94
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 152
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 208
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 132 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 190 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 124/318 (38%), Gaps = 58/318 (18%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K  LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVXECLDG----------------GELFSRIQDRGDQAFTEREASEIX 167
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK         +   +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            YY APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR- 278
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
               +     EF  P+     W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 279 ----IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPW 324
Query: 322 FDE-LRDPNTRLPNGRPL 338
             +  + P T L   R L
Sbjct: 325 IXQSTKVPQTPLHTSRVL 342

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 124/298 (41%), Gaps = 44/298 (14%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 96
           Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            +    D                +++I R      +    +   L+T  I + + Y+H  
Sbjct: 84  VY---DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV---LFT--ITKTVEYLH-A 134
Query: 157 IGICHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
            G+ HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + APE +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFVAPE-V 191
Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                Y  A DIWS G ++   L G   F      D   EI+  +G+             
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------------ 238
Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF---FDEL 325
              KF  +    W+ V        A DLV +     P+ R TA     HP+   +D+L
Sbjct: 239 ---KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQL 287

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 94
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 94
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 152
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 148
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 208
            H   GI HRD+KP N++++  T+ +K+ DFG A+ +     +V    + I +  Y +PE
Sbjct: 149 SHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
              G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 207 QARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +G G+FGV    + ++  E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T                 +    R +S    R        +  Q+   ++Y H  + + 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYAH-AMQVA 137
Query: 161 HRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 219
           HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKV 197
Query: 220 IDIWSTGCVMAELLLG 235
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/107 (39%), Positives = 64/107 (59%), Gaps = 7/107 (6%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YI 199
           +T QI   + + H+ + I HRDIKPQN+L++ +   LK+ DFG AK L +     +   +
Sbjct: 116 FTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVL 173
Query: 200 CSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
            +  Y +PE   G AT+  T  DI+S G V+ E+L+G+P F GE+ V
Sbjct: 174 GTVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 84
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 202
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E 
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 44  VGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G+F VV +     TG     +I+  KK+  +D +   RE +I ++L H NIV L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              + +                 + +AR Y         I       QI  A+ + H  +
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ-M 122
Query: 158 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 213
           G+ HRD+KP+NLL+        +KL DFG A + V+G+      +  +  Y +PE +   
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPE-VLRK 180
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 223
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            FP  +   W  V      PEA +L+ +    +P  R TA EA  HP+
Sbjct: 224 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 154
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 155 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 146 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 202
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 249
Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 331
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 250 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
Query: 332 LPNGRPL 338
           L   R L
Sbjct: 302 LHTARVL 308

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 37/307 (12%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 154
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 155 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +   I HRD+KP+NLL         LKL DFG AK   +         + YY APE + G
Sbjct: 127 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE-VLG 183
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       +
Sbjct: 184 PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQ 230
Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTR 331
           + FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T 
Sbjct: 231 YGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282
Query: 332 LPNGRPL 338
           L   R L
Sbjct: 283 LHTARVL 289

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPN 90
           +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I + L HPN
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV L       +                 +  +AR +         I       QI  ++
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------QQILESI 117
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y +PE
Sbjct: 118 AYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 176
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
            +     Y+  +DIW+ G ++  LL+G P F  E 
Sbjct: 177 -VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 210

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 84
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 85  MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 144
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSR 202
           QI  ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E 
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQ-------------------- 177
           +KLY  +I +AL Y+   + + H D+KP+N+L++ P+  +                    
Sbjct: 139 IKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 178 ---LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 234
              +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  
Sbjct: 198 STGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYT 254
Query: 235 GQPLFPGESGVDQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ------- 277
           G  LF     ++ L  +  ++           T T    K +N +  +  +P+       
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINS 313
Query: 278 ----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
                K  P +K+ +  L     D +    Q  P LR +  E   H F +
Sbjct: 314 IKHVKKCLPLYKIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 44  VGTGSFGVVFQAKCRE-----TGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G G+F VV +   +        +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
              + +                 + +AR Y         I+      QI  ++ +IH   
Sbjct: 99  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH------QILESVNHIHQH- 149
Query: 158 GICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNV--SYICSRYYRAPELIFGA 213
            I HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +   
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPE-VLRK 207
Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y   +DIW+ G ++  LL+G P F  E    +L + IK                   +
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAY 250
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            FP  +   W  V      PEA +L+ +    +P  R TA +A  HP+
Sbjct: 251 DFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 35  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 87
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 323 DELRDPNTRLPNGRPLPPLFNFKP 346
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 85/164 (51%), Gaps = 20/164 (12%)
Query: 142 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           Y++Q+ R + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 204 YSFQVARGMEFLSSRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 255
            +R    + APE IF    Y+T  D+WS G ++ E+  LG   +PG       V++ +  
Sbjct: 260 DTRLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDF 311
Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 299
            +  RE ++   P Y+  +  QI    WH+  ++R  P   +LV
Sbjct: 312 CSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELV 353

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 43/277 (15%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD-HPNIVALKHCFF 99
           +G GSF +  +   +++ +  A+K +   KR +    +E+  +++ + HPNIV L   F 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 100 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
              D+                 RI +           I  KL +     A++++H+ +G+
Sbjct: 77  ---DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHD-VGV 127
Query: 160 CHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEY 216
            HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL+     Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGY 186
Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             + D+WS G ++  +L GQ  F            VEI+K +                +F
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-------------GDF 233
Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
            F   +   W  V Q     EA DL+       PN R
Sbjct: 234 SF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 156
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 215
             I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 180
Query: 216 YTTAIDIWSTGCVMAELLLGQP 237
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 88/346 (25%), Positives = 127/346 (36%), Gaps = 65/346 (18%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 93
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 208
           H+   I HRD+KP  +L+    +   +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 147 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 203
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 247
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE---- 324
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E    
Sbjct: 248 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKERDRY 296
Query: 325 ------------LRDPNTRLP-NGRPLPPLFNFKPPELSGIPPETI 357
                       LR  N R    G  L  + + K     G PPE +
Sbjct: 297 AYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEEL 342

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 153
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 87  HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 212
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 138 QSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 194
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 145
Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYT 217
           I HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 218 TAIDIWSTGCVMAELLLGQP 237
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 113/296 (38%), Gaps = 48/296 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 93
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 93  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 148
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNV---SYICSRYYRAPE 208
           H+   I HRD+KP  +L+    +   +KL  FG A  L  GE  +     + + ++ APE
Sbjct: 149 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPE 205
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++     Y   +D+W  G ++  LL G                +   GT  R     +  
Sbjct: 206 VV-KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKG 249
Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
            Y      ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 250 KY------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 51/324 (15%)
Query: 35  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 87
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
             L  +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y AP
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ + 
Sbjct: 355 EVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL- 400
Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 322
                     +K  P  + + +R  P+A  L  +     P  R      +A E   HP F
Sbjct: 401 ----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 323 DELRDPNTRLPNGRPLPPLFNFKP 346
            +L     RL  G   PP   FKP
Sbjct: 449 KKLN--FKRLGAGMLEPP---FKP 467

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 95
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 153
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 408 HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-YYRAPELIFG 212
            +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I  
Sbjct: 459 QS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 515
Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 8/177 (4%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 315
             I+ C+    ++   F +I+ HPW +     LP E  ++        P+ +  ALE
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAALE 291

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 156
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 138
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 215
             I HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 216 YTTAIDIWSTGCVMAELLLGQP 237
           Y +  DIWS G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 232
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 266 HLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 156
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 123
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATE 215
             I HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 180
Query: 216 YTTAIDIWSTGCVMAELLLGQP 237
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 176
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 177 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 118 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 175
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 176 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 235
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 236 HLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 177
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 178 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 238 HLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 75/145 (51%), Gaps = 5/145 (3%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  +
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 264
Query: 261 EEIK-CMNPNYTEF-KFPQIKPHPW 283
             I+ C+    ++   F +I+ HPW
Sbjct: 265 HLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 117 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 174
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 257
             +R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 234
Query: 258 PTREEIK-CMNPNYTEF-KFPQIKPHPW 283
             +  I+ C+    ++   F +I+ HPW
Sbjct: 235 ECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 159 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 216
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 257
             +R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 276
Query: 258 PTREEIK-CMNPNYTEF-KFPQIKPHPW 283
             +  I+ C+    ++   F +I+ HPW
Sbjct: 277 ECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 257
             +R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 249
Query: 258 PTREEIK-CMNPNYTEF-KFPQIKPHPW 283
             +  I+ C+    ++   F +I+ HPW
Sbjct: 250 ECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 142 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 199
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 235
           R Y  PE I     +  +  +WS G ++ +++ G
Sbjct: 200 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 151 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 208
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 257
             +R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 268
Query: 258 PTREEIK-CMNPNYTEF-KFPQIKPHPW 283
             +  I+ C+    ++   F +I+ HPW
Sbjct: 269 ECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 131 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 188
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT 257
             +R Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 248
Query: 258 PTREEIK-CMNPNYTEF-KFPQIKPHPW 283
             +  I+ C+    ++   F +I+ HPW
Sbjct: 249 ECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 13/209 (6%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           +    F    +                +  I          +    +     ++   L Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYRA 206
           +H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + A
Sbjct: 137 LHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLG 235
           PE++     Y    DIWS G    EL  G
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 167 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 224
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 225 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
             +R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 204
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 131 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 188
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
             +R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
            + + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
             +R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 205
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 13/210 (6%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
            Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNI
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V+    F    +                +  I          +    +     ++   L 
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNVSYICSRYYR 205
           Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ +  + 
Sbjct: 131 YLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLG 235
           APE++     Y    DIWS G    EL  G
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 86  LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 146 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 200
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 261 EEIKCMNPNYTEF 273
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 99
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 100 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 196
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 197 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 256 GTPTRE 261
            + + E
Sbjct: 242 RSVSIE 247

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 50/302 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 92
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 72  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 123
Query: 153 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 124 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 183 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 229
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           + E  F                   A D + R     P  R T  ++  H +   +R  N
Sbjct: 230 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
Query: 330 TR 331
            R
Sbjct: 277 VR 278

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 33  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 82
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 10  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 141
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 119
Query: 142 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 192
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 120 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 175
Query: 193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 176 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 33  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 82
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 9   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 141
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 118
Query: 142 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 192
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 119 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 174
Query: 193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 175 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 110/246 (44%), Gaps = 38/246 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 99
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 100 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 196
           +YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 197 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
            S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKL 241
Query: 256 GTPTRE 261
            + + E
Sbjct: 242 RSVSIE 247

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 103
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 155
Query: 104 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 163
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 210
Query: 164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 217
           +K  N+L++       LCDFG A  L       S +   Y      + APE++ G +   
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CD 269
Query: 218 TAIDIWSTGCVMAELLLG 235
             +D+WS+ C+M  +L G
Sbjct: 270 AKVDVWSSCCMMLHMLNG 287

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 86  LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 146 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 200
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 261 EEIKCMNPNYTEF 273
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 33  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 82
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 22  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 141
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 131
Query: 142 YTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 192
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 132 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVR 187
Query: 193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 188 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 128 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 182
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 183 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 230
           FG  + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 231 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 290
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 291 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 86  LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 146 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 200
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236
Query: 261 EEIKCMNPNYTEF 273
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 92
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 94  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + +   + HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G VM E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 86  LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 146 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 200
           +CR    AL ++H+   + HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 261 EEIKCMNPNYTEF 273
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 103
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 120
Query: 104 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 163
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 175
Query: 164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 217
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 234
Query: 218 TAIDIWSTGCVMAELLLG 235
             +DIWS+ C+M  +L G
Sbjct: 235 AKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 103
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 136
Query: 104 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 163
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 191
Query: 164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 217
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 250
Query: 218 TAIDIWSTGCVMAELLLG 235
             +DIWS+ C+M  +L G
Sbjct: 251 AKVDIWSSCCMMLHMLNG 268

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 134 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 193
           +P+  +K     +  + +YIHN   ICHRD+KP N+L++ +  ++KL DFG ++ +V  +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKK 206
Query: 194 PNVSYICSRYYRAPELIFGATEYTTA-IDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
              S   +  +  PE     + Y  A +DIWS G  +  +      F  +     LVE+ 
Sbjct: 207 IKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELF 262
Query: 253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR-------LPPEAVDLVCRFFQY 305
             + T   E             +P  + H  + +  K+       L  E +D +  F + 
Sbjct: 263 NNIRTKNIE-------------YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 306 SPNLRCTALEACVHPFF-----DELRDPNTRLPNGR 336
           +P  R T+ +A  H +      ++LR+ +  L   R
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLDHPNIVALKHCFFSTT 102
           +G GS+G VF+ + +E G + A+K+ +   R  K+R  ++ ++  H  +     C     
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV--RL 122
Query: 103 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 162
           ++                  + ++       +P   V  Y      ALA++H+  G+ H 
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHL 181
Query: 163 DIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
           D+KP N+ + P   + KL DFG         A  + +G+P         Y APEL+ G+ 
Sbjct: 182 DVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPELLQGS- 231
Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 248
            Y TA D++S G  + E+     L  G  G  QL
Sbjct: 232 -YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 38/221 (17%)
Query: 33  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 82
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 6   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 141
           ++ L    IV  +   +                     +   R++ + H+ R+    + L
Sbjct: 62  LKALHSDFIVKYRGVSYGPG------RPELRLVMEYLPSGCLRDFLQRHRARLDASRLLL 115
Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKG 192
           Y+ QIC+ + Y+    C+   HRD+  +N+LV    H +K+ DFG AK+L       V  
Sbjct: 116 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVR 171
Query: 193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           EP  S I   ++ APE +     ++   D+WS G V+ EL 
Sbjct: 172 EPGQSPI---FWYAPESL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 22/223 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 95
           V+G G+FG V   K +   ++ A+K + + +  K         E  ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           H  F   +               T+       S+   R+P    + Y  ++  A+  +H 
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTL------LSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 210
            +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 211 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             G   Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 28/234 (11%)
Query: 24  TIGG-RNGNSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE 79
           ++GG + G +++ V  +   ++G G FG V++       GE   VA+K   +D    N+E
Sbjct: 1   SMGGPQYGIAREDV--VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE 58
Query: 80  -----LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 134
                  IM+ LDHP+IV L        ++                + + RN       +
Sbjct: 59  KFMSEAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSL 110
Query: 135 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 194
            ++ + LY+ QIC+A+AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E 
Sbjct: 111 KVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDED 167
Query: 195 NVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 243
                 +R    + +PE I     +TTA D+W     M E+L    QP F  E+
Sbjct: 168 YYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 92
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 79  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G VM E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 103
           +G GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 134
Query: 104 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 163
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 189
Query: 164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 217
           +K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G     
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 248
Query: 218 TAIDIWSTGCVMAELLLG 235
             +DIWS+ C+M  +L G
Sbjct: 249 AKVDIWSSCCMMLHMLNG 266

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 92
           E V+G G FG V   + +  G+      I  +K    DK+ ++   E  IM   DHPNI+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 73  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G VM E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 27  GRNGNSKQKVSYI-AEHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN-- 77
           GR+   + + S I  E ++G+G  G V   + R  G+      I A+K    +++ ++  
Sbjct: 39  GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 78  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 137
            E  IM   DHPNI+ L+        +              +++   R +      M L+
Sbjct: 99  SEASIMGQFDHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
            +      +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +
Sbjct: 155 GM---LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAA 208
Query: 198 YICSR-----YYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           Y  +       + APE I   T +++A D+WS G VM E+L
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 103
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 136
Query: 104 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 163
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 191
Query: 164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YRAPELIFGATEYT 217
           +K  N+L++       LCDFG A  L         +   Y      + APE++ G +   
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CD 250
Query: 218 TAIDIWSTGCVMAELLLG 235
             +D+WS+ C+M  +L G
Sbjct: 251 AKVDVWSSCCMMLHMLNG 268

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 28/253 (11%)
Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 86  LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 145
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 146 ICR----ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYIC 200
           +CR    AL ++H+   + HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 201 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 237
Query: 261 EEIKCMNPNYTEF 273
           +  + ++  + +F
Sbjct: 238 QNPEKLSAIFRDF 250

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 34/208 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 98
           +G GSFG V++     T E+VAIK +       +     +E+ ++   D P I      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI--------YVKLYTYQICRAL 150
             +T                    I   Y      + L+        Y+     +I + L
Sbjct: 87  LKSTKLW-----------------IIMEYLGGGSALDLLKPGPLEETYIATILREILKGL 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPEL 209
            Y+H+   I HRDIK  N+L++     +KL DFG A  L   +     ++ + ++ APE+
Sbjct: 130 DYLHSERKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 187
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQP 237
           I   + Y    DIWS G    EL  G+P
Sbjct: 188 I-KQSAYDFKADIWSLGITAIELAKGEP 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 90
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 151 AYIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 205
              H        + HRD+KP N+ ++     +KL DFG A++L   E     ++ + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 31/193 (16%)
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNV 196
           +  AL ++H   GI HRD+KP+N+L         +K+CDF  GS   L         P +
Sbjct: 120 VAAALDFLHT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 197 SYIC-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QL 248
           +  C S  Y APE++      AT Y    D+WS G V+  +L G P F G  G D     
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 308
            E+ +V      E I+       +++FP      W       +  EA DL+ +       
Sbjct: 239 GEVCRVCQNKLFESIQ-----EGKYEFPD---KDW-----AHISSEAKDLISKLLVRDAK 285
Query: 309 LRCTALEACVHPF 321
            R +A +   HP+
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 39  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 90
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 71  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 122
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 123 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 179
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 243
           E I     +TTA D+W     M E+L    QP F  E+
Sbjct: 180 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 39  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 90
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 87  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 138
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
           AY+ + I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +P
Sbjct: 139 AYLES-INCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 195
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 243
           E I     +TTA D+W     M E+L    QP F  E+
Sbjct: 196 ESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 50/302 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 92
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 93  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 144
Query: 153 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 145 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           +          D+WS G +   LL G   F GE+  + L              I  +N +
Sbjct: 204 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYD 250
Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
           + E  F                   A D + R     P  R    ++  H +   +R  N
Sbjct: 251 FDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297
Query: 330 TR 331
            R
Sbjct: 298 VR 299

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 94
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 89  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 142
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 209
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 143 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           +   +++  A D+WS G  + ELL
Sbjct: 201 LM-QSKFYIASDVWSFGVTLHELL 223

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 123/295 (41%), Gaps = 38/295 (12%)
Query: 29  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN------ 77
            G   QK S ++   +G+G+FG V+ A  +E  + V +K     KVL+D   ++      
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 78  -RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 136
             E+ I+  ++H NI+ +   F     +               ++  A  +   H R+  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFA--FIDRHPRLDE 129
Query: 137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
                   Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+   
Sbjct: 130 PLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFY 187
Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVD--------- 246
           ++  +  Y APE++ G       +++WS G  +  L+  + P    E  V+         
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 247 --QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ---IKPHPWHKVFQKRLPPEAV 296
             +L+ ++  L  P  E    +    T+    Q   +  + W +VF+   P   V
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGV 302

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPN+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        +               ++   R +     +  +I +      I   + Y
Sbjct: 108 HLE----GVVTRGKPVMIVIEFMENGALDAFLRKHD---GQFTVIQLVGMLRGIAAGMRY 160
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + AP
Sbjct: 161 LAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G VM E++
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   +   +   +  +I +      I   + Y
Sbjct: 87  HLE----GVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKY 139
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 140 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G VM E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 94
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 77  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 130
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAPEL 209
                  HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ APE 
Sbjct: 131 -GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           +   +++  A D+WS G  + ELL
Sbjct: 189 LM-QSKFYIASDVWSFGVTLHELL 211

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 95
           V+G G+FG V   K + T  I A+K + + +  K         E  ++   D   I AL 
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 156
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 157 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 210
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 210 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 211 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 128 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQL---KLCD 182
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L   H +Q+   K+CD
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCE-HPNQVSPVKICD 157
Query: 183 FG-SAKVLVKGE------PNVSYIC-SRYYRAPELIFGATE----YTTAIDIWSTGCVMA 230
           F   + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++ 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 231 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 290
            LL G P F G  G D   +  +    P  + +   +    +++FP      W       
Sbjct: 218 ILLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AH 267
Query: 291 LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
           +   A DL+ +        R +A +   HP+       NT
Sbjct: 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 95
           V+G G+FG V   K + T  I A+K + + +  K         E  ++   D   I AL 
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 140
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 141 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNVSY-ICSRYYRAPELI--- 210
            +   HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++   
Sbjct: 194 -LHYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 211 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
             G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 108 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 160
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 161 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 217
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 218 EAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 2/95 (2%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +Q+  A+ + HN  G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +
Sbjct: 115 FFWQVLEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 172
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
           R Y  PE I     +  +  +WS G ++ +++ G 
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 30/261 (11%)
Query: 44  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 92
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 147
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 204
           + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLKEGT 264
Query: 264 KCMNPNYTEFKFPQIKPHPWH 284
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 25/225 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 92
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 79  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 130
Query: 153 IHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           +H+   I H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           +          D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL---------QIMQMLDHPNIVAL 94
           +G G FGVVF+AK +      AIK++    R  NREL         + +  L+HP IV  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 95  KHCFF--STTDKXXXXXXXXXXXXXXTVNR------IARNYSRIHQRMPLIYVKLYTYQI 146
            + +   +TT+K               + R             I +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-QI 127
Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVSY- 198
             A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 199 -----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
                + ++ Y +PE I G + Y+  +DI+S G ++ ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 98  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 150
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 151 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 36  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 86
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 145
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 73  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 202
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 203 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
               + APE I    ++T+A D WS G VM E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 99
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 100 STTDKXXXXXXXXXXXX---XXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
              +                  +V  + +N       +   ++     +I R L+++H  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 148
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSYICSRYYRAPELIF--- 211
             + HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I    
Sbjct: 149 -KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 205
Query: 212 --GATEYTTAIDIWSTGCVMAELLLGQP 237
              AT Y    D+WS G    E+  G P
Sbjct: 206 NPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 134 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 193
           + L ++  Y++Q+ + + ++ +   I HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 194 PNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLV 249
             V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 41  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAP 207
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E I    ++T+A D+WS G V+ E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 191
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 90
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 151 AYIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 205
              H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 250
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 303
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 304 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 97
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 153 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 205
           +HN    I HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + 
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWM 206
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL-LGQP 237
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 252
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 305
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 306 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 243
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 296
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 297 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIXK 200
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 101/260 (38%), Gaps = 72/260 (27%)
Query: 131 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN---------------------- 168
           +Q +P+  VK    Q+ + L Y+H+   I H DIKP+N                      
Sbjct: 134 YQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQK 193
Query: 169 ------------------LLVNP------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
                             LLVNP         ++K+ D G+A  + K       I +R Y
Sbjct: 194 AGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQY 251
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTP 258
           R+ E++ GA  Y+T  DIWST C+  EL  G  LF   SG       D +  II++LG+ 
Sbjct: 252 RSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSI 310
Query: 259 TREEIKCMNPNYTEFKF---------PQIKPHPWHKVFQKRL------PPEAVDLVCRFF 303
            R     ++  Y+   F          ++KP     V  ++         +  D +    
Sbjct: 311 PRH--FALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPML 368
Query: 304 QYSPNLRCTALEACVHPFFD 323
           +  P  R +A E   HP+ +
Sbjct: 369 EMVPEKRASAGECLRHPWLN 388

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 245
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 298
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 299 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 15/218 (6%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 90
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 151 AYIHNCIG----ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 205
              H        + HRD+KP N+ ++     +KL DFG A++L        +++ + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
           +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 184 SPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 103
           +G GSFG VF+     T ++VAIK +  D      E++ +Q      I  L  C  S   
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQ----EITVLSQCDSSYVT 84
Query: 104 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNCIGICH 161
           K                     +   + +  P    ++ T   +I + L Y+H+   I H
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-H 143
Query: 162 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAI 220
           RDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y +  
Sbjct: 144 RDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 201
Query: 221 DIWSTGCVMAELLLGQP 237
           DIWS G    EL  G+P
Sbjct: 202 DIWSLGITAIELAKGEP 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGKFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILIGELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    V   
Sbjct: 190 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 255
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +  
Sbjct: 246 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 297
Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
               +E  +   P+YT  +  Q     WH
Sbjct: 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 27  GRNGNSKQKVSYI-AEHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN-- 77
           GR+   + + S I  E ++G+G  G V   + R  G+      I A+K    +++ ++  
Sbjct: 39  GRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 78  RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 137
            E  IM   DHPNI+ L+        +              +++   R +      M L+
Sbjct: 99  SEASIMGQFDHPNIIRLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
            +      +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +
Sbjct: 155 GM---LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAA 208
Query: 198 YICSR-----YYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
              +       + APE I   T +++A D+WS G VM E+L
Sbjct: 209 XTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 202
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 203 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 255
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 256 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 191
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 134 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 200
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 70/260 (26%)
Query: 131 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 171
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 172 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTR 257
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 256
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 258 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 257 TPTREEIKCMNPNYTEFK-------FPQIKPHPWHKVFQKRLP---PEAV---DLVCRFF 303
              R+ I     +   F          ++KP    +V  ++      EA    D +    
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 376
Query: 304 QYSPNLRCTALEACVHPFFD 323
           +  P  R TA E   HP+ +
Sbjct: 377 ELIPEKRATAAECLRHPWLN 396

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGVFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 97
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 153 IHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------YR 205
           +HN    I HR++K  NLLV+   + +K+CDFG +++        +++ S+       + 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWM 206
Query: 206 APELIFGATEYTTAIDIWSTGCVMAELL-LGQP 237
           APE++        + D++S G ++ EL  L QP
Sbjct: 207 APEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 99
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 100 STTDKXXXXXXXXXXXXXXTVNRIARN---YSRIH------QRMPLIYVKLYTYQICRAL 150
              +                      N   Y  IH      QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNV------- 196
           +YIH+  GI HR++KP N+ ++  +  +K+ DFG AK       +L     N+       
Sbjct: 130 SYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 197 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
            S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+K L
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNILKKL 241
Query: 256 GTPTRE 261
            + + E
Sbjct: 242 RSVSIE 247

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 100/231 (43%), Gaps = 18/231 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ----MLDHP 89
           Q+  +    V+G G+F  V   K ++TG++ A+K + +    K  E+   +    +L + 
Sbjct: 59  QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           +   +    F+  D+               +  +    S+  +R+P    + Y  +I  A
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMA 174
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGE-PNVSYICSRYYRAP 207
           +  +H  +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +P
Sbjct: 175 IDSVHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 208 ELIFGATEYTTAI------DIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
           E++                D W+ G    E+  GQ  F  +S  +   +I+
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 70/260 (26%)
Query: 131 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------- 171
           +Q +PL  VK    Q+ + L Y+H    I H DIKP+N+L+                   
Sbjct: 124 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 183
Query: 172 -----------------------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
                                        N    ++K+ D G+A  + K       I +R
Sbjct: 184 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTR 241
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLG 256
            YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II++LG
Sbjct: 242 QYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 300
Query: 257 TPTREEIKCMNPNYTEFK-------FPQIKPHPWHKVFQKRLP---PEAV---DLVCRFF 303
              R+ I     +   F          ++KP    +V  ++      EA    D +    
Sbjct: 301 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 360
Query: 304 QYSPNLRCTALEACVHPFFD 323
           +  P  R TA E   HP+ +
Sbjct: 361 ELIPEKRATAAECLRHPWLN 380

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 98  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 150
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 206
           + + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 151 LAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 208
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELL 233
           PE I    ++T+A D+WS G VM E++
Sbjct: 209 PEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H+ + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 94
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 207
           +   I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 SQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 41  EHVVGTGSFGVVFQAKCRETG---EI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 91
           + V+G G FG V++   + +    E+ VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L+        K               +++  R        + L+ +      I   + 
Sbjct: 109 IRLEGVI----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM---LRGIAAGMK 161
Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRA 206
           Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 162 YLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTA 218
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELL 233
           PE I    ++T+A D+WS G VM E++
Sbjct: 219 PEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 90
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            Y+H  + I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + AP
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           E++          D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 94
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           K C                           R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 151
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNVSYICSRYYRAP 207
               I HRD+  +N+L++ +   +K+ DFG AK + +G       E   S +   ++ AP
Sbjct: 152 AQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FWYAP 206
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E +    ++  A D+WS G  + ELL
Sbjct: 207 ECL-KEYKFYYASDVWSFGVTLYELL 231

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/332 (20%), Positives = 118/332 (35%), Gaps = 77/332 (23%)
Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------- 77
           G +G+  Q   Y  +  +G GS+GVV  A         A+K + + K  +          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 78  ---------------------RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXX--- 113
                                +E+ I++ LDHPN+V L        +             
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 114 -XXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN 172
                 T+  ++ + +R            Y   + + + Y+H    I HRDIKP NLLV 
Sbjct: 124 PVMEVPTLKPLSEDQAR-----------FYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG 171
Query: 173 PHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAPELIFGATEYTT--AIDIWSTGCVM 229
              H +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  +
Sbjct: 172 EDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 230 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 289
              + GQ  F                     E I C++         +IK        Q 
Sbjct: 231 YCFVFGQCPF-------------------MDERIMCLH--------SKIKSQALEFPDQP 263
Query: 290 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +  +  DL+ R    +P  R    E  +HP+
Sbjct: 264 DIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 94
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 207
               I HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 135 AQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 189
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E +    ++  A D+WS G  + ELL
Sbjct: 190 ECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 90
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 209
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           + G  EY  ++D ++ G  + E++
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 90
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 209
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           + G  EY  ++D ++ G  + E++
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 90
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 209
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
           + G  EY  ++D ++ G  + E++  +  F
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 30/261 (11%)
Query: 44  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 92
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 147
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 204
           + + ++ +   I HRD+  +N+L++   + +K+ DFG A+ + K    V    +R    +
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRLKEGT 264
Query: 264 KCMNPNYTEFKFPQIKPHPWH 284
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 90
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPEL 209
            ++H    I +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           + G  EY  ++D ++ G  + E++
Sbjct: 361 LLG-EEYDFSVDYFALGVTLYEMI 383

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 129/303 (42%), Gaps = 47/303 (15%)
Query: 35  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIV 92
           K+S+  + V+G G+ G +      +  + VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVI 81
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
                 +  T+K              T+          H  +  I +     Q    LA+
Sbjct: 82  R-----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL---LQQTTSGLAH 133
Query: 153 IHNCIGICHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNVSYIC----SRYY 204
           +H+ + I HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 205 RAPELIFGATEY--TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
            APE++    +   T  +DI+S GCV    ++ +   P    + +   I+  LG  +   
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS--- 246
Query: 263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           + C++P                   +K     A +L+ +     P  R +A     HPFF
Sbjct: 247 LDCLHP-------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
Query: 323 DEL 325
             L
Sbjct: 288 WSL 290

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 36  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 86
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 87  DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 145
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 75  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--- 202
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 203 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
               + APE I    ++T+A D WS G VM E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 121/318 (38%), Gaps = 79/318 (24%)
Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 87
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 88  HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 148 R----ALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICS 201
           +    A+ Y+H+ I I HRD+KP+NLL         LKL DFG AK    GE        
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE-------- 173
Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
                        +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 174 -------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 214
Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 215 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 259
Query: 322 -FDELRDPNTRLPNGRPL 338
                + P T L   R L
Sbjct: 260 IMQSTKVPQTPLHTSRVL 277

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G FG V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 179
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 241
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 67/131 (51%), Gaps = 19/131 (14%)
Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-- 189
           Q++P+     Y  +I  AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +  
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINS 233
Query: 190 ---VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
              + G P         ++APE++   T  T A DI++ G  +A L L  P   G   VD
Sbjct: 234 FGYLYGTPG--------FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VD 282
Query: 247 QLVEIIKVLGT 257
            L E   VL T
Sbjct: 283 GLPEDDPVLKT 293

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 94
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 128
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 207
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 129 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 183
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E +    ++  A D+WS G  + ELL
Sbjct: 184 ECL-KECKFYYASDVWSFGVTLYELL 208

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 92
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 93  ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 152 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  VS   +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 209 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGES 243
           +   A        +Y   +D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 116/278 (41%), Gaps = 33/278 (11%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK--------NRELQIMQMLDHP 89
           Y+   ++G GS+G V +    ET    A+K + + K  +         +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           N++ L    ++   +               +       S   +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD-----SVPEKRFPVCQAHGYFCQLIDG 121
Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNVSYICSRYYRA 206
           L Y+H+  GI H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLTT-GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 207 PELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--------LGT 257
           PE+  G   ++   +DIWS G  +  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 258 PTREEIKCM--NPNYTEFKFPQIKPHPWHKVFQKRLPP 293
           P  + +K M        F   QI+ H W   F+K+ PP
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSW---FRKKHPP 273

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 44  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 94
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 129
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-------YYRAP 207
               I HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       ++ AP
Sbjct: 130 AQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFWYAP 184
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL 233
           E +    ++  A D+WS G  + ELL
Sbjct: 185 ECL-KECKFYYASDVWSFGVTLYELL 209

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 91
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + HPNI
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 152 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/223 (21%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 26  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 82
           G  +    ++     +H +G G +G V++   ++    VA+K + +D        +E  +
Sbjct: 1   GSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 60
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 142
           M+ + HPN+V L         +               +    R  +R  Q +  + +   
Sbjct: 61  MKEIKHPNLVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYM 114
Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
             QI  A+ Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 115 ATQISSAMEYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAK 171
Query: 203 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 241
           +   + APE +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 172 FPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 90
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLAD-GTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 148
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 150
Query: 149 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY--Y 204
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ------IMQMLDHPN 90
           ++  ++++G G FG V++ +  + G +VA+K+ L+++R +  ELQ      ++ M  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGRLAD-GXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQI--CR 148
           ++ L+    + T++               +        R   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 142
Query: 149 ALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY--Y 204
            LAY+H+     I HRD+K  N+L++     + + DFG AK++   + +V         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 239
            APE +    + +   D++  G ++ EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 154
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 209
           +     HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 SK-RFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 210 IFGATEYTTAIDIWSTGCVMAELLL 234
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
           Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS   L+  EP   +  +R Y
Sbjct: 147 QVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVY 204
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
             PE I     +     +WS G ++ +++ G 
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 22/223 (9%)
Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 92
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 93  ALKHCFFSTTDKXXXXXXXXXX-XXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
            L      TT +               TV     N   + +   LI ++     +   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVGGMN 126
Query: 152 YIHNCIGICHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           ++    GI HR+IKP N++  +      + KL DFG+A+ L   E  V    +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 209 LIFGAT-------EYTTAIDIWSTGCVMAELLLGQ-PLFPGES 243
           +   A        +Y   +D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAP 182
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 75  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 128
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 129 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 185
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 186 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 230

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 9   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 69  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 122
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 123 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAP 179
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 241
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 180 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 24/207 (11%)
Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 93  ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 72  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 124
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 206
           + + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + A
Sbjct: 125 LAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELL 233
           PE I    ++T+A D+WS G VM E++
Sbjct: 183 PEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 124
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 71  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 124
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 125 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 182 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 226

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 24  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 83
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 84  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 137
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 138 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 194
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 195 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 239

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 183
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 76  LVQL----LGVCTREPPFYIIIEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 129
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 130 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 186
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 187 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 231

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 81  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 132
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 133 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 187
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 188 -NFRRFTSASDVWMFGVCMWEILM 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 43  VVGTGSFGVVFQAKC---RETGEIVAIK-KVLQDKRYKNR------ELQIM-QMLDHPNI 91
           V+G+G+FG V  A      +TG  + +  K+L++K   +       EL++M Q+  H NI
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 92  VALK---------HCFFSTTDKXXXXXXXXXXXXXXTVNRIA-RNYSRIHQRMPLIYVKL 141
           V L          +  F                   + + I   N  R+ +   L  +  
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 142 -----YTYQICRALAYIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 194
                + YQ+ + + ++   +C+   HRD+  +N+LV  H   +K+CDFG A+ ++    
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVT-HGKVVKICDFGLARDIMSDSN 227
Query: 195 NVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  + ++   +  +   +    Q  R + Y+H  
Sbjct: 72  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLH-A 126
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF-- 211
             I HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 127 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 80  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 131
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 132 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 186
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 187 -NFRRFTSASDVWMFGVCMWEILM 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 106 GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 157
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 158 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 212
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 213 -NFRRFTSASDVWMFGVCMWEILM 235

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 75  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 126
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 127 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 181
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 182 -NFRRFTSASDVWMFGVCMWEILM 204

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 184
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 87/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 83  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 134
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE I
Sbjct: 135 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESI 189
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 190 -NFRRFTSASDVWMFGVCMWEILM 212

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 39  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 91
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 73  VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 124
Query: 152 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 203
           Y+       HRD+  +N LLVN   H  K+ DFG +K L     + SY  +R        
Sbjct: 125 YLEE-KNFVHRDLAARNVLLVN--RHYAKISDFGLSKAL---GADDSYYTARSAGKWPLK 178
Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           + APE I    ++++  D+WS G  M E L
Sbjct: 179 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 154
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPEL 209
           +     HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE 
Sbjct: 509 SK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPES 563
Query: 210 IFGATEYTTAIDIWSTGCVMAELLL 234
           I     +T+A D+W  G  M E+L+
Sbjct: 564 I-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 278 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAM 331
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 332 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388
Query: 208 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 389 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 433

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 25  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 74
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 75  YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 131
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 232
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEETSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 91
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 141
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTLSTRDLLH 168
Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 91
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----------L 141
           V L     + T                 +N + R  SR+ +  P   +            
Sbjct: 113 VNL---LGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTASTRDLLH 168
Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 169 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 91
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 152 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  + ++   +  LI +     Q  R + Y+H  
Sbjct: 84  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMK-KLIDI---ARQTARGMDYLH-A 138
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 211
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 39  IAEHVVGTGSFGVVFQA--KCRETGEIVAIKKVLQ-----DKRYKNRELQIMQMLDHPNI 91
           IA+  +G G+FG V Q   + R+    VAIK + Q     D     RE QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L     +                   V +         + +P+  V    +Q+   + 
Sbjct: 399 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMK 450
Query: 152 YIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY------- 203
           Y+       HR++  +N LLVN   H  K+ DFG +K L   +   SY  +R        
Sbjct: 451 YLEE-KNFVHRNLAARNVLLVN--RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           + APE I    ++++  D+WS G  M E L
Sbjct: 505 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 102/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 257 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 316
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 317 LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 370
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HR++  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + AP
Sbjct: 371 EYLEKK-NFIHRNLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 427
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 428 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 472

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 91
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 152 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 43  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 94
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 76  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 155 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 259
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 260 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 304
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 249 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 303
Query: 305 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 345
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 304 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 131/343 (38%), Gaps = 52/343 (15%)
Query: 43  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 94
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 92  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 155 NCIGICHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 259
             L      Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 260 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 304
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 265 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 319
Query: 305 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 345
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 91
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 104
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 149
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 204
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 165 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 221 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 91
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 149
           V L                         + R A          PL    L  ++ Q+ + 
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---Y 204
           +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +    +R    +
Sbjct: 173 MAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 229 MAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 91
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 152 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 25  IGGRNGNSKQKVSYIAEHV----------VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 74
           +G +N  S   + Y +  +          +GTG FGVV   K R   + VAIK + +   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM 61
Query: 75  YKN---RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 131
            ++    E ++M  L H  +V L   +   T +               +N +     R  
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
            +  L   K     +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++ 
Sbjct: 119 TQQLLEMCK----DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 172
Query: 192 GEPNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAEL 232
            E   S + S++   +  PE++   +++++  DIW+ G +M E+
Sbjct: 173 DEYTSS-VGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEI 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 73  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 126
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 127 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 183
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 184 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 228

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 91  IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           +V L         +               +    R  +R  Q +  + +     QI  A+
Sbjct: 72  LVQL----LGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAM 125
Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAP 207
            Y+       HRD+  +N LV    H +K+ DFG ++ L+ G+   +   +++   + AP
Sbjct: 126 EYLEKK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAP 182
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 253
           E +    +++   D+W+ G ++ E+   G   +PG   + Q+ E+++
Sbjct: 183 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLE 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 91
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 152 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 91
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + H N+
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 152 YIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
           Y+H    I H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           ++          D+WS G +   LL G   F G++  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 71
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 126
Query: 161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 217
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 127 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 183
Query: 218 TAIDIWSTGCVMAEL 232
           +  DIW+ G +M E+
Sbjct: 184 SKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 72
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 127
Query: 161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 217
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 128 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 184
Query: 218 TAIDIWSTGCVMAEL 232
           +  DIW+ G +M E+
Sbjct: 185 SKSDIWAFGVLMWEI 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 78
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 133
Query: 161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 217
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 134 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 190
Query: 218 TAIDIWSTGCVMAEL 232
           +  DIW+ G +M E+
Sbjct: 191 SKSDIWAFGVLMWEI 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 100
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL---YGV 67
Query: 101 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
            T +               +N +     R   +  L   K     +C A+ Y+ +     
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK----DVCEAMEYLES-KQFL 122
Query: 161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELIFGATEYT 217
           HRD+  +N LVN     +K+ DFG ++ ++  E   S + S++   +  PE++   ++++
Sbjct: 123 HRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLM-YSKFS 179
Query: 218 TAIDIWSTGCVMAEL 232
           +  DIW+ G +M E+
Sbjct: 180 SKSDIWAFGVLMWEI 194

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 34  QKVSYIAEHVVGTGSFGVVF------QAKCRETGEIVAIKKVLQDKRYKN--RELQIMQM 85
           ++V   ++ V+G G FGVV+      QA+ R    I ++ ++ + ++ +   RE  +M+ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 86  LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-YTY 144
           L+HPN++AL                          +     + R  QR P +   + +  
Sbjct: 79  LNHPNVLALIGIMLPPEG-------LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
           Q+ R + Y+       HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R+ 
Sbjct: 132 QVARGMEYLAEQ-KFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHRHA 188
Query: 205 RAPELIFGATE------YTTAIDIWSTGCVMAELL 233
           R P + + A E      +TT  D+WS G ++ ELL
Sbjct: 189 RLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 105 LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC----VQIAKGMMYL 156
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 210
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 157 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 211 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 215 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 252
Query: 269 NYTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 253 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 293
Query: 327 DPNTRL 332
              +R+
Sbjct: 294 AEFSRM 299

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGXLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   +                  + +  + ++   +  LI +     Q  R + Y+H  
Sbjct: 84  LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK-KLIDI---ARQTARGMDYLH-A 138
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIF-- 211
             I HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 34  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPN 90
           ++     +H +G G +G V+    ++    VA+K + +D        +E  +M+ + HPN
Sbjct: 30  ERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 89
Query: 91  IVALKHC------FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--Y 142
           +V L         F+  T+                      +Y R   R  +  V L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLL--------------DYLRECNREEVTAVVLLYM 135
Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
             QI  A+ Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  ++
Sbjct: 136 ATQISSAMEYLEKK-NFIHRDLAARNCLVGEN-HVVKVADFGLSR-LMTGDTYTAHAGAK 192
Query: 203 Y---YRAPELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 241
           +   + APE +   T ++   D+W+ G ++ E+   G   +PG
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPG 234

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 26  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQI 82
           GG      + ++++ E  +GTG FGVV   K R   + VAIK + +    ++    E ++
Sbjct: 1   GGSWEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKV 57
Query: 83  MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 142
           M  L H  +V L   +   T +               +N +     R   +  L   K  
Sbjct: 58  MMNLSHEKLVQL---YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK-- 112
Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
              +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++  E    Y  SR
Sbjct: 113 --DVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDE----YTSSR 164
Query: 203 YYR-----APELIFGATEYTTAIDIWSTGCVMAEL 232
             +     +P  +   +++++  DIW+ G +M E+
Sbjct: 165 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 67/306 (21%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L     S T                 +  +  +   I  ++ L +      QI + + Y+
Sbjct: 82  LLGVCLSPT----IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW----CVQIAKGMMYL 133
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 210
                + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E I
Sbjct: 134 EER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 211 FGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
               ++T   D+WS G  + EL+   G+P                  G PTRE      P
Sbjct: 192 H-YRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTRE-----IP 229
Query: 269 NYTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
           +  E   + PQ              PP     +C    Y   ++C  ++A   P F EL 
Sbjct: 230 DLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKELA 270
Query: 327 DPNTRL 332
              +R+
Sbjct: 271 AEFSRM 276

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 39/232 (16%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDKRYKNRELQIMQML-DHPNI 91
            +G G+FG V +A     G+  A+ KV            +K     EL+IM  L  H NI
Sbjct: 38  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 97
Query: 92  VAL--------------KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 137
           V L              ++C +                      +      +   R PL 
Sbjct: 98  VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR-PLE 156
Query: 138 YVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 193
              L  ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++   
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDS 212
Query: 194 PNVSYICSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
             +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 213 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 44  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 95
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-----YYRAPELI 210
                HRDI  +N+LV+ +   +KL DFG ++ +   E +     S+      + APE I
Sbjct: 130 -KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESI 184
Query: 211 FGATEYTTAIDIWSTGCVMAELLL 234
                +T+A D+W  G  M E+L+
Sbjct: 185 -NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 202 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 137 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 195 ILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 135 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 193 ILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 107 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 158 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 216 ILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 83  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 134 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 192 ILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 88  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 139 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 197 ILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 85  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 136 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 194 ILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           ++ Q+ + +A++   NCI   HRD+  +N+L+  + H  K+ DFG A+ ++     +   
Sbjct: 171 FSSQVAQGMAFLASKNCI---HRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 200 CSRY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 227 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 92  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 143 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 201 ILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 17/154 (11%)
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNVSYICSR 202
           QI   + Y+H    I H D+KPQN+L++       +K+ DFG ++ +         + + 
Sbjct: 139 QILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
            Y APE I      TTA D+W+ G +   LL     F GE   +  + I +V    + E 
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 263 IKCMNPNYTEF------KFPQIKP-------HPW 283
              ++   T+F      K P+ +P       H W
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 202 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   + + R       N+E+     +M  +D+P++  
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 116 LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 167 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 225 ILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 76  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 185 ILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 96
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPNIV    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            + ST                 T+    + Y +  +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTL----KTYLKRFKVXKIKVLRSWCRQILKGLQFLHTR 148
Query: 157 IG-ICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 216 YTTAIDIWSTG 226
           Y  ++D+++ G
Sbjct: 206 YDESVDVYAFG 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  V     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 202 RY---YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
           R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 69/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 86
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 87  DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 193
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 194 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 251
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 244
Query: 252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 311
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 245 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 277
Query: 312 TALEAC------VHPFFDEL 325
           T LE        +HP F E+
Sbjct: 278 TFLEIVNLLKDDLHPSFPEV 297

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+G+G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI   + Y
Sbjct: 79  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 130 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 188 ILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 217
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 218 TAIDIWSTGCVMAELLLGQPLFPGE 242
              DI++  CV+ E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 98
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 156
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPE-LIFG 212
           I   HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 213 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 243
              Y++  D+WS G ++ E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA--------- 93
           V+G+G+FG V++      GE V I   ++  R         ++LD   ++A         
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 94  -LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L  C  ST                  ++ +  N  R+  +  L +      QI + ++Y
Sbjct: 84  LLGICLTSTV-----QLVTQLMPYGCLLDHVRENRGRLGSQDLLNW----CMQIAKGMSY 134
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E 
Sbjct: 135 LED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     +T   D+WS G  + EL+
Sbjct: 193 IL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNVS 197
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +
Sbjct: 172 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 198 Y------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 233
           Y      + ++ Y +PE I G   Y+  +DI+S G ++ ELL
Sbjct: 230 YATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKN-RELQIMQMLDHPNIVALKHCF 98
           +G G+FG VF  + R    +VA+K   +    D + K  +E +I++   HPNIV L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 99  FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--C 156
              T K               +  +    +R+  +  L  V          + Y+ +  C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG----DAAAGMEYLESKCC 234
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE- 215
           I   HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 235 I---HRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 216 -----YTTAIDIWSTGCVMAELL-LGQPLFPGES 243
                Y++  D+WS G ++ E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 95
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 156 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 237
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 133 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 191 ILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 95
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 96  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 144
Query: 156 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 145 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 237
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALK 95
           +G G FGVV++     T   VA+KK+         + K+  ++E+++M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 96  HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                ++D                ++R+    S +    PL +     +  C+      N
Sbjct: 90  --LGFSSDGDDLCLVYVYMPNGSLLDRL----SCLDGTPPLSW-----HMRCKIAQGAAN 138
Query: 156 CIGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
            I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y A
Sbjct: 139 GINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQP 237
           PE + G  E T   DI+S G V+ E++ G P
Sbjct: 198 PEALRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI  L  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
             +ST  +                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQLAIVTQWCEG------SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNREL----QIMQMLDHPNIVA 93
           V+ +G+FG V++      GE V I   +++ R       N+E+     +M  +D+P++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAY 152
           L     ++T +                     +Y R H+  +   Y+  +  QI + + Y
Sbjct: 89  LLGICLTSTVQLIMQLMPFGCLL---------DYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPEL 209
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 140 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 210 IFGATEYTTAIDIWSTGCVMAELL 233
           I     YT   D+WS G  + EL+
Sbjct: 198 ILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 124
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 125 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 149
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 150 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)
Query: 33  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK-----NRELQI 82
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K + ++          RE  +
Sbjct: 46  RNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 83  MQMLDHPNIVAL--------KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 134
           M   D+PNIV L          C                     TV  ++ +      R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 135 ------PLIYVK--LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 186
                 PL   +      Q+   +AY+       HRD+  +N LV      +K+ DFG +
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVG-ENMVVKIADFGLS 221
Query: 187 KVLVKGEPNVSYICSRYYRA------------PELIFGATEYTTAIDIWSTGCVMAELL 233
           + +   +         YY+A            PE IF    YTT  D+W+ G V+ E+ 
Sbjct: 222 RNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 270

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYK----------NRELQIMQMLDHP 89
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           NIV L +       +               +++       +  R+ L         I   
Sbjct: 84  NIVKL-YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML--------DIALG 134
Query: 150 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 203
           + Y+ N    I HRD++  N+ +        +C    DFG+++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLLGNFQ 191
Query: 204 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 239
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/321 (21%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 86
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 87  DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 193
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 186
Query: 194 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 250
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 243
Query: 251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
            +             M+  Y +      +P           P    DL+   +Q++P +R
Sbjct: 244 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMR 276
Query: 311 CTALEAC------VHPFFDEL 325
            T LE        +HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/321 (21%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 86
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 12  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 65
Query: 87  DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +  +++    C           K               +    R+     +  P      
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 193
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 126 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXX 183
Query: 194 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 250
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 240
Query: 251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
            +             M+  Y +      +P           P    DL+   +Q++P +R
Sbjct: 241 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMR 273
Query: 311 CTALEAC------VHPFFDEL 325
            T LE        +HP F E+
Sbjct: 274 PTFLEIVNLLKDDLHPSFPEV 294

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 68/320 (21%), Positives = 129/320 (40%), Gaps = 63/320 (19%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 86
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 16  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 69
Query: 87  DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +  +++    C           K               +    R+     +  P      
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 193
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + + +  
Sbjct: 130 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 187
Query: 194 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 251
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 188 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 245
Query: 252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 311
           +             M+  Y +      +P           P    DL+   +Q++PN+R 
Sbjct: 246 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPNMRP 278
Query: 312 TALEAC------VHPFFDEL 325
           T LE        +HP F E+
Sbjct: 279 TFLEIVNLLKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 73/329 (22%), Positives = 130/329 (39%), Gaps = 81/329 (24%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 81
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 82  IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
           L  +     +I   +AY+ N     HR++  +N +V  H   +K+ DFG  + + +    
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---- 182
Query: 196 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 242
                + YYR            APE +     +TT+ D+WS G V+ E+  L +  + G 
Sbjct: 183 -----TDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
           S  +Q+++ +             M+  Y +      +P           P    DL+   
Sbjct: 237 SN-EQVLKFV-------------MDGGYLD------QP--------DNCPERVTDLMRMC 268
Query: 303 FQYSPNLRCTALEAC------VHPFFDEL 325
           +Q++PN+R T LE        +HP F E+
Sbjct: 269 WQFNPNMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 142
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 143 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/320 (21%), Positives = 128/320 (40%), Gaps = 63/320 (19%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 81
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 14  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 82  IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 72  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 127
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 193
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 128 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 185
Query: 194 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 251
                 +    + APE +     +TT+ D+WS G V+ E+  L +  + G S  +Q+++ 
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF 243
Query: 252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 311
           +             M+  Y +      +P           P    DL+   +Q++P +R 
Sbjct: 244 V-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMRP 276
Query: 312 TALEAC------VHPFFDEL 325
           T LE        +HP F E+
Sbjct: 277 TFLEIVNLLKDDLHPSFPEV 296

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 96
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F   + K                + +  +   I  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQLAIVTQWCEG----SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNVSYIC-SRYYRAPELIFGA 213
             I HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 214 TE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
            +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 96
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 75
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 133
Query: 157 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 191
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 48/222 (21%)
Query: 44  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKRYK----NRELQIMQMLDHPNIVAL 94
           +G G+FG VF A+C      +   +VA+K + +          RE +++ ML H +IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 107
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 144
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 108 ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 145 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 203
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 165 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 213
Query: 204 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 233
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 214 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 96
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 157 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 191
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/321 (21%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNRELQIMQML 86
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R    ++ L
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFL 68
Query: 87  DHPNIVALKHC-----FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +  +++    C           K               +    R+     +  P      
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-- 193
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +  
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYY 186
Query: 194 -PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGESGVDQLVE 250
                 +    + APE +     +TT+ D+WS G V+ E+  L  QP + G S  +Q+++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 243
Query: 251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
            +             M+  Y +      +P           P    DL+   +Q++P +R
Sbjct: 244 FV-------------MDGGYLD------QP--------DNCPERVTDLMRMCWQFNPKMR 276
Query: 311 CTALEAC------VHPFFDEL 325
            T LE        +HP F E+
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEV 297

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 96
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 73
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 131
Query: 157 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 191
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 132 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 75/330 (22%), Positives = 130/330 (39%), Gaps = 83/330 (25%)
Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRE--TGEI---VAIKKVLQDKRYKNR-----ELQ 81
           S++K++ + E  +G GSFG+V++   R+   GE    VA+K V +    + R     E  
Sbjct: 15  SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 82  IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP------ 135
           +M+     ++V L         K               +    R+     +  P      
Sbjct: 73  VMKGFTCHHVVRL----LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
           L  +     +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + +    
Sbjct: 129 LQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYE---- 182
Query: 196 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPG 241
                + YYR            APE +     +TT+ D+WS G V+ E+  L  QP + G
Sbjct: 183 -----TAYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQG 235
Query: 242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR 301
            S  +Q+++ +             M+  Y +      +P           P    DL+  
Sbjct: 236 LSN-EQVLKFV-------------MDGGYLD------QP--------DNCPERVTDLMRM 267
Query: 302 FFQYSPNLRCTALEAC------VHPFFDEL 325
            +Q++P +R T LE        +HP F E+
Sbjct: 268 CWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQML-DHPNIVALKH 96
           +G+G FG VF+   R  G I AIK+  +      D++   RE+    +L  H ++V    
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV---R 71
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F +  +                 + I+ NY RI        +K    Q+ R L YIH+ 
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHS- 129
Query: 157 IGICHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 191
           + + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 93
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 98  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 149
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 210
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 150 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 211 -FGATEYTTAIDIWSTGCVMAELL 233
            FG  +YT   D+WS G  + EL+
Sbjct: 208 HFG--KYTHQSDVWSYGVTVWELM 229

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 44  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 94
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 84
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 144
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 85  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 145 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 203
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 142 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 190
Query: 204 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 233
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 191 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 231

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 48/222 (21%)
Query: 44  VGTGSFGVVFQAKCR----ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVAL 94
           +G G+FG VF A+C     E  +++   K L++     ++   RE +++ ML H +IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 78
Query: 95  KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM---------PLIYVKLYTY- 144
              FF    +               +NR  R++    + +         PL   +L    
Sbjct: 79  ---FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 145 -QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 203
            Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +           + Y
Sbjct: 136 SQVAAGMVYLAG-LHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS---------TDY 184
Query: 204 YRA------------PELIFGATEYTTAIDIWSTGCVMAELL 233
           YR             PE I    ++TT  D+WS G V+ E+ 
Sbjct: 185 YRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 225

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR------ELQIMQMLDHPNIVA 93
           V+G+G FG V +      GE + I    KV++DK  +         +  +  LDH +IV 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 94  LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L                         ++ + ++   +  ++ L +      QI + + Y+
Sbjct: 80  L----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----GVQIAKGMYYL 131
Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---YRAPELI 210
               G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A E I
Sbjct: 132 EEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 211 -FGATEYTTAIDIWSTGCVMAELL 233
            FG  +YT   D+WS G  + EL+
Sbjct: 190 HFG--KYTHQSDVWSYGVTVWELM 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 31/211 (14%)
Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHCFF 99
           V   G FG V++A+     E VA+K   +QDK+    E ++  +  + H NI+       
Sbjct: 31  VKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 100 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-- 157
             T                +++   +  + +     L ++      + R LAY+H  I  
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHI---AETMARGLAYLHEDIPG 143
Query: 158 -------GICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP---NVSYICSRYYR 205
                   I HRDIK +N+L+    + L  C  DFG A     G+        + +R Y 
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 206 APELIFGATEYTTA----IDIWSTGCVMAEL 232
           APE++ GA  +       ID+++ G V+ EL
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKK-VLQDKRYK----------NRELQIMQMLDHP 89
           E  +G G FG+V + +  +   +VAIK  +L D   +           RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 90  NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           NIV L +       +               +++       +  R+ L         I   
Sbjct: 84  NIVKL-YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML--------DIALG 134
Query: 150 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNVSYICSRY- 203
           + Y+ N    I HRD++  N+ +        +C    DFG ++  V    +VS +   + 
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQ 191
Query: 204 YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLF 239
           + APE I GA E  YT   D +S   ++  +L G+  F
Sbjct: 192 WMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 44  VGTGSFGVVFQAKCRETGEI-VAIKKVL-----QDKRYKNRELQIMQMLDHPNIVALKHC 97
           +G+GSFG V++ K    G++ V I KV+     Q + ++N E+ +++   H NI+     
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----L 96
Query: 98  FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F     K                  +    ++  Q   LI +     Q  + + Y+H   
Sbjct: 97  FMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKF-QMFQLIDI---ARQTAQGMDYLH-AK 151
Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNVSY-ICSRYYRAPELIFGAT 214
            I HRD+K  N+ ++     +K+ DFG A V  +  G   V     S  + APE+I    
Sbjct: 152 NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 215 E--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
              ++   D++S G V+ EL+ G+  +   +  DQ++ ++
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 45  GTGSFGVVFQAKCRETGEIVAIKKVL--------QDKRYKNRELQIMQMLDHPNIVALKH 96
           G G FGVV++     T   VA+KK+         + K+  ++E+++     H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 97  CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
               ++D                ++R+    S +    PL +     +  C+      N 
Sbjct: 87  -LGFSSDGDDLCLVYVYXPNGSLLDRL----SCLDGTPPLSW-----HXRCKIAQGAANG 136
Query: 157 IGICH------RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 207
           I   H      RDIK  N+L++      K+ DFG A+   K    V     + +  Y AP
Sbjct: 137 INFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQP 237
           E + G  E T   DI+S G V+ E++ G P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 196
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 197 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNG 335
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 196
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 197 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 268
Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNG 335
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 196
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 197 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 308
Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNG 335
           P  R +  E   HP+      P  ++  G
Sbjct: 309 PKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 196
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 197 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 280
Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNG 335
           P  R +  E   HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 78/209 (37%), Gaps = 42/209 (20%)
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 196
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 197 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           S + +  Y  PE I   +            +   D+WS GC++  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           Q++  I  L          ++PN+ E +FP I       V +           C   +  
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 261
Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNG 335
           P  R +  E   HP+      P  ++  G
Sbjct: 262 PKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 196
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 170
Query: 197 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 228
Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 229 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 264
Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNG 335
           P  R +  E   HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 42/209 (20%)
Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--- 196
           K Y   +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 197 SYICSRYYRAPELIFGATE----------YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           S + +  Y  PE I   +            +   D+WS GC++  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           Q+ ++  ++           +PN+ E +FP I       V +           C   +  
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPEKDLQDVLK----------CC--LKRD 260
Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNG 335
           P  R +  E   HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	376
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-101
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-95
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-93
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-92
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-92
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-89
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-89
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-89
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-89
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-88
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-88
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-87
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-86
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-86
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-84
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-84
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-84
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-80
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-62
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-60
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-59
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-59
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-58
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-58
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-58
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-57
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-57
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-56
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-55
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-54
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-53
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-53
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-53
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-53
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-53
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-53
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-52
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-52
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-51
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-51
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-51
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-50
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-50
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-50
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-50
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-50
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-50
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-50
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-49
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-49
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-49
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-49
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-49
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-48
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-48
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-48
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-48
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-48
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-48
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-48
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-48
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-48
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-47
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-47
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-47
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-47
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-46
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-46
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-44
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-44
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-43
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-43
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-43
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-43
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-41
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-41
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-40
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-40
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-40
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-40
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-40
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-40
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-40
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-39
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-39
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-39
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-39
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-39
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-38
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-38
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-38
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-37
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-37
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-37
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-36
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-36
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-36
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-36
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-36
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-35
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-35
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-34
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-32
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-09

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  617 bits (1593), Expect = 0.0
 Identities = 242/359 (67%), Positives = 287/359 (79%), Gaps = 5/359 (1%)

Query: 11  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 70
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query: 71  QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSR 129
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K +E+YLNLVL+YVPETV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query: 310 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 368
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS   P     LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHARIQ 385

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  613 bits (1584), Expect = 0.0
 Identities = 228/366 (62%), Positives = 286/366 (78%), Gaps = 5/366 (1%)

Query: 6   EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVA 65
               ++ +      +      G+ G  ++ ++Y    V+G GSFGVVFQAK  E+ E VA
Sbjct: 11  NGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VA 68

Query: 66  IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-ELYLNLVLEYVPETVNRIA 124
           IKKVLQDKR+KNRELQIM+++ HPN+V LK  F+S  DK+ E++LNLVLEYVPETV R +
Sbjct: 69  IKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS 128

Query: 125 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG 184
           R+Y+++ Q MP++ +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL++P +  LKL DFG
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFG 187

Query: 185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 244
           SAK+L+ GEPNVSYICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG
Sbjct: 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

Query: 245 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 304
           +DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307

Query: 305 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 364
           Y+P+ R TA+EA  HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I+RL+P+H
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQH 366

Query: 365 ARKQNL 370
           A  + L
Sbjct: 367 AEAELL 372

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  588 bits (1517), Expect = 0.0
 Identities = 163/358 (45%), Positives = 224/358 (62%), Gaps = 12/358 (3%)

Query: 18  GHVIRTTIGGRNG--NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 75
           G ++           + K+   +  E + G G+FG V   K + TG  VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 76  KNRELQIMQML---DHPNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRI 130
           +NRELQIMQ L    HPNIV L+  F++    D+ ++YLN+V+EYVP+T++R  RNY R 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 131 HQRMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 189
               P I +K++ +Q+ R++  +H   + +CHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
              EPNV+YICSRYYRAPELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYS 306
           EI++VLG P+RE ++ +NP++T+      K  PW  VF     +   EA DL+    QY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP-LFNFKPPELSGIPPETINRLIPE 363
           P  R    EA  HP+FDEL DP T+LPN + LP  LF F P E+  +      +L+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  565 bits (1457), Expect = 0.0
 Identities = 171/382 (44%), Positives = 243/382 (63%), Gaps = 43/382 (11%)

Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP 89
           G       Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 90  NIVALKHCFFSTTDK---------------------------------EELYLNLVLEYV 116
           NI+ L   F++T D+                                 +  YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 117 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH 176
           P+T++++ +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179

Query: 177 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 236
            LKLCDFGSAK L+  EP+V+YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 237 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAV 296
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 297 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPP 347
           DL+ +  +Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P 
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 348 ELSGIPPETINRLIPEHARKQN 369
           ELS IP   +NR++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  300 bits (771), Expect = e-101
 Identities = 105/312 (33%), Positives = 161/312 (51%), Gaps = 22/312 (7%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G GS+GVVF+ + R+TG+IVAIKK L+ +          RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
           F     + +  L+LV EY   TV      Y    + +P   VK  T+Q  +A+ + H   
Sbjct: 71  F-----RRKRRLHLVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 216
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 274
              +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 275 FPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
            P  +   P    F   +   A+ L+       P  R T  +   HP+F+ +R+    L 
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI-EDLA 298

Query: 334 NGRPLPPLFNFK 345
                P    + 
Sbjct: 299 KEHDKPAENLYF 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  295 bits (757), Expect = 1e-98
 Identities = 99/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           VG GS+G+V + + ++TG IVAIKK L+    K       RE+++++ L H N+V L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                 K+  YL  V E+V  T+      +      +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEY 216
            I HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 217 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 274
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 275 FPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
            P+IK   P  + +  +L    +DL  +     P+ R    E   H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  291 bits (748), Expect = 2e-97
 Identities = 99/324 (30%), Positives = 167/324 (51%), Gaps = 33/324 (10%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLD 87
           +YI    +G G++  V++ K + T  +VA+K++    R ++         RE+ +++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           H NIV L         ++ L L  V EY+ + + +   +       + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDDCG---NIINMHNVKLFLFQLL 110

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYY 204
           R LAY H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 261
           R P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            I      +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 322 FDELRDPNTRLPNGRPLPPLFNFK 345
           F  L +   +LP+   +  L   +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQ 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  291 bits (746), Expect = 7e-97
 Identities = 107/312 (34%), Positives = 158/312 (50%), Gaps = 33/312 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 94
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
               F         ++LV +++   +  I ++ S     +   ++K Y     + L Y+H
Sbjct: 78  -LDAFGHKSN----ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIF 211
               I HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 268
           GA  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
           +Y    F      P H +F      + +DL+   F ++P  R TA +A    +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 329 NTRLPNGRPLPP 340
                   P P 
Sbjct: 300 GPTPGCQLPRPN 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  286 bits (733), Expect = 4e-95
 Identities = 88/303 (29%), Positives = 146/303 (48%), Gaps = 23/303 (7%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQML-DHPNIVAL 94
           Y     +G G +  VF+A      E V +K +  ++ K+ K RE++I++ L   PNI+ L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
                    +       V E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
           +  GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 215 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 271
            Y  ++D+WS GC++A ++   +P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 272 EFK--FPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
            F     +     W +      Q  + PEA+D + +  +Y    R TA EA  HP+F  +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 326 RDP 328
              
Sbjct: 327 VKD 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  284 bits (728), Expect = 1e-94
 Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           VG G++GVV++AK    G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                 +  L L  V E++ + + ++          +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            I HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 271
           +Y+T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           +  F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  283 bits (727), Expect = 3e-94
 Identities = 89/315 (28%), Positives = 148/315 (46%), Gaps = 34/315 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD----KR-YKNRELQIMQMLDHPNI 91
           Y+    +G G  G+VF A   +  + VAIKK+ L D    K     RE++I++ LDH NI
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 92  VALKHCF-----------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK 140
           V +                S T+   +Y+  V EY+   +  +          +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 141 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--- 197
           L+ YQ+ R L YIH+   + HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 198 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
             + +++YR+P L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 257 TPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 314
               E+ + +      +          P  ++    +  EAVD + +   +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 315 EACVHPFFDELRDPN 329
           EA  HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  282 bits (725), Expect = 7e-94
 Identities = 90/313 (28%), Positives = 151/313 (48%), Gaps = 41/313 (13%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                    L+L  + EY    + +        +  + +  +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 158 GICHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 210
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 267
            G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
           P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A  HP+F     
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325

Query: 328 PNTRLPNGRPLPP 340
                       P
Sbjct: 326 ---------DFDP 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  280 bits (718), Expect = 3e-93
 Identities = 101/294 (34%), Positives = 158/294 (53%), Gaps = 28/294 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                 K+ L L  V E++ + + ++          +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 271
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E 
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  277 bits (711), Expect = 7e-92
 Identities = 97/318 (30%), Positives = 159/318 (50%), Gaps = 37/318 (11%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 94
           +G G++  V++   + TG  VA+K+V    +  +         RE+ +M+ L H NIV L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAY 152
                    + +L L  V E++   + +   +R      + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPEL 209
            H    I HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 266
           + G+  Y+T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 267 NPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            P Y      Q  P    +V Q      L    +D +    Q +P++R +A +A  HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 323 DELRDPNTRLPNGRPLPP 340
            E       +   R    
Sbjct: 298 AEYYHH-ASMGGSRSHHH 314

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  278 bits (714), Expect = 7e-92
 Identities = 106/349 (30%), Positives = 180/349 (51%), Gaps = 39/349 (11%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-KR-YKNRELQIMQMLDHPN 90
           +  + ++G G++GVV  A  + TGEIVAIKK+          R    RE++I++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 91  IVALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           I+ + +     + +   E+Y+  + E +   ++R+        Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLR 123

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 197
           A+  +H    + HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
           ++ +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 258 PTREEI--KCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 313
           P  +       +P   E+    P     P  K+F + + P+ +DL+ R   + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 314 LEACVHPFFDELRDPNTRLPNGRPLPPL-FNFKPPELSGIPPETINRLI 361
            EA  HP+     DPN   P G P+PP  F F       +  + + +LI
Sbjct: 301 KEALEHPYLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  276 bits (708), Expect = 8e-92
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 28/298 (9%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
                  ++L L  V E+  + + +   + +     +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELIFGAT 214
            + HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 215 EYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 270
            Y+T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
             +            V   +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 237 KPYPMYP-ATTSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  276 bits (709), Expect = 5e-91
 Identities = 92/336 (27%), Positives = 153/336 (45%), Gaps = 37/336 (11%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------------RELQI 82
           Y  +  + +GS+G V        G  VAIK+V                       RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 83  MQMLDHPNIVALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IY 138
           +    HPNI+ L+  F  F      +LYL  V E +   + ++        QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           ++ + Y I   L  +H   G+ HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 258
           +  R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 259 TREEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 314
             E++    +P   +Y       +    W  V      P A+DL+ +  +++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 315 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 350
           +A  HP+F+ L DP   L  G      F+F      
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHFDESVTD 345

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  271 bits (695), Expect = 1e-89
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQML---DHPNI 91
           +G G++G V++A+   +G  VA+K V                 RE+ +++ L   +HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L     ++    E+ + LV E+V + +             +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPE 208
           ++H    I HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 269 NYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
                    FP   P P   V    +      L+     ++P+ R +A  A  H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 326 RDPN 329
            + N
Sbjct: 304 -EGN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  271 bits (696), Expect = 2e-89
 Identities = 95/330 (28%), Positives = 158/330 (47%), Gaps = 33/330 (10%)

Query: 28  RNGNSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN-------RE 79
           ++G  +    Y     +G G++G VF+A+  +  G  VA+K+V      +        RE
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIRE 61

Query: 80  LQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL 136
           + +++ L   +HPN+V L      +    E  L LV E+V + +             +P 
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119

Query: 137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
             +K   +Q+ R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++       +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-M 174

Query: 197 SY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
           +    + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ 
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

Query: 254 VLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
           V+G P  E+     P         F      P  K     +     DL+ +   ++P  R
Sbjct: 234 VIGLPGEEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKR 288

Query: 311 CTALEACVHPFFDELRDPNTRLPNGRPLPP 340
            +A  A  HP+F +L      L +   LPP
Sbjct: 289 ISAYSALSHPYFQDLERCKENLDS--HLPP 316

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  272 bits (698), Expect = 2e-89
 Identities = 98/305 (32%), Positives = 161/305 (52%), Gaps = 27/305 (8%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y++   VG+G++G V  A  + +GE VAIKK+          +   REL +++ + H N+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 92  VALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           + L   F   +      + YL  V+ ++   + +I      +  +     ++   YQ+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKI------MGLKFSEEKIQYLVYQMLK 137

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAP 207
            L YIH+  G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYRAP 192

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 266
           E+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ + 
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252

Query: 267 NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           +     +    PQ     + ++F  R  P+A DL+ +  +   + R TA +A  HPFF+ 
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

Query: 325 LRDPN 329
            RDP 
Sbjct: 312 FRDPE 316

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  272 bits (698), Expect = 2e-89
 Identities = 93/306 (30%), Positives = 164/306 (53%), Gaps = 24/306 (7%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 92
           Y     +G G++G+V  A        VAIKK+         +   RE++I+    H NI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 93  ALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            +       +    +++Y+  V + +   + ++ +      Q +   ++  + YQI R L
Sbjct: 89  GINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGL 141

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----YICSRYYRA 206
            YIH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259

Query: 267 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
            N     +    P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

Query: 324 ELRDPN 329
           +  DP+
Sbjct: 319 QYYDPS 324

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  270 bits (692), Expect = 2e-88
 Identities = 97/305 (31%), Positives = 158/305 (51%), Gaps = 26/305 (8%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y     VG+G++G V  A    TG  VAIKK+          +   REL++++ + H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 92  VALKHCFF---STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           + L   F    +  D  + YL  V+ ++   + ++ ++     +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-YICSRYYRAP 207
            L YIH   GI HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 266
           E+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 267 NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           +     +    P+++   +  +      P AV+L+ +        R TA EA  HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 325 LRDPN 329
           L D  
Sbjct: 314 LHDTE 318

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  269 bits (690), Expect = 4e-88
 Identities = 94/335 (28%), Positives = 153/335 (45%), Gaps = 34/335 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y     +G+G+ G+V  A        VAIKK+          +   REL +M+ ++H NI
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 92  VALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           + L + F      E   ++Y+  V+E +   + ++      I   +    +    YQ+  
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQV------IQMELDHERMSYLLYQMLC 138

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           +I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P
Sbjct: 197 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 269 NYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALE 315
               +    P+   + + K+F            K    +A DL+ +      + R +  E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315

Query: 316 ACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 350
           A  HP+ +   DP+       P  P       E +
Sbjct: 316 ALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  266 bits (682), Expect = 5e-87
 Identities = 88/315 (27%), Positives = 139/315 (44%), Gaps = 26/315 (8%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 97
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 98  FFSTTDKEELYLN---LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             +             LV ++    +  +  N   +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNVSY---ICSRYYRAPEL 209
               I HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 266
           + G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 267 NPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
              Y + +  + +        +     P A+DL+ +     P  R  + +A  H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317

Query: 326 RDPNTRLPNGRPLPP 340
            DP      G     
Sbjct: 318 -DPMPSDLKGMLSTH 331

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  268 bits (687), Expect = 2e-86
 Identities = 94/316 (29%), Positives = 151/316 (47%), Gaps = 37/316 (11%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 89
           Y     +G+G+ G+V  A        VAIKK+ +        KR Y  REL +M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 90  NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 146
           NI++L + F      E   ++YL  V+E +   + ++      I   +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQV------IQMELDHERMSYLLYQM 173

Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
              + ++H+  GI HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE+I G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 267 NPNYTEF--KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTA 313
            P    +    P+     + K+F            K    +A DL+ +     P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 314 LEACVHPFFDELRDPN 329
            +A  HP+ +   DP 
Sbjct: 351 DDALQHPYINVWYDPA 366

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  264 bits (678), Expect = 3e-86
 Identities = 104/306 (33%), Positives = 159/306 (51%), Gaps = 28/306 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 89
           Y     VG+G++G V  A   +TG  VA+KK+ +        KR Y  REL++++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 90  NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 146
           N++ L   F      E   ++YL  V   +   +N I +      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 147 CRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
            R L YIH+   I HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRA
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTG--YVATRWYRA 197

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K +
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257

Query: 267 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
            + +   +     Q+    +  VF     P AVDL+ +      + R TA +A  H +F 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

Query: 324 ELRDPN 329
           +  DP+
Sbjct: 317 QYHDPD 322

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  260 bits (666), Expect = 3e-84
 Identities = 97/373 (26%), Positives = 176/373 (47%), Gaps = 65/373 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---QD----KR-YKNRELQIMQ-MLDH 88
           Y     +G G++G+V+++  R TGE+VA+KK+    Q+    +R +  RE+ I+  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 89  PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
            NIV L +   +  D++ +YL  V +Y+   ++ + R        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIK 120

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS----------- 197
            + Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 198 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 247 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLP----------- 292
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 293 ----PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE 348
                EA+DL+ +  Q++PN R +A +A  HPF     +PN           +      +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIITIPIND 354

Query: 349 LSGIPPETINRLI 361
                 +    L+
Sbjct: 355 NVKHSIDDYRNLV 367

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  262 bits (672), Expect = 3e-84
 Identities = 107/366 (29%), Positives = 160/366 (43%), Gaps = 87/366 (23%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 89
           Y   H++GTGS+G V +A  +    +VAIKK+L+        KR    RE+ I+  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 90  NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 145
           ++V +            +ELY+  VLE       ++          + L  +++K   Y 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYV--VLEIADSDFKKL------FRTPVYLTELHIKTLLYN 164

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 197
           +   + Y+H+  GI HRD+KP N LVN     +K+CDFG A+ +   E   S        
Sbjct: 165 LLVGVKYVHSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 198 --------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--- 234
                               ++ +R+YRAPELI     YT AID+WS GC+ AELL    
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 235 --------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM 266
                     PLFPG S                      DQL  I  +LGTP+ E+I+ +
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342

Query: 267 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
              +   +   FP+ +     + F      +A+ L+ R   ++PN R T  E   HPFF 
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401

Query: 324 ELRDPN 329
           E+R   
Sbjct: 402 EVRIAE 407

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  261 bits (668), Expect = 6e-84
 Identities = 104/358 (29%), Positives = 159/358 (44%), Gaps = 79/358 (22%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQD-KR-YKNRELQIMQMLDHP 89
           YI +H++G GS+G V+ A  + T + VAIKKV      L D KR    RE+ I+  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 90  NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 145
            I+ L            +ELY+  VLE     + ++          + L   ++K   Y 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL------FKTPIFLTEEHIKTILYN 137

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-------- 197
           +     +IH   GI HRD+KP N L+N     +K+CDFG A+ +   +            
Sbjct: 138 LLLGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 198 ---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ------ 236
                          ++ +R+YRAPELI     YT +IDIWSTGC+ AELL         
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 237 -----PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF 273
                PLFPG S                   DQL  I  ++GTPT +++K +  P   ++
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315

Query: 274 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
              FP  KP    + +   +  + ++L+    +++PN R T  +A  HP+  ++R   
Sbjct: 316 IKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  252 bits (644), Expect = 1e-80
 Identities = 89/362 (24%), Positives = 159/362 (43%), Gaps = 44/362 (12%)

Query: 44  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 99
           VG G++G V++AK ++    +  A+K++       +  RE+ +++ L HPN+++L+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 100 STTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           S  D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 155 NCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNVSY------ICSRYYR 205
               + HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQLVEIIKVLG 256
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 257 TPTRE---------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 307
            P  +         E   +  ++    +       + +  + +   +A  L+ +     P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 308 NLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 367
             R T+ +A   P+F E  DP             +  +       P +  ++   +  + 
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQG 380

Query: 368 QN 369
            N
Sbjct: 381 NN 382

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  204 bits (521), Expect = 3e-62
 Identities = 92/338 (27%), Positives = 149/338 (44%), Gaps = 73/338 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 88
           Y    V+G GSFG V +A   +  + VA+K V  +KR+      E++I++ L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 89  PNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLI 137
            N++ +   F         F     E L +NL  +++      N+         Q   L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF-----ELLSMNLYELIKK-----NK--------FQGFSLP 200

Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
            V+ + + I + L  +H    I H D+KP+N LL       +K+ DFGS+      +   
Sbjct: 201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVY 257

Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
           +YI SR+YRAPE+I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG
Sbjct: 258 TYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316

Query: 257 TPTREEIK-----------CMNPNYTEFKF---------------PQIKPHPWHKVFQKR 290
            P+++ +               P Y                     +++  P  + +   
Sbjct: 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376

Query: 291 LPPEA----VDLVCRFFQYSPNLRCTALEACVHPFFDE 324
           L        +D + +  ++ P +R T  +A  HP+   
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  196 bits (501), Expect = 9e-60
 Identities = 86/340 (25%), Positives = 137/340 (40%), Gaps = 44/340 (12%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 89
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 90  NIVALKHC-----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 144
           + +   H       F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNVSYI 199
           Q+   L Y+H   GI H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 253
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP--------------EAVDLV 299
           +LG      ++        F   +       K+    L                E  D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 300 CRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 339
               Q  P  R  A     HP+  +           R L 
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  196 bits (499), Expect = 2e-59
 Identities = 100/385 (25%), Positives = 149/385 (38%), Gaps = 90/385 (23%)

Query: 3   KTDEPDIIDGVGAETGH---VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRE 59
           K +     DG   +              R         Y  + ++G GSFG V +A  R 
Sbjct: 27  KKERKVYNDGYDDDNYDYIVKNGEKWMDR---------YEIDSLIGKGSFGQVVKAYDRV 77

Query: 60  TGEIVAIKKVLQDKRYKN---RELQIMQML------DHPNIVALKHCF---------FST 101
             E VAIK +   K + N    E+++++++          IV LK  F         F  
Sbjct: 78  EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF-- 135

Query: 102 TDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLIYVKLYTYQICRALAYIHNC-IG 158
              E L  NL              +  R      + L   + +  Q+C AL ++    + 
Sbjct: 136 ---EMLSYNL-------------YDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS 179

Query: 159 ICHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 217
           I H D+KP+N LL NP    +K+ DFGS+     G+    YI SR+YR+PE++ G   Y 
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYD 236

Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---------------- 261
            AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P                   
Sbjct: 237 LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLP 296

Query: 262 ----EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA---------------VDLVCRF 302
                +K       E+K P  +        +   P                   DL+ R 
Sbjct: 297 DGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356

Query: 303 FQYSPNLRCTALEACVHPFFDELRD 327
             Y P  R     A  H FF +  D
Sbjct: 357 LDYDPKTRIQPYYALQHSFFKKTAD 381

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  192 bits (490), Expect = 7e-59
 Identities = 68/319 (21%), Positives = 115/319 (36%), Gaps = 60/319 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPN- 90
           Y     +G+G    VFQ    E  +I AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 91  -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            I+ L          + +Y+  V+E     +N   +      + +     K Y   +  A
Sbjct: 89  KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 139

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
           +  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 207 PELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
           PE I             ++ +   D+WS GC++  +  G+  F         +  I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 252

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
                    ++PN+ E +FP I               +  D++    +  P  R +  E 
Sbjct: 253 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 290

Query: 317 CVHPFFDELRDPNTRLPNG 335
             HP+      P  ++  G
Sbjct: 291 LAHPYVQIQTHPVNQMAKG 309

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  192 bits (489), Expect = 3e-58
 Identities = 77/346 (22%), Positives = 131/346 (37%), Gaps = 82/346 (23%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 89
           ++    +G G+FG V   +  +  +  A+K V   K+Y      E  I++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 90  NIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLIY 138
           NIV     F         F     E L  +L  ++            NY        +  
Sbjct: 97  NIVKYHGKFMYYDHMCLIF-----EPLGPSLYEIIT---------RNNY----NGFHIED 138

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------------PH 174
           +KLY  +I +AL Y+     + H D+KP+N+L++                          
Sbjct: 139 IKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 175 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 234
           +  +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  
Sbjct: 198 STGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYT 254

Query: 235 GQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKPHPWHK 285
           G  LF     ++ L  +  ++    +  +         K +N +  +  +P+        
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSI 314

Query: 286 VFQKRLPPEA--------VDLVCRFFQYSPNLRCTALEACVHPFFD 323
              K+  P           D +    Q  P LR +  E   H F +
Sbjct: 315 KHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  191 bits (487), Expect = 5e-58
 Identities = 79/354 (22%), Positives = 129/354 (36%), Gaps = 76/354 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 87
           Y     +G G+FG V +      G   VA+K +    +Y+     E+ +++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 88  HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 136
               V +   F         F     E L  N    L+           N+    Q  PL
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAF-----ELLGKNTFEFLK---------ENNF----QPYPL 122

Query: 137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 178
            +V+   YQ+C AL ++H    + H D+KP+N+L                         +
Sbjct: 123 PHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 179 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 238
           ++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC++ E   G  L
Sbjct: 182 RVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTL 238

Query: 239 FPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKPHPWHKVFQK 289
           F      + LV + K+LG      I               + E            K  + 
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298

Query: 290 RLPPEA------VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 337
            +  ++       DL+ R  ++ P  R T  EA +HPFF  L          R 
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  190 bits (485), Expect = 7e-58
 Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 60/319 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN- 90
           Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 91  -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            I+ L          + +Y+  V+E     +N   +      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 120

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRA 206
           +  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 207 PELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
           PE I             ++ +   D+WS GC++  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
                    ++PN+ E +FP I               +  D++    +  P  R +  E 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 317 CVHPFFDELRDPNTRLPNG 335
             HP+      P  ++  G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  191 bits (488), Expect = 8e-58
 Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 60/325 (18%)

Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQM 85
           S +   Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 86  LDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 143
           L   +  I+ L          + +Y+  V+E     +N   +      + +     K Y 
Sbjct: 111 LQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYW 161

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYIC 200
             +  A+  IH   GI H D+KP N L+      LKL DFG A  +     +V   S + 
Sbjct: 162 KNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 201 SRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 250
           +  Y  PE I             ++ +   D+WS GC++  +  G+  F         + 
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 310
            I             ++PN+ E +FP I               +  D++    +  P  R
Sbjct: 279 AI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQR 312

Query: 311 CTALEACVHPFFDELRDPNTRLPNG 335
            +  E   HP+      P  ++  G
Sbjct: 313 ISIPELLAHPYVQIQTHPVNQMAKG 337

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  189 bits (482), Expect = 1e-57
 Identities = 58/304 (19%), Positives = 110/304 (36%), Gaps = 27/304 (8%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 92
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            L      TT +    L  ++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTRH-KVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 151 AYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 208 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 258
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 318
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 319 HPFF 322
               
Sbjct: 303 ETSD 306

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  187 bits (478), Expect = 8e-57
 Identities = 78/345 (22%), Positives = 135/345 (39%), Gaps = 76/345 (22%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 87
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q+++ L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 88  HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 136
               V +   F         F     E L L+    ++            +        L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVF-----ELLGLSTYDFIK---------ENGF----LPFRL 117

Query: 137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN------------------PHTHQL 178
            +++   YQIC+++ ++H+   + H D+KP+N+L                         +
Sbjct: 118 DHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 179 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL 238
           K+ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  LG  +
Sbjct: 177 KVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 239 FPGESGVDQLVEIIKVLGTPTREEIK---------CMNPNYTEFKFPQIKPHPWHKVFQK 289
           FP     + L  + ++LG   +  I+             ++ E            K  ++
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293

Query: 290 RLPPE------AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
            +  +        DL+ +  +Y P  R T  EA  HPFFD L+  
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  185 bits (471), Expect = 2e-56
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 42/299 (14%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHCF 98
           V+G G++G+V+  +       +AIK++  +D RY      E+ + + L H NIV      
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83

Query: 99  FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
           +  +  E  ++ + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN 141

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIFGATE 215
             I HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I     
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 216 -YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y  A DIWS GC + E+  G+P F       +L E    +                 FK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------FK 237

Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 333
               K HP      + +  EA   + + F+  P+ R  A +  V  F           P
Sbjct: 238 VGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  184 bits (470), Expect = 5e-56
 Identities = 67/287 (23%), Positives = 106/287 (36%), Gaps = 49/287 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM-QMLDHPNIVALK 95
            +G GS+G VF+ + +E G + A+K+ +      +D+  K  E+    ++  HP  V L+
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +    +   LY  L  E    +   + ++       +P   V  Y      ALA++H+
Sbjct: 124 QAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             G+ H D+KP N+ + P     KL DFG    L              Y APEL+     
Sbjct: 176 Q-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGS 231

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y TA D++S G  + E+     L  G  G  QL +                         
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--------------------- 270

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
           P+             L  E   ++    +  P LR TA      P  
Sbjct: 271 PEFTAG---------LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  187 bits (476), Expect = 1e-55
 Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 51/302 (16%)

Query: 35  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIV 92
           K+S+  + V+G G+ G +   +       VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
                      K+  +  + +E         + +         P+  ++    Q    LA
Sbjct: 82  RYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLA 132

Query: 152 YIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNVSY---IC-SRY 203
           ++H+   I HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  
Sbjct: 133 HLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 204 YRAPELIFGATE--YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 260
           + APE++    +   T  +DI+S GCV   ++  G   F                G   +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQ 235

Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
            +   +            + H             A +L+ +     P  R +A     HP
Sbjct: 236 RQANILLGAC-SLDCLHPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHP 285

Query: 321 FF 322
           FF
Sbjct: 286 FF 287

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  184 bits (467), Expect = 5e-55
 Identities = 50/338 (14%), Positives = 90/338 (26%), Gaps = 57/338 (16%)

Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQ 84
           S+ +        +  G   VVF  +  E  E  A+K                +       
Sbjct: 58  SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117

Query: 85  MLDHPNIVALKHCF---------------------FSTTDKEELYLNLVLEYVP---ETV 120
            L   +    +                            D       L++       E +
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 121 NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL 180
                          ++ + + T Q+ R  A + +  G+ H    P NL + P    L L
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LML 235

Query: 181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLF 239
            D  +   +  G    +      Y   E +      +T A++ W  G  +  +      F
Sbjct: 236 GDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 240 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 299
              +   +       L  P  +                             LP     L+
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLI 333

Query: 300 CRFFQYSPNLRCTALEACVHPFFDELRD-PNTRLPNGR 336
            RF  +    R   LEA   P F +L++  ++ L  G+
Sbjct: 334 GRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  183 bits (466), Expect = 2e-54
 Identities = 63/313 (20%), Positives = 115/313 (36%), Gaps = 32/313 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 92
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            L      TT +      L++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125

Query: 151 AYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            ++    GI HR+IKP N++           KL DFG+A+ L   E  VS   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 208 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 258
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 318
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 319 HPFFDELRDPNTR 331
             FF E  D   R
Sbjct: 300 --FFAETSDILHR 310

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  178 bits (454), Expect = 1e-53
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 61/320 (19%)

Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD 87
           + +    +    V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60

Query: 88  HPNIVALKHCF--------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 137
           H  +V     +          T  K++  L + +EY       + I        +     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
             +    QI  AL+YIH+  GI HRD+KP N+ ++  +  +K+ DFG AK + +    + 
Sbjct: 121 LFR----QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILK 174

Query: 198 YICSR---------------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 242
                                Y A E++ G   Y   ID++S G +  E++   P   G 
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGM 232

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
                 V I+K L +                +FP     P    F          ++   
Sbjct: 233 E----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLL 267

Query: 303 FQYSPNLRCTALEACVHPFF 322
             + PN R  A       + 
Sbjct: 268 IDHDPNKRPGARTLLNSGWL 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  182 bits (463), Expect = 1e-53
 Identities = 75/323 (23%), Positives = 127/323 (39%), Gaps = 60/323 (18%)

Query: 29  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD 87
           N     K   ++E ++G GS G V   +    G  VA+K++L D       E++++   D
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66

Query: 88  -HPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARN--YSRIHQRMPLIYVKLYT 143
            HPN++   +C  +      LY+   LE       + +          +           
Sbjct: 67  DHPNVIRY-YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVK 191
            QI   +A++H+   I HRD+KPQN+LV+  +             ++ + DFG  K L  
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 192 GEPNVSY----IC-SRYYRAPELIFGATE------YTTAIDIWSTGCVMAELL-LGQPLF 239
           G+ +          +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 240 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 299
             +    +   II+                   F   ++K      +       EA DL+
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276

Query: 300 CRFFQYSPNLRCTALEACVHPFF 322
            +   + P  R TA++   HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  182 bits (465), Expect = 2e-53
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 52/318 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 91
           Y     +G+G++G V   + + T    AIK +               E+ ++++LDHPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 147
           + L   F     +++    LV+E     E  + I     ++        +   +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE-------VDAAVIIKQVL 146

Query: 148 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
             + Y+H    I HRD+KP+N LL +      +K+ DFG + V    +     + + YY 
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE++    +Y    D+WS G ++  LL G P F G++  DQ  EI+         +++ 
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
               +            W  V        A DL+ +  Q+    R +A +A  HP+  E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 326 RDPNTRLPNGRPLPPLFN 343
                       L     
Sbjct: 299 CSKKESGIELPSLANAIE 316

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  177 bits (450), Expect = 3e-53
 Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           V          D+    L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 151 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 205
              H        + HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           +PE +     Y    DIWS GC++ EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                 E KF +I               E  +++ R        R +  E   +P   E
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  181 bits (462), Expect = 5e-53
 Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 49/296 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPN 90
           Y  + V+G GSFG V   K + TG+  A+K +    ++ K  K    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           I+ L   F     +++ Y  LV E     E  + I        +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLS 137

Query: 149 ALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRA 206
            + Y+H    I HRD+KP+N LL +      +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE++ G   Y    D+WSTG ++  LL G P F G +  +   +I+        ++++  
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
              +            W KV        A DL+ +   Y P++R +A +A  H + 
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  181 bits (461), Expect = 7e-53
 Identities = 76/318 (23%), Positives = 129/318 (40%), Gaps = 52/318 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 91
           Y    ++G GSFG V + K R T +  A+K +       +D     RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 147
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 148 RALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
             + Y+H    I HRD+KP+N LL +      +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE++ G   Y    D+WS G ++  LL G P F G++  +   +I+        + ++ 
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
               +            W  +       +A DL+ +   + P+LR TA +   HP+  + 
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 326 RDPNTRLPNGRPLPPLFN 343
                 + +   L     
Sbjct: 284 SSETPTISDLPSLESAMT 301

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  184 bits (469), Expect = 8e-53
 Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 29/322 (9%)

Query: 26  GGRNGNSKQKV--SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----R 78
           GGR+ +   +    +  +  +GTG FG V +   ++TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 79  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP--ETVNRIARNYSRIHQRMP 135
           E+QIM+ L+HPN+V+ +             L  L +EY    +    + +        + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119

Query: 136 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGE 193
              ++     I  AL Y+H    I HRD+KP+N+++ P   +   K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 194 PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
               ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ----YSPNL 309
                + E I   +      KF  + P P        L       + R+ Q    +    
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTP------NHLSGILAGKLERWLQCMLMWHQRQ 288

Query: 310 RCTALEACVHPFFDELRDPNTR 331
           R T  +      F  L    + 
Sbjct: 289 RGTDPQNPNVGCFQALDSILSL 310

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  179 bits (457), Expect = 4e-52
 Identities = 81/306 (26%), Positives = 127/306 (41%), Gaps = 59/306 (19%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------------REL 80
           Y     +G+G++G V   K +      AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 81  QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY 138
            +++ LDHPNI+ L   F    DK+  Y  LV E+    E   +I  N  +  +      
Sbjct: 98  SLLKSLDHPNIIKLFDVF---EDKKYFY--LVTEFYEGGELFEQII-NRHKFDEC----D 147

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNV 196
                 QI   + Y+H    I HRDIKP+N LL N ++   +K+ DFG +    K     
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206

Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
             + + YY APE++    +Y    D+WS G +M  LL G P F G++  DQ  +II    
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
               ++++     +          + W  +       EA +L+     Y  N RCTA EA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 317 CVHPFF 322
               + 
Sbjct: 300 LNSRWI 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  175 bits (445), Expect = 5e-52
 Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 47/292 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKH 96
              +  VG GSFG V + K ++TG   A+KKV L+   ++  EL     L  P IV L  
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                  +E  ++N+ +E +   ++ ++ +        +P      Y  Q    L Y+H 
Sbjct: 118 AV-----REGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHT 168

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRAPEL 209
              I H D+K  N+L++    +  LCDFG A  L       S +          + APE+
Sbjct: 169 R-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           + G       +DIWS+ C+M  +L G   +         ++I      P           
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI---------- 275

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                  +I P            P     +    +  P  R +A+E      
Sbjct: 276 ------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  177 bits (451), Expect = 6e-52
 Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 54/305 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQM 85
           YI    +G+G+ G V  A  R+T + VAI+ + + K                 E++I++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 143
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 245

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 201
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 202 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 360

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 361 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 320 PFFDE 324
           P+  +
Sbjct: 401 PWLQD 405

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  173 bits (441), Expect = 7e-52
 Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 56/297 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 96
            +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
            + ST   ++  + LV E +   T+    + Y +  + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 156 C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNVSYICSRYYRAP 207
               I HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E+     +Y  ++D+++ G  M E+   +  +       Q+   +               
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-------------- 243

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                     +KP      F K   PE  +++    + + + R +  +   H FF E
Sbjct: 244 --------SGVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  174 bits (442), Expect = 1e-51
 Identities = 66/328 (20%), Positives = 103/328 (31%), Gaps = 56/328 (17%)

Query: 24  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRE 79
            I  ++        Y+    +G G F  V   +    G   A+K++L    QD+    RE
Sbjct: 25  IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76

Query: 80  LQIMQMLDHPNIVALKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 137
             + ++ +HPNI+ L          K E +  L+L +    T+             +   
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----- 192
            +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS            
Sbjct: 135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSR 192

Query: 193 -----EPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 245
                +   +  C+  YRAPEL             D+WS GCV+  ++ G+  +      
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 305
              V +  V                 +   PQ            R       L+      
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286

Query: 306 SPNLRCTALEACVHPFFDELRDPNTRLP 333
            P+ R             +   P     
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPGQHTT 314

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  172 bits (438), Expect = 2e-51
 Identities = 77/327 (23%), Positives = 121/327 (37%), Gaps = 68/327 (20%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 90
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 77  VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 126

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 199
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 127 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 180

Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
               Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K      
Sbjct: 181 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 230

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 231 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 266

Query: 320 PFFDELRDPNTRLPNGRPLPPLFNFKP 346
            FF     P         +PP F+  P
Sbjct: 267 EFFTSGYIPARLPITCLTIPPRFSIAP 293

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  171 bits (435), Expect = 5e-51
 Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 46/317 (14%)

Query: 19  HVIRTTIGGRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQ 71
           H    + G  N   +  +   +I +  +G+G+FG V   + R +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 72  DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSR 129
                  E+++++ LDHPNI+ +   F    D   +Y  +V+E     E + RI    +R
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMY--IVMETCEGGELLERIVSAQAR 117

Query: 130 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK 187
             + +   YV     Q+  ALAY H+   + H+D+KP+N+L    +    +K+ DFG A+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 247
           +    E + +   +  Y APE+     + T   DIWS G VM  LL G   F G S  + 
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 307
             +                     E  +               L P+AVDL+ +     P
Sbjct: 234 QQKATYK-----------------EPNYA---VECRP------LTPQAVDLLKQMLTKDP 267

Query: 308 NLRCTALEACVHPFFDE 324
             R +A +   H +F +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  172 bits (438), Expect = 6e-51
 Identities = 80/341 (23%), Positives = 125/341 (36%), Gaps = 71/341 (20%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 90
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           +V     F    D + ++  +VLE       +    R      + +     + Y  QI  
Sbjct: 103 VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 152

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYI 199
              Y+H    + HRD+K  NL +N    ++K+ DFG + KV   GE        PN    
Sbjct: 153 GCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPN---- 206

Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
               Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K      
Sbjct: 207 ----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                       E+  P              + P A  L+ +  Q  P  R T  E    
Sbjct: 257 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 292

Query: 320 PFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 360
            FF     P         +PP F+  P   S + P     L
Sbjct: 293 EFFTSGYIPARLPITCLTIPPRFSIAP---SSLDPSNRKPL 330

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  169 bits (431), Expect = 2e-50
 Identities = 58/305 (19%), Positives = 110/305 (36%), Gaps = 52/305 (17%)

Query: 31  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 90
           + +  + +    ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH N
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65

Query: 91  IVALKHCF-----------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 137
           IV    C+            +++  +   L + +E+         I +   R  +++  +
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKV 122

Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
                  QI + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L        
Sbjct: 123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
              +  Y +PE I    +Y   +D+++ G ++AELL                ++      
Sbjct: 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD---- 233

Query: 258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                                       +       +   L+ +     P  R    E  
Sbjct: 234 ---------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

Query: 318 VHPFF 322
                
Sbjct: 267 RTLTV 271

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  170 bits (433), Expect = 2e-50
 Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 44/294 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 90
           +  E  +G G F  V++A C   G  VA+KKV        + +    +E+ +++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           ++     F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C A
Sbjct: 94  VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNVSYICSRYYRAPE 208
           L ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN 267
            I     Y    DIWS GC++ E+   Q  F G+   +  L + I+              
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------------- 251

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
               +  +P +               E   LV       P  R           
Sbjct: 252 ----QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  172 bits (438), Expect = 2e-50
 Identities = 89/355 (25%), Positives = 136/355 (38%), Gaps = 51/355 (14%)

Query: 3   KTDEPDIID---GVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRE 59
           K D P I D            +   +  + G+      Y     +G+G+FGVV +   + 
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEELGSGAFGVVHRCVEKA 74

Query: 60  TGEIVAIK----KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY 115
           TG +   K        DK     E+ IM  L HP ++ L   F    DK E+   L+LE+
Sbjct: 75  TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---EDKYEMV--LILEF 129

Query: 116 VP--ETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-V 171
           +   E  +RI A +Y      M    V  Y  Q C  L ++H    I H DIKP+N++  
Sbjct: 130 LSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCE 183

Query: 172 NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAE 231
                 +K+ DFG A  L   E       +  + APE I          D+W+ G +   
Sbjct: 184 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIGVLGYV 242

Query: 232 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL 291
           LL G   F GE  ++ L  + +                  +++F       +  V     
Sbjct: 243 LLSGLSPFAGEDDLETLQNVKRC-----------------DWEFD---EDAFSSV----- 277

Query: 292 PPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPNGRPLPPLFNFK 345
            PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R        K
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 332

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  170 bits (434), Expect = 2e-50
 Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 54/303 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN--------RELQIMQM 85
           YI    +G+G+ G V  A  R+T + VAIK    +       +          E++I++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 143
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 72  LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 120

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICS 201
           YQ+  A+ Y+H   GI HRD+KP+N+L++       +K+ DFG +K+L +     +   +
Sbjct: 121 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 202 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 235

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 236 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 275

Query: 320 PFF 322
           P+ 
Sbjct: 276 PWL 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  170 bits (432), Expect = 2e-50
 Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 52/306 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIVA 93
           +I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRA 149
           L+  +         Y  LV++ V   E  +RI     Y+   ++   + ++    Q+  A
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118

Query: 150 LAYIHNCIGICHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRA 206
           + Y+H   GI HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE +     Y+ A+D WS G +   LL G P F  E+      +I +             
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                 ++F       W  +        A D +C   +  PN R T  +A  HP+ D   
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269

Query: 327 DPNTRL 332
             +  +
Sbjct: 270 ALHRDI 275

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  168 bits (429), Expect = 3e-50
 Identities = 76/306 (24%), Positives = 123/306 (40%), Gaps = 66/306 (21%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKHC 97
           G G FG V+ A+ +++  I+A+K     ++ +        RE++I   L HPNI+ L   
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 98  FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    D   +Y  L+LEY P       + +       +        Y  ++  AL+Y H+
Sbjct: 78  FH---DATRVY--LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS 127

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRAPE 208
              + HRDIKP+NLL+      LK+ DFG +            G  +        Y  PE
Sbjct: 128 K-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLPPE 177

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           +I G   +   +D+WS G +  E L+G+P F   +  +    I +V              
Sbjct: 178 MIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------- 222

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
              EF FP      +       +   A DL+ R  +++P+ R    E   HP+       
Sbjct: 223 ---EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267

Query: 329 NTRLPN 334
            +   N
Sbjct: 268 PSNCQN 273

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  168 bits (429), Expect = 3e-50
 Identities = 84/307 (27%), Positives = 132/307 (42%), Gaps = 52/307 (16%)

Query: 30  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIM 83
           G++K  ++  Y  E+ +G GS+G V  A  + T    A K      ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 84  QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 139
           + LDHPNI+ L   F    D  ++Y  LV+E     E   R+     +            
Sbjct: 61  KSLDHPNIIRLYETF---EDNTDIY--LVMELCTGGELFERVVHKRVFRE-------SDA 108

Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVS 197
                 +  A+AY H    + HRD+KP+N L    +    LKL DFG A     G+   +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

Query: 198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +    
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222

Query: 258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                          F FP      W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 318 VHPFFDE 324
            H +F++
Sbjct: 261 EHEWFEK 267

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  171 bits (434), Expect = 3e-50
 Identities = 78/359 (21%), Positives = 127/359 (35%), Gaps = 68/359 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           V  +  F     +E   L +V++Y    +   RI     +         +  +  QIC A
Sbjct: 86  VQYRESF-----EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLA 137

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 208
           L ++H+   I HRDIK QN+ +      ++L DFG A+VL            + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           +      Y    DIW+ GCV+ EL   +  F   S +  LV  I             ++ 
Sbjct: 196 ICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------SGSFPPVSL 247

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL--- 325
           +Y                       +   LV + F+ +P  R +        F  +    
Sbjct: 248 HY---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

Query: 326 -----------------RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 367
                            +  +  +P  RP     +        I        IP   +K
Sbjct: 287 FLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKK 345

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  170 bits (432), Expect = 4e-50
 Identities = 82/348 (23%), Positives = 133/348 (38%), Gaps = 84/348 (24%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---------QDKRYKNRELQIMQMLDH 88
           Y  +  +G GS+GVV  A   +T  I AIK +          +D      E+++M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 89  PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKL----- 141
           PNI  L   +    D++ + L  V+E       ++++         +  +  VK      
Sbjct: 88  PNIARLYEVY---EDEQYICL--VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 142 ------------------------------YTYQICRALAYIHNCIGICHRDIKPQN-LL 170
                                            QI  AL Y+HN  GICHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201

Query: 171 VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-----SRYYRAPELIFGATE-YTTAIDIWS 224
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 225 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            G ++  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 285 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 332
            +      P A DL+      + + R  A+ A  HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  168 bits (427), Expect = 2e-49
 Identities = 74/295 (25%), Positives = 122/295 (41%), Gaps = 54/295 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVA---IKKVLQDKRYKNRELQIMQMLDHPNIVAL 94
           Y+    +G G FG+V +     + +      +K    D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VKLYTYQIC 147
              F      EEL   ++ E++   +   RI    +               +  Y +Q+C
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112

Query: 148 RALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYR 205
            AL ++H+   I H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y 
Sbjct: 113 EALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYY 170

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE +      +TA D+WS G ++  LL G   F  E+  +Q  +II        E I  
Sbjct: 171 APE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMN 217

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
               + E  F +I               EA+D V R        R TA EA  HP
Sbjct: 218 AEYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  173 bits (440), Expect = 3e-49
 Identities = 76/308 (24%), Positives = 130/308 (42%), Gaps = 45/308 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 93
           Y     +GTG+FGVV +   R TG   A K V      DK    +E+Q M +L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           L   F    D  E+   ++ E++   E   ++A  ++++ +   + Y++    Q+C+ L 
Sbjct: 219 LHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 152 YIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF--DELRDP 328
            +  F  I               +  D + +     PN R T  +A  HP+         
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 329 NTRLPNGR 336
           ++++P+ R
Sbjct: 423 DSQIPSSR 430

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  168 bits (428), Expect = 3e-49
 Identities = 85/325 (26%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 88
           Y    V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 89  PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLY 142
           P+IV L   +   +    LY  +V E++   +    I +           +Y       Y
Sbjct: 86  PHIVELLETY---SSDGMLY--MVFEFMDGADLCFEIVK-----RADAGFVYSEAVASHY 135

Query: 143 TYQICRALAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC 200
             QI  AL Y H+   I HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 201 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
            + ++ APE +     Y   +D+W  G ++  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                       ++K     P  W  +        A DLV R     P  R T  EA  H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 320 PFFDELRDPNTRLPNGRPLPPLFNF 344
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  166 bits (422), Expect = 4e-49
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 52/299 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y    ++G GSFG V + K R T +  A+K + +            RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 147
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 148 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
             + Y+H    I HRD+KP+N+L+        +K+ DFG +    +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APE++ G   Y    D+WS G ++  LL G P F G++  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                 ++ F       W  +       +A DL+ +   + P+LR TA +   HP+  +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  165 bits (420), Expect = 8e-49
 Identities = 58/339 (17%), Positives = 101/339 (29%), Gaps = 90/339 (26%)

Query: 26  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQ- 81
           G     S+    +     +G+G FG VF+   R  G I AIK+    L     +   L+ 
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 82  ---IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 137
                 +  H ++V     +      E+ ++ +  EY    ++        RI       
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115

Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH------------------THQLK 179
            +K    Q+ R L YIH+   + H DIKP N+ ++                        K
Sbjct: 116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 180 LCDFGSAKVL-----VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL 234
           + D G    +      +G+          + A E++     +    DI++    +     
Sbjct: 175 IGDLGHVTRISSPQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAG 226

Query: 235 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP- 293
            +PL                                            WH++ Q RLP  
Sbjct: 227 AEPLPRNG--------------------------------------DQWHEIRQGRLPRI 248

Query: 294 ------EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                 E  +L+       P  R +A+    H       
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  165 bits (419), Expect = 9e-49
 Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 67/305 (21%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 97
           G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L + 
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 98  FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
           F    D   +Y  LVLE     E    +        +       + + +QI   + Y+H+
Sbjct: 80  F---EDSNYVY--LVLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS 130

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------PNVSYICSRYYRA 206
             GI HRD+   NLL+  +   +K+ DFG + ++ +  E        PN        Y +
Sbjct: 131 H-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPN--------YIS 180

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE+    + +    D+WS GC+   LL+G+P F  ++  + L +++              
Sbjct: 181 PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------------ 227

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                +++ P      +       L  EA DL+ +  + +P  R +      HPF     
Sbjct: 228 -----DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

Query: 327 DPNTR 331
              ++
Sbjct: 271 STKSK 275

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  167 bits (424), Expect = 9e-49
 Identities = 62/325 (19%), Positives = 122/325 (37%), Gaps = 52/325 (16%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN----------------RELQIM 83
             G F  +      +  +  A+K      + + + +                   ELQI+
Sbjct: 40  NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 84  QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIY 138
             + +   +  +      T+ +E+Y+  + EY+      +               +P+  
Sbjct: 98  TDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           +K     +  + +YIHN   ICHRD+KP N+L++ +   +KL DFG ++ +V  +   S 
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKKIKGS- 210

Query: 199 IC-SRYYRAPELIFGATEY-TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
              +  +  PE     + Y    +DIWS G  +  +      F  +  + +L   I+   
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR--- 266

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
               + I+   P      F     +         L  E +D +  F + +P  R T+ +A
Sbjct: 267 ---TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 317 CVHPFF-----DELRDPNTRLPNGR 336
             H +      ++LR+ +  L   R
Sbjct: 321 LKHEWLADTNIEDLREFSKELYKKR 345

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  166 bits (422), Expect = 1e-48
 Identities = 79/319 (24%), Positives = 129/319 (40%), Gaps = 45/319 (14%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHC 97
           +++ V+G G  G V +   R TG+  A+K +L D     +E+         P+IV +   
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD- 89

Query: 98  FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 151
            +      +  L +++E +   E        +SRI +R    +           I  A+ 
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 152 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 208
           ++H+   I HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE
Sbjct: 143 FLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE 199

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
            + G  +Y  + D+WS G +M  LL G P F   +G      + +         I+    
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-- 248

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRD 327
              ++ FP      W +V       +A  L+    +  P  R T  +   HP+    +  
Sbjct: 249 ---QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

Query: 328 PNTRLPNGRPLPPLFNFKP 346
           P T L   R L    +   
Sbjct: 298 PQTPLHTARVLQEDKDHWD 316

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  167 bits (424), Expect = 1e-48
 Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 45/304 (14%)

Query: 25  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNREL 80
           +  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 81  QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLI 137
            +M  LDH N++ L   F     K ++   LV+EYV   E  +RI   +Y+     +  +
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTEL 187

Query: 138 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNV 196
              L+  QIC  + ++H    I H D+KP+N+L VN    Q+K+ DFG A+     E   
Sbjct: 188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246

Query: 197 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
               +  + APE +      +   D+WS G +   LL G   F G++  + L  I+    
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
                           +         +  +       EA + + +      + R +A EA
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

Query: 317 CVHP 320
             HP
Sbjct: 341 LKHP 344

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  165 bits (420), Expect = 2e-48
 Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 59/326 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 87
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYT 143
           H N++ L   +    ++ ++   L+LE V   E  + +A+  + S             + 
Sbjct: 74  HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSE-------EEATSFI 121

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYIC 200
            QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 201 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
            +  + APE I          D+WS G +   LL G   F G++  + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                        + F       +           A D + +        R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 320 PFFDELRDPNTRLPNGRPLPPLFNFK 345
           P+     D    +     +  L NF+
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFR 298

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  164 bits (418), Expect = 2e-48
 Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 60/318 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIV 92
           +     +G G FGVVF+AK +      AIK++        +    RE++ +  L+HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 93  ALKHCFF-------STTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTY 144
              + +              ++YL + ++    E +         I +R           
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR-- 202
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 203 -----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 251
                       Y +PE I G   Y+  +DI+S G ++ ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 311
           ++                    KFP +              P    +V      SP  R 
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272

Query: 312 TALEACVHPFFDELRDPN 329
            A+    +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  164 bits (417), Expect = 2e-48
 Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 62/314 (19%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 87
           Y     +G+G F +V + + + TG+  A K          +    +    RE+ I++ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 141
           HPNI+ L   F    +K ++   L+LE V   E  + +A   S                 
Sbjct: 67  HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKES---------LTEDEATQ 112

Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           +  QI   + Y+H+   I H D+KP+N+++   N    ++KL DFG A  +  G      
Sbjct: 113 FLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKN 170

Query: 199 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
           I  +  + APE I          D+WS G +   LL G   F GE+  + L  I  V   
Sbjct: 171 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV--- 226

Query: 258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                          + F       +           A D + R     P  R T  ++ 
Sbjct: 227 --------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSL 264

Query: 318 VHPFFDELRDPNTR 331
            H +   +R  N R
Sbjct: 265 EHSWIKAIRRRNVR 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  163 bits (416), Expect = 3e-48
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 66/296 (22%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 95
            +G G FG V+ A+ ++   I+A+K     ++ ++       RE++I   L HPNI+ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F    D++ +Y  L+LE+ P  E    + +     H R        +  ++  AL Y 
Sbjct: 81  NYFH---DRKRIY--LMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYC 130

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNVSYICSRYYRA 206
           H    + HRDIKP+NLL+      LK+ DFG +            G  +        Y  
Sbjct: 131 HER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YLP 180

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE+I G   +   +D+W  G +  E L+G P F   S  +    I+ V            
Sbjct: 181 PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                + KFP     P+       L   + DL+ +  +Y P  R        HP+ 
Sbjct: 228 -----DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  165 bits (420), Expect = 3e-48
 Identities = 87/291 (29%), Positives = 123/291 (42%), Gaps = 46/291 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 95
           +  E  +G G+  +V++ K + T +  A+K + +    K    E+ ++  L HPNI+ LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 151
             F       E+   LVLE V   E  +RI     YS   +R     VK    QI  A+A
Sbjct: 115 EIF---ETPTEIS--LVLELVTGGELFDRIVEKGYYS---ERDAADAVK----QILEAVA 162

Query: 152 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           Y+H   GI HRD+KP+NLL   P     LK+ DFG +K++       +   +  Y APE 
Sbjct: 163 YLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE- 220

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           I     Y   +D+WS G +   LL G   F  E G   +   I            C    
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC---- 266

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
             E+ F       W +V        A DLV +     P  R T  +A  HP
Sbjct: 267 --EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  165 bits (421), Expect = 3e-48
 Identities = 80/319 (25%), Positives = 120/319 (37%), Gaps = 51/319 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 147
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 91  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138

Query: 148 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 139 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
                  + +P      W  V      PEA  L+      +P  R TA +A   P+    
Sbjct: 246 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 326 RDPNTRLPNGRPLPPLFNF 344
               + +     +  L  F
Sbjct: 292 ERVASAIHRQDTVDCLKKF 310

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  164 bits (417), Expect = 7e-48
 Identities = 71/328 (21%), Positives = 121/328 (36%), Gaps = 63/328 (19%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 87
           Y     +G+G F VV + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 141
           HPN++ L   +    +K ++   L+LE V   E  + +A   S                 
Sbjct: 73  HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKES---------LTEEEATE 118

Query: 142 YTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           +  QI   + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G      
Sbjct: 119 FLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKN 176

Query: 199 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
           I  +  + APE I          D+WS G +   LL G   F G++  + L  +  V   
Sbjct: 177 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV--- 232

Query: 258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                          ++F       +           A D + R     P  R T  ++ 
Sbjct: 233 --------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSL 270

Query: 318 VHPFFDELRDPNTRLPNGRPLPPLFNFK 345
            HP+    +D    L        +  FK
Sbjct: 271 QHPWIKP-KDTQQALSRKASAVNMEKFK 297

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  166 bits (423), Expect = 1e-47
 Identities = 77/320 (24%), Positives = 119/320 (37%), Gaps = 52/320 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y     +G G+F VV +      G+  A   +   K          RE +I ++L HPNI
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 147
           V L       +++   Y  L+ + V   E    I     YS                QI 
Sbjct: 73  VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYSE-------ADASHCIQQIL 120

Query: 148 RALAYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYY 204
            A+ + H   G+ HR++KP+NLL  +      +KL DFG A  +   +        +  Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            +PE +     Y   +D+W+ G ++  LL+G P F  E       +I             
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227

Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                   + FP      W  V      PEA DL+ +    +P+ R TA EA  HP+   
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

Query: 325 LRDPNTRLPNGRPLPPLFNF 344
                + +     +  L  F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  164 bits (418), Expect = 1e-47
 Identities = 71/329 (21%), Positives = 118/329 (35%), Gaps = 65/329 (19%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 87
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VK 140
           HPNI+ L   +    ++ ++   L+LE V   E  + +  +                   
Sbjct: 74  HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKES----------LSEEEAT 118

Query: 141 LYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVS 197
            +  QI   + Y+H    I H D+KP+N+++   N     +KL DFG A  +  G     
Sbjct: 119 SFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176

Query: 198 YIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
            I  +  + APE I          D+WS G +   LL G   F G++  + L  I  V  
Sbjct: 177 NIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-- 233

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 316
                           + F       + +         A D + +        R T  EA
Sbjct: 234 ---------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEA 270

Query: 317 CVHPFFDELRDPNTRLPNGRPLPPLFNFK 345
             HP+     D    +     +  L NFK
Sbjct: 271 LRHPWITP-VDTQQAMVRRESVVNLENFK 298

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  165 bits (420), Expect = 1e-47
 Identities = 83/311 (26%), Positives = 124/311 (39%), Gaps = 42/311 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKH 96
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 97  CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRAL 150
             +         L +V+E +   E        +SRI  R    +           I  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 151 AYIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPE 208
            Y+H+   I HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
            + G  +Y  + D+WS G +M  LL G P F    G+     +           I+    
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR---- 280

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 327
              +++FP      W +V       E   L+    +  P  R T  E   HP+  +    
Sbjct: 281 -MGQYEFPN---PEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

Query: 328 PNTRLPNGRPL 338
           P T L   R L
Sbjct: 332 PQTPLHTSRVL 342

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  163 bits (415), Expect = 2e-47
 Identities = 74/319 (23%), Positives = 125/319 (39%), Gaps = 59/319 (18%)

Query: 19  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 78
           H I   +   +        Y  +  +G GS+ V  +   + T    A+K + + KR    
Sbjct: 7   HSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64

Query: 79  ELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS----- 128
           E++I+     HPNI+ LK  +    D + +Y  +V E +   E +++I R   +S     
Sbjct: 65  EIEILLRYGQHPNIITLKDVY---DDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS 119

Query: 129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGS 185
            +             + I + + Y+H   G+ HRD+KP N+L    + +   +++CDFG 
Sbjct: 120 AV------------LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGF 166

Query: 186 AKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 244
           AK L      +   C +  + APE +     Y  A DIWS G ++  +L G   F     
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 245 VDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 303
                 + ++  G               +F         W+ V        A DLV +  
Sbjct: 226 DTPEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKML 262

Query: 304 QYSPNLRCTALEACVHPFF 322
              P+ R TA     HP+ 
Sbjct: 263 HVDPHQRLTAALVLRHPWI 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  160 bits (407), Expect = 6e-47
 Identities = 78/297 (26%), Positives = 115/297 (38%), Gaps = 51/297 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 147
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 68  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115

Query: 148 RALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
            ++AY H+  GI HR++KP+NLL+        +KL DFG A  +   E    +  +  Y 
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                  + +P      W  V      PEA  L+      +P  R TA +A   P+ 
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  160 bits (406), Expect = 3e-46
 Identities = 67/307 (21%), Positives = 115/307 (37%), Gaps = 48/307 (15%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNI 91
           +    +G G F VV Q   + TG+  A K + + +R ++       E+ ++++    P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           + L   +    +  E+   L+LEY    E  +        + + +    V     QI   
Sbjct: 92  INLHEVY---ENTSEII--LILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEG 143

Query: 150 LAYIHNCIGICHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRA 206
           + Y+H    I H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y A
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLA 201

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE I      TTA D+W+ G +   LL     F GE   +  + I +V            
Sbjct: 202 PE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------ 248

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                   +       +  V        A D +      +P  R TA     H +  +  
Sbjct: 249 -----NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295

Query: 327 DPNTRLP 333
             N   P
Sbjct: 296 FENLFHP 302

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  159 bits (405), Expect = 4e-46
 Identities = 67/311 (21%), Positives = 132/311 (42%), Gaps = 42/311 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQMLD-HPNIVALK 95
            + +  +G GSF +  +   +++ +  A+K + +       +E+  +++ + HPNIV L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 151
             F    D+   +  LV+E +   E   RI +  ++S   +            ++  A++
Sbjct: 73  EVF---HDQLHTF--LVMELLNGGELFERIKKKKHFS---ETE----ASYIMRKLVSAVS 120

Query: 152 YIHNCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 208
           ++H+  G+ HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE
Sbjct: 121 HMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
            +     Y  + D+WS G ++  +L GQ  F            ++++     ++IK    
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG-- 231

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 327
              +F F       W  V       EA DL+       PN R        + +  +    
Sbjct: 232 ---DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

Query: 328 PNTRLPNGRPL 338
            +  L     L
Sbjct: 281 SSNPLMTPDIL 291

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  158 bits (402), Expect = 4e-46
 Identities = 77/317 (24%), Positives = 121/317 (38%), Gaps = 62/317 (19%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYK-NRELQIMQ 84
           Y  + ++G G   VV +   + T +  A+K            + +Q+ R    +E+ I++
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 85  MLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 139
            +  HPNI+ LK  +         +  LV + +   E  + +      S    R      
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR------ 127

Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
                 +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE      
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVC 184

Query: 200 CSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
            +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I+  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 314
                             ++F       W             DLV RF    P  R TA 
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279

Query: 315 EACVHPFFDELRDPNTR 331
           EA  HPFF +      R
Sbjct: 280 EALAHPFFQQYVVEEVR 296

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  158 bits (402), Expect = 1e-45
 Identities = 74/340 (21%), Positives = 120/340 (35%), Gaps = 56/340 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQML-DHPNIV 92
                V+  G F  V++A+   +G   A+K++L    +  R   +E+  M+ L  HPNIV
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 93  ALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
                     +         L+L  + +               +    V    YQ CRA+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 151 AYIHNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EPNV 196
            ++H     I HRD+K +NLL++     +KLCDFGSA  +                E  +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 197 SYICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 254
           +   +  YR PE+I  +         DIW+ GC++  L   Q  F   +           
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----------- 257

Query: 255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 314
                  +++ +N  Y+      I PH                L+    Q +P  R +  
Sbjct: 258 -------KLRIVNGKYS------IPPHD-------TQYTVFHSLIRAMLQVNPEERLSIA 297

Query: 315 EACVHPF-FDELRDPNTRLPNGRPLPPLFNFKPPELSGIP 353
           E           R+ N + P    L     +    LS  P
Sbjct: 298 EVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  157 bits (397), Expect = 1e-44
 Identities = 52/338 (15%), Positives = 108/338 (31%), Gaps = 80/338 (23%)

Query: 32  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 84
            ++  + +   V+G        +A  +ETGE   +      +R  +        E+  ++
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128

Query: 85  ML-------------------------DHPNIVALKHCFFSTTDKEELYLNLVLEYVPET 119
           +L                             ++ ++            +L   ++   +T
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 120 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK 179
              +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P +++++     + 
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VF 246

Query: 180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELI----------FGATEYTTAIDIWSTGCVM 229
           L  F      V+    V    SR +  PEL              T  T + D W+ G V+
Sbjct: 247 LTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 230 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK 289
             +         ++ +               E I         F+              K
Sbjct: 304 YWIWCADLPITKDAALG------------GSEWI---------FRSC------------K 330

Query: 290 RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            +P     L+  F +Y    R   L+A   P +++LR 
Sbjct: 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  154 bits (391), Expect = 2e-44
 Identities = 79/307 (25%), Positives = 121/307 (39%), Gaps = 72/307 (23%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 95
           ++G GSF  V  A+   T    AIK      ++++    Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
             F    D E+LY    L Y    E +  I +              + YT +I  AL Y+
Sbjct: 97  FTF---QDDEKLY--FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYL 146

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS---------YICSRYY 204
           H   GI HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+     
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV----- 199

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            +PEL+        + D+W+ GC++ +L+ G P F   +    + + I            
Sbjct: 200 -SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------- 245

Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP------NLRCTALEACV 318
                  E+ FP            ++  P+A DLV +                       
Sbjct: 246 -----KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288

Query: 319 HPFFDEL 325
           HPFF+ +
Sbjct: 289 HPFFESV 295

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  155 bits (393), Expect = 1e-43
 Identities = 56/382 (14%), Positives = 115/382 (30%), Gaps = 90/382 (23%)

Query: 20  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-- 77
            + + +G R        + +   V+G        +A  +ETGE   +      +R  +  
Sbjct: 68  RVESELGER------PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121

Query: 78  -----RELQIMQML-------------------------DHPNIVALKHCFFSTTDKEEL 107
                 E+  +++L                             ++ ++            
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 181

Query: 108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 167
           +L   ++   +T   +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P 
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPV 240

Query: 168 NLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY----YRAPELIFGA----TEYTTA 219
           +++++     + L  F        G   VS I   +      A  ++       T  T A
Sbjct: 241 DIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297

Query: 220 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 279
            D W+ G  +  +         ++ +                                  
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------------- 326

Query: 280 PHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD---PNTRLPN 334
                 +F+  K +P     L+  F +Y    R   L+A   P +++LR        L  
Sbjct: 327 ----EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQ 382

Query: 335 GRPLPPLFNFKPPELSGIPPET 356
               P      PP  +  P E 
Sbjct: 383 TDGEPTREGGAPPSGTSQPDEA 404

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  154 bits (390), Expect = 1e-43
 Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 65/309 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----------KVLQDKRYK-NRELQIMQM 85
           Y  + V+G G   VV +   R TG   A+K           + L++ R    RE  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 86  L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS-RIHQRMPLIYV 139
           +  HP+I+ L   +        ++  LV + +   E  + +      S +          
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEKVALSEK--------ET 202

Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           +     +  A++++H    I HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +
Sbjct: 203 RSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LREL 259

Query: 200 C-SRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 253
           C +  Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319

Query: 254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 313
                             +++F       W             DL+ R  Q  P  R TA
Sbjct: 320 G-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354

Query: 314 LEACVHPFF 322
            +A  HPFF
Sbjct: 355 EQALQHPFF 363

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  153 bits (387), Expect = 3e-43
 Identities = 70/316 (22%), Positives = 129/316 (40%), Gaps = 33/316 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 92
           +     +G G+ GVVF+   + +G ++A K +   ++        RELQ++   + P IV
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
                F+S  +     +++ +E++   +++++ +   RI    P   +   +  + + L 
Sbjct: 95  GFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRI----PEQILGKVSIAVIKGLT 145

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           Y+     I HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + 
Sbjct: 146 YLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQ 203

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
           G   Y+   DIWS G  + E+ +G+   P     +  +     +     E          
Sbjct: 204 GTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 272 EFKFPQIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEA 316
                 +   P   +F+           +LP      E  D V +    +P  R    + 
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322

Query: 317 CVHPFFDELRDPNTRL 332
            VH F           
Sbjct: 323 MVHAFIKRSDAEEVDF 338

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  153 bits (388), Expect = 4e-43
 Identities = 79/320 (24%), Positives = 135/320 (42%), Gaps = 61/320 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 95
            +G GSFG V   +  +T ++ A+K     K ++    R   +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F    D+E+++  +V++ +   +    + +N            VKL+  ++  AL Y+
Sbjct: 82  YSF---QDEEDMF--MVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYL 131

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-- 211
            N   I HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+    
Sbjct: 132 QNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPN 269
               Y+ A+D WS G    ELL G+  +   S     ++V   +                
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---------------- 233

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDP 328
            T   +P                 E V L+ +  + +P+ R + L      P+     D 
Sbjct: 234 TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---NDI 278

Query: 329 N-TRLPNGRPLPPLFNFKPP 347
           N   +   R +P    F P 
Sbjct: 279 NWDAVFQKRLIPG---FIPN 295

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  151 bits (383), Expect = 5e-43
 Identities = 77/332 (23%), Positives = 126/332 (37%), Gaps = 65/332 (19%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQML-DHPNIVA 93
           + E V+G G+   V       T +  A+K    +    +    RE++++     H N++ 
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT-------- 143
           L   F    +++  Y  LV E +             S IH+R      + +         
Sbjct: 76  LIEFF---EEEDRFY--LVFEKMRGGSI-------LSHIHKR------RHFNELEASVVV 117

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------P 194
             +  AL ++HN  GI HRD+KP+N+L  +P     +K+CDF     +           P
Sbjct: 118 QDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 195 NVSYIC-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
            +   C S  Y APE++      A+ Y    D+WS G ++  LL G P F G  G D   
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 250 EIIKVLGTPTR---EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 306
           +  +          E I+       +++FP      W  +        A DL+ +     
Sbjct: 237 DRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRD 283

Query: 307 PNLRCTALEACVHPFFDELRDPNTRLPNGRPL 338
              R +A +   HP+      P   LP    L
Sbjct: 284 AKQRLSAAQVLQHPWVQG-CAPENTLPTPMVL 314

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  150 bits (381), Expect = 6e-43
 Identities = 77/318 (24%), Positives = 117/318 (36%), Gaps = 56/318 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKH 96
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 97  CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
             +         L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 155 NCIGICHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +   I HRD+KP+NLL  +   +  LKL DFG AK                         
Sbjct: 135 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------------- 173

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  + D+WS G +M  LL G P F    G+     +           I+       +
Sbjct: 174 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MGQ 218

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD-PNTR 331
           ++FP      W +V       E   L+    +  P  R T  E   HP+  +    P T 
Sbjct: 219 YEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

Query: 332 LPNGRPLPPLFNFKPPEL 349
           L   R L      +  ++
Sbjct: 271 LHTSRVL-KEDKERWEDV 287

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  152 bits (387), Expect = 1e-42
 Identities = 85/377 (22%), Positives = 130/377 (34%), Gaps = 100/377 (26%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKR--YKNRELQIMQMLDHPNIVALK 95
           V+G G+F  V   K ++TG++ A+K      +L+         E  ++   D   I  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
             F    D+  LY  LV+EY    + +  +    S+  +R+P    + Y  +I  A+  +
Sbjct: 128 FAF---QDENYLY--LVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 205
           H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+      
Sbjct: 179 HR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL------ 230

Query: 206 APELI------FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
           +PE++       G   Y    D W+ G    E+  GQ  F  +S   +    I       
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------- 282

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEA 316
                 ++        P +            +P EA D + R     P  R     A + 
Sbjct: 283 ------VHYK-EHLSLPLVDEG---------VPEEARDFIQRLLC-PPETRLGRGGAGDF 325

Query: 317 CVHPFF-----DELRDPNTRLPNGRPLPPLF-----------NF------KPPELSGIPP 354
             HPFF     D LRD            P F           NF          +SG   
Sbjct: 326 RTHPFFFGLDWDGLRD----------SVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGE 375

Query: 355 ETINRLIPEHARKQNLF 371
              +            F
Sbjct: 376 TLSDIREGAPLGVHLPF 392

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  150 bits (382), Expect = 2e-42
 Identities = 87/351 (24%), Positives = 139/351 (39%), Gaps = 56/351 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 92
           Y     +G+G+FGV    + + T E+VA+K       + +     RE+   + L HPNIV
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
             K    + T    L   +++EY    E   RI         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGV 129

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           +Y H+ + ICHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 210 IFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           +    EY     D+WS G  +  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
              ++  P              + PE   L+ R F   P  R +  E   H +F  L++ 
Sbjct: 238 ---KYSIP---DDIR-------ISPECCHLISRIFVADPATRISIPEIKTHSWF--LKNL 282

Query: 329 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA------RKQNLFMA 373
              L N         F+ PE      +TI ++I E        R  + FM 
Sbjct: 283 PADLMN--ESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMT 331

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  152 bits (386), Expect = 2e-42
 Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 57/307 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 95
           V+G G+FG V   K +   ++ A+K     ++L+         E  ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F    D   LY  LV++Y    + +  +    S+   R+P    + Y  ++  A+  +
Sbjct: 141 YAF---QDDNNLY--LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-ICSRY-YRAPELI- 210
           H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++ 
Sbjct: 192 HQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 211 ---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
               G   Y    D WS G  M E+L G+  F  ES + +    I             MN
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MN 295

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN-LRCT-ALEACVHPFF--- 322
                F+FP              +   A DL+ R      + L      +   HPFF   
Sbjct: 296 HK-ERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345

Query: 323 --DELRD 327
             D +R+
Sbjct: 346 DWDNIRN 352

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  146 bits (371), Expect = 2e-41
 Identities = 75/326 (23%), Positives = 130/326 (39%), Gaps = 59/326 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---RELQIMQMLDHP 89
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           N++ L    ++   K+++Y  +V+EY      E ++ +        +R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEE-KQKMY--MVMEYCVCGMQEMLDSVP------EKRFPVCQAHGYFCQ 117

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SR 202
           +   L Y+H+  GI H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHSQ-GIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 203 YYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            ++ PE+  G   ++   +DIWS G  +  +  G   F G++        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
            I         +  P                P   DL+    +Y P  R +  +   H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 322 FDELRDPNTRLPNGRPLPPLFNFKPP 347
           F +   P        P+PP  + K  
Sbjct: 267 FRKKHPPAEAPV---PIPPSPDTKDR 289

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  147 bits (373), Expect = 3e-41
 Identities = 44/297 (14%), Positives = 92/297 (30%), Gaps = 36/297 (12%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIK----KVLQDKRYKNRELQIMQMLD 87
                H++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQ 145
               +           +    L  V E       +N I    +   + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----------LKLCDFGSAKVLVKGEPN 195
           +   +  +H+C  I H DIKP N ++     +          L L D G +  +      
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 196 V---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEI 251
               +   +  ++  E++     +   ID +     +  +L G  +    E G  +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 252 IKVL-GTPTREEIKCMNPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQ 304
            + L       E   +  N  +               KVFQ+    +   L  R   
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  147 bits (374), Expect = 1e-40
 Identities = 82/321 (25%), Positives = 133/321 (41%), Gaps = 63/321 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 95
           ++G G+FG V   K + TG   A+K      ++      +   E +++Q   HP + ALK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F  T D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+
Sbjct: 215 YSF-QTHDR--LCF--VMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYL 264

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H+   + +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++  
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I                   E
Sbjct: 324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEE 365

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 327
            +FP            + L PEA  L+    +  P  R       A E   H FF     
Sbjct: 366 IRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AG 410

Query: 328 PN-TRLPNGRPLPPLFNFKPP 347
                +   +  PP   FKP 
Sbjct: 411 IVWQHVYEKKLSPP---FKPQ 428

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  145 bits (367), Expect = 1e-40
 Identities = 84/350 (24%), Positives = 141/350 (40%), Gaps = 60/350 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 89
           Y     +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           NIV L     +        L L++EY    E  + +       H RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIV 124

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
            A+ Y H    I HRD+K +NLL++     +K+ DFG +     G    ++  +  Y AP
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182

Query: 208 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           EL  G  +Y    +D+WS G ++  L+ G   F G++ + +L E +              
Sbjct: 183 ELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------- 227

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                +++ P      +       +  +  +L+ RF   +P  R T  +     + +   
Sbjct: 228 ---RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272

Query: 327 DPNTRLPNGRPLPPLFNFKPPELS---GIPPETINRLIPEHARKQNLFMA 373
           + +   P   P   + + K  ++    G   E I   +     K +   A
Sbjct: 273 EEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL--SKMKYDEITA 320

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  142 bits (361), Expect = 3e-40
 Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 50/296 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--VSYIC-SRYYRAP 207
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 208 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                          PW K     +    + L+ +    +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  144 bits (365), Expect = 3e-40
 Identities = 83/320 (25%), Positives = 133/320 (41%), Gaps = 64/320 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 95
           ++G G+FG V   + + TG   A+K      ++      +   E +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           +  F T D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+
Sbjct: 72  YA-FQTHDR--LC--FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYL 121

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIFG 212
           H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++  
Sbjct: 122 HS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  A+D W  G VM E++ G+  F  +   ++L E+I                   E
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------MEE 221

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 327
            +FP            + L PEA  L+    +  P  R       A E   H FF     
Sbjct: 222 IRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---LS 266

Query: 328 PN-TRLPNGRPLPPLFNFKP 346
            N   +   + LPP   FKP
Sbjct: 267 INWQDVVQKKLLPP---FKP 283

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  142 bits (361), Expect = 4e-40
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 96
            +G G++GVV + +   +G+I+A+K++   +  +  K    +L I M+ +D P  V    
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
             F   D     + + +E +  ++++  +      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG---A 213
           + + HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
             Y+   DIWS G  M EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 332
             PQ+    +          E VD   +  + +   R T  E   HPFF       T +
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  148 bits (374), Expect = 4e-40
 Identities = 74/322 (22%), Positives = 121/322 (37%), Gaps = 58/322 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 94
           V+G G FG VF  + + TG++ A  K L  KR K R        E +I+  +    IV+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            +  F T       L LV+  +   +    I       +          YT QI   L +
Sbjct: 251 AYA-FETKTD----LCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEH 304

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 211
           +H    I +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+ 
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
           G  EY  ++D ++ G  + E++  +  F       +  E+         + +      Y 
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTYP 413

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 326
           +                    P + D      Q  P  R      +      HP F   R
Sbjct: 414 DK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF---R 453

Query: 327 DPN-TRLPNGRPLPPLFNFKPP 347
           D +  +L  G   PP   F P 
Sbjct: 454 DISWRQLEAGMLTPP---FVPD 472

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  143 bits (363), Expect = 5e-40
 Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 50/313 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
                          Y  L LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV--SYIC-SRYYRAP 207
            Y+H  IGI HRDIKP+NLL++     LK+ DFG A V          + +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 208 ELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           EL+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                          PW K     +    + L+ +    +P+ R T  +     ++++  
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

Query: 327 DPNTRLPNGRPLP 339
               + P      
Sbjct: 270 KKGAKRPRVTSGG 282

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  149 bits (377), Expect = 6e-40
 Identities = 73/324 (22%), Positives = 128/324 (39%), Gaps = 65/324 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 91
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           V + + F      ++L    +L+ +   +    +++     H       ++ Y  +I   
Sbjct: 255 VCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 304

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPEL 209
           L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE+
Sbjct: 305 LEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEV 361

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           +     Y ++ D +S GC++ +LL G   F      D             + EI      
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI------ 402

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CT---ALEACVHPFFDE 324
                                  PE   L+    Q   N R  C    A E    PFF  
Sbjct: 403 -----DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

Query: 325 LRDPN-TRLPNGRPLPPLFNFKPP 347
           L   +   +   +  PP     PP
Sbjct: 456 L---DWQMVFLQKYPPP---LIPP 473

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  142 bits (361), Expect = 1e-39
 Identities = 87/359 (24%), Positives = 148/359 (41%), Gaps = 86/359 (23%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 95
            +GTGSFG V   + R  G   A+K      V++ K   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
             F    D ++++  ++++Y+   E  + + ++     QR P    K Y  ++C AL Y+
Sbjct: 73  GTF---QDAQQIF--MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYL 122

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 207
           H+   I +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y AP
Sbjct: 123 HSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIAP 172

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E++     Y  +ID WS G ++ E+L G   F   +   +  E I               
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 322
               E +FP                 +  DL+ R           NL+    +   HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

Query: 323 DELRDPN-TRLPNGRPLPPLFNFKPPELSG---------IPPETINRLIPEHARKQNLF 371
            E+      +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 263 KEV---VWEKLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 315

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  141 bits (358), Expect = 2e-39
 Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 67/321 (20%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 87
           Y    ++G+G FG V+          VAIK     ++       N      E+ +++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 88  H--PNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 142
                ++ L   +F   D     L  +LE      +  + I          +     + +
Sbjct: 105 SGFSGVIRLLD-WFERPDS--FVL--ILERPEPVQDLFDFITE-----RGALQEELARSF 154

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 201
            +Q+  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS  +L            +
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF--DGT 211

Query: 202 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
           R Y  PE I     Y   +  +WS G ++ +++ G   F  +       EII+       
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257

Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
                      +  F             +R+  E   L+       P+ R T  E   HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 321 FFDELRDPNTRLP-NGRPLPP 340
           +  ++  P      +   L P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  143 bits (363), Expect = 2e-39
 Identities = 80/306 (26%), Positives = 125/306 (40%), Gaps = 68/306 (22%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 95
           V+G G+FG V   + + T ++ A+K     ++++     +   E  IM   + P +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           + F    D   LY  +V+EY+P  + VN ++         +P  + + YT ++  AL  I
Sbjct: 136 YAF---QDDRYLY--MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAI 184

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--------YICSRYYR 205
           H+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI      
Sbjct: 185 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI------ 236

Query: 206 APELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 262
           +PE++    G   Y    D WS G  + E+L+G   F  +S    LV             
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS--------- 283

Query: 263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVH 319
            K MN       FP              +  EA +L+C F      +R       E   H
Sbjct: 284 -KIMNHK-NSLTFP---DDND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 330

Query: 320 PFFDEL 325
            FF   
Sbjct: 331 LFFKND 336

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  146 bits (370), Expect = 2e-39
 Identities = 85/321 (26%), Positives = 135/321 (42%), Gaps = 59/321 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 94
           V+G G FG V   + R TG++ A  K L+ KR K R        E QI++ ++   +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            +  + T D     L LVL  +   +    I   Y       P      Y  +IC  L  
Sbjct: 250 AYA-YETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +H    I +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++  
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
              YT + D W+ GC++ E++ GQ  F       +  E+ ++        +K +   Y+E
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPEEYSE 410

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 327
                               P+A  L  +     P  R      +A E   HP F   + 
Sbjct: 411 R-----------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF---KK 450

Query: 328 PN-TRLPNGRPLPPLFNFKPP 347
            N  RL  G   PP   FKP 
Sbjct: 451 LNFKRLGAGMLEPP---FKPD 468

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  139 bits (352), Expect = 5e-39
 Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 40/289 (13%)

Query: 27  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------R 78
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 79  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 136
           E+Q +++  HP+I+ L     + TD    +  +V+EYV   E  + I +     H R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICK-----HGRVEE 110

Query: 137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
           +  +    QI  A+ Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 197 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 254
              C S  Y APE+I G       +DIWS G ++  LL G   F  E  V  L + I+  
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG 226

Query: 255 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 293
                  L       +  M   +P         I+ H W   F++ LP 
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW---FKQDLPS 271

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  138 bits (351), Expect = 3e-38
 Identities = 89/324 (27%), Positives = 136/324 (41%), Gaps = 68/324 (20%)

Query: 43  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDHPNI 91
           V+G G +G VFQ +      TG+I A+K      ++++ +       E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           V L + F  T  K  LYL  +LEY+   E   ++ R                Y  +I  A
Sbjct: 84  VDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMA 133

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPE 208
           L ++H   GI +RD+KP+N+++N   H +KL DFG  K  +         C    Y APE
Sbjct: 134 LGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++   + +  A+D WS G +M ++L G P F GE+   + ++ I                
Sbjct: 192 ILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL--------------- 234

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFD 323
              +   P              L  EA DL+ +  + +   R       A E   HPFF 
Sbjct: 235 -KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF- 280

Query: 324 ELRDPN-TRLPNGRPLPPLFNFKP 346
             R  N   L   +  PP   FKP
Sbjct: 281 --RHINWEELLARKVEPP---FKP 299

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  138 bits (350), Expect = 4e-38
 Identities = 86/322 (26%), Positives = 137/322 (42%), Gaps = 66/322 (20%)

Query: 43  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR-ELQIMQMLDHPNIVA 93
           V+G GSFG VF  K     +  ++ A+K      +    R + + E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 94  LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           L + F  T  K  LYL  +L+++   +   R+++             VK Y  ++  AL 
Sbjct: 91  LHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALD 140

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELI 210
           ++H+  GI +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE++
Sbjct: 141 HLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                +T + D WS G +M E+L G   F G+    + + +I                  
Sbjct: 199 NR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL----------------K 240

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDEL 325
            +   PQ             L PEA  L+   F+ +P  R         E   H FF   
Sbjct: 241 AKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF--- 285

Query: 326 RDPN-TRLPNGRPLPPLFNFKP 346
              +  +L      PP   FKP
Sbjct: 286 STIDWNKLYRREIHPP---FKP 304

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  138 bits (349), Expect = 5e-38
 Identities = 86/339 (25%), Positives = 140/339 (41%), Gaps = 63/339 (18%)

Query: 32  SKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIM 83
           SK+ +  YI    +G GSFG V  A   +T + VA+K      + +   +    RE+  +
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 84  QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLY 142
           ++L HP+I+ L     + TD   +   +V+EY   E  + I        +RM     + +
Sbjct: 64  KLLRHPHIIKLYDVITTPTD---IV--MVIEYAGGELFDYIVE-----KKRMTEDEGRRF 113

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 201
             QI  A+ Y H    I HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S
Sbjct: 114 FQQIICAIEYCH-RHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGS 170

Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 261
             Y APE+I G       +D+WS G V+  +L+G+  F  E  +  L + +         
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------- 221

Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                      +  P      +       L P A  L+ R     P  R T  E    P+
Sbjct: 222 --------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

Query: 322 FDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 360
           F      N  LP       L   +  + S      +++L
Sbjct: 262 F------NVNLP-----DYLRPMEEVQGSYADSRIVSKL 289

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  137 bits (346), Expect = 7e-38
 Identities = 68/313 (21%), Positives = 114/313 (36%), Gaps = 73/313 (23%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---------------------- 77
           G GS+GVV  A         A+K     K+++   +                        
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 78  ---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQ 132
              +E+ I++ LDHPN+V L        +++ LY+  V E V     +           +
Sbjct: 82  QVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVPT------LK 132

Query: 133 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 192
            +     + Y   + + + Y+H    I HRDIKP NLLV      +K+ DFG +      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGS 190

Query: 193 EPNVSYIC-SRYYRAPELIFGAT-EYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 249
           +  +S    +  + APE +      ++  A+D+W+ G  +   + GQ  F  E  +  L 
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLH 249

Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
             IK                    +FP     P        +  +  DL+ R    +P  
Sbjct: 250 SKIK----------------SQALEFPD---QPD-------IAEDLKDLITRMLDKNPES 283

Query: 310 RCTALEACVHPFF 322
           R    E  +HP+ 
Sbjct: 284 RIVVPEIKLHPWV 296

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  137 bits (346), Expect = 2e-37
 Identities = 79/326 (24%), Positives = 130/326 (39%), Gaps = 77/326 (23%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K     KV++ K   +   E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 96  HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
             F    D   LY  +V+EYV   E  + +     R   R    + + Y  QI     Y+
Sbjct: 108 FSF---KDNSNLY--MVMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNVSYICSRYYRAP 207
           H+   + +RD+KP+NLL++   + +++ DFG AK +        G P           AP
Sbjct: 158 HSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALAP 207

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I          +    
Sbjct: 208 EIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG-- 253

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFF 322
               + +FP                 +  DL+    Q        NL+    +   H +F
Sbjct: 254 ----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

Query: 323 DELRDPN-TRLPNGRPLPPLFNFKPP 347
                 +   +   +   P   F P 
Sbjct: 298 ATT---DWIAIYQRKVEAP---FIPK 317

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  136 bits (344), Expect = 2e-37
 Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 46/301 (15%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 96
            +G+G+ G V++ + R+TG ++A+K++      +  K    +L + ++  D P IV    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
            F + TD     + + +E +     ++     R+   +P   +   T  I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI----FG 212
            G+ HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 271
             +Y    D+WS G  + EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 331
               P +  H            +    V          R    +   H F          
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 332 L 332
           +
Sbjct: 297 V 297

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  135 bits (343), Expect = 3e-37
 Identities = 68/323 (21%), Positives = 115/323 (35%), Gaps = 68/323 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 87
           Y    ++G G FG VF          VAIK     +VL      +      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 88  ----HPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVK 140
               HP ++ L   +F T +     L  VLE      +  + I          +     +
Sbjct: 93  AGGGHPGVIRL-LDWFETQEG--FML--VLERPLPAQDLFDYITE-----KGPLGEGPSR 142

Query: 141 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 200
            +  Q+  A+ + H+  G+ HRDIK +N+L++      KL DFGS  +L           
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--D 199

Query: 201 -SRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 258
            +R Y  PE I    +Y      +WS G ++ +++ G   F  +       EI++     
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248

Query: 259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 318
                        E  FP              + P+   L+ R     P+ R +  E  +
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 319 HPFFDELRDPNTRLPNGRPLPPL 341
            P+     +     P+     PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  135 bits (342), Expect = 3e-37
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 28/220 (12%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 99  FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT-----YQICRALAY 152
               +     + LV+EY    ++      Y+ +H   PL Y           Q  + +AY
Sbjct: 70  --CLNP----VCLVMEYAEGGSL------YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 153 IHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           +H+     + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+ 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 250
            G + Y+   D++S G ++ E++  +  F    G    + 
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  135 bits (342), Expect = 5e-37
 Identities = 63/358 (17%), Positives = 116/358 (32%), Gaps = 103/358 (28%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           +     +G G FGVVF+AK +      AIK++    R        RE++ +  L+HP IV
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 93  ALKHCF----------------------------------------------------FS 100
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 101 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 160
                ++YL + ++   +   +   N     +            QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186

Query: 161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNVSYICSRYYRAP 207
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E I G   Y+  +DI+S G ++ ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
                 KFP +    +         P+   +V      SP  R  A +   +  F+ L
Sbjct: 288 ----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  136 bits (344), Expect = 5e-37
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLD-HPNIVAL 94
           V+G GSFG V  ++ + T E+ A+K      V+QD   +    E +++ +    P +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 87  HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 136

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 211
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I 
Sbjct: 137 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 195 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 236

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 326
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 237 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 281

Query: 327 DPN-TRLPNGRPLPPLFNFKP 346
             +  +L      PP   +KP
Sbjct: 282 YIDWEKLERKEIQPP---YKP 299

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  134 bits (340), Expect = 9e-37
 Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 39/300 (13%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 96
            +G G++G V +   + +G+I+A+K++   + +K  K    +L + M+  D P IV    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   D       + +E +  + ++  +  YS +   +P   +   T    +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
            + I HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 216 ---YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
              Y    D+WS G  + EL  G+  +P  + V   +  + V G P         P    
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP---------P---- 248

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 332
            +    +   +         P  ++ V        + R    E   HPF     +    +
Sbjct: 249 -QLSNSEEREF--------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  134 bits (340), Expect = 2e-36
 Identities = 82/318 (25%), Positives = 136/318 (42%), Gaps = 61/318 (19%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 94
           ++G GSFG VF A+ ++T +  AIK      VL D   +    E +++ +  +HP +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
               F T +   L+   V+EY+   + +  I         +  L     Y  +I   L +
Sbjct: 84  FCT-FQTKEN--LF--FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQF 133

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 211
           +H+  GI +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ 
Sbjct: 134 LHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
           G  +Y  ++D WS G ++ E+L+GQ  F G+   ++L   I+                  
Sbjct: 192 G-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------MD 233

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDPN- 329
              +P            + L  EA DL+ + F   P  R         HP F   R+ N 
Sbjct: 234 NPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF---REINW 278

Query: 330 TRLPNGRPLPPLFNFKPP 347
             L      PP   F+P 
Sbjct: 279 EELERKEIDPP---FRPK 293

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  134 bits (340), Expect = 2e-36
 Identities = 79/320 (24%), Positives = 124/320 (38%), Gaps = 64/320 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIM-QMLDHPNIVAL 94
           V+G GSFG V  A+ +      A+K      +L+ K  ++   E  ++ + + HP +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
               F T DK  LY   VL+Y+   E    + R      +       + Y  +I  AL Y
Sbjct: 105 HFS-FQTADK--LY--FVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGY 154

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 211
           +H+ + I +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE++ 
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               Y   +D W  G V+ E+L G P F   +   ++ + I                   
Sbjct: 213 K-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NK 254

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----CTALEACVHPFFDELRD 327
             +                +   A  L+    Q     R       +E   H FF     
Sbjct: 255 PLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF---SL 299

Query: 328 PN-TRLPNGRPLPPLFNFKP 346
            N   L N +  PP   F P
Sbjct: 300 INWDDLINKKITPP---FNP 316

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  134 bits (339), Expect = 2e-36
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 66/322 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 94
           V+G GSFG V  A+ +ETG++ A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             C F T D+  L+   V+E+V   + +  I +      +R      + Y  +I  AL +
Sbjct: 90  FCC-FQTPDR--LF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMF 139

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-YRAPELIF 211
           +H+  GI +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE++ 
Sbjct: 140 LHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ 197

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               Y  A+D W+ G ++ E+L G   F  E+  D L E I                   
Sbjct: 198 E-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------ND 239

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 325
           E  +P              L  +A  ++  F   +P +R              HPFF   
Sbjct: 240 EVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF--- 284

Query: 326 RDPN-TRLPNGRPLPPLFNFKP 346
           ++ +  +L + +  PP   F+P
Sbjct: 285 KEIDWAQLNHRQIEPP---FRP 303

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  133 bits (338), Expect = 4e-36
 Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 66/328 (20%)

Query: 43  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDH-PN 90
           V+GTG++G VF  +     +TG++ A+K      ++Q  +       E Q+++ +   P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           +V L + F  T  K  L+L  +L+Y+   E    +++      +R     V++Y  +I  
Sbjct: 121 LVTLHYAF-QTETK--LHL--ILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVL 170

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY-IC-SRYYRA 206
           AL ++H  +GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMA 228

Query: 207 PELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           P+++ G    +  A+D WS G +M ELL G   F  +   +   EI           I  
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL- 279

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHP 320
                +E  +PQ             +   A DL+ R     P  R       A E   H 
Sbjct: 280 ----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323

Query: 321 FFDELRDPN-TRLPNGRPLPPLFNFKPP 347
           FF   +  N   L   +   P   FKP 
Sbjct: 324 FF---QKINWDDLAAKKVPAP---FKPV 345

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  135 bits (341), Expect = 8e-36
 Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 40/289 (13%)

Query: 27  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--R 78
            +  + + K+  YI    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 79  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 136
           E+Q +++  HP+I+ L     + +D   ++  +V+EYV   E  + I +     + R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSD---IF--MVMEYVSGGELFDYICK-----NGRLDE 115

Query: 137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
              +    QI   + Y H    + HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 197 SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV- 254
              C S  Y APE+I G       +DIWS+G ++  LL G   F  +  V  L + I   
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDG 231

Query: 255 -------LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 293
                  L       +K M   +P         I+ H W   F++ LP 
Sbjct: 232 IFYTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW---FKQDLPK 276

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  133 bits (337), Expect = 9e-36
 Identities = 79/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQML-----DHP 89
           Y     +G G F  V+ +   +  + VA+K V   + Y      E+++++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 90  N---IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 146
           N   +V L   F   +     ++ +V E +   + +     +  +Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 147 CRALAYIHNCIGICHRDIKPQNLLV----------------------------------- 171
            + L Y+H    I H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 172 -------------NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT 218
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 219 AIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 265
             DIWST C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLP------PEAVDLVCRFFQYSPNLRCTALEACVH 319
                      ++KP    +V  ++            D +    +  P  R TA E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 320 PFFD 323
           P+ +
Sbjct: 393 PWLN 396

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  131 bits (332), Expect = 2e-35
 Identities = 79/322 (24%), Positives = 138/322 (42%), Gaps = 57/322 (17%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 94
           V+G GS+  V   + ++T  I A+K      V  D+   +   E  + +   +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             C F T  +  L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 76  HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 125

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 211
           +H   GI +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ 
Sbjct: 126 LHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
           G  +Y  ++D W+ G +M E++ G+  F      D   +        T + +        
Sbjct: 184 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-------- 227

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDEL 325
              F  I          + L  +A  ++  F    P  R          +   HPFF   
Sbjct: 228 ---FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF--- 279

Query: 326 RDPN-TRLPNGRPLPPLFNFKP 346
           R+ +   +   + +PP   FKP
Sbjct: 280 RNVDWDMMEQKQVVPP---FKP 298

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  130 bits (330), Expect = 3e-35
 Identities = 72/328 (21%), Positives = 122/328 (37%), Gaps = 71/328 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-------RELQIMQM 85
           Y     +G+G+FG V+ A  +E  + V +K     KVL+D   ++        E+ I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 142
           ++H NI+ +   F    ++      LV+E      +    I R     H R+        
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYI 135

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-S 201
             Q+  A+ Y+     I HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 202 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 260
             Y APE++ G   Y    +++WS G  +  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
                          P              +  E + LV    Q  P  R T  +    P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 321 FFDELRDPNTRLPNGRPLPPLFNFKPPE 348
           +  +  +             +F    PE
Sbjct: 277 WVTQPVN-----LADYTWEEVFRVNKPE 299

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  130 bits (329), Expect = 1e-34
 Identities = 82/369 (22%), Positives = 149/369 (40%), Gaps = 64/369 (17%)

Query: 1   MMKTDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEH-----VVGTGSFGVVFQA 55
           +  T+       +G+             +G +   +    +      V+G GS+  V   
Sbjct: 14  IPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG--LQDFDLLRVIGRGSYAKVLLV 71

Query: 56  KCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVALKHCFFSTTDKEEL 107
           + ++T  I A++      V  D+   +   E  + +   +HP +V L  C F T  +  L
Sbjct: 72  RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-FQTESR--L 128

Query: 108 YLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK 165
           +   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y+H   GI +RD+K
Sbjct: 129 F--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLK 180

Query: 166 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWS 224
             N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G  +Y  ++D W+
Sbjct: 181 LDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWA 238

Query: 225 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 284
            G +M E++ G+  F      D   +        T + +           F  I      
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-----------FQVILEKQIR 280

Query: 285 KVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC----VHPFFDELRDPN-TRLPNGRP 337
               + L  +A  ++  F    P  R  C           HPFF   R+ +   +   + 
Sbjct: 281 --IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF---RNVDWDMMEQKQV 335

Query: 338 LPPLFNFKP 346
           +PP   FKP
Sbjct: 336 VPP---FKP 341

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  127 bits (320), Expect = 3e-34
 Identities = 50/224 (22%), Positives = 85/224 (37%), Gaps = 30/224 (13%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHP 89
           E  +G G FG+V + +  +   +VAIK ++                  RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           NIV L        +       +V+E+VP   +     + +     +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133

Query: 149 ALAYIHNC-IGICHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNVSYICSRY 203
            + Y+ N    I HRD++  N+ +           K+ DFG ++           + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 204 YRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 246
           + APE I    E YT   D +S   ++  +L G+  F   S   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  126 bits (319), Expect = 3e-34
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIV 92
           E ++G G FG V++A     G+ VA+K    D             +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 93  ALK-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           AL+  C      +  L   LV+E+     +NR+        +R+P   +  +  QI R +
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118

Query: 151 AYIHNC--IGICHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
            Y+H+   + I HRD+K  N+L+             LK+ DFG A+   +    +S   +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177

Query: 202 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 241
             + APE+I  +  ++   D+WS G ++ ELL G+  F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  129 bits (325), Expect = 5e-33
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 65/321 (20%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQM-LDHPNIVAL 94
           V+G GSFG V  ++ + T E+ A+K      V+QD        E +++ +    P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 408 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 457

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIF 211
           + +  GI +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I 
Sbjct: 458 LQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                   
Sbjct: 516 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EH 557

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 326
              +P            K +  EAV +        P  R         +   H FF   R
Sbjct: 558 NVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---R 602

Query: 327 DPN-TRLPNGRPLPPLFNFKP 346
             +  +L      PP   +KP
Sbjct: 603 YIDWEKLERKEIQPP---YKP 620

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (325), Expect = 6e-33
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 36/231 (15%)

Query: 23  TTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD-------KR 74
             + G+         Y  +  +  G  G ++ A  R   G  V +K  L           
Sbjct: 76  DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125

Query: 75  YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP-ETVNRIARNYSRIHQ 132
               E Q +  + HP+IV +   F   TD+    +  +V+EYV  +++ R         Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRS------KGQ 177

Query: 133 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 192
           ++P+     Y  +I  AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +   
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRI--N 232

Query: 193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
                Y  +  ++APE++      T A DI++ G  +A L L  P   G  
Sbjct: 233 SFGYLYG-TPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  123 bits (311), Expect = 7e-33
 Identities = 73/311 (23%), Positives = 120/311 (38%), Gaps = 46/311 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 93  ALKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           +    F     K+EL+  LV++      V + +  I          +    +     ++ 
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSR---- 202
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 203 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                  N        P ++     K   K+       ++    Q  P  R TA E   H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

Query: 320 PFFDELRDPNT 330
            FF + ++   
Sbjct: 289 KFFQKAKNKEF 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (315), Expect = 1e-32
 Identities = 58/346 (16%), Positives = 119/346 (34%), Gaps = 44/346 (12%)

Query: 45  GTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
           G      V  A+ + TGE V ++++      ++       EL + ++ +HPNIV  +  F
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 99  FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 157
            +  +     L +V  ++   +   +   +      M  + +      + +AL YIH+ +
Sbjct: 96  IADNE-----LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147

Query: 158 GICHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNVSYICSRYYRAPEL 209
           G  HR +K  ++L++    ++ L    S         +  V  +     +    + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 210 IF-GATEYTTAIDIWSTGCVMAELLLGQP----------LF-------PGESGVDQLVEI 251
           +      Y    DI+S G    EL  G            L        P       +   
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266

Query: 252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC 311
              +          ++ + T               + +   P     V +  Q +P+ R 
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

Query: 312 TALEACVHPFFDELRDPNTRL--PNGRPLPPLFNFKPPELSGIPPE 355
           +A     H FF +++   +       RP+ P+ NF+  +       
Sbjct: 327 SASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  123 bits (310), Expect = 1e-32
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 94
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ IM+ L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 95  KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
                + T    L   +V EY+   ++ R+    S   +++         Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 154 HNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYRAPELIF 211
           HN    I HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPG 241
                    D++S G ++ EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  120 bits (303), Expect = 1e-31
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKN--RELQIMQMLDHPNIVALKH 96
             V+G G FG   +   RETGE++ +K++++  ++  +   +E+++M+ L+HPN++    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                   + L    + EY+   T+  I ++      + P      +   I   +AY+H+
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS 126

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------------- 202
              I HRD+   N LV      + + DFG A+++V  +     + S              
Sbjct: 127 M-NIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 203 --YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 241
             Y+ APE+I G   Y   +D++S G V+ E++      P 
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (304), Expect = 2e-31
 Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 51/303 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 90
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            +  + C+            LV+EY   + + +   + +    +  + +   T+   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 211 FGATE--YTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
               E  Y   +D+WS G +   EL   +P     + +  L  I +              
Sbjct: 223 LAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ------------NE 269

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
                   P ++   W + F+        + V    Q  P  R T+     H F    R 
Sbjct: 270 S-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314

Query: 328 PNT 330
           P  
Sbjct: 315 PTV 317

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (299), Expect = 4e-31
 Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 39/241 (16%)

Query: 19  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------ 72
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 73  ---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYS 128
              KR++ RE+     L H NIV++        + +  YL  V+EY+   T+      Y 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102

Query: 129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
             H  + +     +T QI   + + H+ + I HRDIKPQN+L++     LK+ DFG AK 
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 189 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 244
           L   E +++     + +  Y +PE   G        DI+S G V+ E+L+G+P F GE+ 
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

Query: 245 V 245
           V
Sbjct: 218 V 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (300), Expect = 5e-31
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 21  IRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRY 75
             + +  R         Y    ++G G    V  A+       VA+K VL     +D  +
Sbjct: 6   TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55

Query: 76  KNR---ELQIMQMLDHPNIVALKHCFF---STTDKEELYLNLVLEYVP-ETVNRIARNYS 128
             R   E Q    L+HP IVA+    +              +V+EYV   T+    R+  
Sbjct: 56  YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107

Query: 129 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 188
                M            C+AL + H   GI HRD+KP N++++  T+ +K+ DFG A+ 
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARA 165

Query: 189 LVKGEPNVSY----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 244
           +     +V+     I +  Y +PE   G +      D++S GCV+ E+L G+P F G+S 
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSP 224

Query: 245 V 245
           V
Sbjct: 225 V 225

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  119 bits (299), Expect = 7e-31
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 96
              +G G +G V+  K R  GE VA+K     ++    RE +I Q   + H NI+  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 154
               T    +LYL  + +Y    ++    ++ +      + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 155 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 202
             I        I HRD+K +N+LV  +     + D G A   +     V    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 203 YYRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 233
            Y  PE++  +      +     D++S G ++ E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (296), Expect = 1e-30
 Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           +     +G GSFG VF+     T ++VAIK +  ++         +E+ ++   D P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
                +   T      L +++EY+   +   +          +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 210
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
             +  Y +  DIWS G    EL  G+P                    P  E    ++P  
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP--------------------PHSE----LHPMK 226

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
             F  P+  P P     +        + V       P+ R TA E   H F        +
Sbjct: 227 VLFLIPKNNP-P---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

Query: 331 RL 332
            L
Sbjct: 283 YL 284

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  117 bits (295), Expect = 1e-30
 Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 96
              VG G +G V++   +  GE VA+K    +D++   RE ++     L H NI+  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 154
              S     +L+L  +  Y    ++    +  +      + ++        I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122

Query: 155 NCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----R 202
             I        I HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 203 YYRAPELI-----FGATEYTTAIDIWSTGCVMAELL 233
            Y APE++         +    +DIW+ G V+ E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (294), Expect = 2e-30
 Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 26/224 (11%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 94
              +G+GSFG V++ K       VA+K +               E+ +++   H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 95  KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
              F   +   +L +  V ++    ++            +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYL 136

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAPELI 210
           H    I HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 HAK-SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 211 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
                  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  117 bits (295), Expect = 2e-30
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 47/292 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 93
           Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+   +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
               +    +     L +V+EY+   ++  +          M    +     +  +AL +
Sbjct: 82  YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEF 131

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-VSYICSRYYRAPELIF 211
           +H+   + HRDIK  N+L+      +KL DFG    +   +    + + + Y+ APE++ 
Sbjct: 132 LHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 212 GATEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
               Y   +DIWS G +MA E++ G+P +  E+ +  L  I    GTP  +         
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN-------- 238

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                    P     +F+        D + R  +     R +A E   H F 
Sbjct: 239 ---------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  116 bits (292), Expect = 2e-30
 Identities = 24/211 (11%), Positives = 71/211 (33%), Gaps = 22/211 (10%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 94
              +     G +++ + +  G  + +K +          R  N E   +++  HPN++ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 95  KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
                        +  L+  ++P  ++  +    +     +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL 127

Query: 154 HNC-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           H     I    +  ++++++      ++                +      + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182

Query: 213 --ATEYTTAIDIWSTGCVMAELLLGQPLFPG 241
                   + D+WS   ++ EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  116 bits (293), Expect = 4e-30
 Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 39/296 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 95
           +     +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             +F  TD     L +V+EY       ++      ++ +    +        + L Y+H 
Sbjct: 91  GSYFKNTD-----LWIVMEYCG--AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGAT 214
            +   HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I    
Sbjct: 144 -MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI- 200

Query: 215 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
            Y    DIWS G    E+  G+P +     +  +  I      PT  +            
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK------------ 247

Query: 275 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                P  W   F         D V +    SP  R TA +   HPF    +  + 
Sbjct: 248 -----PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  115 bits (291), Expect = 8e-30
 Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 47/286 (16%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 99
           +G GS G+V  A+ + +G  VA+K +     Q +     E+ IM+   H N+V +   + 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 100 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 158
                EEL++  ++E++    +  I         R+    +      + +ALAY+H   G
Sbjct: 113 V---GEELWV--LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QG 161

Query: 159 ICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELIFGATEYT 217
           + HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I   + Y 
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219

Query: 218 TAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 276
           T +DIWS G +M  E++ G+P +  +S V  +  +      P  +               
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN-------------- 263

Query: 277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
               H    V +        D + R     P  R TA E   HPF 
Sbjct: 264 ---SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  115 bits (289), Expect = 1e-29
 Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 28/219 (12%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYK---NRELQIMQMLDHP 89
           Y    +VG G  G V++A+      IVA+K ++      D  ++    RE +    L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           ++V +           +LY+   +  +             R    +          QI  
Sbjct: 95  HVVPI---HDFGEIDGQLYV--DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYY 204
           AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHA-AGATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 243
            APE    +   T   DI++  CV+ E L G P + G+ 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (289), Expect = 1e-29
 Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 54/307 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 93
           +     +G G+FG V++AK +ETG + A K +     ++      E++I+   DHP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 94  LKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           L   ++         L +++E+     V   +  + R        +    +++   Q+  
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLE 128

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAP 207
           AL ++H+   I HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ AP
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 208 ELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           E++   T     Y    DIWS G  + E+   +P     + +  L++I K    PT    
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT- 244

Query: 264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 323
                           P  W   F+        D +      +P  R +A +   HPF  
Sbjct: 245 ----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVS 280

Query: 324 ELRDPNT 330
            +     
Sbjct: 281 SITSNKA 287

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 3e-29
 Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 42/307 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQML-DHPNIVA 93
           +    +VG G++G V++ +  +TG++ AIK +     ++    +E+ +++    H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 94  LKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
               F        +  L LV+E+    +V  + +N       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLS 143

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNVSYICSRYYRAPELI 210
           ++H    + HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 211 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
           NP       P++K   W K FQ          +      + + R    +   HPF  +  
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 327 DPNTRLP 333
           +      
Sbjct: 295 NERQVRI 301

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  113 bits (285), Expect = 9e-29
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 96
           +  +G G FG V++ K R  GE VA+K    +++R   RE +I Q   L H NI+  +  
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 97  CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                    +L+L  V +Y    ++      Y+   + M    +KL        LA++H 
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157

Query: 156 CI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS-----RY 203
            I        I HRD+K +N+LV  +     + D G A         +    +     + 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 204 YRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 233
           Y APE++  +      E     DI++ G V  E+ 
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  112 bits (283), Expect = 1e-28
 Identities = 56/247 (22%), Positives = 98/247 (39%), Gaps = 35/247 (14%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 96
             V   G FG V++A+     E VA+K    QDK+    E ++  +  + H NI+  +  
Sbjct: 29  LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
               T+   +L+L  +  +          ++ + +         +    + R LAY+H  
Sbjct: 87  EKRGTSVDVDLWL--ITAFHE---KGSLSDFLKANVVSWNELCHIA-ETMARGLAYLHED 140

Query: 157 I---------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 203
           I          I HRDIK +N+L+  +     + DFG A      E   S   +      
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGDTHGQVGT 196

Query: 204 --YRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 257
             Y APE++ GA     +    ID+++ G V+ EL        G      L    ++   
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256

Query: 258 PTREEIK 264
           P+ E+++
Sbjct: 257 PSLEDMQ 263

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  112 bits (283), Expect = 1e-28
 Identities = 39/223 (17%), Positives = 83/223 (37%), Gaps = 37/223 (16%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 94
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   +   H N+V  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 95  K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
              C         L   ++       T+  + R+       + +   +    +I + + Y
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGY 145

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------YYRA 206
           +H   GI H+D+K +N+  +     + + DFG   +    +        R       + A
Sbjct: 146 LHAK-GILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 207 PELIFGATE--------YTTAIDIWSTGCVMAELLLGQPLFPG 241
           PE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  112 bits (281), Expect = 3e-28
 Identities = 56/254 (22%), Positives = 98/254 (38%), Gaps = 39/254 (15%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHC 97
             ++G G +G V++         VA+K     +++    E  I ++  ++H NI      
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 98  FFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
               T    +   LV+EY P       ++ + S       L +       + R LAY+H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129

Query: 156 CI--------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY---- 203
            +         I HRD+  +N+LV        + DFG +  L                  
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 204 -----YRAPELIFGA------TEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD-QLVE 250
                Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 251 IIKVLGTPTREEIK 264
             +V   PT E+++
Sbjct: 249 QTEVGNHPTFEDMQ 262

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (263), Expect = 8e-26
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 52/238 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 92  VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 149
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 205
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 206 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  103 bits (260), Expect = 1e-25
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 46/218 (21%)

Query: 41  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
              +G G+FG V   +       TGE+VA+KK LQ    ++     RE++I++ L H NI
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 92  VALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 149
           V  K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ 
Sbjct: 74  VKYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 205
           + Y+     I   HRD+  +N+LV  + +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 206 ----------APELIFGATEYTTAIDIWSTGCVMAELL 233
                     APE +   ++++ A D+WS G V+ EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 3e-25
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 44/217 (20%)

Query: 41  EHVVGTGSFGVVFQAKCR----ETGEIVAIK--KVLQDKRYKN--RELQIMQMLDHPNIV 92
              +G G+FG V   +       TGE+VA+K  +   ++  ++  RE++I++ L H NIV
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 93  ALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 150
             K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 206 ---------APELIFGATEYTTAIDIWSTGCVMAELL 233
                    APE +   ++++ A D+WS G V+ EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  101 bits (253), Expect = 2e-24
 Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 44/235 (18%)

Query: 41  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
              +G G FG V           TGE+VA+K +  D   ++     +E+ I++ L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           +  K C     D     L LV+EYVP       R+Y   H  + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 152 YIH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 205
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 206 --------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 251
                   APE +     +  A D+WS G  + ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  100 bits (252), Expect = 2e-24
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 44/217 (20%)

Query: 41  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
              +G G+FG V   +       TG +VA+K  LQ           RE+QI++ L    I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 150
           V  +        ++ L   LV+EY+P   +   R++ + H+ R+    + LY+ QIC+ +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+    C+   HRD+  +N+LV      +K+ DFG AK+L   +         YY    
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188

Query: 206 ---------APELIFGATEYTTAIDIWSTGCVMAELL 233
                    APE +     ++   D+WS G V+ EL 
Sbjct: 189 PGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (250), Expect = 4e-24
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 41  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
              +G G FG V   +       TGE VA+K +  +    +     +E++I++ L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRAL 150
           V  K      T+     + L++E++P   +   + Y   +  ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 206 ---------APELIFGATEYTTAIDIWSTGCVMAELL 233
                    APE +  +  +  A D+WS G  + ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 47/232 (20%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKV---LQDKRYKN---RELQIMQMLDHPN 90
           + +  +G+G+FG V +   +    +  VA+K +     D   K+    E  +MQ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV +        + E     LV+E            Y + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 206 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                    APE + +   ++++  D+WS G +M E    GQ  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.5 bits (246), Expect = 9e-24
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 97
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 153
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 207
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 208 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
           E L +   +++   D+W+ G ++ E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 154
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 208
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 209 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
            L     +++T  D+WS G ++ E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 49/238 (20%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 91
           IA+  +G G+FG V Q   R   +   VAIK + Q     +      E QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 150
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 206 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 31/220 (14%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 97
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 153
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 207
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
           E +     ++   D+W+ G ++ E+   G   +PG     
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 98
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 99  FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 154
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------APE 208
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 209 -LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
            L     +++T  D+WS G ++ E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 50/237 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 92  VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 149
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 205
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 206 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
                    A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 99.1 bits (247), Expect = 5e-23
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 97
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 153
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 207
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 38/231 (16%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
             V+G+G FG V +      GE     V IK +      ++       +  +  LDH +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 150
           V L            L   LV +Y+P        ++ R H+  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +     +     +   
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181

Query: 206 ---APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
              A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 44/235 (18%), Positives = 79/235 (33%), Gaps = 50/235 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDKRYKN----RELQIMQMLDHP 89
              +G G+F  +F+   RE G+        V +K + +  R  +        +M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 90  NIVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQIC 147
           ++V     C       +E    LV E+V          Y + ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 148 RALAYI--HNCIGICHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNVSY 198
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 199 ICSRYYR------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                 +       PE I        A D WS G  + E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 97
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 153
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR------AP 207
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
           E       +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 97
              +G G FG V+        + VA+K + Q     +    E  +M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 153
            ++   +E +Y  ++ EY+    N    ++ +    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 205
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 206 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 250
              APE + +G   +T   D+WS G ++ E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 47/232 (20%)

Query: 39  IAEHVVGTGSFGVVFQAKCR-ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 91
           IA+  +G G+FG V Q   R    +I VAIK + Q     +      E QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 150
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 206 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                    APE + F   ++++  D+WS G  M E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.8 bits (234), Expect = 3e-22
 Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 96
              +G+G FGVV   K +   + VA+K + +    ++   +E Q M  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 153
           C    + +  +Y  +V EY+    N    NY R H +       L   Y +C  +A++  
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 205
           H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y          
Sbjct: 123 HQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169

Query: 206 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 250
              APE   +   +Y++  D+W+ G +M E+  LG+  +   +   V   V 
Sbjct: 170 KWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 47/232 (20%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 97
           E  +G G FG V+ A   +  + VA+K +            E  +M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 98  FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 153
                 KE +Y  ++ E++         ++ +  +       KL  ++ QI   +A+I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 205
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 206 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
              APE + FG   +T   D+WS G ++ E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.0 bits (232), Expect = 5e-22
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 45/226 (19%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 96
              +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 153
           C     ++  +   LV E++    +    +Y R  + +      L     +C  +AY+  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 205
              I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y          
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169

Query: 206 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
              +PE   F    Y++  D+WS G +M E+   G+  +   S  +
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 92.6 bits (231), Expect = 9e-22
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 48/230 (20%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
             ++G G FG V++            VA+K   +D    N+     E  IM+ LDHP+IV
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 151
            L        ++E  +  +++E  P        +Y   ++  + ++ + LY+ QIC+A+A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 152 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 205
           Y+   NC+   HRDI  +N+LV      +KL DFG ++ +   +         YY+    
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174

Query: 206 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                  +PE + F    +TTA D+W     M E+L  G+  F      D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 52/239 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
             ++G G FG V +A+ ++       VA+K +  D    +      RE   M+  DHP++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 92  VALKH-CFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYT 143
             L      S          ++L ++           +RI  N   +  +  L+    + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143

Query: 144 YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICS 201
             I   + Y+   N I   HRD+  +N ++      + + DFG ++ +  G+        
Sbjct: 144 VDIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD-------- 191

Query: 202 RYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
            YYR            A E L      YT   D+W+ G  M E++  GQ  + G    +
Sbjct: 192 -YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 49/230 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 95
              +G G+FG VF  + R    +VA+K   +      +     E +I++   HPNIV L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 96  H--CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY 152
              C    T K+ +Y  +V+E V          + R       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 153 IH--NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR----- 205
           +    CI   HRD+  +N LV    + LK+ DFG ++    G          Y       
Sbjct: 229 LESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLR 275

Query: 206 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                  APE L +G   Y++  D+WS G ++ E   LG   +P  S   
Sbjct: 276 QVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 52/239 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN-------RELQIMQMLDHPN 90
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 149
           ++ L    +       +   +V E  P        +  R HQ    L  +  Y  Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 205
           + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y   
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 206 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
                     APE L      ++ A D W  G  + E+   GQ  + G +G      ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 51/238 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
             ++G G FG V +   ++       VA+K +  D   +        E   M+   HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 144
           + L       + +      ++L ++           +R+      I  +  L+    +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154

Query: 145 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
            I   + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         
Sbjct: 155 DIALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD--------- 201

Query: 203 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
           YYR            A E L      YT+  D+W+ G  M E+   G   +PG    +
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 90.7 bits (226), Expect = 6e-21
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 45/226 (19%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 96
              +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 97  CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 153
           C    T +  ++  ++ EY+    N    NY R  +        L     +C A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-------- 205
              +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y          
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185

Query: 206 ---APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
               PE L++   ++++  DIW+ G +M E+  LG+  +   +  +
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 90.4 bits (225), Expect = 8e-21
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 151
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 152 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 205
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177

Query: 206 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 250
                  APE + F    +T+A D+W  G  M E+L  G   F G    D    +E
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 60/250 (24%), Positives = 94/250 (37%), Gaps = 60/250 (24%)

Query: 45  GTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHPNIVA 93
           G G+FG V +A        +    VA+K +     L ++     EL+++  L +H NIV 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 94  LKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVK 140
           L       T        ++ EY                 +             + L    
Sbjct: 92  LLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 141 LYT--YQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
           L +  YQ+ + +A++   NCI   HRD+  +N+L+       K+CDFG A+ +       
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKNDS--- 199

Query: 197 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 243
                  Y             APE IF    YT   D+WS G  + EL  LG   +PG  
Sbjct: 200 ------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 244 GVDQLVEIIK 253
              +  ++IK
Sbjct: 253 VDSKFYKMIK 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 31/263 (11%), Positives = 55/263 (20%), Gaps = 60/263 (22%)

Query: 4   TDEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEI 63
            +     D V    G  I     GR         Y      G       +QA        
Sbjct: 11  RESSAPPDDVQLVPGARI---ANGR---------YRLLIFHGGVPPLQFWQALDTALDRQ 58

Query: 64  VAIKKVL----QDKRYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 116
           VA+  V                    +  +D P +  +         +    +  V E++
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--VAEWI 113

Query: 117 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT 175
              ++  +A            +        +  A    H   G+      P  + V+   
Sbjct: 114 RGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-D 165

Query: 176 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 235
             + L                                        DI   G  +  LL+ 
Sbjct: 166 GDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVN 198

Query: 236 QPLFPGESGVDQLVEIIKVLGTP 258
           +   P       L    +     
Sbjct: 199 RWPLPEAGVRSGLAPAERDTAGQ 221

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 49/232 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           E ++G+G  G V   + R  G+    VAIK +      + R     E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 93  ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRAL 150
            L+       T        +V EY+    N     + R H     I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 206 ---------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                    APE + F    +++A D+WS G VM E+L  G+  +   +  D
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 50/236 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 151
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 152 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 205
           Y+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+    
Sbjct: 506 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 552

Query: 206 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 250
                  APE + F    +T+A D+W  G  M E+L  G   F G     V   +E
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 47/231 (20%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 92
           + VVG G FG V   + +   +    VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 93  ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 150
            L+       T  + +   +V EY+    N    ++ R H  +  +I +      I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 151 AYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR--- 205
            Y+     +   HRD+  +N+L+N +    K+ DFG  +VL              Y    
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRG 209

Query: 206 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                   +PE + +   ++T+A D+WS G V+ E++  G+  +   S  D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 55/236 (23%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE---IVAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 92
           + V+G G FGVV+  +  +  +     AIK    + + +      RE  +M+ L+HPN++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 148
           AL          E L   ++L Y+    +     + R  QR P    LI    +  Q+ R
Sbjct: 86  ALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135

Query: 149 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 205
            + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E         YY  
Sbjct: 136 GMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE---------YYSV 182

Query: 206 -------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                        A E L      +TT  D+WS G ++ ELL  G P +      D
Sbjct: 183 QQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 61/248 (24%)

Query: 45  GTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALK 95
           G G+FG VF A+C          +VA+K +    L  ++   RE +++  L H +IV   
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83

Query: 96  HCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKLY-- 142
                  D + L   +V EY+                 I  +      +  L   ++   
Sbjct: 84  GV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 143 TYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 200
             QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++ +   +       
Sbjct: 139 ASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTD------- 187

Query: 201 SRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGV 245
             YYR             PE +++   ++TT  D+WS G ++ E+   G QP +   S  
Sbjct: 188 --YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-WFQLS-N 241

Query: 246 DQLVEIIK 253
            +++E I 
Sbjct: 242 TEVIECIT 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 88.2 bits (219), Expect = 9e-20
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 46/231 (19%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 91
           + V+G G FG V++   + +       VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 92  VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 149
           + L+       +  + +   ++ EY+    N     + R       ++ +      I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 150 LAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR-- 205
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL             Y    
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAT------YTTSG 209

Query: 206 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                   APE + +    +T+A D+WS G VM E++  G+  +   S  +
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)

Query: 42  HVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HPN 90
             +G G+FG V +A         T   VA+K +       + R    EL+I+  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLI 137
           +V L      T     L   +++E+               E V             + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 138 YVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
           ++  Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K    
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDIYKDP-- 202

Query: 196 VSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 242
                   Y             APE IF    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 203 -------DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV 254

Query: 243 SGVDQLVEIIK 253
              ++    +K
Sbjct: 255 KIDEEFCRRLK 265

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 52/233 (22%), Positives = 92/233 (39%), Gaps = 49/233 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 92
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALA 151
           +L         +      +VL Y+    +   RN+ R     P +   + +  Q+ + + 
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 152 YI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR---- 205
           Y+     +   HRD+  +N +++     +K+ DFG A+ +   E         YY     
Sbjct: 143 YLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNK 189

Query: 206 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                     A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 190 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 50/245 (20%), Positives = 99/245 (40%), Gaps = 54/245 (22%)

Query: 42  HVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLDHPNI 91
             +G GSFG+V++   +   +      VAIK V     ++++     E  +M+  +  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 144
           V L       +  +     +++E +            R A   + +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 145 QICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
           +I   +AY+  +  +   HRD+  +N +V      +K+ DFG  + + + +         
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192

Query: 203 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 248
           YYR            +PE L  G   +TT  D+WS G V+ E+  L +  + G S  +Q+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQV 249

Query: 249 VEIIK 253
           +  + 
Sbjct: 250 LRFVM 254

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 49/233 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 92
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 148
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203

Query: 149 ALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR- 205
            + ++     +   HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 204 GMKFLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 206 ----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
                     A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 68/260 (26%)

Query: 41  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 90
              +G G FG V +A             VA+K +       + R    E  +++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 131
           ++ L       +    L   L++EY                      +      +     
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 132 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 187
               L    L  + +QI + + Y+     +   HRD+  +N+LV     ++K+ DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198

Query: 188 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-L 234
            + + +          Y             A E +F    YTT  D+WS G ++ E++ L
Sbjct: 199 DVYEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248

Query: 235 G-QPLFPGESGVDQLVEIIK 253
           G  P +PG    ++L  ++K
Sbjct: 249 GGNP-YPGIP-PERLFNLLK 266

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 60/251 (23%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNI 91
           +  +G G+FG VF A+C          +VA+K +       ++   RE +++ ML H +I
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP----------ETVNRIARNYSRIHQRMPLIYVKL 141
           V         T+   L   +V EY+              +             PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 142 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
                Q+   + Y+   + +   HRD+  +N LV      +K+ DFG ++ +   +    
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212

Query: 198 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 242
                YYR             PE +++   ++TT  D+WS G V+ E+   G QP +   
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQL 264

Query: 243 SGVDQLVEIIK 253
           S   + ++ I 
Sbjct: 265 S-NTEAIDCIT 274

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 58/251 (23%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLD-HP 89
              +G G+FG V +A     G+      VA+K +       +K     EL+IM  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVP---------ETVNRIARNYSRIHQRMPLIYVK 140
           NIV L       T    +   ++ EY                +  + +            
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 141 L--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV 196
           L  ++ Q+ + +A++   NCI   HRD+  +N+L+    H  K+ DFG A+ ++      
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS--- 218

Query: 197 SYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 242
                  Y             APE IF    YT   D+WS G ++ E+  LG  P +PG 
Sbjct: 219 ------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGI 270

Query: 243 SGVDQLVEIIK 253
               +  +++K
Sbjct: 271 LVNSKFYKLVK 281

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 59/260 (22%), Positives = 97/260 (37%), Gaps = 67/260 (25%)

Query: 41  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHP 89
             V+G+G+FG V  A             VA+K +       ++     EL++M  L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVP------------------ETVNRIARNYSRIH 131
           NIV L       T    +Y  L+ EY                    E      +      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 132 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 187
               L +  L  + YQ+ + + ++   +C+   HRD+  +N+LV      +K+CDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220

Query: 188 VLVKGEPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAEL--L 233
            ++             Y             APE +F    YT   D+WS G ++ E+  L
Sbjct: 221 DIMSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270

Query: 234 LGQPLFPGESGVDQLVEIIK 253
              P +PG        ++I+
Sbjct: 271 GVNP-YPGIPVDANFYKLIQ 289

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 50/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 41  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 90
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 146
           IV        +      +  +++E +      +  R  R        + ++ +      I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 147 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 202
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 203 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 248
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 249 VEIIK 253
           +E + 
Sbjct: 255 LEFVT 259

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 52/245 (21%)

Query: 41  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 90
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 146
           IV        +      +  ++LE +      +  R  R        + ++ +      I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 147 CRALAYI--HNCIGICHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNVSYICSR 202
                Y+  ++ I   HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 203 YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 248
           YYR             PE  + G   +T+  D WS G ++ E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 249 VEIIK 253
           +E + 
Sbjct: 296 LEFVT 300

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 82.6 bits (205), Expect = 4e-18
 Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 62/253 (24%)

Query: 41  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 90
              +G   FG V++         E  + VAIK +        +     E  +   L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYV 139
           +V L       T  + L   ++  Y                + +         +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 140 KL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 195
                  QI   + Y+  H+ +   H+D+  +N+LV      +K+ D G  + +   +  
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182

Query: 196 VSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFP 240
                  YY+            APE +++G  +++   DIWS G V+ E+   G QP + 
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YC 232

Query: 241 GESGVDQLVEIIK 253
           G S    +VE+I+
Sbjct: 233 GYS-NQDVVEMIR 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 56/261 (21%), Positives = 99/261 (37%), Gaps = 70/261 (26%)

Query: 41  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 90
              +G G+FG VFQA+       E   +VA+K +        +    RE  +M   D+PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 131
           IV L          + +   L+ EY+                       +   R      
Sbjct: 112 IVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 132 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK 187
              PL   +      Q+   +AY+     +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVVKIADFGLSR 222

Query: 188 VLVKGEPNVSYICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL- 233
            +   +         YY+             PE + +    YTT  D+W+ G V+ E+  
Sbjct: 223 NIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

Query: 234 LG-QPLFPGESGVDQLVEIIK 253
            G QP + G +  ++++  ++
Sbjct: 272 YGLQP-YYGMA-HEEVIYYVR 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 61/254 (24%)

Query: 41  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 87
              +G G FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 136
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 137 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 192
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256

Query: 193 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 239
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 306

Query: 240 PGESGVDQLVEIIK 253
           PG   V++L +++K
Sbjct: 307 PGIP-VEELFKLLK 319

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 61/254 (24%)

Query: 41  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 87
              +G G+FG V  A+              VA+K +      +D      E+++M+M+  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPL 136
           H NI+ L       T    LY  +++EY                          +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 137 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 192
               L    YQ+ R + Y+    CI   HRD+  +N+LV    + +K+ DFG A+ +   
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244

Query: 193 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 239
           +         YY+            APE +F    YT   D+WS G ++ E+  LG   +
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPY 294

Query: 240 PGESGVDQLVEIIK 253
           PG   V++L +++K
Sbjct: 295 PGVP-VEELFKLLK 307

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 61/254 (24%)

Query: 41  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 87
              +G G+FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 136
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 137 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 192
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  + + +K+ DFG A+ +   
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210

Query: 193 EPNVSYICSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLF 239
           +         YY+            APE +F    YT   D+WS G +M E+  LG   +
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 260

Query: 240 PGESGVDQLVEIIK 253
           PG   V++L +++K
Sbjct: 261 PGIP-VEELFKLLK 273

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.9 bits (195), Expect = 9e-17
 Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 94
           Y     +G GSFGV+F+       + VAIK   +         E +  ++L     I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            +       +E L+  LV++ +  ++  +     R   +  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123

Query: 155 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 187
               + +RDIKP N L+    + + + + + DFG  K
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 60/238 (25%)

Query: 41  EHVVGTGSFGVVFQAKCRETGE--IVAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 92
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKL 141
            L         +  LY  L +EY P             +               L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 142 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS 197
             +   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 198 YICSRYYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 241
                 Y             A E L +    YTT  D+WS G ++ E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 78.8 bits (193), Expect = 1e-16
 Identities = 46/330 (13%), Positives = 91/330 (27%), Gaps = 74/330 (22%)

Query: 44  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----------RELQIMQML----- 86
           +G G FG VF  +       VAIK + ++     N            E+ I + L     
Sbjct: 28  IGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 87  ----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIY-- 138
                    + L            L L     Y     + N     +      + L +  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 139 -----------------VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC 181
                             K   +Q+  +LA     +   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 241
              + K        +                  +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCGL-------------QVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 242 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKPHPW--HKVFQKRLP 292
           +   D   +I +++           +P       +Y   K  +        +    K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 293 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            +  +       +S     +A +       
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 16/157 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQMLDH-PNIVAL 94
           +     +G G+FG +   K   T E VAIK   +       + E +  + L     I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            +           Y  +VLE +  ++  +     R      L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122

Query: 155 NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSAK 187
           +   + +RD+KP+N L+    N     + + DF  AK
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 14/155 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 94
           Y     +G+GSFG ++       GE VAIK      ++     E +I +M+     I  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           + C       E  Y  +V+E +  ++  +    SR   +  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122

Query: 155 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 187
           +     HRD+KP N L+      + + + DFG AK
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQML-DHPNIVAL 94
           +     +G+GSFG ++     +T E VAIK      ++     E +I ++L     I  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
           +         E  Y  LV++ +  ++  +   ++   +++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 155 NCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK 187
           +     HRDIKP N L+      +Q+ + DFG AK
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 45/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 17  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK 76
            G V+    G +         ++    +G+G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 77  N---RELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVPET 119
                EL+  Q +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 120 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQL 178
           + +I    +          V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKI-SGQNG---TFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 179 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWSTG 226
            L D+G +        +  Y         +   G  E+ T++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 227 CVMAELLLGQ 236
             M   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 4e-14
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 56/236 (23%)

Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQ 81
            N  ++   +  + +G G FGVV+  K       VA+KK+                 E++
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82

Query: 82  IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS------RIHQRMP 135
           +M    H N+V L     S+   +     LV  Y+P        N S       +    P
Sbjct: 83  VMAKCQHENLVELLGF--SSDGDDLC---LVYVYMP--------NGSLLDRLSCLDGTPP 129

Query: 136 LIYVKLYTYQIC----RALAYIH-NCIGICHRDIKPQNLLV----NPHTHQLKLCDFGSA 186
           L +      +I       + ++H N   I HRDIK  N+L+           K+ DFG A
Sbjct: 130 LSWHM--RCKIAQGAANGINFLHENHH-I-HRDIKSANILLDEAFTA-----KISDFGLA 180

Query: 187 KVLVKGEPNVSYICSR----Y-YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 237
           +   K     + + SR      Y APE + G  E T   DI+S G V+ E++ G P
Sbjct: 181 RASEKFA--QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 47/220 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVAL-K 95
           + ++G G FG V++   R+ G  VA+K+   +          E++ +    HP++V+L  
Sbjct: 44  KFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQIC----RA 149
            C       E   + L+ +Y+    N   +   Y      M + + +    +IC    R 
Sbjct: 103 FC------DERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARG 151

Query: 150 LAYIHN-CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY----- 203
           L Y+H   I I HRD+K  N+L++ +    K+ DFG +K   + +   +++ +       
Sbjct: 152 LHYLHTRAI-I-HRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVKGTLG 206

Query: 204 YRAPELIFGATEY------TTAIDIWSTGCVMAELLLGQP 237
           Y  P       EY      T   D++S G V+ E+L  + 
Sbjct: 207 YIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 48/221 (21%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 95
           ++++G G FG V++ +    G +VA+K++ +++          E++++ M  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-------RIHQRMPLIYVKLYTYQIC- 147
                 T  E L   LV  Y+         N S       R   + PL + K    +I  
Sbjct: 94  GF--CMTPTERL---LVYPYMA--------NGSVASCLRERPESQPPLDWPK--RQRIAL 138

Query: 148 ---RALAYIHN-C-IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR 202
              R LAY+H+ C   I HRD+K  N+L++    +  + DFG AK++   +   +++ + 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTA 194

Query: 203 Y-----YRAPE-LIFG-ATEYTTAIDIWSTGCVMAELLLGQ 236
                 + APE L  G ++E T   D++  G ++ EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 46/252 (18%), Positives = 76/252 (30%), Gaps = 52/252 (20%)

Query: 18  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 77
           G +I                +     +G G FG ++ A    + E V        K   +
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPS 75

Query: 78  R------ELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVP 117
                  EL+  Q    P  +                           + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 118 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTH 176
             + +I    ++   R     V   + +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 177 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------DIWS 224
           Q+ L D+G A        + +Y             G  E+ T+I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 225 TGCVMAELLLGQ 236
            G  M + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 37/255 (14%), Positives = 78/255 (30%), Gaps = 56/255 (21%)

Query: 17  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG--------EIVAIK- 67
           TG V+    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 68  -----------KVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 114
                         Q   K  +  + + +       I             ++ Y  LVL 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLP 138

Query: 115 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP- 173
            +  ++        +    +    V     ++  AL ++H      H ++  +N+ V+P 
Sbjct: 139 SLGRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPE 195

Query: 174 HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAI------------D 221
              Q+ L  +G A        +V+Y             G  E+  ++            D
Sbjct: 196 DQSQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSD 250

Query: 222 IWSTGCVMAELLLGQ 236
           + S G  M + L G 
Sbjct: 251 LQSLGYCMLKWLYGF 265

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 29/127 (22%)

Query: 142 YTYQICRALAYI--HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
           Y++Q+ + + ++    CI   HRD+  +N+L++   + +K+CDFG A+ + K        
Sbjct: 198 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYKDP------ 247

Query: 200 CSRYYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 246
               Y             APE IF    YT   D+WS G ++ E+  LG   +PG    +
Sbjct: 248 ---DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 247 QLVEIIK 253
           +    +K
Sbjct: 304 EFCRRLK 310

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	376
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.58
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.11
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.11
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.79
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.76
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.66
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.5
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.48
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.29
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.17
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.16
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.06
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.93
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.71
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.68
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.64
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.81

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.2e-65  Score=458.19  Aligned_cols=255  Identities=31%  Similarity=0.514  Sum_probs=220.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.++|||||+++++|.+     .
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~  104 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----D  104 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----C
Confidence            346799999999999999999999999999999998643       1345689999999999999999999843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .++|+|||||+| +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGl  178 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGT  178 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCC
Confidence            348999999985 88877764    4679999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCC---CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          186 AKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       186 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      |+.....   ....+.+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.+|.+.        
T Consensus       179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------  249 (311)
T 4aw0_A          179 AKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------  249 (311)
T ss_dssp             CEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred             ceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence            9876432   234467899999999999764 5899999999999999999999999998888877777652        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHH------HhcCCcccccCCCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDPN  329 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~------ll~hp~f~~~~~~~  329 (376)
                               .+.+            +..+|+++++||++||++||++|+|++|      +++||||++++|..
T Consensus       250 ---------~~~~------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          250 ---------EYDF------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             ---------CCCC------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             ---------CCCC------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence                     1222            2468999999999999999999999987      58999999988654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-65  Score=474.06  Aligned_cols=288  Identities=37%  Similarity=0.644  Sum_probs=240.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      .++|++++.||+|+||+||+|+++.||+.||||++.+..      ....+|+.+|+.++|||||++++++..... ....
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999999999999999986432      234579999999999999999998754321 2334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+|+|||||+|+|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus       133 ~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceee
Confidence            5889999999998777653    5679999999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccCC-----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          188 VLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       188 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .....     ....+.+||++|+|||++.+...|+.++||||+||++|||++|++||.+.+..+++..|....+.|+...
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            65332     2345678999999999998777789999999999999999999999999999999999999999998765


Q ss_pred             HhhcCcCcc---cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          263 IKCMNPNYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       263 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      +........   ...++.....+|...+ +.++++++|||++||++||.+|||+.|+|+||||++..++.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~  355 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD  355 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence            543321111   1234445555565555 57899999999999999999999999999999999987664

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.2e-65  Score=450.82  Aligned_cols=249  Identities=29%  Similarity=0.412  Sum_probs=202.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+|+.++||||+++++++.+.     ..
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence            57999999999999999999999999999999986432       2356899999999999999999998543     34


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +|+|||||+|+|.+.+..    .+.+++.+++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        88 ~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  161 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC--
T ss_pred             EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCee
Confidence            889999999998877754    4679999999999999999999998 9999999999999999998 799999999987


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ........+.+||+.|+|||++.+..+++.++|||||||++|+|+||++||.+.+....+..+.+.              
T Consensus       162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------------  227 (275)
T 3hyh_A          162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------------  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred             cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence            766666667899999999999977665678999999999999999999999988766666655542              


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                         .+.            ++..+|+++++||++||+.||++|||++|+++||||+.
T Consensus       228 ---~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 ---VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence               111            12458999999999999999999999999999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.1e-64  Score=455.67  Aligned_cols=252  Identities=28%  Similarity=0.446  Sum_probs=216.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..|++.+.||+|+||+||+|+++.||+.||||++...    .....+|+.+|+.++|||||+++++|.+..     .+|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence            5699999999999999999999999999999998542    344678999999999999999999996543     4899


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |||||+| +|.+++..     .++++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999985 77776653     579999999999999999999998 9999999999999999998 79999999998764


Q ss_pred             CC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .. ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..... +           
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~-----------  288 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P-----------  288 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-C-----------
T ss_pred             CCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C-----------
Confidence            43 34456789999999999955 4589999999999999999999999999888777776654210 0           


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                          .++          ....+|+++++||.+||+.||++|||+.|+|+||||++..
T Consensus       289 ----~~~----------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          289 ----RLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             ----CCS----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----CCC----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                000          1135899999999999999999999999999999998743

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-63  Score=454.96  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=210.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..-++|++++.||+|+||+||+|+++.+|+.||||++.+..      ....+|+.+|+.++|||||++++++.+.     
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----   95 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----   95 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----
Confidence            33468999999999999999999999999999999986532      2355899999999999999999998543     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+|+|||||+| +|.+++...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        96 ~~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl  171 (350)
T 4b9d_A           96 GSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGI  171 (350)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEccccc
Confidence            348999999984 888887642  23457999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          186 AKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       186 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      |+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.++.+..         
T Consensus       172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------  241 (350)
T 4b9d_A          172 ARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS---------  241 (350)
T ss_dssp             ESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC---------
T ss_pred             ceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC---------
Confidence            98664322 2245679999999999965 459999999999999999999999999998888887776521         


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                ++         .++..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       242 ----------~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 ----------FP---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ----------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ----------CC---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                      00         012468999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-62  Score=456.07  Aligned_cols=252  Identities=28%  Similarity=0.446  Sum_probs=216.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..|++++.||+|+||+||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|.+..     .+|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence            5699999999999999999999999999999998542    344678999999999999999999996543     4899


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |||||+| +|.+++..     .++++..++.++.||+.||+|||+ +||+||||||+|||++.+| .+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999985 77776653     579999999999999999999998 9999999999999999998 79999999998764


Q ss_pred             CC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .. ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..... +           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~-----------  365 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-P-----------  365 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----------
T ss_pred             CCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-C-----------
Confidence            43 34557789999999999965 4589999999999999999999999999888877776654210 0           


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                          .++          ....+|+++++||.+||+.||.+|+|+.|+|+||||++..
T Consensus       366 ----~~~----------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          366 ----RLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             ----CCS----------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----CCc----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                000          1146899999999999999999999999999999998743

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-63  Score=444.20  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=210.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++++.||+|+||+||+|++.   .+++.||||++.+.      .....+|+.+|+.++|||||++++++.+.    
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~----   98 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE----   98 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET----
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----
Confidence            468999999999999999999984   47889999998543      23456799999999999999999998543    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                       ..+|+|||||+| +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        99 -~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFG  171 (304)
T 3ubd_A           99 -GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFG  171 (304)
T ss_dssp             -TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSE
T ss_pred             -CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEecccc
Confidence             348999999985 88777754    4679999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +|+..... ....+.+||+.|+|||++.+. .|+.++|||||||++|||+||++||.+.+..+.+..+.+.         
T Consensus       172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------  241 (304)
T 3ubd_A          172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------  241 (304)
T ss_dssp             EEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             cceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------
Confidence            99865433 344567899999999999654 5999999999999999999999999999888887777652         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                              ...            ++..+|+++++||++||+.||++|||     ++|+++||||+++++
T Consensus       242 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          242 --------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             --------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             --------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence                    111            12468999999999999999999998     479999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.4e-62  Score=433.62  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=208.9

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      |++.+.||+|+||+||+|.+..+++.||+|++....      ..+.+|+++|+.++|||||+++++|.+.. ....++|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            588899999999999999999999999999986432      23468999999999999999999886533 23456889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcC-CCCCeEEEecCCcc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSAK  187 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~-~~~~vkl~Dfg~a~  187 (376)
                      |||||++ +|.+++..    .+.+++..++.++.||+.||+|||+ +|  |+||||||+|||++. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            9999985 88777764    4679999999999999999999998 88  999999999999985 56 79999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .. ......+.+||+.|||||++.+  .|+.++|||||||++|||+||++||.+.+....+...+.....|         
T Consensus       181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------  248 (290)
T 3fpq_A          181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------  248 (290)
T ss_dssp             GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred             eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC---------
Confidence            54 3344556789999999999854  49999999999999999999999998877665554443311000         


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                       ..++..+++++++||.+||+.||.+|||+.|+|+||||++
T Consensus       249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                             0122457899999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.6e-62  Score=442.31  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=215.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEe
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  114 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e  114 (376)
                      ...|++.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+|+.++|||||++++++.+.     .++|+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVREG-----PWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEEET-----TEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEe
Confidence            3579999999999999999999999999999999976543 34899999999999999999998543     34899999


Q ss_pred             cccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC
Q 017131          115 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  193 (376)
Q Consensus       115 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  193 (376)
                      ||+| +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9985 88887764    3679999999999999999999998 9999999999999999887569999999998764332


Q ss_pred             C------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          194 P------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       194 ~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .      ....+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+.+.++...  .++        
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~--------  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP--------  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG--------
T ss_pred             cccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC--------
Confidence            1      123579999999999976 45999999999999999999999999988877777666552  110        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHH-------------hcCCcccccCCCC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-------------CVHPFFDELRDPN  329 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~l-------------l~hp~f~~~~~~~  329 (376)
                                      ...+++.+|+++++||.+||+.||.+|||+.|+             ++|||+.+.++|.
T Consensus       275 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          275 ----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             ----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             ----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                            011235789999999999999999999999997             6799998876553

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.1e-61  Score=450.06  Aligned_cols=333  Identities=68%  Similarity=1.176  Sum_probs=296.3

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCC-CCceEE
Q 017131           31 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  109 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  109 (376)
                      ......+|++.+.||+|+||+||+|++..+++ +|+|++..+.....+|+.+++.++||||+++++++..... ....++
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            34456789999999999999999999987766 8999888777777799999999999999999999876554 456678


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc-CCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~-~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++++...+.......+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+||+|||+|+.
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~  191 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI  191 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCccc
Confidence            8999999998888887777677889999999999999999999998 9999999999999999 566 899999999987


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...+.......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+..+++
T Consensus       192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            76666667788999999999997766799999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPE  348 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (376)
                      ++....++.....++...+...+++++++||.+||++||.+|||+.++++||||++++++....++...+|+++++...+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (394)
T 4e7w_A          272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEE  351 (394)
T ss_dssp             GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHH
T ss_pred             hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHH
Confidence            99999999999999999898889999999999999999999999999999999999998888888888888888887544


Q ss_pred             CCCCCHHHHhhhchHHHhh
Q 017131          349 LSGIPPETINRLIPEHARK  367 (376)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~  367 (376)
                      .. ..++.+.++++.+.++
T Consensus       352 ~~-~~~~~~~~~~~~~~~~  369 (394)
T 4e7w_A          352 LS-VRPDLISRLVPQHAEA  369 (394)
T ss_dssp             HH-TCGGGHHHHSCGGGCS
T ss_pred             hh-cCHHHHHhhccHhhhh
Confidence            33 3557777777776643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-61  Score=453.20  Aligned_cols=331  Identities=51%  Similarity=0.982  Sum_probs=284.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCC-----------
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-----------  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----------  103 (376)
                      ..+|++++.||+|+||+||+|.+..+|+.||||++..+.....+|+.+++.++||||+++++++....+           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            457999999999999999999999999999999998877777799999999999999999999876543           


Q ss_pred             ----------------------CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccc
Q 017131          104 ----------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  161 (376)
Q Consensus       104 ----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH  161 (376)
                                            ....++++||||++++|.+.+..+......+++..++.++.||+.||+|||+ +||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCcc
Confidence                                  3455688999999999998888877777889999999999999999999998 99999


Q ss_pred             cCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017131          162 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  241 (376)
Q Consensus       162 ~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  241 (376)
                      |||||+|||++.+...+||+|||+|+............+|+.|+|||++.+...++.++||||+||++|+|++|++||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998433389999999998776666667778899999999997766799999999999999999999999999


Q ss_pred             CCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                      .+..+++..+++.++.|+.+.+..+++.+....++......|...++..+++++++||.+||+.||.+|||+.|+++|||
T Consensus       245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCC-------CCCCCCCC--CCCCCCCCCCCCCCCCCCHHHHhhhchHHHh
Q 017131          322 FDELRD-------PNTRLPNG--RPLPPLFNFKPPELSGIPPETINRLIPEHAR  366 (376)
Q Consensus       322 f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (376)
                      |+++++       +...+++.  ..+|++++|.+.+++.++++..++++|++..
T Consensus       325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  378 (383)
T 3eb0_A          325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS  378 (383)
T ss_dssp             GHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred             HHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence            998754       33334444  5677788888777777788888888887654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-60  Score=452.02  Aligned_cols=316  Identities=72%  Similarity=1.228  Sum_probs=283.9

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCC-CCceEE
Q 017131           31 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  109 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  109 (376)
                      ......+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+.+|+.++||||++++++++.... ....++
T Consensus        49 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             CCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             CCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3455668999999999999999999999999999999998777777789999999999999999998865433 456678


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++..
T Consensus       129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            8999999999988888776667889999999999999999999998 999999999999999977557899999999877


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ..........+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++++.++.|..+.+..++++
T Consensus       208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~  287 (420)
T 1j1b_A          208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  287 (420)
T ss_dssp             CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred             ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            66666667789999999999977667999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP  347 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~  347 (376)
                      +..+.++.....+|...+...+++++++||++||++||.+|||+.++++||||++++++...+++....|..++|...
T Consensus       288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~  365 (420)
T 1j1b_A          288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ  365 (420)
T ss_dssp             CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHH
T ss_pred             hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHH
Confidence            999999999999999988889999999999999999999999999999999999999887777777667776666543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.3e-60  Score=436.94  Aligned_cols=279  Identities=27%  Similarity=0.439  Sum_probs=215.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc--ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||+|+||+||+|+++   .+++.||||++.+..  ....+|+++|+.+ +||||++++++|.+.     .+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-----~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-----DH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-----TE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-----CE
Confidence            457999999999999999999875   467899999886543  3356899999998 699999999998543     34


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+|||||++ +|.+++       +.+++.+++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            8999999984 776655       359999999999999999999998 9999999999999999874489999999997


Q ss_pred             cccCCC-----------------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 017131          188 VLVKGE-----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  238 (376)
Q Consensus       188 ~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  238 (376)
                      ......                             ...+.+||++|+|||++.+...|+.++||||+||++|+|++|++|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            543221                             123457999999999998777799999999999999999999999


Q ss_pred             CC-CCCchHHHHHHHHHhCCCCHHHHhhcCcCc--c-------------------cccCCCc----cccccccccccCCC
Q 017131          239 FP-GESGVDQLVEIIKVLGTPTREEIKCMNPNY--T-------------------EFKFPQI----KPHPWHKVFQKRLP  292 (376)
Q Consensus       239 f~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~-------------------~~~~~~~----~~~~~~~~~~~~~~  292 (376)
                      |. +.+..+++..|.+.+|.+............  .                   ....|..    ............+|
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            85 566778899999888865443322111000  0                   0000000    00000011124689


Q ss_pred             hhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          293 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       293 ~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ++++|||++||++||++|+|++|+|+||||+++.
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999999763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.3e-59  Score=421.62  Aligned_cols=260  Identities=23%  Similarity=0.394  Sum_probs=194.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC-------
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD-------  103 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------  103 (376)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++|||||++++++.+...       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            36999999999999999999999999999999986432     234579999999999999999999876543       


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                      ....++|+|||||++ +|.+++..... ....++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEcc
Confidence            234568999999985 88777764221 1234566789999999999999998 9999999999999999998 799999


Q ss_pred             cCCcccccCCCC-------------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 017131          183 FGSAKVLVKGEP-------------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  249 (376)
Q Consensus       183 fg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  249 (376)
                      ||+|+.......             ..+.+||+.|||||++.+ ..|+.++|||||||++|||++   ||.+..  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999987643321             234579999999999965 459999999999999999996   775432  2222


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       250 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .+...........+                         ...++.+.+||.+||+.||.+|||+.|+++||||+++++|.
T Consensus       236 ~~~~~~~~~~p~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPPLF-------------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCHHH-------------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCCCC-------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            22222111110000                         23467889999999999999999999999999999887654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.3e-59  Score=451.99  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=210.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHH---HHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ..++|++++.||+|+||+||+|+++.||+.||||++.+..       ....+   ++.+++.++|||||+++++|.+.  
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--  264 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--  264 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--
Confidence            4468999999999999999999999999999999986432       11223   35666778999999999999543  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                         ..+|+|||||+| +|..++..    .+.+++..++.|+.||+.||+|||+ +|||||||||+|||++.+| .+||+|
T Consensus       265 ---~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL~D  335 (689)
T 3v5w_A          265 ---DKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISD  335 (689)
T ss_dssp             ---SEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEECC
T ss_pred             ---CEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEecc
Confidence               348999999985 88777754    4679999999999999999999998 9999999999999999999 799999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHHHhCCCC
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPT  259 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~i~~~~~~~~  259 (376)
                      ||+|+..... ...+.+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+..   ..+...     
T Consensus       336 FGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-----  409 (689)
T 3v5w_A          336 LGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----  409 (689)
T ss_dssp             CTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-----
T ss_pred             cceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-----
Confidence            9999876443 3456789999999999965556999999999999999999999999875433322   222210     


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCCC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  328 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~~  328 (376)
                                  ...            ++..+|+++++||.+||+.||.+|++     ++|+++||||++++|.
T Consensus       410 ------------~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          410 ------------AVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             ------------CCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             ------------CCC------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence                        111            22468999999999999999999998     7999999999998764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-57  Score=443.99  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=220.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++|++++.||+|+||+||+|.++.+|+.||||++....    ....+|+.+|+.++||||++++++|.+     ...+|+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEE
Confidence            58999999999999999999999999999999986533    345689999999999999999999843     344899


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC--CCCeEEEecCCccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKV  188 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~vkl~Dfg~a~~  188 (376)
                      |||||+| +|.+.+..   ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.+  + .+||+|||+|+.
T Consensus       232 v~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~-~vKl~DFG~a~~  306 (573)
T 3uto_A          232 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAH  306 (573)
T ss_dssp             EEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCSSCEE
T ss_pred             EEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCC-CEEEeeccceeE
Confidence            9999985 77665532   34579999999999999999999998 999999999999999864  5 799999999998


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ..........+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+....           
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-----------  374 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-----------  374 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-----------
T ss_pred             ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-----------
Confidence            7666666677899999999999764 5899999999999999999999999999888888777653111           


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                            ++.        .....+|+++++||++||++||.+|||+.|+|+||||+...++.
T Consensus       375 ------~~~--------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          375 ------MDD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ------CCS--------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ------CCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                  111        11146899999999999999999999999999999999876553

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-56  Score=402.95  Aligned_cols=254  Identities=23%  Similarity=0.355  Sum_probs=207.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++....    ..+.+|+++|++++|||||++++++.+..   
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC---
Confidence            457999999999999999999875     367899999986432    33568999999999999999999985433   


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhh---------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYS---------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                        .+|+|||||+ |+|.+++....         .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++
T Consensus        89 --~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 --PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG
T ss_pred             --EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCC
Confidence              3889999998 59988887642         123469999999999999999999998 9999999999999999988


Q ss_pred             CCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017131          176 HQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  251 (376)
Q Consensus       176 ~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  251 (376)
                       .+||+|||+|+.......   .....||+.|+|||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             799999999986543322   2235689999999999654 59999999999999999998 99999998877776666


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .+... +                           ..+..+|+++.+||.+||+.||++|||+.++  |+|++++.
T Consensus       244 ~~~~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          244 TQGRV-L---------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HcCCC-C---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            54210 0                           0124689999999999999999999999999  56887653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-55  Score=418.81  Aligned_cols=322  Identities=32%  Similarity=0.528  Sum_probs=238.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++++.||+|+||+||+|++..+++.||||++.+..      ....+|+.+|+.++||||+++++++.........
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            3468999999999999999999999999999999986421      3345799999999999999999998665444445


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+|+||||++++|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus       131 ~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~  204 (458)
T 3rp9_A          131 ELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLAR  204 (458)
T ss_dssp             CEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCB
T ss_pred             eEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccch
Confidence            5889999999998777753    4579999999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccCCC----------------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-----
Q 017131          188 VLVKGE----------------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-----  234 (376)
Q Consensus       188 ~~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-----  234 (376)
                      ......                            .....+||++|+|||++.....|+.++|||||||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            653221                            22445789999999987666679999999999999999998     


Q ss_pred             ------CCCCCCCCC--------------------chHHHHHHHHHhCCCCHHHHhhcCcCccc---ccCCCcccccccc
Q 017131          235 ------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHK  285 (376)
Q Consensus       235 ------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  285 (376)
                            |.++|.+.+                    ..+++..+.+.+|.|..+.+.........   ..++......+..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  788887765                    36788899999999998887654322110   1233333334444


Q ss_pred             ccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHhhhchHHH
Q 017131          286 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA  365 (376)
Q Consensus       286 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (376)
                      .+ +.+++++++||++||++||.+|||++|+|+||||++++++........  +....+.  .....+.+.++..+.++.
T Consensus       365 ~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~--~~~~~~~--~~~~~~~~~~~~~~~~e~  439 (458)
T 3rp9_A          365 RF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATE--KVRLPFN--DWMNMDEPQLRYAFVKEI  439 (458)
T ss_dssp             GS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSS--CCCCSSC--TTSCCCHHHHHHHHHHHH
T ss_pred             HC-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCC--CCCCCcc--ccccCCHHHHHHHHHHHH
Confidence            44 467999999999999999999999999999999999887654322111  1111122  234466677777666555


Q ss_pred             h
Q 017131          366 R  366 (376)
Q Consensus       366 ~  366 (376)
                      .
T Consensus       440 ~  440 (458)
T 3rp9_A          440 Q  440 (458)
T ss_dssp             T
T ss_pred             H
Confidence            3

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.6e-54  Score=411.95  Aligned_cols=322  Identities=31%  Similarity=0.514  Sum_probs=248.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+|+.++||||+++++++.........
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3468999999999999999999999999999999986431      3345899999999999999999988654433334


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+|+||||++++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus       104 ~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~  177 (432)
T 3n9x_A          104 ELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLAR  177 (432)
T ss_dssp             CEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcc
Confidence            5889999999998877753    4569999999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccCCC-----------------------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh----------
Q 017131          188 VLVKGE-----------------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL----------  234 (376)
Q Consensus       188 ~~~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt----------  234 (376)
                      ......                       .....+||++|+|||++.....++.++|||||||++|+|++          
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            664322                       12566889999999997666779999999999999999998          


Q ss_pred             -CCCCCCCCC-----------------chHHHHHHHHHhCCCCHHHHhhcCcCccc---ccCCCccccccccccccCCCh
Q 017131          235 -GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPP  293 (376)
Q Consensus       235 -g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  293 (376)
                       |.++|.+.+                 ..+++..+...+|.|+.+.+.........   ..++.....++...+ +.+++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~  336 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISD  336 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCH
Confidence             566666654                 36788999999999999887655322110   122333333343334 46899


Q ss_pred             hHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHhhhchHHHh
Q 017131          294 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR  366 (376)
Q Consensus       294 ~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (376)
                      ++++||++||++||.+|||++|+|+||||++++++..........  ...+.  ....++.+.++.++.++..
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~e~~  405 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI--ILPFD--DWMVLSETQLRYIFLKEVQ  405 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCC--CCSSC--TTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCC--CCChh--hcccCCHHHHHHHHHHHHH
Confidence            999999999999999999999999999999998765432211111  11122  2245667778777766654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4e-55  Score=419.01  Aligned_cols=286  Identities=31%  Similarity=0.529  Sum_probs=229.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  106 (376)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++.+..      ....+|+.+++.++||||+++++++..... ...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3468999999999999999999999999999999986531      234579999999999999999999865432 233


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+|+||||+++++.+.+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus       140 ~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC
T ss_pred             CeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEee
Confidence            4578999999998766553      459999999999999999999998 9999999999999999998 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +...........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+++.++++.+|.|..+.+...
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            877665556678899999999999764 5999999999999999999999999999999999999999999998877655


Q ss_pred             CcCcccc--cCCCccccccccccccC-----------CChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          267 NPNYTEF--KFPQIKPHPWHKVFQKR-----------LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       267 ~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ......+  ..+......+...++..           .++++++||++||++||.+|||++|+|+||||+.+.++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence            3221111  11111112222222111           15679999999999999999999999999999987654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.2e-55  Score=410.15  Aligned_cols=316  Identities=30%  Similarity=0.594  Sum_probs=233.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .+|++++.||+|+||.||+|.+..+|+.||||++.+.      .....+|+.+++.+. ||||+++++++....   ...
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CCE
Confidence            5799999999999999999999999999999988542      123447999999997 999999999885432   234


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +|+||||++++|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence            789999999998877764     579999999999999999999998 9999999999999999998 799999999976


Q ss_pred             ccC----------------------CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH
Q 017131          189 LVK----------------------GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  246 (376)
Q Consensus       189 ~~~----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  246 (376)
                      ...                      .......+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            532                      1122346789999999999776679999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccC------CCcccccccccc------------ccCCChhHHHHHHHhhccCCC
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPN  308 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~  308 (376)
                      ++..+...++.|..+.+......+.....      .......+...+            ...+++++.+||++||++||.
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            99999999999998877654332211000      000001111111            126789999999999999999


Q ss_pred             CCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHhhhchHHH
Q 017131          309 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA  365 (376)
Q Consensus       309 ~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (376)
                      +|||++++|+||||+.+.++........    .+.++-......+.+.++..+.+..
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  371 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHNPNEEPNCDH----IITIPINDNVKHSIDDYRNLVYSEI  371 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCCGGGCCCCSS----CCCCC------CCHHHHHHHHHHHH
T ss_pred             cCCCHHHHhCCHHHHHhcCCccCCCCCC----CCCCCccccccCCHHHHHHHHHHHH
Confidence            9999999999999998876543211111    1111111122345566666655554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.1e-55  Score=398.02  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=199.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ...+|.+.+.||+|+||+||+|++.     .+++.||||++....    ..+.+|+++|+.++|||||++++++.+..  
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~--  116 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR--  116 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence            3467999999999999999999865     468899999986432    33568999999999999999999985433  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhh-----------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                         .+|+|||||+ |+|.+++.....           ....+++.++..++.||+.||+|||+ ++|+||||||+|||++
T Consensus       117 ---~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          117 ---PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVG  192 (329)
T ss_dssp             ---SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEEC
Confidence               3889999998 588888765321           23469999999999999999999998 9999999999999999


Q ss_pred             CCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHH
Q 017131          173 PHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  248 (376)
Q Consensus       173 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  248 (376)
                      .++ .+||+|||+|+.......   .....||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+
T Consensus       193 ~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          193 QGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             TTT-EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             CCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            988 899999999986543322   234568999999999965 459999999999999999999 99999998877776


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          249 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       249 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..+.+.. .               ..            .+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       271 ~~i~~g~-~---------------~~------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          271 DCITQGR-E---------------LE------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHTC-C---------------CC------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHcCC-C---------------CC------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            6665421 0               00            124689999999999999999999999999763

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-54  Score=404.05  Aligned_cols=301  Identities=48%  Similarity=0.900  Sum_probs=246.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHhCCCCCeeeccceeeecCC--CCceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLDHPNIVALKHCFFSTTD--KEELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~  108 (376)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++..+...   ..+|+..+..++||||+++++++.....  ....+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            446899999999999999999999999999999988655432   3456777788899999999999876443  45667


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH--hcCCccccCCCCCcEEEcC-CCCCeEEEecCC
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--NCIGICHRDIKPQNLLVNP-HTHQLKLCDFGS  185 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~iiH~Dlkp~Nill~~-~~~~vkl~Dfg~  185 (376)
                      +++||||+++++...+.........+++..++.++.|++.||.|||  + +||+||||||+|||++. ++ .+||+|||+
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~  178 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADG-TLKLCDFGS  178 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTT-EEEECCCTT
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCC-cEEEeeCCC
Confidence            8899999999988877776666778999999999999999999999  8 89999999999999997 66 899999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ++............+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.+.++.++.+.+..
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            98776665556677899999999997766689999999999999999999999999999999999999999999999888


Q ss_pred             cCcCcccccCCCcccccccccccc---CCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR  336 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~  336 (376)
                      +.+.............+|...+..   ..++++.+||.+||+.||.+|||+.++|+||||+++.++...+++..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~  332 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNK  332 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSC
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCC
Confidence            877666655555555555554432   25789999999999999999999999999999999887765544433

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-55  Score=392.91  Aligned_cols=247  Identities=21%  Similarity=0.291  Sum_probs=196.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..++++.+.||+|+||+||+|++..   .||||+++...      ..+.+|+.+|+.++|||||++++++..    +.  
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~~--  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----DN--  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SS--
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----Ce--
Confidence            4578999999999999999998653   59999885321      335589999999999999999997621    11  


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +++|||||+ |+|.+++..   ....+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccCce
Confidence            679999998 588777753   23579999999999999999999998 9999999999999999988 89999999998


Q ss_pred             cccCC---CCCceeeeeccccchhhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          188 VLVKG---EPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       188 ~~~~~---~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .....   ......+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..++....      
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~------  254 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY------  254 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC------
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC------
Confidence            65432   223456799999999999642  3589999999999999999999999998877766665554211      


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                 ..|..      ..++..+|+++.+||.+||+.||++|||+.++++
T Consensus       255 -----------~~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          255 -----------ASPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             -----------CCCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             -----------CCCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                       11110      1122468999999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.8e-55  Score=395.20  Aligned_cols=249  Identities=20%  Similarity=0.275  Sum_probs=203.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ..++++.+.||+|+||+||+|...     .+++.||||++....     ..+.+|+.++++++|||||++++++....  
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~--  102 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ--  102 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC--
Confidence            357999999999999999999863     467899999985432     34568999999999999999999985432  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  171 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill  171 (376)
                         .+++|||||+ |+|.+++....            .....+++..+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus       103 ---~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          103 ---PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV  178 (308)
T ss_dssp             ---SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             ---EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence               2789999998 58888886432            123468999999999999999999998 999999999999999


Q ss_pred             cCCCCCeEEEecCCcccccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHH
Q 017131          172 NPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  247 (376)
Q Consensus       172 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  247 (376)
                      +.++ .+||+|||+|+......   ......||+.|+|||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9988 79999999998654332   23345789999999999654 59999999999999999998 8999999887666


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       248 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ...+.+...                  .+          .+..+|+++.+|+.+||+.||.+|||+.+++++
T Consensus       257 ~~~i~~~~~------------------~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRNRQV------------------LP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTTCC------------------CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCC------------------CC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            655543110                  00          124689999999999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.1e-54  Score=386.31  Aligned_cols=281  Identities=34%  Similarity=0.556  Sum_probs=227.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++.+.     ..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence            47999999999999999999999999999999986432      2345799999999999999999998543     348


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++..
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            89999999988666543   34679999999999999999999998 9999999999999999998 7999999999765


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+..+.+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            432 2234457799999999997766689999999999999999987655 67777788888999988888776654432


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ........+..........+.+.+++++++||++||+.||.+|||++|+++||||+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            21111111222212222223356899999999999999999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.1e-53  Score=394.65  Aligned_cols=319  Identities=31%  Similarity=0.603  Sum_probs=252.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+|++++.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999999999999999986432     234579999999999999999999866544444558


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||++++|.+++..     +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEec
Confidence            89999999998887754     569999999999999999999998 9999999999999999988 7999999999765


Q ss_pred             cCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          190 VKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       190 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .....    .....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+..+.+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            43221    23457899999999987766789999999999999999999999999999999999999999999887765


Q ss_pred             cCcCc---ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCC
Q 017131          266 MNPNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF  342 (376)
Q Consensus       266 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~  342 (376)
                      .....   .....+.....++...+ ..+++++.+||.+||++||.+|||+.++|+||||++..++....    .....+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~  333 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF  333 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence            42110   01122333333343333 56899999999999999999999999999999999875543221    111122


Q ss_pred             CCCCCCCCCCCHHHHhhhchHHHh
Q 017131          343 NFKPPELSGIPPETINRLIPEHAR  366 (376)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~  366 (376)
                      .++ .....++.+.+++++.++..
T Consensus       334 ~~~-~~~~~~~~~~~~~~~~~e~~  356 (364)
T 3qyz_A          334 KFD-MELDDLPKEKLKELIFEETA  356 (364)
T ss_dssp             CCC------CCHHHHHHHHHHHTG
T ss_pred             Ccc-cccccCCHHHHHHHHHHHHH
Confidence            222 34556677778777666553

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-53  Score=395.96  Aligned_cols=286  Identities=33%  Similarity=0.611  Sum_probs=231.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            457999999999999999999999999999999985432      234579999999999999999999855422 1123


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+|+||||++++|.+++..     ..+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus       104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeeccc
Confidence            3689999998898887764     579999999999999999999998 9999999999999999988 79999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  ......+|++|+|||++.+...++.++|+||+||++|+|++|++||.+.+..+++..+.+..+.|+.+.+..+.
T Consensus       177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            6532  34456789999999999775679999999999999999999999999999999999999999999988776543


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~  330 (376)
                      .....   ..++......+...+ ..+++++.+||.+||+.||.+|||+.++|+||||+++.++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence            22110   123334444444444 578999999999999999999999999999999999876643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-54  Score=392.99  Aligned_cols=291  Identities=32%  Similarity=0.617  Sum_probs=231.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ++|++++.||+|+||+||+|.+..+++.||||++.....     ...+|+.+++.++||||+++++++....     ..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence            479999999999999999999999999999998854322     2336999999999999999999885433     378


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+++++.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++...
T Consensus        77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            9999999988777764   24569999999999999999999998 9999999999999999998 79999999997554


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc-
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  268 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  268 (376)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+..+.+..... 
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 233456799999999997766789999999999999999999999999999999999999999887765543311 


Q ss_pred             -CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCC
Q 017131          269 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP  337 (376)
Q Consensus       269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~  337 (376)
                       .+..+.++.......... ...+++++.+||++||+.||.+|||+.|+|+||||.++.+.....+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~  300 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSH-APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTS  300 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSC
T ss_pred             hhhcccccccccchhhhhh-cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCc
Confidence             111222333222222222 24689999999999999999999999999999999998766554444433

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-53  Score=388.78  Aligned_cols=280  Identities=35%  Similarity=0.661  Sum_probs=226.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|++++.||+|+||+||+|++. +|+.||+|++....      ....+|+.+++.++||||+++++++.+.     ..
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-----RC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----SC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----CE
Confidence            358999999999999999999985 58999999985432      2345899999999999999999988433     34


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++||||+++++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        94 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~  168 (311)
T 3niz_A           94 LTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLARA  168 (311)
T ss_dssp             EEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCcee
Confidence            889999999988776654   33569999999999999999999998 9999999999999999998 799999999986


Q ss_pred             ccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence            5432 223445779999999999776678999999999999999999999999999999999999999888765544322


Q ss_pred             cC--cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .-  +....+......++... .+.+++++++||++||++||.+|||+.|+++||||+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSI-IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHH-STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccchhhhcccccccCCcHHHh-CcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            10  11111122222233332 256899999999999999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-54  Score=395.53  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=205.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCC-----CcEEEEEEeeccc-----ccHHHHHHHHHhCCC-CCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDH-PNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~  103 (376)
                      .++|++++.||+|+||+||+|.+..+     ++.||||.+....     ..+.+|+.+|..++| ||||++++++.... 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-
Confidence            36899999999999999999998654     3689999986532     235579999999976 89999999874322 


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  170 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nil  170 (376)
                         ..+++|||||+ |+|.++++.....            ...+++..+..++.||+.||+|||+ ++||||||||+|||
T Consensus       142 ---~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL  217 (353)
T 4ase_A          142 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  217 (353)
T ss_dssp             ---SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence               23789999998 5998888764321            2458999999999999999999998 99999999999999


Q ss_pred             EcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 017131          171 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  246 (376)
Q Consensus       171 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  246 (376)
                      ++.++ .+||+|||+|+........   ....||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99988 8999999999876444322   345789999999999754 59999999999999999998 999999877666


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .+.+++.....+.                           ++..+++++.+||.+||+.||++|||+.++++|
T Consensus       296 ~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            6655554311110                           124689999999999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.7e-53  Score=386.28  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=217.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++.+..      ....+|+.+++.++||||+++++++.+     ..
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            3467999999999999999999999999999999986532      224579999999999999999998843     23


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||++ ++|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a  161 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFS  161 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCC
T ss_pred             EEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCc
Confidence            4889999996 477776654    3679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...            
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------  229 (328)
T 3fe3_A          162 NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------  229 (328)
T ss_dssp             GGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             eecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            87766555667789999999999987665568999999999999999999999988876666655541            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                           .+.+            +..+++++.+||++||+.||.+|||++++++||||+...+
T Consensus       230 -----~~~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          230 -----KYRI------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             -----CCCC------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             -----CCCC------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence                 1111            1357999999999999999999999999999999987654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-53  Score=385.97  Aligned_cols=284  Identities=29%  Similarity=0.526  Sum_probs=231.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCC---CCCeeeccceeeecC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLD---HPNIVALKHCFFSTT  102 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++....         ....+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            457999999999999999999999999999999986322         23457888877764   999999999997766


Q ss_pred             CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          103 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                      ......++++|||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEee
Confidence            66666789999999999888776422  2349999999999999999999998 9999999999999999988 899999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ||+++............+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+.++...
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9999877655556667889999999999664 489999999999999999999999999999999999999988887654


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      +..... .....++.....+.... .+.+++++.+||.+||++||.+|||+.++|+||||++.
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          243 WPRDVS-LPRGAFPPRGPRPVQSV-VPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCS-SCGGGSCCCCCCCHHHH-SCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ccchhh-ccccccCCCCCCcHHHh-CccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            432111 01112222222222222 25689999999999999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-53  Score=396.51  Aligned_cols=317  Identities=32%  Similarity=0.533  Sum_probs=235.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~  106 (376)
                      ...+|++++.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3467999999999999999999999999999999986432      234479999999999999999998854321 122


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+|+++|+++++|.+++..     +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC----
T ss_pred             CeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccc
Confidence            34789999999888777653     579999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +...  .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+...
T Consensus       180 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          180 RHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cccc--ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            7653  23445678999999999977567999999999999999999999999999999999999999999998877654


Q ss_pred             CcCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCC
Q 017131          267 NPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  343 (376)
Q Consensus       267 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~  343 (376)
                      ......   ..++..+..++...+ ..+++++++||++||+.||.+|||+.++|+||||+.+.++....     ..+.+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~-----~~~~~~  331 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYD  331 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC-----CCCCCC
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC-----CCCCCC
Confidence            322110   123333444444444 46899999999999999999999999999999999987665321     111222


Q ss_pred             CCCCCCCCCCHHHHhhhchHHHh
Q 017131          344 FKPPELSGIPPETINRLIPEHAR  366 (376)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~  366 (376)
                      +. .+......+.+++++.++..
T Consensus       332 ~~-~~~~~~~~~~~~~~~~~e~~  353 (367)
T 2fst_X          332 QS-LESRDLLIDEWKSLTYDEVI  353 (367)
T ss_dssp             GG-GSSCCCCHHHHHHHHHHHHH
T ss_pred             cc-hhhccCCHHHHHHHHHHHHH
Confidence            22 12334566777777666554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.8e-53  Score=379.85  Aligned_cols=278  Identities=35%  Similarity=0.632  Sum_probs=222.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++++.||+|+||+||+|++ .+|+.||+|++....      ....+|+.+++.++||||+++++++....     .+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence            4799999999999999999998 678999999985432      33458999999999999999999985433     38


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++..
T Consensus        76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            89999999988777654   23579999999999999999999998 9999999999999999988 7999999998765


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            322 2233457799999999997666689999999999999999999999999998899999998888776554432211


Q ss_pred             Cc-ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          269 NY-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       269 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      .. ....+......++.. +...+++++++||++||+.||++|||+.++++||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            00 000111222223332 235689999999999999999999999999999999863

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-52  Score=385.86  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=214.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.+.     .
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence            357999999999999999999999999999999986531       2345799999999999999999988443     3


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||+++ +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            48899999985 77666653    4679999999999999999999998 9999999999999999998 7999999999


Q ss_pred             cccc-CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...           
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  220 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------  220 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence            7643 2334456789999999999965 45899999999999999999999999988766666555441           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                            ...            ++..+++++++||.+||+.||.+||     ++.++++||||+++++
T Consensus       221 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                  111            2246899999999999999999999     8999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-52  Score=383.12  Aligned_cols=286  Identities=33%  Similarity=0.571  Sum_probs=217.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .+|++++.||+|+||+||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++..     ...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeEE
Confidence            57999999999999999999999999999999986432     345689999999999999999998843     33488


Q ss_pred             EEEecccccHHHHHHHhhhh--cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          111 LVLEYVPETVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +||||++++|.+++......  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            99999999998887764321  2458999999999999999999998 9999999999999999988 799999999976


Q ss_pred             ccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            5432 223455789999999999766668999999999999999999999999999999999999988887765443321


Q ss_pred             c--CcccccCCCcccccc----ccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          268 P--NYTEFKFPQIKPHPW----HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       268 ~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .  .+. ..+.......+    .......++.++++||.+||+.||.+|||+.++++||||++...+.
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          238 KLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             GCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             hhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence            1  000 00111111111    1112235789999999999999999999999999999999876543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-52  Score=387.14  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=217.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      -.++|++++.||+|+||+||+|.++.+|+.||+|++.+..          ....+|+.+++.++||||+++++++.+   
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---   86 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---   86 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe---
Confidence            3457999999999999999999999999999999986532          235689999999999999999999843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC---CeE
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLK  179 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~vk  179 (376)
                        ...+++||||++ ++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.   .+|
T Consensus        87 --~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           87 --RTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             --SSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             --CCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEE
Confidence              334889999996 587766643    4679999999999999999999998 99999999999999987663   599


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+|||+++...........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            999999987766555667789999999999965 4589999999999999999999999999887777766654321111


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .+                         +...+++++++||++||..||.+|||+.++++||||+...
T Consensus       239 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          239 EE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             ch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            11                         1145799999999999999999999999999999998653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8e-53  Score=389.34  Aligned_cols=253  Identities=28%  Similarity=0.475  Sum_probs=210.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||+++++++.+.    
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----   96 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP----   96 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC----
Confidence            3467999999999999999999999999999999986532       2345799999988 799999999988432    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                       ..+|+||||+++ +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        97 -~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DFG  169 (353)
T 3txo_A           97 -DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFG  169 (353)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             -CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEcccc
Confidence             348899999985 77666654    4679999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +|+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+...         
T Consensus       170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------  239 (353)
T 3txo_A          170 MCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND---------  239 (353)
T ss_dssp             TCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             ceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Confidence            9975432 3334566889999999999654 4899999999999999999999999998888777777652         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH------HHHhcCCcccccCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  327 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~~ll~hp~f~~~~~  327 (376)
                              ...+            +..+++++.+||++||+.||.+||++      .++++||||+++++
T Consensus       240 --------~~~~------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          240 --------EVVY------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             --------CCCC------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             --------CCCC------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                    1111            23579999999999999999999998      89999999998865

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-52  Score=391.15  Aligned_cols=322  Identities=30%  Similarity=0.489  Sum_probs=234.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      .++|++++.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            457999999999999999999999999999999986532      234579999999999999999998854331 2234


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+|+||||+++++.+.+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC--
T ss_pred             ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeeccc
Confidence            588999999998876664      468999999999999999999998 9999999999999999988 79999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+..+.
T Consensus       176 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          176 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             ccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            76554445567889999999999664 58999999999999999999999999999999999999998988877665443


Q ss_pred             cCcccc--cCCCccccccccccc-----------cCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCC
Q 017131          268 PNYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN  334 (376)
Q Consensus       268 ~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~  334 (376)
                      +....+  ..+......+...++           ...++++++||++||+.||.+|||++++|+||||+...++..... 
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~-  333 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA-  333 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC-
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC-
Confidence            211100  001111111111110           112578999999999999999999999999999997655332111 


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHhhhchHHHhhhh
Q 017131          335 GRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN  369 (376)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (376)
                        ..|.... .........-+.+++++.+....-+
T Consensus       334 --~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 2xrw_A          334 --PPPKIPD-KQLDEREHTIEEWKELIYKEVMDLE  365 (371)
T ss_dssp             --CCCCCCT-TTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred             --CCCCCCC-hhhccccCcHHHHHHHHHHHHHHHh
Confidence              1111111 1122334456778887777766543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-52  Score=385.59  Aligned_cols=285  Identities=31%  Similarity=0.540  Sum_probs=227.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++...     
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----
Confidence            34468999999999999999999999999999999985432      2335799999999999999999998543     


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC----CCeEEEe
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----HQLKLCD  182 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~----~~vkl~D  182 (376)
                      ..+++||||++++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++    ..+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            34889999999998777764    4569999999999999999999998 9999999999999995333    1599999


Q ss_pred             cCCcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          183 FGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       183 fg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ||+++..... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+...
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            9999765322 223445679999999999776668999999999999999999999999999999999999998888765


Q ss_pred             HHhhcCcC-cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          262 EIKCMNPN-YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       262 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      .+...... .....++......+...+...+++++++||.+||+.||.+|||+.++|+||||++..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            54322110 0112333344444444555568999999999999999999999999999999998653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2e-52  Score=391.22  Aligned_cols=256  Identities=27%  Similarity=0.479  Sum_probs=209.2

Q ss_pred             CccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .....+|++++.||+|+||+||+|+++.+++.||+|++.+..       ....+|..++..+ +||||+++++++.+   
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~---  124 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT---  124 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE---
Confidence            344568999999999999999999999999999999986532       2345799999876 89999999998843   


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                        ...+|+||||+++ +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus       125 --~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~D  196 (396)
T 4dc2_A          125 --ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTD  196 (396)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECC
T ss_pred             --CCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEee
Confidence              3348899999986 77666653    4679999999999999999999998 9999999999999999998 799999


Q ss_pred             cCCcccc-cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch--------HHHHHHHH
Q 017131          183 FGSAKVL-VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--------DQLVEIIK  253 (376)
Q Consensus       183 fg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~  253 (376)
                      ||+|+.. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....        +.+.+.+.
T Consensus       197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~  275 (396)
T 4dc2_A          197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  275 (396)
T ss_dssp             CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred             cceeeecccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence            9999863 33344556789999999999965 45899999999999999999999999753221        11222111


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH------HHHhcCCcccccCC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  327 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~~ll~hp~f~~~~~  327 (376)
                      .                ....            ++..+++++++||++||+.||.+|+++      +++++||||++++|
T Consensus       276 ~----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          276 E----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             H----------------CCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             c----------------cccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            1                0111            224689999999999999999999985      79999999998865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-52  Score=385.42  Aligned_cols=284  Identities=35%  Similarity=0.604  Sum_probs=227.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....         ....+|+.+++.++||||+++++++....  
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   85 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--   85 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC--
Confidence            3467999999999999999999999999999999985321         23458999999999999999999884332  


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                         ..++||||+++++...+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        86 ---~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  157 (346)
T 1ua2_A           86 ---NISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFG  157 (346)
T ss_dssp             ---CCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCG
T ss_pred             ---ceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEecc
Confidence               3789999999988766643   23468999999999999999999998 9999999999999999988 79999999


Q ss_pred             CcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +++..... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+
T Consensus       158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            99765432 23345678999999999976666899999999999999999999999999999999999999888877655


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ...........+...+..++...+ ..+++++++||++||+.||.+|||+.|+++||||++...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhccCcccccccccCCCChHHhh-ccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            443221111222222222222222 4688999999999999999999999999999999986544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-52  Score=393.76  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=217.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...+|++++.||+|+||+||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++++.+     .
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----C
Confidence            346899999999999999999999999999999998642       2345689999999999999999998843     3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .++|+||||++ |+|.+++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEeccce
Confidence            34889999996 588776653     469999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCCCC--CceeeeeccccchhhhcCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          186 AKVLVKGEP--NVSYICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |+.......  ....+||+.|+|||++.+..   .++.++|||||||++|+|++|.+||.+.+..+...++.+...    
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----  290 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----  290 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc----
Confidence            976543321  23567899999999996543   278899999999999999999999999888887777765310    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCCCCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~~~~  330 (376)
                                 .+.+|.          ...+++++++||++||+.+|.+  |++++++++||||+++.+.+.
T Consensus       291 -----------~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~  341 (410)
T 3v8s_A          291 -----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  341 (410)
T ss_dssp             -----------HCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred             -----------cccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence                       011111          0358999999999999999988  999999999999999876543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-51  Score=381.43  Aligned_cols=319  Identities=27%  Similarity=0.540  Sum_probs=240.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------------ccHHHHHHHHHhCCCCCeeeccceee
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKHCFF   99 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (376)
                      .++|++.+.||+|+||.||+|.+.. |+.||||++....               ....+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            3579999999999999999999865 8999999885321               33468999999999999999999997


Q ss_pred             ecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeE
Q 017131          100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  179 (376)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vk  179 (376)
                      .........+|+||||+++++.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEE
T ss_pred             eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEE
Confidence            766666667899999999988777653   34569999999999999999999998 9999999999999999888 799


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+|||+++............+|+.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+....+.+.
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999998665555556678899999999997656789999999999999999999999999999999999999999988


Q ss_pred             HHHHhhcCcC----cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCC
Q 017131          260 REEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  335 (376)
Q Consensus       260 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~  335 (376)
                      .+.+......    +........+...+.. ....+++.+.+||.+||+.||.+|||+.++++||||+++.++....   
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~---  330 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT---  330 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT---
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc---
Confidence            7765432111    0011112222222322 2356789999999999999999999999999999999986543221   


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHhhhchHHHh
Q 017131          336 RPLPPLFNFKPPELSGIPPETINRLIPEHAR  366 (376)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (376)
                      ...+..+.+.   ....+...+.+.+.++..
T Consensus       331 ~~~~~~~~~~---~~~~~~~~~~~~~~~e~~  358 (362)
T 3pg1_A          331 EGLSERFHFD---ESVTDVYDMHKIFTAEVE  358 (362)
T ss_dssp             TTCCCCCCCC---TTCCCHHHHHHHHHHHHH
T ss_pred             cccccccChh---hhhhhHHHHHHHHHHHHH
Confidence            1222223333   233445566665555443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-51  Score=383.63  Aligned_cols=314  Identities=32%  Similarity=0.585  Sum_probs=241.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCC-Cce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  107 (376)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357999999999999999999999999999999986532      2345799999999999999999998554331 112


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++||||+++++.+.+      ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       121 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC-
T ss_pred             eEEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCccc
Confidence            24799999999876554      3469999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...  .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+..++
T Consensus       193 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          193 HAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             ccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            553  233455779999999999775679999999999999999999999999999999999999999999887665443


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  344 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~  344 (376)
                      .....   ...+......+...+ ..+++++.+||++||+.||.+|||+.++|+||||+.+.++.......++..+    
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~----  345 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD----  345 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHS-TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC----
T ss_pred             hhhhhhhhhccCCCcchhHHHhc-cccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc----
Confidence            22111   112222222222222 4689999999999999999999999999999999988766543222222211    


Q ss_pred             CCCCCCCCCHHHHhhhchHH
Q 017131          345 KPPELSGIPPETINRLIPEH  364 (376)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~  364 (376)
                       ..+...+..+.+++.+.++
T Consensus       346 -~~~~~~~~~~~~~~~~~~~  364 (371)
T 4exu_A          346 -SLEHEKLTVDEWKQHIYKE  364 (371)
T ss_dssp             -TTSSCCCCHHHHHHHHHHH
T ss_pred             -chhhcccchHHHHHHHHHH
Confidence             1223345556666655543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=373.77  Aligned_cols=284  Identities=36%  Similarity=0.622  Sum_probs=220.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++++.||+|+||+||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...     ...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence            47999999999999999999999999999999885432      2234799999999999999999998543     347


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      ++||||+++++...+   ......+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHH---HHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHH---HhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            899999998653322   2234679999999999999999999998 9999999999999999988 8999999999765


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc--
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  266 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  266 (376)
                      ... .......+|+.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+....+.+.++..........  
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            432 22345578999999999977677899999999999999999999999999999999888888887766543322  


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      ...+.....+............+.+++++.+||++||+.||.+|||++++++||||+++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            111111222221111111111246899999999999999999999999999999999986543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-52  Score=383.60  Aligned_cols=253  Identities=27%  Similarity=0.479  Sum_probs=213.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||+++++++.+     
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-----   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----
Confidence            3457999999999999999999999999999999986532       2345788888876 99999999998843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+|+||||+++ +|..++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeECh
Confidence            2348899999975 88776654    3579999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+...         
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------  233 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------  233 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC---------
Confidence            9976432 2334566889999999999654 5899999999999999999999999988877666666541         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH-HHhcCCcccccCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  327 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~-~ll~hp~f~~~~~  327 (376)
                              ...            ++..+++++++||.+||+.||.+||++. ++++||||+++.+
T Consensus       234 --------~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          234 --------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             --------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             --------CCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                    111            1245799999999999999999999998 9999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-51  Score=376.71  Aligned_cols=250  Identities=27%  Similarity=0.475  Sum_probs=214.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..+|++.+.||+|+||+||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++.+     ..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence            457999999999999999999999999999999986431       234579999999999999999998843     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcc
Confidence            48899999985 88777654    4679999999999999999999998 9999999999999999998 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +....  .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+...++...            
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------  218 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------  218 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------
T ss_pred             eecCC--ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence            86532  3445678999999999965 45899999999999999999999999988877777666652            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                           ...            ++..+++++++||++||+.||.+|+     +++++++||||+++.+
T Consensus       219 -----~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          219 -----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence                 111            1245799999999999999999999     8999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.1e-53  Score=387.36  Aligned_cols=252  Identities=29%  Similarity=0.431  Sum_probs=211.8

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++.+.       .....+|+.+++.++||||+++++++.+..   
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---   82 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT---   82 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS---
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC---
Confidence            3446899999999999999999999999999999998642       234568999999999999999999985432   


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                        .+++||||++|++.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        83 --~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~  154 (336)
T 3h4j_B           83 --DIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGL  154 (336)
T ss_dssp             --EEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSC
T ss_pred             --EEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEecc
Confidence              3889999999988777654    3679999999999999999999998 8999999999999999988 799999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+              
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------------  220 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------------  220 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------
Confidence            987766655667789999999999976654588999999999999999999999765422111000              


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                     ......++..+++++.+||++||+.||.+|||+.++++||||+.
T Consensus       221 ---------------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          221 ---------------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             ---------------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             ---------------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                           00011123468999999999999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3e-51  Score=379.63  Aligned_cols=321  Identities=32%  Similarity=0.635  Sum_probs=241.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++..........
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3457999999999999999999999999999999986432     22347999999999999999998875443333455


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      .++||||++++|.+.+..     +.+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++.
T Consensus        89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEecccccc
Confidence            889999999998877754     579999999999999999999998 9999999999999999988 799999999976


Q ss_pred             ccCCCC-----------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          189 LVKGEP-----------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       189 ~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      ......           .....||+.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            543211           123467999999999876667899999999999999999999999999988888888888877


Q ss_pred             CCHHHH-hhcCcC-ccc--ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCC
Q 017131          258 PTREEI-KCMNPN-YTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP  333 (376)
Q Consensus       258 ~~~~~~-~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~  333 (376)
                      +..... .+.... ...  ...+.....++.... ..+++++.+||.+||+.||.+|||+.++++||||+...++.... 
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~-  319 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEP-  319 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC-
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhc-ccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccc-
Confidence            653211 100000 000  011112222222222 46899999999999999999999999999999999987765432 


Q ss_pred             CCCCCCC-CCCCCCCCCCCCCHHHHhhhchHH
Q 017131          334 NGRPLPP-LFNFKPPELSGIPPETINRLIPEH  364 (376)
Q Consensus       334 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                      .....|+ .+++. .....+....+++.+.++
T Consensus       320 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  350 (353)
T 2b9h_A          320 EGEPIPPSFFEFD-HYKEALTTKDLKKLIWNE  350 (353)
T ss_dssp             CCCCCCGGGGGGG-CCSSCCCHHHHHHHHHHH
T ss_pred             ccCCCCcceeeec-chhhcCCHHHHHHHHHHH
Confidence            2222222 23333 223335566666555443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2e-51  Score=389.25  Aligned_cols=263  Identities=26%  Similarity=0.411  Sum_probs=219.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+.       .....+|+.++..++||||+++++++.+     ..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----DN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----SS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CC
Confidence            35899999999999999999999999999999998642       2335689999999999999999998843     33


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||+. |+|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            4889999996 588777754   24579999999999999999999998 9999999999999999998 7999999999


Q ss_pred             ccccCCCCC--ceeeeeccccchhhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          187 KVLVKGEPN--VSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       187 ~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +........  ...+||+.|+|||++.    +...++.++|||||||++|||++|++||.+.+..+...++.....    
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----  298 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----  298 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----
Confidence            765443322  2357899999999996    244589999999999999999999999999888888877764210    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCC--CCCHHHHhcCCcccccCCCCCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPNTR  331 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~s~~~ll~hp~f~~~~~~~~~  331 (376)
                                 .+.+|..         ...+++++++||++||+.+|.+  |++++++++||||++++|....
T Consensus       299 -----------~~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          299 -----------RFQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             -----------HCCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             -----------cccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence                       1112211         1358999999999999999888  9999999999999998876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-51  Score=381.12  Aligned_cols=254  Identities=25%  Similarity=0.406  Sum_probs=214.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|..++..+ +||||+++++++.+     
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence            3457999999999999999999999999999999986532       2345789999887 89999999998843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+|+||||++| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG  166 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG  166 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence            2348899999975 88776654    3579999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +++.... .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+...         
T Consensus       167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------  236 (353)
T 2i0e_A          167 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH---------  236 (353)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             cccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence            9976432 334456688999999999965 45899999999999999999999999988877777666652         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  328 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~~  328 (376)
                              ...            ++..+++++++||++||+.||.+||+     +.++++||||+.+.+.
T Consensus       237 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          237 --------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             --------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             --------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                    111            12468999999999999999999994     6999999999987653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.1e-51  Score=388.84  Aligned_cols=279  Identities=30%  Similarity=0.539  Sum_probs=227.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhC------CCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML------DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++++.||+|+||+||+|.+..+++.||||++....   ....+|+.+++.+      +|+||+++++++...    
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~----  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR----  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC----
Confidence            457999999999999999999999999999999987543   2344688888877      577999999988543    


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC--eEEEec
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ--LKLCDF  183 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~--vkl~Df  183 (376)
                       ..+++||||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .  +||+||
T Consensus       172 -~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~-~~~vkL~DF  246 (429)
T 3kvw_A          172 -NHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQG-RSGIKVIDF  246 (429)
T ss_dssp             -TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTT-SCCEEECCC
T ss_pred             -CeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCC-CcceEEeec
Confidence             3488999999999988776532  2459999999999999999999998 8999999999999999887 4  999999


Q ss_pred             CCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          184 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       184 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      |+++...  .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|+...+
T Consensus       247 G~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          247 GSSCYEH--QRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TTCEETT--CCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccceecC--CcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            9997543  334456889999999999764 4899999999999999999999999999999999999999999998876


Q ss_pred             hhcCcCccccc---CC---------------------------CccccccccccccCCChhHHHHHHHhhccCCCCCCCH
Q 017131          264 KCMNPNYTEFK---FP---------------------------QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  313 (376)
Q Consensus       264 ~~~~~~~~~~~---~~---------------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~  313 (376)
                      .........+.   .+                           ......|...+....++++++||++||++||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence            54321100000   00                           0112233334444568899999999999999999999


Q ss_pred             HHHhcCCccccc
Q 017131          314 LEACVHPFFDEL  325 (376)
Q Consensus       314 ~~ll~hp~f~~~  325 (376)
                      .|+|+||||++.
T Consensus       404 ~e~L~Hpw~~~~  415 (429)
T 3kvw_A          404 GQALRHPWLRRR  415 (429)
T ss_dssp             HHHHTSTTTC--
T ss_pred             HHHhCChhhccC
Confidence            999999999873

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.4e-51  Score=377.59  Aligned_cols=253  Identities=27%  Similarity=0.487  Sum_probs=207.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++.+.||+|+||.||+|+++.+++.||||++.+..       ....+|+.+++.+ +||||+++++++.+     
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----   81 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----   81 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----
Confidence            3468999999999999999999999999999999987542       2245799999887 89999999998843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+|+||||+++ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFG  155 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYG  155 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCGG
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEecc
Confidence            2348899999975 77666653    3579999999999999999999998 9999999999999999998 79999999


Q ss_pred             Cccccc-CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------hHHH-HHHHHH
Q 017131          185 SAKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQL-VEIIKV  254 (376)
Q Consensus       185 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~-~~i~~~  254 (376)
                      +++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.....        ...+ ..+...
T Consensus       156 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          156 MCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             GCBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             ccccccCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence            997643 2334456688999999999965 4589999999999999999999999975321        1111 112110


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH------HHHhcCCcccccCC
Q 017131          255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  327 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~------~~ll~hp~f~~~~~  327 (376)
                                       ...            ++..+++++++||++||+.||.+||++      .++++||||+++.+
T Consensus       235 -----------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          235 -----------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             -----------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             -----------------CCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                             111            224689999999999999999999995      89999999998764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-51  Score=379.12  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=215.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...++|++++.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++.+     
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----  112 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----
Confidence            45578999999999999999999999999999999986432       234579999999999999999998843     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+|+||||++ ++|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg  186 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFG  186 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEcccc
Confidence            334889999996 588777654    3579999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +++....  .....+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+...          
T Consensus       187 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------  253 (350)
T 1rdq_E          187 FAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------  253 (350)
T ss_dssp             TCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             cceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence            9986533  34456899999999999654 5899999999999999999999999988877766666552          


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                             ...            ++..+++++.+||++||+.||.+||+     ++++++||||+++++
T Consensus       254 -------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          254 -------KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -------CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -------CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                   111            12468999999999999999999998     999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-51  Score=376.72  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=215.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.+....   ....+|+.+++.++||||+++++++.+..     .+++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-----ELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEEE
Confidence            357999999999999999999999999999999886432   33458999999999999999999985433     4889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC--CCCCeEEEecCCccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKV  188 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~vkl~Dfg~a~~  188 (376)
                      ||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.  ++ .+||+|||+++.
T Consensus        79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeE
Confidence            9999985 77666542   23469999999999999999999998 99999999999999987  55 799999999987


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...+.......+|+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+.......+...+     
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----  227 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-----  227 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-----
T ss_pred             CCCCCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh-----
Confidence            765555566778999999999965 44799999999999999999999999998877777777653222222211     


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                          ..+++++++||.+||..||.+|||+.++|+||||++.
T Consensus       228 --------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          228 --------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             --------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             --------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                                3579999999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.8e-51  Score=368.33  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=213.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++....    ....+|+.+++.++||||+++++++....     .+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----EL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EE
Confidence            4568999999999999999999999999999999985432    33568999999999999999999886533     37


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||++ ++|.+++..     ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~  165 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  165 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            89999996 588777653     469999999999999999999998 9999999999999999988 799999999876


Q ss_pred             ccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+..... +.        
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~--------  235 (297)
T 3fxz_A          166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE--------  235 (297)
T ss_dssp             CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC--------
T ss_pred             cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC--------
Confidence            54433 23456789999999999664 589999999999999999999999998887766665554211 00        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                           .            ..+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       236 -----~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          236 -----L------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             -----C------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----C------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                 0            0124578999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-51  Score=383.05  Aligned_cols=262  Identities=27%  Similarity=0.442  Sum_probs=216.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.++..++||||+++++++.+     .
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence            346899999999999999999999999999999998642       2345689999999999999999998843     3


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      .++|+||||+. ++|.+++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechh
Confidence            34889999996 5887777642   3479999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCCCC--CceeeeeccccchhhhcC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          186 AKVLVKGEP--NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       186 a~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      ++.......  ....+||+.|+|||++..      ...++.++|||||||++|||++|++||.+.+..+...++..... 
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-  287 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE-  287 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred             heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence            986644332  224578999999999962      34589999999999999999999999999888777777764210 


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCC---CCHHHHhcCCcccccCCCCC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELRDPNT  330 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~s~~~ll~hp~f~~~~~~~~  330 (376)
                                    ...+|.         +...+|+++++||++||+ +|.+|   ++++++++||||++++|...
T Consensus       288 --------------~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          288 --------------HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             --------------HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             --------------CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                          011111         113589999999999999 99998   48999999999999887654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.2e-51  Score=376.69  Aligned_cols=259  Identities=29%  Similarity=0.376  Sum_probs=211.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc---------cccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      -.++|++.+.||+|+||+||+|.+..+|+.||||++...         .....+|+.+++.++||||+++++++...   
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---   98 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD---   98 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence            346899999999999999999999999999999998532         23456899999999999999999988543   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEE
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLC  181 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~  181 (376)
                        ..+|+||||++ ++|.+.+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+
T Consensus        99 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           99 --GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             --TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             --CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEe
Confidence              34889999998 58877776655555569999999999999999999998 99999999999999986552  49999


Q ss_pred             ecCCcccccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          182 DFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       182 Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+....+.+.......
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence            9999987654332 3356789999999999654 58999999999999999999999998753 3333334332111111


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ..                         ...+++++++||.+||+.||.+|||+.++++||||+..
T Consensus       254 ~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          254 RQ-------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cc-------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            11                         13579999999999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-51  Score=386.07  Aligned_cols=290  Identities=28%  Similarity=0.477  Sum_probs=214.2

Q ss_pred             ccceEE-eeeeeecCceEEEEEEEC--CCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIA-EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+.|.+ +++||+|+||+||+|+++  .+++.||||++....  ....+|+.+|+.++||||+++++++....   ...+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeE
Confidence            356887 558999999999999965  578899999986543  34568999999999999999999986532   3358


Q ss_pred             EEEEecccccHHHHHHHhhhhc-----CCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE----cCCCCCeEE
Q 017131          110 NLVLEYVPETVNRIARNYSRIH-----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKL  180 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill----~~~~~~vkl  180 (376)
                      ++||||+++++.+++.......     ..+++..++.++.||+.||+|||+ +||+||||||+|||+    +.++ .+||
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl  173 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKI  173 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEE
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEE
Confidence            8999999999988887544322     249999999999999999999998 999999999999999    5556 7999


Q ss_pred             EecCCcccccCC----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------hHH
Q 017131          181 CDFGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQ  247 (376)
Q Consensus       181 ~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~  247 (376)
                      +|||+|+.....    .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.         .++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999765432    2234467899999999997766799999999999999999999999987654         478


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCc---------ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          248 LVEIIKVLGTPTREEIKCMNPNY---------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       248 ~~~i~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +..++..++.|....|.....-.         ....+.......+........++++.+||++||++||.+|||+.|+|+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            88999999988876554321100         000000000000111111234789999999999999999999999999


Q ss_pred             CCcccccCCCC
Q 017131          319 HPFFDELRDPN  329 (376)
Q Consensus       319 hp~f~~~~~~~  329 (376)
                      ||||++...+.
T Consensus       334 hp~f~~~~~~~  344 (405)
T 3rgf_A          334 DPYFLEDPLPT  344 (405)
T ss_dssp             SGGGTSSSCCC
T ss_pred             ChhhccCCCCc
Confidence            99999865443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.8e-51  Score=377.09  Aligned_cols=289  Identities=29%  Similarity=0.474  Sum_probs=226.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC---C
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---K  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~  104 (376)
                      ..++|++++.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4568999999999999999999999999999999885432      234589999999999999999998865432   1


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ....+++||||+++++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccch
Confidence            1345889999999988766654   33569999999999999999999998 9999999999999999988 89999999


Q ss_pred             CcccccCC-----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      +++.....     .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+.++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99765321     2224456799999999997766789999999999999999999999999999999999998888776


Q ss_pred             HHHHhhcCcC--cccccCCCcccccccccc-ccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          260 REEIKCMNPN--YTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       260 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      .+.+......  +................+ ....++++++||.+||+.||.+|||+.|+|+||||++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            6544332110  001111110000000000 0013788999999999999999999999999999987443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=381.75  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=211.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+..       ....+|+.+++.++||||+++++++.+.     .
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence            468999999999999999999999999999999986432       3345799999999999999999988543     3


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||+.+ +|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG~a  162 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFNIA  162 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEecccee
Confidence            48899999975 77666643    4579999999999999999999998 9999999999999999998 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHHHHHhCCCCHHH
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ--LVEIIKVLGTPTREE  262 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~~  262 (376)
                      +...........+||+.|+|||++.+  ...++.++|||||||++|+|++|..||.+.+....  ........       
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------  235 (384)
T 4fr4_A          163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-------  235 (384)
T ss_dssp             EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-------
T ss_pred             eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-------
Confidence            87766666677889999999999964  23489999999999999999999999986543322  21211110       


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-HHHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~~ll~hp~f~~~~~  327 (376)
                               ...            ++..+++++.+||.+||+.||.+||+ ++++++||||+++.+
T Consensus       236 ---------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 ---------VVT------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             ---------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             ---------ccC------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                     011            22467999999999999999999998 899999999998865

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.9e-52  Score=374.56  Aligned_cols=266  Identities=21%  Similarity=0.207  Sum_probs=187.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-c--HHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-Y--KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~--~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++..... .  .++|+..+..++|||||++++++..... ....+|+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEE
Confidence            4699999999999999999987  489999999865432 2  2345666678899999999998865432 23457899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--------CccccCCCCCcEEEcCCCCCeEEEec
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      ||||+ |+|.+++..     ..+++..+..++.|++.||+|||+ +        +|+||||||+|||++.++ .+||+||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DF  152 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  152 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeC
Confidence            99998 588887754     569999999999999999999997 6        999999999999999998 8999999


Q ss_pred             CCcccccCCCC-----CceeeeeccccchhhhcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017131          184 GSAKVLVKGEP-----NVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       184 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  253 (376)
                      |+|+.......     ....+||+.|+|||++.+..     .++.++|||||||++|||+||.+||...........-. 
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~-  231 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-  231 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc-
Confidence            99986644332     22457999999999996532     36779999999999999999988775432111000000 


Q ss_pred             HhCCCCHHHHhh-cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          254 VLGTPTREEIKC-MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       254 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ....+..+.+.. ....   ..-|..+.    .......+..+.+|+.+||+.||++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~---~~rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCEQ---KLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCSSCCHHHHHHHHTTS---CCCCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHhcc---cCCCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            000000000000 0000   00000000    00001234578999999999999999999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=371.24  Aligned_cols=256  Identities=23%  Similarity=0.370  Sum_probs=215.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....          ....+|+.+++.++||||+++++++..   
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   85 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---   85 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence            4468999999999999999999999999999999986432          235689999999999999999998843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC---CeE
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLK  179 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~vk  179 (376)
                        ...+++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.   .+|
T Consensus        86 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           86 --KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             --SSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEE
Confidence              234889999996 488776643    4679999999999999999999998 99999999999999987652   599


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            999999987755555556788999999999954 4589999999999999999999999998887776666654321111


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ..                         ....+++.+++||++||+.||.+|||+.++++||||+..
T Consensus       238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            11                         113578999999999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.4e-51  Score=379.53  Aligned_cols=254  Identities=24%  Similarity=0.420  Sum_probs=209.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHHH-HHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ....+|++++.||+|+||+||+|+++.+++.||||++.+...       ...+|..+ ++.++||||+++++++.+    
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----  110 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----  110 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----
Confidence            455789999999999999999999999999999999865432       22345555 466899999999998843    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       ...+|+||||++| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       111 -~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DF  183 (373)
T 2r5t_A          111 -ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDF  183 (373)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeC
Confidence             2348899999985 77666654    4679999999999999999999998 9999999999999999998 7999999


Q ss_pred             CCcccccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          184 GSAKVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       184 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      |+++.... .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+...        
T Consensus       184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------  254 (373)
T 2r5t_A          184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--------  254 (373)
T ss_dssp             CBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--------
T ss_pred             ccccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------
Confidence            99986432 334456789999999999965 45899999999999999999999999988877777766652        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH----HHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~~ll~hp~f~~~~~  327 (376)
                               ...            ++..+++++++||++||+.||.+|+++    .++++||||+.++|
T Consensus       255 ---------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          255 ---------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             ---------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             ---------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence                     111            124689999999999999999999986    69999999998765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.4e-51  Score=377.86  Aligned_cols=260  Identities=27%  Similarity=0.438  Sum_probs=199.4

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ...++|++++.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++||||+++++++.+.     ..+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~   91 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL   91 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEE
Confidence            34568999999999999999999999999999999986543   3456899999999999999999998543     348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC-CeEEEecCCcc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAK  187 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~-~vkl~Dfg~a~  187 (376)
                      ++||||+.+ +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||+++
T Consensus        92 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           92 AIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            899999964 77766654    4579999999999999999999998 99999999999999987652 49999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.......         
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~---------  237 (361)
T 3uc3_A          167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV---------  237 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT---------
T ss_pred             cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC---------
Confidence            65444555567899999999999776544555999999999999999999998765544443333321100         


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                          .+.++.          ...+++++++||++||+.||.+|||+.++++||||.+.
T Consensus       238 ----~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          238 ----KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ----CCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ----CCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                111111          12578999999999999999999999999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.8e-51  Score=385.87  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=211.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      -.++|++.+.||+|+||+||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.+     ..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----SS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----CC
Confidence            3468999999999999999999999999999999986532      234589999999999999999998843     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC---CCCCeEEEec
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDF  183 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~---~~~~vkl~Df  183 (376)
                      ..|+||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.   ++ .+||+||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~-~vkL~DF  157 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGA-AVKLADF  157 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTC-CEEECCC
T ss_pred             EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCC-cEEEccC
Confidence            48899999975 77666654    4679999999999999999999998 99999999999999984   34 7999999


Q ss_pred             CCcccccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          184 GSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       184 g~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      |++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......     
T Consensus       158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----  231 (444)
T 3soa_A          158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-----  231 (444)
T ss_dssp             SSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----
T ss_pred             ceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-----
Confidence            99976644332 345678999999999965 45899999999999999999999999998877777766553111     


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                  ++.   ..     ...+++++++||.+||+.||.+|||+.++|+||||+..
T Consensus       232 ------------~~~---~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 ------------FPS---PE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ------------CCT---TT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ------------CCc---cc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                        110   00     13579999999999999999999999999999999763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=374.11  Aligned_cols=315  Identities=32%  Similarity=0.566  Sum_probs=240.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCC-Cce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~  107 (376)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357999999999999999999999999999999986432      2345799999999999999999988543321 112


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++||||+++++.+.+      ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus       103 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTT
T ss_pred             eEEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeeccccc
Confidence            35799999998765443      2469999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...  .......+|+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.++.+.+..+.
T Consensus       175 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCC--CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            643  223456789999999999765678999999999999999999999999999999999999999998887665443


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  344 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~  344 (376)
                      .....   ..++......+... ...+++++.+||.+||+.||.+|||+.++++||||+...++.......    ..+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~----~~~~~  327 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ----QPFDD  327 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTT-CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCS----SCCCC
T ss_pred             hHHHHHHHHhCcCCCCccHHHh-cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCC----CCCcc
Confidence            22110   11222222222222 246899999999999999999999999999999999877654321111    11211


Q ss_pred             CCCCCCCCCHHHHhhhchHHH
Q 017131          345 KPPELSGIPPETINRLIPEHA  365 (376)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~  365 (376)
                       ..+...++.+.+++.+.++.
T Consensus       328 -~~~~~~~~~~~~~~~~~~~~  347 (353)
T 3coi_A          328 -SLEHEKLTVDEWKQHIYKEI  347 (353)
T ss_dssp             -TTTTCCCCHHHHHHHHHHHH
T ss_pred             -chhhccCCHHHHHHHHHHHH
Confidence             12234456666766665544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-50  Score=371.68  Aligned_cols=285  Identities=33%  Similarity=0.582  Sum_probs=227.3

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           31 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .....++|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++...   
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   96 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK---   96 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC---
Confidence            4456679999999999999999999999999999999885432      2234799999999999999999998543   


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        ...++||||+++++...+.   .....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        97 --~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg  169 (331)
T 4aaa_A           97 --KRWYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFG  169 (331)
T ss_dssp             --TEEEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             --CEEEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEEEeCC
Confidence              3488999999986644332   234679999999999999999999998 9999999999999999988 89999999


Q ss_pred             CcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +++..... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.......
T Consensus       170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            99765432 22344568999999999977657899999999999999999999999999999999999988887766543


Q ss_pred             hhc--CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          264 KCM--NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       264 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ...  .+.+.....+............+.+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            322  22233334443333333333334689999999999999999999999999999999863

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.9e-51  Score=378.11  Aligned_cols=255  Identities=28%  Similarity=0.401  Sum_probs=212.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.+     ...
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence            458999999999999999999999999999999986532      234579999999999999999998843     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCeEEEecCC
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  185 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg~  185 (376)
                      .|+||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ..+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            7899999986 77655542    4579999999999999999999998 9999999999999998654  2599999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +.............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....         
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~---------  247 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY---------  247 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------
T ss_pred             ceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            987765555556788999999999965 4589999999999999999999999998887666666554211         


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                              .++.   ..     ...+++++++||.+||+.||.+|||+.++|+||||+..
T Consensus       248 --------~~~~---~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          248 --------DYPS---PE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             --------CCCT---TG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             --------CCCc---cc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                    1110   00     13579999999999999999999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.5e-50  Score=365.82  Aligned_cols=291  Identities=31%  Similarity=0.546  Sum_probs=233.3

Q ss_pred             CccccceEEeeeeeecCceEEEEEEEC-CCCcEEEEEEeeccc------ccHHHHHHHHHhC---CCCCeeeccceeeec
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFST  101 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~  101 (376)
                      ....++|++.+.||+|+||.||+|.+. .+|+.||+|++....      ....+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            345568999999999999999999995 678999999885422      2445788887776   899999999988644


Q ss_pred             CCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          102 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                      ........++||||++++|.+++....  ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEe
Confidence            444566788999999999988776532  2459999999999999999999998 9999999999999999988 89999


Q ss_pred             ecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       182 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      |||+++............+|+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+...
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            99999766444444456789999999999654 58999999999999999999999999999999999999988888766


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .+...... ....+......+ ...+...+++.+++||.+||+.||.+|||+.++++||||++++...
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          242 DWPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             GSCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cCcccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            54321110 001111111111 1223357899999999999999999999999999999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-50  Score=360.78  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=207.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|++....     ....+|+.+++.++||||+++++++..     ...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCe
Confidence            3468999999999999999999999999999999986543     345689999999999999999998843     234


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc---CCCCCeEEEecC
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDFG  184 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~---~~~~~vkl~Dfg  184 (376)
                      .++||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++   .++ .+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHS-PIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence            8899999985 8888887766666789999999999999999999998 9999999999999994   344 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ++.............+|+.|+|||++.  ..++.++|+|||||++|+|++|..||.+.+..+....+....  +      
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~------  242 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--P------  242 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------
T ss_pred             cceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--c------
Confidence            998765555555667899999999984  358999999999999999999999998877555444433210  0      


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                               ..+         .....+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       243 ---------~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 ---------NYA---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ---------CCC---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ---------ccc---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                     000         001247899999999999999999999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.8e-50  Score=368.35  Aligned_cols=253  Identities=29%  Similarity=0.457  Sum_probs=206.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc--------ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      ...+|++.+.||+|+||.||+|++.   .+|+.||+|++.+..        ....+|+.+++.++||||+++++++....
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            4468999999999999999999985   689999999986431        23457999999999999999999885433


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          103 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                           .+|+||||++ ++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus        95 -----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           95 -----KLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             -----CEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             -----EEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEEE
Confidence                 3889999997 477666653    3579999999999999999999998 9999999999999999988 79999


Q ss_pred             ecCCcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          182 DFGSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       182 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.+.      
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------  236 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC------  236 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------
Confidence            99998754322 22334578999999999965 45899999999999999999999999988877776666552      


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                                 ...            ++..+++++++||.+||..||.+||     ++.++++||||+++.+
T Consensus       237 -----------~~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          237 -----------KLN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             -----------CCC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             -----------CCC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                       111            1245789999999999999999999     8899999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.4e-51  Score=388.57  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=206.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.+..       ....+|+.+++.++||||+++++++....     
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence            468999999999999999999999999999999986431       23346899999999999999999885433     


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+.+||+||||||+|||++.++ .+||+|||+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a  296 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLC  296 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCC
T ss_pred             EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCc
Confidence            38899999986 77666643    467999999999999999999999427999999999999999988 7999999999


Q ss_pred             ccccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...           
T Consensus       297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  364 (446)
T 4ejn_A          297 KEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------  364 (446)
T ss_dssp             CTTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             eeccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            76432 233445678999999999965 45899999999999999999999999988776666655541           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                            ...            ++..+++++.+||.+||+.||.+||     ++.++++||||+++.+
T Consensus       365 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          365 ------EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence                  111            1245799999999999999999999     9999999999998865

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.5e-51  Score=368.27  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=205.0

Q ss_pred             CccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------------------------ccHHHHHH
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQ   81 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~   81 (376)
                      ....++|++.+.||+|+||.||+|++..+++.||||++....                              ....+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            344568999999999999999999999999999999986432                              23568999


Q ss_pred             HHHhCCCCCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCcc
Q 017131           82 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC  160 (376)
Q Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ii  160 (376)
                      +++.++||||+++++++...   ....+++||||+++ ++.++.     ....+++..++.++.||+.||+|||+ +||+
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iv  159 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHY-QKII  159 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             HHHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCee
Confidence            99999999999999988542   23458899999985 443321     23579999999999999999999998 9999


Q ss_pred             ccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC-CceeeeeccccchhhhcCCCC--CCCchhHHHHHHHHHHHHhCCC
Q 017131          161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQP  237 (376)
Q Consensus       161 H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~  237 (376)
                      ||||||+|||++.++ .+||+|||+++....... .....+|+.|+|||++.+...  ++.++|||||||++|+|++|..
T Consensus       160 H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          160 HRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            999999999999988 799999999986543322 234578999999999965432  4788999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          238 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       238 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                      ||.+.+.......+...                 ...++.          ...+++++.+||.+||+.||.+|||+.+++
T Consensus       239 pf~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l  291 (298)
T 2zv2_A          239 PFMDERIMCLHSKIKSQ-----------------ALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIK  291 (298)
T ss_dssp             SSCCSSHHHHHHHHHHC-----------------CCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCCccHHHHHHHHhcc-----------------cCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence            99887655444443331                 111111          135789999999999999999999999999


Q ss_pred             cCCcccc
Q 017131          318 VHPFFDE  324 (376)
Q Consensus       318 ~hp~f~~  324 (376)
                      +||||+.
T Consensus       292 ~hp~~~~  298 (298)
T 2zv2_A          292 LHPWVTR  298 (298)
T ss_dssp             TCHHHHC
T ss_pred             cCccccC
Confidence            9999963

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.8e-50  Score=372.63  Aligned_cols=277  Identities=25%  Similarity=0.430  Sum_probs=220.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCC-----CCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----HPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~~  106 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.+.     ||||+++++++....    
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~----  109 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD----  109 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT----
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC----
Confidence            357999999999999999999999999999999986432   33456999999986     999999999885533    


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC-------------
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-------------  173 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~-------------  173 (376)
                       ..++||||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.             
T Consensus       110 -~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          110 -HMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             -EEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             -eeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhcc
Confidence             488999999889988887532  2459999999999999999999998 99999999999999975             


Q ss_pred             ------------CCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 017131          174 ------------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  241 (376)
Q Consensus       174 ------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  241 (376)
                                  ++ .+||+|||+++...  .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus       186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKST-GIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCC-CEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCC-CEEEEeccCceecC--CCCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        55 79999999997643  233456789999999999654 589999999999999999999999999


Q ss_pred             CCchHHHHHHHHHhCCCCHHHHhhcCcCcc-c--------ccCCCcccc--------ccccccccCCChhHHHHHHHhhc
Q 017131          242 ESGVDQLVEIIKVLGTPTREEIKCMNPNYT-E--------FKFPQIKPH--------PWHKVFQKRLPPEAVDLVCRFFQ  304 (376)
Q Consensus       242 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~  304 (376)
                      .+..+.+..+....+.++...+........ .        ..++.....        .....+....++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            998888888888888777665543321100 0        011110000        00001111235788899999999


Q ss_pred             cCCCCCCCHHHHhcCCccc
Q 017131          305 YSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       305 ~dp~~R~s~~~ll~hp~f~  323 (376)
                      .||.+|||+.++|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-50  Score=371.84  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=208.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++.+......+|++++..+ +||||+++++++.+     ...+|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDD-----GKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCEEEEEE
Confidence            4689999999999999999999999999999999987777777899999888 79999999998843     34588999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC---CeEEEecCCcccc
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKLCDFGSAKVL  189 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~vkl~Dfg~a~~~  189 (376)
                      ||+.+ +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||+..+..   .+||+|||+++..
T Consensus        96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99975 77666643    4569999999999999999999998 99999999999999854321   4999999999865


Q ss_pred             cCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHHHhCCCCHHHHhh
Q 017131          190 VKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       190 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ... ......++|+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+..   ..+....+...           
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----------  238 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-----------  238 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-----------
T ss_pred             cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-----------
Confidence            433 233456789999999999653 48899999999999999999999998642   22223333221           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            .+.++        ......+++++++||++||..||.+|||+.++++||||.+..
T Consensus       239 ------~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          239 ------KFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             ------CCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             ------CcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                  11111        001145899999999999999999999999999999997743

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-50  Score=385.80  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=215.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...++|++++.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++.+.    
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----   88 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP----   88 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS----
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----
Confidence            34568999999999999999999999999999999986432       2456899999999999999999988543    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                       ..+|+||||++ ++|.+++.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        89 -~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG  161 (476)
T 2y94_A           89 -SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFG  161 (476)
T ss_dssp             -SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             -CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEecc
Confidence             34889999996 47766654    34679999999999999999999998 9999999999999999988 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +++....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++....         
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------  232 (476)
T 2y94_A          162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---------  232 (476)
T ss_dssp             SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC---------
T ss_pred             chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------
Confidence            99877665556677899999999999776556889999999999999999999999887766666554311         


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                              +.            .+..+++++++||++||+.||.+|||+.++++||||+.
T Consensus       233 --------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          233 --------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             --------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             --------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                    11            11357899999999999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9e-50  Score=386.74  Aligned_cols=278  Identities=28%  Similarity=0.439  Sum_probs=223.9

Q ss_pred             cccccccCCCCCCceEEecccCCCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------
Q 017131            6 EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------   73 (376)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------   73 (376)
                      +|...+++....+.++....+      ....+|++++.||+|+||+||+|.+..+++.||||++.+..            
T Consensus        12 ~~~~~~~~~~~~~~~~~~~~~------~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~   85 (504)
T 3q5i_A           12 ENLYFQGIAINPGMYVRKKEG------KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN   85 (504)
T ss_dssp             GGGSSCCCCCCGGGGCCEECS------CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC--------------
T ss_pred             ccccccceeechhheeeccCC------CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchh
Confidence            445555555444544443322      23457999999999999999999999999999999986432            


Q ss_pred             -----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHH
Q 017131           74 -----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQIC  147 (376)
Q Consensus        74 -----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~  147 (376)
                           ....+|+.+++.++||||+++++++.+     ...+|+|||||++ +|.+.+..    ...+++..++.++.||+
T Consensus        86 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~  156 (504)
T 3q5i_A           86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQIL  156 (504)
T ss_dssp             --CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHH
Confidence                 234579999999999999999999843     3448899999975 77666654    36799999999999999


Q ss_pred             HHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHH
Q 017131          148 RALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWST  225 (376)
Q Consensus       148 ~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  225 (376)
                      .||+|||+ +||+||||||+|||++.++.  .+||+|||+++............||+.|+|||++.+  .++.++||||+
T Consensus       157 ~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Diwsl  233 (504)
T 3q5i_A          157 SGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSC  233 (504)
T ss_dssp             HHHHHHHH-TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHH
T ss_pred             HHHHHHHH-CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHH
Confidence            99999998 99999999999999987753  599999999987766555666789999999999853  58999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhcc
Q 017131          226 GCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY  305 (376)
Q Consensus       226 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  305 (376)
                      ||++|+|++|.+||.+.+..+.+..+.......+...+                         ..+|+++++||++||+.
T Consensus       234 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------------------~~~s~~~~~li~~~L~~  288 (504)
T 3q5i_A          234 GVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW-------------------------KNISDEAKELIKLMLTY  288 (504)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-------------------------TTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc-------------------------CCCCHHHHHHHHHHcCC
Confidence            99999999999999998887777776653211121111                         35899999999999999


Q ss_pred             CCCCCCCHHHHhcCCcccccC
Q 017131          306 SPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       306 dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ||.+|||+.++|+||||++..
T Consensus       289 dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          289 DYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             STTTSCCHHHHHTSHHHHHTC
T ss_pred             ChhHCCCHHHHhcCHhhhhch
Confidence            999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.2e-50  Score=366.74  Aligned_cols=255  Identities=27%  Similarity=0.350  Sum_probs=207.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++++.||+|+||+||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeE
Confidence            357999999999999999999999999999999985432     445689999999999999999998843     3347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  154 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATV  154 (323)
T ss_dssp             EEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeeccce
Confidence            899999975 6644442    34569999999999999999999998 9999999999999999988 799999999975


Q ss_pred             ccCC---CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          189 LVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       189 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....   .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..............        
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------  226 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------  226 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--------
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--------
Confidence            5322   22335678999999999977665688999999999999999999999876654333322221000        


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                              ..     .+     ...+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       227 --------~~-----~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          227 --------YL-----NP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             --------TS-----TT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             --------cC-----Cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                    00     00     135789999999999999999999999999999998643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-49  Score=373.82  Aligned_cols=288  Identities=20%  Similarity=0.329  Sum_probs=211.6

Q ss_pred             CCccccceEEeeeeeec--CceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           31 NSKQKVSYIAEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      .....++|++++.||+|  +||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++....
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            34566799999999999  99999999999999999999986542      33457999999999999999999985433


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          103 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                           .+++||||++ ++|.+++...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus       100 -----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~  170 (389)
T 3gni_B          100 -----ELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLS  170 (389)
T ss_dssp             -----EEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEEC
T ss_pred             -----EEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEc
Confidence                 4889999998 5887777643  22569999999999999999999998 9999999999999999988 89999


Q ss_pred             ecCCcccccCC--------CCCceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017131          182 DFGSAKVLVKG--------EPNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  252 (376)
Q Consensus       182 Dfg~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  252 (376)
                      |||.+......        .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  250 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL  250 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred             ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            99987644221        112234678899999999653 458999999999999999999999999887776665544


Q ss_pred             HHhCCCC-------HHHHhh-c-----CcCccc-----ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH
Q 017131          253 KVLGTPT-------REEIKC-M-----NPNYTE-----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  314 (376)
Q Consensus       253 ~~~~~~~-------~~~~~~-~-----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~  314 (376)
                      .......       .+.+.. .     ......     ...+.. .......+...+++++++||++||+.||.+|||+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~  329 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN-GDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS  329 (389)
T ss_dssp             --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCcccccc-CCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence            3211000       000000 0     000000     000000 00011113346899999999999999999999999


Q ss_pred             HHhcCCcccccCCC
Q 017131          315 EACVHPFFDELRDP  328 (376)
Q Consensus       315 ~ll~hp~f~~~~~~  328 (376)
                      ++|+||||+++...
T Consensus       330 ell~hp~f~~~~~~  343 (389)
T 3gni_B          330 TLLNHSFFKQIKRR  343 (389)
T ss_dssp             HHTTSGGGGGC---
T ss_pred             HHhcCHHHHHHhhc
Confidence            99999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.7e-50  Score=367.63  Aligned_cols=286  Identities=30%  Similarity=0.509  Sum_probs=220.9

Q ss_pred             CCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-cccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceE
Q 017131           31 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .....++|++.+.||+|+||+||+|.+..+++.||||++... .....+|+.+++.++ ||||+++++++...   ....
T Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~  107 (330)
T 3nsz_A           31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRT  107 (330)
T ss_dssp             CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCC
T ss_pred             cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCc
Confidence            334557899999999999999999999999999999998643 345668999999997 99999999988542   2334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||||+++ ++..++       +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++
T Consensus       108 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEEEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            7899999985 554443       248999999999999999999998 9999999999999999776579999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHHHhCCCCHHHH-hh
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEI-KC  265 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~  265 (376)
                      ............+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+....+.+..... ..
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            76655555667889999999999775679999999999999999999999985 44556666666666554332211 11


Q ss_pred             cCcCccc---ccCCCccccccccc----cccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          266 MNPNYTE---FKFPQIKPHPWHKV----FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      .......   ..........|...    ....+++++++||++||+.||.+|||++++|+||||+++..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            1100000   00000011111111    11237999999999999999999999999999999998753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-50  Score=376.11  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=213.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++....    ....+|+.+++.++||||+++++++..     ...++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence            458999999999999999999999999999999986532    345689999999999999999998843     33488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC-CCCeEEEecCCccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKV  188 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~-~~~vkl~Dfg~a~~  188 (376)
                      +||||+.+ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+++.
T Consensus       125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999975 77655542   23469999999999999999999998 999999999999999753 22799999999987


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....             
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~-------------  266 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-------------  266 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-------------
T ss_pred             cCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            765555556678999999999965 458999999999999999999999999988777666655421             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                          +.++.        .....+++++++||.+||+.||.+|||+.++++||||++..
T Consensus       267 ----~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          267 ----WEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ----CCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ----CCCCc--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                11110        01135799999999999999999999999999999998743

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-49  Score=356.51  Aligned_cols=257  Identities=28%  Similarity=0.383  Sum_probs=213.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence            467999999999999999999999999999999986543      234579999999999999999998843     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecCC
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGS  185 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg~  185 (376)
                      .++||||+.+ ++.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.  .+||+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7899999976 66555543    3679999999999999999999998 99999999999999986651  499999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +.............+|+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+.......+.......       
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------  226 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-------  226 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC-------
Confidence            987665555556678999999999965 458999999999999999999999999887766666655421111       


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                                +.        .....+++++.+||.+||+.||.+|||+.++++||||++.+.
T Consensus       227 ----------~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          227 ----------PS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             ----------CT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             ----------Cc--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence                      10        001357899999999999999999999999999999988654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.8e-50  Score=360.79  Aligned_cols=258  Identities=25%  Similarity=0.387  Sum_probs=199.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++.....      ...++...++.++||||+++++++.....    
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~----   80 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD----   80 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS----
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC----
Confidence            34689999999999999999999999999999999864321      12234455778899999999998864332    


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                       .++||||+++++.+.+.........+++..++.++.|++.||+|||+ + ||+||||||+||+++.++ .+||+|||++
T Consensus        81 -~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T 3fme_A           81 -VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGIS  157 (290)
T ss_dssp             -EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred             -EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence             78999999999988888766667789999999999999999999998 7 999999999999999988 8999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhh---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCHHH
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~  262 (376)
                      +............+|+.|+|||++   .....++.++|+|||||++|+|++|..||..... ...+...... ..+    
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~----  232 (290)
T 3fme_A          158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSP----  232 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCC----
T ss_pred             ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCC----
Confidence            876555555556789999999997   2445689999999999999999999999986433 3333333221 000    


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                 .           .....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       233 -----------~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 -----------Q-----------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             -----------C-----------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -----------C-----------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                       0           0113578999999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-50  Score=391.32  Aligned_cols=256  Identities=26%  Similarity=0.439  Sum_probs=212.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+|+.++||||+++++++.+     .
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----K  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----C
Confidence            4568999999999999999999999999999999985431       234579999999999999999998843     2


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+|+||||++ ++|...+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFGl  332 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLGL  332 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEeccc
Confidence            34889999996 5877666532  12349999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhCCCCHHH
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPTREE  262 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~  262 (376)
                      ++....+......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..   ..+...+...       
T Consensus       333 a~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-------  404 (576)
T 2acx_A          333 AVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------  404 (576)
T ss_dssp             CEECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-------
T ss_pred             ceecccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-------
Confidence            987765555566789999999999965 45899999999999999999999999876532   2222222210       


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                               ..            .++..+++++++||++||+.||.+||     ++.++++||||+++++
T Consensus       405 ---------~~------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          405 ---------PE------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             ---------cc------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence                     00            12246899999999999999999999     7899999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-49  Score=362.16  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=215.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      -.++|++.+.||+|+||.||+|.+..+|+.||+|++....          ....+|+.+++.++||||+++++++..   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   86 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---   86 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence            3467999999999999999999999999999999986432          235689999999999999999998843   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC---CeE
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLK  179 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~vk  179 (376)
                        ....++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.   .+|
T Consensus        87 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           87 --RTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             --SSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             --CCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEE
Confidence              234889999996 588777653    4579999999999999999999998 99999999999999997763   599


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+|||++.............+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.......+
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence            999999987765555556678999999999965 4589999999999999999999999998877666665544211111


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .                         .+...+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       239 ~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          239 E-------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             H-------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             h-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            1                         11245789999999999999999999999999999998754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.1e-50  Score=386.78  Aligned_cols=257  Identities=23%  Similarity=0.382  Sum_probs=212.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.+.     
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----  257 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----  257 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----
Confidence            3468999999999999999999999999999999986432       2345799999999999999999988432     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+|+||||++| +|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DFGl  335 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDLGL  335 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeecce
Confidence            348899999984 8877776544334579999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCCCCC-ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHHHhCCCCH
Q 017131          186 AKVLVKGEPN-VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV----DQLVEIIKVLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~  260 (376)
                      ++........ ...+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..    +....+...      
T Consensus       336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~------  408 (543)
T 3c4z_A          336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ------  408 (543)
T ss_dssp             CEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC------
T ss_pred             eeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc------
Confidence            9876544332 34589999999999965 45899999999999999999999999876432    222222220      


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                                 ...            ++..+++++++||++||+.||.+||+     ++++++||||+++.+
T Consensus       409 -----------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 -----------AVT------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             -----------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             -----------ccC------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                       011            22468999999999999999999996     589999999998764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.7e-50  Score=385.23  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=212.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      -..+|++++.||+|+||+||+|.+..+++.||||++.+.      .....+|+.+++.++||||+++++++..     ..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CC
Confidence            346899999999999999999999999999999998532      2345689999999999999999998843     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCeEEEecC
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFG  184 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg  184 (376)
                      .+|+||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++  ..+||+|||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            48899999975 77666643    3679999999999999999999998 9999999999999996432  269999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +++............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........     
T Consensus       170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----  242 (486)
T 3mwu_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-----  242 (486)
T ss_dssp             CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-----
T ss_pred             cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----
Confidence            9987665555566788999999999964  489999999999999999999999999887777776655211110     


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                .+     .     ...+|+++++||++||+.||.+|||+.++|+||||+...
T Consensus       243 ----------~~-----~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          243 ----------LP-----Q-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ----------SG-----G-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ----------Cc-----c-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                      00     0     135799999999999999999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.7e-49  Score=354.16  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=214.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .++|++.+.||+|+||+||+|.+..++..+|+|++...    .....+|+.+++.++||||+++++++..     ....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeEE
Confidence            46899999999999999999999999999999998643    2345689999999999999999998843     33488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE---cCCCCCeEEEecCCc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSA  186 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill---~~~~~~vkl~Dfg~a  186 (376)
                      +||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999975 77666654    4569999999999999999999998 999999999999999   6666 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .............+|+.|+|||++.+  .++.++|+|||||++|+|++|..||.+.+..+....+.......+...+   
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---  231 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred             eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence            87765555566778999999999854  3899999999999999999999999988877777666553222222111   


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                            ..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                  25789999999999999999999999999999998743

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.6e-50  Score=397.47  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=214.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++++.||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ +||+|+.+++++.+     
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-----  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----
Confidence            3468999999999999999999999999999999986431       2345688888887 79999999988833     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+|+||||+++ +|..++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeecc
Confidence            3348899999975 77766654    3579999999999999999999998 9999999999999999998 79999999


Q ss_pred             Cccccc-CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLV-KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +|+... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...         
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------  557 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH---------  557 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS---------
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence            998643 3334456789999999999965 45899999999999999999999999998887777776541         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCH-----HHHhcCCcccccCCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRDP  328 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~-----~~ll~hp~f~~~~~~  328 (376)
                              ...            ++..+++++++||++||+.||.+|+++     +++++||||++++|.
T Consensus       558 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          558 --------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             --------CCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             --------CCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence                    111            224689999999999999999999997     999999999998753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.5e-50  Score=364.27  Aligned_cols=287  Identities=29%  Similarity=0.499  Sum_probs=219.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecC--------
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT--------  102 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------  102 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....    ....+|+.+++.++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            457999999999999999999999999999999886433    33457999999999999999998874321        


Q ss_pred             -CCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          103 -DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       103 -~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                       .......++||||++++|.+.+.     .+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++..+||+
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEc
Confidence             12335588999999999877764     2579999999999999999999998 9999999999999998544489999


Q ss_pred             ecCCcccccCC----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          182 DFGSAKVLVKG----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       182 Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |||+++.....    .......+|+.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+....+......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99999765322    12233456889999999876567899999999999999999999999999988888888887776


Q ss_pred             CCHHHHhhcCcCcccc---cCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          258 PTREEIKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      +..+...........+   ... .+..++. .+...++.++++||.+||+.||.+|||+.++++||||+....|.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMT-EPHKPLT-QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTT-SCCCCHH-HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CchhhhhhhhhcCccccccccc-CCCCChh-HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            6655443321110000   000 0111111 12246899999999999999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-49  Score=360.13  Aligned_cols=247  Identities=27%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc------HHHHHHHHHh-CCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQM-LDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ++|++.++||+|+||+||+|++..+|+.||||++......      ..+|+..+.. .+||||+++++++..     ...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence            6899999999999999999999999999999987543211      1234444444 499999999998843     334


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +++||||+++++.+.+...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8899999999987777653   4579999999999999999999998 9999999999999999988 799999999987


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.....   .+..  +..+         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~---------  270 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLP---------  270 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCC---------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCC---------
Confidence            655555556678999999999865  58999999999999999999987775533221   1111  0000         


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                      ..+...+++++.+||.+||+.||.+|||+.++++||||++
T Consensus       271 ----------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 ----------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ----------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                            1122468999999999999999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.3e-49  Score=364.83  Aligned_cols=250  Identities=26%  Similarity=0.413  Sum_probs=211.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++....     
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----  127 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----  127 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence            357999999999999999999999999999999986432       23457999999999999999999885433     


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..++||||+.|++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       128 ~~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  202 (348)
T 1u5q_A          128 TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSAS  202 (348)
T ss_dssp             EEEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCB
T ss_pred             eEEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCce
Confidence            4889999999988777654   24679999999999999999999998 9999999999999999988 89999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....   .....||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+.+..+.+..+.... .+       
T Consensus       203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~~-------  271 (348)
T 1u5q_A          203 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP-------  271 (348)
T ss_dssp             SSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC-------
T ss_pred             ecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC-------
Confidence            6532   234578999999999853  3458999999999999999999999999887766666554410 00       


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                 .        .....+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus       272 -----------~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          272 -----------A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             -----------C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             -----------C--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence                       0        011357899999999999999999999999999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.8e-50  Score=386.41  Aligned_cols=256  Identities=31%  Similarity=0.488  Sum_probs=215.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      -.++|++.+.||+|+||+||+|.+..+|+.||||++.+.       .....+|+.+++.++||||+++++++..     .
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~   98 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----K   98 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence            346899999999999999999999999999999998543       2335689999999999999999998843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc---CCCCCeEEEe
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCD  182 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~---~~~~~vkl~D  182 (376)
                      .++++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++   .++ .+||+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~D  172 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRIID  172 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECC
T ss_pred             CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEEe
Confidence            458899999975 77665543    4679999999999999999999998 9999999999999994   455 799999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ||+++............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+......   
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  247 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---  247 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            999987765555566778999999999965  589999999999999999999999999888777776655211110   


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                                  .+     .     ...+|+++++||++||+.||.+|||+.++|+||||+....
T Consensus       248 ------------~~-----~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          248 ------------LP-----Q-----WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             ------------SG-----G-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             ------------Cc-----c-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                        00     0     1357999999999999999999999999999999998653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.6e-49  Score=364.61  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=212.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhC-CCCCeeeccceeeecC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTT  102 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  102 (376)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++..  
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  171 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--  171 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence            57999999999999999999999999999999886432            2345799999999 89999999998843  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                         ....++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+
T Consensus       172 ---~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          172 ---SSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             ---SSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred             ---CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence               3348899999986 77777653    3579999999999999999999998 9999999999999999988 79999


Q ss_pred             ecCCcccccCCCCCceeeeeccccchhhhcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 017131          182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  256 (376)
Q Consensus       182 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  256 (376)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987766555566788999999999853     23478999999999999999999999988776666665554221


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      ......+                         ..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       323 ~~~~~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPEW-------------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHHH-------------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCccc-------------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            1111111                         357899999999999999999999999999999973

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-49  Score=383.06  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=210.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..+|++++.||+|+||+||+|++..+++.||||++.+.      .....+|+.+++.++||||+++++++.+     ...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence            35799999999999999999999999999999998643      2345689999999999999999999843     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCeEEEecCC
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGS  185 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg~  185 (376)
                      +|+|||||.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++..+  ..+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            8899999975 77665543    3679999999999999999999998 9999999999999997643  1599999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ++............||+.|+|||++.  ..++.++||||+||++|+|++|.+||.+.+..+.+..+..........    
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  259 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----  259 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence            98776655556678999999999984  358999999999999999999999999988877777665531111100    


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                      .     ...+++++++||++||+.||.+|||+.++|+||||++.
T Consensus       260 ----------------~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          260 ----------------E-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ----------------G-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ----------------h-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                            0     13579999999999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.1e-49  Score=363.91  Aligned_cols=256  Identities=29%  Similarity=0.419  Sum_probs=195.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...++|++.+.||+|+||+||+|++..+++.||||++...  .....+|+.+++.++||||+++++++...     ..++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeEE
Confidence            3446799999999999999999999999999999998653  33456799999999999999999998433     3488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC---CCCCeEEEecCCc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSA  186 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~---~~~~vkl~Dfg~a  186 (376)
                      +||||+.+ +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.   ++ .+||+|||++
T Consensus       125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a  198 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLS  198 (349)
T ss_dssp             EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCccc
Confidence            99999974 77665543    4569999999999999999999998 99999999999999975   55 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH-HHHHHhCCCCHHHHhh
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~  265 (376)
                      +............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........ .+....          
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~----------  267 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE----------  267 (349)
T ss_dssp             --------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC----------
T ss_pred             cccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC----------
Confidence            876554444566789999999999654 58999999999999999999999998776655333 332210          


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                             ...+        ......++.++++||++||+.||.+|||+.++++||||++.
T Consensus       268 -------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          268 -------YYFI--------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             -------CCCC--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             -------CccC--------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                   0000        00113578999999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1e-49  Score=371.52  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=206.4

Q ss_pred             ceEE--eeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIA--EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|.+  .+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++...     ..++
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~  162 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIV  162 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEE
Confidence            4555  67899999999999999999999999998653    23456899999999999999999988442     3488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE--cCCCCCeEEEecCCcc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--NPHTHQLKLCDFGSAK  187 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill--~~~~~~vkl~Dfg~a~  187 (376)
                      +||||+++ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||+  +.++ .+||+|||+++
T Consensus       163 lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~  237 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLAR  237 (373)
T ss_dssp             EEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCE
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCce
Confidence            99999975 77665543   23468999999999999999999998 999999999999999  4455 79999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........       
T Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------  309 (373)
T 2x4f_A          238 RYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-------  309 (373)
T ss_dssp             ECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-------
T ss_pred             ecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-------
Confidence            7765555556678999999999854 45899999999999999999999999998888777777653211110       


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                        .....+++++++||.+||+.||.+|||+.++++||||++.+
T Consensus       310 ------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 ------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             ------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             ------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                              01135799999999999999999999999999999998753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.5e-49  Score=369.99  Aligned_cols=283  Identities=27%  Similarity=0.387  Sum_probs=220.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCC--------CCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD--------HPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~~~~~~~~~~~  103 (376)
                      .++|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++        |+||+++++++.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            368999999999999999999999999999999987543   33457999999885        788999999885432 


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CccccCCCCCcEEEcCCC-------
Q 017131          104 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT-------  175 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~iiH~Dlkp~Nill~~~~-------  175 (376)
                      .....+++||||+++++.+.+...  ..+.+++..++.++.||+.||+|||+ + ||+||||||+|||++.++       
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhh
Confidence            234568899999999887766542  22569999999999999999999998 8 999999999999998764       


Q ss_pred             -----------------------------------------CCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCC
Q 017131          176 -----------------------------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGAT  214 (376)
Q Consensus       176 -----------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~  214 (376)
                                                               ..+||+|||+++....  ......+|+.|+|||++.+. 
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-  268 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGS-  268 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTS-
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCC-
Confidence                                                     2699999999976533  24456789999999999765 


Q ss_pred             CCCCchhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHHHHHhCCCCHHHHhhcCcCcccc-------cCCCcccc
Q 017131          215 EYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPH  281 (376)
Q Consensus       215 ~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~  281 (376)
                      .++.++|||||||++|+|++|..||.+.+      ..+.+..+...++.++...+.........+       ........
T Consensus       269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (397)
T 1wak_A          269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW  348 (397)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred             CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence            48999999999999999999999998755      456677888888888876654322110000       00000000


Q ss_pred             cccc------ccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          282 PWHK------VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       282 ~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      ....      .++...++++++||.+||+.||.+|||+.++|+||||++
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0000      011234567899999999999999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.6e-49  Score=366.72  Aligned_cols=281  Identities=32%  Similarity=0.559  Sum_probs=217.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHhCC-CC-----CeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLD-HP-----NIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~  105 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.....   ...+|+.+++.++ |+     +|+++++++...    
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~----  128 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR----  128 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC----
Confidence            4589999999999999999999999999999999875432   3346888888875 44     488888887543    


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCcEEEcC--CCCCeEEEe
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIGICHRDIKPQNLLVNP--HTHQLKLCD  182 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~iiH~Dlkp~Nill~~--~~~~vkl~D  182 (376)
                       ..+++||||++++|.+++....  ...+++..++.++.|++.||.|||+ ..||+||||||+|||++.  ++ .+||+|
T Consensus       129 -~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D  204 (382)
T 2vx3_A          129 -NHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD  204 (382)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred             -CceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence             3488999999999988887532  2469999999999999999999993 179999999999999953  45 799999


Q ss_pred             cCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          183 FGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       183 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ||+++...  .......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus       205 FG~a~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLG--QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETT--CCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceecc--cccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99997653  334456789999999999664 489999999999999999999999999999999999999999888776


Q ss_pred             HhhcCcCcccc-cCCC-----------------cccccccccccc-----------------CCChhHHHHHHHhhccCC
Q 017131          263 IKCMNPNYTEF-KFPQ-----------------IKPHPWHKVFQK-----------------RLPPEAVDLVCRFFQYSP  307 (376)
Q Consensus       263 ~~~~~~~~~~~-~~~~-----------------~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~dp  307 (376)
                      +.........+ .++.                 .....+...+..                 ..++++++||++||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            54321100000 0000                 000000000000                 001478999999999999


Q ss_pred             CCCCCHHHHhcCCcccccC
Q 017131          308 NLRCTALEACVHPFFDELR  326 (376)
Q Consensus       308 ~~R~s~~~ll~hp~f~~~~  326 (376)
                      ++|||+.|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.4e-49  Score=373.78  Aligned_cols=256  Identities=30%  Similarity=0.444  Sum_probs=198.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.+..            ....+|+.+|+.++||||+++++++..  
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence            468999999999999999999999999999999986532            235689999999999999999998621  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLK  179 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vk  179 (376)
                         . ..++||||+.+ +|.+.+    .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.  .+|
T Consensus       212 ---~-~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          212 ---E-DYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             ---S-EEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             ---C-ceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence               1 16799999975 654333    234679999999999999999999998 99999999999999975441  599


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |+|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+...+.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987765555566788999999999853  345788999999999999999999999876554444333331111


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ...                        ......+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       363 ~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NFI------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CCC------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CCC------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            100                        00113579999999999999999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-48  Score=353.47  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=211.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----N   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----C
Confidence            4468999999999999999999999999999999986532       234579999999999999999998843     2


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ...++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~  161 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGL  161 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccC
Confidence            34889999998 477665543    4579999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          186 AKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       186 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +...... .......+|+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+...          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------  230 (294)
T 2rku_A          162 ATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------  230 (294)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred             ceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------
Confidence            9765432 23344568999999999965 45899999999999999999999999887765554443321          


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                             ...            ++..+++.+.+||.+||+.||.+|||+.++++||||++...+.
T Consensus       231 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          231 -------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             -------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             -------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence                   111            1245789999999999999999999999999999998765444

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.5e-49  Score=371.35  Aligned_cols=260  Identities=27%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             cccceEEe-eeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHH-HhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           34 QKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        34 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..++|.+. +.||+|+||+||+|.+..+|+.||||++.. .....+|+.++ +..+||||+++++++.... .+..++|+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            34568777 799999999999999999999999999864 34456888887 4558999999999885422 23456889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC---CCCCeEEEecCCcc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAK  187 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~---~~~~vkl~Dfg~a~  187 (376)
                      ||||+++ +|.+++...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.   ++ .+||+|||+++
T Consensus       137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~  212 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  212 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEeccccc
Confidence            9999975 887777642  12469999999999999999999998 99999999999999997   55 79999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHHHHHhCCCCHHHH
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEI  263 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~  263 (376)
                      ...........++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...    ....+...         
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------  282 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------  282 (400)
T ss_dssp             ECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT---------
T ss_pred             ccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC---------
Confidence            7655555566788999999999854 458999999999999999999999998765432    22222211         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                              .+.++.   .     ....+++++++||++||+.||.+|||+.++++||||.+.
T Consensus       283 --------~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          283 --------QYEFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             --------CCCCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --------cccCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                    111111   0     013579999999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-49  Score=366.67  Aligned_cols=263  Identities=30%  Similarity=0.456  Sum_probs=209.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....         ....+|+.+++.++||||+++++++.+     
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-----   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-----
Confidence            468999999999999999999999999999999985431         335579999999999999999999843     


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhh------------------------------------cCCCcHHHHHHHHHHHHH
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRI------------------------------------HQRMPLIYVKLYTYQICR  148 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~  148 (376)
                      ....++||||++ ++|.+.+..+...                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            334889999996 4776665321100                                    112467889999999999


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEcCCCC-CeEEEecCCcccccCCC-----CCceeeeeccccchhhhcCC-CCCCCchh
Q 017131          149 ALAYIHNCIGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNVSYICSRYYRAPELIFGA-TEYTTAID  221 (376)
Q Consensus       149 al~~LH~~~~iiH~Dlkp~Nill~~~~~-~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~D  221 (376)
                      ||+|||+ +||+||||||+||+++.++. .+||+|||+++......     ......+|+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999998 99999999999999986652 69999999997653321     12455789999999999642 56899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHH
Q 017131          222 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  301 (376)
Q Consensus       222 iwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  301 (376)
                      ||||||++|+|++|..||.+.+..+....+.........                         .....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHH
Confidence            999999999999999999998877777766652111100                         0013478999999999


Q ss_pred             hhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          302 FFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       302 ~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ||+.||.+|||+.++++||||+++.+.
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.6e-49  Score=360.20  Aligned_cols=258  Identities=25%  Similarity=0.427  Sum_probs=186.0

Q ss_pred             cceEEe---eeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAE---HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .+|.+.   +.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+++.+. ||||+++++++.+     ....|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCEEE
Confidence            467776   78999999999999999999999999987543 44568999999997 9999999999843     33478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecCCcc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAK  187 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg~a~  187 (376)
                      +||||+++ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999975 88776654    4679999999999999999999998 99999999999999976542  69999999997


Q ss_pred             cccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHhCCCCHHHH
Q 017131          188 VLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEI  263 (376)
Q Consensus       188 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~  263 (376)
                      ..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....   ...+...+...     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----  231 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----  231 (325)
T ss_dssp             ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----
Confidence            65433 22345677999999999965 4589999999999999999999999987543211   11111111000     


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                              .+.++        ......+++++++||.+||+.||.+|||+.++++||||++.
T Consensus       232 --------~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          232 --------DFSFE--------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             --------CCCCC--------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             --------CCCCC--------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                    00000        00113579999999999999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=362.84  Aligned_cols=245  Identities=24%  Similarity=0.384  Sum_probs=206.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++..  
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--  100 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--  100 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence            458999999999999999999999999999999986532            234579999999999999999998843  


Q ss_pred             CCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          103 DKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                         ...+++||||+.+  ++...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||
T Consensus       101 ---~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL  171 (335)
T 3dls_A          101 ---QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKL  171 (335)
T ss_dssp             ---SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEE
T ss_pred             ---CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEE
Confidence               3348899998864  66665543    4579999999999999999999998 9999999999999999988 7999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +|||+++............||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence            99999987766666667789999999999977665588999999999999999999999652210      00       


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                ...            ..+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       239 ----------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 ----------AAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ----------TCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ----------hcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                      000            0113479999999999999999999999999999999763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.8e-49  Score=351.89  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=210.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----------cccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...          .....+|+.+++.++||||+++++++...   
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK---   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC---
Confidence            35799999999999999999999999999999998643          23356899999999999999999988532   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC---CeEE
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  180 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~vkl  180 (376)
                        ...++||||++ ++|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.   .+||
T Consensus        81 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           81 --TDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             --CeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEE
Confidence              34789999996 588777754    3579999999999999999999998 99999999999999987652   5999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +|||++.............+|+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.........
T Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T 3bhy_A          154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE  232 (283)
T ss_dssp             CCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred             EecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence            99999987655555556678999999999854 45899999999999999999999999988766665554432111111


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                                               .....+++.+.+||.+||..||.+|||+.++++||||+.++..
T Consensus       233 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          233 -------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             -------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                                     1113578999999999999999999999999999999987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-48  Score=355.40  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=210.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ....|...+.||+|+||+||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++....     ..
T Consensus        43 ~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~  117 (321)
T 2c30_A           43 PRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-----EL  117 (321)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             chhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EE
Confidence            3446999999999999999999999999999999986432    23458999999999999999999885533     38


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++ +|.+++.     ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++..
T Consensus       118 ~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~  190 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQ  190 (321)
T ss_dssp             EEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeee
Confidence            899999975 7766553     2569999999999999999999998 9999999999999999988 799999999876


Q ss_pred             ccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ..... ......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.... .+.        
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~--------  260 (321)
T 2c30_A          191 ISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPK--------  260 (321)
T ss_dssp             CCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCC--------
T ss_pred             cccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC--------
Confidence            54432 2345678999999999965 458999999999999999999999998877666555444310 000        


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                             .          .....+++++.+||.+||+.||.+|||+.++++||||....
T Consensus       261 -------~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          261 -------L----------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -------C----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -------c----------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                   0          00135789999999999999999999999999999998643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.6e-48  Score=358.83  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=213.5

Q ss_pred             CccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .....+|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++.+    
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  112 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----  112 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            345578999999999999999999999999999999986532       234579999999999999999998843    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       ...+++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+||
T Consensus       113 -~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Df  185 (335)
T 2owb_A          113 -NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDF  185 (335)
T ss_dssp             -SSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCC
T ss_pred             -CCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeec
Confidence             2348899999984 77666543    3679999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          184 GSAKVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       184 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      |++...... .......+|+.|+|||++.+. .++.++|+|||||++|+|++|..||.+....+....+...        
T Consensus       186 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------  256 (335)
T 2owb_A          186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------  256 (335)
T ss_dssp             TTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------
T ss_pred             cCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--------
Confidence            999765432 233445689999999999654 4899999999999999999999999887765555444331        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                               .+.            ++..+++++.+||.+||+.||.+|||+.++++||||+....+
T Consensus       257 ---------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          257 ---------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ---------CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                     111            123578999999999999999999999999999999875543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-48  Score=351.44  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=213.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------------ccHHHHHHHHHhCC-CCCeeeccceeee
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFS  100 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~  100 (376)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....             ....+|+.+++.+. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            457999999999999999999999999999999986432             22347999999995 9999999998843


Q ss_pred             cCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeE
Q 017131          101 TTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLK  179 (376)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vk  179 (376)
                           ....++||||++ ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+|
T Consensus        96 -----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~k  164 (298)
T 1phk_A           96 -----NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIK  164 (298)
T ss_dssp             -----SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEE
T ss_pred             -----CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cEE
Confidence                 345889999998 488777754    3579999999999999999999998 9999999999999999988 799


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  254 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  254 (376)
                      |+|||++.............+|+.|+|||++.     ....++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999998766555556667899999999985     2345789999999999999999999999887766665555442


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      ..                 ..+.   .     ....++.++.+||.+||+.||.+|||+.++++||||++...
T Consensus       245 ~~-----------------~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          245 NY-----------------QFGS---P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             CC-----------------CCCT---T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             Cc-----------------ccCc---c-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            11                 1000   0     01357899999999999999999999999999999998654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-48  Score=358.75  Aligned_cols=257  Identities=24%  Similarity=0.370  Sum_probs=200.2

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC------
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD------  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  103 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            468999999999999999999999999999999986432     335589999999999999999998865432      


Q ss_pred             ----------------------------------------------CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcH
Q 017131          104 ----------------------------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPL  136 (376)
Q Consensus       104 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~  136 (376)
                                                                    ....++++||||+++ +|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                          223458899999986 77777764322 234566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCC-------------CCceeeeecc
Q 017131          137 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNVSYICSRY  203 (376)
Q Consensus       137 ~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~t~~  203 (376)
                      ..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7789999999999999998 9999999999999999888 89999999998764432             2234568999


Q ss_pred             ccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcccccc
Q 017131          204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  283 (376)
Q Consensus       204 y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (376)
                      |+|||++.+. .++.++|+|||||++|+|++|..|+..     ....+..........                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc----------------------
Confidence            9999999654 589999999999999999998766421     111111111100000                      


Q ss_pred             ccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          284 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       284 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                         .....++++.+||.+||+.||.+|||+.++++||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               002357889999999999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-48  Score=350.18  Aligned_cols=250  Identities=30%  Similarity=0.481  Sum_probs=207.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++...     .
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----T   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----C
Confidence            46899999999999999999999999999999998543       23355799999999999999999988432     3


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..++||||+++ ++.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .++|+|||++
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~  156 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWS  156 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCCEE
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEecccc
Confidence            48899999985 77666654    3569999999999999999999998 9999999999999999988 7999999998


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ..... .......+|+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+...            
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------  222 (279)
T 3fdn_A          157 VHAPS-SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------  222 (279)
T ss_dssp             SCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------------
T ss_pred             ccCCc-ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC------------
Confidence            65432 23345678999999999965 45899999999999999999999999987766666555431            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                           ...            ++..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       223 -----~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          223 -----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             -----CCC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                 111            1235789999999999999999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-48  Score=355.50  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=198.9

Q ss_pred             cccceEEe-eeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      -.++|++. +.||+|+||+||+|.+..+++.||||++....    ....+|+.+++++ +||||+++++++...     .
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~   84 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----D   84 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----C
Confidence            34579995 78999999999999999999999999986542    3355899999884 799999999998543     3


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecC
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFG  184 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg  184 (376)
                      .+++||||++ ++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++.  .+||+|||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            4889999997 588777754    3579999999999999999999998 99999999999999997762  39999999


Q ss_pred             CcccccCCC--------CCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH------
Q 017131          185 SAKVLVKGE--------PNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD------  246 (376)
Q Consensus       185 ~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------  246 (376)
                      ++.......        ......+|+.|+|||++.+    ...++.++|||||||++|+|++|..||.+....+      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            987543211        1223458999999999853    1347899999999999999999999998764321      


Q ss_pred             ---------HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          247 ---------QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       247 ---------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                               ....+...                 .+.++.        .....+++++++||++||+.||.+|||+.+++
T Consensus       240 ~~~~~~~~~~~~~i~~~-----------------~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          240 EACPACQNMLFESIQEG-----------------KYEFPD--------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             -CCHHHHHHHHHHHHHC-----------------CCCCCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ccchhHHHHHHHHHhcc-----------------CcccCc--------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                     11122111                 011110        00135789999999999999999999999999


Q ss_pred             cCCcccccC
Q 017131          318 VHPFFDELR  326 (376)
Q Consensus       318 ~hp~f~~~~  326 (376)
                      +||||++..
T Consensus       295 ~hp~~~~~~  303 (316)
T 2ac3_A          295 QHPWVQGCA  303 (316)
T ss_dssp             HSTTCC---
T ss_pred             cChhhcCCC
Confidence            999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.5e-48  Score=349.20  Aligned_cols=252  Identities=28%  Similarity=0.418  Sum_probs=202.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||+++++++...    
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   83 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP----   83 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS----
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC----
Confidence            34568999999999999999999999999999999986432       2345899999999999999999988442    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                       ...++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        84 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg  156 (276)
T 2h6d_A           84 -TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFG  156 (276)
T ss_dssp             -SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             -CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeecc
Confidence             348899999974 88777754    3569999999999999999999998 8999999999999999988 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ++.............+|+.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.......+...          
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------  226 (276)
T 2h6d_A          157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG----------  226 (276)
T ss_dssp             GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC----------
Confidence            9987655544455678999999999976554578999999999999999999999887655554444331          


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                             ...            ++..++.++.+||.+||+.||.+|||+.++++||||++
T Consensus       227 -------~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          227 -------VFY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             -------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -------ccc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                   001            12357899999999999999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-48  Score=358.43  Aligned_cols=259  Identities=24%  Similarity=0.330  Sum_probs=208.1

Q ss_pred             cceEEe-eeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ++|.+. +.||+|+||+||+|.+..+++.||+|++....      ....+|+.+++.+ .||||+++++++..     ..
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-----~~  102 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-----TS  102 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-----CC
Confidence            578888 89999999999999999999999999986432      3445799999999 46999999998843     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC---CCCCeEEEec
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDF  183 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~---~~~~vkl~Df  183 (376)
                      .+++||||+.+ +|.+++..  .....+++..++.++.||+.||+|||+ +||+||||||+||+++.   ++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence            48899999986 66444421  123569999999999999999999998 99999999999999987   56 7999999


Q ss_pred             CCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          184 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       184 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      |+++............+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.........   
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  254 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---  254 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             ccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---
Confidence            99987755555556678999999999965 45899999999999999999999999998877776666553211111   


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                                            .....+++.+.+||.+||+.||.+|||++++++||||+++.+..
T Consensus       255 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          255 ----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             ----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                                  01135789999999999999999999999999999999876554

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.3e-48  Score=346.90  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=208.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ....|++.+.||+|+||+||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.... ....
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~  102 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK  102 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCc
Confidence            3447999999999999999999999999999999986432      23457999999999999999999876543 3355


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEc-CCCCCeEEEec
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVN-PHTHQLKLCDF  183 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~-~~~~~vkl~Df  183 (376)
                      ++++||||+++ +|.+++..    ...+++..++.++.||+.||+|||+ +|  |+||||||+||+++ .++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~-~~kl~Df  176 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDL  176 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCT
T ss_pred             eEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCC-CEEEeeC
Confidence            68899999975 88777754    3679999999999999999999998 89  99999999999998 566 8999999


Q ss_pred             CCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          184 GSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       184 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      |++.... ........+|+.|+|||++.+  .++.++|+|||||++|+|++|..||.+................+     
T Consensus       177 g~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----  248 (290)
T 1t4h_A          177 GLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-----  248 (290)
T ss_dssp             TGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----
T ss_pred             CCccccc-ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-----
Confidence            9996543 333445678999999998853  48999999999999999999999998866655544433211000     


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                           ..++...++++.+||.+||+.||.+|||+.++++||||++
T Consensus       249 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 ---------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                 1122456889999999999999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.4e-50  Score=376.86  Aligned_cols=254  Identities=18%  Similarity=0.256  Sum_probs=195.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHH---HHHhCCCCCeeeccceee-----
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQ---IMQMLDHPNIVALKHCFF-----   99 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~---~l~~l~h~~iv~~~~~~~-----   99 (376)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++....       ....+|+.   +++.++||||+++++.+.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999999999999999986321       33457984   455558999999984332     


Q ss_pred             --ecC---------CCCce---EEEEEEecccccHHHHHHHhhhhcC---CCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 017131          100 --STT---------DKEEL---YLNLVLEYVPETVNRIARNYSRIHQ---RMPLIYVKLYTYQICRALAYIHNCIGICHR  162 (376)
Q Consensus       100 --~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~~~iiH~  162 (376)
                        ...         +....   ..|++|||++|+|.+++........   .+++..++.++.||+.||+|||+ +||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence              211         11111   2789999999999988876433211   24458888899999999999998 999999


Q ss_pred             CCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCC----------CCCCCchhHHHHHHHHHHH
Q 017131          163 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAEL  232 (376)
Q Consensus       163 Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el  232 (376)
                      ||||+|||++.++ .+||+|||+++..  +.......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999988 8999999999753  223344566 999999999654          2589999999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC
Q 017131          233 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT  312 (376)
Q Consensus       233 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s  312 (376)
                      ++|+.||.+.+.......+..                                 ....+++++.+||.+||+.||.+|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFR---------------------------------SCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGGS---------------------------------SCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhhh---------------------------------hccCCCHHHHHHHHHHcCCCchhCCC
Confidence            999999976542221111000                                 01368999999999999999999999


Q ss_pred             HHHHhcCCcccccC
Q 017131          313 ALEACVHPFFDELR  326 (376)
Q Consensus       313 ~~~ll~hp~f~~~~  326 (376)
                      +.++++||||++++
T Consensus       354 ~~e~l~hp~f~~~~  367 (377)
T 3byv_A          354 PLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHTSHHHHHHH
T ss_pred             HHHHhhChHHHHHH
Confidence            99999999998764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.1e-48  Score=360.05  Aligned_cols=288  Identities=30%  Similarity=0.471  Sum_probs=220.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCC-----------CCCeeecccee
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCF   98 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~   98 (376)
                      ....+|++.+.||+|+||+||+|.+..+++.||||++..+.   ....+|+.+++.++           ||||+++++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            34568999999999999999999999999999999987543   33457999998876           89999999988


Q ss_pred             eecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CccccCCCCCcEEEcCCC--
Q 017131           99 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHT--  175 (376)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~iiH~Dlkp~Nill~~~~--  175 (376)
                      .... ....+++++||+++++|.+++....  ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++  
T Consensus        96 ~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETT
T ss_pred             hccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCC
Confidence            6543 2344688999999889988887532  3469999999999999999999998 8 999999999999995322  


Q ss_pred             ---CCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------chH
Q 017131          176 ---HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVD  246 (376)
Q Consensus       176 ---~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~  246 (376)
                         ..+||+|||+++....  ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+      ..+
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence               1699999999976533  23445789999999999764 48999999999999999999999998654      456


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccc-------cCCCccccccc------cccccCCChhHHHHHHHhhccCCCCCCCH
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWH------KVFQKRLPPEAVDLVCRFFQYSPNLRCTA  313 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~R~s~  313 (376)
                      .+..+...++.++...+.........+       ........+..      ..++..+++++.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            677888888888776554321110000       00000000000      01223456789999999999999999999


Q ss_pred             HHHhcCCcccccCC
Q 017131          314 LEACVHPFFDELRD  327 (376)
Q Consensus       314 ~~ll~hp~f~~~~~  327 (376)
                      .++++||||++...
T Consensus       329 ~ell~hp~f~~~~~  342 (373)
T 1q8y_A          329 GGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHTCGGGTTCTT
T ss_pred             HHHhhChhhhcccC
Confidence            99999999998543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=352.03  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=210.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....        ....+|+.+++.++||||+++++++...   ...
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EKQ   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCC
Confidence            57999999999999999999999999999999986432        3456899999999999999999987542   223


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      ..++||||+++++.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++.
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence            478999999998777666532  4579999999999999999999998 9999999999999999888 89999999997


Q ss_pred             cccCCC---CCceeeeeccccchhhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          188 VLVKGE---PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       188 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ......   ......+|+.|+|||++.+.. .++.++|+|||||++|+|++|..||.+.+..+....+.+.         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---------  228 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG---------  228 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---------
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC---------
Confidence            653221   123446799999999986533 2477999999999999999999999887765555444331         


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                              ...            ++..+++++.+||.+||..||.+|||+.++++||||++...+
T Consensus       229 --------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          229 --------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             --------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             --------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence                    011            124578999999999999999999999999999999986543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.7e-49  Score=365.29  Aligned_cols=266  Identities=16%  Similarity=0.145  Sum_probs=189.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-------cHHHHHHHHHhC--CCCCeeeccceee------
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML--DHPNIVALKHCFF------   99 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l--~h~~iv~~~~~~~------   99 (376)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++.....       ...+|+.+++.+  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3469999999999999999999999999999999976432       234575444444  6999888654332      


Q ss_pred             -ecCC--------C----CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHH------HHHHHHHHHHHHHHHhcCCcc
Q 017131          100 -STTD--------K----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV------KLYTYQICRALAYIHNCIGIC  160 (376)
Q Consensus       100 -~~~~--------~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~ii  160 (376)
                       ....        .    ....+|+||||++++|.+++.....   .+++...      ..++.||+.||+|||+ +||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence             1111        0    1144789999999999988876532   3444444      5677999999999998 9999


Q ss_pred             ccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 017131          161 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLF  239 (376)
Q Consensus       161 H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf  239 (376)
                      ||||||+|||++.++ .+||+|||+|+...  .......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999998 79999999998653  22224566799999999954 145899999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          240 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .+......                    ..+............+.......+++++.+||.+||+.||++|||+.++++|
T Consensus       294 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            87642210                    0000000000001111111124689999999999999999999999999999


Q ss_pred             CcccccCC
Q 017131          320 PFFDELRD  327 (376)
Q Consensus       320 p~f~~~~~  327 (376)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.3e-48  Score=354.12  Aligned_cols=281  Identities=26%  Similarity=0.475  Sum_probs=219.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEE-CCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCC------CeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKC-RETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~  104 (376)
                      .++|++.+.||+|+||+||+|.+ ..+++.||||++....   ....+|+.+++.++|+      +++++++++...   
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~---   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH---   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET---
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC---
Confidence            35799999999999999999998 5688999999986543   3345799999888665      488888887443   


Q ss_pred             CceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC-----------
Q 017131          105 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-----------  173 (376)
Q Consensus       105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~-----------  173 (376)
                        ..+++||||+++++.+.+....  ...+++..++.++.||+.||+|||+ +||+||||||+|||++.           
T Consensus        90 --~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           90 --GHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             --TEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             --CcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCcc
Confidence              3488999999989988776522  2368999999999999999999998 99999999999999987           


Q ss_pred             --------CCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch
Q 017131          174 --------HTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV  245 (376)
Q Consensus       174 --------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  245 (376)
                              ++ .+||+|||+++...  .......+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..
T Consensus       165 ~~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINP-DIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCC-CEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCC-CceEeeCcccccCc--cccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    44 69999999997643  23345678999999999965 45899999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcc----cccCCCcc---------ccccc--cccccCCChhHHHHHHHhhccCCCCC
Q 017131          246 DQLVEIIKVLGTPTREEIKCMNPNYT----EFKFPQIK---------PHPWH--KVFQKRLPPEAVDLVCRFFQYSPNLR  310 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R  310 (376)
                      +....+....+..+...+........    ...+....         ..++.  .......++++.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            88888888888777765543321100    00000000         00000  00111235789999999999999999


Q ss_pred             CCHHHHhcCCcccccCC
Q 017131          311 CTALEACVHPFFDELRD  327 (376)
Q Consensus       311 ~s~~~ll~hp~f~~~~~  327 (376)
                      ||+.++++||||+.++.
T Consensus       321 pt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          321 ITLREALKHPFFDLLKK  337 (339)
T ss_dssp             CCHHHHTTSGGGGGGGC
T ss_pred             cCHHHHhcCHHHHHHhc
Confidence            99999999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=347.89  Aligned_cols=251  Identities=28%  Similarity=0.457  Sum_probs=185.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence            357999999999999999999999999999999986432       345689999999999999999998843     33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..++||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~  159 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLA  159 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence            48899999975 77666653   23569999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ...... .......+|+.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+....+..            
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            765422 22334578999999999865 4589999999999999999999999987654333221110            


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                           ..+            .++..++.++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       227 -----~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          227 -----ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             -----SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             -----ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                 001            1124578999999999999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.3e-48  Score=347.95  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=203.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  106 (376)
                      -..+|++.+.||+|+||+||+|.+..+++.||||++....      ....+|+..+..+ +||||+++++++....    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~----   84 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD----   84 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----
Confidence            3468999999999999999999999999999999986432      2344788888888 9999999999885432    


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC----------
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT----------  175 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~----------  175 (376)
                       ..++||||+++ +|.+++.........+++..++.++.||+.||+|||+ +||+||||||+||+++.++          
T Consensus        85 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           85 -HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             -EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------
T ss_pred             -eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence             48899999975 9999888766656789999999999999999999998 9999999999999998432          


Q ss_pred             --------CCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH
Q 017131          176 --------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  247 (376)
Q Consensus       176 --------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  247 (376)
                              ..+||+|||.+......   ....+|+.|+|||++.+...++.++|||||||++|+|++|.+++...+.   
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                    26999999999765432   2345899999999997665677899999999999999999987754432   


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       248 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ...+...                   ..+         .++..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       237 ~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIRQG-------------------RLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHTT-------------------CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHcC-------------------CCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            2222110                   001         1224689999999999999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.1e-48  Score=349.02  Aligned_cols=254  Identities=28%  Similarity=0.442  Sum_probs=209.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      -.++|++.+.||+|+||+||+|++..+|+.||+|++....    ....+|+.+++.++||||+++++++..     ....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEE
Confidence            3468999999999999999999999999999999986532    335689999999999999999998843     2348


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE---cCCCCCeEEEecCC
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGS  185 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill---~~~~~~vkl~Dfg~  185 (376)
                      ++||||+++ +|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+||++   +.++ .+||+|||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~  155 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGL  155 (304)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCST
T ss_pred             EEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCc
Confidence            899999974 87766654    3579999999999999999999998 999999999999999   5566 799999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +..... .......+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+.....         
T Consensus       156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------  224 (304)
T 2jam_A          156 SKMEQN-GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY---------  224 (304)
T ss_dssp             TCCCCC-BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC---------
T ss_pred             ceecCC-CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            875432 23344568999999999865 4589999999999999999999999988876666655544210         


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                              .++        ..+...+++++.+||.+||..||.+|||+.++++||||++.
T Consensus       225 --------~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          225 --------EFE--------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             --------CCC--------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             --------CCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                    000        01124579999999999999999999999999999999863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-47  Score=344.83  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=210.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...       .....+|+.+++.++||||+++++++..     .
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   86 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----R   86 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----C
Confidence            346899999999999999999999999999999998543       1345689999999999999999998843     2


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ...++||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~  160 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFGW  160 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEecccc
Confidence            347899999975 88777654    3579999999999999999999998 9999999999999999888 799999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +..... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+...           
T Consensus       161 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----------  227 (284)
T 2vgo_A          161 SVHAPS-LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------  227 (284)
T ss_dssp             CEECSS-SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred             cccCcc-cccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------
Confidence            865533 22345578999999999965 45899999999999999999999999887766555444331           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                            ...            ++..++.++++||.+||+.||.+|||+.++++||||+...
T Consensus       228 ------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          228 ------DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ------ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                  111            1245789999999999999999999999999999998743

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-49  Score=358.52  Aligned_cols=276  Identities=21%  Similarity=0.320  Sum_probs=208.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++....   ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence            457999999999999999999999999999999986432     33458999999999999999999875432   2347


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE----cCCCCCeEEEecC
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG  184 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill----~~~~~~vkl~Dfg  184 (376)
                      ++||||++ ++|.+++..... ...+++..++.++.||+.||+|||+ +||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999997 588877765322 2349999999999999999999998 999999999999998    6665 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHHH
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFG-------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIK  253 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~  253 (376)
                      +++............+|+.|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+.++..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9987766665566778999999999852       34589999999999999999999999975443    233333333


Q ss_pred             HhCCCCHHHHhhcC-cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          254 VLGTPTREEIKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       254 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                      .  .| ...+.... .....+.+..  ..+....+...++..+.+||++||+.||++|||++|+|+||-
T Consensus       242 ~--~p-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          242 G--KP-SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             H--CC-TTCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             C--CC-cccchhhhcccCCccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            2  11 11110000 0000000000  000011122345678999999999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4e-48  Score=354.24  Aligned_cols=256  Identities=30%  Similarity=0.460  Sum_probs=205.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            457999999999999999999999999999999885432            235689999999999999999998732  


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLK  179 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vk  179 (376)
                        ..  .++||||+.+ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++.  .+|
T Consensus        87 --~~--~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 --ED--YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             --SS--EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred             --Cc--eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence              11  6799999975 7765553    24679999999999999999999998 99999999999999987652  499


Q ss_pred             EEecCCcccccCCCCCceeeeeccccchhhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          180 LCDFGSAKVLVKGEPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |+|||+++............+|+.|+|||++.  +...++.++|+|||||++|+|++|..||.+......+...+.....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998664433334456899999999974  3456899999999999999999999999876554333333322111


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      ...                        ......+++++.+||.+||..||.+|||+.++++||||++.
T Consensus       238 ~~~------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 NFI------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CCC------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             ccC------------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            100                        00113578999999999999999999999999999999764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.2e-48  Score=344.59  Aligned_cols=253  Identities=26%  Similarity=0.334  Sum_probs=205.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++...     ...+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEEE
Confidence            57999999999999999999999999999999986432     3456899999999999999999988543     3478


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ +|.+.+.    ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~  155 (276)
T 2yex_A           82 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  155 (276)
T ss_dssp             EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence            99999985 6654442    34569999999999999999999998 9999999999999999988 7999999998755


Q ss_pred             cCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....   ......+|+.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.............          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------  225 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC----------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc----------
Confidence            3221   233456799999999997655457899999999999999999999987665433222211100          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                            ...+          ....+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus       226 ------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          226 ------TYLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             ------TTST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ------cccC----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence                  0000          013578999999999999999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.1e-48  Score=353.30  Aligned_cols=260  Identities=25%  Similarity=0.351  Sum_probs=208.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++..... ...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence            457999999999999999999999999999999986532       134579999999999999999998865432 233


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..|+||||++ ++|.+++..    .+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence            4689999996 588777754    3579999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          187 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       187 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      +.......    .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......+... 
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  241 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-  241 (311)
T ss_dssp             ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH-
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc-
Confidence            76543221    2335689999999999654 58999999999999999999999999888776666555421111110 


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                                              ....+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus       242 ------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          242 ------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                    11358999999999999999999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9e-48  Score=354.96  Aligned_cols=252  Identities=25%  Similarity=0.349  Sum_probs=198.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCC--CCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+|++.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+++.++|  |||+++++++..     .
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----C
Confidence            45799999999999999999998 468999999986432      234579999999987  999999998843     3


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .++++|||+.+++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++ ++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a  154 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIA  154 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSS
T ss_pred             CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeecccc
Confidence            35889999888898887764    4679999999999999999999998 9999999999999998 45 7999999999


Q ss_pred             ccccCCCC---CceeeeeccccchhhhcC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHH
Q 017131          187 KVLVKGEP---NVSYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEII  252 (376)
Q Consensus       187 ~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~  252 (376)
                      +.......   .....||+.|+|||++.+          ...++.++|||||||++|+|++|..||.+.... ..+..+.
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  234 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  234 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence            76543322   234578999999999853          245899999999999999999999999865432 2222221


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      .   ..                        ....++...+.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       235 ~---~~------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          235 D---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             C---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             c---CC------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            1   00                        00112234678999999999999999999999999999998643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-47  Score=359.56  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=199.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCC--CCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+|++.+.||+|+||+||+|.+.. ++.||||++....      ....+|+.+|+.++  ||||+++++++...     
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----  128 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----  128 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence            3469999999999999999999865 8999999986432      23457999999996  59999999987542     


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..+|+|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++ .+||+|||++
T Consensus       129 ~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~-~~kl~DFG~a  201 (390)
T 2zmd_A          129 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIA  201 (390)
T ss_dssp             SEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SS-CEEECCCSSS
T ss_pred             CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CC-eEEEEecCcc
Confidence            24889999888888887764    3578999999999999999999998 9999999999999996 45 7999999999


Q ss_pred             ccccCCCC---CceeeeeccccchhhhcC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHH
Q 017131          187 KVLVKGEP---NVSYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEII  252 (376)
Q Consensus       187 ~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~  252 (376)
                      +.......   ....+||+.|+|||++.+          ...++.++|||||||++|+|++|.+||.+.... ..+..+.
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            86643321   234578999999999864          135899999999999999999999999875432 2222222


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      ..   .            ....            ++...+.++.+||.+||+.||.+|||+.++++||||+....
T Consensus       282 ~~---~------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 DP---N------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CT---T------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             Cc---c------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            10   0            0011            12345789999999999999999999999999999986543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-47  Score=354.53  Aligned_cols=280  Identities=26%  Similarity=0.437  Sum_probs=217.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCC-cEEEEEEeeccc---ccHHHHHHHHHhCCCCC------eeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK---RYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~  105 (376)
                      ++|++.+.||+|+||+||+|.+..++ +.||+|++....   ....+|+.+++.++|++      ++.+++++...    
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~----   94 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH----   94 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET----
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC----
Confidence            47999999999999999999998877 689999986532   33457999999987665      77777776432    


Q ss_pred             ceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE--------------
Q 017131          106 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--------------  171 (376)
Q Consensus       106 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill--------------  171 (376)
                       ...++||||+++++.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||+              
T Consensus        95 -~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           95 -GHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             -CeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence             348899999999887766542  22469999999999999999999998 999999999999999              


Q ss_pred             -----cCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH
Q 017131          172 -----NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  246 (376)
Q Consensus       172 -----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  246 (376)
                           +.++ .+||+|||+++...  .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus       171 ~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNT-SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCC-CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCC-cEEEeecCcccccc--ccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 4455 79999999997643  333456789999999999654 58999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCccc----ccCCCcc---------ccccc--cccccCCChhHHHHHHHhhccCCCCCC
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTE----FKFPQIK---------PHPWH--KVFQKRLPPEAVDLVCRFFQYSPNLRC  311 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~  311 (376)
                      .+..+.+..+.++...+.........    ..++...         ..++.  .......++++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            88888888888777655433211000    0000000         00000  000012346899999999999999999


Q ss_pred             CHHHHhcCCcccccCC
Q 017131          312 TALEACVHPFFDELRD  327 (376)
Q Consensus       312 s~~~ll~hp~f~~~~~  327 (376)
                      |+.++++||||+++.+
T Consensus       327 t~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CHHHHTTSGGGGGCCH
T ss_pred             CHHHHhcChhhcCCCh
Confidence            9999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.5e-48  Score=346.02  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=210.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..     ....
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   96 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSSF   96 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCeE
Confidence            57999999999999999999999999999999985432      335589999999999999999998843     2347


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecCCc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA  186 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg~a  186 (376)
                      ++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++.  .+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            899999974 77665543    3579999999999999999999998 99999999999999976432  6999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .............+|+.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+..+....+.......        
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  241 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--------  241 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred             eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            87655544455678999999999854  48999999999999999999999999887666555544311000        


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                             ..+          ....+++++.+||++||..||.+|||+.++++||||++..+
T Consensus       242 -------~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          242 -------DLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             -------CSG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             -------Cch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                   000          01357899999999999999999999999999999998653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-48  Score=359.95  Aligned_cols=258  Identities=28%  Similarity=0.438  Sum_probs=205.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc--------ccHHHHHHHHHhC-CCCCeeeccceeeec
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFST  101 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~  101 (376)
                      ...+|++.+.||+|+||+||+|++.   .+++.||||++.+..        ....+|+.+++.+ .||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3468999999999999999999984   589999999885421        2344799999999 699999999988543


Q ss_pred             CCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          102 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                           ..+++||||+++ +|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus       132 -----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl  200 (355)
T 1vzo_A          132 -----TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVL  200 (355)
T ss_dssp             -----TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEE
T ss_pred             -----ceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEEE
Confidence                 248899999975 88777754    3579999999999999999999998 9999999999999999988 7999


Q ss_pred             EecCCcccccCCC--CCceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017131          181 CDFGSAKVLVKGE--PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       181 ~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      +|||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+..... 
T Consensus       201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-  279 (355)
T 1vzo_A          201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-  279 (355)
T ss_dssp             SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-
T ss_pred             eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-
Confidence            9999997653222  22345789999999999652 3478999999999999999999999986543322222222110 


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                             ..     .            ..++..++..+++||.+||..||.+||     |+.++++||||+++.+
T Consensus       280 -------~~-----~------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          280 -------KS-----E------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             -------HC-----C------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -------cc-----C------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                   00     0            011246789999999999999999999     9999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=347.30  Aligned_cols=261  Identities=23%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc---cccHHHHHHHHHhC-CCCCeeeccceeeecCCC-CceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~  108 (376)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...   .....+|+.+++.+ +||||+++++++...... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            446799999999999999999999999999999998643   34456899999998 899999999998664321 1345


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +++||||+++ +|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCce
Confidence            8899999986 8888776532  3569999999999999999999998 9999999999999999888 79999999987


Q ss_pred             cccCC-CCCceeeeeccccchhhhcC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          188 VLVKG-EPNVSYICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       188 ~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ..... .......+|+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+.......+....       
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------  250 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-------  250 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------
Confidence            65332 22334568999999999852    3458899999999999999999999998877665554443310       


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                  .+        ......+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus       251 ------------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 ------------AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ------------CC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ------------cc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                        00        01124578999999999999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3e-47  Score=341.17  Aligned_cols=258  Identities=25%  Similarity=0.385  Sum_probs=212.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++...   ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence            4568999999999999999999999999999999986432      2345799999999999999999987543   233


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-----ccccCCCCCcEEEcCCCCCeEEE
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-----iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                      .+++||||+++ +|.+++.........+++..++.++.|++.||+|||+ +|     |+||||||+||+++.++ .+||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence            48899999975 9988888765555669999999999999999999998 88     99999999999999888 79999


Q ss_pred             ecCCcccccCCCC-CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          182 DFGSAKVLVKGEP-NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       182 Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |||+++....... .....+|+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+....     
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-----  232 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-----  232 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----
T ss_pred             cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-----
Confidence            9999876533221 1234678999999999654 58999999999999999999999998877655554444310     


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                    .+         .++..+++++.++|.+||+.||.+|||+.++++|||+.+-
T Consensus       233 --------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          233 --------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --------------cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                          00         1124578999999999999999999999999999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.4e-48  Score=357.53  Aligned_cols=283  Identities=24%  Similarity=0.388  Sum_probs=208.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++...     .
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~  104 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----G  104 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----T
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----C
Confidence            34568999999999999999999999999999999986542     2345799999999999999999988543     3


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..++||||+++ +|.+++..    ...+++..++.++.|++.||.|||+ + ||+||||||+||+++.++ .+||+|||+
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  178 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG-EIKLCDFGV  178 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTC-CEEECCCCC
T ss_pred             EEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCC-CEEEEECCC
Confidence            38899999975 88777754    3579999999999999999999997 6 999999999999999988 799999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC-CCHHHHh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT-PTREEIK  264 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~  264 (376)
                      +...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+...... .......
T Consensus       179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          179 SGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             CHHHHHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             Ccccccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            8654322 2345678999999999965 45899999999999999999999999887654433222111100 0000000


Q ss_pred             hc--CcCcccccCCCcc------------ccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          265 CM--NPNYTEFKFPQIK------------PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       265 ~~--~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      ..  ......+......            ...........++.++.+||++||+.||.+|||+.++++||||+.....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence            00  0000000000000            0000011113478899999999999999999999999999999986543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.8e-47  Score=343.79  Aligned_cols=258  Identities=26%  Similarity=0.427  Sum_probs=206.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++....     .
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----K   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----e
Confidence            34468999999999999999999999999999999885432    33457999999999999999999885433     3


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||||+++ ++..++..   ....+++..++.++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++.
T Consensus        91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  165 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSA  165 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCc
Confidence            7899999976 66665543   24679999999999999999999998 9999999999999999888 79999999875


Q ss_pred             cccC-CCCCceeeeeccccchhhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          188 VLVK-GEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       188 ~~~~-~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .... ........+|+.|+|||++.    ....++.++|+|||||++|+|++|..||...+.......+....  ++   
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---  240 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PP---  240 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC---
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Cc---
Confidence            3321 11223456899999999984    34558999999999999999999999999887666655544310  00   


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                    .       ...+..++.++.+||.+||..||.+|||+.++++||||+++.
T Consensus       241 --------------~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          241 --------------T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             --------------C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             --------------c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                          0       011245789999999999999999999999999999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.4e-48  Score=349.55  Aligned_cols=267  Identities=25%  Similarity=0.388  Sum_probs=193.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++.....     .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~   88 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE-----L   88 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC-----E
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC-----c
Confidence            45799999999999999999999999999999987543     2334579999999999999999998855433     7


Q ss_pred             EEEEeccc-ccHHHHHHHhhhh----cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          110 NLVLEYVP-ETVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ++||||++ ++|.+++......    ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg  166 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADFG  166 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEecc
Confidence            89999996 5888877654322    3459999999999999999999998 9999999999999999988 79999999


Q ss_pred             CcccccCCC------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          185 SAKVLVKGE------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       185 ~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      ++.......      ......+|+.|+|||++.+...++.++|+|||||++|+|++|..||.+.+...........  .+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~  244 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--DP  244 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--SC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--CC
Confidence            987553321      1234568999999999865455899999999999999999999999887766555433321  00


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      ..                 .............+++++.+||.+||+.||.+|||+.++++||||++.+.
T Consensus       245 ~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          245 PS-----------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CC-----------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             Cc-----------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            00                 00000001122467899999999999999999999999999999998653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=342.91  Aligned_cols=257  Identities=30%  Similarity=0.437  Sum_probs=206.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||.+....  ....+|+.+++.++||||+++++++....     .++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence            34468999999999999999999999999999999986543  34568999999999999999999885432     378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ +|.+++..   ....+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .+||+|||++...
T Consensus       101 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~  175 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQL  175 (314)
T ss_dssp             EEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhh
Confidence            99999986 88777653   24679999999999999999999998 9999999999999999988 7999999999765


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......+|+.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+.... .+          
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------  243 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP----------  243 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC----------
T ss_pred             hhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc----------
Confidence            4332 23345689999999999654 58999999999999999999999998877655444332210 00          


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                         .+            ..+..++.++.+||.+||..||.+|||+.++++||||++..
T Consensus       244 ---~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 ---TF------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ---CC------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ---cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence               00            01134789999999999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.6e-47  Score=342.18  Aligned_cols=257  Identities=26%  Similarity=0.381  Sum_probs=203.2

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~   83 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----D   83 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----S
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----C
Confidence            3457999999999999999999999999999999885322       234579999999999999999998743     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+++||||+++ +|.+++..    .+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~  157 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGI  157 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSS
T ss_pred             CeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCC
Confidence            348899999976 88777754    3579999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          186 AKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       186 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      ++......  ......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+...+.... ..+.    
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~----  231 (294)
T 4eqm_A          158 AKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD-SVPN----  231 (294)
T ss_dssp             STTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS-CCCC----
T ss_pred             ccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-cCCC----
Confidence            97654332  22345689999999999764 4899999999999999999999999988766554443321 0011    


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                         ....+...+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus       232 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 -------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                               01112246899999999999999999999776777777765443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.1e-47  Score=342.23  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=209.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ....|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++...     ..
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   94 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TK   94 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----Ce
Confidence            3457999999999999999999999999999999986432     3456899999999999999999988543     24


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||||+++ +|.+++.     ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++.
T Consensus        95 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~  167 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAG  167 (303)
T ss_dssp             EEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccce
Confidence            8899999986 7766654     3579999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...... ......+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+...  .+        
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------  236 (303)
T 3a7i_A          168 QLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP--------  236 (303)
T ss_dssp             ECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC--------
T ss_pred             ecCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC--------
Confidence            654332 2334568999999999965 45899999999999999999999999887765554443321  00        


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                        ..+...++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       237 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 ------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ------------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ------------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                              01224678999999999999999999999999999999763

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.4e-46  Score=338.93  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=198.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCC--------
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD--------  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--------  103 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            457999999999999999999999999999999986533   234579999999999999999998765321        


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                      ......++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEee
Confidence            235668899999975 888877642   3457889999999999999999998 9999999999999999988 799999


Q ss_pred             cCCcccccCC---------------CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-H
Q 017131          183 FGSAKVLVKG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-D  246 (376)
Q Consensus       183 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~  246 (376)
                      ||++......               .......+|+.|+|||++.+...++.++|+|||||++|+|++   ||...... +
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765321               122345689999999999766568999999999999999998   55432221 1


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      ....+...                 ...++        ..+....++.+++||.+||+.||.+|||+.++++||||+.
T Consensus       237 ~~~~~~~~-----------------~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          237 ILKKLRSV-----------------SIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHST-----------------TCCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHhcccc-----------------ccccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            12111110                 00111        1122456788999999999999999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-46  Score=345.17  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=186.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-----cHHHHHH-HHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++.....     ...+|+. +++.++||||+++++++...     ..
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence            4579999999999999999999999999999999865321     1223444 67778999999999988543     24


Q ss_pred             EEEEEecccccHHHHHHHhhh-hcCCCcHHHHHHHHHHHHHHHHHHHhcC-CccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          109 LNLVLEYVPETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .++||||+++++.+++..... ....+++..++.++.|++.||.|||+ . ||+||||||+||+++.++ .+||+|||++
T Consensus        96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  173 (327)
T 3aln_A           96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGIS  173 (327)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred             eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence            789999999998887765433 25679999999999999999999998 8 999999999999999988 8999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCHHH
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  262 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  262 (376)
                      +............+|+.|+|||++.   ....++.++|||||||++|+|++|..||.+.+.. +.+..+.          
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----------  243 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----------  243 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC----------
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh----------
Confidence            8765544444557899999999983   2345899999999999999999999999764321 1110000          


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                               ....+     .+.......+++++.+||.+||+.||.+|||+.++++||||....
T Consensus       244 ---------~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          244 ---------KGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ---------CSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ---------cCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                     00000     111111235799999999999999999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=343.53  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=190.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc------cHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++.....      ...++..+++.++||||+++++++...     .
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----T   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----C
Confidence            45689999999999999999999999999999999865422      122345567888999999999988543     3


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC-CccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++||||+++.+..+...   ....+++..++.++.|++.||.|||+ + ||+||||||+||+++.++ .+||+|||++
T Consensus        98 ~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  172 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGIS  172 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             cEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence            4889999997766555443   24679999999999999999999997 6 999999999999999988 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~  261 (376)
                      .............+|+.|+|||++.    ....++.++|||||||++|+|++|..||..... .+.+..+...  .+.  
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~--  248 (318)
T 2dyl_A          173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--EPP--  248 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--CCC--
T ss_pred             hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--CCC--
Confidence            7665555455567899999999985    234588999999999999999999999987443 3334433331  000  


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                  ..+.          ...+++++.+||.+||+.||.+|||+.++++||||++.+
T Consensus       249 ------------~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 ------------LLPG----------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             ------------CCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             ------------CCCc----------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                        0000          125789999999999999999999999999999998754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.8e-47  Score=348.48  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=184.8

Q ss_pred             cccceEEee-eeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           34 QKVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        34 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      -.++|++.+ .||+|+||+||+|.+..+|+.||||++........+....++.++||||+++++++.... ....++++|
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  104 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLII  104 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEE
Confidence            345799965 699999999999999999999999999766555444555677889999999999885433 234568899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCeEEEecCCcccc
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  189 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg~a~~~  189 (376)
                      |||+++ +|.+++...  ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++  ..+||+|||+++..
T Consensus       105 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          105 MECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            999976 887777642  22469999999999999999999998 9999999999999998643  25999999999765


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................            
T Consensus       182 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  247 (336)
T 3fhr_A          182 TQ-NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------  247 (336)
T ss_dssp             ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred             cc-cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc------------
Confidence            43 23345677999999999854 45889999999999999999999999776543322111111000            


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                       ....++.        .....+++++++||.+||+.||.+|||+.++++||||++.
T Consensus       248 -~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 -GQYGFPN--------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ----CCCT--------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -cccccCc--------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence             0000100        0113579999999999999999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.8e-47  Score=348.34  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCC--CCCeeeccceeeec
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFST  101 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~  101 (376)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....          ....+|+.+++.++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4568999999999999999999999999999999986432          23457999999996  59999999988433


Q ss_pred             CCCCceEEEEEEeccc--ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc-CCCCCe
Q 017131          102 TDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTHQL  178 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~-~~~~~v  178 (376)
                           ...++|||++.  ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++ .+
T Consensus       121 -----~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~-~~  189 (320)
T 3a99_A          121 -----DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRG-EL  189 (320)
T ss_dssp             -----SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTT-EE
T ss_pred             -----CcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCC-CE
Confidence                 34789999997  678777654    4679999999999999999999998 9999999999999999 455 89


Q ss_pred             EEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          179 KLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      ||+|||+++.... .......+|+.|+|||++.+...++.++|+|||||++|+|++|..||...+      .+...    
T Consensus       190 kL~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~----  258 (320)
T 3a99_A          190 KLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG----  258 (320)
T ss_dssp             EECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC----
T ss_pred             EEeeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc----
Confidence            9999999976543 333456789999999999766656789999999999999999999996532      11110    


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                                   ..            .++..+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       259 -------------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 -------------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             -------------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             -------------cc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                         00            112468999999999999999999999999999999987643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.9e-47  Score=350.14  Aligned_cols=274  Identities=20%  Similarity=0.316  Sum_probs=206.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------------------ccHHHHHHHHHhCCCCCee
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------------RYKNRELQIMQMLDHPNIV   92 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~~iv   92 (376)
                      ..++|++.+.||+|+||.||+|.+  +|+.||||++....                     ....+|+.+++.++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            346899999999999999999999  89999999985431                     4566899999999999999


Q ss_pred             eccceeeecCCCCceEEEEEEecccc-cHHHHHHHh--hh--hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131           93 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY--SR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      ++++++...     ...++||||+++ +|.+++...  ..  ....+++..++.++.|++.||+|||+.+||+||||||+
T Consensus       107 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          107 TCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             eEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            999998543     348899999986 665441110  11  14679999999999999999999995279999999999


Q ss_pred             cEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCc-h
Q 017131          168 NLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESG-V  245 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~-~  245 (376)
                      ||+++.++ .+||+|||++...... ......+|+.|+|||++.+...++. ++|+|||||++|+|++|..||.+.+. .
T Consensus       182 Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999988 7999999999765433 3345568999999999976544655 99999999999999999999988776 3


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      +....+.......+.        ....+.. .... .........+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       260 ~~~~~i~~~~~~~~~--------~~~~~~~-~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          260 ELFNNIRTKNIEYPL--------DRNHFLY-PLTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHTSCCCCCCC--------SSSSSTT-TTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHhccCcCCcc--------chhhhhc-cccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            333333221000000        0000000 0000 00011224689999999999999999999999999999999875


Q ss_pred             C
Q 017131          326 R  326 (376)
Q Consensus       326 ~  326 (376)
                      .
T Consensus       330 ~  330 (348)
T 2pml_X          330 N  330 (348)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.7e-46  Score=341.71  Aligned_cols=248  Identities=19%  Similarity=0.189  Sum_probs=200.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...  .....+|+.+++.+ +||||+++++++...     .+.++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----CccEE
Confidence            45799999999999999999999999999999998643  34567899999999 999999999988542     34789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC-----eEEEecCCc
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ-----LKLCDFGSA  186 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~-----vkl~Dfg~a  186 (376)
                      ||||++++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .     +||+|||++
T Consensus        83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           83 VLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTC
T ss_pred             EEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEcccc
Confidence            9999988998887653   4679999999999999999999998 9999999999999999877 5     999999999


Q ss_pred             ccccCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHh
Q 017131          187 KVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVL  255 (376)
Q Consensus       187 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~~  255 (376)
                      +.......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.   +..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            86543322        235678999999999965 4589999999999999999999999988544332   33332211


Q ss_pred             CCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ...+.+.                        ....++ ++.+||.+||..||.+||+++++++
T Consensus       237 ~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          237 RATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111110                        012344 9999999999999999999987765

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=336.49  Aligned_cols=254  Identities=24%  Similarity=0.447  Sum_probs=202.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++...     ...
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~   82 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRL   82 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----Cee
Confidence            3468999999999999999999999999999999885432    3345899999999999999999998543     338


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||+++ +|.+++..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  157 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARL  157 (310)
T ss_dssp             EEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeeccccee
Confidence            899999975 88777764   24579999999999999999999998 9999999999999999988 799999999976


Q ss_pred             ccCCCCC---------------ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017131          189 LVKGEPN---------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       189 ~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  253 (376)
                      .......               ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---  233 (310)
T 3s95_A          158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---  233 (310)
T ss_dssp             CC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---
T ss_pred             cccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---
Confidence            5433221               14568999999999965 4589999999999999999999999876432111000   


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                             ...........+..+++.+.+||.+||+.||.+|||+.++++  +++.++
T Consensus       234 -----------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          234 -----------------------LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             -----------------------BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             -----------------------hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence                                   000000001122468999999999999999999999999986  776654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-45  Score=331.89  Aligned_cols=250  Identities=19%  Similarity=0.191  Sum_probs=202.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+|+.+++.+ +|+|++.+++++..     ....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----CceeEE
Confidence            45799999999999999999999999999999988643  34567899999999 79999999988743     334789


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC----CeEEEecCCcc
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH----QLKLCDFGSAK  187 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~----~vkl~Dfg~a~  187 (376)
                      ||||++++|.+++...   ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++.    .+||+|||+++
T Consensus        84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999988998888652   3469999999999999999999998 99999999999999987662    39999999998


Q ss_pred             cccCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhC
Q 017131          188 VLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLG  256 (376)
Q Consensus       188 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~  256 (376)
                      .......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..   ..+..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            6644322        234568999999999965 45899999999999999999999999885432   33333332211


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .++...                        +...+++++.+||.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          239 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            111111                        11357999999999999999999999998875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.6e-46  Score=337.43  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=195.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ...+|++.+.||+|+||+||+|++  +|+.||||++....      ....+|+.+++.++||||+++++++....     
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-----  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-----
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence            346899999999999999999987  48899999986432      23457999999999999999999884332     


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      .+++||||+++ +|.+++.... ....+++..++.++.|++.||+|||+ +|  |+||||||+||+++.++ .+||+|||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg  184 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDFG  184 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCCC
Confidence            27899999975 8877776422 12348999999999999999999998 89  99999999999999988 89999999


Q ss_pred             CcccccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          185 SAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       185 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      +++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......      
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------  257 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------  257 (309)
T ss_dssp             -----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC------
T ss_pred             CCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Confidence            997543322 23456789999999999654 4899999999999999999999999887766555444321100      


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc--CCcccc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  324 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~--hp~f~~  324 (376)
                               .            .++..+++++.+||.+||+.||.+|||+.++++  +++++.
T Consensus       258 ---------~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 ---------L------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ---------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ---------C------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                     0            122468999999999999999999999999986  455544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6e-46  Score=339.90  Aligned_cols=260  Identities=19%  Similarity=0.266  Sum_probs=189.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++.+.||+|+||+||+|.+..+++   .||||++....      ....+|+.+++.++||||+++++++......+
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4579999999999999999999887765   89999886431      33458999999999999999999886543321


Q ss_pred             -ceEEEEEEecccc-cHHHHHHHhhhh--cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          106 -ELYLNLVLEYVPE-TVNRIARNYSRI--HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       106 -~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                       ....++||||+.+ +|.+++......  ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl~  179 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCVA  179 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEEC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEEe
Confidence             1224799999986 888777654322  1258999999999999999999998 9999999999999999988 89999


Q ss_pred             ecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017131          182 DFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       182 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |||+++.......   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..... 
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-  257 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-  257 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred             eccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC-
Confidence            9999976543322   2233457789999999654 58999999999999999999 9999998887766665543210 


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-------HHHHhcCCccccc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-------ALEACVHPFFDEL  325 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-------~~~ll~hp~f~~~  325 (376)
                                     .            ..+..+++++.+||.+||+.||.+|||       +++++.|||+...
T Consensus       258 ---------------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          258 ---------------L------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             ---------------C------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             ---------------C------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                           0            012467899999999999999999999       7788899999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=333.22  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=199.8

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      |.....||+|+||.||+|.+..+++.||||.+....    ....+|+.+++.++||||+++++++...     ...++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEE
Confidence            334459999999999999999999999999986532    3345799999999999999999988543     3488999


Q ss_pred             eccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC-CCCCeEEEecCCcccccC
Q 017131          114 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       114 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~-~~~~vkl~Dfg~a~~~~~  191 (376)
                      ||++ ++|.+++.... ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++ .+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~-~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAG  175 (295)
T ss_dssp             ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTC-CEEECCTTTCEESCC
T ss_pred             EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCC-CEEEeecccccccCC
Confidence            9996 58877776521 12356789999999999999999998 99999999999999997 55 899999999976543


Q ss_pred             CC-CCceeeeeccccchhhhcCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          192 GE-PNVSYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       192 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .. ......+|+.|+|||++.+. ..++.++|+|||||++|+|++|..||.+................            
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  243 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------  243 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------
Confidence            22 23345689999999998543 23789999999999999999999999765443322111111100            


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                    ...++..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       244 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          244 --------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             --------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                          0012246799999999999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=349.21  Aligned_cols=256  Identities=18%  Similarity=0.211  Sum_probs=204.3

Q ss_pred             cccceEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ...+|++.+.||+|+||+||+|.     +..+++.||||++....     ....+|+.+++.++||||+++++++.... 
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence            44689999999999999999999     45678899999985421     23457999999999999999999884332 


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--C
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--Q  177 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~  177 (376)
                          ..++||||+.+ +|.+++......   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  .
T Consensus       148 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          148 ----PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             ----CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCce
Confidence                26799999964 888888764321   2358999999999999999999998 99999999999999985542  5


Q ss_pred             eEEEecCCcccccCC---CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKG---EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  253 (376)
                      +||+|||+++.....   .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999754221   222345668899999999654 58999999999999999998 9999998876665555443


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      ....                            ..+..+++.+.+||.+||+.||.+|||+.++++|.++..
T Consensus       302 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          302 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            1100                            011457899999999999999999999999999988754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.8e-46  Score=341.99  Aligned_cols=268  Identities=21%  Similarity=0.251  Sum_probs=200.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||+||+|++.  ++.||||++.....   ...+|+.+++.++||||+++++++..... ....++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence            4568999999999999999999876  78999999865432   23468888999999999999999865432 234578


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC----------CccccCCCCCcEEEcCCCCCeE
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------GICHRDIKPQNLLVNPHTHQLK  179 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------~iiH~Dlkp~Nill~~~~~~vk  179 (376)
                      +||||+++ +|.+++..     ..+++..++.++.|++.||+|||+ .          ||+||||||+|||++.++ .+|
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEE
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEE
Confidence            99999975 88887754     469999999999999999999998 8          999999999999999988 899


Q ss_pred             EEecCCcccccCCCC---CceeeeeccccchhhhcCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017131          180 LCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  252 (376)
Q Consensus       180 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  252 (376)
                      |+|||+++.......   .....+|+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+...........
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976543322   2335789999999999653    235668899999999999999999998765433222222


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCcccccccccc-ccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .....+....+......  ....+     .....+ ....++++.+||.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVH--KKKRP-----VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTT--SCCCC-----CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhc--ccCCC-----CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            22333333332211000  00000     000000 0123456999999999999999999999975

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=337.30  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=199.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ....+|++.+.||+|+||+||+|.+..+++   .||||++....     ....+|+.+++.++||||+++++++..    
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  121 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR----  121 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            345789999999999999999999986655   49999986532     234579999999999999999998843    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       ....++||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Df  195 (325)
T 3kul_A          122 -GRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDF  195 (325)
T ss_dssp             -GGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCC
T ss_pred             -CCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCC
Confidence             3347899999975 88777753   23579999999999999999999998 9999999999999999988 8999999


Q ss_pred             CCcccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          184 GSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       184 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      |+++........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  273 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-  273 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-
Confidence            999866433221    122346789999999654 48999999999999999999 99999888776665555432100 


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                                 ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       274 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 ---------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                       012468999999999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.6e-46  Score=334.16  Aligned_cols=253  Identities=23%  Similarity=0.352  Sum_probs=210.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecC-----------
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT-----------  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------  102 (376)
                      -..+|++.+.||+|+||.||+|.+..+++.||+|++........+|+.+++.++||||+++++++....           
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            345899999999999999999999999999999999877777889999999999999999999874311           


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                      ......+++||||+++ +|.+++....  ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~  164 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIG  164 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEEC
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEEC
Confidence            1234558899999986 8888886532  3579999999999999999999998 9999999999999999888 89999


Q ss_pred             ecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       182 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      |||++.............+|+.|+|||.+.+ ..++.++|+|||||++|+|++|..||....   .......        
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~--------  232 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLR--------  232 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHH--------
T ss_pred             cchhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhh--------
Confidence            9999987765555556678999999999965 458999999999999999999998874211   1111100        


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                .            ..++..++.++.+||.+||..||.+|||+.++++|++.-.
T Consensus       233 ----------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          233 ----------D------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------T------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------c------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                      0            0012357899999999999999999999999999988754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.3e-45  Score=333.50  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=196.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCC--CCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++....      ....+|+.+++.++  |+||+++++++..     .
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----S
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----C
Confidence            457999999999999999999985 58899999986432      23457999999997  5999999998843     2


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .++++|||+.+++|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++. + .+||+|||++
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred             CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeecccc
Confidence            34889999888898887764    3578999999999999999999998 99999999999999974 5 7999999999


Q ss_pred             ccccCCCC---CceeeeeccccchhhhcCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHH
Q 017131          187 KVLVKGEP---NVSYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEII  252 (376)
Q Consensus       187 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~  252 (376)
                      +.......   .....+|+.|+|||++.+.          ..++.++|||||||++|+|++|..||....... .+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            76543322   2345689999999998541          357889999999999999999999997654322 222211


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ..              . ...            .++...+.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       254 ~~--------------~-~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          254 DP--------------N-HEI------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CT--------------T-SCC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             hc--------------c-ccc------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            10              0 000            11234688999999999999999999999999999998743

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-45  Score=343.10  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=201.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeee
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS  100 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~  100 (376)
                      ..++|++.+.||+|+||+||+|++.       .++..||||++....     ....+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3468999999999999999999975       345679999986542     2345799999999 89999999998843


Q ss_pred             cCCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131          101 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      .     ..+|+||||+.+ +|.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus       159 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~  232 (370)
T 2psq_A          159 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR  232 (370)
T ss_dssp             S-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred             C-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence            2     237899999975 88888875321            12458999999999999999999998 99999999999


Q ss_pred             cEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017131          168 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  243 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  243 (376)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999988 799999999986543321   2234567889999999654 58999999999999999999 999999877


Q ss_pred             chHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          244 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       244 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..+....+.....                            ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       311 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6655544432100                            01124678999999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-45  Score=342.42  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=202.6

Q ss_pred             ccceEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .++|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+.+++.+ +||||+++++++.... 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-   99 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-   99 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-
Confidence            4689999999999999999999     56677999999986532     2355799999999 7899999999874322 


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh----------------------------------------------------
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRI----------------------------------------------------  130 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------------------------------------------------  130 (376)
                         ..+++||||+.+ +|.+++......                                                    
T Consensus       100 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A          100 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             ---SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             ---CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence               236799999985 888887654321                                                    


Q ss_pred             ----------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCC---Cce
Q 017131          131 ----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVS  197 (376)
Q Consensus       131 ----------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~  197 (376)
                                ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.......   ...
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence                      1128999999999999999999998 9999999999999999888 799999999976543322   234


Q ss_pred             eeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 017131          198 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  276 (376)
Q Consensus       198 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  276 (376)
                      ..+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+...........+                  
T Consensus       255 ~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------  315 (359)
T 3vhe_A          255 ARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------  315 (359)
T ss_dssp             CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred             cCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence            567889999999965 458999999999999999998 999999877666555554431111                  


Q ss_pred             CccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          277 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                               ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       316 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                     0123578999999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-45  Score=327.58  Aligned_cols=246  Identities=19%  Similarity=0.316  Sum_probs=200.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||+||+|.+. +++.||+|++....   ....+|+.+++.++||||+++++++.+.     ...+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceE
Confidence            4468999999999999999999986 47789999986543   3456899999999999999999988433     2378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++..
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEeccccccccc
Confidence            99999975 78777654   23468999999999999999999998 9999999999999999888 7999999999755


Q ss_pred             cCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....  ......+|+.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.....          
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  225 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  225 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence            3221  12234457789999999654 48999999999999999999 9999998876666555543110          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                        ...+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                              01123578999999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=353.93  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=190.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      .+|.+.+.||+|+||+|+. ....+|+.||||++.... ....+|+.+|+.+ +||||+++++++.+     ..+.|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEEEEEE
Confidence            3699999999999999764 345678999999986543 4467899999999 79999999988743     33488999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC---C-CCeEEEecCCcccc
Q 017131          114 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH---T-HQLKLCDFGSAKVL  189 (376)
Q Consensus       114 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~---~-~~vkl~Dfg~a~~~  189 (376)
                      ||++++|.+++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+   + ..+||+|||+|+..
T Consensus        98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            99999998877642   2345555678899999999999998 999999999999999532   2 15789999999866


Q ss_pred             cCCC----CCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          190 VKGE----PNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       190 ~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||....... ...+.   +...   
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~---~~~~---  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILL---GACS---  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHT---TCCC---
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHh---ccCC---
Confidence            4332    2334578999999999964  3457889999999999999999 999996544322 11111   1100   


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                  .....       .....+..+++||.+||+.||.+|||+.++++||||..+
T Consensus       247 ------------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          247 ------------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             ------------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ------------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                        00000       001235678999999999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.9e-45  Score=327.53  Aligned_cols=250  Identities=21%  Similarity=0.217  Sum_probs=200.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.++|++++..+..+...    ....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEE
Confidence            45799999999999999999999999999999988643  34567899999999999887776655332    2347899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc---CCCCCeEEEecCCcccc
Q 017131          113 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       113 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~---~~~~~vkl~Dfg~a~~~  189 (376)
                      |||++++|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++   .++ .+||+|||+++..
T Consensus        84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence            99998899888764   23579999999999999999999998 9999999999999994   566 7999999999866


Q ss_pred             cCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhCCC
Q 017131          190 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTP  258 (376)
Q Consensus       190 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~  258 (376)
                      .....        .....+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.   ...+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            44322        2455789999999999654 489999999999999999999999987432   23333333321111


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +...                        +...+|+++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 PIEV------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHH------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chHH------------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1111                        11457999999999999999999999998875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=336.67  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=187.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCC-CCCeeeccceeeecCC---CCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD---KEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---~~~  106 (376)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....    ....+|+.+++.+. ||||+++++++.....   ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            348999999999999999999999999999999885433    23457999999995 9999999998854322   455


Q ss_pred             eEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          107 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       107 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ..++++|||++++|.+++.... ....+++..++.++.||+.||+|||+ +|  |+||||||+|||++.++ .+||+|||
T Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCT
T ss_pred             ceEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCc
Confidence            6688999999999988886543 24569999999999999999999998 89  99999999999999988 79999999


Q ss_pred             CcccccCCCCC-------------ceeeeeccccchhhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 017131          185 SAKVLVKGEPN-------------VSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  249 (376)
Q Consensus       185 ~a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  249 (376)
                      +++........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|..||.+........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  263 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN  263 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence            99765433221             1445899999999983  23457889999999999999999999997644322111


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCc
Q 017131          250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  321 (376)
Q Consensus       250 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~  321 (376)
                      ..                     ...+          .....+..+.+||.+||+.||.+|||+.++++|-+
T Consensus       264 ~~---------------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          264 GK---------------------YSIP----------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----------------------CCCC----------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             Cc---------------------ccCC----------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            00                     0000          11346788999999999999999999999998744

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.1e-45  Score=339.26  Aligned_cols=259  Identities=17%  Similarity=0.128  Sum_probs=198.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCC-----CcEEEEEEeecccccHHHHH---------------HHHHhCCCCCeee
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYKNREL---------------QIMQMLDHPNIVA   93 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~E~---------------~~l~~l~h~~iv~   93 (376)
                      ...+|++.+.||+|+||.||+|.+..+     ++.||||++........+|+               ..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345899999999999999999998765     58899999876554444444               4455667999999


Q ss_pred             ccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc-
Q 017131           94 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-  172 (376)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~-  172 (376)
                      +++++.... ....+.++||||++++|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++ 
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEES
T ss_pred             EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEec
Confidence            999886543 23456889999998899888765   23679999999999999999999998 9999999999999998 


Q ss_pred             -CCCCCeEEEecCCcccccCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 017131          173 -PHTHQLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES  243 (376)
Q Consensus       173 -~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  243 (376)
                       .++ .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus       188 ~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          188 KNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             SCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence             676 799999999976543221        1334589999999999654 48999999999999999999999998654


Q ss_pred             chHHHHHHHHHhCCCCH-HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          244 GVDQLVEIIKVLGTPTR-EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       244 ~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..............+.. ..+...        +           ....+++++.+||.+||..||.+||++.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~--------~-----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          266 KDPKYVRDSKIRYRENIASLMDKC--------F-----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TCHHHHHHHHHHHHHCHHHHHHHH--------S-----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHHhhhhHHHHHHHh--------c-----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            43333322221111111 111100        0           01357999999999999999999999998875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-44  Score=326.98  Aligned_cols=250  Identities=22%  Similarity=0.227  Sum_probs=198.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec--ccccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .++|++.+.||+|+||+||+|.+..+++.||||++..  ......+|+.+++.++|++++..+..+...    ..+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEE
Confidence            3579999999999999999999999999999998643  334567899999999999888777666432    2347899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE---cCCCCCeEEEecCCcccc
Q 017131          113 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       113 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill---~~~~~~vkl~Dfg~a~~~  189 (376)
                      |||++++|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||+   +.++ .+||+|||+++..
T Consensus        84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence            99998899887764   24579999999999999999999998 999999999999999   6666 7999999999866


Q ss_pred             cCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhCCC
Q 017131          190 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTP  258 (376)
Q Consensus       190 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~  258 (376)
                      .....        .....+|+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..   .....+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            44322        2345789999999999654 4899999999999999999999999875432   2333332221111


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +..                        .....+++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            111                        111357899999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.4e-45  Score=324.68  Aligned_cols=246  Identities=20%  Similarity=0.294  Sum_probs=200.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++....   ....+|+.+++.++||||+++++++..     ....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceE
Confidence            4568999999999999999999876 56789999986543   345689999999999999999998833     23378


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            9999997 4787777653   3469999999999999999999998 9999999999999999988 7999999999765


Q ss_pred             cCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....  .....+|+.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR----------  223 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence            43321  1223446779999999654 48999999999999999999 9999988776665555433110          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                        ...+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              00113468999999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=339.57  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=197.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhC----CCCCeeeccceee
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQML----DHPNIVALKHCFF   99 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~~~~~~~   99 (376)
                      -.++|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3467999999999999999999999999999999985432          2234699999998    8999999999884


Q ss_pred             ecCCCCceEEEEEEec-cc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc-CCCC
Q 017131          100 STTDKEELYLNLVLEY-VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN-PHTH  176 (376)
Q Consensus       100 ~~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~-~~~~  176 (376)
                      ..     ...++|||+ +. ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++ .++ 
T Consensus       109 ~~-----~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-  177 (312)
T 2iwi_A          109 TQ-----EGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG-  177 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-
T ss_pred             cC-----CeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-
Confidence            33     236789998 44 588777764    3569999999999999999999998 8999999999999999 566 


Q ss_pred             CeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 017131          177 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  256 (376)
Q Consensus       177 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  256 (376)
                      .+||+|||++..... .......+|+.|+|||++.+....+.++|+|||||++|+|++|+.||.+..      .+...  
T Consensus       178 ~~kl~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--  248 (312)
T 2iwi_A          178 CAKLIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--  248 (312)
T ss_dssp             EEEECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--
T ss_pred             eEEEEEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--
Confidence            899999999986543 334456789999999998765545668999999999999999999996531      11110  


Q ss_pred             CCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                     ...            ++..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       249 ---------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          249 ---------------ELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             ---------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ---------------ccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                           011            1246799999999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-45  Score=340.18  Aligned_cols=251  Identities=21%  Similarity=0.306  Sum_probs=202.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCC-------CcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceee
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFF   99 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   99 (376)
                      ...++|++.+.||+|+||+||+|.+..+       +..||||++....     ....+|+++++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            3457899999999999999999997543       3579999986542     2345799999999 9999999999884


Q ss_pred             ecCCCCceEEEEEEecccc-cHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 017131          100 STTDKEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  166 (376)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp  166 (376)
                      ...     .+++||||+++ +|.+++......            ...+++..++.++.||+.||+|||+ +||+||||||
T Consensus       146 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp  219 (382)
T 3tt0_A          146 QDG-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA  219 (382)
T ss_dssp             SSS-----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred             cCC-----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence            332     37899999975 888888764311            2359999999999999999999998 9999999999


Q ss_pred             CcEEEcCCCCCeEEEecCCcccccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 017131          167 QNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  242 (376)
Q Consensus       167 ~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  242 (376)
                      +|||++.++ .+||+|||+++......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus       220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999988 89999999997654322   2233456888999999965 458999999999999999999 99999887


Q ss_pred             CchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       243 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      +..+....+.....                            ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       298 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          298 PVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76555444332100                            00124689999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.7e-45  Score=340.99  Aligned_cols=246  Identities=22%  Similarity=0.308  Sum_probs=199.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++...     ..
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence            4468999999999999999999999999999999986432     2345799999999999999999988432     23


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +++||||++ ++|.+++...   ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence            789999997 5887777642   3468999999999999999999998 9999999999999999888 79999999997


Q ss_pred             cccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHH
Q 017131          188 VLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  263 (376)
Q Consensus       188 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  263 (376)
                      .......   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+....        
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------  332 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG--------  332 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC--------
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            5432211   1122457789999999654 48999999999999999998 999998877655443332210        


Q ss_pred             hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                ..          ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       333 ----------~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          333 ----------RL----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                      00          012457899999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.4e-45  Score=349.02  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=190.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCceEEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++.+     ...+|+||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEEEE
Confidence            468889999999999998754 4679999999986543 3346899999876 89999999888733     34488999


Q ss_pred             ecccccHHHHHHHhhhhcCC---CcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC------------CCe
Q 017131          114 EYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT------------HQL  178 (376)
Q Consensus       114 e~~~~~l~~~~~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~------------~~v  178 (376)
                      |||+++|.+++.........   .++..++.++.||+.||+|||+ +||+||||||+|||++.++            ..+
T Consensus        89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            99999998888753322111   1333467899999999999998 9999999999999997532            269


Q ss_pred             EEEecCCcccccCCCC-----CceeeeeccccchhhhcC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 017131          179 KLCDFGSAKVLVKGEP-----NVSYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  246 (376)
Q Consensus       179 kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  246 (376)
                      ||+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |..||.+.....
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            9999999987644322     224578999999999964      2458999999999999999999 999997654332


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                        ..+....                 +..+...     ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 --~~i~~~~-----------------~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 --SNIIRGI-----------------FSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             --HHHHHTC-----------------CCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             --HHHhcCC-----------------CCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence              2232210                 1111110     0011235688999999999999999999999999999964

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.1e-45  Score=332.82  Aligned_cols=250  Identities=20%  Similarity=0.335  Sum_probs=201.3

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ...+|++.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+.+++.++||||+++++++...  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD--   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--
Confidence            4568999999999999999999983     456899999986532     2345799999999999999999988432  


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh--------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHR  162 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~  162 (376)
                         ...++||||+. ++|.+++.....                    ....+++..++.++.||+.||+|||+ +||+||
T Consensus        99 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~  174 (314)
T 2ivs_A           99 ---GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR  174 (314)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred             ---CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence               23789999998 588888876432                    12348999999999999999999998 999999


Q ss_pred             CCCCCcEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 017131          163 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL  238 (376)
Q Consensus       163 Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p  238 (376)
                      ||||+||+++.++ .+||+|||+++.......   .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999888 799999999976543322   2233457889999999654 48999999999999999999 9999


Q ss_pred             CCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          239 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      |.+.+.......+....                .            ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGH----------------R------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTC----------------C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCC----------------c------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            98877655544433210                0            0112468999999999999999999999999986


Q ss_pred             C
Q 017131          319 H  319 (376)
Q Consensus       319 h  319 (376)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            4

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-44  Score=324.90  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=196.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----------ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++....           ....+|+.+++.++||||+++++++..  
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   94 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--   94 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--
Confidence            3457999999999999999999999999999999985321           345689999999999999999998732  


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcCCCC---
Q 017131          103 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTH---  176 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~---  176 (376)
                         ..  ++||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +|  |+||||||+||+++.++.   
T Consensus        95 ---~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           95 ---PP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             ---TT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             ---CC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCc
Confidence               22  48999998 577665543   34579999999999999999999998 89  999999999999987762   


Q ss_pred             -CeEEEecCCcccccCCCCCceeeeeccccchhhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHH
Q 017131          177 -QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL-VEIIK  253 (376)
Q Consensus       177 -~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~i~~  253 (376)
                       .+||+|||+++...  .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..... .....
T Consensus       166 ~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          166 VCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             CCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             eeEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence             29999999997543  23445678999999999842 334788999999999999999999999876544332 11111


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..+                          ....++..+++++.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          244 EEG--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HSC--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccC--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            110                          001122468999999999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-44  Score=330.01  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  102 (376)
                      ...+|++.+.||+|+||.||+|.+     ..+++.||||++....     ....+|+.+++.+ +||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346899999999999999999995     4577899999986432     3345799999999 9999999999884432


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhh--------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                           ..++||||+++ +|.+++.....              ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus       101 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~  174 (313)
T 1t46_A          101 -----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (313)
T ss_dssp             -----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             -----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence                 36799999975 88888875432              12258999999999999999999998 99999999999


Q ss_pred             cEEEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017131          168 NLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  243 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  243 (376)
                      ||+++.++ .+||+|||+++........   ....+|+.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+..
T Consensus       175 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999888 8999999999766443321   234567889999998654 58999999999999999999 999999877


Q ss_pred             chHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          244 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       244 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..............+                           ..+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          253 VDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            666665555431110                           1124578999999999999999999999999863

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=352.04  Aligned_cols=273  Identities=22%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++....     ....+|+++++.++||||+++++++....   ....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence            457999999999999999999999999999999986432     33458999999999999999999875432   2347


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE----cCCCCCeEEEecC
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----NPHTHQLKLCDFG  184 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill----~~~~~~vkl~Dfg  184 (376)
                      ++||||++ ++|.+++.... ....+++..++.++.||+.||+|||+ +||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            89999997 48877765432 22349999999999999999999998 999999999999998    6655 69999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHHHH
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIK  253 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~  253 (376)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+.+.++..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99876555545566789999999998531       347889999999999999999999997533    2333333333


Q ss_pred             HhCCCCHHHHhhcCc-CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          254 VLGTPTREEIKCMNP-NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                        +.|. ..+..... ....+.+..  ..+....+...+++.+.++|++||++||++|||+.++++
T Consensus       242 --~~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 --GKPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             --SCCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             --CCCc-ccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence              2221 11110000 000000000  000011122345678899999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-45  Score=337.68  Aligned_cols=254  Identities=23%  Similarity=0.325  Sum_probs=203.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||++....     ....+|+.+++.++||||+++++++...  
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence            4568999999999999999999997     455899999986542     2345799999999999999999988432  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh--------------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRI--------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHR  162 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~  162 (376)
                         ...++||||+++ +|.+++......                    ...+++..++.++.||+.||.|||+ +||+||
T Consensus       123 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~  198 (343)
T 1luf_A          123 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR  198 (343)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred             ---CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence               237899999975 888888763211                    2569999999999999999999998 999999


Q ss_pred             CCCCCcEEEcCCCCCeEEEecCCcccccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 017131          163 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL  238 (376)
Q Consensus       163 Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p  238 (376)
                      ||||+||+++.++ .+||+|||+++......   ......+|+.|+|||.+.+. .++.++|+|||||++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999888 79999999987553221   22344568899999998654 48999999999999999999 9999


Q ss_pred             CCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          239 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      |.+.+..+....+....                   .+         .++..+++++.+||.+||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCC-------------------cC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            98877655554443310                   00         012467899999999999999999999999975


Q ss_pred             CCccccc
Q 017131          319 HPFFDEL  325 (376)
Q Consensus       319 hp~f~~~  325 (376)
                        .++++
T Consensus       329 --~L~~~  333 (343)
T 1luf_A          329 --ILQRM  333 (343)
T ss_dssp             --HHHHT
T ss_pred             --HHHHH
Confidence              44443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-44  Score=323.01  Aligned_cols=242  Identities=28%  Similarity=0.443  Sum_probs=188.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..+|++.+.||+|+||.||+|.+.  ++.||||++....        ....+|+.+++.++||||+++++++...     
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence            357999999999999999999985  8899999885431        2345799999999999999999988432     


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC---ccccCCCCCcEEEcC--------C
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG---ICHRDIKPQNLLVNP--------H  174 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~---iiH~Dlkp~Nill~~--------~  174 (376)
                      ...++||||+++ +|.+++.     .+.+++..++.++.|++.||+|||+ +|   |+||||||+||+++.        +
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccC
Confidence            337899999974 6665553     4679999999999999999999998 89   999999999999986        4


Q ss_pred             CCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017131          175 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  254 (376)
Q Consensus       175 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  254 (376)
                      + .+||+|||++...... ......+|+.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+...
T Consensus       153 ~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  229 (271)
T 3dtc_A          153 K-ILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN  229 (271)
T ss_dssp             C-CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred             c-ceEEccCCcccccccc-cccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence            4 7999999999765432 23356789999999999654 5899999999999999999999999887765554443321


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .                 .          ...++..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       230 ~-----------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 K-----------------L----------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             C-----------------C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-----------------C----------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            0                 0          001224678999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.5e-45  Score=327.68  Aligned_cols=243  Identities=17%  Similarity=0.243  Sum_probs=194.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCC-------cEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (376)
                      ...+|++.+.||+|+||+||+|.+..++       ..||+|++....    ....+|+.+++.++||||+++++++....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4568999999999999999999998877       469999985433    33457999999999999999999885432


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC----
Q 017131          103 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ----  177 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~----  177 (376)
                           ..++||||++ ++|.+++...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .    
T Consensus        86 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~~~~  155 (289)
T 4fvq_A           86 -----ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREE-DRKTG  155 (289)
T ss_dssp             -----CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECC-BGGGT
T ss_pred             -----CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCC-ccccc
Confidence                 2679999998 5888877652   2349999999999999999999998 9999999999999999877 4    


Q ss_pred             ----eEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHH
Q 017131          178 ----LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEII  252 (376)
Q Consensus       178 ----vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~  252 (376)
                          +||+|||++.....   .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+. .......
T Consensus       156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~  231 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFY  231 (289)
T ss_dssp             BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHH
T ss_pred             ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHh
Confidence                99999999865422   234457889999999976566899999999999999999954 55544443 3332222


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ...                 ..            ++...++++.+||.+||+.||.+|||+.++++|
T Consensus       232 ~~~-----------------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          232 EDR-----------------HQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HTT-----------------CC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hcc-----------------CC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            210                 00            113468899999999999999999999999863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.8e-45  Score=330.29  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=193.9

Q ss_pred             cccceEEeeeeeecCceEEEEEE----ECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++++.||+|+||+||+|+    +..+++.||||++....    ....+|+.+++.++||||+++++++....   
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            45689999999999999999999    56789999999986543    33458999999999999999999875422   


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+++||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCc
Confidence            223679999996 4888877653   3459999999999999999999998 9999999999999999888 89999999


Q ss_pred             CcccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          185 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       185 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +++.......    .....++..|+|||.+.+. .++.++|||||||++|+|++|..||.....  .   .....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~---~~~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--H---HHHHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChH--H---HHhhhcCccc
Confidence            9976543321    1223456779999999654 489999999999999999999999864321  1   1111111110


Q ss_pred             HH------HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          261 EE------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       261 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ..      .......   .          ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~---~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          234 GQMIVFHLIELLKNN---G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             THHHHHHHHHHHHTT---C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cchhHHHHHHHHhcc---C----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00      0000000   0          00112468999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.7e-45  Score=325.92  Aligned_cols=247  Identities=21%  Similarity=0.288  Sum_probs=198.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ....+|++.+.||+|+||.||+|.+. ++..||+|++....   ....+|+.+++.++||||+++++++...     ...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC-----CCe
Confidence            34568999999999999999999886 57789999986543   3456899999999999999999988432     337


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ++||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++.
T Consensus        95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            89999996 5787777542   3569999999999999999999998 9999999999999999988 799999999975


Q ss_pred             ccCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          189 LVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       189 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .....  ......+|+.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+......        
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  240 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------  240 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred             ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence            53221  12233457789999999654 48999999999999999998 99999988776666555432100        


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                          ..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                0113578999999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-44  Score=328.99  Aligned_cols=255  Identities=19%  Similarity=0.268  Sum_probs=194.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECC---CCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ...+|++.+.||+|+||.||+|.+..   ++..||+|++....      ....+|+.+++.++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45689999999999999999998765   56689999986432      2345799999999999999999998765443


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhh--hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                      .....++||||+.+ +|.+++....  .....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl~  189 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCVA  189 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEEe
Confidence            33456899999985 8877775432  223569999999999999999999998 9999999999999999988 79999


Q ss_pred             ecCCcccccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017131          182 DFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       182 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |||+++......   ......+++.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+..... 
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  267 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-  267 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-
Confidence            999997654332   1223455788999999965 458999999999999999999 9999988877666555443110 


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                                 ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus       268 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ---------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ---------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       01124688999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-44  Score=324.95  Aligned_cols=246  Identities=26%  Similarity=0.351  Sum_probs=189.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCC---CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ....+|++.+.||+|+||.||+|.+..+   +..||+|++....     ....+|+.+++.++||||+++++++..    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence            3456899999999999999999998654   4579999875422     234579999999999999999998621    


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      +  ..++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+||
T Consensus        88 ~--~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Df  160 (281)
T 1mp8_A           88 N--PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF  160 (281)
T ss_dssp             S--SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred             C--ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECcc
Confidence            1  26799999985 887777542   3469999999999999999999998 9999999999999999888 8999999


Q ss_pred             CCcccccCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          184 GSAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       184 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |+++.......  .....+|+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.....    
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----  235 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----  235 (281)
T ss_dssp             ------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred             ccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----
Confidence            99976543322  123345778999999964 458999999999999999997 9999998877666655543100    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                  .            .++..+++++.+||.+||..||.+|||+.++++
T Consensus       236 ------------~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          236 ------------L------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             ------------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------C------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                        0            012468999999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.2e-45  Score=326.53  Aligned_cols=247  Identities=20%  Similarity=0.334  Sum_probs=203.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||+||+|.+..+++.||+|++..+.   ....+|+.+++.++||||+++++++...     ...+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCEE
Confidence            4568999999999999999999999999999999987544   3345899999999999999999988432     2378


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||++ ++|.+++...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus        86 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCccceec
Confidence            9999998 5888777642  23569999999999999999999998 8999999999999999888 7999999999765


Q ss_pred             cCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....  .....+|+.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+.......+.....          
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------  230 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------  230 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred             cCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC----------
Confidence            43322  2234567889999999654 58999999999999999999 9999988776555444432100          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                        ...+..+++++.+||.+||..||.+|||+.++++
T Consensus       231 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                              0112467899999999999999999999999975

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.6e-45  Score=328.43  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=193.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHh--CCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||+||+|.+  +++.||||++.... ....+|.+++..  ++||||+++++++.... .....+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence            45799999999999999999987  58999999986543 233457777766  79999999999875533 23455789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH--------hcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                      ||||+++ +|.+++.     ...+++..++.++.|++.||+|||        + +||+||||||+|||++.++ .+||+|
T Consensus        84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~D  156 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIAD  156 (301)
T ss_dssp             EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEECC
T ss_pred             ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEee
Confidence            9999985 8877774     357999999999999999999999        8 8999999999999999988 899999


Q ss_pred             cCCcccccCCCCC-----ceeeeeccccchhhhcCCC-----CCCCchhHHHHHHHHHHHHhC----------CCCCCCC
Q 017131          183 FGSAKVLVKGEPN-----VSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLG----------QPLFPGE  242 (376)
Q Consensus       183 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg----------~~pf~~~  242 (376)
                      ||+++........     ....||+.|+|||++.+..     .++.++|||||||++|+|++|          ..||.+.
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            9999765433322     2347899999999996543     244789999999999999999          8888654


Q ss_pred             Cch----HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          243 SGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       243 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ...    ..........                 ...+..    ....+...+++++.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVD-----------------QQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCSSCCHHHHHHHHTTS-----------------CCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCcchhhhhHHHhcc-----------------CCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            322    2222221100                 000000    011112235678999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.5e-45  Score=332.29  Aligned_cols=247  Identities=22%  Similarity=0.300  Sum_probs=196.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcE----EEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ....+|++.+.||+|+||+||+|.+..+++.    ||+|.+....     ....+|+.+++.++||||+++++++..   
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---
Confidence            3456899999999999999999999888876    6677663321     334579999999999999999997721   


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                         ...++||||+. ++|.+.+...   ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        87 ---~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~D  158 (325)
T 3kex_A           87 ---SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVAD  158 (325)
T ss_dssp             ---SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECS
T ss_pred             ---CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECC
Confidence               12779999998 5776666532   3568999999999999999999998 9999999999999999888 799999


Q ss_pred             cCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          183 FGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       183 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      ||+++.......   .....+|..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....   
T Consensus       159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---  234 (325)
T 3kex_A          159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---  234 (325)
T ss_dssp             CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC---
T ss_pred             CCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---
Confidence            999987643322   2344567789999999654 48999999999999999999 999998876655444433210   


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                   ..            ..+..++.++.+||.+||..||.+|||+.++++|
T Consensus       235 -------------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 -------------RL------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -------------BC------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -------------CC------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         00            0113468899999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=334.27  Aligned_cols=253  Identities=21%  Similarity=0.293  Sum_probs=202.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEeecc-----cccHHHHHHHHHhC-CCCCeeeccceeeecC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTT  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  102 (376)
                      ...+|++.+.||+|+||.||+|.+     ..++..||||++...     .....+|+.+++.+ +||||+++++++....
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            446899999999999999999997     345678999998643     23456899999999 9999999999884432


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhh-------------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRI-------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHR  162 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~  162 (376)
                           .+++||||+++ +|.+++......                   ...+++..++.++.||+.||+|||+ +||+||
T Consensus       123 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~  196 (344)
T 1rjb_A          123 -----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR  196 (344)
T ss_dssp             -----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred             -----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence                 37899999975 888888653211                   1348999999999999999999998 999999


Q ss_pred             CCCCCcEEEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 017131          163 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPL  238 (376)
Q Consensus       163 Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p  238 (376)
                      ||||+||+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus       197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999988 8999999999765443322   234567889999998654 58999999999999999998 9999


Q ss_pred             CCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          239 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      |.+.+.......+......+                           ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99877666555554421000                           012357899999999999999999999999997


Q ss_pred             CCc
Q 017131          319 HPF  321 (376)
Q Consensus       319 hp~  321 (376)
                      |..
T Consensus       328 ~l~  330 (344)
T 1rjb_A          328 FLG  330 (344)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.9e-46  Score=350.07  Aligned_cols=253  Identities=20%  Similarity=0.223  Sum_probs=193.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCC-CCeeeccce----------
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDH-PNIVALKHC----------   97 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-~~iv~~~~~----------   97 (376)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++...       .....+|+.+++.+.| +|...+..+          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4699999999999999999999999999999988632       2334589999999987 322211111          


Q ss_pred             -----------eeecCCCCceEEEEEEecccccHHHHHHHhhh---hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 017131           98 -----------FFSTTDKEELYLNLVLEYVPETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  163 (376)
Q Consensus        98 -----------~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~D  163 (376)
                                 +...........+++|+++.++|.+++.....   ....+++..+..++.||+.||+|||+ +||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence                       11101111223678999999999888864422   23457888899999999999999998 9999999


Q ss_pred             CCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhc---------CCCCCCCchhHHHHHHHHHHHHh
Q 017131          164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF---------GATEYTTAIDIWSTGCVMAELLL  234 (376)
Q Consensus       164 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ellt  234 (376)
                      |||+|||++.++ .+||+|||+++.....  ....+| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999998 7999999998765332  344566 9999999983         33457889999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH
Q 017131          235 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  314 (376)
Q Consensus       235 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~  314 (376)
                      |+.||.+.+.......+                       +..          ...+|+++.+||.+||+.||.+|||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~-----------------------~~~----------~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI-----------------------FRS----------CKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG-----------------------GSS----------CCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcchhhhHHHH-----------------------Hhh----------cccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999775432211110                       000          035789999999999999999999999


Q ss_pred             HHhcCCcccccC
Q 017131          315 EACVHPFFDELR  326 (376)
Q Consensus       315 ~ll~hp~f~~~~  326 (376)
                      ++++||||+.+.
T Consensus       360 ~~l~~~~~~~~~  371 (413)
T 3dzo_A          360 QAMETPEYEQLR  371 (413)
T ss_dssp             HHTTSHHHHHHH
T ss_pred             HHHhCHHHHHHH
Confidence            999999998763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.3e-45  Score=334.81  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=200.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEE--EEEEeecc-----cccHHHHHHHHHhC-CCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..++|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+.+++.+ +||||+++++++...    
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----   98 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----   98 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC----
Confidence            3468999999999999999999999888865  99987542     23456899999999 999999999988543    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN  172 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~  172 (376)
                       ..+++||||+++ +|.+++....            .....+++..++.++.||+.||+|||+ +||+||||||+||+++
T Consensus        99 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           99 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG  176 (327)
T ss_dssp             -TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred             -CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEc
Confidence             348899999965 8888876532            123469999999999999999999998 9999999999999999


Q ss_pred             CCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017131          173 PHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  251 (376)
Q Consensus       173 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  251 (376)
                      .++ .+||+|||+++............+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       177 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          177 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            888 799999999975443333344556888999999965 348999999999999999998 99999887755544333


Q ss_pred             HHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          252 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ...                  ..          ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       255 ~~~------------------~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          255 PQG------------------YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGT------------------CC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcC------------------CC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            221                  00          01123578999999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-44  Score=330.50  Aligned_cols=259  Identities=21%  Similarity=0.280  Sum_probs=207.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||||++....     ....+|+.+++.++||||+++++++.... 
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-  101 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-  101 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC-
Confidence            4468999999999999999999986     457889999986432     22457999999999999999999884322 


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH  176 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~  176 (376)
                          ..++||||+++ +|.+++......      ...+++..++.++.||+.||+|||+ +||+||||||+||+++.++ 
T Consensus       102 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~-  175 (322)
T 1p4o_A          102 ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-  175 (322)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-
T ss_pred             ----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC-
Confidence                37799999975 888888764432      1457899999999999999999998 9999999999999999988 


Q ss_pred             CeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 017131          177 QLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  252 (376)
Q Consensus       177 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  252 (376)
                      .+||+|||+++.......   .....+|+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            799999999975533221   223456889999999865 448999999999999999999 899998877655544443


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC------CcccccC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH------PFFDELR  326 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h------p~f~~~~  326 (376)
                      ...                   .+         ..+..+++++.+||.+||+.||.+|||+.++++|      |+|+.+.
T Consensus       255 ~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          255 EGG-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             TTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             cCC-------------------cC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            210                   00         0124688999999999999999999999999875      7777665


Q ss_pred             CC
Q 017131          327 DP  328 (376)
Q Consensus       327 ~~  328 (376)
                      ..
T Consensus       307 ~~  308 (322)
T 1p4o_A          307 FY  308 (322)
T ss_dssp             ST
T ss_pred             cc
Confidence            43

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=331.30  Aligned_cols=258  Identities=23%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....    ....+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            57999999999999999999999999999999885432    33457999999999999999999886432 23445789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+.+ +|.+++.........+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999986 9988888766566789999999999999999999998 9999999999999999888 79999999986542


Q ss_pred             CCCCC----------ceeeeeccccchhhhcCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCC
Q 017131          191 KGEPN----------VSYICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGT  257 (376)
Q Consensus       191 ~~~~~----------~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~  257 (376)
                      .....          ....+|+.|+|||++.+..  .++.++|||||||++|+|++|..||...... .........   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence            21110          1234688999999985432  2688999999999999999999999531100 001111110   


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                    ....+          ....+++++.+||.+||+.||.+|||+.+++++  +..+
T Consensus       263 --------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~  304 (317)
T 2buj_A          263 --------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEAL  304 (317)
T ss_dssp             --------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHT
T ss_pred             --------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhc
Confidence                          00111          013578999999999999999999999999974  4444

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=333.68  Aligned_cols=259  Identities=16%  Similarity=0.137  Sum_probs=193.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECC---CCcEEEEEEeeccccc---------------HHHHHHHHHhCCCCCeeec
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRY---------------KNRELQIMQMLDHPNIVAL   94 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~~   94 (376)
                      ...++|++.+.||+|+||.||+|.+..   ++..+|||++......               ..+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            344689999999999999999999987   7889999998654322               2356777888899999999


Q ss_pred             cceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC
Q 017131           95 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  174 (376)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~  174 (376)
                      ++++.... ....+.|+||||++++|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+
T Consensus       114 ~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          114 YGSGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESS
T ss_pred             eccccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccC
Confidence            99886643 23456889999997788776653    3379999999999999999999998 999999999999999866


Q ss_pred             C-CCeEEEecCCcccccCCC--------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-c
Q 017131          175 T-HQLKLCDFGSAKVLVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-G  244 (376)
Q Consensus       175 ~-~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~  244 (376)
                      + ..+||+|||+++......        ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            4 269999999997653221        11345789999999999754 58999999999999999999999996532 2


Q ss_pred             hHHHHHHHHH-hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          245 VDQLVEIIKV-LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       245 ~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .......... ....+.......                    -...+++++.+||.+||..||.+|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          267 PVAVQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cHHHHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            2222222221 111111111100                    00258999999999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.5e-44  Score=330.52  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=203.4

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCc-----EEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  102 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  102 (376)
                      ...+|++.+.||+|+||.||+|.+..+++     .||+|.+....     ....+|+.+++.+ +||||+++++++....
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            34689999999999999999999987665     79999986532     3345899999999 8999999999884332


Q ss_pred             CCCceEEEEEEecccc-cHHHHHHHhhhh----------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE
Q 017131          103 DKEELYLNLVLEYVPE-TVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  171 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill  171 (376)
                           .+++||||+++ +|.+++......          ...+++..++.++.|++.||+|||+ +||+||||||+||++
T Consensus       124 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          124 -----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL  197 (333)
T ss_dssp             -----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred             -----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence                 37899999975 998888765432          3468999999999999999999998 999999999999999


Q ss_pred             cCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHH
Q 017131          172 NPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  247 (376)
Q Consensus       172 ~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  247 (376)
                      +.++ .+||+|||+++........   ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+......
T Consensus       198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            9888 8999999999765433321   234567889999998654 48999999999999999998 9999998776666


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       248 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ...+......+                           ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            65555431110                           011357899999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.6e-44  Score=324.45  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=191.9

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||+++++++....   
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---  105 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN---  105 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT---
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---
Confidence            45568999999999999999999999999999999986421       23457999999999999999999885433   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        ..++||||+++ +|.+++.........+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||
T Consensus       106 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg  181 (310)
T 2wqm_A          106 --ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLG  181 (310)
T ss_dssp             --EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC-
T ss_pred             --cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEecc
Confidence              48899999986 8988888766666779999999999999999999998 9999999999999999888 89999999


Q ss_pred             CcccccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCHHH
Q 017131          185 SAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  262 (376)
Q Consensus       185 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  262 (376)
                      ++....... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.... ..........       
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  253 (310)
T 2wqm_A          182 LGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------  253 (310)
T ss_dssp             -----------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-------
T ss_pred             ceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-------
Confidence            987654322 2234568999999999965 45899999999999999999999999765322 1222211110       


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                 .++.        .....+++++.+||.+||..||.+|||+.++++
T Consensus       254 -----------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          254 -----------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             -----------CSCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------cCCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                       0110        011357899999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7e-44  Score=324.21  Aligned_cols=248  Identities=24%  Similarity=0.307  Sum_probs=190.0

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++||||+++++++...    
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~----  106 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID----  106 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET----
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC----
Confidence            34568999999999999999999999999999999986432       3345799999999999999999988543    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                       ..+++||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus       107 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg  179 (309)
T 2h34_A          107 -GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFG  179 (309)
T ss_dssp             -TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCC
T ss_pred             -CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCc
Confidence             348899999985 88777764    3579999999999999999999998 9999999999999999888 79999999


Q ss_pred             CcccccCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          185 SAKVLVKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       185 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ++.......  ......+|+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.. ......... .+    
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~----  252 (309)
T 2h34_A          180 IASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-IP----  252 (309)
T ss_dssp             C----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-CC----
T ss_pred             cCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-CC----
Confidence            987654322  2234568999999999965 45899999999999999999999999876543 222222210 00    


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-CHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-s~~~ll~  318 (376)
                                          ....+...+++++.+||.+||+.||.+|| |++++++
T Consensus       253 --------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 --------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             --------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             --------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                00112246899999999999999999999 7777764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.7e-45  Score=333.36  Aligned_cols=268  Identities=22%  Similarity=0.308  Sum_probs=201.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++....     ....+|+.+++.++||||+++++++.....     .
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-----~  102 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-----R  102 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC-----C
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc-----e
Confidence            35799999999999999999985 468999999986432     245689999999999999999998854332     6


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC---CccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ++||||+.+ +|.+++.........+++..++.++.|++.||+|||+ +   ||+||||||+|||++.++ .+||+|||+
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  180 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFGL  180 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCSS
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCcc
Confidence            799999975 8888887655455569999999999999999999998 8   999999999999999988 799999999


Q ss_pred             cccccCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CchHHHHHHHHHhCCCC
Q 017131          186 AKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE----SGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       186 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~~~~  259 (376)
                      ++.......  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...    .............    
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  255 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL----  255 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT----
T ss_pred             ccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH----
Confidence            986543322  2334589999999999654 4899999999999999999999999521    1111111111100    


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                             .   ................+....+..+.+|+.+||+.||.+|||+.++++|-.-..+
T Consensus       256 -------~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          256 -------L---KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             -------T---SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             -------h---hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence                   0   0001111111111111222345789999999999999999999999987665443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-44  Score=327.60  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=201.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEE-----CCCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .++|++.+.||+|+||+||+|.+     ..+++.||||++....     ....+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            46899999999999999999985     4567899999986532     2345799999999 789999999987432  


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhh------------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  170 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nil  170 (376)
                        ...+++||||+++ +|.+++......            ...+++..++.++.|++.||.|||+ +||+||||||+||+
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence              2236799999985 888877653221            1228999999999999999999998 99999999999999


Q ss_pred             EcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchH
Q 017131          171 VNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  246 (376)
Q Consensus       171 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  246 (376)
                      ++.++ .+||+|||+++........   ....+|+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+....+
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99888 7999999999765443322   23456889999999965 448999999999999999998 999998877655


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ...........+                           ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            554444321110                           0113578999999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.8e-44  Score=321.66  Aligned_cols=250  Identities=20%  Similarity=0.285  Sum_probs=188.8

Q ss_pred             CccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .-..++|++.+.||+|+||+||+|.+..   .+|+|++....      ....+|+.+++.++||||++++++.. ..   
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~---   92 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP---   92 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS---
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CC---
Confidence            3445689999999999999999998753   59999885432      23457999999999999999988541 11   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        ..++||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        93 --~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg  165 (289)
T 3og7_A           93 --QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFG  165 (289)
T ss_dssp             --SCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC
T ss_pred             --ccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEccce
Confidence              26799999984 77665532   24569999999999999999999998 9999999999999999988 89999999


Q ss_pred             CcccccCC---CCCceeeeeccccchhhhc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKG---EPNVSYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      +++.....   .......+|+.|+|||++.  ....++.++|||||||++|+|++|..||.+.+..+...........++
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  245 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP  245 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence            98754321   2223456899999999985  234578899999999999999999999998877776666555321111


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .                       ...+...+++++.+||.+||+.||.+|||+.++++
T Consensus       246 ~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 D-----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             C-----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c-----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0                       00112467899999999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-44  Score=330.01  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=192.6

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEE----EEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ....+|++.+.||+|+||+||+|++..+++.+    |+|.+...     .....+|+.+++.++||||+++++++...  
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence            34568999999999999999999998887754    77766432     23456799999999999999999988532  


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                        .  .+++++|+. ++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus        90 --~--~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~D  160 (327)
T 3poz_A           90 --T--VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITD  160 (327)
T ss_dssp             --S--EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECC
T ss_pred             --C--eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEcc
Confidence              1  557888887 577776654   23569999999999999999999998 9999999999999999988 799999


Q ss_pred             cCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          183 FGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       183 fg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      ||+++........   ....+|+.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....  
T Consensus       161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--  237 (327)
T 3poz_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--  237 (327)
T ss_dssp             TTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred             CcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC--
Confidence            9999765433322   23345778999999965 458999999999999999999 9999988776554433332100  


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                      .          ..+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus       238 ----------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 ----------------L----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------C----------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------------C----------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                            0          0113578999999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-45  Score=335.97  Aligned_cols=267  Identities=19%  Similarity=0.209  Sum_probs=199.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ...++|++.+.||+|+||+||+|.+ .+|+.||||++....    ....+|+.+++.++||||+++++++...     ..
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-----NE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----TC
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----Ce
Confidence            3456899999999999999999996 468999999886432    3346899999999999999999988432     23


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  187 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISK  187 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeeccccc
Confidence            7899999975 7765554322223458999999999999999999998 9999999999999999988 89999999997


Q ss_pred             cccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          188 VLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       188 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      ......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+........     .... 
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~-  260 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESH-  260 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHH-
T ss_pred             ccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcc-
Confidence            643221   22345689999999998654 5899999999999999999999999875433211110000     0000 


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  320 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp  320 (376)
                       ..     ..+...........+....+..+.+++.+||+.||.+|||+.++++|.
T Consensus       261 -~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          261 -NN-----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             -TT-----TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -cc-----ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence             00     001111111111122234567899999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.2e-44  Score=330.09  Aligned_cols=269  Identities=23%  Similarity=0.312  Sum_probs=201.1

Q ss_pred             CCCCCCccccceEEeeeeeecCceEEEEEE----ECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeecccee
Q 017131           27 GRNGNSKQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCF   98 (376)
Q Consensus        27 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~   98 (376)
                      +.....-...+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++||||+++++++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           14 CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             ---CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            334444566799999999999999999999    56789999999986543    2356899999999999999999987


Q ss_pred             eecCCCCceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131           99 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                      ..   .....+++||||++ ++|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .
T Consensus        94 ~~---~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~  165 (327)
T 3lxl_A           94 YG---PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-H  165 (327)
T ss_dssp             EC---SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-E
T ss_pred             ec---CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-C
Confidence            54   23345889999995 5888777653   2469999999999999999999998 9999999999999999888 8


Q ss_pred             eEEEecCCcccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  253 (376)
                      +||+|||+++.......    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......... ....
T Consensus       166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~  243 (327)
T 3lxl_A          166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGC  243 (327)
T ss_dssp             EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC-
T ss_pred             EEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hccc
Confidence            99999999986543322    2234567889999999654 4799999999999999999999999653321110 0000


Q ss_pred             HhCCCCHHHH-hhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          254 VLGTPTREEI-KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       254 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ....+....+ ......             .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          244 ERDVPALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             ---CCHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccccHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0000000000 000000             000112468999999999999999999999999965

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-44  Score=317.91  Aligned_cols=246  Identities=19%  Similarity=0.315  Sum_probs=199.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|++....   ....+|+.+++.++||||+++++++....     ..+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~   79 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC   79 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SCE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CeE
Confidence            3468999999999999999999986 57889999987543   34568999999999999999999884432     378


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ +|++||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~  154 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  154 (267)
T ss_dssp             EEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEccccccccc
Confidence            99999974 887777542   3468999999999999999999998 9999999999999999888 7999999998755


Q ss_pred             cCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....  ......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------  223 (267)
T 3t9t_A          155 LDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------  223 (267)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred             ccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------
Confidence            3211  1223445778999999965 448999999999999999999 8999988776655554433100          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                        ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                              00123578999999999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-43  Score=338.48  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ...+|++.+.||+|+||.||+|.+.  |+.||||++..+.  ....+|+.+|+.++||||+++++++....    ..+++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i  264 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI  264 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence            4468999999999999999999985  7899999987543  34568999999999999999999875432    23789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+.+ +|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCccccc
Confidence            9999975 8888876531  2347999999999999999999998 9999999999999999988 79999999997543


Q ss_pred             CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ..  .....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.+..              
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------------  403 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  403 (450)
T ss_dssp             --------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC--------------
T ss_pred             cc--ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            22  223356788999999965 458999999999999999998 999999877666555443310              


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                          ..          ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       404 ----~~----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 ----KM----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ----CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                00          112468999999999999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=333.83  Aligned_cols=256  Identities=14%  Similarity=0.101  Sum_probs=197.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCC--------CcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccc----------
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRET--------GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH----------   96 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~----------   96 (376)
                      .++|++.+.||+|+||.||+|++..+        ++.||||++... ....+|+.+++.++||||+++++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            35799999999999999999999874        889999998765 45679999999999999998433          


Q ss_pred             -----eeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE
Q 017131           97 -----CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  171 (376)
Q Consensus        97 -----~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill  171 (376)
                           ++..    ...+.++||||++++|.+++....  ...+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus       120 ~~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          120 PTCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFV  192 (352)
T ss_dssp             CCCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEE
T ss_pred             cchhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence                 3321    234588999999889988887531  3579999999999999999999998 999999999999999


Q ss_pred             cCCCC-CeEEEecCCcccccCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 017131          172 NPHTH-QLKLCDFGSAKVLVKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  242 (376)
Q Consensus       172 ~~~~~-~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  242 (376)
                      +.++. .+||+|||+++.......        .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            98752 699999999976543221        1334789999999999654 5899999999999999999999999876


Q ss_pred             C-chHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          243 S-GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       243 ~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      . ....+...........        ..     +..   .   ......+++++.+||.+||+.||.+|||+.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~--------~~-----~~~---~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKP--------GP-----FVG---P---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSC--------CC-----EEC---T---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CcCHHHHHHHHHhccCCh--------hh-----hhh---h---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            4 3333333322110000        00     000   0   0001357899999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.7e-44  Score=328.33  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=198.9

Q ss_pred             cccceEEeeeeeecCceEEEEEEEC-------CCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeee
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS  100 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~  100 (376)
                      ..++|++.+.||+|+||.||+|.+.       .++..||||++....     ....+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4468999999999999999999986       456789999986542     2345799999999 89999999998843


Q ss_pred             cCCCCceEEEEEEecccc-cHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 017131          101 TTDKEELYLNLVLEYVPE-TVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  167 (376)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~  167 (376)
                      .     ..+++||||+++ +|.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus       113 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~  186 (334)
T 2pvf_A          113 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR  186 (334)
T ss_dssp             S-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGG
T ss_pred             C-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccc
Confidence            2     237899999975 88888765321            12348999999999999999999998 99999999999


Q ss_pred             cEEEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 017131          168 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  243 (376)
Q Consensus       168 Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  243 (376)
                      ||+++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       187 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          187 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999888 799999999976543321   2233457889999998654 48999999999999999999 999998877


Q ss_pred             chHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          244 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       244 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..+....+.....                            ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus       265 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          265 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6555444433100                            00124578999999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.7e-44  Score=319.86  Aligned_cols=246  Identities=27%  Similarity=0.365  Sum_probs=196.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECC---CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++.+.||+|+||+||+|.+..   ++..||+|.+....     ....+|+.+++.++||||+++++++..    .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----C
Confidence            44689999999999999999999654   34569999986542     334579999999999999999998732    1


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      .  .++||||+. ++|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        86 ~--~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg  158 (281)
T 3cc6_A           86 P--TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGDFG  158 (281)
T ss_dssp             S--CEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECCCC
T ss_pred             C--CEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCccC
Confidence            1  468999998 488777754   23569999999999999999999998 9999999999999999888 89999999


Q ss_pred             CcccccCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          185 SAKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       185 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ++........  .....+|+.|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+......    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~----  233 (281)
T 3cc6_A          159 LSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL----  233 (281)
T ss_dssp             GGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC----
T ss_pred             CCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC----
Confidence            9976543321  223445788999999964 458999999999999999998 99999887766655544431100    


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                  .            .+..+++.+.+||.+||..||.+|||+.+++++
T Consensus       234 ------------~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 ------------P------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ------------C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------C------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                        0            113578999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-44  Score=327.51  Aligned_cols=245  Identities=22%  Similarity=0.338  Sum_probs=190.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEE----EEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ...+|++.+.||+|+||+||+|.+..+++.+    |+|.+...     .....+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---   89 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   89 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence            3467999999999999999999998888765    55555321     23456799999999999999999988532   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       .  .+++++|+. ++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus        90 -~--~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~Df  161 (327)
T 3lzb_A           90 -T--VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             -S--EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             -C--ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccC
Confidence             1  567888887 477776654   24569999999999999999999998 9999999999999999888 7999999


Q ss_pred             CCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          184 GSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       184 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+++........   ....+|+.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....   
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---  237 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---  237 (327)
T ss_dssp             TC----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred             cceeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---
Confidence            999765433222   23345778999999965 458999999999999999999 9999988776655444332100   


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                     .          ..+..++.++.+||.+||..||.+|||+.++++
T Consensus       238 ---------------~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          238 ---------------L----------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ---------------C----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------C----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           0          011357899999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.8e-44  Score=322.65  Aligned_cols=262  Identities=23%  Similarity=0.367  Sum_probs=195.6

Q ss_pred             cccceEEeeeeeecCceEEEEEE----ECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ...+|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+.+++.++||||+++++++....  
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--   96 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence            34579999999999999999999    57789999999986432     34568999999999999999999885432  


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       ...+++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+||
T Consensus        97 -~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Df  170 (302)
T 4e5w_A           97 -GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDF  170 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred             -CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECcc
Confidence             2337899999975 888777542   3569999999999999999999998 9999999999999999888 8999999


Q ss_pred             CCcccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          184 GSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       184 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |++........    .....+|..|+|||.+.+. .++.++|+|||||++|+|++|..|+...     ........+...
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~  244 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTH  244 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCC
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcc
Confidence            99986644332    2234567789999999654 4789999999999999999999886432     111111111111


Q ss_pred             HH-HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 RE-EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .. ...........         ......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          245 GQMTVTRLVNTLKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GGGHHHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cccCHHHHHHHHhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            00 00000000000         0001122468999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.4e-44  Score=345.59  Aligned_cols=247  Identities=20%  Similarity=0.355  Sum_probs=202.5

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||.||+|.+..++..||||++..+.   ....+|+.+|+.++||||+++++++....     .++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cEE
Confidence            4568999999999999999999999999999999987543   34558999999999999999999884332     378


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeecccceec
Confidence            9999998 58888776422  3468999999999999999999998 9999999999999999888 7999999999865


Q ss_pred             cCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....  .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...            
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------  435 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------  435 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT------------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence            33221  1223456789999999654 48999999999999999999 99999988766554443321            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                            ...          ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       436 ------~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          436 ------YRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CCC----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                  000          112468999999999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.9e-44  Score=334.00  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=188.7

Q ss_pred             ccccceEEeeeeeecCceEEEEEEEC---CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ....+|.+.+.||+|+||.||+|++.   .++..||||++....     ....+|+.+++.++||||+++++++...   
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  118 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS---  118 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC---
Confidence            34568999999999999999999986   467789999986432     2345799999999999999999988432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                        ...++||||++ ++|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       119 --~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Df  191 (373)
T 2qol_A          119 --KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDF  191 (373)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             --CceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcC
Confidence              23789999996 588877754   23469999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          184 GSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       184 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      |+++........    ....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....   
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~---  267 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---  267 (373)
T ss_dssp             ----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE---
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            999765433211    12234678999999965 458999999999999999998 999998877655554443211   


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                     ..+          .+..++..+.+||.+||+.||.+||++.++++
T Consensus       268 ---------------~~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          268 ---------------RLP----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------ECC----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCC----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                           010          11357899999999999999999999998875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-43  Score=319.38  Aligned_cols=243  Identities=23%  Similarity=0.296  Sum_probs=194.8

Q ss_pred             ccceEEee-eeeecCceEEEEEE--ECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEH-VVGTGSFGVVFQAK--CRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++.+ .||+|+||+||+|.  +..+++.||||++....      ....+|+.+++.++||||+++++++ ...   
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~---   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE---   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence            45799999 99999999999995  46678899999986432      3355799999999999999999987 221   


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        ..++||||+. ++|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccCC
Confidence              2679999998 578777754    4569999999999999999999998 9999999999999999888 89999999


Q ss_pred             CcccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      ++.........    ....+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+.+..+....+... .   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~---  237 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-E---  237 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C---
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C---
Confidence            99765433221    122346789999999654 47899999999999999999 99999887765544433221 0   


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                     .         ..++..+++++.++|.+||+.||.+|||+.++++
T Consensus       238 ---------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          238 ---------------R---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---------------C---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0         0012468999999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.3e-43  Score=319.36  Aligned_cols=244  Identities=26%  Similarity=0.344  Sum_probs=188.1

Q ss_pred             cccceEEe-eeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHH-HhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           34 QKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        34 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..++|.+. +.||+|+||.||+|.+..+++.||||++... ....+|+.++ +..+||||+++++++.... ....++++
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l   92 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   92 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence            34568887 7899999999999999999999999998653 4456888888 6679999999999885422 23456889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC---CCCCeEEEecCCcc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAK  187 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~---~~~~vkl~Dfg~a~  187 (376)
                      ||||+++ +|.+++...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++.   ++ .+||+|||++.
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~  168 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  168 (299)
T ss_dssp             EECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEecccccc
Confidence            9999975 888877652  22469999999999999999999998 99999999999999997   55 79999999986


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...                      ...++.++|+|||||++|+|++|..||.+.+..........              
T Consensus       169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------------  212 (299)
T 3m2w_A          169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------------  212 (299)
T ss_dssp             ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------------
T ss_pred             ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------------
Confidence            432                      13478899999999999999999999977543221100000              


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                          ......   ..+.......+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       213 ----~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 ----RIRMGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ----SSCTTC---CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ----HHhhcc---ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                000000   0000111135799999999999999999999999999999998743

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-43  Score=315.91  Aligned_cols=245  Identities=13%  Similarity=0.184  Sum_probs=198.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|++....      ....+|+.+++.++||||+++++++....   ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---AP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CC
Confidence            4468999999999999999999985  8899999986432      23457999999999999999999885431   23


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ..++||||+++ +|.+++...  ....+++..++.++.|++.||+|||+ +|  |+||||||+||+++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEecc
Confidence            47799999985 888877642  12258999999999999999999998 89  99999999999999888 79999998


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ++....    .....+|+.|+|||.+.+...  ++.++|||||||++|+|++|..||.+.+..+....+......     
T Consensus       159 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  229 (271)
T 3kmu_A          159 VKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-----  229 (271)
T ss_dssp             SCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             ceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence            875432    223467999999999965432  333899999999999999999999988776665555432100     


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                            ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus       230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 ----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                  0122468999999999999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-44  Score=320.28  Aligned_cols=247  Identities=26%  Similarity=0.315  Sum_probs=198.2

Q ss_pred             cccceEEee-eeeecCceEEEEEEEC--CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ..++|.+.+ .||+|+||.||+|.+.  .++..||||++....     ....+|+.+++.++||||+++++++. ..   
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~---   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE---   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS---
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC---
Confidence            345788877 9999999999999864  467889999986532     23457999999999999999999872 21   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        ..++||||+++ +|.+++..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        83 --~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg  155 (287)
T 1u59_A           83 --ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFG  155 (287)
T ss_dssp             --SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCT
T ss_pred             --CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECccc
Confidence              17899999986 77766643   23569999999999999999999998 9999999999999999888 89999999


Q ss_pred             CcccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      ++........    .....+|+.|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..+....+....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~----  230 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----  230 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC----
Confidence            9976643322    1223457889999999643 48999999999999999998 999998877665554443210    


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  320 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp  320 (376)
                                     .         ..++..+++++.+||.+||..||.+|||+.++++|.
T Consensus       231 ---------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          231 ---------------R---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ---------------C---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ---------------c---------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                           0         012246899999999999999999999999999764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-43  Score=316.71  Aligned_cols=244  Identities=22%  Similarity=0.330  Sum_probs=192.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..++|++.+.||+|+||+||+|.+.  |+.||+|++..+.  ....+|+.+++.++||||+++++++....    ...++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~l   92 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI   92 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceEE
Confidence            3468999999999999999999875  8899999986543  33568999999999999999999864322    23779


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ +|.+++....  ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  168 (278)
T ss_dssp             EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred             EEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeecccccccc
Confidence            9999986 8888876532  2248899999999999999999998 9999999999999999888 79999999987543


Q ss_pred             CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ..  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+....              
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------------  231 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  231 (278)
T ss_dssp             ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred             cc--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            22  233456888999999965 458999999999999999998 999998876655544332210              


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                    ....+..+++.+.++|.+||..||.+|||+.++++
T Consensus       232 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 --------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                          00112468999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4e-44  Score=328.40  Aligned_cols=256  Identities=18%  Similarity=0.210  Sum_probs=198.8

Q ss_pred             cccceEEeeeeeecCceEEEEEE-----ECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ...+|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+.+++.++||||+++++++.... 
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-
Confidence            45689999999999999999999     55678899999985432     23457999999999999999999884332 


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhhh---cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CC
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQ  177 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~  177 (376)
                          ..++||||++ ++|.+++......   ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++  ..
T Consensus       107 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          107 ----PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             ----CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence                3679999995 5888888764321   1358999999999999999999998 9999999999999998433  26


Q ss_pred             eEEEecCCcccccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  253 (376)
                      +||+|||++.......   ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999987543222   12234568899999998654 58999999999999999998 9999988776554444332


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      .. .+                           ..+..+++.+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus       261 ~~-~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          261 GG-RM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-CC---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            10 00                           012457899999999999999999999999999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=323.43  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=193.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCC----cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  103 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (376)
                      ....+|++.+.||+|+||+||+|.+..++    ..||||++....     ....+|+.+++.++||||+++++++..   
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---  117 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK---  117 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec---
Confidence            34568999999999999999999987654    359999986432     234579999999999999999998843   


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                        ....++||||+++ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|
T Consensus       118 --~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~D  190 (333)
T 1mqb_A          118 --YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSD  190 (333)
T ss_dssp             --SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECC
T ss_pred             --CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECC
Confidence              2337899999986 88777754   23579999999999999999999998 9999999999999999988 899999


Q ss_pred             cCCcccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017131          183 FGSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       183 fg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      ||+++........    ....+|+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+....  
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~--  267 (333)
T 1mqb_A          191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF--  267 (333)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--
T ss_pred             CCcchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC--
Confidence            9999765432211    12234778999999965 458999999999999999999 999998877655554443210  


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                      ..+          .+..+++++.+||.+||+.||.+||++.+++++
T Consensus       268 ----------------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          268 ----------------RLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ----------------CCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            000          113578999999999999999999999998863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.2e-43  Score=337.00  Aligned_cols=258  Identities=21%  Similarity=0.214  Sum_probs=202.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .++|++++.||+|+||.||+|.+..+++.||||++...  .....+|+++++.+.|++++..+..+..    ...+.++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEE
Confidence            45799999999999999999999999999999987543  3456789999999988665555544432    22347899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE---cCCCCCeEEEecCCcccc
Q 017131          113 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       113 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill---~~~~~~vkl~Dfg~a~~~  189 (376)
                      |||++++|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||+   +.++ .+||+|||+++..
T Consensus        82 me~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~  156 (483)
T 3sv0_A           82 MDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY  156 (483)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCcceec
Confidence            99998899888764   24579999999999999999999998 999999999999999   4666 7999999999876


Q ss_pred             cCCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHhCCC
Q 017131          190 VKGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTP  258 (376)
Q Consensus       190 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~~~~~  258 (376)
                      .....        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......   +..+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            44322        1256789999999999654 589999999999999999999999988654333   22222211111


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc----------CCcccccC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV----------HPFFDELR  326 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~----------hp~f~~~~  326 (376)
                      ..+                        .+...+++++.+||.+||..||.+||++.++++          ++|+..+.
T Consensus       236 ~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~d  289 (483)
T 3sv0_A          236 SIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFD  289 (483)
T ss_dssp             CHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCH
T ss_pred             cHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcC
Confidence            111                        111357999999999999999999999887653          66665543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.3e-45  Score=359.75  Aligned_cols=283  Identities=25%  Similarity=0.330  Sum_probs=206.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  109 (376)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++..... ......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            46999999999999999999999999999999886432     234579999999999999999887643211 123446


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC--CeEEEecCCc
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSA  186 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~vkl~Dfg~a  186 (376)
                      ++||||++ ++|.+++.... ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.  .+||+|||++
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            79999996 58877776422 12368999999999999999999998 99999999999999997662  3899999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .............+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+..........   ........+...
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~  247 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVY  247 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSC
T ss_pred             cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhh
Confidence            87766655666788999999999865 45899999999999999999999999875432221110   000000000000


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ........+...  .+....+...+++.+.+||.+||.+||.+|||+.++++||||+.+.
T Consensus       248 ~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          248 DDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            000011111111  1111223345678999999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-43  Score=318.25  Aligned_cols=247  Identities=21%  Similarity=0.314  Sum_probs=194.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCC---cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...+|++.+.||+|+||+||+|.+..++   ..+|+|.+....     ....+|+.+++.++||||+++++++...    
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   98 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----   98 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence            3457999999999999999999975443   358999876432     2345799999999999999999986432    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ....++||||+++ +|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg  173 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFG  173 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCG
T ss_pred             CCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECccc
Confidence            2236799999986 88777753   23568999999999999999999998 9999999999999999988 79999999


Q ss_pred             CcccccCCC-----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          185 SAKVLVKGE-----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       185 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      +++......     ......+|+.|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+....+.....  
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~--  250 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--  250 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC--
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC--
Confidence            997653321     12334567889999999654 58999999999999999999 6788877766655554443110  


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                                ...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       251 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      0012357899999999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-43  Score=337.75  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=199.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||+||+|.+. ++..||||++....   ....+|+.+|+.++||||+++++++. .   +  .++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~---~--~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K---E--PIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S---S--SCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C---C--ccE
Confidence            4468999999999999999999985 46789999987543   34568999999999999999998873 1   1  267


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            9999997 48888876432  2368899999999999999999998 9999999999999999988 7999999999865


Q ss_pred             cCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....  ......+|..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+.....          
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  403 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------  403 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC----------
T ss_pred             CCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            3221  1122345778999999964 458999999999999999999 9999998887666655544211          


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                              .+          .+..+++++.+||.+||..||.+|||+.+++.
T Consensus       404 --------~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          404 --------MP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             --------CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CC----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                    11          11457999999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=325.18  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=188.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHhC--CCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|++.+.||+|+||.||+|++.  ++.||||++..... ...+|.+++..+  +||||+++++++..... ....+++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEEE
Confidence            58999999999999999999985  89999999865432 233566666554  99999999998865432 22458899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC--------CccccCCCCCcEEEcCCCCCeEEEec
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      |||+++ +|.+++..     ..+++..++.++.|++.||+|||+ +        ||+||||||+|||++.++ .+||+||
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            999975 88887753     469999999999999999999997 8        999999999999999888 8999999


Q ss_pred             CCcccccCCCCC-----ceeeeeccccchhhhcCCCCCCC------chhHHHHHHHHHHHHhC----------CCCCCCC
Q 017131          184 GSAKVLVKGEPN-----VSYICSRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLG----------QPLFPGE  242 (376)
Q Consensus       184 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~elltg----------~~pf~~~  242 (376)
                      |+++........     ....||+.|+|||++.+.. +..      ++|||||||++|+|++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433222     2447899999999996543 344      39999999999999999          6676543


Q ss_pred             Cch----HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          243 SGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       243 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ...    ..........                     ..............+++++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIK---------------------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTS---------------------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhh---------------------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            221    1111111100                     000000000111245678999999999999999999999987


Q ss_pred             C
Q 017131          319 H  319 (376)
Q Consensus       319 h  319 (376)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-43  Score=314.97  Aligned_cols=248  Identities=21%  Similarity=0.318  Sum_probs=195.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .....|.+.+.||+|+||+||+|.+..+++   .||+|++....     ....+|+.+++.++||||+++++++.+..  
T Consensus        18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   95 (298)
T 3pls_A           18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--   95 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS--
T ss_pred             ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC--
Confidence            445579999999999999999999765554   79999886432     23457999999999999999999885432  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                        ...+++|||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+||
T Consensus        96 --~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Df  168 (298)
T 3pls_A           96 --GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADF  168 (298)
T ss_dssp             --SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCT
T ss_pred             --CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcC
Confidence              22468999985 588776653   34578999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccCC-----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017131          184 GSAKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       184 g~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |+++.....     .......+|+.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+......
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL  247 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence            999754322     22234456889999999965 458999999999999999999 55666655555544433321100


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                                  ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       248 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 ----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                        012357899999999999999999999999885

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.5e-43  Score=314.10  Aligned_cols=251  Identities=23%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|.+....   ....+|+.+++.++||||+++++++..    +  ..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~--~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC----C--CcE
Confidence            3468999999999999999999975 56789999986543   345689999999999999999988731    1  167


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+. ++|.+++....  ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence            9999996 58877765421  2368999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             cCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....  .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+....           
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----------  227 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----------  227 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred             cCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-----------
Confidence            43321  123345778999999964 348999999999999999999 999998877655554443210           


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc--CCcccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~--hp~f~~  324 (376)
                             .          ...+..+++++.+||.+||..||.+|||+.++++  ..++..
T Consensus       228 -------~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          228 -------R----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------C----------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                   0          0112467899999999999999999999999875  344443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8e-44  Score=327.52  Aligned_cols=276  Identities=22%  Similarity=0.301  Sum_probs=193.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc-cHHHHHHH--HHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQI--MQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ..++|++.+.||+|+||.||+|++  +++.||||++..... ....|.++  +..++||||+++++.+..........++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            345799999999999999999986  589999999865432 22234444  4558999999998876555555566688


Q ss_pred             EEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC---------CccccCCCCCcEEEcCCCCCeEE
Q 017131          111 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------GICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       111 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                      +||||++ ++|.+++..     ...++..++.++.||+.||+|||+ .         ||+||||||+|||++.++ .+||
T Consensus        89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL  161 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVI  161 (336)
T ss_dssp             EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEEE
T ss_pred             EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEEE
Confidence            9999996 488887754     456889999999999999999998 8         999999999999999988 8999


Q ss_pred             EecCCcccccCCC---------CCceeeeeccccchhhhcCC------CCCCCchhHHHHHHHHHHHHhCCCCCC-CCCc
Q 017131          181 CDFGSAKVLVKGE---------PNVSYICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLLGQPLFP-GESG  244 (376)
Q Consensus       181 ~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~elltg~~pf~-~~~~  244 (376)
                      +|||+++......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||. +...
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999997654321         12234689999999999652      345678999999999999999965553 3322


Q ss_pred             hHHHHHHHH-HhCCCCHHHHhhcC-cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc----
Q 017131          245 VDQLVEIIK-VLGTPTREEIKCMN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV----  318 (376)
Q Consensus       245 ~~~~~~i~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~----  318 (376)
                      .+....+.. ....+....+.... .......++.    .+..  ...+++++.+||.+||+.||.+|||+.++++    
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            111111111 11222222221110 0000001110    0000  0124568999999999999999999999954    


Q ss_pred             --CCcccc
Q 017131          319 --HPFFDE  324 (376)
Q Consensus       319 --hp~f~~  324 (376)
                        ++|-++
T Consensus       316 ll~~~~~~  323 (336)
T 3g2f_A          316 LMMIWERN  323 (336)
T ss_dssp             HHHCCCC-
T ss_pred             HHHHHHhc
Confidence              566554

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=329.12  Aligned_cols=249  Identities=20%  Similarity=0.300  Sum_probs=189.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCC---cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .....|++.+.||+|+||+||+|.+..++   ..||+|.+....     ....+|+.+++.++||||+++++++....  
T Consensus        86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--  163 (373)
T 3c1x_A           86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE--  163 (373)
T ss_dssp             STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS--
T ss_pred             hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--
Confidence            34457999999999999999999975433   468999885432     23457999999999999999999764322  


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                        ...++||||+++ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       164 --~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DF  236 (373)
T 3c1x_A          164 --GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADF  236 (373)
T ss_dssp             --SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             --CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeec
Confidence              236799999985 88777753   23568999999999999999999998 9999999999999999988 7999999


Q ss_pred             CCcccccCCCC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017131          184 GSAKVLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  257 (376)
Q Consensus       184 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  257 (376)
                      |+++.......     .....+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....  
T Consensus       237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--  313 (373)
T 3c1x_A          237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--  313 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--
T ss_pred             cccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--
Confidence            99976533221     123456788999999965 458999999999999999999 788998876655554443210  


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .                          ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       314 ~--------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 R--------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                          00124578999999999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.4e-43  Score=335.84  Aligned_cols=245  Identities=25%  Similarity=0.371  Sum_probs=195.6

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++....   ....+|+.+|+.++||||+++++++..    +  .++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~--~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----E--PIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC----C--ceE
Confidence            34689999999999999999999875 4679999987543   345689999999999999999988732    1  267


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+.+ +|.+++...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence            99999975 888877542  23568999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             cCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .....  .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....           
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-----------  398 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----------  398 (452)
T ss_dssp             ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred             CCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            43221  1233457789999999654 58999999999999999999 999999887666555543311           


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                             ..+          .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       399 -------~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          399 -------RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             -------CCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   010          12467999999999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=314.40  Aligned_cols=245  Identities=28%  Similarity=0.390  Sum_probs=187.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .++|++.+.||+|+||+||+|.+.  ++.||||++....  ....+|+.+++.++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            458999999999999999999975  7889999986543  33558999999999999999998773     12  5699


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc--CCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |||+++ +|.+++.... ....+++..+..++.|++.||+|||+.  +||+||||||+||+++.++..+||+|||++...
T Consensus        78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999975 8877776421 122478899999999999999999962  589999999999999988744899999999754


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ..  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||................+..           
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  222 (307)
T 2eva_A          157 QT--HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-----------  222 (307)
T ss_dssp             ----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-----------
T ss_pred             cc--ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-----------
Confidence            32  2334568999999999965 458999999999999999999999998654322111111100000           


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                     ......+++.+.+||.+||+.||.+|||+.++++
T Consensus       223 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 ---------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ---------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                           0012468999999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-43  Score=322.08  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=197.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--------cccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .....|...+.||+|+||.||+|.+  +++.||+|++...        .....+|+.+++.++||||+++++++....  
T Consensus        28 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--  103 (307)
T 2nru_A           28 DERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--  103 (307)
T ss_dssp             CCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             ccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--
Confidence            3445677789999999999999986  5789999988542        123458999999999999999999884432  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                         ..++||||++ ++|.+.+.... ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+||
T Consensus       104 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Df  177 (307)
T 2nru_A          104 ---DLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDF  177 (307)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCC
T ss_pred             ---ceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeec
Confidence               3779999996 58877776432 24569999999999999999999998 9999999999999999888 8999999


Q ss_pred             CCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC--
Q 017131          184 GSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP--  258 (376)
Q Consensus       184 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--  258 (376)
                      |+++.......   .....+|+.|+|||.+.+  .++.++|+|||||++|+|++|.+||.+.........+.......  
T Consensus       178 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  255 (307)
T 2nru_A          178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK  255 (307)
T ss_dssp             TTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred             ccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence            99876543222   223467999999999854  47999999999999999999999998765544333333321111  


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ....+  ...     .++         ......+..+.+++.+||..||.+|||+.++++
T Consensus       256 ~~~~~--~~~-----~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          256 TIEDY--IDK-----KMN---------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             CHHHH--SCS-----SCS---------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhhh--ccc-----ccc---------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11100  000     000         011234678999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=327.09  Aligned_cols=245  Identities=16%  Similarity=0.182  Sum_probs=190.9

Q ss_pred             ccceEEeeeeeecCceEEEEE-----EECCCCcEEEEEEeeccc-ccHHHHHHHHHhCC---CCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQA-----KCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  105 (376)
                      ..+|++.+.||+|+||+||+|     .+..+++.||||++.... ....+|+.+++.+.   |+||+.+++++.....  
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~--  141 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG--  141 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC--
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC--
Confidence            468999999999999999999     467889999999986543 34557888888887   9999999998855433  


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhh-hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC----------
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP----------  173 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~----------  173 (376)
                         .++||||++ ++|.+++..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.          
T Consensus       142 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          142 ---SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             ---EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred             ---cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence               789999997 588888876543 24569999999999999999999998 99999999999999987          


Q ss_pred             -CCCCeEEEecCCcccccC---CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 017131          174 -HTHQLKLCDFGSAKVLVK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  249 (376)
Q Consensus       174 -~~~~vkl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  249 (376)
                       ++ .+||+|||+|+....   .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......   
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence             66 799999999965432   2223445689999999999664 48999999999999999999999996532110   


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 017131          250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  320 (376)
Q Consensus       250 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp  320 (376)
                                             ........    .   ...++.+.+++.+||+.+|.+|++..+.+.+.
T Consensus       293 -----------------------~~~~~~~~----~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          293 -----------------------CKPEGLFR----R---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             -----------------------EEECSCCT----T---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             -----------------------eeechhcc----c---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                                   00000000    0   12367889999999999999997765555443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.1e-43  Score=320.46  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=191.8

Q ss_pred             ceEEeeeeeecCceEEEEEE----ECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .|++++.||+|+||+||+|.    +..+++.||||++....     ....+|+.+++.++||||+++++++....   ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~  108 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AA  108 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cc
Confidence            45999999999999998875    34578999999987543     23468999999999999999999886532   33


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++||||+++ +|.+++..     ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+|||++
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a  181 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLA  181 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred             eEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCcccc
Confidence            57899999975 87766643     459999999999999999999998 9999999999999999988 8999999999


Q ss_pred             ccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH-
Q 017131          187 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-  261 (376)
Q Consensus       187 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-  261 (376)
                      ........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......     .....+..... 
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~  255 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM  255 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch
Confidence            87644332    2234567889999999654 4789999999999999999999999653211     00111111000 


Q ss_pred             ---HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          262 ---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       262 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                         .+......            ......+..+++++.+||++||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          256 TVLRLTELLER------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHhc------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               00000000            0001112468999999999999999999999999984

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-42  Score=319.20  Aligned_cols=253  Identities=21%  Similarity=0.229  Sum_probs=193.3

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHh--CCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|++.+.||+|+||.||+|.+  +|+.||||++.... ....+|+++++.  ++||||+++++++..... ....+++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEE
Confidence            5899999999999999999998  48999999986543 334578888887  799999999998855432 12247899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH--------hcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      |||+++ +|.+++..     ..+++..++.++.|++.||+|||        + .||+||||||+||+++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999986 88887754     46999999999999999999999        8 8999999999999999988 8999999


Q ss_pred             CCcccccCCCC-----CceeeeeccccchhhhcCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 017131          184 GSAKVLVKGEP-----NVSYICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLG----------QPLFPGES  243 (376)
Q Consensus       184 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg----------~~pf~~~~  243 (376)
                      |++........     .....+|+.|+|||++.+...     ++.++|||||||++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99976644332     234468999999999965422     23689999999999999999          77886643


Q ss_pred             ch----HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          244 GV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       244 ~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..    +..........              ....++       .......++..+.+||.+||+.||.+|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~--------------~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQK--------------LRPNIP-------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSC--------------CCCCCC-------GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHH--------------hCCCCc-------ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            21    22222111000              000000       000112345689999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.8e-43  Score=314.73  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=191.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-CCc--EEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ..+|++.+.||+|+||+||+|.+.. +++  .||||++....       ....+|+.+++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            4589999999999999999998643 333  68999875431       2345799999999999999999988432   


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       .  .++||||+. ++|.+.+...   ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+||
T Consensus        94 -~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           94 -P--MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             -S--CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -C--ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEccc
Confidence             1  568999997 5887777643   3569999999999999999999998 9999999999999999888 8999999


Q ss_pred             CCcccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          184 GSAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       184 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      |++.........    ....+|..|+|||++.+. .++.++|+||||+++|+|++ |..||.+.+..+....+....   
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---  241 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG---  241 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC---
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC---
Confidence            999766443321    233457789999999654 47899999999999999999 999999887665555443310   


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                                    ...+          .+..+++++.++|.+||..||.+|||+.++++  +++++
T Consensus       242 --------------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          242 --------------ERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             --------------CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             --------------CCCC----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence                          0000          11457999999999999999999999999986  55544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=338.43  Aligned_cols=245  Identities=24%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++....   ..+.+|+.+|+.++||||+++++++..      ..++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            34689999999999999999999875 4679999987543   345689999999999999999988732      1267


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||+.+ +|.+++...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence            99999975 888877542  23568999999999999999999998 9999999999999999888 7999999999765


Q ss_pred             cCCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....  ......++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+....           
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-----------  481 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----------  481 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred             CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            3211  11223456789999998654 58999999999999999999 999999887666555543311           


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                             ..+          .+..++.++.+||.+||+.||.+|||+.++++
T Consensus       482 -------~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          482 -------RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             -------CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                   110          12468999999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=317.70  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=196.3

Q ss_pred             ccccceEEeeeeeecCceEEEEEE----ECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ....+|++++.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++||||+++++++....  
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence            355689999999999999999999    46789999999986533    23558999999999999999999875432  


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                       ...+++||||+++ +|.+++...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++ .+||+||
T Consensus       116 -~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          116 -RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecC
Confidence             2236799999975 888777642   3469999999999999999999998 9999999999999999888 8999999


Q ss_pred             CCcccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          184 GSAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       184 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      |+++.......    .....++..|+|||.+.+. .++.++|||||||++|+|++|..||....     .......+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhcccc
Confidence            99986644322    1223457789999999654 48899999999999999999999886421     11111111111


Q ss_pred             HHH------HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REE------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ...      .......   ...          ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~---~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNN---GRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CTHHHHHHHHHHHHTT---CCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHHHHhhcC---CCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            100      0000000   000          112468999999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.8e-42  Score=340.61  Aligned_cols=241  Identities=23%  Similarity=0.301  Sum_probs=191.6

Q ss_pred             ceEEe-eeeeecCceEEEEEEE--CCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAE-HVVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~-~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+.+. +.||+|+||.||+|.+  ..+++.||||++....      ....+|+.+|+.++||||+++++++.. .   . 
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~---~-  443 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E---S-  443 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S---S-
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C---C-
Confidence            34443 4899999999999954  5667899999986432      345689999999999999999998731 1   1 


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                       +++||||+.+ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       444 -~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla  516 (635)
T 4fl3_A          444 -WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLS  516 (635)
T ss_dssp             -EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHH
T ss_pred             -EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCc
Confidence             6799999985 78777753    4679999999999999999999998 9999999999999999988 8999999999


Q ss_pred             ccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      +.......    .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.....     
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----  590 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-----  590 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----
T ss_pred             cccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            86643322    223345788999999965 458999999999999999998 9999998877665555443110     


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                 .            ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       591 -----------~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 -----------M------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------C------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------C------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                       0            012468999999999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=338.96  Aligned_cols=248  Identities=25%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             cceEEee-eeeecCceEEEEEEEC--CCCcEEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+|.+.+ .||+|+||.||+|.+.  .++..||||++...     .....+|+.+|+.++||||+++++++.. .     
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----
Confidence            4566666 8999999999999875  35667999998653     2345689999999999999999998743 1     


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++||||+.+ +|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla  483 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLS  483 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred             CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence            17899999985 77666643   24569999999999999999999998 9999999999999999888 8999999999


Q ss_pred             ccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      +........    ....+++.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+....      
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------  556 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------  556 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC------
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------
Confidence            865433221    12234678999999964 458999999999999999998 999999988776665554310      


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHh---cCCccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC---VHPFFD  323 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll---~hp~f~  323 (376)
                                  .          ..++..+++++.+||.+||..||.+||++.+++   ++.|+.
T Consensus       557 ------------~----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          557 ------------R----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ------------C----------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ------------C----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                        0          011246899999999999999999999999875   454443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.1e-44  Score=331.50  Aligned_cols=248  Identities=17%  Similarity=0.151  Sum_probs=182.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhCC---------CCCe--
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD---------HPNI--   91 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~~i--   91 (376)
                      .++|++.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         ||||  
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  68999999987542            34568999999886         5554  


Q ss_pred             ---------------eeccceeeecCC--------CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHH
Q 017131           92 ---------------VALKHCFFSTTD--------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQIC  147 (376)
Q Consensus        92 ---------------v~~~~~~~~~~~--------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~  147 (376)
                                     ++++++|.+...        .....+|+||||+.+ ++.+.+     ..+.+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-----~~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-----TTTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-----HhcCCCHHHHHHHHHHHH
Confidence                           444444432100        013458899999965 332222     125689999999999999


Q ss_pred             HHHHHHH-hcCCccccCCCCCcEEEcCCC-------------------CCeEEEecCCcccccCCCCCceeeeeccccch
Q 017131          148 RALAYIH-NCIGICHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP  207 (376)
Q Consensus       148 ~al~~LH-~~~~iiH~Dlkp~Nill~~~~-------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aP  207 (376)
                      .||+||| + +||+||||||+|||++.++                   ..+||+|||+|+....    ...+||+.|+||
T Consensus       172 ~aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aP  246 (336)
T 2vuw_A          172 ASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCS
T ss_pred             HHHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccCh
Confidence            9999999 8 8999999999999999775                   1699999999986543    245889999999


Q ss_pred             hhhcCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCchH-HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcccccccc
Q 017131          208 ELIFGATEYTTAIDIWSTGCV-MAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  285 (376)
Q Consensus       208 E~~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (376)
                      |++.+..  +.++||||+|++ .+++++|..||.+..... ....+....                  .......    .
T Consensus       247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------~~~~~~~----~  302 (336)
T 2vuw_A          247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM------------------TFKTKCN----T  302 (336)
T ss_dssp             GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC------------------CCSSCCC----S
T ss_pred             hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh------------------ccCcccc----h
Confidence            9996543  889999998777 778888999985421111 111222110                  0000000    0


Q ss_pred             ccccCCChhHHHHHHHhhccCCCCCCCHHHHh-cCCccc
Q 017131          286 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC-VHPFFD  323 (376)
Q Consensus       286 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll-~hp~f~  323 (376)
                      .....+++++++||++||++|     |+.|+| +||||+
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            111347899999999999987     999999 999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=314.50  Aligned_cols=250  Identities=18%  Similarity=0.256  Sum_probs=194.1

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..++|++.+.||+|+||.||+|.+..   .+|+|++...      .....+|+.+++.++||||+++++++....     
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-----  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-----
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence            34689999999999999999999864   4999988542      133457999999999999999999885433     


Q ss_pred             EEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+++||||+. ++|.+++..   ....+++..++.++.||+.||+|||+ +||+||||||+||+++ ++ .+||+|||++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~  176 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLF  176 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred             ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCc
Confidence            2789999997 477666643   23469999999999999999999998 9999999999999998 55 7999999998


Q ss_pred             ccccC------CCCCceeeeeccccchhhhcC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017131          187 KVLVK------GEPNVSYICSRYYRAPELIFG--------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  252 (376)
Q Consensus       187 ~~~~~------~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  252 (376)
                      +....      ........+|+.|+|||++.+        ...++.++|||||||++|+|++|..||.+.+.......+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            65421      112233457899999999864        2347889999999999999999999998877655554443


Q ss_pred             HHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ...                   .+.        .....++.++.++|.+||..||.+|||+.++++  .++.+.
T Consensus       257 ~~~-------------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~  301 (319)
T 2y4i_B          257 TGM-------------------KPN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP  301 (319)
T ss_dssp             TTC-------------------CCC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred             cCC-------------------CCC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence            210                   000        011257899999999999999999999999986  455443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-41  Score=337.82  Aligned_cols=246  Identities=26%  Similarity=0.351  Sum_probs=197.5

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCC---CcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      ....+|++.+.||+|+||.||+|.+..+   +..||||++....     ....+|+.+++.++||||+++++++..    
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            3457899999999999999999998654   4579999876432     334579999999999999999998721    


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      +  ..++||||++ ++|.+++..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       463 ~--~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DF  535 (656)
T 2j0j_A          463 N--PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF  535 (656)
T ss_dssp             S--SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred             C--ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEec
Confidence            1  2679999998 588777754   23468999999999999999999998 9999999999999999888 8999999


Q ss_pred             CCcccccCCCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          184 GSAKVLVKGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       184 g~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |+++........  ....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....    
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~----  610 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----  610 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC----
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----
Confidence            999865433221  223457889999999654 58999999999999999997 9999998887766665544210    


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                  .            .++..+++++.+||.+||..||.+|||+.++++
T Consensus       611 ------------~------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 ------------L------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             ------------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------C------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                        0            012468999999999999999999999999875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-42  Score=344.43  Aligned_cols=242  Identities=26%  Similarity=0.360  Sum_probs=195.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||+|+||+||+|.+.. +|+.||||++....     ....+|+.+++.++||||+++++++..........
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4689999999999999999999976 78999999885432     23457999999999999999999987765545555


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .|+||||+++ +|.+.+.      ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+  .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccch
Confidence            7899999985 5544332      379999999999999999999998 999999999999999974  69999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....                      
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------  282 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------  282 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------------------
T ss_pred             hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------------------
Confidence            65432   455789999999998543  588999999999999999999988653210                      


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                            ..+..  .+     ....++.+.+||.+||+.||.+||++.+.+.|+|+.-+
T Consensus       283 ------~~~~~--~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 ------GLPED--DP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ------SCCTT--CH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------ccccc--cc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                  00000  00     01246889999999999999999999999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.3e-40  Score=296.44  Aligned_cols=221  Identities=14%  Similarity=0.051  Sum_probs=174.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.++..++||||+++++++...     .
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----A  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----C
Confidence            357999999999999999999999999999999986542       3345799999999999999999988543     3


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      ..|+||||++| +|.+++..      ......+..++.|++.||+|||+ +||+||||||+|||++.++ .+||++++  
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~--  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPA--  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCC--
T ss_pred             cEEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEecc--
Confidence            48899999974 87776632      34556788899999999999998 9999999999999999988 79988543  


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                                       |++        .++.++|||||||++|+|++|+.||.+.+..+.+....+             
T Consensus       175 -----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-------------  216 (286)
T 3uqc_A          175 -----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-------------  216 (286)
T ss_dssp             -----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-------------
T ss_pred             -----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-------------
Confidence                             222        378999999999999999999999987654321100000             


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                              ..... ......+...+++++.+||.+||+.||.+| |+.++++
T Consensus       217 --------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          217 --------DTAGQ-PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             --------CTTSC-BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             --------HhccC-CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                    00000 001111224689999999999999999999 9999986

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=9.7e-34  Score=276.59  Aligned_cols=179  Identities=17%  Similarity=0.059  Sum_probs=124.1

Q ss_pred             eeeecCceEEEEEEECCCCcEEEEEEeeccc--------------ccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           43 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        43 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ..+.|+.|.+..++...+|+.||+|++.++.              ..+.+|+++|+++ .|+||+++++++.+     +.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-----~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-----AQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----SS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----CC
Confidence            3567778888888888889999999986541              2345799999999 79999999999843     34


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+||||||++| +|.+++..    .+.+++.   .|+.||+.||+|+|+ +|||||||||+|||++.+| .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccC
Confidence            48999999997 88777764    3567654   478999999999998 9999999999999999998 7999999999


Q ss_pred             ccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCC
Q 017131          187 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP  237 (376)
Q Consensus       187 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~  237 (376)
                      +..... ....+.+||+.|+|||++.+  .+..++|+||+|++++++.++..
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence            866443 33456789999999999965  36788999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=6e-28  Score=234.45  Aligned_cols=179  Identities=16%  Similarity=0.239  Sum_probs=132.3

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      +...+.||+|+||+||+|.  ..++.+|+|+.....            ....+|+++++.++||||+++..+......  
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--  413 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--  413 (540)
T ss_dssp             ----------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--
T ss_pred             CCCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--
Confidence            3557799999999999994  457889999764321            124689999999999999955444443222  


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                         .|+||||++ ++|.+++..            +..++.|++.||+|||+ +||+||||||+|||++.   .+||+|||
T Consensus       414 ---~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFG  474 (540)
T 3en9_A          414 ---KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFG  474 (540)
T ss_dssp             ---TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCT
T ss_pred             ---cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECc
Confidence               479999997 587666543            56789999999999998 99999999999999997   69999999


Q ss_pred             CcccccCCCC--------CceeeeeccccchhhhcC-CCCCCCchhHHHHHHHHHHHHhCCCCC
Q 017131          185 SAKVLVKGEP--------NVSYICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLF  239 (376)
Q Consensus       185 ~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf  239 (376)
                      +++.......        .....||+.|+|||++.. ...|+..+|+||..+-..+.+.++.+|
T Consensus       475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9987643221        135678999999999954 123788899999999888888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=7.4e-25  Score=195.63  Aligned_cols=138  Identities=18%  Similarity=0.166  Sum_probs=109.0

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------------------ccHHHHHHHHHhCCCCCeeecc
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK   95 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~   95 (376)
                      |.+.+.||+|+||.||+|.+ .+|+.||||++....                      ....+|+.+++.++  | ++++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            45559999999999999999 889999999985321                      22458999999999  5 6666


Q ss_pred             ceeeecCCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC
Q 017131           96 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  174 (376)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~  174 (376)
                      +++..      ...|+||||++| +|.+ +          .......++.|++.||.|||+ +||+||||||+|||++ +
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T
T ss_pred             eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-C
Confidence            65522      125799999976 6643 2          122355789999999999998 9999999999999999 7


Q ss_pred             CCCeEEEecCCcccccCCCCCceeeeeccccchhhhc
Q 017131          175 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF  211 (376)
Q Consensus       175 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~  211 (376)
                      + .+||+|||+|+.            +..+.|||.+.
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            7 899999999863            33478999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=7.9e-22  Score=173.84  Aligned_cols=135  Identities=17%  Similarity=0.230  Sum_probs=103.7

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcE--EEEEEeeccc----------------------------ccHHHHHHHHHhC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK----------------------------RYKNRELQIMQML   86 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l   86 (376)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+|+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            489999999999999999999778999  9999864321                            1356799999999


Q ss_pred             CCCCeeeccceeeecCCCCceEEEEEEecccc------cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHH-hcCCc
Q 017131           87 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCIGI  159 (376)
Q Consensus        87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~i  159 (376)
                      .|+++... ..+.. .     ..++||||+++      .|.+...       ..++..+..++.|++.||.||| + .||
T Consensus       128 ~~~~i~~p-~~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYTY-M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL  192 (258)
T ss_dssp             HHTTCCCC-CEEEE-E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred             HhCCCCCC-eEEEc-C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            88865322 11111 1     15699999953      4543321       1335567889999999999999 8 899


Q ss_pred             cccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       160 iH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999997   5999999999653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=9.3e-19  Score=160.49  Aligned_cols=134  Identities=13%  Similarity=0.122  Sum_probs=92.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccc--------------------------cHHHHHHHHHhCCCCC
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------YKNRELQIMQMLDHPN   90 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~E~~~l~~l~h~~   90 (376)
                      -|.++++||.|++|.||+|.+. +|+.||||+++....                          ...+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            4999999999999999999984 699999998642110                          0123555555554333


Q ss_pred             eeeccceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 017131           91 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  170 (376)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nil  170 (376)
                      +... ..+.. .   .  .++||||++|...   ..      -........++.||+.+|.+||+ +|||||||||.|||
T Consensus       175 v~vp-~p~~~-~---~--~~LVME~i~G~~L---~~------l~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FPVP-EPIAQ-S---R--HTIVMSLVDALPM---RQ------VSSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNIL  237 (397)
T ss_dssp             CSCC-CEEEE-E---T--TEEEEECCSCEEG---GG------CCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred             CCCC-eeeec-c---C--ceEEEEecCCccH---hh------hcccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEE
Confidence            2211 11100 0   1  2589999987321   11      11223356778999999999998 99999999999999


Q ss_pred             EcCCCC---------CeEEEecCCccc
Q 017131          171 VNPHTH---------QLKLCDFGSAKV  188 (376)
Q Consensus       171 l~~~~~---------~vkl~Dfg~a~~  188 (376)
                      ++.++.         .+.|+||+.+..
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EeCCCCcccccccccceEEEEeCCccc
Confidence            987652         278999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=1.2e-11  Score=108.85  Aligned_cols=134  Identities=14%  Similarity=0.094  Sum_probs=99.6

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec----ccccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .|++...++.|+.+.||++...  ++.+++|+...    ......+|+.+++.+. +..+++++++...     ....|+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceEE
Confidence            5899999999999999999854  67899998753    3345778999999985 5667777766532     234789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------  156 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------------------------------  156 (376)
                      |||+++| ++....         .+......++.++..+|+.||+.                                  
T Consensus        88 v~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999998 443221         11122346678999999999960                                  


Q ss_pred             ------------------------CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 ------------------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ------------------------~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                                              ..++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                    2489999999999998644 56799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=1.2e-10  Score=102.00  Aligned_cols=132  Identities=16%  Similarity=0.100  Sum_probs=88.8

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-cccHHHHHHHHHhCCCCC--eeeccceeeecCCCCceEEEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      .|.+....+.|..+.||++.. .+|+.+++|+.... .....+|+.+++.+.+.+  +++++.+....     ...++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEEE
Confidence            356555545667799999964 56778999987543 244678999999986544  44565554221     2267999


Q ss_pred             ecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 017131          114 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----------------------------------  158 (376)
Q Consensus       114 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-----------------------------------  158 (376)
                      ||++|.... .       ....   ...++.++...|..||+ ..                                   
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            999873211 0       0111   12445667777777775 33                                   


Q ss_pred             -----------------------ccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          159 -----------------------ICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       159 -----------------------iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                                             ++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                   99999999999998654 56799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=6.5e-10  Score=102.33  Aligned_cols=141  Identities=16%  Similarity=0.187  Sum_probs=99.1

Q ss_pred             EEeeeeeecCceEEEEEEECCCCcEEEEEEee--cc-----cccHHHHHHHHHhCCC--CCeeeccceeeecCCCCceEE
Q 017131           39 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QD-----KRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        39 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .-.+.|+.|.++.||++...  +..+++|+..  ..     .....+|+.+++.+..  ..+++++....+.  ......
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCe
Confidence            34678899999999999864  4678899765  22     2456789999999974  4456666554222  111235


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc---------------------------------
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC---------------------------------  156 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------  156 (376)
                      ++|||+++|...   ..  ..-..++......++.++..+|..||+.                                 
T Consensus       117 ~~vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          117 FYIMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEEEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            689999997321   00  1123467788888899999999999961                                 


Q ss_pred             ------------------------CCccccCCCCCcEEEcCCCC-CeEEEecCCccc
Q 017131          157 ------------------------IGICHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  188 (376)
Q Consensus       157 ------------------------~~iiH~Dlkp~Nill~~~~~-~vkl~Dfg~a~~  188 (376)
                                              ..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    36899999999999997752 368999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=4.1e-10  Score=101.15  Aligned_cols=184  Identities=13%  Similarity=0.183  Sum_probs=111.6

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCC-CCCeeeccceeeecC-CCCceEEEEEEecc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPNIVALKHCFFSTT-DKEELYLNLVLEYV  116 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~~~~~~lv~e~~  116 (376)
                      .+.++.|....||++.     ..+++|+....  .....+|+.+|+.+. +..+ .+...+.... .......|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v-~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPL-PIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSS-CCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCC-CCCceEeecCCCCCCCcceEEEccc
Confidence            4558999999999874     45889976543  234568999998884 3332 2222222211 12122346899999


Q ss_pred             cc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 017131          117 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC---------------------------------------  156 (376)
Q Consensus       117 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------------  156 (376)
                      +| .+.....      ..++..+...++.|+...|+.||+.                                       
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            97 3221111      2466666777777777777777740                                       


Q ss_pred             ------------------CCccccCCCCCcEEEcCC-CCCeEEEecCCcccccCCCCCceeeeeccc---cchhhhc---
Q 017131          157 ------------------IGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYY---RAPELIF---  211 (376)
Q Consensus       157 ------------------~~iiH~Dlkp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y---~aPE~~~---  211 (376)
                                        ..++|+|++|.||+++.+ +..+.|+||+.+....   ..........+   ..|+...   
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~---~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD---PDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC---TTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC---hHHHHHHHHhhccccCHHHHHHHH
Confidence                              137999999999999974 3367899999886431   11110000001   2222210   


Q ss_pred             C-CC---------CCCCchhHHHHHHHHHHHHhCCCCC
Q 017131          212 G-AT---------EYTTAIDIWSTGCVMAELLLGQPLF  239 (376)
Q Consensus       212 ~-~~---------~~~~~~DiwslG~il~elltg~~pf  239 (376)
                      . ..         ....-.+.|++|.++|.+.+|..+|
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0 00         0122358999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.58  E-value=5.3e-07  Score=80.83  Aligned_cols=133  Identities=15%  Similarity=0.098  Sum_probs=80.0

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCC---eeeccceeeecCCCCceEEEEEEec
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN---IVALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      .+.++.|....||+.     |..+++|+....  .....+|+.+|+.+.+..   +...+.+..  .  .....++||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEec
Confidence            456789999999998     466889975432  234568999999997532   333333221  1  12335699999


Q ss_pred             ccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 017131          116 VPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN---------------------------------------  155 (376)
Q Consensus       116 ~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---------------------------------------  155 (376)
                      ++| .+.....      ..++......++.++...|..||+                                       
T Consensus        95 i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           95 VQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             cCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            997 3222100      112233333333333333333332                                       


Q ss_pred             --------------------cCCccccCCCCCcEEEcC---CCCCeEEEecCCccc
Q 017131          156 --------------------CIGICHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  188 (376)
Q Consensus       156 --------------------~~~iiH~Dlkp~Nill~~---~~~~vkl~Dfg~a~~  188 (376)
                                          ...++|+|++|.||+++.   ++..+.|+||+.+..
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                124699999999999987   352358999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=5.4e-06  Score=72.66  Aligned_cols=129  Identities=15%  Similarity=0.133  Sum_probs=83.0

Q ss_pred             eeecCce-EEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHhCCC-CCeeeccceeeecCCCCceEEEEEEecccc-c
Q 017131           44 VGTGSFG-VVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-T  119 (376)
Q Consensus        44 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~  119 (376)
                      +..|..+ .||+......+..+++|+-.... ....+|...|+.+.. -.+.+++.+..+.     ...++||++++| .
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCcc
Confidence            3445444 79998887777789999765432 345689999988842 2244444444222     236799999987 4


Q ss_pred             HHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 017131          120 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI------------------------------------------  157 (376)
Q Consensus       120 l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------  157 (376)
                      +.+....        .......+..++...|.-||+ .                                          
T Consensus       107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          107 AFQVLEE--------YPDSGENIVDALAVFLRRLHS-IPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             HHHHHHH--------CGGGHHHHHHHHHHHHHHHHT-SCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             ccccccC--------CHHHHHHHHHHHHHHHHHhcC-CCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            4333221        111223445566666666663 1                                          


Q ss_pred             ----------------CccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          158 ----------------GICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       158 ----------------~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                                      .++|+|+.+.||+++.++ .+-|+||+.+.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                            179999999999999765 56799999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=3.6e-06  Score=76.36  Aligned_cols=30  Identities=23%  Similarity=0.469  Sum_probs=26.6

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            6899999999999997666 69999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.11  E-value=7.9e-06  Score=75.91  Aligned_cols=72  Identities=18%  Similarity=0.195  Sum_probs=44.9

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeecc-----------cccHHHHHHHHHhCCC--CC-eeeccceeeecCCCC
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--PN-IVALKHCFFSTTDKE  105 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~  105 (376)
                      -.+.||.|..+.||++.+..+++.+++|.....           .....+|.++++.+..  +. +++++.+  +.   .
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~---~  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---E  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---T
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC---C
Confidence            356899999999999987666788999975321           1223579999988742  33 3344322  21   1


Q ss_pred             ceEEEEEEecccc
Q 017131          106 ELYLNLVLEYVPE  118 (376)
Q Consensus       106 ~~~~~lv~e~~~~  118 (376)
                      .  .++|||++++
T Consensus       109 ~--~~lvmE~l~g  119 (397)
T 2olc_A          109 M--AVTVMEDLSH  119 (397)
T ss_dssp             T--TEEEECCCTT
T ss_pred             c--cEEEEEeCCC
Confidence            1  3589999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.96  E-value=1.8e-05  Score=72.36  Aligned_cols=79  Identities=9%  Similarity=0.100  Sum_probs=49.9

Q ss_pred             eEEeeee-eecCceEEEEEEEC---C---CCcEEEEEEeeccc-------ccHHHHHHHHHhCCC---CCeeeccceeee
Q 017131           38 YIAEHVV-GTGSFGVVFQAKCR---E---TGEIVAIKKVLQDK-------RYKNRELQIMQMLDH---PNIVALKHCFFS  100 (376)
Q Consensus        38 y~~~~~l-g~G~~g~V~~~~~~---~---~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~~~~~~~~  100 (376)
                      ....+.| +.|....+|++...   .   +++.+++|+.....       ....+|+.+++.+..   -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            4456778 88888999988753   0   25678999765432       346789999988842   235555544321


Q ss_pred             cCCCCceEEEEEEecccc
Q 017131          101 TTDKEELYLNLVLEYVPE  118 (376)
Q Consensus       101 ~~~~~~~~~~lv~e~~~~  118 (376)
                      .  ......++|||+++|
T Consensus       102 ~--~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 G--DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             S--TTTSSCEEEEECCCC
T ss_pred             C--CccCCceEEEEecCC
Confidence            1  111224589999986

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.79  E-value=0.00047  Score=57.30  Aligned_cols=98  Identities=18%  Similarity=0.112  Sum_probs=64.2

Q ss_pred             cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCcee
Q 017131          119 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY  198 (376)
Q Consensus       119 ~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~  198 (376)
                      +|.+++..+   +.+++++++|.+++|.+.+|.-+-..+.-..+=+.|..|++..+| .|.+.+ ..+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            787888764   578999999999999999988763212212233457899999998 676553 1110           


Q ss_pred             eeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh
Q 017131          199 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL  234 (376)
Q Consensus       199 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt  234 (376)
                      .....+.|||...  ...+.+.-|+|||+++|.-+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1122367888763  345788899999999999885

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.76  E-value=0.00011  Score=65.34  Aligned_cols=65  Identities=12%  Similarity=0.059  Sum_probs=41.0

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCe-eeccceeeecCCCCceEEEEEEecc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYLNLVLEYV  116 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~~  116 (376)
                      .+.|+.|....+|++      +.+++|+.....   ....+|+.+++.+....+ .+++...     .+.  -+++++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            678899999999999      458899775432   223578888887743333 3333322     111  23789999


Q ss_pred             -cc
Q 017131          117 -PE  118 (376)
Q Consensus       117 -~~  118 (376)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             64

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.66  E-value=0.00099  Score=58.70  Aligned_cols=74  Identities=14%  Similarity=0.056  Sum_probs=49.3

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ...-++.+|.|..+.||++.. .+|+.|.+|+.....    ....+|+..|+.+....-+.+-.++....      -++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------RTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------TEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC------ceEE
Confidence            356688999999999999986 568899999764322    24578999999885322122222221111      2478


Q ss_pred             Eeccc
Q 017131          113 LEYVP  117 (376)
Q Consensus       113 ~e~~~  117 (376)
                      ||++.
T Consensus        89 ~e~l~   93 (288)
T 3f7w_A           89 MEWVD   93 (288)
T ss_dssp             EECCC
T ss_pred             EEeec
Confidence            99986

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.50  E-value=0.00029  Score=65.87  Aligned_cols=77  Identities=13%  Similarity=-0.035  Sum_probs=44.3

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCcccccCCCCCceeee--eccccchhhhcCCCC--CCCchhHHHHHHHHHHH
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGATE--YTTAIDIWSTGCVMAEL  232 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~--~~~~~DiwslG~il~el  232 (376)
                      ..++|+|++|.||+++.++  +.|+||+.+......-.......  ...|.+|+.......  -....++.++...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6899999999999998764  99999998864211100000011  123566654421110  11123444677777777


Q ss_pred             HhC
Q 017131          233 LLG  235 (376)
Q Consensus       233 ltg  235 (376)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.48  E-value=0.0004  Score=62.24  Aligned_cols=143  Identities=13%  Similarity=0.055  Sum_probs=76.0

Q ss_pred             EEeeeeeecCceEEEEEEECCCCcEEEEEEeec--ccccHHHHHHHHHhCCCCCe--eeccceeeecCCC----CceEEE
Q 017131           39 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTDK----EELYLN  110 (376)
Q Consensus        39 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~----~~~~~~  110 (376)
                      .-.+.|+.|....+|++... .| .+++|+...  .......|+.+++.+....+  ++++..   ..+.    .....+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPA   99 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEE
Confidence            34567788888999999864 23 688998765  33456678888887743222  233211   1110    012357


Q ss_pred             EEEecccccH------------HHHHHHhhhhcCCC--------cHHHHHH---------------HHHHHHHHHHHHHh
Q 017131          111 LVLEYVPETV------------NRIARNYSRIHQRM--------PLIYVKL---------------YTYQICRALAYIHN  155 (376)
Q Consensus       111 lv~e~~~~~l------------~~~~~~~~~~~~~l--------~~~~~~~---------------i~~qi~~al~~LH~  155 (376)
                      +++++++|..            ...+.........+        .......               +...+...++.+..
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            8999998621            11111111110011        1000000               00113344555552


Q ss_pred             ------cCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          156 ------CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       156 ------~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                            ..+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence                  14799999999999998764 45799999774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.29  E-value=0.0022  Score=59.99  Aligned_cols=70  Identities=17%  Similarity=0.248  Sum_probs=46.7

Q ss_pred             EeeeeeecCceEEEEEEECC-------CCcEEEEEEeec-cc-ccHHHHHHHHHhCCCCCe-eeccceeeecCCCCceEE
Q 017131           40 AEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ-DK-RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL  109 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  109 (376)
                      -.+.|+.|....||++....       .++.+++|+... .. ....+|..+++.+...++ +++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            45678889999999998653       257899998744 22 344579999988854344 4444433     11    


Q ss_pred             EEEEecccc
Q 017131          110 NLVLEYVPE  118 (376)
Q Consensus       110 ~lv~e~~~~  118 (376)
                      .+|++|++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            168898875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.17  E-value=0.0028  Score=58.09  Aligned_cols=138  Identities=20%  Similarity=0.255  Sum_probs=77.5

Q ss_pred             eeeeeecCceEEEEEEECC-------CCcEEEEEEeecc---cccHHHHHHHHHhCCCCCe-eeccceeeecCCCCceEE
Q 017131           41 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL  109 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  109 (376)
                      ++.|..|....+|++....       .++.|++|+.-..   .....+|..+++.+....+ .+++..+     .+    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            4567778888999998642       3578999986331   2334579999988843333 3444433     11    


Q ss_pred             EEEEeccccc------------HHHHHHHhhhhcC-------CC--cHHHHHHHHHHHHH-------------------H
Q 017131          110 NLVLEYVPET------------VNRIARNYSRIHQ-------RM--PLIYVKLYTYQICR-------------------A  149 (376)
Q Consensus       110 ~lv~e~~~~~------------l~~~~~~~~~~~~-------~l--~~~~~~~i~~qi~~-------------------a  149 (376)
                      .+||||++|.            ...+.......+.       ..  -...+..+..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            1789998851            1122222222211       11  13455555554422                   2


Q ss_pred             HHHHHh-------cCCccccCCCCCcEEEcCC---CCCeEEEecCCcc
Q 017131          150 LAYIHN-------CIGICHRDIKPQNLLVNPH---THQLKLCDFGSAK  187 (376)
Q Consensus       150 l~~LH~-------~~~iiH~Dlkp~Nill~~~---~~~vkl~Dfg~a~  187 (376)
                      +..|.+       ...++|+|+.+.||+++.+   ...+.|+||..+.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            333321       1359999999999999876   1279999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.16  E-value=0.0025  Score=57.35  Aligned_cols=31  Identities=39%  Similarity=0.608  Sum_probs=26.6

Q ss_pred             CCccccCCCCCcEEEcCC----CCCeEEEecCCccc
Q 017131          157 IGICHRDIKPQNLLVNPH----THQLKLCDFGSAKV  188 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~----~~~vkl~Dfg~a~~  188 (376)
                      ..++|+|+.+.||+++.+    + .+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~-~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLA-RVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGG-GEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCC-CeEEEeCCCcCc
Confidence            579999999999999874    4 689999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.11  E-value=0.005  Score=57.99  Aligned_cols=70  Identities=16%  Similarity=0.196  Sum_probs=45.8

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHhCCCCCee-eccceeeecCCCCceEEEEEEec
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      -.+.|+.|....+|++.....+..+++|+......   ...+|..+++.+...++. +++..+     . +   ..|++|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEe
Confidence            45678889999999998765457899998743221   225899999999755553 454443     1 1   148999


Q ss_pred             ccc
Q 017131          116 VPE  118 (376)
Q Consensus       116 ~~~  118 (376)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.10  E-value=0.0035  Score=56.12  Aligned_cols=73  Identities=14%  Similarity=0.020  Sum_probs=43.1

Q ss_pred             eeeeecCceEEEEEEECCCCcEEEEEEeecc---cccHHHHHHHHHhCCCCC--eeeccceeeecCC--CCceEEEEEEe
Q 017131           42 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPN--IVALKHCFFSTTD--KEELYLNLVLE  114 (376)
Q Consensus        42 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e  114 (376)
                      ..++ |....||++.. .+|+.+++|.....   ......|..+++.+....  +++++..  +...  ......+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence            3455 77889998864 34667999987532   334567888888774322  3333321  1000  01223568999


Q ss_pred             cccc
Q 017131          115 YVPE  118 (376)
Q Consensus       115 ~~~~  118 (376)
                      +++|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.06  E-value=0.0015  Score=59.78  Aligned_cols=70  Identities=13%  Similarity=0.130  Sum_probs=41.4

Q ss_pred             EeeeeeecCceEEEEEEECC--------CCcEEEEEEeecccc---cHHHHHHHHHhCCCCCe-eeccceeeecCCCCce
Q 017131           40 AEHVVGTGSFGVVFQAKCRE--------TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEEL  107 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~  107 (376)
                      -.+.|+.|....+|++....        .++.+++|+......   ...+|..+++.+...++ ++++..+     .   
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---  108 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---  108 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C---
Confidence            35567888889999998643        136788998754322   23578888888853333 3444322     1   


Q ss_pred             EEEEEEecccc
Q 017131          108 YLNLVLEYVPE  118 (376)
Q Consensus       108 ~~~lv~e~~~~  118 (376)
                       -++||+|++|
T Consensus       109 -~~~v~e~i~G  118 (369)
T 3c5i_A          109 -GGRIEEWLYG  118 (369)
T ss_dssp             -TEEEEECCCS
T ss_pred             -CcEEEEEecC
Confidence             1368999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.93  E-value=0.0034  Score=55.97  Aligned_cols=72  Identities=14%  Similarity=0.035  Sum_probs=50.3

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHhCC---CCCeeeccceeeecCCCCceEEEEEEec
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYLNLVLEY  115 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e~  115 (376)
                      -.+.|+.|....+|+...  .+..+++|+..... ....+|+..|+.+.   ...+++++.....     ....++|||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEe
Confidence            357789999999999985  36788899875432 34568999998884   2445555554321     1236799999


Q ss_pred             ccc
Q 017131          116 VPE  118 (376)
Q Consensus       116 ~~~  118 (376)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            985

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.68  E-value=0.008  Score=54.23  Aligned_cols=31  Identities=26%  Similarity=0.532  Sum_probs=26.7

Q ss_pred             CCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          157 IGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       157 ~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      ..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            4699999999999998766 699999987753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.64  E-value=0.078  Score=49.21  Aligned_cols=70  Identities=13%  Similarity=0.118  Sum_probs=44.8

Q ss_pred             EeeeeeecCceEEEEEEECCC-------CcEEEEEEeecccc---cHHHHHHHHHhCCCCCe-eeccceeeecCCCCceE
Q 017131           40 AEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDKR---YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELY  108 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~  108 (376)
                      -++.+..|....+|++.....       ++.|++|+......   ...+|..+++.+...++ .++++.+     .    
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            455677788889999987521       57899998643221   23589999988853333 3444322     1    


Q ss_pred             EEEEEecccc
Q 017131          109 LNLVLEYVPE  118 (376)
Q Consensus       109 ~~lv~e~~~~  118 (376)
                      -++|++|++|
T Consensus       145 ~~~I~efI~G  154 (424)
T 3mes_A          145 EGRIEEFIDG  154 (424)
T ss_dssp             TEEEEECCCS
T ss_pred             CCEEEEEeCC
Confidence            1468999886

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.81  E-value=0.19  Score=46.25  Aligned_cols=30  Identities=30%  Similarity=0.546  Sum_probs=24.1

Q ss_pred             ccccCCCCCcEEEcC-----CCCCeEEEecCCccc
Q 017131          159 ICHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  188 (376)
Q Consensus       159 iiH~Dlkp~Nill~~-----~~~~vkl~Dfg~a~~  188 (376)
                      ++|+|+.+.|||+..     +...+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            689999999999932     233799999998853

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	376
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-124
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-73
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-69
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-66
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-66
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-65
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-65
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-65
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-65
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-63
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-63
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-62
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-61
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-59
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-58
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-58
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-56
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-56
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-53
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-51
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-51
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-48
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-48
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-41
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-38
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-37
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-20

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  361 bits (927), Expect = e-124
 Identities = 238/341 (69%), Positives = 279/341 (81%), Gaps = 3/341 (0%)

Query: 27  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 86
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70

Query: 87  DHPNIVALKHCFFST-TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 145
           DH NIV L++ F+S+   K+E+YLNLVL+YVPETV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           + R+LAYIH+  GICHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR 366
           RDPN +LPNGR  P LFNF   ELS  PP     LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLA-TILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 4e-73
 Identities = 102/342 (29%), Positives = 175/342 (51%), Gaps = 25/342 (7%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKN---RELQIMQMLDHPNIV 92
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            +     + T ++   + LV   +   + ++ +      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 124

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRAPE 208
           IH+   + HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 266
           ++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 267 -NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
                     P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 367
            DP+       P+         EL  +P E +  LI E   +
Sbjct: 302 YDPSD-----EPIAEAPFKFDMELDDLPKEKLKELIFEETAR 338

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 6e-70
 Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 31/305 (10%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           +     +G G+ GVVF+   + +G ++A K +  + +        RELQ++   + P IV
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
                F       E+ +   +E++            +   R+P   +   +  + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +     I HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 271
            T Y+   DIWS G  + E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 272 EFKF--------------PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
              +                I   P  K+       E  D V +    +P  R    +  
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 318 VHPFF 322
           VH F 
Sbjct: 297 VHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 5e-69
 Identities = 99/303 (32%), Positives = 149/303 (49%), Gaps = 23/303 (7%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 93
            +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L   F     K  + L  V +++      +          +   ++K Y     + L Y+
Sbjct: 65  LLDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPELIFG 212
           H    I HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+FG
Sbjct: 117 HQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
           A  Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+   M      
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 330
             F      P H +F      + +DL+   F ++P  R TA +A    +F     P    
Sbjct: 235 VTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293

Query: 331 RLP 333
           +LP
Sbjct: 294 QLP 296

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  210 bits (534), Expect = 7e-66
 Identities = 89/300 (29%), Positives = 147/300 (49%), Gaps = 21/300 (7%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALK 95
           Y     +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
                  D       LV E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             GI HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 216 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 274
           Y  ++D+WS GC++A ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 275 FPQIKPHPWHKVFQKRLP--------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
           F  I      K +++ +         PEA+D + +  +Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 8e-66
 Identities = 102/307 (33%), Positives = 163/307 (53%), Gaps = 21/307 (6%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           +     +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L           E  L LV E++ + + +     +     +PL  +K Y +Q+ + LA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLA 116

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 210
           + H+   + HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 269
            G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
             +  FP+     + KV    L  +   L+ +   Y PN R +A  A  HPFF ++  P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 330 TRLPNGR 336
             +P+ R
Sbjct: 293 --VPHLR 297

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 2e-65
 Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y     +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 92  VALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           V L     +     ++ +  + LV ++     + +A   S +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-----SYICSRY 203
            L YIH    I HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           YR PEL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 264 KCMNPNYTEFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 320
             ++      K   +K        ++      P A+DL+ +     P  R  + +A  H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 321 FFDELRDPN 329
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  208 bits (531), Expect = 4e-65
 Identities = 73/309 (23%), Positives = 120/309 (38%), Gaps = 41/309 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 93
           Y     +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L   F    D  E+ +  + E++      +    +  H +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 154 HNCIGICHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 330
                             +  +  D + +     PN R T  +A  HP+      P  ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 331 RLPNGRPLP 339
           ++P+ R   
Sbjct: 294 QIPSSRYTK 302

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 5e-65
 Identities = 100/335 (29%), Positives = 159/335 (47%), Gaps = 24/335 (7%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 91
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL++++ + H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           + L   F      EE     ++ ++         N     Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           YIH+   I HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
               Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 272 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
                   Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 329 NTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 363
           +       P+   ++    E   +  +    L  +
Sbjct: 311 DD-----EPVADPYDQ-SFESRDLLIDEWKSLTYD 339

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 9e-65
 Identities = 97/316 (30%), Positives = 158/316 (50%), Gaps = 21/316 (6%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y     VG+G++G V  A    TG  VAIKK+ +  + +       REL++++ + H N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 92  VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           + L   F      ++     LV+ ++   + ++ +     H+++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGL 134

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            YIH   GI HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 271 TEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 327
            +      P+++   +  +      P AV+L+ +        R TA EA  HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 328 PNTRLPNGRPLPPLFN 343
                P  +     F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-63
 Identities = 90/299 (30%), Positives = 147/299 (49%), Gaps = 17/299 (5%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDKRYKN------RELQIMQML---D 87
           Y     +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           HPN+V L      +    E  L LV E+V +  +            +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--DLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
           R L ++H+   + HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E++   + Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                  F      P  K     +     DL+ +   ++P  R +A  A  HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 5e-63
 Identities = 96/299 (32%), Positives = 150/299 (50%), Gaps = 18/299 (6%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y     +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L           +  L LV E+       + + +   +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 210
           + H+   + HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 211 FGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           FGA  Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
                +P             +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  198 bits (503), Expect = 8e-62
 Identities = 96/295 (32%), Positives = 151/295 (51%), Gaps = 20/295 (6%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NI
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L           +  L LV E++      + +        +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNVSYICSRYYRAPELI 210
           Y H+   + HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 269
            G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
             +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  199 bits (507), Expect = 2e-61
 Identities = 80/335 (23%), Positives = 127/335 (37%), Gaps = 44/335 (13%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 98
            +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 99  FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 156
               DK E+ L  +LE++   E  +RIA        +M    V  Y  Q C  L ++H  
Sbjct: 96  ---EDKYEMVL--ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 157 IGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
             I H DIKP+N++        +K+ DFG A  L   E       +  + APE++     
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EP 204

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
                D+W+ G +   LL G   F GE  ++ L  + +       +              
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------ 252

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPN 334
                          + PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299

Query: 335 GRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN 369
            R        K        P+     I   +  + 
Sbjct: 300 SRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRK 334

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-61
 Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 34/309 (11%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKH 96
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++  +    P+IV +  
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 72

Query: 97  CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            + +     +  L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 73  VYENLYAGRK-CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 155 NCIGICHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 212
           +   I HRD+KP+NLL         LKL DFG AK         +   + YY APE++  
Sbjct: 129 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +Y  + D+WS G +M  LL G P F    G+     +   +                +
Sbjct: 188 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------Q 233

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTR 331
           ++FP  +           +  E   L+    +  P  R T  E   HP+     + P T 
Sbjct: 234 YEFPNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 332 LPNGRPLPP 340
           L   R L  
Sbjct: 286 LHTSRVLKE 294

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-60
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 44/295 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
                             L LEY          +       MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCS---GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 209
           +H   GI HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 210 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
           +     +   +D+WS G V+  +L G+  +   S   Q                      
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------------- 219

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
               K  +   +PW K+         + L+ +    +P+ R T  +     ++++
Sbjct: 220 ----KEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 8e-60
 Identities = 60/289 (20%), Positives = 117/289 (40%), Gaps = 40/289 (13%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 94
           +  +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
            +  + +T K +  + LV E +    +   + Y +  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 155 -NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 213
                I HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 214 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 273
            +Y  ++D+++ G  M E+   +  +       Q+   +     P               
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233

Query: 274 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                        F K   PE  +++    + + + R +  +   H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (490), Expect = 2e-59
 Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 49/305 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 90
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            +  + C+     +   +  LV+EY        +       + +  + +   T+   + L
Sbjct: 77  TIQYRGCY---LREHTAW--LVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 211 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 328
                + P ++   W             + V    Q  P  R T+     H F    R P
Sbjct: 229 ----NESPALQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 329 NTRLP 333
              + 
Sbjct: 277 TVIMD 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 5e-59
 Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 90
           +     +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ L   F    D   +YL  +LEY P           +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           +Y H+   + HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
            G   +   +D+WS G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
            EF FP              +   A DL+ R  +++P+ R    E   HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 8e-59
 Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 91
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           V         T+     L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 151 AYIH----NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV-SYICSRYYR 205
              H        + HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           +PE +     Y    DIWS GC++ EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                 E KF +I               E  +++ R        R +  E   +P 
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-58
 Identities = 99/344 (28%), Positives = 156/344 (45%), Gaps = 33/344 (9%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 91
           Y     +G+G+ G+V  A        VAIKK+ +  + +       REL +M+ ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 92  VALKHCFFSTTDKEEL-YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           ++L + F      EE   + LV+E +       A     I   +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMD------ANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            ++H+  GI HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---- 266
            G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +    
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 267 ------NPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 317
                  P Y    FP++ P    P      K    +A DL+ +     P  R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 318 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI 361
            HP+ +   DP        P P +++ +  E      E    LI
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQLDERE-HTIEEWKELI 349

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-58
 Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 44/294 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 93
           +     +G G+FG V++A+ +ET  + A K +     ++      E+ I+   DHPNIV 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L   F     +  L++  ++E+       +      + + +    +++   Q   AL Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNVSYICSRYYRAPELIFG 212
           H+   I HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 213 AT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
            T     Y    D+WS G  + E+   +P     + +  L++I K               
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------------- 230

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 322
                        P       R      D + +  + + + R T  +   HPF 
Sbjct: 231 ------------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-58
 Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 42/293 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVAL 94
           Y+    +G G FG+V +     + +    K V     D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 95  KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
              F      EEL +  + E++   +   RI  +   +++R     +  Y +Q+C AL +
Sbjct: 67  HESF---ESMEELVM--IFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117

Query: 153 IHNCIGICHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIF 211
           +H+   I H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+  
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 212 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
                +TA D+WS G ++  LL G   F  E+    +  I+    T   E          
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                            K +  EA+D V R        R TA EA  HP+  +
Sbjct: 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  190 bits (482), Expect = 7e-58
 Identities = 95/349 (27%), Positives = 150/349 (42%), Gaps = 49/349 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 94
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 95  KH----------CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 144
                         F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNVSYI 199
           Q+   L Y+H   GI H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIK 253
            +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 254 VLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKV------FQKRLPPEAVDLVC 300
           +LG      ++      T F          ++K  P   V      F K    E  D + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 301 RFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 342
              Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 9e-57
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 45/309 (14%)

Query: 30  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQM 85
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 86  LDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 145
             +PNIV     +      +EL++  V+EY+                 M    +     +
Sbjct: 74  NKNPNIVNYLDSY---LVGDELWV--VMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYY 204
             +AL ++H+   + HRDIK  N+L+      +KL DFG    +   +   S +  + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP      
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234

Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                  E + P            ++L     D + R        R +A E   H F   
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Query: 325 LRDPNTRLP 333
            +  ++  P
Sbjct: 276 AKPLSSLTP 284

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 42/303 (13%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
           Y    V+GTG+F  V  A+ + T ++VAIK + +            E+ ++  + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           AL   +        LYL  +++ V         +                 +Q+  A+ Y
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 153 IHNCIGICHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
           +H+   I HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 330
                           +   +   A D +    +  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 331 RLP 333
            + 
Sbjct: 276 NIH 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  182 bits (464), Expect = 4e-56
 Identities = 75/306 (24%), Positives = 121/306 (39%), Gaps = 54/306 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------------LQDKRYKNRELQIMQ 84
           Y  + ++G G   VV +   + T +  A+K +              + +    +E+ I++
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 85  ML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 143
            +  HPNI+ LK  +     +   +  LV + +         +Y      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 144 YQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY 203
             +   +  +H    I HRD+KP+N+L++   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 204 YRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 258
           Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 318
                  M+ NY +F  P+                   DLV RF    P  R TA EA  
Sbjct: 228 -------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 319 HPFFDE 324
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 6e-56
 Identities = 89/329 (27%), Positives = 132/329 (40%), Gaps = 67/329 (20%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPN 90
           +    ++G GSF  V  A+   T    AIK + +    K        RE  +M  LDHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
            V L   F    D E+LY    L Y     N     Y R          + YT +I  AL
Sbjct: 70  FVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAP 207
            Y+H    I HRD+KP+N+L+N   H +++ DFG+AKVL          S++ +  Y +P
Sbjct: 122 EYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           EL+        + D+W+ GC++ +L+ G P F   +      +IIK+             
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPF 321
               E+ FP+            +  P+A DLV +        R    E         HPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

Query: 322 FDELRDPNTRLPNGRPLPPLFNFKPPELS 350
           F+ +   N           L    PP+L+
Sbjct: 270 FESVTWEN-----------LHQQTPPKLT 287

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 9e-53
 Identities = 84/354 (23%), Positives = 142/354 (40%), Gaps = 62/354 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ--------IMQMLDHP 89
           +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++        +    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
            +  +   F     KE L+  +  EY+          + +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF---QTKENLFFVM--EYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC-SRYYRAPE 208
           L ++H+  GI +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 209 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
           ++ G  +Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFFDELRD 327
            Y  +                 L  EA DL+ + F   P  R         HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262

Query: 328 PNTRLPNGRPLPP----------LFNFKPPELSGIPPETINRLIPEHARKQNLF 371
               L      PP            NF    L+  P  +       ++  QN+F
Sbjct: 263 -WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 65/317 (20%), Positives = 120/317 (37%), Gaps = 49/317 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 87
           Y     +G+G F VV + + + TG   A K + + +   +          RE+ I++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           HPN++ L   +    +K ++ L  +LE V         ++    + +       +  QI 
Sbjct: 72  HPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 148 RALAYIHNCIGICHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
             + Y+H+   I H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
            APE++          D+WS G +   LL G   F G++  + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 324
                                 +       A D + R     P  R T  ++  HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 325 LRDPNTRLPNGRPLPPL 341
            +D    L +    P  
Sbjct: 277 -KDTQQALSSAWSHPQF 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  171 bits (435), Expect = 3e-51
 Identities = 81/355 (22%), Positives = 143/355 (40%), Gaps = 68/355 (19%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 90
           +     +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+ +   F     ++   + ++++Y+         +  R  QR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELI 210
            Y+H+   I +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 211 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDEL 325
            E +FP                 +  DL+ R      + R         +   HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

Query: 326 RDPNTRLPNGRPLPPLFNFKPPELSGI---------PPETINRLIPEHARKQNLF 371
                +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 264 --VWEKLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 313

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 7e-51
 Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 56/303 (18%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 87
           Y    ++G+G FG V+          VAIK V +D+               E+ +++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 88  --HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 145
                ++ L   F            L+LE       +   ++      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 146 ICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYR 205
           +  A+ + HNC G+ HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 206 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
            PE I     +  +  +WS G ++ +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
                                F++R+  E   L+       P+ R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 326 RDP 328
             P
Sbjct: 262 LLP 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  171 bits (433), Expect = 2e-50
 Identities = 69/325 (21%), Positives = 122/325 (37%), Gaps = 57/325 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 87
           +    ++G G FG V+  +  +TG++ A+K + + +            +   L ++   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
            P IV + + F      ++L    +L+ +          +   H       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
             L ++HN   + +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 267
           E++     Y ++ D +S GC++ +LL G   F      D+  EI +              
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------------- 219

Query: 268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFF 322
                                    PE   L+    Q   N R       A E    PFF
Sbjct: 220 -----------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 323 DELRDPNTRLPNGRPLPPLFNFKPP 347
             L      +   +  PP     PP
Sbjct: 269 RSL--DWQMVFLQKYPPP---LIPP 288

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (412), Expect = 2e-48
 Identities = 65/295 (22%), Positives = 106/295 (35%), Gaps = 43/295 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 90
           Y    ++G G    V  A+       VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IVA+ +              +V+EYV        R+       M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV----SYICSRYYRA 206
            + H   GI HRD+KP N++++   + +K+ DFG A+ +     +V    + I +  Y +
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           PE   G        D++S GCV+ E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
                                 + L  +   +V +    +P  R           
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 9e-48
 Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 59/328 (17%)

Query: 35  KVS---YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 84
           KV+   +    ++G G+FG V   + + TG   A+K + ++             E +++Q
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 85  MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 144
              HP + ALK+ F      + L        +          +    +       + Y  
Sbjct: 61  NTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGA 112

Query: 145 QICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYY 204
           +I  AL Y+H+   + +RDIK +NL+++   H +K+ DFG  K  +     +   C    
Sbjct: 113 EIVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 205 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 264
                +    +Y  A+D W  G VM E++ G+  F  +        I+            
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------- 219

Query: 265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVH 319
                  E +FP            + L PEA  L+    +  P  R       A E   H
Sbjct: 220 ------EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 320 PFFDELRDPNTRLPNGRPLPPLFNFKPP 347
            FF  +      +   + LPP   FKP 
Sbjct: 262 RFFLSIN--WQDVVQKKLLPP---FKPQ 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-46
 Identities = 52/294 (17%), Positives = 106/294 (36%), Gaps = 47/294 (15%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 90
                  +G+GSFG V++ K       VA+K +               E+ +++   H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           I+                L +V ++   +   +  +   I  +  +I +     Q  + +
Sbjct: 66  ILLFMGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY---ICSRYYRAP 207
            Y+H    I HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + AP
Sbjct: 118 DYLH-AKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 208 ELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           E+I       Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++             
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------- 224

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
               Y      +++ +          P     L+    +   + R    +    
Sbjct: 225 ---GYLSPDLSKVRSN---------CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (394), Expect = 2e-45
 Identities = 56/315 (17%), Positives = 103/315 (32%), Gaps = 54/315 (17%)

Query: 25  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 82
           +G R         Y     +G+GSFG ++       GE VAIK      ++     E +I
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 83  MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 142
            +M+     +       +  D    Y  +V+E +  ++  +   ++   ++  L  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLL 108

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNV---- 196
             Q+   + YIH+     HRD+KP N L+        +   DFG AK       +     
Sbjct: 109 ADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 197 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 252
               +   +  Y +     G  E +   D+ S G V+    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225

Query: 253 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 312
                                +  + K     +V  K  P E    +        + +  
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 313 A---LEACVHPFFDE 324
                +   + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (383), Expect = 5e-44
 Identities = 48/280 (17%), Positives = 96/280 (34%), Gaps = 33/280 (11%)

Query: 25  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 82
           +G           Y     +G GSFGV+F+       + VAIK   +         E + 
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 83  MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 142
            ++L     +   + F      E L+  LV++ +  ++  +     R   +  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106

Query: 143 TYQICRALAYIHNCIGICHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNV-- 196
             Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 197 ------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 250
                 +   +  Y +     G  E +   D+ + G V    L G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 251 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 290
             ++        ++ +   + E +F +   +  +  F   
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 9e-44
 Identities = 54/281 (19%), Positives = 99/281 (35%), Gaps = 43/281 (15%)

Query: 42  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 99
             +G G FG V        G  VA+K +  D   +    E  +M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
                    L +V EY+ +  + +    SR    +    +  ++  +C A+ Y+      
Sbjct: 71  EEKG----GLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTA 219
            HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++T 
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180

Query: 220 IDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 278
            D+WS G ++ E+   G+  +P     D +  + K                         
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------------- 215

Query: 279 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
               +        PP   +++   +     +R + L+    
Sbjct: 216 ---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (380), Expect = 6e-43
 Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 57/312 (18%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 95
            +GTGSFG V   K +E+G   A+K + + K  K         E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 96  HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 155
             F   ++   +   +    +   + R          R    + + Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 156 CIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATE 215
              + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I     
Sbjct: 160 L-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KG 214

Query: 216 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 275
           Y  A+D W+ G ++ E+  G P F  +  +    +I                        
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------------ 250

Query: 276 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPNT 330
                      F      +  DL+    Q        NL+    +   H +F      + 
Sbjct: 251 -----VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTDW 302

Query: 331 RLPNGRPLPPLF 342
                R +   F
Sbjct: 303 IAIYQRKVEAPF 314

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-41
 Identities = 58/299 (19%), Positives = 110/299 (36%), Gaps = 35/299 (11%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVA 93
           + + +  +G G FG V+  + +  GE VA+K     +    ++  E+    ML H NI+ 
Sbjct: 4   TIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
                 +  +     L LV +Y     +    +Y      + +  +          LA++
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHE---HGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116

Query: 154 HNCI-------GICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS-----YICS 201
           H  I        I HRD+K +N+LV        + D G A         +       + +
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 202 RYYRAPELIFGA-----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 256
           + Y APE++  +      E     DI++ G V  E+     +  G     QL     V  
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPS 234

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 315
            P+ EE++ +          +++P+  ++            ++   +  +   R TAL 
Sbjct: 235 DPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-41
 Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 61/337 (18%)

Query: 33  KQKVS---YIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKV--------LQDKRYKNR 78
            +KV    +    V+GTG++G VF  +     +TG++ A+K +         +   +   
Sbjct: 18  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 79  ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 138
           E Q+++ +     +   H  F    + +L+L L      E    +++      +R     
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQ-----RERFTEHE 130

Query: 139 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSY 198
           V++Y  +I  AL ++H   GI +RDIK +N+L++ + H + L DFG +K  V  E   +Y
Sbjct: 131 VQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAY 188

Query: 199 IC---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 255
                  Y     +  G + +  A+D WS G +M ELL G   F  +   +   EI +  
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-- 246

Query: 256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----- 310
                                  +       + + +   A DL+ R     P  R     
Sbjct: 247 -----------------------RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

Query: 311 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 347
             A E   H FF ++   +  L   +   P   FKP 
Sbjct: 284 RDADEIKEHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 8e-40
 Identities = 67/300 (22%), Positives = 110/300 (36%), Gaps = 47/300 (15%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVA 93
           S   E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L         +E +Y+  V EY+ +             + + L  +     QI   +AY+
Sbjct: 77  LYAVV----SEEPIYI--VTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNVSYICSRYYRAPELIF 211
                  HRD++  N+LV  +    K+ DFG A+++   E            + APE   
Sbjct: 130 ERM-NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 212 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 270
               +T   D+WS G ++ EL   G+  +PG    + L ++ +    P   E        
Sbjct: 188 Y-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------- 239

Query: 271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFFDELRDP 328
                                P    DL+C+ ++  P  R T   L+A +  +F      
Sbjct: 240 ---------------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 94
                 +G G FG V+          VA+K + Q     +    E  +M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
                    +E +Y+  + EY+    + +    +    ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFG 212
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 213 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
              +T   D+WS G ++ E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE--ACVHPFF 322
                      +  V     P E   L+   ++  P  R T     + +  FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 7e-39
 Identities = 53/293 (18%), Positives = 114/293 (38%), Gaps = 43/293 (14%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 94
              +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
                  T +   Y+    E++               Q +  + +     QI  A+ Y+ 
Sbjct: 79  LGVC---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 132

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR--YYRAPELIFG 212
                 HRD+  +N LV  + H +K+ DFG ++++                + APE +  
Sbjct: 133 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 213 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 272
             +++   D+W+ G ++ E+            + Q+ E+++                   
Sbjct: 191 -NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYR 234

Query: 273 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 325
            + P            +  P +  +L+   +Q++P+ R +  E  +H  F+ +
Sbjct: 235 MERP------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 8e-39
 Identities = 65/309 (21%), Positives = 117/309 (37%), Gaps = 54/309 (17%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVL-----QDKRYKNRELQIMQMLDH 88
               E V+G G FG V     +  G+    VAIK +      + +R    E  IM   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 89  PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 148
           PN++ L+      T    +   ++ E++      +     +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 149 ALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR------ 202
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 203 YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 261
            + APE I    ++T+A D+WS G VM E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 321
           +                             P     L+   +Q   N R    +  V+  
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQ-IVNTL 287

Query: 322 FDELRDPNT 330
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-38
 Identities = 57/298 (19%), Positives = 103/298 (34%), Gaps = 53/298 (17%)

Query: 43  VVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIV 92
            +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
            L              + +V E  P     +     +      L  +  Y  Q+   + Y
Sbjct: 75  RLYGVV------LTPPMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNV---SYICSRYYRAPEL 209
           + +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +      
Sbjct: 127 LESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 210 IFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 268
                 ++ A D W  G  + E+   GQ  + G +G   L +I K      R E      
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE------ 238

Query: 269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 326
                                  P +  +++ + + + P  R T +   +  F  E +
Sbjct: 239 ---------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-38
 Identities = 47/282 (16%), Positives = 96/282 (34%), Gaps = 43/282 (15%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 99
            +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L     
Sbjct: 12  EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69

Query: 100 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 159
              ++  +   LV E++      ++              +      +C  +AY+     +
Sbjct: 70  --LEQAPIC--LVFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CV 122

Query: 160 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAPELIFGATEYT 217
            HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y+
Sbjct: 123 IHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYS 180

Query: 218 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 277
           +  D+WS G +M E+     +        ++VE I                         
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------------------ 216

Query: 278 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                +     +        ++   ++  P  R         
Sbjct: 217 ---TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-37
 Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 56/301 (18%)

Query: 39  IAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 90
           + +  +G+G+FG V +   +  +  + VA+K +  +            E  +MQ LD+P 
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 91  IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 150
           IV +        + E   L  V+E            Y + ++ +    +    +Q+   +
Sbjct: 70  IVRMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 151 AYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NVSYICSRYYRA 206
            Y+       HRD+  +N+L+    H  K+ DFG +K L   E              + A
Sbjct: 121 KYLEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 207 PELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 265
           PE I    ++++  D+WS G +M E    GQ  + G  G +    + K            
Sbjct: 179 PECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-- 235

Query: 266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFF 322
                                     P E  DL+   + Y    R       +   + ++
Sbjct: 236 --------------------------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269

Query: 323 D 323
           D
Sbjct: 270 D 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-37
 Identities = 68/300 (22%), Positives = 111/300 (37%), Gaps = 54/300 (18%)

Query: 39  IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 91
           IA+  +G G+FG V Q   R   +   VAIK + Q     +     RE QIM  LD+P I
Sbjct: 12  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71

Query: 92  VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 151
           V L          +   L LV+E        + +      + +P+  V    +Q+   + 
Sbjct: 72  VRLIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 152 YIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR----YYRAP 207
           Y+       HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + AP
Sbjct: 124 YLE-EKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           E I    ++++  D+WS G  M E L  GQ  +    G + +  I +             
Sbjct: 182 ECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------ 228

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFFD 323
                  K  +  P           PPE   L+   + Y    R   L         ++ 
Sbjct: 229 -------KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-37
 Identities = 62/317 (19%), Positives = 107/317 (33%), Gaps = 70/317 (22%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDKRYKN-----RELQIMQML- 86
                V+G+G+FG V  A      +      VA+K + +            EL++M  L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 87  DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------------ETVNRIARN 126
            H NIV L       T    +Y  L+ EY                      E  N+    
Sbjct: 99  SHENIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 127 YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA 186
                  +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLA 211

Query: 187 KVLVKGEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGE 242
           + ++     V    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 243 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 302
                  ++I+               N  +   P                 E   ++   
Sbjct: 271 PVDANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSC 303

Query: 303 FQYSPNLRCTALEACVH 319
           + +    R +       
Sbjct: 304 WAFDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 3e-37
 Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 45/288 (15%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 94
                 +GTG FGVV   K R     VAIK + +    ++    E ++M  L H  +V L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 95  KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 154
                  T +  ++  ++ EY+      +      +  R     +      +C A+ Y+ 
Sbjct: 65  YGVC---TKQRPIF--IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 155 NCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVS--YICSRYYRAPELIFG 212
                 HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++  
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 213 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 271
            +++++  DIW+ G +M E+  LG+  +   +  +    I + L                
Sbjct: 176 -SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------------- 218

Query: 272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
               P +               +   ++   +    + R T      +
Sbjct: 219 RLYRPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 6e-37
 Identities = 64/329 (19%), Positives = 119/329 (36%), Gaps = 55/329 (16%)

Query: 43  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 93
           V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 94  LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 153
           L     ++T      + L+ + +P     +          +   Y+  +  QI + + Y+
Sbjct: 76  LLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 154 HNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSR---YYRAPELI 210
            +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E I
Sbjct: 128 EDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 211 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 269
                YT   D+WS G  + EL+  G   + G     ++  I++      +  I      
Sbjct: 186 LH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI------ 237

Query: 270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 329
                                   +   ++ + +    + R    E  +  F    RDP 
Sbjct: 238 ---------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQ 275

Query: 330 TRLPNGRPLPPLFNFKPPELSGIPPETIN 358
             L          +   P  S      ++
Sbjct: 276 RYLV--IQGDERMHLPSPTDSNFYRALMD 302

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-35
 Identities = 62/308 (20%), Positives = 106/308 (34%), Gaps = 65/308 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQML- 86
                 +G G+FG V +A        +    VA+K +              EL+++  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 87  DHPNIVALKHCFFSTTDKEELYLNLVLEYVP---------------ETVNRIARNYSRIH 131
           +H NIV L       T        ++ EY                               
Sbjct: 85  NHMNIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
             + L  +  ++YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197

Query: 192 GEPNVSYICSR---YYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
               V    +R    + APE IF    YT   D+WS G  + EL  LG   +PG     +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 307
             ++IK                             +  +  +  P E  D++   +   P
Sbjct: 257 FYKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 308 NLRCTALE 315
             R T  +
Sbjct: 290 LKRPTFKQ 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (316), Expect = 4e-34
 Identities = 61/318 (19%), Positives = 108/318 (33%), Gaps = 73/318 (22%)

Query: 43  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
            +G G+FG VFQA+       E   +VA+K + ++          RE  +M   D+PNIV
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP---------------------ETVNRIARNYSRIH 131
                       + + L  + EY+                        ++  AR  S   
Sbjct: 80  ---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134

Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
             +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ +  
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIYS 192

Query: 192 GEPNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
            +      +      +  PE IF    YTT  D+W+ G V+ E+   G   + G +  + 
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 307
           +  +                          I   P      +  P E  +L+   +   P
Sbjct: 252 IYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKLP 283

Query: 308 NLRCTALEACVHPFFDEL 325
             R +     +H     +
Sbjct: 284 ADRPSFCS--IHRILQRM 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 4e-34
 Identities = 66/293 (22%), Positives = 100/293 (34%), Gaps = 50/293 (17%)

Query: 38  YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHP 89
                 +G G FG V Q            VAIK               +E   M+  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 90  NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 149
           +IV L           E  + +++E        +          + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 150 LAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC--SRYYRAP 207
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           E I     +T+A D+W  G  M E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                                    PP    L+ + + Y P+ R    E    
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 5e-34
 Identities = 52/304 (17%), Positives = 106/304 (34%), Gaps = 57/304 (18%)

Query: 41  EHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 92
             V+G G FG V+     +        A+K + +            E  IM+   HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 152
           +L      +    E    +VL Y+     R             +  +  +  Q+ + + +
Sbjct: 92  SLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145

Query: 153 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRY-----YRAP 207
           +       HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 208 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 266
           E +    ++TT  D+WS G ++ EL+  G P +P  +  D  V +++       E     
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC--- 259

Query: 267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHP 320
                                    P    +++ + +     +R +       + A    
Sbjct: 260 -------------------------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 321 FFDE 324
           F  E
Sbjct: 295 FIGE 298

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 9e-34
 Identities = 55/292 (18%), Positives = 98/292 (33%), Gaps = 50/292 (17%)

Query: 37  SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLD 87
               + V+G G FG V++   + +       VAIK +      K       E  IM    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
           H NI+ L+         +   + ++ EY+        +          ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC----SRY 203
             + Y+ N     HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 204 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 263
           + APE I    ++T+A D+WS G VM E++        E    ++++ I           
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 264 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 315
                              +        P     L+ + +Q     R    +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 56/300 (18%)

Query: 41  EHVVGTGSFGVVFQAKCRETGEI--VAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 92
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 93  ALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQRMPLIYV 139
            L             YL L +EY P                +      +     +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 140 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYI 199
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 200 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 259
               + A E +   + YTT  D+WS G ++ E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 319
                         + P                 E  DL+ + ++  P  R +  +  V 
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 60/309 (19%), Positives = 113/309 (36%), Gaps = 66/309 (21%)

Query: 38  YIAEHVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDKRYKN-----RELQIMQM 85
            +    +G G+FG V  A+     +        VA+K +  D   K+      E+++M+M
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 86  L-DHPNIVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIH 131
           +  H NI+ L          ++  L +++EY              P  +           
Sbjct: 75  IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 132 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 191
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 192 GEPNVS---YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 247
            +             + APE +F    YT   D+WS G ++ E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 248 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 307
           L +++K                  E        +            E   ++   +   P
Sbjct: 246 LFKLLK------------------EGHRMDKPSN---------CTNELYMMMRDCWHAVP 278

Query: 308 NLRCTALEA 316
           + R T  + 
Sbjct: 279 SQRPTFKQL 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-32
 Identities = 58/310 (18%), Positives = 107/310 (34%), Gaps = 62/310 (20%)

Query: 38  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQML 86
                 +G G+FG V +A         T   VA+K + +       +   +    ++ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 87  DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQR 133
            H N+V L              L +++E+               E V             
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 134 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 193
           + L ++  Y++Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 194 PNV---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLV 249
             V          + APE IF    YT   D+WS G ++ E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 250 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 309
             +K                 T  + P                PE    +   +   P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 310 RCTALEACVH 319
           R T  E   H
Sbjct: 281 RPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 3e-30
 Identities = 56/315 (17%), Positives = 113/315 (35%), Gaps = 63/315 (20%)

Query: 38  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD 87
                 +G GSFG+V++   +     E    VAIK V     ++++     E  +M+  +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 88  HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVK 140
             ++V L                +++E +            R A   + +     L  + 
Sbjct: 82  CHHVVRLLGVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 141 LYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYIC 200
               +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +       
Sbjct: 137 QMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGK 194

Query: 201 ---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLG 256
                 + +PE +     +TT  D+WS G V+ E+  L +  + G S    L  +++   
Sbjct: 195 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--- 250

Query: 257 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--- 313
                                +   P         P    +L+   +QY+P +R +    
Sbjct: 251 -------------------GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 314 ---LEACVHPFFDEL 325
              ++  + P F E+
Sbjct: 286 ISSIKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.8 bits (209), Expect = 5e-20
 Identities = 31/204 (15%), Positives = 57/204 (27%), Gaps = 34/204 (16%)

Query: 43  VVGTGSFGVVFQAKCRETGEIVAIKKV--------------LQDKRYKNRELQIMQMLDH 88
           ++G G    VF     E      +K                     + +         + 
Sbjct: 7   LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 89  PNIVALKHCFFSTT-DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 147
             +  L+          E   +  ++E             ++   R+ +         I 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 148 RALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAP 207
             +A  ++   I H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 208 ELIFGATEYTTAIDIWSTGCVMAE 231
              F    Y T  DI S    + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	376
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.32
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.83
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.94
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.51

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-66  Score=474.13  Aligned_cols=331  Identities=71%  Similarity=1.207  Sum_probs=286.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHhCCCCCeeeccceeeecCC-CCceEEEE
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNL  111 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~l  111 (376)
                      .+..+|+.+++||+|+||+||+|++..+|+.||||++.++.....+|+.+|+.++||||++++++|..... ....++|+
T Consensus        17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            34458999999999999999999999999999999998887777899999999999999999999876543 45677899


Q ss_pred             EEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          112 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       112 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||||++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++....
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            99999998877777766667789999999999999999999998 99999999999999998876799999999988776


Q ss_pred             CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          192 GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       192 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                      .....+..||+.|+|||.+.+...|+.++||||+||++|||++|.+||.+.+..+++..+.+.+|.+..+.+....+.+.
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  255 (350)
T d1q5ka_         176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  255 (350)
T ss_dssp             TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred             CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence            66677788999999999997777799999999999999999999999999999999999999999999999999888888


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG  351 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (376)
                      ...++.....++.......+++++++||++||++||.+|||+.|+|+||||+++.++...+++.+..+...++...+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~  335 (350)
T d1q5ka_         256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS  335 (350)
T ss_dssp             CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred             hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccC
Confidence            88888888888888887889999999999999999999999999999999999998888877777666666655433332


Q ss_pred             CCHHHHhhhchHHH
Q 017131          352 IPPETINRLIPEHA  365 (376)
Q Consensus       352 ~~~~~~~~~~~~~~  365 (376)
                       ++.....++|+++
T Consensus       336 -~~~~~~~~~p~~~  348 (350)
T d1q5ka_         336 -NPPLATILIPPHA  348 (350)
T ss_dssp             -CGGGHHHHSCTTT
T ss_pred             -CccccccCCCccc
Confidence             3333334455443

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-61  Score=434.15  Aligned_cols=277  Identities=35%  Similarity=0.603  Sum_probs=228.0

Q ss_pred             EeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           40 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+|+.++||||+++++++.+..     ++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----cee
Confidence            4789999999999999999999999999985432         23458999999999999999999985433     378


Q ss_pred             EEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          111 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       111 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      +||||+.+++...+.   .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccC
Confidence            999999987644332   345679999999999999999999998 9999999999999999988 89999999997654


Q ss_pred             CCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      ... .....++|+.|+|||++.+...|+.++||||+||++|+|++|.+||.+.+..+++.++.+.++.|..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            432 3345678999999999977677899999999999999999999999999999999999999999887765443322


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      .....+...+..++...+ ..+++++++||++||+.||++|||+.|+|+||||++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            222233333333443333 468999999999999999999999999999999987543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-61  Score=424.67  Aligned_cols=247  Identities=30%  Similarity=0.494  Sum_probs=212.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++.+     ...
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence            5799999999999999999999999999999998542       1234579999999999999999999854     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+|||||++ +|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        81 ~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~  154 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWSV  154 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSCS
T ss_pred             EEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeecccceee
Confidence            8899999985 87776654    4679999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.             
T Consensus       155 ~~~~-~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------------  219 (263)
T d2j4za1         155 HAPS-SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------  219 (263)
T ss_dssp             CCCC-CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred             ecCC-CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence            6543 34456689999999999976 45899999999999999999999999988877666655431             


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                          .+.            ++..+|+++++||.+||+.||.+|||+.|+|+||||++
T Consensus       220 ----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         220 ----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                111            22458999999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-61  Score=427.98  Aligned_cols=252  Identities=27%  Similarity=0.340  Sum_probs=209.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++||||+++++++.+.     ..+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeE
Confidence            57999999999999999999999999999999985432     3456899999999999999999998553     3488


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +|||||++ +|.+++.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus        80 ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~  153 (271)
T d1nvra_          80 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF  153 (271)
T ss_dssp             EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhheee
Confidence            99999985 7655543    34679999999999999999999998 9999999999999999988 7999999999866


Q ss_pred             cCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          190 VKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       190 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ....   .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+...............        
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------  225 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------  225 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Confidence            4332   23456799999999999776656788999999999999999999998766554444333311000        


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                   ..     ....+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       226 -------------~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 -------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -------------CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                         00     01357999999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-61  Score=429.60  Aligned_cols=255  Identities=31%  Similarity=0.518  Sum_probs=213.8

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+++|+.++||||+++++++.+     .
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   80 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----D   80 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----S
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----C
Confidence            3457999999999999999999999999999999986421       235689999999999999999999843     3


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                      ..+|+|||||++ +|.+++..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~  154 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGT  154 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEeccccc
Confidence            348899999985 77666553    4679999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          186 AKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       186 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      |+......   .....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+..+.+.++.+.        
T Consensus       155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--------  225 (288)
T d1uu3a_         155 AKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------  225 (288)
T ss_dssp             CEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--------
T ss_pred             ceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--------
Confidence            98764322   23456799999999999664 5899999999999999999999999998877777666541        


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHH------HhcCCcccccCCCC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDPN  329 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~------ll~hp~f~~~~~~~  329 (376)
                               .+.            ++..+++++++||++||+.||++|||++|      +++||||+++++..
T Consensus       226 ---------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         226 ---------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             ---------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             ---------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence                     111            22468999999999999999999999987      57899999987543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-61  Score=428.30  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=213.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++|++.+.||+|+||+||+|++..+|+.||||++....    ....+|+.+|+.++||||+++++++.+..     ++|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence            47999999999999999999999999999999986432    33568999999999999999999986533     3889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |||||++ +|.+++.     .+.+++.+++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeec
Confidence            9999985 7765543     2579999999999999999999998 9999999999999999988 79999999998764


Q ss_pred             CC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          191 KG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+.... .+.          
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~----------  235 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE----------  235 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC----------
T ss_pred             cccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC----------
Confidence            43 33456679999999999965 458999999999999999999999999988877777766531 110          


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                           +          ..+..+|+++++||++||+.||.+|||+.|+|+||||+.
T Consensus       236 -----~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 -----L----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             -----C----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -----C----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                 0          012468999999999999999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=425.50  Aligned_cols=289  Identities=31%  Similarity=0.549  Sum_probs=236.1

Q ss_pred             CccccceEEeeeeeecCceEEEEEEECCC-CcEEEEEEeecc------cccHHHHHHHHHhC---CCCCeeeccceeeec
Q 017131           32 SKQKVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFST  101 (376)
Q Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~  101 (376)
                      .+..++|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+|+.+   +||||++++++|...
T Consensus         3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            34457899999999999999999999766 667999998542      22345788887766   799999999998766


Q ss_pred             CCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEE
Q 017131          102 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLC  181 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~  181 (376)
                      ......+++++|||+++++......  .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~  158 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLA  158 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeec
Confidence            5566777999999999876554433  234679999999999999999999998 9999999999999999988 79999


Q ss_pred             ecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          182 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       182 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      |||+++............||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+..+++..+.+..+.+...
T Consensus       159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             chhhhhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            9999987665555667789999999999965 459999999999999999999999999999999999999999988876


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      .+...... ....+......+.. .+...+++++++||++||++||++|||+.|+|+||||++++.
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         238 DWPRDVAL-PRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             GSCTTCSS-CGGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccc-hhhhhccccccchh-hccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            65432111 11111111122222 233578999999999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=421.92  Aligned_cols=254  Identities=25%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|++++.||+|+||+||+|+++.+|+.||||.+....      ....+|+++|+.++||||+++++++.+.   .+..
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence            467999999999999999999999999999999985432      2345799999999999999999988543   2334


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC-----ccccCCCCCcEEEcCCCCCeEEEe
Q 017131          109 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-----iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                      +|+|||||+ |+|.+++.......+.+++..++.++.||+.||+|||+ +|     |+||||||+|||++.++ .+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            789999998 49989888776667889999999999999999999998 66     99999999999999998 799999


Q ss_pred             cCCcccccCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          183 FGSAKVLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       183 fg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      ||+|+...... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+....      
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~------  230 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK------  230 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------
Confidence            99998765433 2345678999999999955 458999999999999999999999999888776666655410      


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  322 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f  322 (376)
                                   .+         .++..+|+++++||++||+.||.+|||+.|+++|||+
T Consensus       231 -------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                         00         1224689999999999999999999999999999995

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-60  Score=425.07  Aligned_cols=283  Identities=35%  Similarity=0.644  Sum_probs=231.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++..+      .....+|+++|++++||||+++++++.+..     .+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence            4799999999999999999999999999999998543      233458999999999999999999996543     38


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |+||||+++++...+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceec
Confidence            999999998876655432  34579999999999999999999998 9999999999999999988 8999999999766


Q ss_pred             cC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .. ........||+.|+|||++.....++.++|+||+||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            43 23445567899999999987777779999999999999999999999999999999999999888877654432211


Q ss_pred             Cc-ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          269 NY-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       269 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                      .. ....++......+.... ..+++++++||++||+.||++|||+.|+|+||||+++.+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            00 01112222222222222 4688999999999999999999999999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-60  Score=431.09  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=215.5

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+|+.++||||++++++|.+     ..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----ccc
Confidence            57999999999999999999999999999999986431       334579999999999999999999843     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+|||||+| +|..++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+| .+||+|||+|+
T Consensus        80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~  153 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence            8999999985 66665543    4679999999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccC-CCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          188 VLVK-GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       188 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      .... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....+...            
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------  220 (337)
T d1o6la_         154 EGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------  220 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             ccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------
Confidence            6543 3445567899999999999664 5899999999999999999999999998877766666541            


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                           ...            ++..+|+++++||++||++||.+|++     +.++++||||+++++
T Consensus       221 -----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         221 -----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -----CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                 112            22468999999999999999999994     899999999998753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-60  Score=422.80  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=217.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..          ....+|+.+|+.++||||+++++++.+.   
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK---   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---
Confidence            357999999999999999999999999999999986421          2356899999999999999999998443   


Q ss_pred             CceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC---CeEE
Q 017131          105 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH---QLKL  180 (376)
Q Consensus       105 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~vkl  180 (376)
                        ..+|+|||||++ +|.+++..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.   .+||
T Consensus        86 --~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          86 --TDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             --SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             --CEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEe
Confidence              348899999985 88777754    3579999999999999999999998 99999999999999987763   4999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +|||+|+....+.......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.+..+.+.......
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            99999987766666667788999999999965 45899999999999999999999999998887777776553211111


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                               .+..++|+++++||++||+.||.+|||++|+++||||+...
T Consensus       238 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         238 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             -------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                     12246899999999999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-60  Score=421.41  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=212.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      +.|++++.||+|+||+||+|+++.+|+.||||++....    ....+|+++|+.++||||+++++++.+..     .+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEE
Confidence            46999999999999999999999999999999986432    34568999999999999999999985533     3889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |||||++ +|.+++..   ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999985 77666543   24579999999999999999999998 9999999999999999998 79999999997543


Q ss_pred             CC-CCCceeeeeccccchhhhc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          191 KG-EPNVSYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       191 ~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      .. .......||+.|+|||++.    ....|+.++|||||||++|+|++|++||.+.+..+.+.++.+..  ++      
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~------  233 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP------  233 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC------
Confidence            22 1223567899999999984    23458999999999999999999999999998888887776521  00      


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                            ..            ..+..+|+++++||++||+.||.+|||+.|+|+||||+.
T Consensus       234 ------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ------TL------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ------CC------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ------CC------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                  00            012468999999999999999999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-59  Score=415.31  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=207.4

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  110 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  110 (376)
                      .|++.+.||+|+||+||+|.+..+++.||+|++....      ....+|+++|+.++||||+++++++.+.. .+...+|
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~   88 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV   88 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEE
Confidence            3588889999999999999999999999999986432      23458999999999999999999886543 3345688


Q ss_pred             EEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCcEEEcC-CCCCeEEEecCCc
Q 017131          111 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVNP-HTHQLKLCDFGSA  186 (376)
Q Consensus       111 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--iiH~Dlkp~Nill~~-~~~~vkl~Dfg~a  186 (376)
                      +|||||++ +|.+++..    ...+++..++.++.||+.||+|||+ +|  |+||||||+|||++. ++ .+||+|||+|
T Consensus        89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla  162 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLA  162 (270)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCC-CEEEeecCcc
Confidence            99999985 77776654    4679999999999999999999998 88  999999999999975 56 7999999999


Q ss_pred             ccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          187 KVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       187 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      +... .......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+.+.+... .++       
T Consensus       163 ~~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~-------  231 (270)
T d1t4ha_         163 TLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP-------  231 (270)
T ss_dssp             GGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC-------
T ss_pred             eecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC-------
Confidence            7543 334456789999999999854  48999999999999999999999998776655554433210 000       


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                                        ..++..+++++++||.+||+.||++|||++|+|+||||+
T Consensus       232 ------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 ------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                              012245789999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-60  Score=427.72  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=199.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..     ....+|+.+|+.++||||+++++++.+     ..++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            457999999999999999999999999999999986432     234579999999999999999999843     3348


Q ss_pred             EEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc---CCCCCeEEEecCC
Q 017131          110 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN---PHTHQLKLCDFGS  185 (376)
Q Consensus       110 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~---~~~~~vkl~Dfg~  185 (376)
                      |+|||||+ ++|.+++..    .+.+++.+++.++.||+.||+|||+ +||+||||||+|||+.   .++ .+||+|||+
T Consensus        83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~  156 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGL  156 (307)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC--
T ss_pred             EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEeccce
Confidence            89999998 588777753    4679999999999999999999998 9999999999999995   355 799999999


Q ss_pred             cccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          186 AKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       186 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      |+...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+.+...         
T Consensus       157 a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------  226 (307)
T d1a06a_         157 SKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY---------  226 (307)
T ss_dssp             ----------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC---------
T ss_pred             eEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---------
Confidence            987766665667789999999999965 4589999999999999999999999998887776666654211         


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                              .++        ......+|+++++||.+||+.||.+|||+.|+++||||++
T Consensus       227 --------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         227 --------EFD--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             --------CCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             --------CCC--------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                    110        0112468999999999999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.5e-60  Score=431.58  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=218.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|+.++||||+++++++.+.     ..+|+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence            57999999999999999999999999999999986533    3345899999999999999999998543     34889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcC--CCCCeEEEecCCccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNP--HTHQLKLCDFGSAKV  188 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~vkl~Dfg~a~~  188 (376)
                      |||||++ +|.+.+..   ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.  ++ .+||+|||+|+.
T Consensus       101 vmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~-~vkL~DFG~a~~  175 (350)
T d1koaa2         101 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAH  175 (350)
T ss_dssp             EECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSC-CEEECCCTTCEE
T ss_pred             EEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCC-eEEEeecchhee
Confidence            9999985 77666532   24579999999999999999999998 99999999999999964  44 799999999988


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+......++.        
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------  246 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------  246 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------
T ss_pred             cccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence            7666666678899999999999764 4899999999999999999999999998888888777653211110        


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  328 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~  328 (376)
                                       .....+|+++++||++||+.||++|||++|+|+||||+....+
T Consensus       247 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         247 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             -----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                             1114589999999999999999999999999999999987654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-59  Score=422.24  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      ..|++++.||+|+||+||+|++..+|+.||||++....       ....+|+.+|+.++||||+++++++.+..     .
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----E
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----E
Confidence            36999999999999999999999999999999986532       23457999999999999999999985533     3


Q ss_pred             EEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          109 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       109 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      +|+|||||.++......   ...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus        90 ~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeecccccc
Confidence            88999999976544332   234679999999999999999999998 9999999999999999988 899999999986


Q ss_pred             ccCCCCCceeeeeccccchhhhcC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  266 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  266 (376)
                      ...   .....||+.|+|||++.+  ...|+.++|||||||++|+|++|..||.+.+..+.+..+..... +        
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~-~--------  232 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--------  232 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--------
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-C--------
Confidence            533   345679999999999864  24589999999999999999999999999887777776655210 0        


Q ss_pred             CcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          267 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                .        ..+..+|+++++||.+||+.||.+|||++++|+||||+.
T Consensus       233 ----------~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         233 ----------A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ----------C--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ----------C--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                      0        011357999999999999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-59  Score=430.01  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=216.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++....    ....+|+.+|+.++||||++++++|.+     ...+|+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            46999999999999999999999999999999986543    334579999999999999999999843     334889


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEc--CCCCCeEEEecCCccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVN--PHTHQLKLCDFGSAKV  188 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~--~~~~~vkl~Dfg~a~~  188 (376)
                      |||||+| +|.+.+.   ....++++.+++.++.||+.||+|||+ +||+||||||+|||++  .++ .+||+|||+|+.
T Consensus       104 vmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~  178 (352)
T d1koba_         104 ILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKAS-SVKIIDFGLATK  178 (352)
T ss_dssp             EEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCC-CEEECCCTTCEE
T ss_pred             EEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCC-eEEEeeccccee
Confidence            9999985 6644332   234569999999999999999999998 9999999999999998  445 799999999988


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...........+|+.|+|||++.+ ..|+.++|||||||++|+|+||.+||.+.+..+.+..+.+....           
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----------  246 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----------  246 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             cCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            776666667789999999999965 45899999999999999999999999999888887777663111           


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                            ++.        .....+|+++++||++||++||.+|||+.|+|+||||++.
T Consensus       247 ------~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         247 ------FDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ------CCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ------CCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                  110        1114689999999999999999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=424.79  Aligned_cols=285  Identities=33%  Similarity=0.610  Sum_probs=231.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      ..+|++++.||+|+||+||+|.++.+|+.||||++.+..      ....+|+.+|+.++||||++++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            457999999999999999999999999999999986432      234579999999999999999999865432 1233


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+|+||||++.++..+...     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-cccccccccee
Confidence            4789999998887766543     679999999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...  .......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+....
T Consensus       170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         170 QAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             ECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            653  334567889999999999877778999999999999999999999999999999999999999999887765443


Q ss_pred             cCcc---cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          268 PNYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       268 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      ....   ....+......+...+ ..+++++++||++||++||.+|||+.|+|+||||+++.++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             chhhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence            2211   1123333334444333 57899999999999999999999999999999999987554

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-59  Score=427.64  Aligned_cols=280  Identities=25%  Similarity=0.429  Sum_probs=207.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      .++|++++.||+|+||+||+|++..+|+.||+|++..+.     ....+|+.+|+.++|||||+++++|.+..     .+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----EE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence            468999999999999999999999999999999986432     23458999999999999999999995433     48


Q ss_pred             EEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccc
Q 017131          110 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV  188 (376)
Q Consensus       110 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~  188 (376)
                      |+||||+++ +|.+++..    .+.+++..++.++.|++.||+|||+.+||+||||||+|||++.++ .+||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence            899999985 88777754    357999999999999999999999613899999999999999998 799999999986


Q ss_pred             ccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCCHHHHhhcC
Q 017131          189 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       189 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ... ....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ...+....+.+.........
T Consensus       155 ~~~-~~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         155 LID-SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHH-HTC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             cCC-CccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            543 234467899999999999764 599999999999999999999999988664432 22222222221111000000


Q ss_pred             cC--cccc---cCCCc---------cccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          268 PN--YTEF---KFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       268 ~~--~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                      ..  ....   ..+..         ............+|+++++||.+||++||.+|||++|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            00  0000   00000         000000111124688999999999999999999999999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.5e-59  Score=420.37  Aligned_cols=249  Identities=27%  Similarity=0.476  Sum_probs=213.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc-------cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||+++++++.+     ...
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence            4699999999999999999999999999999998642       1334589999999999999999999854     334


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +|+|||||.| ++..++.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccce
Confidence            8999999986 5544443    35678999999999999999999998 9999999999999999998 79999999998


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+...++.+.             
T Consensus       153 ~~~~--~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------  216 (316)
T d1fota_         153 YVPD--VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------  216 (316)
T ss_dssp             ECSS--CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred             Eecc--ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-------------
Confidence            7643  3456789999999999965 45899999999999999999999999998887777777652             


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                          ...            ++..+|++++++|.+||+.||.+|+     |++++++||||+++.+
T Consensus       217 ----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         217 ----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ----CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence                111            1246899999999999999999996     8999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-58  Score=422.86  Aligned_cols=252  Identities=26%  Similarity=0.409  Sum_probs=215.1

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+|+.++||||+++++++.+     
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----  112 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----
Confidence            34478999999999999999999999999999999986421       234589999999999999999999843     


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      ...+++||||+.+ ++...+..    .+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG  186 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFG  186 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             ccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeece
Confidence            3348899999985 66555543    4679999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +|+....  ......||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+....+.++....         
T Consensus       187 ~a~~~~~--~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------  254 (350)
T d1rdqe_         187 FAKRVKG--RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------  254 (350)
T ss_dssp             TCEECSS--CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             eeeeccc--ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC---------
Confidence            9987643  3456789999999999966 458999999999999999999999999988777777765521         


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                              ..            ++..+++++.+||++||+.||.+|+     |++++++||||++.++
T Consensus       255 --------~~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         255 --------VR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             --------CC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             --------CC------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                    11            1246899999999999999999995     8999999999998754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-58  Score=412.67  Aligned_cols=277  Identities=35%  Similarity=0.636  Sum_probs=224.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++++.||+|+||+||+|+++ +|+.||||++....      ....+|+.+|+.++||||+++++++.....     .
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-----~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-----L   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-----E
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-----e
Confidence            47999999999999999999985 78999999985432      235589999999999999999999865443     8


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++|+++.+++...+.   ...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||.|...
T Consensus        76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            8999999987755554   345779999999999999999999998 9999999999999999998 7999999999765


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .... ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+++.++....+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            4332 234456899999999998777789999999999999999999999999999999999999988887665443211


Q ss_pred             Cc-ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          269 NY-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       269 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      .. ...........++.. +...++++++|||++||++||++|||+.|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcchhh-hcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            10 011122222222322 33578999999999999999999999999999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-58  Score=409.84  Aligned_cols=254  Identities=28%  Similarity=0.411  Sum_probs=216.8

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------------ccHHHHHHHHHhCC-CCCeeeccceeeec
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFST  101 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  101 (376)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+..             ....+|+.+++.++ ||||+++++++.+ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-   81 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence            47999999999999999999999999999999986532             12457999999997 9999999999843 


Q ss_pred             CCCCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          102 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                          +..+|+|||||++ +|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||
T Consensus        82 ----~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          82 ----NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             ----SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred             ----CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEE
Confidence                3458999999975 88887764    4679999999999999999999998 9999999999999999988 7999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  255 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  255 (376)
                      +|||+++....+.......||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+.+.-
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999988766666667789999999999852     3447889999999999999999999999988877777766521


Q ss_pred             CCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          256 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                      .                 ..+.        ....++|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       232 ~-----------------~~~~--------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         232 Y-----------------QFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             C-----------------CCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             C-----------------CCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            1                 1100        0113689999999999999999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=418.45  Aligned_cols=317  Identities=32%  Similarity=0.605  Sum_probs=243.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ..+|++++.||+|+||+||+|+++.+|+.||||++.+..     ....+|+.+|+.++||||+++++++.........++
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357999999999999999999999999999999986432     234579999999999999999999866554445557


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      |+++++++++|.+++..     +++++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeec
Confidence            78888888899888754     579999999999999999999998 9999999999999999988 7999999999765


Q ss_pred             cCCC----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          190 VKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       190 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      ....    .....+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..++.......+..+.......
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            3322    234567899999999987666789999999999999999999999999999999988888888887664432


Q ss_pred             cCcC---cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCCCCCCCCCCCCCCC
Q 017131          266 MNPN---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLF  342 (376)
Q Consensus       266 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~  342 (376)
                      ....   ......+.....++...+ ..+++++++||.+||+.||.+|||+.|+|+||||+....+...    ...+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~----~~~~~~~  314 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE----PIAEAPF  314 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS----CCCSSCC
T ss_pred             hhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC----ccccCcc
Confidence            2100   001233334444444444 4789999999999999999999999999999999976554322    1112222


Q ss_pred             CCCCCCCCCCCHHHHhhhchHH
Q 017131          343 NFKPPELSGIPPETINRLIPEH  364 (376)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~  364 (376)
                      .+. .+...++.+.+++++.++
T Consensus       315 ~~~-~~~~~~~~~~l~~l~~~e  335 (345)
T d1pmea_         315 KFD-MELDDLPKEKLKELIFEE  335 (345)
T ss_dssp             ---------CCHHHHHHHHHHH
T ss_pred             CCC-hhhhhCCHHHHHHHHHHH
Confidence            332 344456677776665443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-58  Score=424.20  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=208.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHH---HHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+..       ....+   |+.+++.++||||+++++++.+.    
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~----   79 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP----   79 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS----
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC----
Confidence            47999999999999999999999999999999985422       11223   46677778899999999998543    


Q ss_pred             ceEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                       ..+|+|||||+ |+|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||
T Consensus        80 -~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DFG  152 (364)
T d1omwa3          80 -DKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLG  152 (364)
T ss_dssp             -SEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCCT
T ss_pred             -CEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeeec
Confidence             34889999998 588777754    4678999999999999999999998 9999999999999999998 79999999


Q ss_pred             CcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHh
Q 017131          185 SAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  264 (376)
Q Consensus       185 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  264 (376)
                      +|+..... ......||+.|+|||++.+...|+.++|||||||++|+|+||+.||.+.+..+...........+      
T Consensus       153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------  225 (364)
T d1omwa3         153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------  225 (364)
T ss_dssp             TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC------
T ss_pred             eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------
Confidence            99866443 34456899999999999766678999999999999999999999998766544332221110000      


Q ss_pred             hcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCC-----HHHHhcCCcccccCC
Q 017131          265 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  327 (376)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-----~~~ll~hp~f~~~~~  327 (376)
                                          ..++..+|+++++||.+||+.||.+|||     ++++++||||+++++
T Consensus       226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         226 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             --------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                                0122468999999999999999999999     799999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=417.28  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=216.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|++++.||+|+||+||+|.++.+|+.||||++....   ....+|+.+|+.++||||++++++|.+.     ..+|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-----EELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEE
Confidence            47999999999999999999999999999999986543   2355899999999999999999998543     348999


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC-CCeEEEecCCccccc
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT-HQLKLCDFGSAKVLV  190 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~-~~vkl~Dfg~a~~~~  190 (376)
                      ||||+| +|.+.+..   ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++...
T Consensus        80 mE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999985 77666643   23469999999999999999999998 9999999999999998543 279999999998776


Q ss_pred             CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCc
Q 017131          191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  270 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  270 (376)
                      .........+|+.|+|||.+.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+.+.....+...+       
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------  227 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------  227 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-------
T ss_pred             cCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc-------
Confidence            6555666788999999999865 45899999999999999999999999999888888887764322222211       


Q ss_pred             ccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          271 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                                        ..+|+++++||++||+.||.+|||++|+++||||++
T Consensus       228 ------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         228 ------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                              358999999999999999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-58  Score=413.94  Aligned_cols=251  Identities=27%  Similarity=0.487  Sum_probs=211.4

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHH-hCCCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.++.       ....+|..++. .++||||+++++++.+.     .
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence            46999999999999999999999999999999986432       12335666654 68999999999998543     3


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||+++ +|.+++..    ...+++.+++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchh
Confidence            48999999985 87777654    4679999999999999999999998 9999999999999999988 7999999999


Q ss_pred             ccccCC-CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhh
Q 017131          187 KVLVKG-EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  265 (376)
Q Consensus       187 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  265 (376)
                      +..... .......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+....+...           
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----------  218 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----------  218 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence            865433 334456789999999999654 5899999999999999999999999998877776666541           


Q ss_pred             cCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH-HHhcCCcccccCC
Q 017131          266 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  327 (376)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~-~ll~hp~f~~~~~  327 (376)
                            ...            ++..+|+++++||++||+.||.+|||+. ++++||||+++++
T Consensus       219 ------~~~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         219 ------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             ------CCC------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                  111            2246899999999999999999999995 8999999998753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-58  Score=409.09  Aligned_cols=246  Identities=25%  Similarity=0.392  Sum_probs=204.7

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------ccHHHHHHHHHhCC--CCCeeeccceeeecC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTT  102 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~  102 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+..          ....+|+.+|+.++  ||||+++++++.+. 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            357999999999999999999999999999999986432          22458999999986  89999999998543 


Q ss_pred             CCCceEEEEEEecccc--cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEE
Q 017131          103 DKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKL  180 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl  180 (376)
                          ..+|+||||+.+  ++..++..    ...+++.+++.++.||+.||+|||+ +||+||||||+|||++.+...+||
T Consensus        82 ----~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          82 ----DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             ----SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEE
T ss_pred             ----CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEE
Confidence                348899999974  55555543    4679999999999999999999998 999999999999999966448999


Q ss_pred             EecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          181 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       181 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      +|||+|+... ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+      .+.+.      
T Consensus       153 ~DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------  219 (273)
T d1xwsa_         153 IDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------  219 (273)
T ss_dssp             CCCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred             Cccccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence            9999997653 3344567899999999999776666788999999999999999999997532      12220      


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccC
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  326 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~  326 (376)
                                 ..            .++..+|+++++||++||+.||++|||++|+++||||+++.
T Consensus       220 -----------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 -----------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -----------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -----------cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                       11            12246899999999999999999999999999999998753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=413.67  Aligned_cols=299  Identities=29%  Similarity=0.498  Sum_probs=226.8

Q ss_pred             ceEEecccCCCCCCccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCee
Q 017131           19 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIV   92 (376)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv   92 (376)
                      +++...+++...  ...++|++++.||+|+||+||+|++..+|+.||||++.+..      ....+|+.+|+.++||||+
T Consensus         2 ~~~~~~~~~~~f--~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv   79 (355)
T d2b1pa1           2 QFYSVEVGDSTF--TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII   79 (355)
T ss_dssp             CEEEEEETTEEE--EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCEEEEeCCcce--eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCee
Confidence            345555555321  22346999999999999999999999999999999986532      2345899999999999999


Q ss_pred             eccceeeecCC-CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEE
Q 017131           93 ALKHCFFSTTD-KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  171 (376)
Q Consensus        93 ~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill  171 (376)
                      +++++|..... ....++|+|||||.+++.+.+      .+.+++..++.++.||+.||+|||+ +||+||||||+|||+
T Consensus        80 ~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~  152 (355)
T d2b1pa1          80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVV  152 (355)
T ss_dssp             CCSEEECSCCSTTTCCEEEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             EEEEEEecccccccCceeEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccc
Confidence            99999864432 244678999999999875544      3579999999999999999999998 999999999999999


Q ss_pred             cCCCCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017131          172 NPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI  251 (376)
Q Consensus       172 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i  251 (376)
                      +.++ .+|++|||+++...........++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+......++
T Consensus       153 ~~~~-~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i  230 (355)
T d2b1pa1         153 KSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  230 (355)
T ss_dssp             CTTC-CEEECCCCC---------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccc-ceeeechhhhhccccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence            9998 799999999987776666677789999999999976 45899999999999999999999999999999999999


Q ss_pred             HHHhCCCCHHHHhhcCcCcccc--cCCCccccccc-----------cccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          252 IKVLGTPTREEIKCMNPNYTEF--KFPQIKPHPWH-----------KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ....+.+..+.+.........+  ..+......+.           .......++++++||++||+.||++||||+|+|+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            9999998887776543322111  00000001111           1111234678999999999999999999999999


Q ss_pred             CCcccccCCC
Q 017131          319 HPFFDELRDP  328 (376)
Q Consensus       319 hp~f~~~~~~  328 (376)
                      ||||+...++
T Consensus       311 Hpw~~~~~~~  320 (355)
T d2b1pa1         311 HPYINVWYDP  320 (355)
T ss_dssp             STTTGGGCCH
T ss_pred             CcccCCCCCc
Confidence            9999986553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-56  Score=409.30  Aligned_cols=282  Identities=29%  Similarity=0.511  Sum_probs=223.7

Q ss_pred             cccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEE
Q 017131           34 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..++|+++++||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++ ||||++++++|...   ...++++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeE
Confidence            3468999999999999999999999999999999987543 44568999999995 99999999988543   2334789


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |||||++ +|..       ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+...
T Consensus       110 v~e~~~~~~L~~-------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         110 VFEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEECCCSCBGGG-------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEeecCCCcHHH-------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceecc
Confidence            9999996 4321       23579999999999999999999998 9999999999999999776579999999998776


Q ss_pred             CCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCCHHHHhhcC-c
Q 017131          191 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMN-P  268 (376)
Q Consensus       191 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~-~  268 (376)
                      ........++|+.|+|||.+.+...++.++|+||+||++|+|++|..||... +..++...+...++.+....+.... .
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            6666677788999999999987777899999999999999999999999765 4456667777777655443332211 1


Q ss_pred             ----CcccccCCCcccccccc----ccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          269 ----NYTEFKFPQIKPHPWHK----VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       269 ----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                          .+.. .........+..    .....++++++|||++||++||++|||++|+|+||||+.+.+
T Consensus       262 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         262 ELDPRFND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCCGGGGG-TCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccCcccch-hcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                0100 011111111111    112347899999999999999999999999999999998754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=400.87  Aligned_cols=282  Identities=34%  Similarity=0.551  Sum_probs=224.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  109 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  109 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++..+.      ....+|+.+|+.++||||+++++++.+..     ..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence            47999999999999999999999999999999986432      23458999999999999999999885433     37


Q ss_pred             EEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccc
Q 017131          110 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  189 (376)
Q Consensus       110 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  189 (376)
                      +++++++.+.....+.   ...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            8999999886543332   345789999999999999999999998 9999999999999999988 7999999999876


Q ss_pred             cCCC-CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          190 VKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       190 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      .... ......+++.|+|||++.+...++.++||||+||++|+|++|+.| |.+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            5433 233445688899999997777689999999999999999999877 55666677788888887777665443322


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  327 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~  327 (376)
                      ........+..............+++++++||++||+.||++|||++|+|+||||+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            111111111122222222333568999999999999999999999999999999998654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=411.53  Aligned_cols=285  Identities=35%  Similarity=0.593  Sum_probs=230.3

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC-CCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~  107 (376)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+..      ....+|+.+|+.++||||+++++++..... +...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            457999999999999999999999999999999986532      234589999999999999999998865433 2233


Q ss_pred             EEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          108 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       108 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .+++++++++++|.+++.     .+++++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhc
Confidence            355666666778877764     3579999999999999999999998 9999999999999999998 79999999986


Q ss_pred             cccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          188 VLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       188 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ..  ........||+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+......
T Consensus       170 ~~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CC--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             cc--CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            54  3334556789999999998777778999999999999999999999999999999999999999888877654332


Q ss_pred             cCccc---ccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccccCCCC
Q 017131          268 PNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  329 (376)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~~~~~  329 (376)
                      .....   ...+..+...+...+ ..+++++++||++||+.||.+|||+.|+|+||||+++.++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             chhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence            21110   122233333333333 46899999999999999999999999999999999887654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=405.83  Aligned_cols=287  Identities=29%  Similarity=0.472  Sum_probs=223.2

Q ss_pred             ccccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCC---
Q 017131           33 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---  103 (376)
Q Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---  103 (376)
                      ...++|++++.||+|+||+||+|++..+|+.||||++..+.      ....+|+.+|+.++||||+++++++.....   
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            44678999999999999999999999999999999985432      234589999999999999999998855322   


Q ss_pred             CCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEec
Q 017131          104 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDF  183 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Df  183 (376)
                      .....+|++|||+.+++....   ......+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~df  161 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADF  161 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCC
T ss_pred             ccCceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeec
Confidence            123458899999998775433   3345679999999999999999999998 9999999999999999998 8999999


Q ss_pred             CCcccccCC-----CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017131          184 GSAKVLVKG-----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       184 g~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      |+++.....     ......+||+.|+|||++.+...|+.++||||+||++|+|++|++||.+.+..+....+.+..+.+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999755322     223445789999999999877779999999999999999999999999999999999999988887


Q ss_pred             CHHHHhhcCcCcc--cccCCCcccccccccc-ccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          259 TREEIKCMNPNYT--EFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       259 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                      ..+.+......-.  .+.............+ ....+++++|||.+||++||++|||+.|+|+||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            7654433221100  0111111111111111 1124788999999999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-57  Score=412.22  Aligned_cols=263  Identities=26%  Similarity=0.355  Sum_probs=209.5

Q ss_pred             ccceEEee-eeeecCceEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHh-CCCCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .++|.+.+ .||+|+||+||+|++..+|+.||||++.+ .....+|+.++.+ .+||||++++++|.+.. ....++|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence            35798875 69999999999999999999999999864 4456689998654 58999999999885432 234568999


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC--CCeEEEecCCcccc
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  189 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~vkl~Dfg~a~~~  189 (376)
                      ||||+ |+|.+++...  ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.++  ..+||+|||+|+..
T Consensus        88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence            99997 4888877642  23569999999999999999999998 9999999999999998632  26999999999887


Q ss_pred             cCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcC
Q 017131          190 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  269 (376)
Q Consensus       190 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  269 (376)
                      .........+||+.|+|||++.+ ..|+.++|||||||++|+|+||++||.+.+.......+......            
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~------------  231 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------  231 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS------------
T ss_pred             cCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc------------
Confidence            76666677889999999999865 45899999999999999999999999887665554444331100            


Q ss_pred             cccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCcccc
Q 017131          270 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  324 (376)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~  324 (376)
                       ..+.++.        .....+|+++++||++||+.||++|||+.|+++||||++
T Consensus       232 -~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 -GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence             0111111        011357999999999999999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.3e-55  Score=387.20  Aligned_cols=256  Identities=26%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            357999999999999999999999999999999986432       23457999999999999999999886543 3345


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                      .+|+||||++| +|...+..    .+.+++.+++.++.||+.||+|||+ +||+||||||+|||++.++ .++|+|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhh
Confidence            57899999985 66554443    4679999999999999999999998 9999999999999999988 7999999988


Q ss_pred             ccccCCC----CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          187 KVLVKGE----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       187 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      .......    .....+||+.|+|||++.+ ..++.++|||||||++|+|+||++||.+.+..+.+.++......++   
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---  234 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---  234 (277)
T ss_dssp             EECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---
T ss_pred             hhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---
Confidence            6543322    2345678999999999965 4589999999999999999999999999888777776665211111   


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccc
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  323 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~  323 (376)
                                            ......+|+++.+||.+||+.||.+||+..+.+.|+|.+
T Consensus       235 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                  111246899999999999999999999544455567654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-54  Score=382.23  Aligned_cols=252  Identities=19%  Similarity=0.325  Sum_probs=203.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..+.   ....+|+.+|+.++||||+++++++.+..     .+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----eeEE
Confidence            357999999999999999999999999999999986543   33568999999999999999999985432     2789


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      |||||+ |++..++...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            999998 5777766542  23579999999999999999999998 9999999999999999988 89999999998664


Q ss_pred             CCCCC--ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          191 KGEPN--VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       191 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      .....  ....+|+.|+|||++.+. .|+.++|||||||++|||++|..||........+.+++...             
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-------------  232 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------------  232 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------------
T ss_pred             CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-------------
Confidence            43222  234578899999998654 58999999999999999999766655544444444444311             


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCCccccc
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  325 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp~f~~~  325 (376)
                          ..          ..++..+|+++++||.+||+.||.+|||+.++++  +|+.+
T Consensus       233 ----~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         233 ----YR----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             ----CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             ----CC----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                00          0122468999999999999999999999999965  55543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=379.00  Aligned_cols=248  Identities=21%  Similarity=0.272  Sum_probs=197.5

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .++|++.+.||+|+||+||+|+..   ..||||++....      ..+.+|+.+|++++||||++++++...    .  .
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--Q   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--E
Confidence            357999999999999999999864   359999985321      334579999999999999999987521    1  2


Q ss_pred             EEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      +++|||||+ |+|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            679999998 588777653   23569999999999999999999998 9999999999999999988 79999999997


Q ss_pred             cccCCC---CCceeeeeccccchhhhcCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          188 VLVKGE---PNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       188 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      ......   ......||+.|+|||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+.........++   
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p---  229 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP---  229 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            654322   22345789999999998542  3489999999999999999999999998887777666555321111   


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                          ....++..+|+++.+||.+||+.||.+|||+.++++|
T Consensus       230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                0011224689999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=374.35  Aligned_cols=245  Identities=19%  Similarity=0.316  Sum_probs=191.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..+|++.+.||+|+||+||+|++. +++.||||++..+.   ....+|+.+++.++||||+++++++.....     +++
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-----~~l   77 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-----ICL   77 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-----CEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCc-----eEE
Confidence            357999999999999999999986 56789999986543   345689999999999999999999854332     779


Q ss_pred             EEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||++ |+|.+++..   ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+...
T Consensus        78 v~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  152 (263)
T ss_dssp             EEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC------
T ss_pred             EEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheecc
Confidence            999997 477776654   23568999999999999999999998 9999999999999999988 89999999998664


Q ss_pred             CCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ....  .....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+..+.+..+.....           
T Consensus       153 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-----------  220 (263)
T d1sm2a_         153 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----------  220 (263)
T ss_dssp             ------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-----------
T ss_pred             CCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            4332  2335678999999999654 59999999999999999999 5777776665555555544210           


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                       ...+..+++++.+||.+||+.||.+|||++++++|
T Consensus       221 -----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         221 -----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             01124578999999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=387.21  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=203.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCc-----EEEEEEeecc-----cccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .++|++++.||+|+||+||+|++..+++     .||+|.+...     .....+|+.+|+.+ +|||||++++++.+.. 
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG-  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence            3689999999999999999999876554     6999987532     22345799999988 8999999999985433 


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh-------------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSR-------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  163 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~D  163 (376)
                          .+|+|||||+ |+|.+++.....                   ....+++..++.++.||+.||+|||+ +||+|||
T Consensus       115 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD  189 (325)
T d1rjba_         115 ----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  189 (325)
T ss_dssp             ----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             ----eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence                3789999998 488888865321                   12358999999999999999999998 9999999


Q ss_pred             CCCCcEEEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 017131          164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLF  239 (376)
Q Consensus       164 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf  239 (376)
                      |||+|||++.++ .+||+|||+|+........   ....+|+.|+|||++.+. .|+.++|||||||++|||+| |.+||
T Consensus       190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999998 8999999999876544432   245679999999999654 58999999999999999997 89999


Q ss_pred             CCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          240 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .+.+....+.+++.....                 .          ..+..+|+++++||.+||+.||++|||++||++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~-----------------~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFK-----------------M----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCC-----------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCC-----------------C----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            988777777766652111                 1          0124689999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-53  Score=380.15  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=189.9

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCc---EEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ...|++.+.||+|+||+||+|+++.+++   .||||.+....     +.+.+|+.+|+.++|||||++++++....    
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----  100 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST----  100 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence            4579999999999999999999987765   58899875432     23568999999999999999999984432    


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                       .+++|||||++ +|.+++..   ....+++.++..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus       101 -~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGl  174 (299)
T d1jpaa_         101 -PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGL  174 (299)
T ss_dssp             -SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             -EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCccc
Confidence             27899999985 67665543   23569999999999999999999998 9999999999999999998 799999999


Q ss_pred             cccccCCCCC------ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017131          186 AKVLVKGEPN------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  258 (376)
Q Consensus       186 a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  258 (376)
                      |+........      ....+|+.|+|||.+.+ ..++.++|||||||++|||+| |.+||.+.+..+....+.+..   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~---  250 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---  250 (299)
T ss_dssp             ---------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence            9866433221      12356889999999965 458999999999999999998 899999888766665554311   


Q ss_pred             CHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          259 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                     ..+          .+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       251 ---------------~~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         251 ---------------RLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ---------------CCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------CCC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                           010          124589999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=377.87  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=201.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      ..+|++.+.||+|+||+||+|.++ +++.||||++....   ....+|+.++++++|||||++++++..    +.  +++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~--~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----EP--IYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----CC--eEE
Confidence            358999999999999999999985 57889999986543   345689999999999999999997622    11  579


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+++ +|.+.+...  ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~  160 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIE  160 (272)
T ss_dssp             EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEcc
Confidence            9999985 776654432  23469999999999999999999998 9999999999999999988 79999999998764


Q ss_pred             CCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...  ......+|+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+.... .          
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-~----------  228 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-R----------  228 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C----------
T ss_pred             CCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-C----------
Confidence            432  22345678999999999654 589999999999999999995 56666665555544443210 0          


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc--CCcccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  324 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~--hp~f~~  324 (376)
                                       ...+..+++++.+||.+||+.||.+|||++++++  |+||++
T Consensus       229 -----------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 -----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                             0112468999999999999999999999999987  888864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=387.07  Aligned_cols=256  Identities=29%  Similarity=0.459  Sum_probs=208.2

Q ss_pred             cceEEeeeeeecCceEEEEEEE---CCCCcEEEEEEeecc--------cccHHHHHHHHHhCCC-CCeeeccceeeecCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD--------KRYKNRELQIMQMLDH-PNIVALKHCFFSTTD  103 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~  103 (376)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++.+.        .....+|++++++++| |||+++++++.+.. 
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~-  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET-  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence            6799999999999999999997   457899999988532        1234579999999977 79999999885433 


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEe
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCD  182 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~D  182 (376)
                          .++++|||+.+ +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|
T Consensus       103 ----~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~D  172 (322)
T d1vzoa_         103 ----KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTD  172 (322)
T ss_dssp             ----EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEESC
T ss_pred             ----ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEee
Confidence                48899999985 77666654    4678999999999999999999998 9999999999999999998 899999


Q ss_pred             cCCcccccCCC--CCceeeeeccccchhhhcCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          183 FGSAKVLVKGE--PNVSYICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       183 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      ||+|+......  ......|++.|+|||.+.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+..... 
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-  251 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-  251 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-
Confidence            99997653322  234567899999999996543 46889999999999999999999998877666655555431100 


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCC-----CHHHHhcCCcccccCC
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  327 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----s~~~ll~hp~f~~~~~  327 (376)
                                  .            ..++..+|+++++||++||++||.+||     |++|+++||||+++++
T Consensus       252 ------------~------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         252 ------------E------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             ------------C------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             ------------C------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence                        0            012246899999999999999999999     5899999999998763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=370.89  Aligned_cols=244  Identities=21%  Similarity=0.295  Sum_probs=202.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|+++++||+|+||+||+|+++ +++.||||++.+..   ....+|+.+++.++||||+++++++.+..     .+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEEE
Confidence            57999999999999999999984 67899999987543   34568999999999999999999885432     28899


Q ss_pred             Eeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccC
Q 017131          113 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  191 (376)
Q Consensus       113 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  191 (376)
                      |||++ |++..++..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99997 566655443   34568999999999999999999998 9999999999999999988 799999999976544


Q ss_pred             CCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCc
Q 017131          192 GEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  268 (376)
Q Consensus       192 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (376)
                      ...  .....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------  220 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----------  220 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            332  2345678999999999654 48999999999999999998 89999998877766655442100           


Q ss_pred             CcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          269 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                       ..+..+++++.+||++||+.||++|||+.++++|
T Consensus       221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             0124578999999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=376.22  Aligned_cols=250  Identities=26%  Similarity=0.330  Sum_probs=202.1

Q ss_pred             ccceEEeee-eeecCceEEEEEEECC--CCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHV-VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      .++|.+.+. ||+|+||+||+|.++.  ++..||||++....     ....+|+++|++++|||||++++++.+ .    
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~----   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S----
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C----
Confidence            457999985 9999999999998754  34579999986432     234579999999999999999998732 1    


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                       .+|+|||||++ +|.+++..   ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGl  155 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGL  155 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchh
Confidence             16899999985 77666532   34579999999999999999999998 9999999999999999988 899999999


Q ss_pred             cccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCH
Q 017131          186 AKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  260 (376)
Q Consensus       186 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  260 (376)
                      |+.......    .....+|+.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+.. .   
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~---  230 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-R---  230 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-C---
T ss_pred             hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C---
Confidence            987644322    2234578899999999654 58999999999999999998 999999887766655554310 0   


Q ss_pred             HHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHH---hcCCcccc
Q 017131          261 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE  324 (376)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~l---l~hp~f~~  324 (376)
                                  .            .++..+|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       231 ------------~------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         231 ------------M------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ------------C------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------------C------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                        0            1224689999999999999999999999877   67888854

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=372.90  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=195.9

Q ss_pred             ceEEe-eeeeecCceEEEEEEEC--CCCcEEEEEEeeccc------ccHHHHHHHHHhCCCCCeeeccceeeecCCCCce
Q 017131           37 SYIAE-HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        37 ~y~~~-~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      .+.+. ++||+|+||+||+|.+.  .+++.||||++....      ....+|+.+|++++||||+++++++.. .   . 
T Consensus         7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~---~-   81 (277)
T d1xbba_           7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E---S-   81 (277)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S---S-
T ss_pred             hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C---C-
Confidence            34444 47999999999999864  456789999985432      235589999999999999999998732 1   1 


Q ss_pred             EEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCc
Q 017131          108 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSA  186 (376)
Q Consensus       108 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a  186 (376)
                       .++|||||++ +|.+++..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus        82 -~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla  154 (277)
T d1xbba_          82 -WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLS  154 (277)
T ss_dssp             -EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             -EEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhh
Confidence             5799999985 77776653    4679999999999999999999998 9999999999999999988 8999999999


Q ss_pred             ccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          187 KVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       187 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      +........    ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+.. .    
T Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~----  228 (277)
T d1xbba_         155 KALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R----  228 (277)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C----
T ss_pred             hhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-C----
Confidence            866433222    234578999999999654 58999999999999999998 899999887665554443310 0    


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHH---hcCCcccc
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE  324 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~l---l~hp~f~~  324 (376)
                                 .            .++..+|+++.+||.+||+.||.+|||+.++   |+|+|++-
T Consensus       229 -----------~------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         229 -----------M------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             -----------C------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -----------C------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                       0            1124689999999999999999999999988   56777653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=370.14  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=197.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .++|++.+.||+|+||+||+|++..+ +.||||++....   ....+|+.++++++|||||++++++..    +.  +++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~--~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EP--IYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CC--eEE
Confidence            35899999999999999999998765 579999986543   345689999999999999999998732    11  579


Q ss_pred             EEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCccccc
Q 017131          112 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  190 (376)
Q Consensus       112 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  190 (376)
                      ||||+.+ ++..++...  ..+.+++.++..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus        89 v~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhhcc
Confidence            9999985 565555432  23569999999999999999999998 9999999999999999988 89999999998654


Q ss_pred             CCC--CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCCHHHHhhcC
Q 017131          191 KGE--PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  267 (376)
Q Consensus       191 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  267 (376)
                      ...  ......+|+.|+|||.+.+ ..++.++||||+||++|||++| .+||.+....+.+..+.+...           
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-----------  232 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  232 (285)
T ss_dssp             -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            332  2234567999999999965 4589999999999999999995 555555555555554433110           


Q ss_pred             cCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc--CCccccc
Q 017131          268 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDEL  325 (376)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~--hp~f~~~  325 (376)
                             .          .++..+++++++||.+||+.||++|||++++++  |+||+..
T Consensus       233 -------~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         233 -------M----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -------C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -------C----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                   0          112468999999999999999999999999987  8888764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=365.53  Aligned_cols=245  Identities=26%  Similarity=0.351  Sum_probs=190.4

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCC---cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      .++|++++.||+|+||+||+|.+..++   ..||||.+....     ....+|+.+++.++||||+++++++..    + 
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~-   80 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N-   80 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----S-
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----C-
Confidence            358999999999999999999986553   468899875322     234579999999999999999998731    1 


Q ss_pred             eEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                       .+|+||||+++ ++..++..   ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+
T Consensus        81 -~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          81 -PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             -SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             -eEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchh
Confidence             26799999985 66555443   34579999999999999999999998 9999999999999999988 899999999


Q ss_pred             cccccCCCC--CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHH
Q 017131          186 AKVLVKGEP--NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  262 (376)
Q Consensus       186 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  262 (376)
                      |+.......  .....+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+...      
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~------  227 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------  227 (273)
T ss_dssp             ----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred             heeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------
Confidence            986543322  234456899999999965 458999999999999999998 8999999888777766654210      


Q ss_pred             HhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          263 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                .            .+++.+|+++.+||.+||+.||.+|||+.++++|
T Consensus       228 ----------~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 ----------L------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ----------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------C------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                      0            1225689999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=363.56  Aligned_cols=245  Identities=22%  Similarity=0.289  Sum_probs=186.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCC----cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      ...|++.+.||+|+||+||+|.++.++    ..||||++....     ....+|+.+++.++|||||++++++....   
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~---   82 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---   82 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC---
Confidence            346999999999999999999987655    469999985432     23458999999999999999999885433   


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        .+++||||+.+ ++...+..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus        83 --~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG  155 (283)
T d1mqba_          83 --PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFG  155 (283)
T ss_dssp             --SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred             --ceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccc
Confidence              27899999986 45444432   34579999999999999999999998 9999999999999999998 89999999


Q ss_pred             CcccccCCCC----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKGEP----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      +|+.......    .....||+.|+|||++.+ ..++.++|||||||++|||++|. +||.+.+..+.+..+... ..+ 
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~-  232 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRL-  232 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC-
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCC-
Confidence            9986544322    223457889999999965 45999999999999999999955 555554444433333221 000 


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                                ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 --------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             --------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                      112457899999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-51  Score=371.12  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=194.1

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCc----EEEEEEeecc-----cccHHHHHHHHHhCCCCCeeeccceeeecCCCCc
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (376)
                      ..|++++.||+|+||+||+|.+..+|+    .||+|.+...     .+...+|+.+++.++||||+++++++.+.    .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----C
Confidence            469999999999999999999988876    5788877432     23456899999999999999999988532    1


Q ss_pred             eEEEEEEeccc-ccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCC
Q 017131          107 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGS  185 (376)
Q Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~  185 (376)
                        .+++++++. ++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus        85 --~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          85 --VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             --EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             --eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeecccc
Confidence              446666665 577665543   35679999999999999999999998 9999999999999999988 799999999


Q ss_pred             cccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHH
Q 017131          186 AKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  261 (376)
Q Consensus       186 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  261 (376)
                      |+........   ....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+..+....+.+.. .++  
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~--  233 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP--  233 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCC--
T ss_pred             ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC--
Confidence            9876443322   234578999999999664 58999999999999999998 899998877666554443311 110  


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcCC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  320 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~hp  320 (376)
                                               .+..+++++.+||.+||+.||.+|||+.+++.|.
T Consensus       234 -------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         234 -------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             -------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                                     1245789999999999999999999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=359.27  Aligned_cols=243  Identities=22%  Similarity=0.335  Sum_probs=194.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  113 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~  113 (376)
                      ++|++.+.||+|+||.||+|+++  |+.||||+++++.  +...+|++++++++||||+++++++....    ..+|+||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEEE
Confidence            47999999999999999999985  7899999996543  44568999999999999999999875422    2268999


Q ss_pred             ecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcccccCC
Q 017131          114 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  192 (376)
Q Consensus       114 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  192 (376)
                      ||+++ +|.+++....  ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.... 
T Consensus        81 ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          81 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS-  155 (262)
T ss_dssp             CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeecccccceecCC-
Confidence            99974 8888776532  2358999999999999999999998 9999999999999999998 799999999986532 


Q ss_pred             CCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 017131          193 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  271 (376)
Q Consensus       193 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  271 (376)
                       ......+|+.|+|||.+.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+..                
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~----------------  217 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  217 (262)
T ss_dssp             -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred             -CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             33445678899999999754 58999999999999999998 789998877666665553210                


Q ss_pred             cccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          272 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                  ...++..+++++.+||++||..||.+|||+.+++++
T Consensus       218 ------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 ------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                        011234688999999999999999999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-51  Score=366.21  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=192.1

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .++|++++.||+|+||+||+|.+..     +++.||||++....     ....+|..++.++ .|+||+.+++++.... 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-
Confidence            3579999999999999999999754     45789999986432     2233566777666 6889999888764322 


Q ss_pred             CCceEEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 017131          104 KEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  170 (376)
Q Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nil  170 (376)
                         ..+++|||||+ |+|.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+|||
T Consensus        91 ---~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL  166 (299)
T d1ywna1          91 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  166 (299)
T ss_dssp             ---SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred             ---CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence               23779999998 588888875432            13458999999999999999999998 99999999999999


Q ss_pred             EcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchH
Q 017131          171 VNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD  246 (376)
Q Consensus       171 l~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~  246 (376)
                      ++.++ .+||+|||+|+.......   .....||+.|+|||++.+ ..++.++||||+||++|||++| .+||.+.+..+
T Consensus       167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99988 799999999986543322   234578999999999976 4589999999999999999986 57898877666


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          247 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       247 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      .+..++.....+                           .++..+++++++||.+||+.||.+|||+.++++|
T Consensus       245 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            666655431111                           0124589999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=358.64  Aligned_cols=244  Identities=24%  Similarity=0.335  Sum_probs=189.9

Q ss_pred             cceEEeeeeeecCceEEEEEEECC-CC--cEEEEEEeeccc-------ccHHHHHHHHHhCCCCCeeeccceeeecCCCC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRE-TG--EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  105 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (376)
                      .+|++.+.||+|+||+||+|++.. ++  ..||||++.++.       ....+|+.+|+.++||||+++++++.+.    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~----   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence            469999999999999999998643 33  368999875421       2346899999999999999999988431    


Q ss_pred             ceEEEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          106 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       106 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                        .+++||||+++ ++.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus        84 --~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          84 --PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             --SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             --chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccch
Confidence              15799999984 66655543   23569999999999999999999998 9999999999999999988 89999999


Q ss_pred             CcccccCCCCC----ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017131          185 SAKVLVKGEPN----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  259 (376)
Q Consensus       185 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  259 (376)
                      +++........    ....++..|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+....+.+...   
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~---  232 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---  232 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC---
Confidence            99876443322    23346778999999965 458999999999999999998 8999999888777766654210   


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                                    ..          ..+..+|+++.+||.+||..||++|||+.++++
T Consensus       233 --------------~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         233 --------------RL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             --------------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                          11          112468999999999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-50  Score=360.38  Aligned_cols=257  Identities=21%  Similarity=0.236  Sum_probs=199.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc--cccHHHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      +++|++++.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+...    ....++|
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~iv   81 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV   81 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEE
Confidence            35799999999999999999999999999999987543  34567899999999988876665544332    2237799


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC--CCCeEEEecCCccccc
Q 017131          113 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH--THQLKLCDFGSAKVLV  190 (376)
Q Consensus       113 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~vkl~Dfg~a~~~~  190 (376)
                      |||+++++...+..   ..+.+++..+..++.|++.||+|||+ +||+||||||+|||++..  ...+||+|||+|+...
T Consensus        82 me~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          82 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99999988665543   35679999999999999999999998 999999999999998642  2269999999998764


Q ss_pred             CCCC--------CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC---CCC
Q 017131          191 KGEP--------NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG---TPT  259 (376)
Q Consensus       191 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---~~~  259 (376)
                      ....        .....||+.|+|||.+.+. .++.++|||||||++|||++|..||.+....+....+.+...   .++
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            4322        2345789999999999654 589999999999999999999999988665544443322110   011


Q ss_pred             HHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHH---HHhcCCcccc
Q 017131          260 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL---EACVHPFFDE  324 (376)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~---~ll~hp~f~~  324 (376)
                      .+                        .....+|+++.+||.+||+.||.+||++.   ++|+|+|.+.
T Consensus       237 ~~------------------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         237 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hh------------------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            10                        11246899999999999999999999986   5577887654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=364.53  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=200.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcE--EEEEEeec-----ccccHHHHHHHHHhC-CCCCeeeccceeeecCCCCce
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  107 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  107 (376)
                      ++|++.+.||+|+||+||+|+++.+|..  ||||.+..     ......+|+++|+++ +||||+++++++.+..     
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence            5799999999999999999999888875  67777643     223456899999998 7999999999986533     


Q ss_pred             EEEEEEeccc-ccHHHHHHHhh------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC
Q 017131          108 YLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH  174 (376)
Q Consensus       108 ~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~  174 (376)
                      .+++||||++ |+|.+++....            .....+++..+..++.||+.||.|||+ +||+||||||+|||++.+
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCC
Confidence            3889999998 58888876431            224579999999999999999999998 999999999999999998


Q ss_pred             CCCeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHH
Q 017131          175 THQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIK  253 (376)
Q Consensus       175 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~  253 (376)
                      + .+||+|||+|+............+|..|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+....+.+
T Consensus       164 ~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 Y-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             G-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             C-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            8 8999999999866555555556789999999999654 5899999999999999999965 67877776555544432


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                      ..                  .          ..++..+++++++||.+||+.||++|||+.++++|
T Consensus       242 ~~------------------~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 GY------------------R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TC------------------C----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cC------------------C----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            10                  0          01124689999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-50  Score=361.25  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=199.6

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .++|++.+.||+|+||+||+|+.+     .+++.||||++....     ..+.+|+.+|+.++||||+++++++..... 
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP-   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc-
Confidence            457999999999999999999975     356789999986432     335689999999999999999998854332 


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhh--------------------hhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYS--------------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  163 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~D  163 (376)
                          .+++|||+. |+|.+++....                    .....+++..+..++.|++.||+|||+ ++|+|||
T Consensus        91 ----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD  165 (301)
T d1lufa_          91 ----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  165 (301)
T ss_dssp             ----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             ----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence                779999997 58888775421                    112358999999999999999999998 9999999


Q ss_pred             CCCCcEEEcCCCCCeEEEecCCcccccCCC---CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 017131          164 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLF  239 (376)
Q Consensus       164 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf  239 (376)
                      |||+|||++.++ .+||+|||+|+......   ......+|+.|+|||.+.+ ..|+.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCC
Confidence            999999999988 79999999997653332   2234567899999999965 45999999999999999999985 789


Q ss_pred             CCCCchHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          240 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .+.+..+....+.+..                   .+         .++..+++++.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~e~~~~v~~~~-------------------~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCC-------------------CC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8887777666554310                   00         012468999999999999999999999999954

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-49  Score=367.22  Aligned_cols=285  Identities=29%  Similarity=0.452  Sum_probs=209.2

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHhCC-----------CCCeeeccceeeec
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFST  101 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~  101 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++.++.   ....+|+.+++.++           |+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            46999999999999999999999999999999997653   33457999888875           57889898877543


Q ss_pred             CCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCC-----
Q 017131          102 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTH-----  176 (376)
Q Consensus       102 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~-----  176 (376)
                      . ......++.++++.++......  ......+++..++.++.||+.||+|||+..||+||||||+|||++.++.     
T Consensus        93 ~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 G-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             E-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             c-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            2 2222233333444444433332  3345679999999999999999999996478999999999999987652     


Q ss_pred             CeEEEecCCcccccCCCCCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------chHHHHH
Q 017131          177 QLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVE  250 (376)
Q Consensus       177 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~  250 (376)
                      .++++|||.|....  .......+|+.|+|||++.+. .++.++|+||+||++++|++|+.||...+      ..+.+..
T Consensus       170 ~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         170 QIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeeEeecccccccc--cccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            39999999997553  334566789999999999764 48999999999999999999999997543      3456677


Q ss_pred             HHHHhCCCCHHHHhhcCcCc-------ccccCCCcccccccc------ccccCCChhHHHHHHHhhccCCCCCCCHHHHh
Q 017131          251 IIKVLGTPTREEIKCMNPNY-------TEFKFPQIKPHPWHK------VFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  317 (376)
Q Consensus       251 i~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll  317 (376)
                      ....+|.++.+.+.......       ...........++..      .+....+++++|||.+||++||.+|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            77888888776654321110       001111111111111      11123567899999999999999999999999


Q ss_pred             cCCcccccC
Q 017131          318 VHPFFDELR  326 (376)
Q Consensus       318 ~hp~f~~~~  326 (376)
                      +||||++..
T Consensus       327 ~Hp~f~~~~  335 (362)
T d1q8ya_         327 NHPWLKDTL  335 (362)
T ss_dssp             TCGGGTTCT
T ss_pred             cCcccCCCC
Confidence            999999653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=358.11  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=193.6

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCC-------cEEEEEEeecccc-----cHHHHHHHHHhC-CCCCeeeccceeeecC
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTT  102 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  102 (376)
                      ++|++++.||+|+||.||+|++..++       ..||||++.++..     ...+|...+.++ +||||+++++++.+. 
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-   91 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-   91 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-
Confidence            58999999999999999999987654       3799999865432     234588888777 899999999998542 


Q ss_pred             CCCceEEEEEEeccc-ccHHHHHHHhhh------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcE
Q 017131          103 DKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  169 (376)
Q Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Ni  169 (376)
                          ..+++||||++ |++.+++.....            ....+++.+++.++.||+.||+|||+ +||+||||||+||
T Consensus        92 ----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~Ni  166 (299)
T d1fgka_          92 ----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  166 (299)
T ss_dssp             ----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             ----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccce
Confidence                33789999998 488887764321            23468999999999999999999998 9999999999999


Q ss_pred             EEcCCCCCeEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCch
Q 017131          170 LVNPHTHQLKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  245 (376)
Q Consensus       170 ll~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  245 (376)
                      |++.++ .+||+|||+++.......   .....+|+.|+|||.+.+ ..|+.++|||||||++|||++ |.+||.+.+..
T Consensus       167 Ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         167 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            999998 799999999986644332   234567899999999965 459999999999999999998 78999877765


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          246 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       246 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      +....+.+. ..+                           .++..+++++.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 ELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            544333221 000                           112468999999999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=357.77  Aligned_cols=255  Identities=21%  Similarity=0.281  Sum_probs=206.0

Q ss_pred             ccceEEeeeeeecCceEEEEEEECC-----CCcEEEEEEeecccc-----cHHHHHHHHHhCCCCCeeeccceeeecCCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDK  104 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  104 (376)
                      .++|++++.||+|+||+||+|.+..     ++..||||++.....     ...+|+.++++++||||+++++++....  
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence            4689999999999999999999853     357899999865322     2458999999999999999999884332  


Q ss_pred             CceEEEEEEeccc-ccHHHHHHHhhhh------cCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCC
Q 017131          105 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQ  177 (376)
Q Consensus       105 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~  177 (376)
                         ..++||||+. |++.+++......      ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .
T Consensus        97 ---~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          97 ---PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC-C
T ss_pred             ---ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc-e
Confidence               2789999997 5787777654321      1346889999999999999999998 9999999999999999988 8


Q ss_pred             eEEEecCCcccccCCCC---CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHH
Q 017131          178 LKLCDFGSAKVLVKGEP---NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIK  253 (376)
Q Consensus       178 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~  253 (376)
                      +||+|||+|+.......   .....+|+.|+|||.+.+ ..++.++||||+||++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999986544322   234468999999999965 4589999999999999999998 588888777666665543


Q ss_pred             HhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc------CCccccc
Q 017131          254 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL  325 (376)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~------hp~f~~~  325 (376)
                      .. .                  +         ..+..+++.+.+||.+||+.||.+|||+.++++      +|+|+++
T Consensus       251 ~~-~------------------~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         251 GG-L------------------L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TC-C------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CC-C------------------C---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            11 0                  0         012468899999999999999999999999987      7777664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-49  Score=353.63  Aligned_cols=249  Identities=24%  Similarity=0.328  Sum_probs=202.8

Q ss_pred             ccceEEeeeeeecCceEEEEEEEC-----CCCcEEEEEEeeccc-----ccHHHHHHHHHhC-CCCCeeeccceeeecCC
Q 017131           35 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  103 (376)
Q Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  103 (376)
                      .++|++++.||+|+||.||+|++.     .+++.||||++....     ....+|+.+++.+ +||||+++++++.+.. 
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~-  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG-  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence            468999999999999999999863     467799999986533     2345799999998 6999999999984432 


Q ss_pred             CCceEEEEEEecccc-cHHHHHHHhhh--------------hcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 017131          104 KEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  168 (376)
Q Consensus       104 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~N  168 (376)
                          .+++|||||++ ++..++.....              ....+++..+..++.||+.||+|||+ +||+||||||+|
T Consensus       101 ----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N  175 (311)
T d1t46a_         101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (311)
T ss_dssp             ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence                27899999984 77777765321              22368999999999999999999998 999999999999


Q ss_pred             EEEcCCCCCeEEEecCCcccccCCCCC---ceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 017131          169 LLVNPHTHQLKLCDFGSAKVLVKGEPN---VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  244 (376)
Q Consensus       169 ill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  244 (376)
                      |+++.++ .+||+|||.++........   ....+|+.|+|||.+.+ ..++.++|||||||++|||+| |.+||.+.+.
T Consensus       176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999988 8999999999876543322   33577999999999965 458999999999999999998 7788888777


Q ss_pred             hHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          245 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       245 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      .+.+.++++....+                           ..+..+++++.+||.+||+.||.+|||++++++
T Consensus       254 ~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            77777766532111                           112457899999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.9e-48  Score=347.52  Aligned_cols=249  Identities=19%  Similarity=0.195  Sum_probs=198.7

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeec--ccccHHHHHHHHHhCCC-CCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      ++|++++.||+|+||+||+|++..+|+.||||++..  +.....+|++.++.++| +|++.+++++..     ....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccEEE
Confidence            469999999999999999999999999999998754  33456789999999976 889998887743     3347899


Q ss_pred             EecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCC----CCCeEEEecCCccc
Q 017131          113 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPH----THQLKLCDFGSAKV  188 (376)
Q Consensus       113 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~----~~~vkl~Dfg~a~~  188 (376)
                      |||++++|.+++..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++.+    .+.+||+|||+|+.
T Consensus        80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99999998877654   34579999999999999999999998 999999999999999742    22799999999986


Q ss_pred             ccCCC--------CCceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HHHHHhCC
Q 017131          189 LVKGE--------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV---EIIKVLGT  257 (376)
Q Consensus       189 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~i~~~~~~  257 (376)
                      .....        ......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+........   ++......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            54321        2234578999999999965 458999999999999999999999998765443332   22221111


Q ss_pred             CCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          258 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ++...                        +..++|+++.+++..|+..+|.+||+...+.+
T Consensus       235 ~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            11111                        11468999999999999999999999876643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=348.22  Aligned_cols=245  Identities=19%  Similarity=0.260  Sum_probs=189.1

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCC---cEEEEEEeeccc-----ccHHHHHHHHHhCCCCCeeeccceeeecCCCCceE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  108 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  108 (376)
                      .+...++||+|+||+||+|.+..++   ..||||++.+..     ..+.+|+++|++++||||+++++++....    ..
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~  103 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS  103 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cc
Confidence            3455789999999999999986643   368999885421     33568999999999999999999875432    24


Q ss_pred             EEEEEecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          109 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       109 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                      .++|||||++ ++.+++..   ....+++..+..++.|++.||.|||+ .+|+||||||+|||+++++ .+||+|||+++
T Consensus       104 ~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~  178 (311)
T d1r0pa_         104 PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLAR  178 (311)
T ss_dssp             EEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGC
T ss_pred             eEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchh
Confidence            7899999985 66555543   34467888899999999999999998 9999999999999999988 89999999998


Q ss_pred             cccCCCC-----CceeeeeccccchhhhcCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCCHH
Q 017131          188 VLVKGEP-----NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTRE  261 (376)
Q Consensus       188 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~  261 (376)
                      .......     .....||+.|+|||.+.+ ..++.++||||||+++|||+||..||...... +....+... ..    
T Consensus       179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~----  252 (311)
T d1r0pa_         179 DMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RR----  252 (311)
T ss_dssp             CTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CC----
T ss_pred             hccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CC----
Confidence            6543322     223567899999999865 45899999999999999999977776554322 222222211 00    


Q ss_pred             HHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhcC
Q 017131          262 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  319 (376)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~h  319 (376)
                                             ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       253 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         253 -----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   01124678999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=343.97  Aligned_cols=267  Identities=21%  Similarity=0.189  Sum_probs=188.0

Q ss_pred             cceEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccccc-H--HHHHHHHHhCCCCCeeeccceeeecCCCCceEEEEE
Q 017131           36 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-K--NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  112 (376)
Q Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv  112 (376)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++..+... .  ++|+..+..++||||+++++++.+.. .....+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            4699999999999999999986  5899999998654322 2  23455556789999999999987654 233457899


Q ss_pred             Eecccc-cHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHh-------cCCccccCCCCCcEEEcCCCCCeEEEecC
Q 017131          113 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-------CIGICHRDIKPQNLLVNPHTHQLKLCDFG  184 (376)
Q Consensus       113 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-------~~~iiH~Dlkp~Nill~~~~~~vkl~Dfg  184 (376)
                      |||+++ +|..++..     ..+++.....++.|++.||+|||+       .+||+||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecC
Confidence            999975 88888764     469999999999999999999995       15999999999999999998 89999999


Q ss_pred             CcccccCCCC-----CceeeeeccccchhhhcCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017131          185 SAKVLVKGEP-----NVSYICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  254 (376)
Q Consensus       185 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  254 (376)
                      +++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||.+||............ ..
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~  232 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LV  232 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TS
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cc
Confidence            9987644332     23457899999999985432     2567899999999999999999887542211100000 00


Q ss_pred             hCCCCHHHHhhcCcCcccccCCCccccccccccccCCChhHHHHHHHhhccCCCCCCCHHHHhc
Q 017131          255 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  318 (376)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ll~  318 (376)
                      ...+....+.....  ....-|..+    ........+..+.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         233 PSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            00011111100000  000000000    00001123456899999999999999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=2.7e-26  Score=191.24  Aligned_cols=159  Identities=17%  Similarity=0.108  Sum_probs=117.1

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeeccc----------------------ccHHHHHHHHHhCCCCCeeecc
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK   95 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~   95 (376)
                      |.++++||+|+||+||+|.+. +|+.||||++....                      ....+|...+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999984 68999999864210                      1123588889999999998876


Q ss_pred             ceeeecCCCCceEEEEEEecccccHHHHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEcCCC
Q 017131           96 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHT  175 (376)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iiH~Dlkp~Nill~~~~  175 (376)
                      ++.     .    .+++|||+++..          ...++...+..++.|++.||+|||+ +||+||||||+|||++.++
T Consensus        81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~~  140 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEEG  140 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETTE
T ss_pred             Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCCC
Confidence            542     1    258999998742          1235566678899999999999998 9999999999999999654


Q ss_pred             CCeEEEecCCcccccCCCCCceeeeeccccc------hhhhcCCCCCCCchhHHHHHHH
Q 017131          176 HQLKLCDFGSAKVLVKGEPNVSYICSRYYRA------PELIFGATEYTTAIDIWSTGCV  228 (376)
Q Consensus       176 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~~DiwslG~i  228 (376)
                        ++|+|||+|.........       .|..      .+.+ . ..|+..+|+||+.--
T Consensus       141 --~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~  188 (191)
T d1zara2         141 --IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-S-RTYRTEKDINSAIDR  188 (191)
T ss_dssp             --EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred             --EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence              999999999754322111       1111      1222 1 347889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.32  E-value=1.4e-06  Score=73.94  Aligned_cols=134  Identities=14%  Similarity=0.097  Sum_probs=82.5

Q ss_pred             ceEEeeeeeecCceEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHhCC-CCCeeeccceeeecCCCCceEEEE
Q 017131           37 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  111 (376)
Q Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l  111 (376)
                      .|++.+..+.++.+.||+..  ..++.+++|+....    .....+|...+..+. +-.+.+++.+..     .+...++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----cCCceEE
Confidence            57777776666678999986  34666788877543    234568999988774 322444444332     1234679


Q ss_pred             EEecccccHH-HHHHHhhhhcCCCcHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 017131          112 VLEYVPETVN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC----------------------------------  156 (376)
Q Consensus       112 v~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------------------------------  156 (376)
                      ||++++|... ...         .+......++.++...++.||+.                                  
T Consensus        88 v~~~l~G~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHT---------TTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEecccccccccc---------cccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            9999987321 111         01111222334444445555530                                  


Q ss_pred             ------------------------CCccccCCCCCcEEEcCCCCCeEEEecCCcc
Q 017131          157 ------------------------IGICHRDIKPQNLLVNPHTHQLKLCDFGSAK  187 (376)
Q Consensus       157 ------------------------~~iiH~Dlkp~Nill~~~~~~vkl~Dfg~a~  187 (376)
                                              ..++|+|+.|.||+++.++ .+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc-eEEEeechhcc
Confidence                                    0279999999999999654 45699999874

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.86  E-value=6e-05  Score=67.58  Aligned_cols=71  Identities=17%  Similarity=0.156  Sum_probs=43.0

Q ss_pred             eeeeeecCceEEEEEEECCCCcEEEEEEeec-----------ccccHHHHHHHHHhCC-C--CCeeeccceeeecCCCCc
Q 017131           41 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD-H--PNIVALKHCFFSTTDKEE  106 (376)
Q Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~~  106 (376)
                      .+.||.|....||++.+..+++.+++|.-..           ......+|.+.|+.+. +  ..+++++.+  +..   .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~---~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE---M  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT---T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC---C
Confidence            5568999999999999887788899996421           1122346888888763 2  234444322  222   1


Q ss_pred             eEEEEEEecccc
Q 017131          107 LYLNLVLEYVPE  118 (376)
Q Consensus       107 ~~~~lv~e~~~~  118 (376)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3479999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.83  E-value=5.2e-05  Score=63.47  Aligned_cols=68  Identities=18%  Similarity=0.125  Sum_probs=42.6

Q ss_pred             eecC-ceEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHhCCCCC--eeeccceeeecCCCCceEEEEEEecccc
Q 017131           45 GTGS-FGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPE  118 (376)
Q Consensus        45 g~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~~  118 (376)
                      ..|. .+.||+... ..+..+++|...... ....+|...++.+....  +.+++.+..+   .  ...++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~---~--~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE---A--GRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC---S--SCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc---c--cceEEEEEeeec
Confidence            3344 468999875 456678889765433 34678999998875433  3344443322   1  236789999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.94  E-value=0.0026  Score=56.51  Aligned_cols=70  Identities=17%  Similarity=0.237  Sum_probs=45.5

Q ss_pred             EeeeeeecCceEEEEEEECC-------CCcEEEEEEeecccc--cHHHHHHHHHhCCCCCe-eeccceeeecCCCCceEE
Q 017131           40 AEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDKR--YKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL  109 (376)
Q Consensus        40 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~  109 (376)
                      -++.|+.|-.-.+|++....       .++.|.+++.-....  ...+|..+++.+.-.++ ++++.++     .+    
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----
Confidence            34678889999999998753       345677887643222  23478999888853344 3555544     11    


Q ss_pred             EEEEecccc
Q 017131          110 NLVLEYVPE  118 (376)
Q Consensus       110 ~lv~e~~~~  118 (376)
                      .+|++|++|
T Consensus       117 g~I~efi~g  125 (395)
T d1nw1a_         117 GRLEEYIPS  125 (395)
T ss_dssp             EEEECCCCE
T ss_pred             ceEEEEecc
Confidence            368888874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.70  E-value=0.003  Score=54.48  Aligned_cols=38  Identities=18%  Similarity=0.009  Sum_probs=27.8

Q ss_pred             ceEEEEEEECCCCcEEEEEEeecc---cccHHHHHHHHHhCC
Q 017131           49 FGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLD   87 (376)
Q Consensus        49 ~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~   87 (376)
                      --.||++.. .+|+.|++|+....   ...+..|...+..|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence            358999986 56888999987543   244567888888774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.51  E-value=0.0043  Score=53.15  Aligned_cols=49  Identities=14%  Similarity=0.045  Sum_probs=31.0

Q ss_pred             eEEeeeeeecCceEEEEEEECCCCcEEEEEEeec--ccccHHHHHHHHHhCCC
Q 017131           38 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH   88 (376)
Q Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h   88 (376)
                      ..-.+.|..|.--+.|++... .| .|++|++..  +......|+.++..+..
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~   70 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAA   70 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHH
T ss_pred             ceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCCHHHHHHHHHHHHhhhh
Confidence            444556677877889999864 34 489998854  23445678888887743